SMILES	Structure: Image	Substance Identification: Reaxys Registry Number	Links to Reaxys	Data Count	CAS Registry Number	Chemical Name	Linear Structure Formula	Molecular Formula	Molecular Weight	Type of Substance	Type and Modification	InChI Key	Composition: Comp. Name	Composition: Comp. Conc.	Composition: Comp. Attrib.	Field Availability	Number of Reactions	Number of References	LogP	H Bond Donors	H Bond Acceptors	Rotatable Bonds	TPSA	Lipinski Number	Veber Number	Target Name	Target Synonyms	Reaxys Target ID	Target Uniprot ID	Target PDB ID	Target GO ID	Target InterPro ID	Target, Subunit, Species	Target Mutant/Chimera Details	Target Species (Bioactivity)	Target Transfection	Substance Action on Target	Substance Effect	Bioassay Category	Bioassay Name	Bioassay Details	Biological Species/NCBI ID	Bioassay Pathology	(Clinical) findings / disease	Organs/Tissues	Cells/Cell Lines	Cell Fraction	Substance RN	Links to Reaxys	Smiles	Substance Name	Substance Dose	Substance Route of Adm.	Substance Dosing Regimen	Measurement Object	Medchem: Measurement Parameter	Unit	Qualitative value	Quantitative value	Deviation	Statistical sgnificance (Qualitative)	Measured protein	Measured substance RN	Measured substance name	Statistical sgnificance (p-value)	Measurement pX	Metabolite RN	Metabolite name	Concomitants: Compound RN	Concomitants: Compound name	Concomitants: Compound role	References	Links to Reaxys	
NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		73010	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D73010&database=RX&origin=ReaxysOutput&ln=	(1 of 1381)	56-65-5	ATP; 5'-ATP; adenosine 5'-triphosphoric acid; adenosine triphosphate; adenosine 5'-triphosphate	(HO)2POOPO(OH)OPO(OH)OCH2C4H4O(OH)2(N4C5H4N)	C10H16N5O13P3	507.184	heterocyclic		ZKHQWZAMYRWXGA-KQYNXXCUSA-N				Identification(43880); Physical Data(431); Spectra(263); Bioactivity(4098)	863	42911	-5.533	7	18	8	308.56	1	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS1 in VAIKIIDKTQLDEENLKK) in HL-60 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				HL-60 cell line		73010	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D73010&database=RX&origin=ReaxysOutput&ln=	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O						IC50	µM	=	23.5							4.63				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O		73010	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D73010&database=RX&origin=ReaxysOutput&ln=	(1 of 1381)	56-65-5	ATP; 5'-ATP; adenosine 5'-triphosphoric acid; adenosine triphosphate; adenosine 5'-triphosphate	(HO)2POOPO(OH)OPO(OH)OCH2C4H4O(OH)2(N4C5H4N)	C10H16N5O13P3	507.184	heterocyclic		ZKHQWZAMYRWXGA-KQYNXXCUSA-N				Identification(43880); Physical Data(431); Spectra(263); Bioactivity(4098)	863	42911	-5.533	7	18	8	308.56	1	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS2 in DLKAENLLLDANLNIK) in PC-3 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				PC-3		73010	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D73010&database=RX&origin=ReaxysOutput&ln=	NC1=NC=NC2=C1N=CN2[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O						IC50	µM	=	16							4.8				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1		9666200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9666200&database=RX&origin=ReaxysOutput&ln=	(2 of 1381)	284461-73-0	sorafenib; bay 43-9006; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide; regorafenib; Nexavar; cm4306; 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide; 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-n2-methylpyridine-2-carboxamide; 4-(4-{[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino}phenoxy)-N-methyl-pyridine-2-carboxamide; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-(methyl)aminoformyl)-4-pyridyloxy)phenyl)urea; SRF; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpyridine-2-carboxamide; BAY 93-4006; SFN; SOR	C21H16ClF3N4O3	C21H16ClF3N4O3	464.831	heterocyclic		MLDQJTXFUGDVEO-UHFFFAOYSA-N				Identification(14811); Physical Data(98); Spectra(95); Bioactivity(2595)	103	16642	3.752	3	6	9	92.35	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS1 in VAIKIIDKTQLDEENLKK) in HL-60 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				HL-60 cell line		9666200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9666200&database=RX&origin=ReaxysOutput&ln=	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1						IC50	µM	>	10							1				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1		9666200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9666200&database=RX&origin=ReaxysOutput&ln=	(2 of 1381)	284461-73-0	sorafenib; bay 43-9006; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide; regorafenib; Nexavar; cm4306; 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide; 4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-n2-methylpyridine-2-carboxamide; 4-(4-{[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino}phenoxy)-N-methyl-pyridine-2-carboxamide; N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-(methyl)aminoformyl)-4-pyridyloxy)phenyl)urea; SRF; 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; 4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpyridine-2-carboxamide; BAY 93-4006; SFN; SOR	C21H16ClF3N4O3	C21H16ClF3N4O3	464.831	heterocyclic		MLDQJTXFUGDVEO-UHFFFAOYSA-N				Identification(14811); Physical Data(98); Spectra(95); Bioactivity(2595)	103	16642	3.752	3	6	9	92.35	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS2 in DLKAENLLLDANLNIK) in PC-3 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				PC-3		9666200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9666200&database=RX&origin=ReaxysOutput&ln=	CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(=C(Cl)C=C3)C(F)(F)F)C=C2)=C1						IC50	µM	>	10							1				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1		7671333	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D7671333&database=RX&origin=ReaxysOutput&ln=	(3 of 1381)	152459-95-5	imatinib; gleevec; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; STI-571; N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-(4-methyl-piperazin-1-ylmethyl)-benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide; [4-((4-methyl-1-piperazinyl)methyl)]-N-[4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]phenyl]benzamide; NSC 759854; Gleevac; IKT-001; glivec	C29H31N7O	C29H31N7O	493.611	heterocyclic		KTUFNOKKBVMGRW-UHFFFAOYSA-N				Identification(14290); Physical Data(124); Spectra(97); Bioactivity(2457)	184	15827	3.037	2	8	8	86.28	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS1 in VAIKIIDKTQLDEENLKK) in HL-60 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				HL-60 cell line		7671333	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D7671333&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1						IC50	µM	>	10							1				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1		7671333	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D7671333&database=RX&origin=ReaxysOutput&ln=	(3 of 1381)	152459-95-5	imatinib; gleevec; 4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide; STI-571; N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-(4-methyl-piperazin-1-ylmethyl)-benzamide; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide; [4-((4-methyl-1-piperazinyl)methyl)]-N-[4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]phenyl]benzamide; NSC 759854; Gleevac; IKT-001; glivec	C29H31N7O	C29H31N7O	493.611	heterocyclic		KTUFNOKKBVMGRW-UHFFFAOYSA-N				Identification(14290); Physical Data(124); Spectra(97); Bioactivity(2457)	184	15827	3.037	2	8	8	86.28	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS2 in DLKAENLLLDANLNIK) in PC-3 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				PC-3		7671333	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D7671333&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC=C(C)C(NC3=NC(=CC=N3)C3=CC=CN=C3)=C2)CC1						IC50	µM	>	10							1				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1		8798958	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D8798958&database=RX&origin=ReaxysOutput&ln=	(4 of 1381)	183321-74-6	erlotinib; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine; Tarceva; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; OSI-774; [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine; 4-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)quinazoline; CP-358774	C22H23N3O4	C22H23N3O4	393.442	heterocyclic		AAKJLRGGTJKAMG-UHFFFAOYSA-N				Identification(1169); Physical Data(74); Spectra(67); Bioactivity(2065)	205	2760	2.704	1	5	10	74.73	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS1 in VAIKIIDKTQLDEENLKK) in HL-60 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				HL-60 cell line		8798958	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D8798958&database=RX&origin=ReaxysOutput&ln=	COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1						IC50	µM	>	10							1				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1		8798958	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D8798958&database=RX&origin=ReaxysOutput&ln=	(4 of 1381)	183321-74-6	erlotinib; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine; Tarceva; N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine; OSI-774; [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine; 4-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)quinazoline; CP-358774	C22H23N3O4	C22H23N3O4	393.442	heterocyclic		AAKJLRGGTJKAMG-UHFFFAOYSA-N				Identification(1169); Physical Data(74); Spectra(67); Bioactivity(2065)	205	2760	2.704	1	5	10	74.73	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS2 in DLKAENLLLDANLNIK) in PC-3 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				PC-3		8798958	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D8798958&database=RX&origin=ReaxysOutput&ln=	COCCOC1=C(OCCOC)C=C2C(NC3=CC(=CC=C3)C#C)=NC=NC2=C1						IC50	µM	>	10							1				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS1 in VAIKIIDKTQLDEENLKK) in HL-60 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				HL-60 cell line		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O						IC50	µM	=	0.088							7.06				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS2 in DLKAENLLLDANLNIK) in PC-3 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				PC-3		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O						IC50	µM	=	0.15							6.82				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		20 - 200 μM				IC50	M		4.52E-10							9.34						Article; Beesu, Mallesh; Caruso, Giuseppe; Salyer, Alex C. D.; Shukla, Nijunj M.; Khetani, Karishma K.; Smith, Luke J.; Fox, Lauren M.; Tanji, Hiromi; Ohto, Umeharu; Shimizu, Toshiyuki; David, Sunil A.; Journal of Medicinal Chemistry; vol. 59; 7; (2016); p. 3311 - 3330;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68846612&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O						IC50	M		1.13E-09							8.95						Article; Jeffries, Daniel E.; Lindsley, Craig W.; Journal of Organic Chemistry; vol. 82; 1; (2017); p. 431 - 437;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D71061227&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	staurosporine	<= 100 μM				IC50	M		9.72E-10							9.01			73010	ATP	Substrate	Article; Hou, Weijie; Ren, Yan; Zhang, Zhenhua; Sun, Huan; Ma, Yongfen; Yan, Bo; Bioorganic and Medicinal Chemistry; vol. 26; 8; (2018); p. 1740 - 1750;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D73309700&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	staurosporine	<= 20 μM				IC50	M		1.74E-09							8.76			73010	ATP	Other compound	Article; Abbott, Jason R.; Patel, Pratiq A.; Howes, Jennifer E.; Akan, Denis T.; Kennedy, J. Phillip; Burns, Michael C.; Browning, Carrie F.; Sun, Qi; Rossanese, Olivia W.; Phan, Jason; Waterson, Alex G.; Fesik, Stephen W.; ACS Medicinal Chemistry Letters; vol. 9; 9; (2018); p. 941 - 946;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D74738457&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	staurosporine					IC50	M		5.7E-10							9.24						Article; Nguyen, William; Jacobson, Jonathan; Jarman, Kate E.; Jousset Sabroux, Helene; Harty, Leigh; McMahon, James; Lewin, Sharon R.; Purcell, Damian F.; Sleebs, Brad E.; Journal of Medicinal Chemistry; vol. 62; 10; (2019); p. 5148 - 5175;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76713084&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	staurosporine					IC50	M		5.21E-10							9.28						Article; Harris, Philip A.; Marinis, Jill M.; Lich, John D.; Berger, Scott B.; Chirala, Anirudh; Cox, Julie A.; Eidam, Patrick M.; Finger, Joshua N.; Gough, Peter J.; Jeong, Jae U.; Kang, James; Kasparcova, Viera; Leister, Lara K.; Mahajan, Mukesh K.; Miller, George; Nagilla, Rakesh; Ouellette, Michael T.; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Sun, Helen H.; Thorpe, James H.; Totoritis, Rachel D.; Wang, Wei; Wu, Dongling; Zhang, Daohua; Bertin, John; Marquis, Robert W.; ACS Medicinal Chemistry Letters; vol. 10; 6; (2019); p. 857 - 862;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D77039396&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	staurosporine					IC50	M		1.24E-09							8.91			73010	ATP	Other compound	Article; Amin, Shantu; Jaiswal, Aruna S.; Law, Brian K.; Narayan, Satya; Ramisetti, Srinivasa; Sharma, Arun K.; Singh, Parvesh; Singh-Pillay, Ashona; European Journal of Medicinal Chemistry; vol. 161; (2019); p. 456 - 467;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75265030&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	staurosporine					IC50	M		2.71E-09							8.57			73010	ATP	Substrate	Article; Blobaum, Anna L.; Borza, Corina M.; Jeffries, Daniel E.; Lindsley, Craig W.; Pozzi, Ambra; ACS Medicinal Chemistry Letters; (2019);	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78618745&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein kinase inhibitor	In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	staurosporine					IC50	M		5.7E-10							9.24						Article; Blackmore, Timothy R.; Jacobson, Jonathan; Jarman, Kate E.; Lewin, Sharon R.; Nguyen, William; Purcell, Damian F.; Sabroux, Helene Jousset; Sleebs, Brad E.; European Journal of Medicinal Chemistry; vol. 195; (2020);	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79450658&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor	antineoplastic agent	In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	staurosporine	20 - 100 μM				IC50	μM		1.16E-09													Article; Li, Bo; Li, Wei; Li, Xue; Quan, Xu; Tan, Bin; Zhang, Xiaomeng; Zhao, Liwen; Zheng, Guochuang; Bioorganic and medicinal chemistry letters; vol. 30; 16; (2020);	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D80038982&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O						IC50	M		6.67E-10							9.18						Article; Thakur, Ashish; Tawa, Gregory J.; Henderson, Mark J.; Danchik, Carina; Liu, Suiyang; Shah, Pranav; Wang, Amy Q.; Dunn, Garrett; Kabir, Md; Padilha, Elias C.; Xu, Xin; Simeonov, Anton; Kharbanda, Surender; Stone, Richard; Grewal, Gurmit; Journal of Medicinal Chemistry; vol. 63; 8; (2020); p. 4256 - 4292;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79839792&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	staurosporine	20 - 100 μM				IC50	M		6.44E-10							9.19						Article; Wang, Junwei;He, Guangchao;Li, Hui;Ge, Yiran;Wang, Shuping;Xu, Yungen;Zhu, Qihua; European Journal of Medicinal Chemistry; vol. 213; (2021);	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81811251&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	staurosporine					IC50	M		1.02E-09							8.99						Article; Yu, Mingfeng;Long, Yi;Yang, Yuchao;Li, Manjun;Teo, Theodosia;Noll, Benjamin;Philip, Stephen;Wang, Shudong; European Journal of Medicinal Chemistry; vol. 218; (2021);	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D83636309&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O		6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	(5 of 1381)	62996-74-1	staurosporine; staurosporin; Sts; stausporine; STSP; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3’,2’, 1’-lm]pyrrolo[3,4-j][1 ,7]benzodiazonin-1-one; [9S-(9α,10β,11β,13α)]-2,3,10,11,12,13-hexa-hydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-g,h:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one; straurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-FYTWVXJKSA-N				Identification(111); Physical Data(17); Spectra(30); Bioactivity(2995)	139	2289	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									6674025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D6674025&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)N1C3=C(C=CC=C3)C3=C1C1=C(C4=C(C=CC=C4)N21)C1=C3CNC1=O	staurosporine					IC50	M		1.74E-09							8.76						Article; Huang, Jianhang; Wang, Xinren; Dong, Ruinan; Liu, Xiaoyue; Li, Hongmei; Zhang, Tianyi; Xu, Junyu; Liu, Chenhe; Zhang, Yanmin; Hou, Shaohua; Tang, Weifang; Lu, Tao; Chen, Yadong; Journal of Medicinal Chemistry; vol. 64; 17; (2021); p. 12548 - 12571;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D99665570&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1		9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	(6 of 1381)	302962-49-8	dasatanib; dasatinib; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS 354825; Sprycel; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; DAS	C22H26ClN7O2S	C22H26ClN7O2S	488.013	heterocyclic		ZBNZXTGUTAYRHI-UHFFFAOYSA-N				Identification(1394); Physical Data(90); Spectra(63); Bioactivity(1163)	295	2243	1.991	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	<	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1		9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	(6 of 1381)	302962-49-8	dasatanib; dasatinib; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS 354825; Sprycel; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; DAS	C22H26ClN7O2S	C22H26ClN7O2S	488.013	heterocyclic		ZBNZXTGUTAYRHI-UHFFFAOYSA-N				Identification(1394); Physical Data(90); Spectra(63); Bioactivity(1163)	295	2243	1.991	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	~	5 - 7							8.3			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1		9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	(6 of 1381)	302962-49-8	dasatanib; dasatinib; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS 354825; Sprycel; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; DAS	C22H26ClN7O2S	C22H26ClN7O2S	488.013	heterocyclic		ZBNZXTGUTAYRHI-UHFFFAOYSA-N				Identification(1394); Physical Data(90); Spectra(63); Bioactivity(1163)	295	2243	1.991	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<=	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1		9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	(6 of 1381)	302962-49-8	dasatanib; dasatinib; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS 354825; Sprycel; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; DAS	C22H26ClN7O2S	C22H26ClN7O2S	488.013	heterocyclic		ZBNZXTGUTAYRHI-UHFFFAOYSA-N				Identification(1394); Physical Data(90); Spectra(63); Bioactivity(1163)	295	2243	1.991	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1		9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	(6 of 1381)	302962-49-8	dasatanib; dasatinib; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS 354825; Sprycel; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; DAS	C22H26ClN7O2S	C22H26ClN7O2S	488.013	heterocyclic		ZBNZXTGUTAYRHI-UHFFFAOYSA-N				Identification(1394); Physical Data(90); Spectra(63); Bioactivity(1163)	295	2243	1.991	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		20 - 50							7.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1		9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	(6 of 1381)	302962-49-8	dasatanib; dasatinib; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS 354825; Sprycel; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; DAS	C22H26ClN7O2S	C22H26ClN7O2S	488.013	heterocyclic		ZBNZXTGUTAYRHI-UHFFFAOYSA-N				Identification(1394); Physical Data(90); Spectra(63); Bioactivity(1163)	295	2243	1.991	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	~	5 - 7							8.3			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1		9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	(6 of 1381)	302962-49-8	dasatanib; dasatinib; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; BMS 354825; Sprycel; N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide; DAS	C22H26ClN7O2S	C22H26ClN7O2S	488.013	heterocyclic		ZBNZXTGUTAYRHI-UHFFFAOYSA-N				Identification(1394); Physical Data(90); Spectra(63); Bioactivity(1163)	295	2243	1.991	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									9966762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9966762&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=CC(=N1)N1CCN(CCO)CC1						IC50	nM	~	5 - 7							8.3			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C		9170597	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9170597&database=RX&origin=ReaxysOutput&ln=	(7 of 1381)	285983-48-4	BIRB-796; Doramapimod; 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea; 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea; 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea	C31H37N5O3	C31H37N5O3	527.666	heterocyclic		MVCOAUNKQVWQHZ-UHFFFAOYSA-N				Identification(312); Physical Data(14); Spectra(14); Bioactivity(434)	23	504	5.114	2	7	10	80.65	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS1 in VAIKIIDKTQLDEENLKK) in HL-60 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				HL-60 cell line		9170597	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9170597&database=RX&origin=ReaxysOutput&ln=	CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C						IC50	µM	>	10							1				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C		9170597	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9170597&database=RX&origin=ReaxysOutput&ln=	(7 of 1381)	285983-48-4	BIRB-796; Doramapimod; 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-[4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl]-urea; 1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea; 1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea	C31H37N5O3	C31H37N5O3	527.666	heterocyclic		MVCOAUNKQVWQHZ-UHFFFAOYSA-N				Identification(312); Physical Data(14); Spectra(14); Bioactivity(434)	23	504	5.114	2	7	10	80.65	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS2 in DLKAENLLLDANLNIK) in PC-3 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				PC-3		9170597	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9170597&database=RX&origin=ReaxysOutput&ln=	CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=CC=C(OCCN2CCOCC2)C2=CC=CC=C12)C(C)(C)C						IC50	µM	>	10							1				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
CNC1CC2OC(C)(C1OC)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13		4359731	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D4359731&database=RX&origin=ReaxysOutput&ln=	(8 of 1381)	62996-74-1	staurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-UHFFFAOYSA-N				Identification(15); Spectra(3); Bioactivity(13)	12	75	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									4359731	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D4359731&database=RX&origin=ReaxysOutput&ln=	CNC1CC2OC(C)(C1OC)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13						IC50	M		1.22E-09							8.91						Article; Wang, Junwei; Li, Hui; He, Guangchao; Chu, Zhaoxing; Peng, Kewen; Ge, Yiran; Zhu, Qihua; Xu, Yungen; Journal of Medicinal Chemistry; vol. 63; 1; (2020); p. 122 - 139;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78840178&database=RX&origin=ReaxysOutput&ln=	
CNC1CC2OC(C)(C1OC)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13		4359731	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D4359731&database=RX&origin=ReaxysOutput&ln=	(8 of 1381)	62996-74-1	staurosporine	C28H26N4O3	C28H26N4O3	466.539	heterocyclic		HKSZLNNOFSGOKW-UHFFFAOYSA-N				Identification(15); Spectra(3); Bioactivity(13)	12	75	6.052	2	7	2	69.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									4359731	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D4359731&database=RX&origin=ReaxysOutput&ln=	CNC1CC2OC(C)(C1OC)N1C3=CC=CC=C3C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C13	Staurosporine					IC50	M		6.44E-10							9.19			86196	L-Trp	Substrate	Article; He, Xin; He, Guangchao; Chu, Zhaoxing; Wu, Huanhuan; Wang, Junjie; Ge, Yiran; Shen, Hui; Zhang, Shan; Shan, Jinxi; Peng, Kewen; Wei, Zhifeng; Zou, Yi; Xu, Yungen; Zhu, Qihua; Journal of Medicinal Chemistry; vol. 64; 24; (2021); p. 17950 - 17968;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D108586424&database=RX&origin=ReaxysOutput&ln=	
CCCCNC1=NC=C2C(=CN([C@H]3CC[C@H](O)CC3)C2=N1)C1=CC=C(CN2CCN(C)CC2)C=C1		25200074	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D25200074&database=RX&origin=ReaxysOutput&ln=	(9 of 1381)		UNC2025	C28H40N6O	C28H40N6O	476.665			MJSHVHLADKXCML-RQNOJGIXSA-N				Identification(28); Physical Data(3); Spectra(6); Bioactivity(8)	10	29	4.477	2	7	8	69.45	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									25200074	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D25200074&database=RX&origin=ReaxysOutput&ln=	CCCCNC1=NC=C2C(=CN([C@H]3CC[C@H](O)CC3)C2=N1)C1=CC=C(CN2CCN(C)CC2)C=C1						IC50	nM		45							7.35			73010	ATP	Substrate	Patent; PFIZER INC; WO2019/6548; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75800680&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(OC)=C(C=C1)N(C(=O)NC1=C(C)C=CC=C1C)C1=NC=NC(NC2=CC=C(C=C2)N2CCN(C)CC2)=C1		24079892	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D24079892&database=RX&origin=ReaxysOutput&ln=	(10 of 1381)		hg-9-91-01; 1-(2,4-dimethoxyphenyl)-3-(2,6-dimethyl phenyl)-1-(6-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)urea	C32H37N7O3	C32H37N7O3	567.691			UYUHRKLITDJEHB-UHFFFAOYSA-N				Identification(20); Physical Data(5); Spectra(6); Bioactivity(11)	2	22	4.819	2	8	10	95.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									24079892	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D24079892&database=RX&origin=ReaxysOutput&ln=	COC1=CC(OC)=C(C=C1)N(C(=O)NC1=C(C)C=CC=C1C)C1=NC=NC(NC2=CC=C(C=C2)N2CCN(C)CC2)=C1						IC50	nM		8.37							8.08						Patent; MASS GENERAL BRIGHAM INC; DANA-FARBER CANCER INSTITUTE; WO2018/160774; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D74873358&database=RX&origin=ReaxysOutput&ln=	
O=C(NCCCNC1=NC(NC2=CC=CC(CN3CCOCC3)=C2)=NC=C1C1CC1)C1CCC1		19608535	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D19608535&database=RX&origin=ReaxysOutput&ln=	(11 of 1381)	1190378-57-4	MRT67307	C26H36N6O2	C26H36N6O2	464.611			UKBGBACORPRCGG-UHFFFAOYSA-N				Identification(16); Physical Data(3); Bioactivity(15)		21	2.881	3	8	12	91.41	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								19608535	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D19608535&database=RX&origin=ReaxysOutput&ln=	O=C(NCCCNC1=NC(NC2=CC=CC(CN3CCOCC3)=C2)=NC=C1C1CC1)C1CCC1	Figure 1.a; Figure 1.c; Figure 1.d ; Figure 3.a; Figure 3.b; Figure 4.d; Figure 4.e; Figure 6.a; Figure 6.b; Figure 6.a; Figure 9.E; Figure 11.A; ; Figure 14.B					IC50	µM		60							4.22						Patent; UNIVERSITY OF DUNDEE; DANA-FARBER CANCER INSTITUTE; WO2013/136070; (2013); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D60320431&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(OC)=C(C=C1)N(C(=O)OC1=C(C)C=CC=C1C)C1=NC(NC2=CC=C(C=C2)N2CCN(C)CC2)=NC=C1		10620352	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D10620352&database=RX&origin=ReaxysOutput&ln=	(12 of 1381)		WH-4-023	C32H36N6O4	C32H36N6O4	568.676	heterocyclic		NBTNHSGBRGTFJS-UHFFFAOYSA-N				Identification(18); Physical Data(1); Spectra(4); Bioactivity(10)	6	20	5.35	1	7	10	92.29	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								10620352	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D10620352&database=RX&origin=ReaxysOutput&ln=	COC1=CC(OC)=C(C=C1)N(C(=O)OC1=C(C)C=CC=C1C)C1=NC(NC2=CC=C(C=C2)N2CCN(C)CC2)=NC=C1	Figure 4.a; Figure 4.c; Figure 4.d ; Figure 3.a; Figure 3.b; Figure 7.c; Figure 8.a; Figure 11.C; Figure 14.A; Figure 14.B; Figure 14.C;; Figure 14.D					IC50	µM		430							3.37						Patent; UNIVERSITY OF DUNDEE; DANA-FARBER CANCER INSTITUTE; WO2013/136070; (2013); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D60320431&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(N=C1)N1C(=O)N(CC2=C1N=C(NC1=C(OC)C=C(C=C1)C1CCN(C)CC1)N=C2)C1=C(C)C=CC=C1Cl		30341907	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D30341907&database=RX&origin=ReaxysOutput&ln=	(13 of 1381)		YKL-05-099	C32H34ClN7O3	C32H34ClN7O3	600.12			VQINULODWGEVBB-UHFFFAOYSA-N				Identification(20); Physical Data(2); Spectra(4); Bioactivity(7)	10	14	4.834	1	8	7	95.95	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									30341907	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D30341907&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(N=C1)N1C(=O)N(CC2=C1N=C(NC1=C(OC)C=C(C=C1)C1CCN(C)CC1)N=C2)C1=C(C)C=CC=C1Cl	3-(2-chloro-6-methylphenyl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM		100 - 200							7			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(N=C1)N1C(=O)N(CC2=C1N=C(NC1=C(OC)C=C(C=C1)C1CCN(C)CC1)N=C2)C1=C(C)C=CC=C1Cl		30341907	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D30341907&database=RX&origin=ReaxysOutput&ln=	(13 of 1381)		YKL-05-099	C32H34ClN7O3	C32H34ClN7O3	600.12			VQINULODWGEVBB-UHFFFAOYSA-N				Identification(20); Physical Data(2); Spectra(4); Bioactivity(7)	10	14	4.834	1	8	7	95.95	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		30341907	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D30341907&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(N=C1)N1C(=O)N(CC2=C1N=C(NC1=C(OC)C=C(C=C1)C1CCN(C)CC1)N=C2)C1=C(C)C=CC=C1Cl	3-(2-chloro-6-methylphenyl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	500 - 1000							6.3						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(N=C1)N1C(=O)N(CC2=C1N=C(NC1=C(OC)C=C(C=C1)C1CCN(C)CC1)N=C2)C1=C(C)C=CC=C1Cl		30341907	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D30341907&database=RX&origin=ReaxysOutput&ln=	(13 of 1381)		YKL-05-099	C32H34ClN7O3	C32H34ClN7O3	600.12			VQINULODWGEVBB-UHFFFAOYSA-N				Identification(20); Physical Data(2); Spectra(4); Bioactivity(7)	10	14	4.834	1	8	7	95.95	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		30341907	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D30341907&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(N=C1)N1C(=O)N(CC2=C1N=C(NC1=C(OC)C=C(C=C1)C1CCN(C)CC1)N=C2)C1=C(C)C=CC=C1Cl	3-(2-chloro-6-methylphenyl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	500 - 1000							6.3						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(N=C1)N1C(=O)N(CC2=C1N=C(NC1=C(OC)C=C(C=C1)C1CCN(C)CC1)N=C2)C1=C(C)C=CC=C1Cl		30341907	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D30341907&database=RX&origin=ReaxysOutput&ln=	(13 of 1381)		YKL-05-099	C32H34ClN7O3	C32H34ClN7O3	600.12			VQINULODWGEVBB-UHFFFAOYSA-N				Identification(20); Physical Data(2); Spectra(4); Bioactivity(7)	10	14	4.834	1	8	7	95.95	3	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		30341907	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D30341907&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(N=C1)N1C(=O)N(CC2=C1N=C(NC1=C(OC)C=C(C=C1)C1CCN(C)CC1)N=C2)C1=C(C)C=CC=C1Cl	3-(2-chloro-6-methylphenyl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	500 - 1000							6.3						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1		33633200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633200&database=RX&origin=ReaxysOutput&ln=	(14 of 1381)		N-(4-chloro-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H25ClN8O2S	C21H25ClN8O2S	489.001			QAMUWRFOZKONDU-UHFFFAOYSA-N				Identification(22); Physical Data(2); Spectra(5); Bioactivity(5)	2	14	0.828	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633200&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(4-chloro-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	>	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1		33633200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633200&database=RX&origin=ReaxysOutput&ln=	(14 of 1381)		N-(4-chloro-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H25ClN8O2S	C21H25ClN8O2S	489.001			QAMUWRFOZKONDU-UHFFFAOYSA-N				Identification(22); Physical Data(2); Spectra(5); Bioactivity(5)	2	14	0.828	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633200&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(4-chloro-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	~	250							6.6			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1		33633200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633200&database=RX&origin=ReaxysOutput&ln=	(14 of 1381)		N-(4-chloro-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H25ClN8O2S	C21H25ClN8O2S	489.001			QAMUWRFOZKONDU-UHFFFAOYSA-N				Identification(22); Physical Data(2); Spectra(5); Bioactivity(5)	2	14	0.828	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									33633200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633200&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(4-chloro-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		200 - 500							6.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1		33633200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633200&database=RX&origin=ReaxysOutput&ln=	(14 of 1381)		N-(4-chloro-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H25ClN8O2S	C21H25ClN8O2S	489.001			QAMUWRFOZKONDU-UHFFFAOYSA-N				Identification(22); Physical Data(2); Spectra(5); Bioactivity(5)	2	14	0.828	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									33633200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633200&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(4-chloro-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	~	250							6.6			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1		33633200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633200&database=RX&origin=ReaxysOutput&ln=	(14 of 1381)		N-(4-chloro-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H25ClN8O2S	C21H25ClN8O2S	489.001			QAMUWRFOZKONDU-UHFFFAOYSA-N				Identification(22); Physical Data(2); Spectra(5); Bioactivity(5)	2	14	0.828	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									33633200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633200&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1						IC50	nM	~	250							6.6			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=CC=C(NC2=NC3=C(CN(C(=O)N3C3CCCCC3)C3=C(C)C=CC=C3C)C=N2)C=C1		32885107	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D32885107&database=RX&origin=ReaxysOutput&ln=	(15 of 1381)		1-cyclohexyl-3-(2,6-dimethylphenyl)-7-(4-(4-methylpiperazin-1-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C31H39N7O	C31H39N7O	525.697			GFXPGVPPWWPDPV-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(2)	6	12	5.081	1	8	5	67.84	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									32885107	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D32885107&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=CC=C(NC2=NC3=C(CN(C(=O)N3C3CCCCC3)C3=C(C)C=CC=C3C)C=N2)C=C1	1-cyclohexyl-3-(2,6-dimethylphenyl)-7-(4-(4-methylpiperazin-1-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM		2.86							8.54						Patent; MASS GENERAL BRIGHAM INC; DANA-FARBER CANCER INSTITUTE; WO2018/160774; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D74873358&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC=C1NC1=NC2=C(CN(C(=O)N2C2CCC2)C2=C(C)C=CC=C2C)C=N1)N1CCN(C)CC1		32885163	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D32885163&database=RX&origin=ReaxysOutput&ln=	(16 of 1381)		1-cyclobutyl-3-(2,6-dimethylphenyl)-7-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H37N7O2	C30H37N7O2	527.669			GVBAXIVNAHMIGH-UHFFFAOYSA-N				Identification(17); Physical Data(2); Spectra(4); Bioactivity(3)	5	12	4.069	1	8	6	77.07	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									32885163	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D32885163&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC=C1NC1=NC2=C(CN(C(=O)N2C2CCC2)C2=C(C)C=CC=C2C)C=N1)N1CCN(C)CC1	1-cyclobutyl-3-(2,6-dimethylphenyl)-7-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM		20.5							7.69						Patent; MASS GENERAL BRIGHAM INC; DANA-FARBER CANCER INSTITUTE; WO2018/160774; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D74873358&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=NC(C)=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=C1		33633203	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633203&database=RX&origin=ReaxysOutput&ln=	(17 of 1381)		N-(2-chloro-6-methylphenyl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H24ClN7OS	C21H24ClN7OS	457.987			IJEYJOYHXCYZGO-UHFFFAOYSA-N				Identification(18); Spectra(1); Bioactivity(2)	1	12	2.7	2	8	6	114.52	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633203	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633203&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=NC(C)=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=C1	N-(2-chloro-6-methylphenyl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	<	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
COC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C=CC=C1F		33633201	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633201&database=RX&origin=ReaxysOutput&ln=	(18 of 1381)		N-(3-fluoro-2-methoxyphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C22H26FN7O3S	C22H26FN7O3S	487.558			QMYROCUVFJMYGR-UHFFFAOYSA-N				Identification(18); Spectra(2); Bioactivity(4)	1	10	1.219	3	9	9	143.98	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633201	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633201&database=RX&origin=ReaxysOutput&ln=	COC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C=CC=C1F	N-(3-fluoro-2-methoxyphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	>	1							6						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(NCCO)=NC(C)=N2)S1		9957362	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9957362&database=RX&origin=ReaxysOutput&ln=	(19 of 1381)		N-(2-chloro-6-methylphenyl)-2-((6-((2-hydroxyethyl)amino)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; N-(2-chloro-6-methylphenyl)-2-[[6-[(2-hydroxyethyl)amino]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide	C18H19ClN6O2S	C18H19ClN6O2S	418.907	heterocyclic		UZKWSGJDJDMOGQ-UHFFFAOYSA-N				Identification(14); Spectra(4); Bioactivity(10)	4	9	1.665	4	8	8	140.3	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									9957362	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D9957362&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(NCCO)=NC(C)=N2)S1	N-(2-chloro-6-methylphenyl)-2-((6-((2-hydroxyethyl)amino)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	<	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1(C)C(=O)N([C@H]2CCC3=C(O)C=CC=C23)C2=C1C=NC(NC1=CC(CN3CCCC3)=CC=C1)=N2		24079895	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D24079895&database=RX&origin=ReaxysOutput&ln=	(20 of 1381)		MRT199665; 7-[(1S)-4-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethyl-2-{[3-(pyrrolidin-1-ylmethyl)phenyl]amino}-5,7-dihydro-6H-pyrrolo[2,3-d]pyrimidin-6-one	C28H31N5O2	C28H31N5O2	469.586			OFIFLUFVENTCNZ-QHCPKHFHSA-N				Identification(11); Physical Data(4); Spectra(6); Bioactivity(5)	1	9	4.092	2	6	5	81.59	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								24079895	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D24079895&database=RX&origin=ReaxysOutput&ln=	CC1(C)C(=O)N([C@H]2CCC3=C(O)C=CC=C23)C2=C1C=NC(NC1=CC(CN3CCCC3)=CC=C1)=N2	MRT199665-Figure 4.a; Figure 4.b; Figure 7.b; Figure 9.E; Figure 9.G; Figure 10.B; Figure 10.D; Figure 10.E; Figure 11.B; Figure 11.D					IC50	µM		43							4.37						Patent; UNIVERSITY OF DUNDEE; DANA-FARBER CANCER INSTITUTE; WO2013/136070; (2013); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D60320431&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC2=CC=C(C=C2)C2=CN([C@H]3CC[C@H](O)CC3)C3=NC(NCCC4CC4)=NC=C23)CC1		24251009	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D24251009&database=RX&origin=ReaxysOutput&ln=	(21 of 1381)		MRX-2843	C29H40N6O	C29H40N6O	488.676			LBEJYFVJIPQSNX-SOAUALDESA-N				Identification(11); Physical Data(1); Spectra(4); Bioactivity(5)	6	9	4.645	2	7	8	69.45	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									24251009	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D24251009&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC2=CC=C(C=C2)C2=CN([C@H]3CC[C@H](O)CC3)C3=NC(NCCC4CC4)=NC=C23)CC1						IC50	nM		27							7.57			73010	ATP	Substrate	Patent; PFIZER INC; WO2019/6548; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75800680&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1		33633198	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633198&database=RX&origin=ReaxysOutput&ln=	(22 of 1381)		N-(2-bromo-6-chlorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H23BrClN7O2S	C21H23BrClN7O2S	552.882			QPZOGIPJSSTCEG-UHFFFAOYSA-N				Identification(17); Spectra(2); Bioactivity(4)	1	9	2.563	3	9	8	134.75	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633198	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633198&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	N-(2-bromo-6-chlorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	<	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CCOC1=CC=CC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		33633205	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633205&database=RX&origin=ReaxysOutput&ln=	(23 of 1381)		N-(2-chloro-6-ethoxyphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C23H28ClN7O3S	C23H28ClN7O3S	518.039			NMYQURJFKQYEMO-UHFFFAOYSA-N				Identification(17); Spectra(2); Bioactivity(4)	1	9	2.103	3	9	10	143.98	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633205	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633205&database=RX&origin=ReaxysOutput&ln=	CCOC1=CC=CC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1	N-(2-chloro-6-ethoxyphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	>	5							5.3						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)COC1=CN2C(C=C1C1=CN(C)N=C1)=NC=C2C1=CC(OC)=C(C(=O)NC2CC2)C(OC(F)F)=C1		34626601	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626601&database=RX&origin=ReaxysOutput&ln=	(24 of 1381)		ethyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxyacetate	C27H27F2N5O6	C27H27F2N5O6	555.538			XZLJMKSIZKJLGH-UHFFFAOYSA-N				Identification(15); Spectra(1); Bioactivity(2)	8	9	4.604	1	8	13	118.21	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626601	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626601&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)COC1=CN2C(C=C1C1=CN(C)N=C1)=NC=C2C1=CC(OC)=C(C(=O)NC2CC2)C(OC(F)F)=C1	ethyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxyacetate					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)COC1=CN2C(C=C1C1=CN(C)N=C1)=NC=C2C1=CC(OC)=C(C(=O)NC2CC2)C(OC(F)F)=C1		34626601	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626601&database=RX&origin=ReaxysOutput&ln=	(24 of 1381)		ethyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxyacetate	C27H27F2N5O6	C27H27F2N5O6	555.538			XZLJMKSIZKJLGH-UHFFFAOYSA-N				Identification(15); Spectra(1); Bioactivity(2)	8	9	4.604	1	8	13	118.21	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626601	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626601&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)COC1=CN2C(C=C1C1=CN(C)N=C1)=NC=C2C1=CC(OC)=C(C(=O)NC2CC2)C(OC(F)F)=C1	ethyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxyacetate					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NC2CC2)C(OC(F)F)=CC(=C1)C1=CN=C2C=C(C3=CN(C)N=C3)C(OCC(O)=O)=CN12		34626602	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626602&database=RX&origin=ReaxysOutput&ln=	(25 of 1381)		2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxyacetic acid	C25H23F2N5O6	C25H23F2N5O6	527.484			ATQQHSUWGXEFBI-UHFFFAOYSA-N				Identification(15); Spectra(1); Bioactivity(2)	8	9	3.86	2	8	11	129.21	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626602	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626602&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NC2CC2)C(OC(F)F)=CC(=C1)C1=CN=C2C=C(C3=CN(C)N=C3)C(OCC(O)=O)=CN12	2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxyacetic acid					IC50	nM	>	10 - 100							8			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NC2CC2)C(OC(F)F)=CC(=C1)C1=CN=C2C=C(C3=CN(C)N=C3)C(OCC(O)=O)=CN12		34626602	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626602&database=RX&origin=ReaxysOutput&ln=	(25 of 1381)		2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxyacetic acid	C25H23F2N5O6	C25H23F2N5O6	527.484			ATQQHSUWGXEFBI-UHFFFAOYSA-N				Identification(15); Spectra(1); Bioactivity(2)	8	9	3.86	2	8	11	129.21	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626602	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626602&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NC2CC2)C(OC(F)F)=CC(=C1)C1=CN=C2C=C(C3=CN(C)N=C3)C(OCC(O)=O)=CN12	2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxyacetic acid					EC50	nM	>	5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3=CN(C)N=C3)C(OCC3=CC=CC=C3)=CN12		34626605	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626605&database=RX&origin=ReaxysOutput&ln=	(26 of 1381)		4-[6-benzyloxy-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C30H27F2N5O4	C30H27F2N5O4	559.572			HUWQTCMUPBRNQU-UHFFFAOYSA-N				Identification(15); Spectra(2); Bioactivity(2)	10	9	6.188	1	6	11	91.91	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626605	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626605&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3=CN(C)N=C3)C(OCC3=CC=CC=C3)=CN12	4-[6-benzyloxy-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	10 - 100							8			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3=CN(C)N=C3)C(OC(C)C#N)=CN12		34626610	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626610&database=RX&origin=ReaxysOutput&ln=	(27 of 1381)		4-[6-(1-cyanoethoxy)-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C26H24F2N6O4	C26H24F2N6O4	522.511			IHGOIAWRIHYBIV-UHFFFAOYSA-N				Identification(15); Spectra(1); Bioactivity(2)	13	9	4.497	1	7	10	115.7	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626610	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626610&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3=CN(C)N=C3)C(OC(C)C#N)=CN12	4-[6-(1-cyanoethoxy)-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(C)OC1=CN2C(C=C1C1=CN(C)N=C1)=NC=C2C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		34626611	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626611&database=RX&origin=ReaxysOutput&ln=	(28 of 1381)		ethyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxypropanoate	C28H29F2N5O6	C28H29F2N5O6	569.565			WRJVJVOHPAGOSI-UHFFFAOYSA-N				Identification(15); Spectra(1); Bioactivity(2)	14	9	5.13	1	8	13	118.21	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626611	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626611&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(C)OC1=CN2C(C=C1C1=CN(C)N=C1)=NC=C2C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	ethyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxypropanoate					IC50	nM	>	10 - 100							8			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3=CN(C)N=C3)C(OC(C)C(O)=O)=CN12		34626612	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626612&database=RX&origin=ReaxysOutput&ln=	(29 of 1381)		2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxypropanoic acid	C26H25F2N5O6	C26H25F2N5O6	541.511			UEHDUYYRCDXTMB-UHFFFAOYSA-N				Identification(15); Spectra(1); Bioactivity(2)	14	9	4.386	2	8	11	129.21	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626612	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626612&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3=CN(C)N=C3)C(OC(C)C(O)=O)=CN12	2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]-7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-6-yl]oxypropanoic acid					IC50	nM	>	10 - 100							8			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NC=C1		36081265	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081265&database=RX&origin=ReaxysOutput&ln=	(30 of 1381)		N-(2,4-dimethylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C22H28N8O2S	C22H28N8O2S	468.583			NEHHEDJQRHQOOW-UHFFFAOYSA-N				Identification(16); Spectra(4); Bioactivity(4)	1	9	0.432	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081265	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081265&database=RX&origin=ReaxysOutput&ln=	CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NC=C1	N-(2,4-dimethylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		867							6.06			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NC=C1		36081265	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081265&database=RX&origin=ReaxysOutput&ln=	(30 of 1381)		N-(2,4-dimethylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C22H28N8O2S	C22H28N8O2S	468.583			NEHHEDJQRHQOOW-UHFFFAOYSA-N				Identification(16); Spectra(4); Bioactivity(4)	1	9	0.432	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081265	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081265&database=RX&origin=ReaxysOutput&ln=	CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NC=C1	N-(2,4-dimethylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		867							6.06			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NC=C1		36081265	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081265&database=RX&origin=ReaxysOutput&ln=	(30 of 1381)		N-(2,4-dimethylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C22H28N8O2S	C22H28N8O2S	468.583			NEHHEDJQRHQOOW-UHFFFAOYSA-N				Identification(16); Spectra(4); Bioactivity(4)	1	9	0.432	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									36081265	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081265&database=RX&origin=ReaxysOutput&ln=	CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NC=C1						IC50	nM		867							6.06			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1		36081267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081267&database=RX&origin=ReaxysOutput&ln=	(31 of 1381)		N-(4-bromo-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H25BrN8O2S	C21H25BrN8O2S	533.452			KSCBSHLEWGZVON-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	1.004	3	10	8	147.64	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081267&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(4-bromo-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		2780							5.56			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1		36081267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081267&database=RX&origin=ReaxysOutput&ln=	(31 of 1381)		N-(4-bromo-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H25BrN8O2S	C21H25BrN8O2S	533.452			KSCBSHLEWGZVON-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	1.004	3	10	8	147.64	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081267&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(4-bromo-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		2780							5.56			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1		36081267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081267&database=RX&origin=ReaxysOutput&ln=	(31 of 1381)		N-(4-bromo-2-methylpyridin-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H25BrN8O2S	C21H25BrN8O2S	533.452			KSCBSHLEWGZVON-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	1.004	3	10	8	147.64	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									36081267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081267&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CN=C2C)=CC(=N1)N1CCN(CCO)CC1						IC50	nM		2780							5.56			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=NC=C2C)=CC(=N1)N1CCN(CCO)CC1		36081268	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081268&database=RX&origin=ReaxysOutput&ln=	(32 of 1381)		N-(3-chloro-5-methylpyridin-4-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H25ClN8O2S	C21H25ClN8O2S	489.001			TZEWBPGVTYPITP-UHFFFAOYSA-N				Identification(16); Physical Data(1); Spectra(4); Bioactivity(4)	1	9	0.739	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081268	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081268&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=NC=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(3-chloro-5-methylpyridin-4-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		677							6.17			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=NC=C2C)=CC(=N1)N1CCN(CCO)CC1		36081268	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081268&database=RX&origin=ReaxysOutput&ln=	(32 of 1381)		N-(3-chloro-5-methylpyridin-4-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H25ClN8O2S	C21H25ClN8O2S	489.001			TZEWBPGVTYPITP-UHFFFAOYSA-N				Identification(16); Physical Data(1); Spectra(4); Bioactivity(4)	1	9	0.739	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081268	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081268&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=NC=C2C)=CC(=N1)N1CCN(CCO)CC1	N-(3-chloro-5-methylpyridin-4-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		677							6.17			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=NC=C2C)=CC(=N1)N1CCN(CCO)CC1		36081268	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081268&database=RX&origin=ReaxysOutput&ln=	(32 of 1381)		N-(3-chloro-5-methylpyridin-4-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H25ClN8O2S	C21H25ClN8O2S	489.001			TZEWBPGVTYPITP-UHFFFAOYSA-N				Identification(16); Physical Data(1); Spectra(4); Bioactivity(4)	1	9	0.739	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									36081268	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081268&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=NC=C2C)=CC(=N1)N1CCN(CCO)CC1						IC50	nM		677							6.17			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=CN=CC(C)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081269	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081269&database=RX&origin=ReaxysOutput&ln=	(33 of 1381)		N-(3,5-dimethylpyridin-4-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C22H28N8O2S	C22H28N8O2S	468.583			RTRHXDLGBINMNM-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	0.343	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081269	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081269&database=RX&origin=ReaxysOutput&ln=	CC1=CN=CC(C)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1	N-(3,5-dimethylpyridin-4-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		340							6.47			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CC1=CN=CC(C)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081269	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081269&database=RX&origin=ReaxysOutput&ln=	(33 of 1381)		N-(3,5-dimethylpyridin-4-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C22H28N8O2S	C22H28N8O2S	468.583			RTRHXDLGBINMNM-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	0.343	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081269	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081269&database=RX&origin=ReaxysOutput&ln=	CC1=CN=CC(C)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1	N-(3,5-dimethylpyridin-4-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		340							6.47			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=CN=CC(C)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081269	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081269&database=RX&origin=ReaxysOutput&ln=	(33 of 1381)		N-(3,5-dimethylpyridin-4-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C22H28N8O2S	C22H28N8O2S	468.583			RTRHXDLGBINMNM-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	0.343	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									36081269	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081269&database=RX&origin=ReaxysOutput&ln=	CC1=CN=CC(C)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1						IC50	nM		340							6.47			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=CN=C2C)=CC(=N1)N1CCN(CCO)CC1		36081270	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081270&database=RX&origin=ReaxysOutput&ln=	(34 of 1381)		2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-methylpyridin-3-yl)thiazole-5-carboxamide	C21H26N8O2S	C21H26N8O2S	454.556			GMTZLHADUFDDDN-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	0.206	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081270	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081270&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=CN=C2C)=CC(=N1)N1CCN(CCO)CC1	2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-methylpyridin-3-yl)thiazole-5-carboxamide					IC50	nM		987							6.01			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=CN=C2C)=CC(=N1)N1CCN(CCO)CC1		36081270	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081270&database=RX&origin=ReaxysOutput&ln=	(34 of 1381)		2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-methylpyridin-3-yl)thiazole-5-carboxamide	C21H26N8O2S	C21H26N8O2S	454.556			GMTZLHADUFDDDN-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	0.206	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081270	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081270&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=CN=C2C)=CC(=N1)N1CCN(CCO)CC1	2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-methylpyridin-3-yl)thiazole-5-carboxamide					IC50	nM		987							6.01			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=CN=C2C)=CC(=N1)N1CCN(CCO)CC1		36081270	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081270&database=RX&origin=ReaxysOutput&ln=	(34 of 1381)		2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-methylpyridin-3-yl)thiazole-5-carboxamide	C21H26N8O2S	C21H26N8O2S	454.556			GMTZLHADUFDDDN-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	0.206	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									36081270	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081270&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=CN=C2C)=CC(=N1)N1CCN(CCO)CC1						IC50	nM		987							6.01			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	(35 of 1381)		N(2-chloro-4-methylthiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H24ClN7O2S2	C20H24ClN7O2S2	494.041			JKDJAOQUTMBBQB-UHFFFAOYSA-N				Identification(16); Physical Data(5); Spectra(4); Bioactivity(4)	8	9	1.333	3	9	8	162.99	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1	N(2-chloro-4-methylthiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		52.3							7.28			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	(35 of 1381)		N(2-chloro-4-methylthiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H24ClN7O2S2	C20H24ClN7O2S2	494.041			JKDJAOQUTMBBQB-UHFFFAOYSA-N				Identification(16); Physical Data(5); Spectra(4); Bioactivity(4)	8	9	1.333	3	9	8	162.99	4	1	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1	N-(2-chloro-4-methylthiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<=	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	(35 of 1381)		N(2-chloro-4-methylthiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H24ClN7O2S2	C20H24ClN7O2S2	494.041			JKDJAOQUTMBBQB-UHFFFAOYSA-N				Identification(16); Physical Data(5); Spectra(4); Bioactivity(4)	8	9	1.333	3	9	8	162.99	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1	N-(2-chloro-4-methylthiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	(35 of 1381)		N(2-chloro-4-methylthiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H24ClN7O2S2	C20H24ClN7O2S2	494.041			JKDJAOQUTMBBQB-UHFFFAOYSA-N				Identification(16); Physical Data(5); Spectra(4); Bioactivity(4)	8	9	1.333	3	9	8	162.99	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1	N-(2-chloro-4-methylthiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		20 - 50							7.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	(35 of 1381)		N(2-chloro-4-methylthiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H24ClN7O2S2	C20H24ClN7O2S2	494.041			JKDJAOQUTMBBQB-UHFFFAOYSA-N				Identification(16); Physical Data(5); Spectra(4); Bioactivity(4)	8	9	1.333	3	9	8	162.99	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1	N-(2-chloro-4-methylthiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		52.3							7.28			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	(35 of 1381)		N(2-chloro-4-methylthiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H24ClN7O2S2	C20H24ClN7O2S2	494.041			JKDJAOQUTMBBQB-UHFFFAOYSA-N				Identification(16); Physical Data(5); Spectra(4); Bioactivity(4)	8	9	1.333	3	9	8	162.99	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									36081271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081271&database=RX&origin=ReaxysOutput&ln=	CC1=CSC(Cl)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1						IC50	nM		52.3							7.28			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CN1N=C(C)C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)=C1C		36081272	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081272&database=RX&origin=ReaxysOutput&ln=	(36 of 1381)		2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(1,3,5-trimethyl-1H-pyrazol-4-yl)thiazole-5-carboxamide	C21H29N9O2S	C21H29N9O2S	471.586			DBHZLVWJMDYRBG-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	0.46	3	11	8	152.57	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081272	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081272&database=RX&origin=ReaxysOutput&ln=	CN1N=C(C)C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)=C1C	2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(1,3,5-trimethyl-1H-pyrazol-4-yl)thiazole-5-carboxamide					IC50	nM		9730							5.01			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CN1N=C(C)C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)=C1C		36081272	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081272&database=RX&origin=ReaxysOutput&ln=	(36 of 1381)		2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(1,3,5-trimethyl-1H-pyrazol-4-yl)thiazole-5-carboxamide	C21H29N9O2S	C21H29N9O2S	471.586			DBHZLVWJMDYRBG-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	0.46	3	11	8	152.57	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081272	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081272&database=RX&origin=ReaxysOutput&ln=	CN1N=C(C)C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)=C1C	2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(1,3,5-trimethyl-1H-pyrazol-4-yl)thiazole-5-carboxamide					IC50	nM		9730							5.01			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CN1N=C(C)C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)=C1C		36081272	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081272&database=RX&origin=ReaxysOutput&ln=	(36 of 1381)		2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(1,3,5-trimethyl-1H-pyrazol-4-yl)thiazole-5-carboxamide	C21H29N9O2S	C21H29N9O2S	471.586			DBHZLVWJMDYRBG-UHFFFAOYSA-N				Identification(16); Physical Data(2); Spectra(4); Bioactivity(4)	1	9	0.46	3	11	8	152.57	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									36081272	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081272&database=RX&origin=ReaxysOutput&ln=	CN1N=C(C)C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)=C1C						IC50	nM		9730							5.01			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(C)=C1NC(=O)N1C\C=C/COC2=CC=CC(NC3=NC=NC1=C3)=C2		29078793	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078793&database=RX&origin=ReaxysOutput&ln=	(37 of 1381)			C23H23N5O2	C23H23N5O2	401.468			LDQJHHHYXMPHSB-ARJAWSKDSA-N				Identification(14); Bioactivity(3)		8	4.135	2	6	3	79.38	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29078793	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078793&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(C)=C1NC(=O)N1C\C=C/COC2=CC=CC(NC3=NC=NC1=C3)=C2						IC50	μM		0.0891							7.05						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
CCN1CCN(CCOC2=C3COC\C=C\CN(C(=O)OC4=C(C)C=CC=C4C)C4=NC(NC(C=C2)=C3)=NC=C4)CC1		29078794	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078794&database=RX&origin=ReaxysOutput&ln=	(38 of 1381)			C32H40N6O4	C32H40N6O4	572.707			DGJKNVLUUBLSDY-AATRIKPKSA-N				Identification(14); Physical Data(2); Spectra(4); Bioactivity(2)	1	8	4.293	1	8	8	92.29	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29078794	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078794&database=RX&origin=ReaxysOutput&ln=	CCN1CCN(CCOC2=C3COC\C=C\CN(C(=O)OC4=C(C)C=CC=C4C)C4=NC(NC(C=C2)=C3)=NC=C4)CC1						IC50	μM		0.4453							6.35						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
CCN1CCN(CCOC2=C3COC\C=C/CN(C(=O)OC4=C(C)C=CC=C4C)C4=NC(NC(C=C2)=C3)=NC=C4)CC1		29078795	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078795&database=RX&origin=ReaxysOutput&ln=	(39 of 1381)			C32H40N6O4	C32H40N6O4	572.707			DGJKNVLUUBLSDY-WAYWQWQTSA-N				Identification(14); Physical Data(2); Spectra(4); Bioactivity(2)	1	8	4.293	1	8	8	92.29	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29078795	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078795&database=RX&origin=ReaxysOutput&ln=	CCN1CCN(CCOC2=C3COC\C=C/CN(C(=O)OC4=C(C)C=CC=C4C)C4=NC(NC(C=C2)=C3)=NC=C4)CC1						IC50	μM		0.07891							7.1						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(C)=C1OC(=O)N1C\C=C\COCC2=C(OCCN3CCC(O)CC3)C=CC(NC3=NC=CC1=N3)=C2		29078796	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078796&database=RX&origin=ReaxysOutput&ln=	(40 of 1381)			C31H37N5O5	C31H37N5O5	559.665			NGBXCJNBLVXEEJ-ONEGZZNKSA-N				Identification(14); Physical Data(2); Spectra(2); Bioactivity(2)	1	8	4.061	2	8	7	109.28	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29078796	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078796&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(C)=C1OC(=O)N1C\C=C\COCC2=C(OCCN3CCC(O)CC3)C=CC(NC3=NC=CC1=N3)=C2						IC50	μM		0.40875							6.39						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(C)=C1OC(=O)N1C\C=C/COCC2=C(OCCN3CCC(O)CC3)C=CC(NC3=NC=CC1=N3)=C2		29078797	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078797&database=RX&origin=ReaxysOutput&ln=	(41 of 1381)			C31H37N5O5	C31H37N5O5	559.665			NGBXCJNBLVXEEJ-ARJAWSKDSA-N				Identification(14); Physical Data(2); Spectra(2); Bioactivity(2)	1	8	4.061	2	8	7	109.28	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29078797	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078797&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(C)=C1OC(=O)N1C\C=C/COCC2=C(OCCN3CCC(O)CC3)C=CC(NC3=NC=CC1=N3)=C2						IC50	μM		0.07366							7.13						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NCCO)=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=N1		38200376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38200376&database=RX&origin=ReaxysOutput&ln=	(42 of 1381)		N-(4-chloro-2-methylpyridin-3-yl)-2-((6-((2-hydroxyethyl)amino)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C17H18ClN7O2S	C17H18ClN7O2S	419.895			FNEDDGRJWXWDNZ-UHFFFAOYSA-N				Identification(14); Physical Data(1); Spectra(2); Bioactivity(3)	1	8	0.502	4	9	8	96.87	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38200376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38200376&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NCCO)=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=N1	N-(4-chloro-2-methylpyridin-3-yl)-2-((6-((2-hydroxyethyl)amino)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		1510							5.82			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NCCO)=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=N1		38200376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38200376&database=RX&origin=ReaxysOutput&ln=	(42 of 1381)		N-(4-chloro-2-methylpyridin-3-yl)-2-((6-((2-hydroxyethyl)amino)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C17H18ClN7O2S	C17H18ClN7O2S	419.895			FNEDDGRJWXWDNZ-UHFFFAOYSA-N				Identification(14); Physical Data(1); Spectra(2); Bioactivity(3)	1	8	0.502	4	9	8	96.87	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38200376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38200376&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NCCO)=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=N1						IC50	nM		1510							5.82			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(C)=C1OC(=O)N1CCCCOCC2=C(OCCN3CCOCC3)C=CC(NC3=NC=CC1=N3)=C2		29078798	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078798&database=RX&origin=ReaxysOutput&ln=	(43 of 1381)			C30H37N5O5	C30H37N5O5	547.654			RPPQQSXXFFXZJA-UHFFFAOYSA-N				Identification(14); Physical Data(2); Spectra(4); Bioactivity(2)	1	7	3.943	1	8	7	98.28	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29078798	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29078798&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(C)=C1OC(=O)N1CCCCOCC2=C(OCCN3CCOCC3)C=CC(NC3=NC=CC1=N3)=C2						IC50	μM		0.1764							6.75						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)N1C=CC(C)=N1		34626449	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626449&database=RX&origin=ReaxysOutput&ln=	(44 of 1381)		2,6-dimethoxy-4-[5-(3-methylpyrazol-1-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			WNTMUYOSYVTKNC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.169	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626449	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626449&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)N1C=CC(C)=N1	2,6-dimethoxy-4-[5-(3-methylpyrazol-1-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)N1C=NC(C)=C1		34626450	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626450&database=RX&origin=ReaxysOutput&ln=	(45 of 1381)		2,6-dimethoxy-4-[5-(4-methylimidazol-1-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			DSZYLVAMDXOSAT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.207	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626450	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626450&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)N1C=NC(C)=C1	2,6-dimethoxy-4-[5-(4-methylimidazol-1-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)N1C=NC(C)=C1		34626450	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626450&database=RX&origin=ReaxysOutput&ln=	(45 of 1381)		2,6-dimethoxy-4-[5-(4-methylimidazol-1-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			DSZYLVAMDXOSAT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.207	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626450	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626450&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)N1C=NC(C)=C1	2,6-dimethoxy-4-[5-(4-methylimidazol-1-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(C)N=N1		34626452	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626452&database=RX&origin=ReaxysOutput&ln=	(46 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H21F2N5O3	C24H21F2N5O3	465.459			BMTPKAWXYIILHD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.392	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626452	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626452&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(C)N=N1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(C)N=N1		34626452	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626452&database=RX&origin=ReaxysOutput&ln=	(46 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H21F2N5O3	C24H21F2N5O3	465.459			BMTPKAWXYIILHD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.392	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626452	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626452&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(C)N=N1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)C=N1		34626457	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626457&database=RX&origin=ReaxysOutput&ln=	(47 of 1381)		2,6-dimethoxy-4-[5-(1-methylimidazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			RZNKXPAMQFOICX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.355	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626457	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626457&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)C=N1	2,6-dimethoxy-4-[5-(1-methylimidazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)C=N1		34626457	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626457&database=RX&origin=ReaxysOutput&ln=	(47 of 1381)		2,6-dimethoxy-4-[5-(1-methylimidazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			RZNKXPAMQFOICX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.355	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626457	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626457&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)C=N1	2,6-dimethoxy-4-[5-(1-methylimidazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NOC(C)=N1		34626461	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626461&database=RX&origin=ReaxysOutput&ln=	(48 of 1381)		2,6-dimethoxy-4-[5-(5-methyl-1,2,4-oxadiazol-3-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H18F3N5O4	C21H18F3N5O4	461.4			DZKGGDDPIDCISQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	7	4.212	1	5	8	104.3	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626461	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626461&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NOC(C)=N1	2,6-dimethoxy-4-[5-(5-methyl-1,2,4-oxadiazol-3-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NOC(C)=N1		34626461	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626461&database=RX&origin=ReaxysOutput&ln=	(48 of 1381)		2,6-dimethoxy-4-[5-(5-methyl-1,2,4-oxadiazol-3-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H18F3N5O4	C21H18F3N5O4	461.4			DZKGGDDPIDCISQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	7	4.212	1	5	8	104.3	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626461	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626461&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NOC(C)=N1	2,6-dimethoxy-4-[5-(5-methyl-1,2,4-oxadiazol-3-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NN=C(C)N1		34626462	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626462&database=RX&origin=ReaxysOutput&ln=	(49 of 1381)		2,6-dimethoxy-4-[5-(5-methyl-4H-1,2,4-triazol-3-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H19F3N6O3	C21H19F3N6O3	460.415			HKSKPUWIZIKPEN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	7	5.063	2	7	8	106.95	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626462	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626462&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NN=C(C)N1	2,6-dimethoxy-4-[5-(5-methyl-4H-1,2,4-triazol-3-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NN=C(C)N1		34626462	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626462&database=RX&origin=ReaxysOutput&ln=	(49 of 1381)		2,6-dimethoxy-4-[5-(5-methyl-4H-1,2,4-triazol-3-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H19F3N6O3	C21H19F3N6O3	460.415			HKSKPUWIZIKPEN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	7	5.063	2	7	8	106.95	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626462	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626462&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NN=C(C)N1	2,6-dimethoxy-4-[5-(5-methyl-4H-1,2,4-triazol-3-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CC=C(C)N=N1		34626465	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626465&database=RX&origin=ReaxysOutput&ln=	(50 of 1381)		8-methoxy-6-[7-(6-methylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H20F3N5O2	C24H20F3N5O2	467.45			PXUJSYCUJCRDBO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	7	4.633	0	6	5	72.62	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626465	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626465&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CC=C(C)N=N1	8-methoxy-6-[7-(6-methylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CC=C(C)N=N1		34626465	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626465&database=RX&origin=ReaxysOutput&ln=	(50 of 1381)		8-methoxy-6-[7-(6-methylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H20F3N5O2	C24H20F3N5O2	467.45			PXUJSYCUJCRDBO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	7	4.633	0	6	5	72.62	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626465	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626465&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CC=C(C)N=N1	8-methoxy-6-[7-(6-methylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(O)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626467	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626467&database=RX&origin=ReaxysOutput&ln=	(51 of 1381)		2-hydroxy-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H18F3N5O3	C21H18F3N5O3	445.401			RXFWKSQNYCMPEI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	7	5.268	2	6	7	93.68	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626467	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626467&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(O)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-hydroxy-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(O)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626467	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626467&database=RX&origin=ReaxysOutput&ln=	(51 of 1381)		2-hydroxy-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H18F3N5O3	C21H18F3N5O3	445.401			RXFWKSQNYCMPEI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	7	5.268	2	6	7	93.68	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626467	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626467&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(O)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-hydroxy-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(C)C)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626469	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626469&database=RX&origin=ReaxysOutput&ln=	(52 of 1381)		N-cyclopropyl-2-isopropoxy-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C25H27N5O3	C25H27N5O3	445.521			KTPUAEHIAAKQOK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.281	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626469	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626469&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(C)C)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-cyclopropyl-2-isopropoxy-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(O)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1		34626470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626470&database=RX&origin=ReaxysOutput&ln=	(53 of 1381)		N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2-hydroxy-6-methoxybenzamide	C22H23N5O3	C22H23N5O3	405.456			HDMPRCLLICSEIL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.238	2	6	7	94.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626470&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(O)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1	N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2-hydroxy-6-methoxybenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1		34626471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626471&database=RX&origin=ReaxysOutput&ln=	(54 of 1381)		2-(difluoromethoxy)-N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-6-methoxybenzamide	C23H23F2N5O3	C23H23F2N5O3	455.464			VNWAWEZKWMFEJY-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	4.415	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626471&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1	2-(difluoromethoxy)-N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-6-methoxybenzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1		34626471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626471&database=RX&origin=ReaxysOutput&ln=	(54 of 1381)		2-(difluoromethoxy)-N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-6-methoxybenzamide	C23H23F2N5O3	C23H23F2N5O3	455.464			VNWAWEZKWMFEJY-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	4.415	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626471&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1	2-(difluoromethoxy)-N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1		34626471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626471&database=RX&origin=ReaxysOutput&ln=	(54 of 1381)		2-(difluoromethoxy)-N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-6-methoxybenzamide	C23H23F2N5O3	C23H23F2N5O3	455.464			VNWAWEZKWMFEJY-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	4.415	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626471&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1	2-(difluoromethoxy)-N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-6-methoxybenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CNC1		34626473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626473&database=RX&origin=ReaxysOutput&ln=	(55 of 1381)		4-[5-[1-(azetidin-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H23F3N6O3	C24H23F3N6O3	500.48			YXTASSHLGJZXDH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	7	3.721	2	7	9	95.23	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626473&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CNC1	4-[5-[1-(azetidin-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CNC1		34626473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626473&database=RX&origin=ReaxysOutput&ln=	(55 of 1381)		4-[5-[1-(azetidin-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H23F3N6O3	C24H23F3N6O3	500.48			YXTASSHLGJZXDH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	7	3.721	2	7	9	95.23	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626473&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CNC1	4-[5-[1-(azetidin-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CNC1		34626473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626473&database=RX&origin=ReaxysOutput&ln=	(55 of 1381)		4-[5-[1-(azetidin-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H23F3N6O3	C24H23F3N6O3	500.48			YXTASSHLGJZXDH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	7	3.721	2	7	9	95.23	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626473&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CNC1	4-[5-[1-(azetidin-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(C)C1		34626474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626474&database=RX&origin=ReaxysOutput&ln=	(56 of 1381)		2,6-dimethoxy-4-[5-[1-(1-methylazetidin-3-yl)pyrazol-4-yl]benzoimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide; 2,6-dimethoxy-4-[5-[1-(1-methylazetidin-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C25H25F3N6O3	C25H25F3N6O3	514.507			IYQMLXVFXPVDDY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	3.96	1	7	9	86.44	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626474&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(C)C1						EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(C)C1		34626474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626474&database=RX&origin=ReaxysOutput&ln=	(56 of 1381)		2,6-dimethoxy-4-[5-[1-(1-methylazetidin-3-yl)pyrazol-4-yl]benzoimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide; 2,6-dimethoxy-4-[5-[1-(1-methylazetidin-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C25H25F3N6O3	C25H25F3N6O3	514.507			IYQMLXVFXPVDDY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	3.96	1	7	9	86.44	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626474&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(C)C1						IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(C)C1		34626474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626474&database=RX&origin=ReaxysOutput&ln=	(56 of 1381)		2,6-dimethoxy-4-[5-[1-(1-methylazetidin-3-yl)pyrazol-4-yl]benzoimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide; 2,6-dimethoxy-4-[5-[1-(1-methylazetidin-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C25H25F3N6O3	C25H25F3N6O3	514.507			IYQMLXVFXPVDDY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	3.96	1	7	9	86.44	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626474&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(C)C1						IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(C)C1		34626474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626474&database=RX&origin=ReaxysOutput&ln=	(56 of 1381)		2,6-dimethoxy-4-[5-[1-(1-methylazetidin-3-yl)pyrazol-4-yl]benzoimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide; 2,6-dimethoxy-4-[5-[1-(1-methylazetidin-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C25H25F3N6O3	C25H25F3N6O3	514.507			IYQMLXVFXPVDDY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	3.96	1	7	9	86.44	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626474&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(C)C1						EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCNCC1		34626475	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626475&database=RX&origin=ReaxysOutput&ln=	(57 of 1381)		2,6-dimethoxy-4-[5-[1-(4-piperidyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C26H27F3N6O3	C26H27F3N6O3	528.534			NLHPIYPSLYYSRQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.437	2	7	9	95.23	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626475	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626475&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCNCC1	2,6-dimethoxy-4-[5-[1-(4-piperidyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCNCC1		34626475	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626475&database=RX&origin=ReaxysOutput&ln=	(57 of 1381)		2,6-dimethoxy-4-[5-[1-(4-piperidyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C26H27F3N6O3	C26H27F3N6O3	528.534			NLHPIYPSLYYSRQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.437	2	7	9	95.23	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626475	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626475&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCNCC1	2,6-dimethoxy-4-[5-[1-(4-piperidyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCN(C)CC1		34626476	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626476&database=RX&origin=ReaxysOutput&ln=	(58 of 1381)		2,6-dimethoxy-4-[5-[1-(1-methyl-4-piperidyl)pyrazol4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C27H29F3N6O3	C27H29F3N6O3	542.561			UAMGYILQBAVFHQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.676	1	7	9	86.44	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626476	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626476&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCN(C)CC1	2,6-dimethoxy-4-[5-[1-(1-methyl-4-piperidyl)pyrazol4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCN(C)CC1		34626476	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626476&database=RX&origin=ReaxysOutput&ln=	(58 of 1381)		2,6-dimethoxy-4-[5-[1-(1-methyl-4-piperidyl)pyrazol4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C27H29F3N6O3	C27H29F3N6O3	542.561			UAMGYILQBAVFHQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.676	1	7	9	86.44	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626476	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626476&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCN(C)CC1	2,6-dimethoxy-4-[5-[1-(1-methyl-4-piperidyl)pyrazol4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(CC#N)C1		34626477	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626477&database=RX&origin=ReaxysOutput&ln=	(59 of 1381)		4-[5-[1-[1-(cyanomethyl)azetidin-3-yl]pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C26H24F3N7O3	C26H24F3N7O3	539.517			BRRRLTLNVIVCDU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	3.453	1	8	10	110.23	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626477	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626477&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(CC#N)C1	4-[5-[1-[1-(cyanomethyl)azetidin-3-yl]pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(CC#N)C1		34626477	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626477&database=RX&origin=ReaxysOutput&ln=	(59 of 1381)		4-[5-[1-[1-(cyanomethyl)azetidin-3-yl]pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C26H24F3N7O3	C26H24F3N7O3	539.517			BRRRLTLNVIVCDU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	3.453	1	8	10	110.23	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626477	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626477&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(CC#N)C1	4-[5-[1-[1-(cyanomethyl)azetidin-3-yl]pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(CC#N)C1		34626477	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626477&database=RX&origin=ReaxysOutput&ln=	(59 of 1381)		4-[5-[1-[1-(cyanomethyl)azetidin-3-yl]pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C26H24F3N7O3	C26H24F3N7O3	539.517			BRRRLTLNVIVCDU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	3.453	1	8	10	110.23	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626477	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626477&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CN(CC#N)C1	4-[5-[1-[1-(cyanomethyl)azetidin-3-yl]pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CN(CCC#N)C1		34626479	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626479&database=RX&origin=ReaxysOutput&ln=	(60 of 1381)		4-[7-[1-[1-(2-cyanoethyl)azetidin-3-yl]pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C27H26F3N7O3	C27H26F3N7O3	553.544			HYKHHDMFOMNZSF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.062	1	8	11	109.71	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626479	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626479&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CN(CCC#N)C1	4-[7-[1-[1-(2-cyanoethyl)azetidin-3-yl]pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CN(CCC#N)C1		34626479	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626479&database=RX&origin=ReaxysOutput&ln=	(60 of 1381)		4-[7-[1-[1-(2-cyanoethyl)azetidin-3-yl]pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C27H26F3N7O3	C27H26F3N7O3	553.544			HYKHHDMFOMNZSF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.062	1	8	11	109.71	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626479	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626479&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CN(CCC#N)C1	4-[7-[1-[1-(2-cyanoethyl)azetidin-3-yl]pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NCC(F)(F)F)C(F)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626480	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626480&database=RX&origin=ReaxysOutput&ln=	(61 of 1381)		2-fluoro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H17F4N5O2	C21H17F4N5O2	447.392			ANGNQGXPOHMINS-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	2	7	4.977	1	6	7	73.45	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626480	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626480&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NCC(F)(F)F)C(F)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-fluoro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NCC(F)(F)F)C(F)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626480	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626480&database=RX&origin=ReaxysOutput&ln=	(61 of 1381)		2-fluoro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H17F4N5O2	C21H17F4N5O2	447.392			ANGNQGXPOHMINS-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	2	7	4.977	1	6	7	73.45	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626480	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626480&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NCC(F)(F)F)C(F)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-fluoro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NCC(F)(F)F)C(F)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626480	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626480&database=RX&origin=ReaxysOutput&ln=	(61 of 1381)		2-fluoro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H17F4N5O2	C21H17F4N5O2	447.392			ANGNQGXPOHMINS-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	2	7	4.977	1	6	7	73.45	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626480	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626480&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NCC(F)(F)F)C(F)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-fluoro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626481	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626481&database=RX&origin=ReaxysOutput&ln=	(62 of 1381)		2-methoxy-6-(methylamino)-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N6O2	C22H21F3N6O2	458.443			KTJQAHSFGRNDLA-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	4.891	2	7	8	85.48	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626481	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626481&database=RX&origin=ReaxysOutput&ln=	CNC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-methoxy-6-(methylamino)-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626481	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626481&database=RX&origin=ReaxysOutput&ln=	(62 of 1381)		2-methoxy-6-(methylamino)-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N6O2	C22H21F3N6O2	458.443			KTJQAHSFGRNDLA-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	4.891	2	7	8	85.48	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626481	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626481&database=RX&origin=ReaxysOutput&ln=	CNC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-methoxy-6-(methylamino)-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626481	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626481&database=RX&origin=ReaxysOutput&ln=	(62 of 1381)		2-methoxy-6-(methylamino)-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N6O2	C22H21F3N6O2	458.443			KTJQAHSFGRNDLA-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	4.891	2	7	8	85.48	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626481	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626481&database=RX&origin=ReaxysOutput&ln=	CNC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-methoxy-6-(methylamino)-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NC2CC2)C(F)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626482	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626482&database=RX&origin=ReaxysOutput&ln=	(63 of 1381)		N-cyclopropyl-2-fluoro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20FN5O2	C22H20FN5O2	405.432			SYHUFDNRVURYRE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.095	1	6	6	73.45	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626482	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626482&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NC2CC2)C(F)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2-fluoro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NC2CC2)C(F)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626482	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626482&database=RX&origin=ReaxysOutput&ln=	(63 of 1381)		N-cyclopropyl-2-fluoro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20FN5O2	C22H20FN5O2	405.432			SYHUFDNRVURYRE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.095	1	6	6	73.45	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626482	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626482&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NC2CC2)C(F)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2-fluoro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COCCOC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626483	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626483&database=RX&origin=ReaxysOutput&ln=	(64 of 1381)		N-cyclopropyl-2-methoxy-6-(2-methoxyethoxy)-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H27N5O4	C25H27N5O4	461.52			PAJCNSYXYSXDPO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.659	1	7	10	91.91	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626483	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626483&database=RX&origin=ReaxysOutput&ln=	COCCOC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2-methoxy-6-(2-methoxyethoxy)-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COCCOC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626483	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626483&database=RX&origin=ReaxysOutput&ln=	(64 of 1381)		N-cyclopropyl-2-methoxy-6-(2-methoxyethoxy)-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H27N5O4	C25H27N5O4	461.52			PAJCNSYXYSXDPO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.659	1	7	10	91.91	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626483	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626483&database=RX&origin=ReaxysOutput&ln=	COCCOC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2-methoxy-6-(2-methoxyethoxy)-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)C1=CNN=C1		34626484	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626484&database=RX&origin=ReaxysOutput&ln=	(65 of 1381)		2,6-dimethoxy-4-[5-[1-(1-methyl-4-piperidyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H18F3N5O3	C21H18F3N5O3	445.401			CNHFLBLGMIUZKI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.475	2	6	8	94.06	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626484	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626484&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)C1=CNN=C1	2,6-dimethoxy-4-[5-[1-(1-methyl-4-piperidyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)C1=CN(CC(C)C)N=C1		34626486	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626486&database=RX&origin=ReaxysOutput&ln=	(66 of 1381)		4-[5-(1-isobutylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C25H26F3N5O3	C25H26F3N5O3	501.508			PNMBQYNJCVBQKG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.358	1	6	10	83.2	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626486	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626486&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)C1=CN(CC(C)C)N=C1	4-[5-(1-isobutylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)C1=CN(CC(C)C)N=C1		34626486	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626486&database=RX&origin=ReaxysOutput&ln=	(66 of 1381)		4-[5-(1-isobutylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C25H26F3N5O3	C25H26F3N5O3	501.508			PNMBQYNJCVBQKG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.358	1	6	10	83.2	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626486	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626486&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)C1=CN(CC(C)C)N=C1	4-[5-(1-isobutylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)C1=CN(CC(C)C)N=C1		34626486	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626486&database=RX&origin=ReaxysOutput&ln=	(66 of 1381)		4-[5-(1-isobutylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C25H26F3N5O3	C25H26F3N5O3	501.508			PNMBQYNJCVBQKG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.358	1	6	10	83.2	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626486	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626486&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)C1=CN(CC(C)C)N=C1	4-[5-(1-isobutylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CNN=C1		34626487	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626487&database=RX&origin=ReaxysOutput&ln=	(67 of 1381)		2,6-dimethoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H18F3N5O3	C21H18F3N5O3	445.401			HTPCQTZQVBJNJX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.926	2	6	8	93.54	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626487	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626487&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CNN=C1	2,6-dimethoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CNN=C1		34626487	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626487&database=RX&origin=ReaxysOutput&ln=	(67 of 1381)		2,6-dimethoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H18F3N5O3	C21H18F3N5O3	445.401			HTPCQTZQVBJNJX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.926	2	6	8	93.54	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626487	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626487&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CNN=C1	2,6-dimethoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CNN=C1		34626487	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626487&database=RX&origin=ReaxysOutput&ln=	(67 of 1381)		2,6-dimethoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H18F3N5O3	C21H18F3N5O3	445.401			HTPCQTZQVBJNJX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.926	2	6	8	93.54	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626487	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626487&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CNN=C1	2,6-dimethoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC(C)(C)C)N=C1		34626488	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626488&database=RX&origin=ReaxysOutput&ln=	(68 of 1381)		tert-butyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C27H28F3N5O5	C27H28F3N5O5	559.545			VJQDWXLVQFQSLS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	5.734	1	8	12	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626488	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626488&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC(C)(C)C)N=C1	tert-butyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC(C)(C)C)N=C1		34626488	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626488&database=RX&origin=ReaxysOutput&ln=	(68 of 1381)		tert-butyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C27H28F3N5O5	C27H28F3N5O5	559.545			VJQDWXLVQFQSLS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	5.734	1	8	12	108.98	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626488	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626488&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC(C)(C)C)N=C1	tert-butyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626490	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626490&database=RX&origin=ReaxysOutput&ln=	(69 of 1381)		8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H20F3N5O2	C23H20F3N5O2	455.439			NFINBSWADQZQBJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.804	0	6	5	64.66	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626490	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626490&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626490	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626490&database=RX&origin=ReaxysOutput&ln=	(69 of 1381)		8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H20F3N5O2	C23H20F3N5O2	455.439			NFINBSWADQZQBJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.804	0	6	5	64.66	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626490	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626490&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626490	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626490&database=RX&origin=ReaxysOutput&ln=	(69 of 1381)		8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H20F3N5O2	C23H20F3N5O2	455.439			NFINBSWADQZQBJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.804	0	6	5	64.66	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626490	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626490&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(C)C(=O)OC(C)(C)C		34626491	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626491&database=RX&origin=ReaxysOutput&ln=	(70 of 1381)		tert-butyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate	C28H30F3N5O5	C28H30F3N5O5	573.572			OENMMZFQRCBAKU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	6.26	1	8	12	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626491	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626491&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(C)C(=O)OC(C)(C)C	tert-butyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(C)C(=O)OC(C)(C)C		34626491	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626491&database=RX&origin=ReaxysOutput&ln=	(70 of 1381)		tert-butyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate	C28H30F3N5O5	C28H30F3N5O5	573.572			OENMMZFQRCBAKU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	6.26	1	8	12	108.98	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626491	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626491&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(C)C(=O)OC(C)(C)C	tert-butyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(C)C(O)=O		34626492	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626492&database=RX&origin=ReaxysOutput&ln=	(71 of 1381)		2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoic acid	C24H22F3N5O5	C24H22F3N5O5	517.464			LPACOJQVZNXYME-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.639	2	8	10	119.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626492	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626492&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(C)C(O)=O	2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoic acid					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(C)C(O)=O		34626492	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626492&database=RX&origin=ReaxysOutput&ln=	(71 of 1381)		2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoic acid	C24H22F3N5O5	C24H22F3N5O5	517.464			LPACOJQVZNXYME-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.639	2	8	10	119.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626492	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626492&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(C)C(O)=O	2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoic acid					EC50	nM	>	5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCCF)N=C1		34626493	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626493&database=RX&origin=ReaxysOutput&ln=	(72 of 1381)		2-fluoroethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C25H23F4N5O5	C25H23F4N5O5	549.482			QLHFJNPTCRWBCZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	5.062	1	8	13	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626493	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626493&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCCF)N=C1	2-fluoroethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCCF)N=C1		34626493	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626493&database=RX&origin=ReaxysOutput&ln=	(72 of 1381)		2-fluoroethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C25H23F4N5O5	C25H23F4N5O5	549.482			QLHFJNPTCRWBCZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	5.062	1	8	13	108.98	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626493	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626493&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCCF)N=C1	2-fluoroethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626494	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626494&database=RX&origin=ReaxysOutput&ln=	(73 of 1381)		methyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C24H22F3N5O5	C24H22F3N5O5	517.464			SGXXFMAFIOLXNQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.434	1	8	11	108.98	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626494	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626494&database=RX&origin=ReaxysOutput&ln=	COC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	methyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626494	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626494&database=RX&origin=ReaxysOutput&ln=	(73 of 1381)		methyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C24H22F3N5O5	C24H22F3N5O5	517.464			SGXXFMAFIOLXNQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.434	1	8	11	108.98	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626494	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626494&database=RX&origin=ReaxysOutput&ln=	COC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	methyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC2CCOC2)N=C1		34626495	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626495&database=RX&origin=ReaxysOutput&ln=	(74 of 1381)		tetrahydrofuran-3-yl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C27H26F3N5O6	C27H26F3N5O6	573.529			HBBGGOXSLBGJDW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.429	1	9	12	118.21	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626495	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626495&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC2CCOC2)N=C1	tetrahydrofuran-3-yl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC2CCOC2)N=C1		34626495	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626495&database=RX&origin=ReaxysOutput&ln=	(74 of 1381)		tetrahydrofuran-3-yl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C27H26F3N5O6	C27H26F3N5O6	573.529			HBBGGOXSLBGJDW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.429	1	9	12	118.21	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626495	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626495&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC2CCOC2)N=C1	tetrahydrofuran-3-yl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCC2CCC2)N=C1		34626496	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626496&database=RX&origin=ReaxysOutput&ln=	(75 of 1381)		cyclobutylmethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C28H28F3N5O5	C28H28F3N5O5	571.556			DFZTZISWQDAQKT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	5.741	1	8	13	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626496	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626496&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCC2CCC2)N=C1	cyclobutylmethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCC2CCC2)N=C1		34626496	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626496&database=RX&origin=ReaxysOutput&ln=	(75 of 1381)		cyclobutylmethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C28H28F3N5O5	C28H28F3N5O5	571.556			DFZTZISWQDAQKT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	5.741	1	8	13	108.98	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626496	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626496&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCC2CCC2)N=C1	cyclobutylmethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC(C)C)N=C1		34626497	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626497&database=RX&origin=ReaxysOutput&ln=	(76 of 1381)		isopropyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C26H26F3N5O5	C26H26F3N5O5	545.518			JXWMLVLAFWXHEY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	5.317	1	8	12	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626497	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626497&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC(C)C)N=C1	isopropyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC(C)C)N=C1		34626497	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626497&database=RX&origin=ReaxysOutput&ln=	(76 of 1381)		isopropyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C26H26F3N5O5	C26H26F3N5O5	545.518			JXWMLVLAFWXHEY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	5.317	1	8	12	108.98	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626497	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626497&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC(C)C)N=C1	isopropyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626563	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626563&database=RX&origin=ReaxysOutput&ln=	(77 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			ARXQRVVEKOEUEV-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	11	7	3.992	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626563	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626563&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626563	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626563&database=RX&origin=ReaxysOutput&ln=	(77 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			ARXQRVVEKOEUEV-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	11	7	3.992	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626563	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626563&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626563	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626563&database=RX&origin=ReaxysOutput&ln=	(77 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			ARXQRVVEKOEUEV-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	11	7	3.992	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626563	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626563&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626568	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626568&database=RX&origin=ReaxysOutput&ln=	(78 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H21F2N5O3	C23H21F2N5O3	453.448			PFTXFNSHFZLJNT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	10	7	4.112	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626568	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626568&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626568	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626568&database=RX&origin=ReaxysOutput&ln=	(78 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H21F2N5O3	C23H21F2N5O3	453.448			PFTXFNSHFZLJNT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	10	7	4.112	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626568	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626568&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626568	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626568&database=RX&origin=ReaxysOutput&ln=	(78 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H21F2N5O3	C23H21F2N5O3	453.448			PFTXFNSHFZLJNT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	10	7	4.112	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626568	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626568&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626568	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626568&database=RX&origin=ReaxysOutput&ln=	(78 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H21F2N5O3	C23H21F2N5O3	453.448			PFTXFNSHFZLJNT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	10	7	4.112	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626568	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626568&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)N1N=C(C)C=C1C		34626572	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626572&database=RX&origin=ReaxysOutput&ln=	(79 of 1381)		4-[5-(3,5-dimethylpyrazol-1-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			SJEQDVZMAOFGPO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.405	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626572	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626572&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)N1N=C(C)C=C1C	4-[5-(3,5-dimethylpyrazol-1-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)N1C=NC(C)=N1		34626573	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626573&database=RX&origin=ReaxysOutput&ln=	(80 of 1381)		2,6-dimethoxy-4-[5-(3-methyl-1,2,4-triazol-1-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H19F3N6O3	C21H19F3N6O3	460.415			JUBAJQOSGDOLBB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.681	1	7	8	96.09	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626573	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626573&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=C1C=CC(=C2)N1C=NC(C)=N1	2,6-dimethoxy-4-[5-(3-methyl-1,2,4-triazol-1-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NN=C(C)O1		34626576	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626576&database=RX&origin=ReaxysOutput&ln=	(81 of 1381)		2,6-dimethoxy-4-[5-(5-methyl-1,3,4-oxadiazol-2-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H18F3N5O4	C21H18F3N5O4	461.4			FSUFVASBEOVHDX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	7	4.953	1	6	8	104.3	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626576	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626576&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NN=C(C)O1	2,6-dimethoxy-4-[5-(5-methyl-1,3,4-oxadiazol-2-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NN=C(C)N1C		34626577	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626577&database=RX&origin=ReaxysOutput&ln=	(82 of 1381)		4-[5-(4,5-dimethyl-1,2,4-triazol-3-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N6O3	C22H21F3N6O3	474.442			BFLPYTUVOMZCSC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	7	5.367	1	7	8	96.09	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626577	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626577&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NN=C(C)N1C	4-[5-(4,5-dimethyl-1,2,4-triazol-3-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NC(C)=NO1		34626578	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626578&database=RX&origin=ReaxysOutput&ln=	(83 of 1381)		2,6-dimcthoxy-4-[5-(3-methyl-1,2,4-oxadiazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H18F3N5O4	C21H18F3N5O4	461.4			QLCGILAIUOEGQR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	7	4.215	1	5	8	104.3	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626578	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626578&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NC(C)=NO1	2,6-dimcthoxy-4-[5-(3-methyl-1,2,4-oxadiazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626579&database=RX&origin=ReaxysOutput&ln=	(84 of 1381)		(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone	C23H21F2N5O3	C23H21F2N5O3	453.448			QNBOOPICAQOKPE-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	7	4.119	0	6	6	73.89	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626579&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626579&database=RX&origin=ReaxysOutput&ln=	(84 of 1381)		(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone	C23H21F2N5O3	C23H21F2N5O3	453.448			QNBOOPICAQOKPE-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	7	4.119	0	6	6	73.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626579&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626579&database=RX&origin=ReaxysOutput&ln=	(84 of 1381)		(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone	C23H21F2N5O3	C23H21F2N5O3	453.448			QNBOOPICAQOKPE-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	7	4.119	0	6	6	73.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626579&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626579&database=RX&origin=ReaxysOutput&ln=	(84 of 1381)		(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone	C23H21F2N5O3	C23H21F2N5O3	453.448			QNBOOPICAQOKPE-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	7	4.119	0	6	6	73.89	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626579&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626580	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626580&database=RX&origin=ReaxysOutput&ln=	(85 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			GWZDHUMHTZNQGC-CYBMUJFWSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	7	5.191	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626580	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626580&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626580	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626580&database=RX&origin=ReaxysOutput&ln=	(85 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			GWZDHUMHTZNQGC-CYBMUJFWSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	7	5.191	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626580	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626580&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626580	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626580&database=RX&origin=ReaxysOutput&ln=	(85 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			GWZDHUMHTZNQGC-CYBMUJFWSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	7	5.191	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626580	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626580&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626580	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626580&database=RX&origin=ReaxysOutput&ln=	(85 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			GWZDHUMHTZNQGC-CYBMUJFWSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	7	5.191	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626580	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626580&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626581	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626581&database=RX&origin=ReaxysOutput&ln=	(86 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			JVNHXXJPPAGFBX-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	7	4.28	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626581	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626581&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626581	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626581&database=RX&origin=ReaxysOutput&ln=	(86 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			JVNHXXJPPAGFBX-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	7	4.28	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626581	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626581&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626581	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626581&database=RX&origin=ReaxysOutput&ln=	(86 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			JVNHXXJPPAGFBX-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	7	4.28	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626581	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626581&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1CC2=C(C1=O)C(F)=CC(=C2)N1C=NC2=C1C=CC(=C2)C1=CN(C)N=C1		34626582	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626582&database=RX&origin=ReaxysOutput&ln=	(87 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C21H18FN5O	C21H18FN5O	375.405			WIIOBORNENPPEJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	7	3.439	0	6	3	55.95	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626582	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626582&database=RX&origin=ReaxysOutput&ln=	CCN1CC2=C(C1=O)C(F)=CC(=C2)N1C=NC2=C1C=CC(=C2)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1CC2=C(C1=O)C(F)=CC(=C2)N1C=NC2=C1C=CC(=C2)C1=CN(C)N=C1		34626582	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626582&database=RX&origin=ReaxysOutput&ln=	(87 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C21H18FN5O	C21H18FN5O	375.405			WIIOBORNENPPEJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	7	3.439	0	6	3	55.95	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626582	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626582&database=RX&origin=ReaxysOutput&ln=	CCN1CC2=C(C1=O)C(F)=CC(=C2)N1C=NC2=C1C=CC(=C2)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM	>	100 - 500							7			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1CC2=C(C1=O)C(NCCO)=CC(=C2)N1C=NC2=C1C=CC(=C2)C1=CN(C)N=C1		34626583	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626583&database=RX&origin=ReaxysOutput&ln=	(88 of 1381)		2-ethyl-7-(2-hydroxyethylamino)-5-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]isoindolin-1-one	C23H24N6O2	C23H24N6O2	416.483			QJHXWBHMHPLQMJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	7	2.215	2	8	6	88.21	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626583	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626583&database=RX&origin=ReaxysOutput&ln=	CCN1CC2=C(C1=O)C(NCCO)=CC(=C2)N1C=NC2=C1C=CC(=C2)C1=CN(C)N=C1	2-ethyl-7-(2-hydroxyethylamino)-5-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]isoindolin-1-one					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1CC2=C(C1=O)C(NCCO)=CC(=C2)N1C=NC2=C1C=CC(=C2)C1=CN(C)N=C1		34626583	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626583&database=RX&origin=ReaxysOutput&ln=	(88 of 1381)		2-ethyl-7-(2-hydroxyethylamino)-5-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]isoindolin-1-one	C23H24N6O2	C23H24N6O2	416.483			QJHXWBHMHPLQMJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	7	2.215	2	8	6	88.21	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626583	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626583&database=RX&origin=ReaxysOutput&ln=	CCN1CC2=C(C1=O)C(NCCO)=CC(=C2)N1C=NC2=C1C=CC(=C2)C1=CN(C)N=C1	2-ethyl-7-(2-hydroxyethylamino)-5-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]isoindolin-1-one					IC50	nM	>	100 - 500							7			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(C)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626589	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626589&database=RX&origin=ReaxysOutput&ln=	(89 of 1381)		ethyl 3-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate	C27H28F3N5O5	C27H28F3N5O5	559.545			CVKYGHBBYRZDJF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	7	5.308	1	8	13	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626589	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626589&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(C)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 3-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(C)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626589	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626589&database=RX&origin=ReaxysOutput&ln=	(89 of 1381)		ethyl 3-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate	C27H28F3N5O5	C27H28F3N5O5	559.545			CVKYGHBBYRZDJF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	7	5.308	1	8	13	108.98	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626589	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626589&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(C)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 3-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1)C(C)C		34626591	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626591&database=RX&origin=ReaxysOutput&ln=	(90 of 1381)		ethyl 2-[[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]methyl]-3-methylbutanoate	C29H32F3N5O5	C29H32F3N5O5	587.599			UYEJDCIABGMNSN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	7	6.385	1	8	14	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626591	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626591&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1)C(C)C	ethyl 2-[[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]methyl]-3-methylbutanoate					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1)C(C)C		34626591	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626591&database=RX&origin=ReaxysOutput&ln=	(90 of 1381)		ethyl 2-[[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]methyl]-3-methylbutanoate	C29H32F3N5O5	C29H32F3N5O5	587.599			UYEJDCIABGMNSN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	7	6.385	1	8	14	108.98	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626591	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626591&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1)C(C)C	ethyl 2-[[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]methyl]-3-methylbutanoate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(C)(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626594	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626594&database=RX&origin=ReaxysOutput&ln=	(91 of 1381)		ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate	C27H28F3N5O5	C27H28F3N5O5	559.545			BABFEOJYBXSOHT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	7	5.493	1	8	12	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626594	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626594&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(C)(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(C)(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626594	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626594&database=RX&origin=ReaxysOutput&ln=	(91 of 1381)		ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate	C27H28F3N5O5	C27H28F3N5O5	559.545			BABFEOJYBXSOHT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	7	5.493	1	8	12	108.98	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626594	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626594&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(C)(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(C(C)C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626596	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626596&database=RX&origin=ReaxysOutput&ln=	(92 of 1381)		ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-3-methylbutanoate	C28H30F3N5O5	C28H30F3N5O5	573.572			PPEGKSLOSUUNDP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	7	6.038	1	8	13	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626596	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626596&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(C(C)C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-3-methylbutanoate					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(C(C)C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626596	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626596&database=RX&origin=ReaxysOutput&ln=	(92 of 1381)		ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-3-methylbutanoate	C28H30F3N5O5	C28H30F3N5O5	573.572			PPEGKSLOSUUNDP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	7	6.038	1	8	13	108.98	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626596	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626596&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(C(C)C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-3-methylbutanoate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCC2CCCO2)N=C1		34626597	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626597&database=RX&origin=ReaxysOutput&ln=	(93 of 1381)		tetrahydrofuran-2-ylmethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C28H28F3N5O6	C28H28F3N5O6	587.555			FNGKYBVVQPEVAR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.787	1	9	13	118.21	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626597	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626597&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCC2CCCO2)N=C1	tetrahydrofuran-2-ylmethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCC2CCCO2)N=C1		34626597	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626597&database=RX&origin=ReaxysOutput&ln=	(93 of 1381)		tetrahydrofuran-2-ylmethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C28H28F3N5O6	C28H28F3N5O6	587.555			FNGKYBVVQPEVAR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.787	1	9	13	118.21	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626597	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626597&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OCC2CCCO2)N=C1	tetrahydrofuran-2-ylmethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CON=C1		34626598	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626598&database=RX&origin=ReaxysOutput&ln=	(94 of 1381)		4-(5-isoxazol-4-ylbenzimidazol-1-yl)-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C21H17F3N4O4	C21H17F3N4O4	446.386			ARKVLGSEBXKOHO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.427	1	4	8	91.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626598	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626598&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CON=C1	4-(5-isoxazol-4-ylbenzimidazol-1-yl)-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CON=C1		34626598	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626598&database=RX&origin=ReaxysOutput&ln=	(94 of 1381)		4-(5-isoxazol-4-ylbenzimidazol-1-yl)-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C21H17F3N4O4	C21H17F3N4O4	446.386			ARKVLGSEBXKOHO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.427	1	4	8	91.41	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626598	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626598&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CON=C1	4-(5-isoxazol-4-ylbenzimidazol-1-yl)-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NC2CC2)C(OC(F)F)=CC(=C1)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1		34626606	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626606&database=RX&origin=ReaxysOutput&ln=	(95 of 1381)		4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H20F2N6O3	C24H20F2N6O3	478.458			JJNQUQHPOYLSGD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	7	3.605	1	7	9	106.99	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626606	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626606&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NC2CC2)C(OC(F)F)=CC(=C1)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1	4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NC2CC2)C(OC(F)F)=CC(=C1)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1		34626606	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626606&database=RX&origin=ReaxysOutput&ln=	(95 of 1381)		4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H20F2N6O3	C24H20F2N6O3	478.458			JJNQUQHPOYLSGD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	7	3.605	1	7	9	106.99	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626606	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626606&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NC2CC2)C(OC(F)F)=CC(=C1)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1	4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(C)(C)C(O)=O		34626613	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626613&database=RX&origin=ReaxysOutput&ln=	(96 of 1381)		2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoic acid	C25H24F3N5O5	C25H24F3N5O5	531.491			YMNDZPUQJAMHGU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	7	4.749	2	8	10	119.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626613	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626613&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(C)(C)C(O)=O	2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoic acid					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN(CC)CCOC(=O)C(C)(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626615	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626615&database=RX&origin=ReaxysOutput&ln=	(97 of 1381)		2-(diethylamino)ethyl2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate	C31H37F3N6O5	C31H37F3N6O5	630.667			HHTPJMZRMWSWDU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	7	5.769	1	9	16	112.22	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626615	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626615&database=RX&origin=ReaxysOutput&ln=	CCN(CC)CCOC(=O)C(C)(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2-(diethylamino)ethyl2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN(CC)CCOC(=O)C(C)(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626615	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626615&database=RX&origin=ReaxysOutput&ln=	(97 of 1381)		2-(diethylamino)ethyl2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate	C31H37F3N6O5	C31H37F3N6O5	630.667			HHTPJMZRMWSWDU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	7	5.769	1	9	16	112.22	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626615	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626615&database=RX&origin=ReaxysOutput&ln=	CCN(CC)CCOC(=O)C(C)(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2-(diethylamino)ethyl2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]-2-methylpropanoate					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626630	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626630&database=RX&origin=ReaxysOutput&ln=	(98 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H21F2N5O3	C23H21F2N5O3	453.448			PJLLVHJOPDTROT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	7	4.563	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626630	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626630&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626630	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626630&database=RX&origin=ReaxysOutput&ln=	(98 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H21F2N5O3	C23H21F2N5O3	453.448			PJLLVHJOPDTROT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	7	4.563	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626630	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626630&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626630	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626630&database=RX&origin=ReaxysOutput&ln=	(98 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H21F2N5O3	C23H21F2N5O3	453.448			PJLLVHJOPDTROT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	7	4.563	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626630	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626630&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1		34626631	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626631&database=RX&origin=ReaxysOutput&ln=	(99 of 1381)		N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C23H25N5O3	C23H25N5O3	419.483			UARVSLPFGRKWQN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	3.701	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626631	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626631&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1	N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1		34626631	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626631&database=RX&origin=ReaxysOutput&ln=	(99 of 1381)		N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C23H25N5O3	C23H25N5O3	419.483			UARVSLPFGRKWQN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	3.701	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626631	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626631&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1	N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1		34626631	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626631&database=RX&origin=ReaxysOutput&ln=	(99 of 1381)		N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C23H25N5O3	C23H25N5O3	419.483			UARVSLPFGRKWQN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	3.701	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626631	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626631&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1	N-ethyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CC=CN=C1		34626632	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626632&database=RX&origin=ReaxysOutput&ln=	(100 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-(3-pyridyl)benzimidazol-1-yl]benzamide	C23H22N4O3	C23H22N4O3	402.453			MUXBZAXISKOARE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.533	1	5	7	78.27	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626632	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626632&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CC=CN=C1	N-ethyl-2,6-dimethoxy-4-[5-(3-pyridyl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CC=CN=C1		34626632	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626632&database=RX&origin=ReaxysOutput&ln=	(100 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-(3-pyridyl)benzimidazol-1-yl]benzamide	C23H22N4O3	C23H22N4O3	402.453			MUXBZAXISKOARE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.533	1	5	7	78.27	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626632	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626632&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CC=CN=C1	N-ethyl-2,6-dimethoxy-4-[5-(3-pyridyl)benzimidazol-1-yl]benzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		34626634	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626634&database=RX&origin=ReaxysOutput&ln=	(101 of 1381)		ethyl 2-[4-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C26H25F2N5O5	C26H25F2N5O5	525.512			DZCPWJZTBCOKGK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.689	1	8	12	108.98	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626634	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626634&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	ethyl 2-[4-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCCO)C(OC)=C1		34626636	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626636&database=RX&origin=ReaxysOutput&ln=	(102 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-N-(2-hydroxyethyl)-2,6-dimethoxybenzamide	C23H25N5O4	C23H25N5O4	435.483			ZUGGIJDUVSFYSA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.569	2	7	9	103.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626636	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626636&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCCO)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-N-(2-hydroxyethyl)-2,6-dimethoxybenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC)C(OC)=C1		34626637	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626637&database=RX&origin=ReaxysOutput&ln=	(103 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-methylbenzamide	C22H23N5O3	C22H23N5O3	405.456			MXJMJNRCJKHFPP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.278	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626637	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626637&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-methylbenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC)C(OC)=C1		34626637	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626637&database=RX&origin=ReaxysOutput&ln=	(103 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-methylbenzamide	C22H23N5O3	C22H23N5O3	405.456			MXJMJNRCJKHFPP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.278	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626637	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626637&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-methylbenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626638	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626638&database=RX&origin=ReaxysOutput&ln=	(104 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H23N5O3	C22H23N5O3	405.456			HRKJFKJZUNJKNU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.278	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626638	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626638&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-ethyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626638	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626638&database=RX&origin=ReaxysOutput&ln=	(104 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H23N5O3	C22H23N5O3	405.456			HRKJFKJZUNJKNU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.278	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626638	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626638&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-ethyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1C		34626639	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626639&database=RX&origin=ReaxysOutput&ln=	(105 of 1381)		4-[5-(1,3-dimethylpyrazol-4-yl)benzimidazol-1-yl]-N-ethyl-2,6-dimethoxybenzamide	C23H25N5O3	C23H25N5O3	419.483			OWPXZMOTIVKKSY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.459	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626639	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626639&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1C	4-[5-(1,3-dimethylpyrazol-4-yl)benzimidazol-1-yl]-N-ethyl-2,6-dimethoxybenzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)C1=C2N=CC(=CN2N=C1)C1=CN(CC)N=C1		34626640	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626640&database=RX&origin=ReaxysOutput&ln=	(106 of 1381)		N-ethyl-4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxybenzamide	C22H24N6O3	C22H24N6O3	420.471			KWAUXZBZNGEYJE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	7	2.911	1	7	8	95.57	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626640	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626640&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)C1=C2N=CC(=CN2N=C1)C1=CN(CC)N=C1	N-ethyl-4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxybenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)C1=C2N=CC(=CN2N=C1)C1=CN(CC)N=C1		34626640	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626640&database=RX&origin=ReaxysOutput&ln=	(106 of 1381)		N-ethyl-4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxybenzamide	C22H24N6O3	C22H24N6O3	420.471			KWAUXZBZNGEYJE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	7	2.911	1	7	8	95.57	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626640	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626640&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)C1=C2N=CC(=CN2N=C1)C1=CN(CC)N=C1	N-ethyl-4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxybenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCCF)C(OC)=C1		34626641	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626641&database=RX&origin=ReaxysOutput&ln=	(107 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-N-(2-fluoroethyl)-2,6-dimethoxybenzamide	C23H24FN5O3	C23H24FN5O3	437.474			DOKWYKZBLRFYBB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.906	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626641	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626641&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCCF)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-N-(2-fluoroethyl)-2,6-dimethoxybenzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCCF)C(OC)=C1		34626641	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626641&database=RX&origin=ReaxysOutput&ln=	(107 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-N-(2-fluoroethyl)-2,6-dimethoxybenzamide	C23H24FN5O3	C23H24FN5O3	437.474			DOKWYKZBLRFYBB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.906	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626641	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626641&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCCF)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-N-(2-fluoroethyl)-2,6-dimethoxybenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)F)C(OC)=C1		34626642	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626642&database=RX&origin=ReaxysOutput&ln=	(108 of 1381)		N-(2,2-difluoroethyl)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C23H23F2N5O3	C23H23F2N5O3	455.464			RPWFGAQCNJHDJP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.187	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626642	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626642&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)F)C(OC)=C1	N-(2,2-difluoroethyl)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)F)C(OC)=C1		34626642	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626642&database=RX&origin=ReaxysOutput&ln=	(108 of 1381)		N-(2,2-difluoroethyl)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C23H23F2N5O3	C23H23F2N5O3	455.464			RPWFGAQCNJHDJP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.187	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626642	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626642&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)F)C(OC)=C1	N-(2,2-difluoroethyl)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626643	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626643&database=RX&origin=ReaxysOutput&ln=	(109 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			XGEBOBAOVSOQCV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.703	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626643	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626643&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626643	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626643&database=RX&origin=ReaxysOutput&ln=	(109 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			XGEBOBAOVSOQCV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.703	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626643	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626643&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCOC)N=C1		34626644	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626644&database=RX&origin=ReaxysOutput&ln=	(110 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-[1-(2-methoxyethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide	C24H27N5O4	C24H27N5O4	449.509			WWTRFWLRGARRAD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.088	1	7	10	92.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626644	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626644&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCOC)N=C1	N-ethyl-2,6-dimethoxy-4-[5-[1-(2-methoxyethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCOC)N=C1		34626644	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626644&database=RX&origin=ReaxysOutput&ln=	(110 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-[1-(2-methoxyethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide	C24H27N5O4	C24H27N5O4	449.509			WWTRFWLRGARRAD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.088	1	7	10	92.43	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626644	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626644&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCOC)N=C1	N-ethyl-2,6-dimethoxy-4-[5-[1-(2-methoxyethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCOCC1		34626645	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626645&database=RX&origin=ReaxysOutput&ln=	(111 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-(1-tetrahydropyran-4-ylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C26H29N5O4	C26H29N5O4	475.547			SGMHSWUFNYQVBA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.631	1	7	8	92.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626645	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626645&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCOCC1	N-ethyl-2,6-dimethoxy-4-[5-(1-tetrahydropyran-4-ylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCOCC1		34626645	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626645&database=RX&origin=ReaxysOutput&ln=	(111 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-(1-tetrahydropyran-4-ylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C26H29N5O4	C26H29N5O4	475.547			SGMHSWUFNYQVBA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.631	1	7	8	92.43	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626645	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626645&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CCOCC1	N-ethyl-2,6-dimethoxy-4-[5-(1-tetrahydropyran-4-ylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1		34626646	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626646&database=RX&origin=ReaxysOutput&ln=	(112 of 1381)		4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-ethyl-2,6-dimethoxybenzamide	C23H22N6O3	C23H22N6O3	430.466			CAWABSRZIMATJO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.771	1	7	8	106.99	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626646	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626646&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1	4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-ethyl-2,6-dimethoxybenzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1		34626646	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626646&database=RX&origin=ReaxysOutput&ln=	(112 of 1381)		4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-ethyl-2,6-dimethoxybenzamide	C23H22N6O3	C23H22N6O3	430.466			CAWABSRZIMATJO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.771	1	7	8	106.99	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626646	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626646&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1	4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-ethyl-2,6-dimethoxybenzamide					EC50	nM	>	5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCO)N=C1		34626647	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626647&database=RX&origin=ReaxysOutput&ln=	(113 of 1381)		N-ethyl-4-[5-[1-(2-hydroxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxybenzamide	C23H25N5O4	C23H25N5O4	435.483			FCJGMZMSVIAAJU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.569	2	7	9	103.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626647	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626647&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCO)N=C1	N-ethyl-4-[5-[1-(2-hydroxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxybenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCO)N=C1		34626647	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626647&database=RX&origin=ReaxysOutput&ln=	(113 of 1381)		N-ethyl-4-[5-[1-(2-hydroxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxybenzamide	C23H25N5O4	C23H25N5O4	435.483			FCJGMZMSVIAAJU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.569	2	7	9	103.43	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626647	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626647&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCO)N=C1	N-ethyl-4-[5-[1-(2-hydroxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxybenzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC(N)=O)N=C1		34626648	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626648&database=RX&origin=ReaxysOutput&ln=	(114 of 1381)		4-[5-[1-(2-amino-2-oxoethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-ethyl-2,6-dimethoxybenzamide	C23H24N6O4	C23H24N6O4	448.481			SVJBHQPXESBDEQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	1.932	2	8	9	126.29	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626648	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626648&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC(N)=O)N=C1	4-[5-[1-(2-amino-2-oxoethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-ethyl-2,6-dimethoxybenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC(N)=O)N=C1		34626648	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626648&database=RX&origin=ReaxysOutput&ln=	(114 of 1381)		4-[5-[1-(2-amino-2-oxoethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-ethyl-2,6-dimethoxybenzamide	C23H24N6O4	C23H24N6O4	448.481			SVJBHQPXESBDEQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	1.932	2	8	9	126.29	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626648	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626648&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC(N)=O)N=C1	4-[5-[1-(2-amino-2-oxoethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-ethyl-2,6-dimethoxybenzamide					EC50	nM	>	5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2CC2)C(OC)=C1		34626649	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626649&database=RX&origin=ReaxysOutput&ln=	(115 of 1381)		N-cyclopropyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C24H25N5O3	C24H25N5O3	431.494			ZMAJVXKEVISHMQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.821	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626649	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626649&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2CC2)C(OC)=C1		34626649	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626649&database=RX&origin=ReaxysOutput&ln=	(115 of 1381)		N-cyclopropyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C24H25N5O3	C24H25N5O3	431.494			ZMAJVXKEVISHMQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.821	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626649	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626649&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CN2N=CC(=C2N=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626650	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626650&database=RX&origin=ReaxysOutput&ln=	(116 of 1381)		4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N6O3	C22H21F3N6O3	474.442			CSBBCZKSODVWSN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.913	1	7	9	95.57	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626650	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626650&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CN2N=CC(=C2N=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CN2N=CC(=C2N=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626650	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626650&database=RX&origin=ReaxysOutput&ln=	(116 of 1381)		4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N6O3	C22H21F3N6O3	474.442			CSBBCZKSODVWSN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.913	1	7	9	95.57	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626650	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626650&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CN2N=CC(=C2N=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CN2N=CC(=C2N=C1)C1=CC(OC)=C(C(=O)NCC(F)F)C(OC)=C1		34626651	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626651&database=RX&origin=ReaxysOutput&ln=	(117 of 1381)		N-(2,2-difluoroethyl)-4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxybenzamide	C22H22F2N6O3	C22H22F2N6O3	456.452			AURYMRJVPZJNJG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.397	1	7	9	95.57	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626651	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626651&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CN2N=CC(=C2N=C1)C1=CC(OC)=C(C(=O)NCC(F)F)C(OC)=C1	N-(2,2-difluoroethyl)-4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxybenzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CN2N=CC(=C2N=C1)C1=CC(OC)=C(C(=O)NCC(F)F)C(OC)=C1		34626651	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626651&database=RX&origin=ReaxysOutput&ln=	(117 of 1381)		N-(2,2-difluoroethyl)-4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxybenzamide	C22H22F2N6O3	C22H22F2N6O3	456.452			AURYMRJVPZJNJG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.397	1	7	9	95.57	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626651	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626651&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CN2N=CC(=C2N=C1)C1=CC(OC)=C(C(=O)NCC(F)F)C(OC)=C1	N-(2,2-difluoroethyl)-4-[6-(1-ethylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-2,6-dimethoxybenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1		34626652	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626652&database=RX&origin=ReaxysOutput&ln=	(118 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-propylbenzamide	C24H27N5O3	C24H27N5O3	433.51			FHFRTNQMPCKRKV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.059	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626652	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626652&database=RX&origin=ReaxysOutput&ln=	CCCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-propylbenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1		34626652	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626652&database=RX&origin=ReaxysOutput&ln=	(118 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-propylbenzamide	C24H27N5O3	C24H27N5O3	433.51			FHFRTNQMPCKRKV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.059	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626652	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626652&database=RX&origin=ReaxysOutput&ln=	CCCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CC)N=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-propylbenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)C1=C2N=CC(=CN2N=C1)C1=CN(C)N=C1		34626653	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626653&database=RX&origin=ReaxysOutput&ln=	(119 of 1381)		N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide	C21H20F2N6O3	C21H20F2N6O3	442.425			BPYXORPLLDJAIF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.974	1	7	8	95.57	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626653	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626653&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)C1=C2N=CC(=CN2N=C1)C1=CN(C)N=C1	N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)C1=C2N=CC(=CN2N=C1)C1=CN(C)N=C1		34626653	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626653&database=RX&origin=ReaxysOutput&ln=	(119 of 1381)		N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide	C21H20F2N6O3	C21H20F2N6O3	442.425			BPYXORPLLDJAIF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.974	1	7	8	95.57	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626653	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626653&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)C1=C2N=CC(=CN2N=C1)C1=CN(C)N=C1	N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2CCC2)C(OC)=C1		34626655	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626655&database=RX&origin=ReaxysOutput&ln=	(120 of 1381)		N-cyclobutyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C25H27N5O3	C25H27N5O3	445.521			ZIBANLZUGFFZAA-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	4.179	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626655	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626655&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2CCC2)C(OC)=C1	N-cyclobutyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2CCC2)C(OC)=C1		34626655	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626655&database=RX&origin=ReaxysOutput&ln=	(120 of 1381)		N-cyclobutyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C25H27N5O3	C25H27N5O3	445.521			ZIBANLZUGFFZAA-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	4.179	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626655	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626655&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2CCC2)C(OC)=C1	N-cyclobutyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)N(C)CCOC)C(OC)=C1		34626656	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626656&database=RX&origin=ReaxysOutput&ln=	(121 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2-methoxyethyl)-N-methylbenzamide	C25H29N5O4	C25H29N5O4	463.536			AFHJPRLCACPYQA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.23	0	7	10	83.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626656	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626656&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)N(C)CCOC)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2-methoxyethyl)-N-methylbenzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)N(C)CC(C)C)C(OC)=C1		34626657	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626657&database=RX&origin=ReaxysOutput&ln=	(122 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-N-isobutyl-2,6-dimethoxy-N-methylbenzamide	C26H31N5O3	C26H31N5O3	461.564			BBXGRMOULOOVKO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.498	0	6	9	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626657	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626657&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)N(C)CC(C)C)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-N-isobutyl-2,6-dimethoxy-N-methylbenzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)N(C)C2CC2)C(OC)=C1		34626658	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626658&database=RX&origin=ReaxysOutput&ln=	(123 of 1381)		N-cyclopropyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-methylbenzamide	C25H27N5O3	C25H27N5O3	445.521			NJMKEYLTIHAWEP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.963	0	6	8	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626658	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626658&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)N(C)C2CC2)C(OC)=C1	N-cyclopropyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-methylbenzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)N(C)CC#N)C(OC)=C1		34626659	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626659&database=RX&origin=ReaxysOutput&ln=	(124 of 1381)		N-(cyanomethyl)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-methylbenzamide	C24H24N6O3	C24H24N6O3	444.493			ZBWHRLNFELWRJV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.913	0	7	8	98.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626659	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626659&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)N(C)CC#N)C(OC)=C1	N-(cyanomethyl)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-methylbenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CCO)N=C1		34626661	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626661&database=RX&origin=ReaxysOutput&ln=	(125 of 1381)		4-[5-[1-(2-hydroxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H22F3N5O4	C23H22F3N5O4	489.454			HDBKJODUGIGTNA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.571	2	7	10	103.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626661	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626661&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CCO)N=C1	4-[5-[1-(2-hydroxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CCO)N=C1		34626661	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626661&database=RX&origin=ReaxysOutput&ln=	(125 of 1381)		4-[5-[1-(2-hydroxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H22F3N5O4	C23H22F3N5O4	489.454			HDBKJODUGIGTNA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.571	2	7	10	103.43	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626661	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626661&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CCO)N=C1	4-[5-[1-(2-hydroxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCCC1		34626662	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626662&database=RX&origin=ReaxysOutput&ln=	(126 of 1381)		2,6-dimethoxy-4-[5-(6-pyrrolidin-1-yl-3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C27H26F3N5O3	C27H26F3N5O3	525.53			YGPUKMNGOYGSIL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	6.098	1	6	9	81.51	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626662	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626662&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCCC1	2,6-dimethoxy-4-[5-(6-pyrrolidin-1-yl-3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCCC1		34626662	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626662&database=RX&origin=ReaxysOutput&ln=	(126 of 1381)		2,6-dimethoxy-4-[5-(6-pyrrolidin-1-yl-3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C27H26F3N5O3	C27H26F3N5O3	525.53			YGPUKMNGOYGSIL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	6.098	1	6	9	81.51	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626662	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626662&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCCC1	2,6-dimethoxy-4-[5-(6-pyrrolidin-1-yl-3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=CC(=C1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626663	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626663&database=RX&origin=ReaxysOutput&ln=	(127 of 1381)		2,6-dimethoxy-4-[5-(5-methoxy-3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H21F3N4O4	C24H21F3N4O4	486.45			UBQTZIYFTYSFOE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.45	1	5	9	87.5	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626663	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626663&database=RX&origin=ReaxysOutput&ln=	COC1=CN=CC(=C1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2,6-dimethoxy-4-[5-(5-methoxy-3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)C#N		34626664	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626664&database=RX&origin=ReaxysOutput&ln=	(128 of 1381)		4-[5-(6-cyano-3-pyridyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H18F3N5O3	C24H18F3N5O3	481.434			KQQHIIXZOXVFSD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.347	1	6	8	102.06	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626664	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626664&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)C#N	4-[5-(6-cyano-3-pyridyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N(C)C		34626666	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626666&database=RX&origin=ReaxysOutput&ln=	(129 of 1381)		4-[5-[6-(dimethylamino)-3-pyridyl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C25H24F3N5O3	C25H24F3N5O3	499.492			JPGROMNRJBWLJY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.472	1	6	9	81.51	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626666	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626666&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N(C)C	4-[5-[6-(dimethylamino)-3-pyridyl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N)N=C1		34626667	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626667&database=RX&origin=ReaxysOutput&ln=	(130 of 1381)		4-[5-(6-amino-3-pyridyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H20F3N5O3	C23H20F3N5O3	471.439			ZDERKZSHASZBPD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.446	2	6	8	104.29	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626667	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626667&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N)N=C1	4-[5-(6-amino-3-pyridyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=CN=C1		34626668	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626668&database=RX&origin=ReaxysOutput&ln=	(131 of 1381)		2,6-dimethoxy-4-[5-(3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H19F3N4O3	C23H19F3N4O3	456.424			GMIHBWKTHZHMRO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.535	1	5	8	78.27	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626668	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626668&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=CN=C1	2,6-dimethoxy-4-[5-(3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1		34626669	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626669&database=RX&origin=ReaxysOutput&ln=	(132 of 1381)		4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1 yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H19F3N6O3	C23H19F3N6O3	484.437			UWHMVUUPXPYDBV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.773	1	7	9	106.99	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626669	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626669&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1	4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1 yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1		34626669	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626669&database=RX&origin=ReaxysOutput&ln=	(132 of 1381)		4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1 yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H19F3N6O3	C23H19F3N6O3	484.437			UWHMVUUPXPYDBV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.773	1	7	9	106.99	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626669	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626669&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CC#N)N=C1	4-[5-[1-(cyanomethyl)pyrazol-4-yl]benzimidazol-1 yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC(C)(C)C)C(OC)=C1		34626671	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626671&database=RX&origin=ReaxysOutput&ln=	(133 of 1381)		N-tert-butyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C25H29N5O3	C25H29N5O3	447.537			BCOYQTYXUUHDTB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.578	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626671	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626671&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC(C)(C)C)C(OC)=C1	N-tert-butyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCCC(F)(F)F)C(OC)=C1		34626672	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626672&database=RX&origin=ReaxysOutput&ln=	(134 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(3,3,3-trifluoropropyl)benzamide	C24H24F3N5O3	C24H24F3N5O3	487.481			OVPLUPVGXBOEOL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.061	1	6	10	83.2	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626672	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626672&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCCC(F)(F)F)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(3,3,3-trifluoropropyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCCC(F)(F)F)C(OC)=C1		34626672	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626672&database=RX&origin=ReaxysOutput&ln=	(134 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(3,3,3-trifluoropropyl)benzamide	C24H24F3N5O3	C24H24F3N5O3	487.481			OVPLUPVGXBOEOL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.061	1	6	10	83.2	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626672	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626672&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCCC(F)(F)F)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(3,3,3-trifluoropropyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2CCCC2)C(OC)=C1		34626673	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626673&database=RX&origin=ReaxysOutput&ln=	(135 of 1381)		N-cyclopentyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C26H29N5O3	C26H29N5O3	459.548			MEKJKWLBVLGUDT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.537	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626673	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626673&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2CCCC2)C(OC)=C1	N-cyclopentyl-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2C[C@H]2C)C(OC)=C1		34626674	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626674&database=RX&origin=ReaxysOutput&ln=	(136 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-[(2R)-2-methylcyclopropyl]benzamide	C25H27N5O3	C25H27N5O3	445.521			JXDJEEBYTMRKCP-NYRJJRHWSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.118	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626674	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626674&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2C[C@H]2C)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-[(2R)-2-methylcyclopropyl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2C[C@H]2C)C(OC)=C1		34626674	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626674&database=RX&origin=ReaxysOutput&ln=	(136 of 1381)		4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-[(2R)-2-methylcyclopropyl]benzamide	C25H27N5O3	C25H27N5O3	445.521			JXDJEEBYTMRKCP-NYRJJRHWSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.118	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626674	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626674&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NC2C[C@H]2C)C(OC)=C1	4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-[(2R)-2-methylcyclopropyl]benzamide					EC50	nM	>	5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC#N)C(OC)=C1		34626675	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626675&database=RX&origin=ReaxysOutput&ln=	(137 of 1381)		N-(cyanomethyl)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C23H22N6O3	C23H22N6O3	430.466			XFAZMVZIGDEQDO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.771	1	7	8	106.99	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626675	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626675&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC#N)C(OC)=C1	N-(cyanomethyl)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC#N)C(OC)=C1		34626675	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626675&database=RX&origin=ReaxysOutput&ln=	(137 of 1381)		N-(cyanomethyl)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide	C23H22N6O3	C23H22N6O3	430.466			XFAZMVZIGDEQDO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.771	1	7	8	106.99	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626675	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626675&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC#N)C(OC)=C1	N-(cyanomethyl)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxybenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		34626676	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626676&database=RX&origin=ReaxysOutput&ln=	(138 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-6-methoxybenzamide	C24H23F2N5O3	C24H23F2N5O3	467.475			NUUPLAGABWRTDM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.535	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626676	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626676&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		34626676	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626676&database=RX&origin=ReaxysOutput&ln=	(138 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-6-methoxybenzamide	C24H23F2N5O3	C24H23F2N5O3	467.475			NUUPLAGABWRTDM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.535	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626676	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626676&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[5-(1-ethylpyrazol-4-yl)benzimidazol-1-yl]-6-methoxybenzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626679	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626679&database=RX&origin=ReaxysOutput&ln=	(139 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			YBNCPKWYYRQKFW-CYBMUJFWSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.74	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626679	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626679&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626679	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626679&database=RX&origin=ReaxysOutput&ln=	(139 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			YBNCPKWYYRQKFW-CYBMUJFWSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.74	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626679	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626679&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCCC#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626680	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626680&database=RX&origin=ReaxysOutput&ln=	(140 of 1381)		N-(2-cyanoethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H22N6O3	C23H22N6O3	430.466			HIGYBLLVKCSKEP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	2.506	1	7	8	106.99	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626680	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626680&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCCC#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(2-cyanoethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COCCCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626681	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626681&database=RX&origin=ReaxysOutput&ln=	(141 of 1381)		2,6-dimethoxy-N-(3-methoxypropyl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H27N5O4	C24H27N5O4	449.509			XZCVHQCPNTVCOT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.023	1	7	10	92.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626681	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626681&database=RX&origin=ReaxysOutput&ln=	COCCCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-N-(3-methoxypropyl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC1=NN(C)C=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626682	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626682&database=RX&origin=ReaxysOutput&ln=	(142 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-[(1-methylpyrazol-3-yl)methyl]benzamide	C25H25N7O3	C25H25N7O3	471.519			UXIPUBBJZOPQPX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.095	1	8	8	101.02	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626682	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626682&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC1=NN(C)C=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-[(1-methylpyrazol-3-yl)methyl]benzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC1=NC=CC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626683	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626683&database=RX&origin=ReaxysOutput&ln=	(143 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2-pyridylmethyl)benzamide	C26H24N6O3	C26H24N6O3	468.515			NMFGVFQVQWZBGR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	3.402	1	7	8	96.09	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626683	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626683&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC1=NC=CC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2-pyridylmethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCCCO)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626684	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626684&database=RX&origin=ReaxysOutput&ln=	(144 of 1381)		N-(3-hydroxypropyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H25N5O4	C23H25N5O4	435.483			YSFIUQUFZBOGFN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.504	2	7	9	103.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626684	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626684&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCCCO)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(3-hydroxypropyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CS(=O)(=O)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626685	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626685&database=RX&origin=ReaxysOutput&ln=	(145 of 1381)		N-(1,1-dioxothietan-3-yl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H23N5O5S	C23H23N5O5S	481.532			ASSAHTCZTPMCED-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.432	1	8	7	125.72	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626685	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626685&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CS(=O)(=O)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(1,1-dioxothietan-3-yl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=C(C=CN=C1)C(N)=O		34626686	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626686&database=RX&origin=ReaxysOutput&ln=	(146 of 1381)		3-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyridine-4-carboxamide	C24H20F3N5O4	C24H20F3N5O4	499.449			HLGMNVPDSCIUQY-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	3.873	2	7	9	120.84	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626686	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626686&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=C(C=CN=C1)C(N)=O	3-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyridine-4-carboxamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=C(C=CN=C1)C(N)=O		34626686	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626686&database=RX&origin=ReaxysOutput&ln=	(146 of 1381)		3-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyridine-4-carboxamide	C24H20F3N5O4	C24H20F3N5O4	499.449			HLGMNVPDSCIUQY-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	3.873	2	7	9	120.84	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626686	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626686&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=C(C=CN=C1)C(N)=O	3-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyridine-4-carboxamide					IC50	nM	>	10 - 100							8			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCCS(C)(=O)=O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626687	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626687&database=RX&origin=ReaxysOutput&ln=	(147 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2-methylsulfonylethyl)benzamide	C23H25N5O5S	C23H25N5O5S	483.548			WYUXSDUDZLIIKO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.67	1	8	9	125.72	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626687	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626687&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCCS(C)(=O)=O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2-methylsulfonylethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CCS(=O)(=O)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626688	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626688&database=RX&origin=ReaxysOutput&ln=	(148 of 1381)		N-(1,1-dioxothiolan-3-yl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H25N5O5S	C24H25N5O5S	495.559			PWXFGRCCONSXQS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.79	1	8	7	125.72	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626688	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626688&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CCS(=O)(=O)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(1,1-dioxothiolan-3-yl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC[C@@H]1COCCO1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626689	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626689&database=RX&origin=ReaxysOutput&ln=	(149 of 1381)		N-[[(2R)-1,4-dioxan-2-yl]methyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C25H27N5O5	C25H27N5O5	477.52			LJQVYUHAHKQRCJ-LJQANCHMSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	2.302	1	8	8	101.66	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626689	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626689&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC[C@@H]1COCCO1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[[(2R)-1,4-dioxan-2-yl]methyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC(C)(C)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626690	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626690&database=RX&origin=ReaxysOutput&ln=	(150 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoro-1,1-dimethylethyl)benzamide	C24H24F3N5O3	C24H24F3N5O3	487.481			WTQOOEHPNCJVNC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.157	1	6	8	83.2	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626690	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626690&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC(C)(C)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoro-1,1-dimethylethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC[C@H]1COCCO1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626691	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626691&database=RX&origin=ReaxysOutput&ln=	(151 of 1381)		N-[[(2S)-1,4-dioxan-2-yl]methyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C25H27N5O5	C25H27N5O5	477.52			LJQVYUHAHKQRCJ-IBGZPJMESA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.302	1	8	8	101.66	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626691	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626691&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC[C@H]1COCCO1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[[(2S)-1,4-dioxan-2-yl]methyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC1=NC=CN1C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626692	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626692&database=RX&origin=ReaxysOutput&ln=	(152 of 1381)		2,6-dimethoxy-N-[(1-methylimidazol-2-yl)methyl]-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C25H25N7O3	C25H25N7O3	471.519			NCBDCQSJJZSVSV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.819	1	8	8	101.02	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626692	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626692&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC1=NC=CN1C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-N-[(1-methylimidazol-2-yl)methyl]-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1=NOC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626693	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626693&database=RX&origin=ReaxysOutput&ln=	(153 of 1381)		N-isoxazol-3-yl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H20N6O4	C23H20N6O4	444.45			ICVFQUCBSVTZLY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.468	1	6	7	109.23	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626693	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626693&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1=NOC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-isoxazol-3-yl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1=CC=NN1C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626694	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626694&database=RX&origin=ReaxysOutput&ln=	(154 of 1381)		2,6-dimethoxy-N-(2-methylpyrazol-3-yl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H23N7O3	C24H23N7O3	457.492			AFHDHCUSFUFGNE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.488	1	8	7	101.02	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626694	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626694&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1=CC=NN1C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-N-(2-methylpyrazol-3-yl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N(C)CC#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626695	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626695&database=RX&origin=ReaxysOutput&ln=	(155 of 1381)		N-(cyanomethyl)-2,6-dimethoxy-N-methyl-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H22N6O3	C23H22N6O3	430.466			VJZRWKPXRAPCMP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.49	0	7	7	98.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626695	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626695&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N(C)CC#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(cyanomethyl)-2,6-dimethoxy-N-methyl-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626696	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626696&database=RX&origin=ReaxysOutput&ln=	(156 of 1381)		N-(cyanomethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H20N6O3	C22H20N6O3	416.439			SYXYZEKJBMGONP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.348	1	7	7	106.99	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626696	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626696&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(cyanomethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=C(C=CN=C1)C#N		34626697	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626697&database=RX&origin=ReaxysOutput&ln=	(157 of 1381)		4-[7-(4-cyano-3-pyridyl)imidazo[1,2]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H18F3N5O3	C24H18F3N5O3	481.434			NLBURDXRJHUWDW-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	4.709	1	6	8	101.54	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626697	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626697&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=C(C=CN=C1)C#N	4-[7-(4-cyano-3-pyridyl)imidazo[1,2]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=C(C=CN=C1)C#N		34626697	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626697&database=RX&origin=ReaxysOutput&ln=	(157 of 1381)		4-[7-(4-cyano-3-pyridyl)imidazo[1,2]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H18F3N5O3	C24H18F3N5O3	481.434			NLBURDXRJHUWDW-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	4.709	1	6	8	101.54	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626697	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626697&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=C(C=CN=C1)C#N	4-[7-(4-cyano-3-pyridyl)imidazo[1,2]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC(C)(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626698	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626698&database=RX&origin=ReaxysOutput&ln=	(158 of 1381)		N-tert-butyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H27N5O3	C24H27N5O3	433.51			RDJIBOSPKNSEEI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.155	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626698	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626698&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC(C)(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-tert-butyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC(C)(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626698	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626698&database=RX&origin=ReaxysOutput&ln=	(158 of 1381)		N-tert-butyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H27N5O3	C24H27N5O3	433.51			RDJIBOSPKNSEEI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.155	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626698	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626698&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC(C)(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-tert-butyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	500							6.3			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC(C)(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626698	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626698&database=RX&origin=ReaxysOutput&ln=	(158 of 1381)		N-tert-butyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H27N5O3	C24H27N5O3	433.51			RDJIBOSPKNSEEI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.155	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626698	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626698&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC(C)(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-tert-butyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM	>	5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CCC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626699	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626699&database=RX&origin=ReaxysOutput&ln=	(159 of 1381)		N-cyclobutyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H25N5O3	C24H25N5O3	431.494			JNCCTDRFOJJEDY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.756	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626699	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626699&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CCC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-cyclobutyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626700	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626700&database=RX&origin=ReaxysOutput&ln=	(160 of 1381)		N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			WRDZOEPVIKBBON-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.764	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626700	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626700&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626700	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626700&database=RX&origin=ReaxysOutput&ln=	(160 of 1381)		N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			WRDZOEPVIKBBON-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.764	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626700	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626700&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626700	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626700&database=RX&origin=ReaxysOutput&ln=	(160 of 1381)		N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			WRDZOEPVIKBBON-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.764	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626700	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626700&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCCF)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626701	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626701&database=RX&origin=ReaxysOutput&ln=	(161 of 1381)		N-(2-fluoroethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H22FN5O3	C22H22FN5O3	423.447			MXIWLRAKEZWFHJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.483	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626701	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626701&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCCF)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(2-fluoroethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626702	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626702&database=RX&origin=ReaxysOutput&ln=	(162 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			YBNCPKWYYRQKFW-ZDUSSCGKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.74	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626702	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626702&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626702	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626702&database=RX&origin=ReaxysOutput&ln=	(162 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			YBNCPKWYYRQKFW-ZDUSSCGKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.74	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626702	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626702&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1=NN(C)C=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626703	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626703&database=RX&origin=ReaxysOutput&ln=	(163 of 1381)		2,6-dimethoxy-N-(1-methylpyrazol-3-yl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H23N7O3	C24H23N7O3	457.492			AJNYMLZFEQOKID-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.321	1	8	7	101.02	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626703	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626703&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1=NN(C)C=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-N-(1-methylpyrazol-3-yl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1=CN(C)C=N1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626704	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626704&database=RX&origin=ReaxysOutput&ln=	(164 of 1381)		2,6-dimethoxy-N-(1-methylimidazol-4-yl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H23N7O3	C24H23N7O3	457.492			QHPUUJXJIQZTRT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.148	1	8	7	101.02	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626704	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626704&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1=CN(C)C=N1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-N-(1-methylimidazol-4-yl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1=CN(C)N=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626705	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626705&database=RX&origin=ReaxysOutput&ln=	(165 of 1381)		2,6-dimethoxy-N-(1-methylpyrazol-4-yl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H23N7O3	C24H23N7O3	457.492			MTISKZPFVUUMEM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.321	1	8	7	101.02	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626705	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626705&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1=CN(C)N=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-N-(1-methylpyrazol-4-yl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626706	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626706&database=RX&origin=ReaxysOutput&ln=	(166 of 1381)		2,6-dimethoxy-4-[5-[1-(2-methoxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H24F3N5O4	C24H24F3N5O4	503.481			KOJPILPRBMWJBJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.09	1	7	11	92.43	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626706	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626706&database=RX&origin=ReaxysOutput&ln=	COCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2,6-dimethoxy-4-[5-[1-(2-methoxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626706	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626706&database=RX&origin=ReaxysOutput&ln=	(166 of 1381)		2,6-dimethoxy-4-[5-[1-(2-methoxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H24F3N5O4	C24H24F3N5O4	503.481			KOJPILPRBMWJBJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.09	1	7	11	92.43	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626706	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626706&database=RX&origin=ReaxysOutput&ln=	COCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2,6-dimethoxy-4-[5-[1-(2-methoxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626706	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626706&database=RX&origin=ReaxysOutput&ln=	(166 of 1381)		2,6-dimethoxy-4-[5-[1-(2-methoxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H24F3N5O4	C24H24F3N5O4	503.481			KOJPILPRBMWJBJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.09	1	7	11	92.43	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626706	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626706&database=RX&origin=ReaxysOutput&ln=	COCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2,6-dimethoxy-4-[5-[1-(2-methoxyethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1COC1		34626707	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626707&database=RX&origin=ReaxysOutput&ln=	(167 of 1381)		2,6-dimethoxy-4-[5-[1-(oxetan-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H22F3N5O4	C24H22F3N5O4	501.465			SMCNGHBAZFLBPJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.917	1	7	9	92.43	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626707	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626707&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1COC1	2,6-dimethoxy-4-[5-[1-(oxetan-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1COC1		34626707	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626707&database=RX&origin=ReaxysOutput&ln=	(167 of 1381)		2,6-dimethoxy-4-[5-[1-(oxetan-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H22F3N5O4	C24H22F3N5O4	501.465			SMCNGHBAZFLBPJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.917	1	7	9	92.43	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626707	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626707&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1COC1	2,6-dimethoxy-4-[5-[1-(oxetan-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1COC1		34626707	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626707&database=RX&origin=ReaxysOutput&ln=	(167 of 1381)		2,6-dimethoxy-4-[5-[1-(oxetan-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H22F3N5O4	C24H22F3N5O4	501.465			SMCNGHBAZFLBPJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.917	1	7	9	92.43	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626707	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626707&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1COC1	2,6-dimethoxy-4-[5-[1-(oxetan-3-yl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC(C)C#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626709	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626709&database=RX&origin=ReaxysOutput&ln=	(168 of 1381)		N-(1-cyanoethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H22N6O3	C23H22N6O3	430.466			GBRIBVBLMXWFGN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.874	1	7	7	106.99	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626709	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626709&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC(C)C#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(1-cyanoethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NN(C)C=C1		34626710	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626710&database=RX&origin=ReaxysOutput&ln=	(169 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-3-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			PACBCQDMMFXBQG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.28	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626710	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626710&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NN(C)C=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-3-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CCCC1(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626711	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626711&database=RX&origin=ReaxysOutput&ln=	(170 of 1381)		N-(2,2-difluorocyclopentyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C25H25F2N5O3	C25H25F2N5O3	481.502			STFLYFXPIHEHGL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.637	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626711	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626711&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CCCC1(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(2,2-difluorocyclopentyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC(C)C(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626712	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626712&database=RX&origin=ReaxysOutput&ln=	(171 of 1381)		N-(2,2-difluoro-1-methylethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H23F2N5O3	C23H23F2N5O3	455.464			XCBOEBJRXCKLBE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.224	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626712	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626712&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC(C)C(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(2,2-difluoro-1-methylethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1COC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626713	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626713&database=RX&origin=ReaxysOutput&ln=	(172 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(oxetan-3-yl)benzamide	C23H23N5O4	C23H23N5O4	433.467			AZABXXFXOPOTAS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.492	1	7	7	92.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626713	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626713&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1COC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(oxetan-3-yl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=NC=C1		34626714	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626714&database=RX&origin=ReaxysOutput&ln=	(173 of 1381)		2,6-dimethoxy-4-(5-pyridazin-4-ylbenzimidazol-1-yl)-N-(2,2,2-trifluoroethyl)benzamide	C22H18F3N5O3	C22H18F3N5O3	457.412			RBLYDSFWLOMDEJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.705	1	6	8	91.16	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626714	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626714&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=NC=C1	2,6-dimethoxy-4-(5-pyridazin-4-ylbenzimidazol-1-yl)-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(C)C		34626715	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626715&database=RX&origin=ReaxysOutput&ln=	(174 of 1381)		4-[5-(1-isopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H24F3N5O3	C24H24F3N5O3	487.481			JPJSWDGWLPCKGT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.163	1	6	9	83.2	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626715	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626715&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(C)C	4-[5-(1-isopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(C)C		34626715	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626715&database=RX&origin=ReaxysOutput&ln=	(174 of 1381)		4-[5-(1-isopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H24F3N5O3	C24H24F3N5O3	487.481			JPJSWDGWLPCKGT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.163	1	6	9	83.2	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626715	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626715&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(C)C	4-[5-(1-isopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(C)C		34626715	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626715&database=RX&origin=ReaxysOutput&ln=	(174 of 1381)		4-[5-(1-isopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H24F3N5O3	C24H24F3N5O3	487.481			JPJSWDGWLPCKGT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.163	1	6	9	83.2	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626715	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626715&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(C)C	4-[5-(1-isopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CC1		34626716	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626716&database=RX&origin=ReaxysOutput&ln=	(175 of 1381)		4-[5-(1-cyclopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H22F3N5O3	C24H22F3N5O3	485.466			FUQWFBZMWJOODE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.823	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626716	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626716&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CC1	4-[5-(1-cyclopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CC1		34626716	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626716&database=RX&origin=ReaxysOutput&ln=	(175 of 1381)		4-[5-(1-cyclopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H22F3N5O3	C24H22F3N5O3	485.466			FUQWFBZMWJOODE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.823	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626716	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626716&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CC1	4-[5-(1-cyclopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CC1		34626716	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626716&database=RX&origin=ReaxysOutput&ln=	(175 of 1381)		4-[5-(1-cyclopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H22F3N5O3	C24H22F3N5O3	485.466			FUQWFBZMWJOODE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.823	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626716	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626716&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C1CC1	4-[5-(1-cyclopropylpyrazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(F)F		34626717	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626717&database=RX&origin=ReaxysOutput&ln=	(176 of 1381)		4-[5-[1-(difluoromethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H18F5N5O3	C22H18F5N5O3	495.409			AIWCSKWNZKWSGE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.994	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626717	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626717&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(F)F	4-[5-[1-(difluoromethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(F)F		34626717	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626717&database=RX&origin=ReaxysOutput&ln=	(176 of 1381)		4-[5-[1-(difluoromethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H18F5N5O3	C22H18F5N5O3	495.409			AIWCSKWNZKWSGE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.994	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626717	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626717&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(F)F	4-[5-[1-(difluoromethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(F)F		34626717	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626717&database=RX&origin=ReaxysOutput&ln=	(176 of 1381)		4-[5-[1-(difluoromethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H18F5N5O3	C22H18F5N5O3	495.409			AIWCSKWNZKWSGE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.994	1	6	9	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626717	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626717&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(N=C1)C(F)F	4-[5-[1-(difluoromethyl)pyrazol-4-yl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CCCC(O)=O)N=C1		34626718	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626718&database=RX&origin=ReaxysOutput&ln=	(177 of 1381)		4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoic acid	C25H24F3N5O5	C25H24F3N5O5	531.491			OSMPZUKBXFEXLM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.629	2	8	12	119.98	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626718	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626718&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CCCC(O)=O)N=C1	4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoic acid					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CCCC(O)=O)N=C1		34626718	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626718&database=RX&origin=ReaxysOutput&ln=	(177 of 1381)		4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoic acid	C25H24F3N5O5	C25H24F3N5O5	531.491			OSMPZUKBXFEXLM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.629	2	8	12	119.98	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626718	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626718&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CCCC(O)=O)N=C1	4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoic acid					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NN1		34626719	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626719&database=RX&origin=ReaxysOutput&ln=	(178 of 1381)		2,6-dimethoxy-4-[5-(3-methyl-1H-pyrazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			BJSUSECIHQXCQY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.751	2	6	8	94.06	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626719	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626719&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NN1	2,6-dimethoxy-4-[5-(3-methyl-1H-pyrazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NN1		34626719	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626719&database=RX&origin=ReaxysOutput&ln=	(178 of 1381)		2,6-dimethoxy-4-[5-(3-methyl-1H-pyrazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			BJSUSECIHQXCQY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.751	2	6	8	94.06	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626719	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626719&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NN1	2,6-dimethoxy-4-[5-(3-methyl-1H-pyrazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NN1		34626719	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626719&database=RX&origin=ReaxysOutput&ln=	(178 of 1381)		2,6-dimethoxy-4-[5-(3-methyl-1H-pyrazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			BJSUSECIHQXCQY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.751	2	6	8	94.06	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626719	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626719&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NN1	2,6-dimethoxy-4-[5-(3-methyl-1H-pyrazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626720	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626720&database=RX&origin=ReaxysOutput&ln=	(179 of 1381)		N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H23N5O3	C23H23N5O3	417.467			KEAAVXWXDLXNHH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.849	1	6	7	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626720	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626720&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626720	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626720&database=RX&origin=ReaxysOutput&ln=	(179 of 1381)		N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H23N5O3	C23H23N5O3	417.467			KEAAVXWXDLXNHH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.849	1	6	7	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626720	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626720&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626720	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626720&database=RX&origin=ReaxysOutput&ln=	(179 of 1381)		N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H23N5O3	C23H23N5O3	417.467			KEAAVXWXDLXNHH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.849	1	6	7	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626720	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626720&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626721	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626721&database=RX&origin=ReaxysOutput&ln=	(180 of 1381)		2,6-dimethoxy-4-[5-(1-propylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H24F3N5O3	C24H24F3N5O3	487.481			XXPHNEADOXPNNK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.061	1	6	10	83.2	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626721	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626721&database=RX&origin=ReaxysOutput&ln=	CCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2,6-dimethoxy-4-[5-(1-propylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626721	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626721&database=RX&origin=ReaxysOutput&ln=	(180 of 1381)		2,6-dimethoxy-4-[5-(1-propylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H24F3N5O3	C24H24F3N5O3	487.481			XXPHNEADOXPNNK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.061	1	6	10	83.2	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626721	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626721&database=RX&origin=ReaxysOutput&ln=	CCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2,6-dimethoxy-4-[5-(1-propylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626721	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626721&database=RX&origin=ReaxysOutput&ln=	(180 of 1381)		2,6-dimethoxy-4-[5-(1-propylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H24F3N5O3	C24H24F3N5O3	487.481			XXPHNEADOXPNNK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.061	1	6	10	83.2	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626721	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626721&database=RX&origin=ReaxysOutput&ln=	CCCN1C=C(C=N1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2,6-dimethoxy-4-[5-(1-propylpyrazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=CN=C1		34626722	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626722&database=RX&origin=ReaxysOutput&ln=	(181 of 1381)		2,6-dimethoxy-4-(5-pyrimidin-5-ylbenzimidazol-1-yl)-N-(2,2,2-trifluoroethyl)benzamide	C22H18F3N5O3	C22H18F3N5O3	457.412			GAANLPRVTBCFNP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.494	1	6	8	91.16	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626722	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626722&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=CN=C1	2,6-dimethoxy-4-(5-pyrimidin-5-ylbenzimidazol-1-yl)-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=C(OC)N=C1		34626723	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626723&database=RX&origin=ReaxysOutput&ln=	(182 of 1381)		2,6-dimethoxy-4-[5-(2-methoxypyrimidin-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H20F3N5O4	C23H20F3N5O4	487.438			KTIANJPEIQICLW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.137	1	6	9	100.39	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626723	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626723&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=C(OC)N=C1	2,6-dimethoxy-4-[5-(2-methoxypyrimidin-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=NC=CC(=C1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626724	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626724&database=RX&origin=ReaxysOutput&ln=	(183 of 1381)		2,6-dimethoxy-4-[5-(2-methoxy-4-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H21F3N4O4	C24H21F3N4O4	486.45			WNKRIGDZZCSTET-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.178	1	5	9	87.5	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626724	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626724&database=RX&origin=ReaxysOutput&ln=	COC1=NC=CC(=C1)C1=CC=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2,6-dimethoxy-4-[5-(2-methoxy-4-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1		34626725	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626725&database=RX&origin=ReaxysOutput&ln=	(184 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H19F3N6O3	C21H19F3N6O3	460.415			NOEKALURDGTVIP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.901	1	7	8	95.57	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626725	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626725&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1		34626725	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626725&database=RX&origin=ReaxysOutput&ln=	(184 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H19F3N6O3	C21H19F3N6O3	460.415			NOEKALURDGTVIP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.901	1	7	8	95.57	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626725	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626725&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1		34626725	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626725&database=RX&origin=ReaxysOutput&ln=	(184 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H19F3N6O3	C21H19F3N6O3	460.415			NOEKALURDGTVIP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.901	1	7	8	95.57	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626725	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626725&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CON=C1C		34626726	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626726&database=RX&origin=ReaxysOutput&ln=	(185 of 1381)		2,6-dimethoxy-4-[5-(3-methylisoxazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H19F3N4O4	C22H19F3N4O4	460.412			DSGHCNMXYONVMU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.608	1	4	8	91.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626726	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626726&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CON=C1C	2,6-dimethoxy-4-[5-(3-methylisoxazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NO1		34626727	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626727&database=RX&origin=ReaxysOutput&ln=	(186 of 1381)		2,6-dimethoxy-4-[5-(3-methylisoxazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H19F3N4O4	C22H19F3N4O4	460.412			XFUWQURAEWZMGF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.703	1	4	8	91.41	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626727	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626727&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NO1	2,6-dimethoxy-4-[5-(3-methylisoxazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NO1		34626727	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626727&database=RX&origin=ReaxysOutput&ln=	(186 of 1381)		2,6-dimethoxy-4-[5-(3-methylisoxazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H19F3N4O4	C22H19F3N4O4	460.412			XFUWQURAEWZMGF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.703	1	4	8	91.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626727	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626727&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NO1	2,6-dimethoxy-4-[5-(3-methylisoxazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NO1		34626727	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626727&database=RX&origin=ReaxysOutput&ln=	(186 of 1381)		2,6-dimethoxy-4-[5-(3-methylisoxazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H19F3N4O4	C22H19F3N4O4	460.412			XFUWQURAEWZMGF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.703	1	4	8	91.41	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626727	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626727&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(C)=NO1	2,6-dimethoxy-4-[5-(3-methylisoxazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CC2CCCO2)N=C1		34626728	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626728&database=RX&origin=ReaxysOutput&ln=	(187 of 1381)		2,6-dimethoxy-4-[5-[1-(tetrahydrofuran-2-ylmethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C26H26F3N5O4	C26H26F3N5O4	529.519			VTSYSGSGGPBNFB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.633	1	7	10	92.43	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626728	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626728&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CC2CCCO2)N=C1	2,6-dimethoxy-4-[5-[1-(tetrahydrofuran-2-ylmethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1		34626730	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626730&database=RX&origin=ReaxysOutput&ln=	(188 of 1381)		N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]benzamide	C22H22N6O3	C22H22N6O3	418.455			PRJCZUUTHGXXEH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	3.019	1	7	7	95.57	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626730	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626730&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1	N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1		34626730	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626730&database=RX&origin=ReaxysOutput&ln=	(188 of 1381)		N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]benzamide	C22H22N6O3	C22H22N6O3	418.455			PRJCZUUTHGXXEH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	3.019	1	7	7	95.57	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626730	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626730&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1	N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1		34626730	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626730&database=RX&origin=ReaxysOutput&ln=	(188 of 1381)		N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]benzamide	C22H22N6O3	C22H22N6O3	418.455			PRJCZUUTHGXXEH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	3.019	1	7	7	95.57	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626730	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626730&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=NN12)C1=CN(C)N=C1	N-cyclopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-b]pyridazin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626731	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626731&database=RX&origin=ReaxysOutput&ln=	(189 of 1381)		N-isobutyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H27N5O3	C24H27N5O3	433.51			ZBOUBYSVMGMFKX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	3.933	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626731	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626731&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-isobutyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCC(C)NC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626732	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626732&database=RX&origin=ReaxysOutput&ln=	(190 of 1381)		2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-sec-butylbenzamide	C24H27N5O3	C24H27N5O3	433.51			QUXRLEJCDKKYBH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.096	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626732	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626732&database=RX&origin=ReaxysOutput&ln=	CCC(C)NC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-sec-butylbenzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626733	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626733&database=RX&origin=ReaxysOutput&ln=	(191 of 1381)		N-isopropyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H25N5O3	C23H25N5O3	419.483			OPXOROKFWPUTAX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	3.738	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626733	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626733&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-isopropyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626734	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626734&database=RX&origin=ReaxysOutput&ln=	(192 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			CLYFBFNQUOYAQJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.443	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626734	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626734&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626734	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626734&database=RX&origin=ReaxysOutput&ln=	(192 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			CLYFBFNQUOYAQJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.443	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626734	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626734&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626734	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626734&database=RX&origin=ReaxysOutput&ln=	(192 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			CLYFBFNQUOYAQJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.443	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626734	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626734&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1		34626735	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626735&database=RX&origin=ReaxysOutput&ln=	(193 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			VVZMEYKGRPKTTF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.243	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626735	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626735&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1		34626735	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626735&database=RX&origin=ReaxysOutput&ln=	(193 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			VVZMEYKGRPKTTF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.243	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626735	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626735&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1		34626735	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626735&database=RX&origin=ReaxysOutput&ln=	(193 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			VVZMEYKGRPKTTF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.243	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626735	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626735&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(=NC=C1)N1CCN(C)CC1		34626737	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626737&database=RX&origin=ReaxysOutput&ln=	(194 of 1381)		2,6-dimethoxy-4-[5-[2-(4-methylpiperazin-1-yl)-4-pyridyl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C28H29F3N6O3	C28H29F3N6O3	554.572			GJTAIIXROMOJEC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.235	1	7	9	84.75	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626737	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626737&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(=NC=C1)N1CCN(C)CC1	2,6-dimethoxy-4-[5-[2-(4-methylpiperazin-1-yl)-4-pyridyl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(=NC=C1)N1CCN(C)CC1		34626737	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626737&database=RX&origin=ReaxysOutput&ln=	(194 of 1381)		2,6-dimethoxy-4-[5-[2-(4-methylpiperazin-1-yl)-4-pyridyl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C28H29F3N6O3	C28H29F3N6O3	554.572			GJTAIIXROMOJEC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.235	1	7	9	84.75	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626737	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626737&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(=NC=C1)N1CCN(C)CC1	2,6-dimethoxy-4-[5-[2-(4-methylpiperazin-1-yl)-4-pyridyl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(=NC=C1)N1CCN(C)CC1		34626737	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626737&database=RX&origin=ReaxysOutput&ln=	(194 of 1381)		2,6-dimethoxy-4-[5-[2-(4-methylpiperazin-1-yl)-4-pyridyl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C28H29F3N6O3	C28H29F3N6O3	554.572			GJTAIIXROMOJEC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.235	1	7	9	84.75	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626737	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626737&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(=NC=C1)N1CCN(C)CC1	2,6-dimethoxy-4-[5-[2-(4-methylpiperazin-1-yl)-4-pyridyl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(=NC=C1)N1CCN(C)CC1		34626737	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626737&database=RX&origin=ReaxysOutput&ln=	(194 of 1381)		2,6-dimethoxy-4-[5-[2-(4-methylpiperazin-1-yl)-4-pyridyl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C28H29F3N6O3	C28H29F3N6O3	554.572			GJTAIIXROMOJEC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.235	1	7	9	84.75	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626737	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626737&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC(=NC=C1)N1CCN(C)CC1	2,6-dimethoxy-4-[5-[2-(4-methylpiperazin-1-yl)-4-pyridyl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=NC(C)=C1		34626738	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626738&database=RX&origin=ReaxysOutput&ln=	(195 of 1381)		2,6-dimethoxy-4-[5-(6-methylpyridazin-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H20F3N5O3	C23H20F3N5O3	471.439			ZYMSUCZTEGSLSC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.02	1	6	8	91.16	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626738	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626738&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=NC(C)=C1	2,6-dimethoxy-4-[5-(6-methylpyridazin-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626739	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626739&database=RX&origin=ReaxysOutput&ln=	(196 of 1381)		N-(cyanomethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20N6O3	C22H20N6O3	416.439			DQWUKZFMYUQZSB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.799	1	7	7	106.47	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626739	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626739&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-(cyanomethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626739	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626739&database=RX&origin=ReaxysOutput&ln=	(196 of 1381)		N-(cyanomethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20N6O3	C22H20N6O3	416.439			DQWUKZFMYUQZSB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.799	1	7	7	106.47	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626739	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626739&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-(cyanomethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626739	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626739&database=RX&origin=ReaxysOutput&ln=	(196 of 1381)		N-(cyanomethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20N6O3	C22H20N6O3	416.439			DQWUKZFMYUQZSB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.799	1	7	7	106.47	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626739	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626739&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-(cyanomethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1		34626740	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626740&database=RX&origin=ReaxysOutput&ln=	(197 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20F2N4O4	C22H20F2N4O4	442.422			IACGYFNVGGFTSV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.866	1	4	8	90.89	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626740	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626740&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1		34626740	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626740&database=RX&origin=ReaxysOutput&ln=	(197 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20F2N4O4	C22H20F2N4O4	442.422			IACGYFNVGGFTSV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.866	1	4	8	90.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626740	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626740&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1		34626740	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626740&database=RX&origin=ReaxysOutput&ln=	(197 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20F2N4O4	C22H20F2N4O4	442.422			IACGYFNVGGFTSV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.866	1	4	8	90.89	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626740	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626740&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC(F)(F)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626741	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626741&database=RX&origin=ReaxysOutput&ln=	(198 of 1381)		N-(3,3-difluorocyclobutyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H23F2N5O3	C24H23F2N5O3	467.475			XMOPMAOIWSNYCZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.279	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626741	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626741&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC(F)(F)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(3,3-difluorocyclobutyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC(F)(F)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626741	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626741&database=RX&origin=ReaxysOutput&ln=	(198 of 1381)		N-(3,3-difluorocyclobutyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H23F2N5O3	C24H23F2N5O3	467.475			XMOPMAOIWSNYCZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.279	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626741	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626741&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC(F)(F)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(3,3-difluorocyclobutyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=CC=N1		34626742	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626742&database=RX&origin=ReaxysOutput&ln=	(199 of 1381)		2,6-dimethoxy-4-(5-pyrazin-2-ylbenzimidazol-1-yl)-N-(2,2,2-trifluoroethyl)benzamide	C22H18F3N5O3	C22H18F3N5O3	457.412			XCTHJDDEQOHSDA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.372	1	6	8	91.16	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626742	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626742&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=CC=N1	2,6-dimethoxy-4-(5-pyrazin-2-ylbenzimidazol-1-yl)-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(C)C)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626743	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626743&database=RX&origin=ReaxysOutput&ln=	(200 of 1381)		N-isobutyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H27N5O3	C24H27N5O3	433.51			SXPLHZLJXMDQAU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.384	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626743	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626743&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(C)C)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-isobutyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(C)C)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626743	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626743&database=RX&origin=ReaxysOutput&ln=	(200 of 1381)		N-isobutyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H27N5O3	C24H27N5O3	433.51			SXPLHZLJXMDQAU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.384	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626743	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626743&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(C)C)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-isobutyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CS(=O)(=O)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626744	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626744&database=RX&origin=ReaxysOutput&ln=	(201 of 1381)		N-(1,1-dioxothietan-3-yl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H23N5O5S	C23H23N5O5S	481.532			VGMOHOLTLLWSHY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.883	1	8	7	125.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626744	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626744&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CS(=O)(=O)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-(1,1-dioxothietan-3-yl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COCCN(C)C(=O)C1=C(OC)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626745	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626745&database=RX&origin=ReaxysOutput&ln=	(202 of 1381)		2,6-dimethoxy-N-(2-methoxyethyl)-N-methyl-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H27N5O4	C24H27N5O4	449.509			QKVOVPAIQYXXJS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.258	0	7	9	83.12	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626745	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626745&database=RX&origin=ReaxysOutput&ln=	COCCN(C)C(=O)C1=C(OC)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-N-(2-methoxyethyl)-N-methyl-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626746	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626746&database=RX&origin=ReaxysOutput&ln=	(203 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			GWZDHUMHTZNQGC-ZDUSSCGKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.191	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626746	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626746&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626746	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626746&database=RX&origin=ReaxysOutput&ln=	(203 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			GWZDHUMHTZNQGC-ZDUSSCGKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.191	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626746	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626746&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626746	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626746&database=RX&origin=ReaxysOutput&ln=	(203 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			GWZDHUMHTZNQGC-ZDUSSCGKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.191	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626746	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626746&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626747	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626747&database=RX&origin=ReaxysOutput&ln=	(204 of 1381)		N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			KDZFRZZAMARNRY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.215	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626747	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626747&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626747	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626747&database=RX&origin=ReaxysOutput&ln=	(204 of 1381)		N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			KDZFRZZAMARNRY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.215	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626747	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626747&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626747	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626747&database=RX&origin=ReaxysOutput&ln=	(204 of 1381)		N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			KDZFRZZAMARNRY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.215	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626747	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626747&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-(2,2-difluoroethyl)-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NC=CN1C		34626748	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626748&database=RX&origin=ReaxysOutput&ln=	(205 of 1381)		2,6-dimethoxy-4-[5-(1-methylimidazol-2-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			MBRAWZWTIRILFD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.044	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626748	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626748&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=NC=CN1C	2,6-dimethoxy-4-[5-(1-methylimidazol-2-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=CN1C		34626749	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626749&database=RX&origin=ReaxysOutput&ln=	(206 of 1381)		2,6-dimethoxy-4-[5-(3-methylimidazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			WSIIBVLHMXBPTH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.044	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626749	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626749&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=CN1C	2,6-dimethoxy-4-[5-(3-methylimidazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=NOC(C)=N1		34626750	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626750&database=RX&origin=ReaxysOutput&ln=	(207 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-(5-methyl-1,2,4-oxadiazol-3-yl)benzimidazol-1-yl]benzamide	C21H19F2N5O4	C21H19F2N5O4	443.41			CTRZSCBQFFOJEW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.924	1	5	8	104.3	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626750	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626750&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=NOC(C)=N1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-(5-methyl-1,2,4-oxadiazol-3-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=C(C)N1C		34626751	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626751&database=RX&origin=ReaxysOutput&ln=	(208 of 1381)		4-[5-(2,3-dimethylimidazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			GMTRQLOEVHRJEI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.28	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626751	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626751&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=C(C)N1C	4-[5-(2,3-dimethylimidazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CCCC[C@H]1N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626752	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626752&database=RX&origin=ReaxysOutput&ln=	(209 of 1381)		N-[(1R,2R)-2-aminocyclohexyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4yl)benzimidazol-1-yl]benzamide	C26H30N6O3	C26H30N6O3	474.563			BQQDOQAOYGAXEC-WOJBJXKFSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.375	2	7	7	109.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626752	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626752&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CCCC[C@H]1N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2R)-2-aminocyclohexyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4yl)benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CCCC[C@H]1N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626752	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626752&database=RX&origin=ReaxysOutput&ln=	(209 of 1381)		N-[(1R,2R)-2-aminocyclohexyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4yl)benzimidazol-1-yl]benzamide	C26H30N6O3	C26H30N6O3	474.563			BQQDOQAOYGAXEC-WOJBJXKFSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.375	2	7	7	109.22	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626752	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626752&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CCCC[C@H]1N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2R)-2-aminocyclohexyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4yl)benzimidazol-1-yl]benzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CCC[C@H]1O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626753	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626753&database=RX&origin=ReaxysOutput&ln=	(210 of 1381)		N-[(1R,2R)-2-hydroxycyclopentyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C25H27N5O4	C25H27N5O4	461.52			ATVMFALHAHVOPQ-WIYYLYMNSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.513	2	7	7	103.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626753	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626753&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CCC[C@H]1O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2R)-2-hydroxycyclopentyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CCC[C@@H]1O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626754	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626754&database=RX&origin=ReaxysOutput&ln=	(211 of 1381)		N-[(1R,2S)-2-hydroxycyclopentyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C25H27N5O4	C25H27N5O4	461.52			ATVMFALHAHVOPQ-NQIIRXRSSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.513	2	7	7	103.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626754	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626754&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CCC[C@@H]1O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2S)-2-hydroxycyclopentyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626755	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626755&database=RX&origin=ReaxysOutput&ln=	(212 of 1381)		(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone	C23H21F2N5O3	C23H21F2N5O3	453.448			RLXGLLAOLICYIM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.668	0	6	6	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626755	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626755&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626755	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626755&database=RX&origin=ReaxysOutput&ln=	(212 of 1381)		(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone	C23H21F2N5O3	C23H21F2N5O3	453.448			RLXGLLAOLICYIM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.668	0	6	6	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626755	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626755&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone					IC50	nM	>	10 - 100							8			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626755	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626755&database=RX&origin=ReaxysOutput&ln=	(212 of 1381)		(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone	C23H21F2N5O3	C23H21F2N5O3	453.448			RLXGLLAOLICYIM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.668	0	6	6	74.41	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626755	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626755&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	(3,3-difluoroazetidin-1-yl)-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@@H]1F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626756	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626756&database=RX&origin=ReaxysOutput&ln=	(213 of 1381)		N-[(1R,2S)-2-fluorocyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H22FN5O3	C23H22FN5O3	435.458			NOBVYZFUMOXRNK-DLBZAZTESA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.542	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626756	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626756&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@@H]1F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2S)-2-fluorocyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@@H]1F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626756	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626756&database=RX&origin=ReaxysOutput&ln=	(213 of 1381)		N-[(1R,2S)-2-fluorocyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H22FN5O3	C23H22FN5O3	435.458			NOBVYZFUMOXRNK-DLBZAZTESA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.542	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626756	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626756&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@@H]1F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2S)-2-fluorocyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN=NC=C1		34626757	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626757&database=RX&origin=ReaxysOutput&ln=	(214 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-(7-pyridazin-4-ylimidazo[1,2-a]pyridin-3-yl)benzamide	C22H19F2N5O3	C22H19F2N5O3	439.421			YAGATXQITFXMRK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.868	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626757	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626757&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN=NC=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-(7-pyridazin-4-ylimidazo[1,2-a]pyridin-3-yl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN=NC=C1		34626757	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626757&database=RX&origin=ReaxysOutput&ln=	(214 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-(7-pyridazin-4-ylimidazo[1,2-a]pyridin-3-yl)benzamide	C22H19F2N5O3	C22H19F2N5O3	439.421			YAGATXQITFXMRK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.868	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626757	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626757&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN=NC=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-(7-pyridazin-4-ylimidazo[1,2-a]pyridin-3-yl)benzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)C#N		34626758	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626758&database=RX&origin=ReaxysOutput&ln=	(215 of 1381)		4-[7-(6-cyano-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-ethyl-6-methoxybenzamide	C24H19F2N5O3	C24H19F2N5O3	463.443			OGJIEYKIYSXOAG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.51	1	6	8	101.54	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626758	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626758&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)C#N	4-[7-(6-cyano-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-ethyl-6-methoxybenzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)C#N		34626758	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626758&database=RX&origin=ReaxysOutput&ln=	(215 of 1381)		4-[7-(6-cyano-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-ethyl-6-methoxybenzamide	C24H19F2N5O3	C24H19F2N5O3	463.443			OGJIEYKIYSXOAG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.51	1	6	8	101.54	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626758	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626758&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)C#N	4-[7-(6-cyano-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-ethyl-6-methoxybenzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626759	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626759&database=RX&origin=ReaxysOutput&ln=	(216 of 1381)		N-cyclopropyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H23N5O3	C23H23N5O3	417.467			OOTMIZGUKMVVMX-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	7	3.398	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626759	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626759&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-cyclopropyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626759	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626759&database=RX&origin=ReaxysOutput&ln=	(216 of 1381)		N-cyclopropyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C23H23N5O3	C23H23N5O3	417.467			OOTMIZGUKMVVMX-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	7	3.398	1	6	7	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626759	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626759&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-cyclopropyl-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCN(CC1)C(=O)OC(C)(C)C		34626760	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626760&database=RX&origin=ReaxysOutput&ln=	(217 of 1381)		tert-butyl 4-[4-[3-[3-(difluoromethoxy)-4-(ethylcarbamoyl)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]piperidine-1-carboxylate	C31H36F2N6O5	C31H36F2N6O5	610.661			RZUJZLWPDJSBHE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	7	6.099	1	9	12	112.22	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626760	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626760&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCN(CC1)C(=O)OC(C)(C)C	tert-butyl 4-[4-[3-[3-(difluoromethoxy)-4-(ethylcarbamoyl)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]piperidine-1-carboxylate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCN(CC1)C(=O)OC(C)(C)C		34626760	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626760&database=RX&origin=ReaxysOutput&ln=	(217 of 1381)		tert-butyl 4-[4-[3-[3-(difluoromethoxy)-4-(ethylcarbamoyl)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]piperidine-1-carboxylate	C31H36F2N6O5	C31H36F2N6O5	610.661			RZUJZLWPDJSBHE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	7	6.099	1	9	12	112.22	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626760	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626760&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCN(CC1)C(=O)OC(C)(C)C	tert-butyl 4-[4-[3-[3-(difluoromethoxy)-4-(ethylcarbamoyl)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]piperidine-1-carboxylate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCN(C)CC1		34626761	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626761&database=RX&origin=ReaxysOutput&ln=	(218 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-[1-(1-methyl-4-piperidyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N6O3	C27H30F2N6O3	524.57			XPEDZLOHQFMGQT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.839	1	7	9	85.92	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626761	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626761&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCN(C)CC1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-[1-(1-methyl-4-piperidyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCN(C)CC1		34626761	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626761&database=RX&origin=ReaxysOutput&ln=	(218 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-[1-(1-methyl-4-piperidyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N6O3	C27H30F2N6O3	524.57			XPEDZLOHQFMGQT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.839	1	7	9	85.92	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626761	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626761&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCN(C)CC1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-[1-(1-methyl-4-piperidyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCNCC1		34626762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626762&database=RX&origin=ReaxysOutput&ln=	(219 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-[1-(4-piperidyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H28F2N6O3	C26H28F2N6O3	510.544			IJPXSGHZNCGERE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.6	2	7	9	94.71	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626762&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCNCC1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-[1-(4-piperidyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCNCC1		34626762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626762&database=RX&origin=ReaxysOutput&ln=	(219 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-[1-(4-piperidyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H28F2N6O3	C26H28F2N6O3	510.544			IJPXSGHZNCGERE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.6	2	7	9	94.71	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626762	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626762&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CCNCC1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-[1-(4-piperidyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=NN=C(C)N1		34626763	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626763&database=RX&origin=ReaxysOutput&ln=	(220 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-(5-methyl-4H-1,2,4-triazol-3-yl)benzimidazol-1-yl]benzamide	C21H20F2N6O3	C21H20F2N6O3	442.425			ZLXOHRXHGZBZSN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.775	2	7	8	106.95	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626763	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626763&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=NN=C(C)N1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-(5-methyl-4H-1,2,4-triazol-3-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(F)F		34626764	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626764&database=RX&origin=ReaxysOutput&ln=	(221 of 1381)		2-(difluoromethoxy)-4-[7-[1-(difluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]-N-ethyl-6-methoxybenzamide	C22H19F4N5O3	C22H19F4N5O3	477.418			OZXXVOOCRQSUHH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	5.157	1	6	9	82.68	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626764	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626764&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(F)F	2-(difluoromethoxy)-4-[7-[1-(difluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]-N-ethyl-6-methoxybenzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(F)F		34626764	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626764&database=RX&origin=ReaxysOutput&ln=	(221 of 1381)		2-(difluoromethoxy)-4-[7-[1-(difluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]-N-ethyl-6-methoxybenzamide	C22H19F4N5O3	C22H19F4N5O3	477.418			OZXXVOOCRQSUHH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	5.157	1	6	9	82.68	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626764	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626764&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C(F)F	2-(difluoromethoxy)-4-[7-[1-(difluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]-N-ethyl-6-methoxybenzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=C(C)N1		34626765	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626765&database=RX&origin=ReaxysOutput&ln=	(222 of 1381)		2,6-dimethoxy-4-[5-(2-methyl-1H-imidazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			UTLYXOKJBANJFB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.976	2	6	8	94.06	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626765	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626765&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=C(C)N1	2,6-dimethoxy-4-[5-(2-methyl-1H-imidazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=C(C)N1		34626765	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626765&database=RX&origin=ReaxysOutput&ln=	(222 of 1381)		2,6-dimethoxy-4-[5-(2-methyl-1H-imidazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			UTLYXOKJBANJFB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.976	2	6	8	94.06	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626765	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626765&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN=C(C)N1	2,6-dimethoxy-4-[5-(2-methyl-1H-imidazol-5-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CNC=N1		34626766	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626766&database=RX&origin=ReaxysOutput&ln=	(223 of 1381)		4-[5-(1H-imidazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C21H18F3N5O3	C21H18F3N5O3	445.401			XVBNAVOFYBYOOG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.051	2	6	8	94.06	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626766	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626766&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CNC=N1	4-[5-(1H-imidazol-4-yl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@H]1CO)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626767	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626767&database=RX&origin=ReaxysOutput&ln=	(224 of 1381)		N-[(1R,2R)-2-(hydroxymethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H25N5O4	C24H25N5O4	447.494			BQRINCPYWVMFNW-MAUKXSAKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.992	2	7	8	103.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626767	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626767&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@H]1CO)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2R)-2-(hydroxymethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@H]1CO)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626767	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626767&database=RX&origin=ReaxysOutput&ln=	(224 of 1381)		N-[(1R,2R)-2-(hydroxymethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H25N5O4	C24H25N5O4	447.494			BQRINCPYWVMFNW-MAUKXSAKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.992	2	7	8	103.43	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626767	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626767&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@H]1CO)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2R)-2-(hydroxymethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@H]1C(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626768	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626768&database=RX&origin=ReaxysOutput&ln=	(225 of 1381)		N-[(1R,2R)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H23F2N5O3	C24H23F2N5O3	467.475			BHWSTJKRWXJCIL-IAGOWNOFSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.181	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626768	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626768&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@H]1C(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2R)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@H]1C(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626768	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626768&database=RX&origin=ReaxysOutput&ln=	(225 of 1381)		N-[(1R,2R)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H23F2N5O3	C24H23F2N5O3	467.475			BHWSTJKRWXJCIL-IAGOWNOFSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.181	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626768	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626768&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@H]1C(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2R)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@@H]1C(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626769	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626769&database=RX&origin=ReaxysOutput&ln=	(226 of 1381)		N-[(1R,2S)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H23F2N5O3	C24H23F2N5O3	467.475			BHWSTJKRWXJCIL-DLBZAZTESA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.181	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626769	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626769&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@@H]1C(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2S)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@@H]1C(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626769	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626769&database=RX&origin=ReaxysOutput&ln=	(226 of 1381)		N-[(1R,2S)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H23F2N5O3	C24H23F2N5O3	467.475			BHWSTJKRWXJCIL-DLBZAZTESA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.181	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626769	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626769&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@@H]1C(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2S)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CC[C@H]1O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626770	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626770&database=RX&origin=ReaxysOutput&ln=	(227 of 1381)		N-[(1R,2R)-2-hydroxycyclobutyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H25N5O4	C24H25N5O4	447.494			AZNGLKLEJPBDLE-YLJYHZDGSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.155	2	7	7	103.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626770	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626770&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CC[C@H]1O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2R)-2-hydroxycyclobutyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CC[C@H]1O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626770	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626770&database=RX&origin=ReaxysOutput&ln=	(227 of 1381)		N-[(1R,2R)-2-hydroxycyclobutyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H25N5O4	C24H25N5O4	447.494			AZNGLKLEJPBDLE-YLJYHZDGSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.155	2	7	7	103.43	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626770	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626770&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1CC[C@H]1O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1R,2R)-2-hydroxycyclobutyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=N1		34626771	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626771&database=RX&origin=ReaxysOutput&ln=	(228 of 1381)		2,6-dimethoxy-4-[5-(1-methyltriazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H19F3N6O3	C21H19F3N6O3	460.415			ARJLPUONRUVGOX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.738	1	7	8	96.09	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626771	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626771&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=N1	2,6-dimethoxy-4-[5-(1-methyltriazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=N1		34626771	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626771&database=RX&origin=ReaxysOutput&ln=	(228 of 1381)		2,6-dimethoxy-4-[5-(1-methyltriazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H19F3N6O3	C21H19F3N6O3	460.415			ARJLPUONRUVGOX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.738	1	7	8	96.09	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626771	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626771&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=N1	2,6-dimethoxy-4-[5-(1-methyltriazol-4-yl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1CCCCC1NC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626772	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626772&database=RX&origin=ReaxysOutput&ln=	(229 of 1381)		2,6-dimethoxy-N-(2-methoxycyclohexyl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C27H31N5O4	C27H31N5O4	489.574			SGOZFEHYCNKRKG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.961	1	7	8	92.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626772	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626772&database=RX&origin=ReaxysOutput&ln=	COC1CCCCC1NC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-N-(2-methoxycyclohexyl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CCC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626773	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626773&database=RX&origin=ReaxysOutput&ln=	(230 of 1381)		azetidin-1-yl-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone	C23H23N5O3	C23H23N5O3	417.467			XFQYSWPZWYJEMB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.145	0	6	6	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626773	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626773&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CCC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	azetidin-1-yl-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCCN)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626774	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626774&database=RX&origin=ReaxysOutput&ln=	(231 of 1381)		N-(2-aminoethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H24N6O3	C22H24N6O3	420.471			CYPBALUNOLBGFE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.079	2	7	8	109.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626774	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626774&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCCN)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(2-aminoethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCCN)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626774	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626774&database=RX&origin=ReaxysOutput&ln=	(231 of 1381)		N-(2-aminoethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H24N6O3	C22H24N6O3	420.471			CYPBALUNOLBGFE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.079	2	7	8	109.22	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626774	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626774&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCCN)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-(2-aminoethyl)-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM	>	5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H]1CCCC[C@@H]1O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626775	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626775&database=RX&origin=ReaxysOutput&ln=	(232 of 1381)		N-[(1S,2S)-2-hydroxycyclohexyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C26H29N5O4	C26H29N5O4	475.547			OKASPQKKOWQHKH-UGKGYDQZSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.871	2	7	7	103.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626775	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626775&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H]1CCCC[C@@H]1O)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-[(1S,2S)-2-hydroxycyclohexyl]-2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H]1CC[C@@H]1O)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626776	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626776&database=RX&origin=ReaxysOutput&ln=	(233 of 1381)		N-[(1S,2S)-2-hydroxycyclobutyl]-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H25N5O4	C24H25N5O4	447.494			UHVKDLNNPYCJNX-HKUYNNGSSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.606	2	7	7	102.91	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626776	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626776&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H]1CC[C@@H]1O)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-[(1S,2S)-2-hydroxycyclobutyl]-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC(C)C)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626777	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626777&database=RX&origin=ReaxysOutput&ln=	(234 of 1381)		N-isopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H25N5O3	C23H25N5O3	419.483			GJXCPASMXJNPSI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.189	1	6	7	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626777	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626777&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC(C)C)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-isopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC(C)C)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626777	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626777&database=RX&origin=ReaxysOutput&ln=	(234 of 1381)		N-isopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H25N5O3	C23H25N5O3	419.483			GJXCPASMXJNPSI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.189	1	6	7	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626777	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626777&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC(C)C)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-isopropyl-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H]1C[C@@H]1C(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626778	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626778&database=RX&origin=ReaxysOutput&ln=	(235 of 1381)		N-[(1S,2S)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H23F2N5O3	C24H23F2N5O3	467.475			JVKAZINWRBIABB-IRXDYDNUSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.632	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626778	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626778&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H]1C[C@@H]1C(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-[(1S,2S)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H]1C[C@@H]1C(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626778	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626778&database=RX&origin=ReaxysOutput&ln=	(235 of 1381)		N-[(1S,2S)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H23F2N5O3	C24H23F2N5O3	467.475			JVKAZINWRBIABB-IRXDYDNUSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.632	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626778	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626778&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H]1C[C@@H]1C(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-[(1S,2S)-2-(difluoromethyl)cyclopropyl]-2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1CC2=C(C1=O)C(OC)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626779	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626779&database=RX&origin=ReaxysOutput&ln=	(236 of 1381)		2-ethyl-7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one	C22H21N5O2	C22H21N5O2	387.441			SXHRAMFFPRNRGR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.644	0	6	4	64.66	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626779	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626779&database=RX&origin=ReaxysOutput&ln=	CCN1CC2=C(C1=O)C(OC)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-ethyl-7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1CC2=C(C1=O)C(OC)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626779	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626779&database=RX&origin=ReaxysOutput&ln=	(236 of 1381)		2-ethyl-7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one	C22H21N5O2	C22H21N5O2	387.441			SXHRAMFFPRNRGR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.644	0	6	4	64.66	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626779	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626779&database=RX&origin=ReaxysOutput&ln=	CCN1CC2=C(C1=O)C(OC)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-ethyl-7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1CC2=C(C1=O)C(OC)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626779	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626779&database=RX&origin=ReaxysOutput&ln=	(236 of 1381)		2-ethyl-7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one	C22H21N5O2	C22H21N5O2	387.441			SXHRAMFFPRNRGR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.644	0	6	4	64.66	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626779	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626779&database=RX&origin=ReaxysOutput&ln=	CCN1CC2=C(C1=O)C(OC)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-ethyl-7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1CC2=C(C1=O)C(OC)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626779	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626779&database=RX&origin=ReaxysOutput&ln=	(236 of 1381)		2-ethyl-7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one	C22H21N5O2	C22H21N5O2	387.441			SXHRAMFFPRNRGR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.644	0	6	4	64.66	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626779	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626779&database=RX&origin=ReaxysOutput&ln=	CCN1CC2=C(C1=O)C(OC)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-ethyl-7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1=NC=C(C)N=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626780	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626780&database=RX&origin=ReaxysOutput&ln=	(237 of 1381)		2,6-dimethoxy-N-(5-methylpyrazin-2-yl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C25H23N7O3	C25H23N7O3	469.503			SIQRTVCVWWZFRE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	2.96	1	8	7	108.98	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626780	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626780&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1=NC=C(C)N=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	2,6-dimethoxy-N-(5-methylpyrazin-2-yl)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CN=C12)C1=CN(C)N=C1		34626781	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626781&database=RX&origin=ReaxysOutput&ln=	(238 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]benzamide	C21H20F2N6O3	C21H20F2N6O3	442.425			YEFUZLJATUKDCG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.468	1	7	8	96.09	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626781	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626781&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CN=C12)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CN=C12)C1=CN(C)N=C1		34626781	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626781&database=RX&origin=ReaxysOutput&ln=	(238 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]benzamide	C21H20F2N6O3	C21H20F2N6O3	442.425			YEFUZLJATUKDCG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.468	1	7	8	96.09	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626781	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626781&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CN=C12)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CN=C12)C1=CN(C)N=C1		34626781	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626781&database=RX&origin=ReaxysOutput&ln=	(238 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]benzamide	C21H20F2N6O3	C21H20F2N6O3	442.425			YEFUZLJATUKDCG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.468	1	7	8	96.09	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626781	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626781&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CN=C12)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CN=C12)C1=CN(C)N=C1		34626781	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626781&database=RX&origin=ReaxysOutput&ln=	(238 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]benzamide	C21H20F2N6O3	C21H20F2N6O3	442.425			YEFUZLJATUKDCG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.468	1	7	8	96.09	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626781	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626781&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CN=C12)C1=CN(C)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[6-(1-methylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1		34626782	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626782&database=RX&origin=ReaxysOutput&ln=	(239 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			FEQOOJWJCGXRBU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.518	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626782	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626782&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1		34626782	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626782&database=RX&origin=ReaxysOutput&ln=	(239 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			FEQOOJWJCGXRBU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.518	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626782	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626782&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1		34626782	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626782&database=RX&origin=ReaxysOutput&ln=	(239 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H21F2N5O3	C22H21F2N5O3	441.437			FEQOOJWJCGXRBU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.518	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626782	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626782&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(C)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626783	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626783&database=RX&origin=ReaxysOutput&ln=	(240 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3,3-dimethylazetidin-1-yl)methanone	C25H27N5O3	C25H27N5O3	445.521			QTZQVTVIVVUUMG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.837	0	6	6	74.41	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626783	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626783&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(C)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3,3-dimethylazetidin-1-yl)methanone					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(C)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626783	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626783&database=RX&origin=ReaxysOutput&ln=	(240 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3,3-dimethylazetidin-1-yl)methanone	C25H27N5O3	C25H27N5O3	445.521			QTZQVTVIVVUUMG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.837	0	6	6	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626783	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626783&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(C)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3,3-dimethylazetidin-1-yl)methanone					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(C)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626783	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626783&database=RX&origin=ReaxysOutput&ln=	(240 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3,3-dimethylazetidin-1-yl)methanone	C25H27N5O3	C25H27N5O3	445.521			QTZQVTVIVVUUMG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.837	0	6	6	74.41	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626783	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626783&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(C)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3,3-dimethylazetidin-1-yl)methanone					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C1=CC=CC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626784	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626784&database=RX&origin=ReaxysOutput&ln=	(241 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-phenylazetidin-1-yl)methanone	C29H27N5O3	C29H27N5O3	493.565			VZCNFDGTUGLGPF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.525	0	6	7	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626784	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626784&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C1=CC=CC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-phenylazetidin-1-yl)methanone					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1C(C)CC1C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626785	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626785&database=RX&origin=ReaxysOutput&ln=	(242 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2,4-dimethylazetidin-1-yl)methanone	C25H27N5O3	C25H27N5O3	445.521			KXLKHFFPSRTLIN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.065	0	6	6	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626785	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626785&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1C(C)CC1C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2,4-dimethylazetidin-1-yl)methanone					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CCC1C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626786	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626786&database=RX&origin=ReaxysOutput&ln=	(243 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2-methylazetidin-1-yl)methanone	C24H25N5O3	C24H25N5O3	431.494			ZTNWJFHSLHTFDP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.605	0	6	6	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626786	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626786&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CCC1C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2-methylazetidin-1-yl)methanone					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(CO)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626787	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626787&database=RX&origin=ReaxysOutput&ln=	(244 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-[3-(hydroxymethyl)azetidin-1-yl]methanone	C24H25N5O4	C24H25N5O4	447.494			XCDONVWARMTFKA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.31	1	7	7	94.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626787	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626787&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(CO)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-[3-(hydroxymethyl)azetidin-1-yl]methanone					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(O)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626788	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626788&database=RX&origin=ReaxysOutput&ln=	(245 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-hydroxyazetidin-1-yl)methanone	C23H23N5O4	C23H23N5O4	433.467			VGXRAYHUNIDGMN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.115	1	7	6	94.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626788	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626788&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(O)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-hydroxyazetidin-1-yl)methanone					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)N(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626789	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626789&database=RX&origin=ReaxysOutput&ln=	(246 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-[3-(dimethylamino)azetidin-1-yl]methanone	C25H28N6O3	C25H28N6O3	460.536			ZVPPVGIBZHRHMN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.677	0	7	7	77.65	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626789	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626789&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)N(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-[3-(dimethylamino)azetidin-1-yl]methanone					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)OCC1=CC=CC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626790	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626790&database=RX&origin=ReaxysOutput&ln=	(247 of 1381)		(3-benzyloxyazetidin-1-yl)-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone	C30H29N5O4	C30H29N5O4	523.591			PUCVIZMZKLONGX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.344	0	7	9	83.64	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626790	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626790&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)OCC1=CC=CC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	(3-benzyloxyazetidin-1-yl)-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CCC1C1=CC=CC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626792	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626792&database=RX&origin=ReaxysOutput&ln=	(248 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2-phenylazetidin-1-yl)methanone	C29H27N5O3	C29H27N5O3	493.565			NVSAATLELIFYLL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.958	0	6	7	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626792	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626792&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CCC1C1=CC=CC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2-phenylazetidin-1-yl)methanone					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1C(C)CC1(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626794	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626794&database=RX&origin=ReaxysOutput&ln=	(249 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2,2,4-trimethylazetidin-1-yl)methanone	C26H29N5O3	C26H29N5O3	459.548			DXPUIFBXVLOSPR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.482	0	6	6	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626794	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626794&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1C(C)CC1(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2,2,4-trimethylazetidin-1-yl)methanone					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1CN(C1)C(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626795	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626795&database=RX&origin=ReaxysOutput&ln=	(250 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-methoxyazetidin-1-yl)methanone	C24H25N5O4	C24H25N5O4	447.494			FMALZWYGKSJKOE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.634	0	7	7	83.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626795	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626795&database=RX&origin=ReaxysOutput&ln=	COC1CN(C1)C(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-methoxyazetidin-1-yl)methanone					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C1CCOCC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626796	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626796&database=RX&origin=ReaxysOutput&ln=	(251 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-tetrahydropyran-4-ylazetidin-1-yl)methanone	C28H31N5O4	C28H31N5O4	501.585			ZWZCSOQRCLMNNO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.567	0	7	7	83.64	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626796	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626796&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C1CCOCC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-tetrahydropyran-4-ylazetidin-1-yl)methanone					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626797	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626797&database=RX&origin=ReaxysOutput&ln=	(252 of 1381)		1-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzoyl]azetidine-3-carbonitrile	C24H22N6O3	C24H22N6O3	442.477			UKDNRMSYCGNRQQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.308	0	7	6	98.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626797	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626797&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	1-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzoyl]azetidine-3-carbonitrile					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626797	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626797&database=RX&origin=ReaxysOutput&ln=	(252 of 1381)		1-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzoyl]azetidine-3-carbonitrile	C24H22N6O3	C24H22N6O3	442.477			UKDNRMSYCGNRQQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.308	0	7	6	98.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626797	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626797&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	1-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzoyl]azetidine-3-carbonitrile					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626797	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626797&database=RX&origin=ReaxysOutput&ln=	(252 of 1381)		1-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzoyl]azetidine-3-carbonitrile	C24H22N6O3	C24H22N6O3	442.477			UKDNRMSYCGNRQQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.308	0	7	6	98.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626797	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626797&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	1-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzoyl]azetidine-3-carbonitrile					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626797	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626797&database=RX&origin=ReaxysOutput&ln=	(252 of 1381)		1-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzoyl]azetidine-3-carbonitrile	C24H22N6O3	C24H22N6O3	442.477			UKDNRMSYCGNRQQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.308	0	7	6	98.2	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626797	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626797&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	1-[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzoyl]azetidine-3-carbonitrile					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CCC1CO)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626798	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626798&database=RX&origin=ReaxysOutput&ln=	(253 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-[2-(hydroxymethyl)azetidin-1-yl]methanone	C24H25N5O4	C24H25N5O4	447.494			XSASAVMOWLJSTN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.473	1	7	7	94.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626798	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626798&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CCC1CO)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-[2-(hydroxymethyl)azetidin-1-yl]methanone					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC2(COC2)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626799	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626799&database=RX&origin=ReaxysOutput&ln=	(254 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2-oxa-6-azaspiro[3.3]heptan-6-yl)methanone	C25H25N5O4	C25H25N5O4	459.505			QYUMSWNMGQYRNQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.591	0	7	6	83.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626799	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626799&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC2(COC2)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2-oxa-6-azaspiro[3.3]heptan-6-yl)methanone					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC2(C1)CS(=O)(=O)C2)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626800	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626800&database=RX&origin=ReaxysOutput&ln=	(255 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2,2-dioxo-2λ6-thia-6-azaspiro[3.3]heptan-6-yl)methanone	C25H25N5O5S	C25H25N5O5S	507.57			QTUAWDATYIATBO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.531	0	8	6	116.93	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626800	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626800&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC2(C1)CS(=O)(=O)C2)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(2,2-dioxo-2λ6-thia-6-azaspiro[3.3]heptan-6-yl)methanone					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CCC(C1)C1=CC=CC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626801	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626801&database=RX&origin=ReaxysOutput&ln=	(256 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-phenylpyrrolidin-1-yl)methanone	C30H29N5O3	C30H29N5O3	507.592			RRXKSFJFQRCFBP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.883	0	6	7	74.41	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626801	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626801&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CCC(C1)C1=CC=CC=C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-phenylpyrrolidin-1-yl)methanone					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CCC(F)CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626803	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626803&database=RX&origin=ReaxysOutput&ln=	(257 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(4-fluoro-1-piperidyl)methanone	C25H26FN5O3	C25H26FN5O3	463.512			VNKVKYOQCMOTEP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.005	0	6	6	74.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626803	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626803&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CCC(F)CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(4-fluoro-1-piperidyl)methanone					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CCC(CC1)OC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626804	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626804&database=RX&origin=ReaxysOutput&ln=	(258 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-[4-(trifluoromethoxy)-1-piperidyl]methanone	C26H26F3N5O4	C26H26F3N5O4	529.519			UIHSAFMAMVNBFF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.602	0	7	8	83.64	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626804	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626804&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CCC(CC1)OC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-[4-(trifluoromethoxy)-1-piperidyl]methanone					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC(C)(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626805	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626805&database=RX&origin=ReaxysOutput&ln=	(259 of 1381)		N-tert-butyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide	C24H25F2N5O3	C24H25F2N5O3	469.491			QFTPPQLMOVRLFT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.869	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626805	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626805&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC(C)(C)C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	N-tert-butyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC(C(C)C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626806	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626806&database=RX&origin=ReaxysOutput&ln=	(260 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[2-methyl-1-(trifluoromethyl)propyl]benzamide	C25H26F3N5O3	C25H26F3N5O3	501.508			PZEZXDQLUSWKCG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.846	1	6	9	82.68	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626806	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626806&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC(C(C)C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[2-methyl-1-(trifluoromethyl)propyl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1CC2=C(C1=O)C(NCCO)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626807	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626807&database=RX&origin=ReaxysOutput&ln=	(261 of 1381)		2-ethyl-7-(2-hydroxyethylamino)-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one	C23H24N6O2	C23H24N6O2	416.483			SJSJHTCJWNUSDO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.666	2	8	6	87.69	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626807	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626807&database=RX&origin=ReaxysOutput&ln=	CCN1CC2=C(C1=O)C(NCCO)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-ethyl-7-(2-hydroxyethylamino)-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1CC2=C(C1=O)C(NCCO)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626807	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626807&database=RX&origin=ReaxysOutput&ln=	(261 of 1381)		2-ethyl-7-(2-hydroxyethylamino)-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one	C23H24N6O2	C23H24N6O2	416.483			SJSJHTCJWNUSDO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.666	2	8	6	87.69	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626807	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626807&database=RX&origin=ReaxysOutput&ln=	CCN1CC2=C(C1=O)C(NCCO)=CC(=C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-ethyl-7-(2-hydroxyethylamino)-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]isoindolin-1-one					IC50	nM	>	10 - 100							8			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(Cl)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626808	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626808&database=RX&origin=ReaxysOutput&ln=	(262 of 1381)		2-chloro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H17ClF3N5O2	C21H17ClF3N5O2	463.846			WRQUYHKATCCMNQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.438	1	6	7	73.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626808	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626808&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(Cl)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-chloro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(Cl)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626808	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626808&database=RX&origin=ReaxysOutput&ln=	(262 of 1381)		2-chloro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H17ClF3N5O2	C21H17ClF3N5O2	463.846			WRQUYHKATCCMNQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.438	1	6	7	73.45	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626808	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626808&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(Cl)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-chloro-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(C)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626809	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626809&database=RX&origin=ReaxysOutput&ln=	(263 of 1381)		[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]-(3,3-dimethylazetidin-1-yl)methanone	C25H27N5O3	C25H27N5O3	445.521			SZQBYSJGDIIOQO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.288	0	6	6	73.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626809	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626809&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(C)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]-(3,3-dimethylazetidin-1-yl)methanone					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(C)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626809	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626809&database=RX&origin=ReaxysOutput&ln=	(263 of 1381)		[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]-(3,3-dimethylazetidin-1-yl)methanone	C25H27N5O3	C25H27N5O3	445.521			SZQBYSJGDIIOQO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.288	0	6	6	73.89	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626809	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626809&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(C)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]-(3,3-dimethylazetidin-1-yl)methanone					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626810	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626810&database=RX&origin=ReaxysOutput&ln=	(264 of 1381)		1-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzoyl]azetidine-3-carbonitrile	C24H22N6O3	C24H22N6O3	442.477			SKTZMPLFOKNRMN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.759	0	7	6	97.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626810	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626810&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	1-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzoyl]azetidine-3-carbonitrile					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626810	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626810&database=RX&origin=ReaxysOutput&ln=	(264 of 1381)		1-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzoyl]azetidine-3-carbonitrile	C24H22N6O3	C24H22N6O3	442.477			SKTZMPLFOKNRMN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.759	0	7	6	97.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626810	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626810&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	1-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzoyl]azetidine-3-carbonitrile					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CCC(C1)C#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626811	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626811&database=RX&origin=ReaxysOutput&ln=	(265 of 1381)		1-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzoyl]pyrrolidine-3-carbonitrile	C25H24N6O3	C25H24N6O3	456.504			JKUXKJNQJGQCLE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.117	0	7	6	97.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626811	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626811&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CCC(C1)C#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	1-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzoyl]pyrrolidine-3-carbonitrile					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CCC(C1)C#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626811	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626811&database=RX&origin=ReaxysOutput&ln=	(265 of 1381)		1-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzoyl]pyrrolidine-3-carbonitrile	C25H24N6O3	C25H24N6O3	456.504			JKUXKJNQJGQCLE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.117	0	7	6	97.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626811	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626811&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CCC(C1)C#N)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	1-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzoyl]pyrrolidine-3-carbonitrile					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CCC(F)(F)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626812	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626812&database=RX&origin=ReaxysOutput&ln=	(266 of 1381)		(3,3-difluoropyrrolidin1-yl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone	C24H23F2N5O3	C24H23F2N5O3	467.475			FLGLMNVMAHPQLP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.477	0	6	6	73.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626812	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626812&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CCC(F)(F)C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	(3,3-difluoropyrrolidin1-yl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CCC(F)(F)CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626814	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626814&database=RX&origin=ReaxysOutput&ln=	(267 of 1381)		(4,4-difluoro-1-piperidyl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone	C25H25F2N5O3	C25H25F2N5O3	481.502			YJSNGIJRFJXMPC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.835	0	6	6	73.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626814	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626814&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CCC(F)(F)CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	(4,4-difluoro-1-piperidyl)-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]methanone					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626815	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626815&database=RX&origin=ReaxysOutput&ln=	(268 of 1381)		[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]-[3-(trifluoromethyl)azetidin-1-yl]methanone	C24H22F3N5O3	C24H22F3N5O3	485.466			GHWVGWWOZNVJTC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.895	0	6	7	73.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626815	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626815&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]-[3-(trifluoromethyl)azetidin-1-yl]methanone					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626815	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626815&database=RX&origin=ReaxysOutput&ln=	(268 of 1381)		[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]-[3-(trifluoromethyl)azetidin-1-yl]methanone	C24H22F3N5O3	C24H22F3N5O3	485.466			GHWVGWWOZNVJTC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.895	0	6	7	73.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626815	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626815&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]-[3-(trifluoromethyl)azetidin-1-yl]methanone					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626815	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626815&database=RX&origin=ReaxysOutput&ln=	(268 of 1381)		[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]-[3-(trifluoromethyl)azetidin-1-yl]methanone	C24H22F3N5O3	C24H22F3N5O3	485.466			GHWVGWWOZNVJTC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.895	0	6	7	73.89	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626815	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626815&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]phenyl]-[3-(trifluoromethyl)azetidin-1-yl]methanone					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1		34626816	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626816&database=RX&origin=ReaxysOutput&ln=	(269 of 1381)		2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			YSPCHSPBDJBJCY-CYBMUJFWSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.266	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626816	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626816&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1	2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1		34626816	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626816&database=RX&origin=ReaxysOutput&ln=	(269 of 1381)		2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			YSPCHSPBDJBJCY-CYBMUJFWSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.266	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626816	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626816&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1	2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1		34626816	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626816&database=RX&origin=ReaxysOutput&ln=	(269 of 1381)		2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			YSPCHSPBDJBJCY-CYBMUJFWSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.266	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626816	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626816&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1	2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1		34626817	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626817&database=RX&origin=ReaxysOutput&ln=	(270 of 1381)		2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			YSPCHSPBDJBJCY-ZDUSSCGKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.266	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626817	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626817&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1	2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1		34626817	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626817&database=RX&origin=ReaxysOutput&ln=	(270 of 1381)		2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			YSPCHSPBDJBJCY-ZDUSSCGKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.266	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626817	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626817&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1	2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM	>	10 - 100							8			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1		34626817	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626817&database=RX&origin=ReaxysOutput&ln=	(270 of 1381)		2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H22F3N5O3	C23H22F3N5O3	473.455			YSPCHSPBDJBJCY-ZDUSSCGKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.266	1	6	8	82.68	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626817	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626817&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)C=N1	2,6-dimethoxy-4-[7-(1-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(O)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626818	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626818&database=RX&origin=ReaxysOutput&ln=	(271 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-hydroxy-3-methylazetidin-1-yl)methanone	C24H25N5O4	C24H25N5O4	447.494			QKCAYEAFMBAFMX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.532	1	7	6	94.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626818	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626818&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C)(O)C1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-hydroxy-3-methylazetidin-1-yl)methanone					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCC1(O)CN(C1)C(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626819	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626819&database=RX&origin=ReaxysOutput&ln=	(272 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-ethyl-3-hydroxyazetidin-1-yl)methanone	C25H27N5O4	C25H27N5O4	461.52			FZIIASQJTASOAS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.89	1	7	7	94.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626819	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626819&database=RX&origin=ReaxysOutput&ln=	CCC1(O)CN(C1)C(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-ethyl-3-hydroxyazetidin-1-yl)methanone					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(O)(C1)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626820	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626820&database=RX&origin=ReaxysOutput&ln=	(273 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl][3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]methanone	C24H22F3N5O4	C24H22F3N5O4	501.465			DNFBGULAOQSSCK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.534	1	7	7	94.64	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626820	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626820&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(O)(C1)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl][3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]methanone					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(O)(C1)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626820	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626820&database=RX&origin=ReaxysOutput&ln=	(273 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl][3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]methanone	C24H22F3N5O4	C24H22F3N5O4	501.465			DNFBGULAOQSSCK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.534	1	7	7	94.64	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626820	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626820&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(O)(C1)C(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl][3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]methanone					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(O)(C1)C1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626821	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626821&database=RX&origin=ReaxysOutput&ln=	(274 of 1381)		(3-cyclopropyl-3-hydroxyazetidin-1-yl)[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone	C26H27N5O4	C26H27N5O4	473.531			QLUGZTWIJMXLJV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.847	1	7	7	94.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626821	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626821&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(O)(C1)C1CC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	(3-cyclopropyl-3-hydroxyazetidin-1-yl)[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]methanone					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(O)(C1)C#C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626822	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626822&database=RX&origin=ReaxysOutput&ln=	(275 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-ethynyl-3-hydroxyazetidin-1-yl)methanone	C25H23N5O4	C25H23N5O4	457.489			LYNPEBILAABJAM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.136	1	7	6	94.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626822	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626822&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(O)(C1)C#C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-ethynyl-3-hydroxyazetidin-1-yl)methanone					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(O)(C1)C#C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626822	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626822&database=RX&origin=ReaxysOutput&ln=	(275 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-ethynyl-3-hydroxyazetidin-1-yl)methanone	C25H23N5O4	C25H23N5O4	457.489			LYNPEBILAABJAM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.136	1	7	6	94.64	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626822	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626822&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(O)(C1)C#C)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-ethynyl-3-hydroxyazetidin-1-yl)methanone					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CNN=C1		34626823	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626823&database=RX&origin=ReaxysOutput&ln=	(276 of 1381)		2,6-dimethoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			RMSPINHMYNACSA-GFCCVEGCSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.386	2	6	8	93.54	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626823	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626823&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CNN=C1	2,6-dimethoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CNN=C1		34626823	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626823&database=RX&origin=ReaxysOutput&ln=	(276 of 1381)		2,6-dimethoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			RMSPINHMYNACSA-GFCCVEGCSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.386	2	6	8	93.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626823	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626823&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CNN=C1	2,6-dimethoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1		34626825	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626825&database=RX&origin=ReaxysOutput&ln=	(277 of 1381)		2,6-dimethoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H21F3N4O4	C23H21F3N4O4	474.439			YMPVCSTXWBZJPS-CYBMUJFWSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.614	1	4	8	90.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626825	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626825&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1	2,6-dimethoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1		34626825	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626825&database=RX&origin=ReaxysOutput&ln=	(277 of 1381)		2,6-dimethoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H21F3N4O4	C23H21F3N4O4	474.439			YMPVCSTXWBZJPS-CYBMUJFWSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.614	1	4	8	90.89	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626825	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626825&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1	2,6-dimethoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1R)-2,2,2-trifluoro-1-methylethyl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1		34626826	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626826&database=RX&origin=ReaxysOutput&ln=	(278 of 1381)		2,6-dimethoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide	C23H21F3N4O4	C23H21F3N4O4	474.439			YMPVCSTXWBZJPS-ZDUSSCGKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.614	1	4	8	90.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626826	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626826&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H](C)C(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1	2,6-dimethoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-[(1S)-2,2,2-trifluoro-1-methylethyl]benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC(=O)C1CN(C1)C(=O)C1=C(OC)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626827	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626827&database=RX&origin=ReaxysOutput&ln=	(279 of 1381)		methyl 1-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzoyl]azetidine-3-carboxylate	C25H25N5O5	C25H25N5O5	475.504			FZGKVTGUSGUVNS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	2.969	0	8	8	100.19	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626827	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626827&database=RX&origin=ReaxysOutput&ln=	COC(=O)C1CN(C1)C(=O)C1=C(OC)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	methyl 1-[2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzoyl]azetidine-3-carboxylate					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1		34626828	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626828&database=RX&origin=ReaxysOutput&ln=	(280 of 1381)		2,6-dimethoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H19F3N4O4	C22H19F3N4O4	460.412			WGRDGKOFTYPERW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.154	1	4	8	90.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626828	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626828&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1	2,6-dimethoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1		34626828	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626828&database=RX&origin=ReaxysOutput&ln=	(280 of 1381)		2,6-dimethoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H19F3N4O4	C22H19F3N4O4	460.412			WGRDGKOFTYPERW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.154	1	4	8	90.89	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626828	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626828&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1	2,6-dimethoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC2CC2)N=C1		34626829	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626829&database=RX&origin=ReaxysOutput&ln=	(281 of 1381)		cyclopropyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C26H24F3N5O5	C26H24F3N5O5	543.502			YDEKSOCUKWOKLP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.977	1	8	12	108.98	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626829	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626829&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC2CC2)N=C1	cyclopropyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC2CC2)N=C1		34626829	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626829&database=RX&origin=ReaxysOutput&ln=	(281 of 1381)		cyclopropyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C26H24F3N5O5	C26H24F3N5O5	543.502			YDEKSOCUKWOKLP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.977	1	8	12	108.98	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626829	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626829&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(=O)OC2CC2)N=C1	cyclopropyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626830	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626830&database=RX&origin=ReaxysOutput&ln=	(282 of 1381)		2,6-dimethoxy-4-[7-(6-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H21F3N4O4	C24H21F3N4O4	486.45			XOLADKXCRYCSIL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.629	1	5	9	86.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626830	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626830&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2,6-dimethoxy-4-[7-(6-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626830	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626830&database=RX&origin=ReaxysOutput&ln=	(282 of 1381)		2,6-dimethoxy-4-[7-(6-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H21F3N4O4	C24H21F3N4O4	486.45			XOLADKXCRYCSIL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.629	1	5	9	86.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626830	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626830&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2,6-dimethoxy-4-[7-(6-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)C#N		34626831	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626831&database=RX&origin=ReaxysOutput&ln=	(283 of 1381)		4-[7-(6-cyano-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H18F3N5O3	C24H18F3N5O3	481.434			LRZYMWFPCMYFKJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.798	1	6	8	101.54	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626831	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626831&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)C#N	4-[7-(6-cyano-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)C#N		34626831	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626831&database=RX&origin=ReaxysOutput&ln=	(283 of 1381)		4-[7-(6-cyano-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H18F3N5O3	C24H18F3N5O3	481.434			LRZYMWFPCMYFKJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.798	1	6	8	101.54	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626831	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626831&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)C#N	4-[7-(6-cyano-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=C(OC)N=C1		34626832	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626832&database=RX&origin=ReaxysOutput&ln=	(284 of 1381)		2,6-dimethoxy-4-[7-(2-methoxypyrimidin-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H20F3N5O4	C23H20F3N5O4	487.438			KEOMMZBKEQDQPR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.588	1	6	9	99.87	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626832	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626832&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=C(OC)N=C1	2,6-dimethoxy-4-[7-(2-methoxypyrimidin-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=C(OC)N=C1		34626832	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626832&database=RX&origin=ReaxysOutput&ln=	(284 of 1381)		2,6-dimethoxy-4-[7-(2-methoxypyrimidin-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H20F3N5O4	C23H20F3N5O4	487.438			KEOMMZBKEQDQPR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.588	1	6	9	99.87	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626832	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626832&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=C(OC)N=C1	2,6-dimethoxy-4-[7-(2-methoxypyrimidin-5-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=CN=C1		34626833	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626833&database=RX&origin=ReaxysOutput&ln=	(285 of 1381)		2,6-dimethoxy-4-(7-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)-N-(2,2,2-trifluoroethyl)benzamide	C22H18F3N5O3	C22H18F3N5O3	457.412			NOVBMTMNNZLGQO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.945	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626833	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626833&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=CN=C1	2,6-dimethoxy-4-(7-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=CN=C1		34626833	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626833&database=RX&origin=ReaxysOutput&ln=	(285 of 1381)		2,6-dimethoxy-4-(7-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)-N-(2,2,2-trifluoroethyl)benzamide	C22H18F3N5O3	C22H18F3N5O3	457.412			NOVBMTMNNZLGQO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.945	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626833	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626833&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=CN=C1	2,6-dimethoxy-4-(7-pyrimidin-5-ylimidazo[1,2-a]pyridin-3-yl)-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC(=O)C(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626834	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626834&database=RX&origin=ReaxysOutput&ln=	(286 of 1381)		methyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate	C25H24F3N5O5	C25H24F3N5O5	531.491			JKRVXAWCFGGMIS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.96	1	8	11	108.98	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626834	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626834&database=RX&origin=ReaxysOutput&ln=	COC(=O)C(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	methyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC(=O)C(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626834	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626834&database=RX&origin=ReaxysOutput&ln=	(286 of 1381)		methyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate	C25H24F3N5O5	C25H24F3N5O5	531.491			JKRVXAWCFGGMIS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.96	1	8	11	108.98	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626834	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626834&database=RX&origin=ReaxysOutput&ln=	COC(=O)C(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	methyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=CC(=C1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626835	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626835&database=RX&origin=ReaxysOutput&ln=	(287 of 1381)		2,6-dimethoxy-4-[7-(5-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H21F3N4O4	C24H21F3N4O4	486.45			VVJGBWIYWZQASZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.901	1	5	9	86.98	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626835	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626835&database=RX&origin=ReaxysOutput&ln=	COC1=CN=CC(=C1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	2,6-dimethoxy-4-[7-(5-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=C(N)N=C1		34626836	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626836&database=RX&origin=ReaxysOutput&ln=	(288 of 1381)		4-[7-(2-aminopyrimidin-5-yl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H19F3N6O3	C22H19F3N6O3	472.426			NPDOOBNCIFYBCI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.856	2	7	8	116.66	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626836	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626836&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=C(N)N=C1	4-[7-(2-aminopyrimidin-5-yl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=NC=C1		34626837	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626837&database=RX&origin=ReaxysOutput&ln=	(289 of 1381)		2,6-dimethoxy-4-(7-pyridazin-4-ylimidazo[1,2-a]pyridin-3-yl)-N-(2,2,2-trifluoroethyl)benzamide	C22H18F3N5O3	C22H18F3N5O3	457.412			JHPSTHVTNGNMPX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.156	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626837	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626837&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=NC=C1	2,6-dimethoxy-4-(7-pyridazin-4-ylimidazo[1,2-a]pyridin-3-yl)-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC1=CN=CC(=C1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626838	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626838&database=RX&origin=ReaxysOutput&ln=	(290 of 1381)		4-[7-(5-ethoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C25H23F3N4O4	C25H23F3N4O4	500.477			OSASNQCXTQLOTR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.324	1	5	10	86.98	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626838	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626838&database=RX&origin=ReaxysOutput&ln=	CCOC1=CN=CC(=C1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	4-[7-(5-ethoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC1=CN=CC(=C1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626838	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626838&database=RX&origin=ReaxysOutput&ln=	(290 of 1381)		4-[7-(5-ethoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C25H23F3N4O4	C25H23F3N4O4	500.477			OSASNQCXTQLOTR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.324	1	5	10	86.98	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626838	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626838&database=RX&origin=ReaxysOutput&ln=	CCOC1=CN=CC(=C1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	4-[7-(5-ethoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1C(F)(F)F		34626839	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626839&database=RX&origin=ReaxysOutput&ln=	(291 of 1381)		2,6-dimethoxy-4-[7-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H19F6N5O3	C23H19F6N5O3	527.426			BBBLQWWWMVTFLO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.611	1	6	9	82.68	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626839	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626839&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1C(F)(F)F	2,6-dimethoxy-4-[7-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=CN=C1OC		34626840	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626840&database=RX&origin=ReaxysOutput&ln=	(292 of 1381)		2,6-dimethoxy-4-[7-(2-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H21F3N4O4	C24H21F3N4O4	486.45			QPLZGSMFWBPAOA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.629	1	5	9	86.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626840	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626840&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=CN=C1OC	2,6-dimethoxy-4-[7-(2-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=NC(C)=C1		34626842	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626842&database=RX&origin=ReaxysOutput&ln=	(293 of 1381)		2,6-dimethoxy-4-[7-(6-methylpyridazin-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H20F3N5O3	C23H20F3N5O3	471.439			UPRWZFIGIDLNGE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.471	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626842	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626842&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=NC(C)=C1	2,6-dimethoxy-4-[7-(6-methylpyridazin-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=NC(C)=C1		34626842	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626842&database=RX&origin=ReaxysOutput&ln=	(293 of 1381)		2,6-dimethoxy-4-[7-(6-methylpyridazin-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H20F3N5O3	C23H20F3N5O3	471.439			UPRWZFIGIDLNGE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.471	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626842	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626842&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=NC(C)=C1	2,6-dimethoxy-4-[7-(6-methylpyridazin-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=NC(C)=C1		34626842	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626842&database=RX&origin=ReaxysOutput&ln=	(293 of 1381)		2,6-dimethoxy-4-[7-(6-methylpyridazin-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H20F3N5O3	C23H20F3N5O3	471.439			UPRWZFIGIDLNGE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.471	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626842	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626842&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN=NC(C)=C1	2,6-dimethoxy-4-[7-(6-methylpyridazin-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=C(N=CN=C1)C(C)C		34626843	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626843&database=RX&origin=ReaxysOutput&ln=	(294 of 1381)		4-[7-(4-isopropylpyrimidin-5-yl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C25H24F3N5O3	C25H24F3N5O3	499.492			TZDZCDQLGKMAGE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.806	1	6	9	90.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626843	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626843&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=C(N=CN=C1)C(C)C	4-[7-(4-isopropylpyrimidin-5-yl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC(=O)CCCN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626845	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626845&database=RX&origin=ReaxysOutput&ln=	(295 of 1381)		methyl 4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoate	C26H26F3N5O5	C26H26F3N5O5	545.518			XMBDJFYHCLRZGE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.95	1	8	13	108.98	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626845	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626845&database=RX&origin=ReaxysOutput&ln=	COC(=O)CCCN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	methyl 4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC(=O)CCCN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626845	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626845&database=RX&origin=ReaxysOutput&ln=	(295 of 1381)		methyl 4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoate	C26H26F3N5O5	C26H26F3N5O5	545.518			XMBDJFYHCLRZGE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.95	1	8	13	108.98	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626845	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626845&database=RX&origin=ReaxysOutput&ln=	COC(=O)CCCN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	methyl 4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)CCCN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626846	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626846&database=RX&origin=ReaxysOutput&ln=	(296 of 1381)		ethyl 4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoate	C27H28F3N5O5	C27H28F3N5O5	559.545			PTGJOOMRCUMQAN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.373	1	8	14	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626846	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626846&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)CCCN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)CCCN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626846	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626846&database=RX&origin=ReaxysOutput&ln=	(296 of 1381)		ethyl 4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoate	C27H28F3N5O5	C27H28F3N5O5	559.545			PTGJOOMRCUMQAN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.373	1	8	14	108.98	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626846	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626846&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)CCCN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 4-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]butanoate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CN(C1)C(=O)OC(C)(C)C		34626847	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626847&database=RX&origin=ReaxysOutput&ln=	(297 of 1381)		tert-butyl 3-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]azetidine-1-carboxylate	C29H31F3N6O5	C29H31F3N6O5	600.598			CAYFFOZFODCQOX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.671	1	9	12	112.22	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626847	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626847&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CN(C1)C(=O)OC(C)(C)C	tert-butyl 3-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]azetidine-1-carboxylate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CN(C1)C(=O)OC(C)(C)C		34626847	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626847&database=RX&origin=ReaxysOutput&ln=	(297 of 1381)		tert-butyl 3-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]azetidine-1-carboxylate	C29H31F3N6O5	C29H31F3N6O5	600.598			CAYFFOZFODCQOX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.671	1	9	12	112.22	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626847	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626847&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(N=C1)C1CN(C1)C(=O)OC(C)(C)C	tert-butyl 3-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]azetidine-1-carboxylate					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626848	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626848&database=RX&origin=ReaxysOutput&ln=	(298 of 1381)		7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)isoindolin-1-one	C22H18F3N5O2	C22H18F3N5O2	441.412			XBBYCDRDQXJJJR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.646	0	6	5	64.66	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626848	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626848&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)isoindolin-1-one					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626848	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626848&database=RX&origin=ReaxysOutput&ln=	(298 of 1381)		7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)isoindolin-1-one	C22H18F3N5O2	C22H18F3N5O2	441.412			XBBYCDRDQXJJJR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.646	0	6	5	64.66	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626848	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626848&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)isoindolin-1-one					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626848	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626848&database=RX&origin=ReaxysOutput&ln=	(298 of 1381)		7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)isoindolin-1-one	C22H18F3N5O2	C22H18F3N5O2	441.412			XBBYCDRDQXJJJR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.646	0	6	5	64.66	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626848	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626848&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)C2)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	7-methoxy-5-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)isoindolin-1-one					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626849	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626849&database=RX&origin=ReaxysOutput&ln=	(299 of 1381)		2-cyclopropyl-8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one	C24H23N5O2	C24H23N5O2	413.479			BVNPDJCOAFIFNY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.922	0	6	4	64.66	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626849	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626849&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-cyclopropyl-8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626849	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626849&database=RX&origin=ReaxysOutput&ln=	(299 of 1381)		2-cyclopropyl-8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one	C24H23N5O2	C24H23N5O2	413.479			BVNPDJCOAFIFNY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.922	0	6	4	64.66	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626849	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626849&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-cyclopropyl-8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626849	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626849&database=RX&origin=ReaxysOutput&ln=	(299 of 1381)		2-cyclopropyl-8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one	C24H23N5O2	C24H23N5O2	413.479			BVNPDJCOAFIFNY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.922	0	6	4	64.66	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626849	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626849&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-cyclopropyl-8-methoxy-6-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626850	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626850&database=RX&origin=ReaxysOutput&ln=	(300 of 1381)		ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate	C26H26F3N5O5	C26H26F3N5O5	545.518			BIVWPTFZXJYCAV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.383	1	8	12	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626850	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626850&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626850	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626850&database=RX&origin=ReaxysOutput&ln=	(300 of 1381)		ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate	C26H26F3N5O5	C26H26F3N5O5	545.518			BIVWPTFZXJYCAV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.383	1	8	12	108.98	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626850	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626850&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626850	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626850&database=RX&origin=ReaxysOutput&ln=	(300 of 1381)		ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate	C26H26F3N5O5	C26H26F3N5O5	545.518			BIVWPTFZXJYCAV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.383	1	8	12	108.98	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626850	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626850&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C(C)N1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]propanoate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		34626851	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626851&database=RX&origin=ReaxysOutput&ln=	(301 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H22F2N4O4	C25H22F2N4O4	480.471			PUYQOTUOSDYVFF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.461	1	5	9	86.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626851	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626851&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		34626851	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626851&database=RX&origin=ReaxysOutput&ln=	(301 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H22F2N4O4	C25H22F2N4O4	480.471			PUYQOTUOSDYVFF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.461	1	5	9	86.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626851	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626851&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methoxy-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=CN=C1C#N		34626852	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626852&database=RX&origin=ReaxysOutput&ln=	(302 of 1381)		4-[7-(2-cyano-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H18F3N5O3	C24H18F3N5O3	481.434			RIJASYLQTFYTQW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.798	1	6	8	101.54	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626852	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626852&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=CN=C1C#N	4-[7-(2-cyano-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=C(C)N=N1		34626853	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626853&database=RX&origin=ReaxysOutput&ln=	(303 of 1381)		2,6-dimethoxy-4-[7-(6-methylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H20F3N5O3	C23H20F3N5O3	471.439			RHQVMLNBPSGRTM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.56	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626853	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626853&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=C(C)N=N1	2,6-dimethoxy-4-[7-(6-methylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1		34626854	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626854&database=RX&origin=ReaxysOutput&ln=	(304 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H20F2N4O4	C23H20F2N4O4	454.433			SLWUOOQOXHIDOP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.986	1	4	8	90.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626854	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626854&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1		34626854	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626854&database=RX&origin=ReaxysOutput&ln=	(304 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H20F2N4O4	C23H20F2N4O4	454.433			SLWUOOQOXHIDOP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.986	1	4	8	90.89	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626854	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626854&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC(C)=NO1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-methylisoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(F)=C(C(=O)NCC(F)(F)F)C(F)=C1		34626855	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626855&database=RX&origin=ReaxysOutput&ln=	(305 of 1381)		2,6-difluoro-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C20H14F5N5O	C20H14F5N5O	435.356			OKGOKFFPZPELNT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	7	5.223	1	6	6	64.22	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626855	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626855&database=RX&origin=ReaxysOutput&ln=	CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(F)=C(C(=O)NCC(F)(F)F)C(F)=C1	2,6-difluoro-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN=NC(C)=C1		34626856	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626856&database=RX&origin=ReaxysOutput&ln=	(306 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methylpyridazin-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H21F2N5O3	C24H21F2N5O3	465.459			WBYWSDPXMPFAJA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.303	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626856	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626856&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN=NC(C)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methylpyridazin-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN=NC(C)=C1		34626856	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626856&database=RX&origin=ReaxysOutput&ln=	(306 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methylpyridazin-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H21F2N5O3	C24H21F2N5O3	465.459			WBYWSDPXMPFAJA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.303	1	6	8	90.64	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626856	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626856&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN=NC(C)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methylpyridazin-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN=CN1C		34626857	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626857&database=RX&origin=ReaxysOutput&ln=	(307 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H21F2N5O3	C23H21F2N5O3	453.448			RCNHYUXMBUGJBW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.327	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626857	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626857&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN=CN1C	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN=CN1C		34626857	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626857&database=RX&origin=ReaxysOutput&ln=	(307 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H21F2N5O3	C23H21F2N5O3	453.448			RCNHYUXMBUGJBW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	7	4.327	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626857	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626857&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN=CN1C	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-methylimidazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(NC(C)C)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626858	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626858&database=RX&origin=ReaxysOutput&ln=	(308 of 1381)		N-cyclopropyl-2-(isopropylamino)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28N6O2	C25H28N6O2	444.536			PKMXLJWHBUMSLN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.892	2	7	8	85.48	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626858	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626858&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(NC(C)C)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2-(isopropylamino)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OCCO)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626859	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626859&database=RX&origin=ReaxysOutput&ln=	(309 of 1381)		N-cyclopropyl-2-(2-hydroxyethoxy)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H25N5O4	C24H25N5O4	447.494			VEYAVZWMXBDKOO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.14	2	7	9	102.91	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626859	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626859&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OCCO)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2-(2-hydroxyethoxy)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OCCO)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626859	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626859&database=RX&origin=ReaxysOutput&ln=	(309 of 1381)		N-cyclopropyl-2-(2-hydroxyethoxy)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H25N5O4	C24H25N5O4	447.494			VEYAVZWMXBDKOO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.14	2	7	9	102.91	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626859	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626859&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OCCO)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	N-cyclopropyl-2-(2-hydroxyethoxy)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(N=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		34626860	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626860&database=RX&origin=ReaxysOutput&ln=	(310 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methoxypyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H21F2N5O4	C24H21F2N5O4	481.459			GFOVAEROOQEYJU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.72	1	6	9	99.87	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626860	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626860&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(N=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methoxypyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(N=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		34626860	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626860&database=RX&origin=ReaxysOutput&ln=	(310 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methoxypyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H21F2N5O4	C24H21F2N5O4	481.459			GFOVAEROOQEYJU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.72	1	6	9	99.87	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626860	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626860&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(N=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-methoxypyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)C(F)(F)F		34626861	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626861&database=RX&origin=ReaxysOutput&ln=	(311 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[6-(trifluoromethyl)pyridazin-3-yl]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H18F5N5O3	C24H18F5N5O3	519.431			APXCUYGDWIUUBD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.091	1	6	9	90.64	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626861	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626861&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)C(F)(F)F	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[6-(trifluoromethyl)pyridazin-3-yl]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)C#N		34626862	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626862&database=RX&origin=ReaxysOutput&ln=	(312 of 1381)		4-[7-(6-cyanopyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H18F2N6O3	C24H18F2N6O3	476.442			YTFHATGBAHAHTK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	3.889	1	7	8	114.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626862	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626862&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)C#N	4-[7-(6-cyanopyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)N(C)C		34626863	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626863&database=RX&origin=ReaxysOutput&ln=	(313 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[6-(dimethylamino)pyridazin-3-yl]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H24F2N6O3	C25H24F2N6O3	494.501			AHHPCDKTZLOKOE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	5.014	1	7	9	93.88	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626863	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626863&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)N(C)C	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[6-(dimethylamino)pyridazin-3-yl]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)C1CC1		34626864	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626864&database=RX&origin=ReaxysOutput&ln=	(314 of 1381)		N-cyclopropyl-4-[7-(6-cyclopropylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C26H23F2N5O3	C26H23F2N5O3	491.497			FDAVTUBXOPQZAH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.598	1	6	9	90.64	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626864	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626864&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)C1CC1	N-cyclopropyl-4-[7-(6-cyclopropylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)C1CC1		34626864	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626864&database=RX&origin=ReaxysOutput&ln=	(314 of 1381)		N-cyclopropyl-4-[7-(6-cyclopropylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C26H23F2N5O3	C26H23F2N5O3	491.497			FDAVTUBXOPQZAH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.598	1	6	9	90.64	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626864	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626864&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)C1CC1	N-cyclopropyl-4-[7-(6-cyclopropylpyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CNN=C1		34626866	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626866&database=RX&origin=ReaxysOutput&ln=	(315 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1H-pyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H19F2N5O3	C22H19F2N5O3	439.421			XYOBQZPDAAMXFF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.307	2	6	8	94.06	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626866	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626866&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CNN=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1H-pyrazol-4-yl)benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CNN=C1		34626866	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626866&database=RX&origin=ReaxysOutput&ln=	(315 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1H-pyrazol-4-yl)benzimidazol-1-yl]benzamide	C22H19F2N5O3	C22H19F2N5O3	439.421			XYOBQZPDAAMXFF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.307	2	6	8	94.06	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626866	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626866&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CNN=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-(1H-pyrazol-4-yl)benzimidazol-1-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CNN=C1		34626867	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626867&database=RX&origin=ReaxysOutput&ln=	(316 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H19F2N5O3	C22H19F2N5O3	439.421			XRDXIWUGEJRXHN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.758	2	6	8	93.54	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626867	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626867&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CNN=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CNN=C1		34626867	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626867&database=RX&origin=ReaxysOutput&ln=	(316 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H19F2N5O3	C22H19F2N5O3	439.421			XRDXIWUGEJRXHN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.758	2	6	8	93.54	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626867	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626867&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CNN=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(NCCO)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626868	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626868&database=RX&origin=ReaxysOutput&ln=	(317 of 1381)		2-(2-hydroxyethylamino)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H23F3N6O3	C23H23F3N6O3	488.469			JSMCBHDQYQRUGH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.182	3	8	10	105.71	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626868	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626868&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(NCCO)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-(2-hydroxyethylamino)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(NCCO)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626868	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626868&database=RX&origin=ReaxysOutput&ln=	(317 of 1381)		2-(2-hydroxyethylamino)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H23F3N6O3	C23H23F3N6O3	488.469			JSMCBHDQYQRUGH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	7	4.182	3	8	10	105.71	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626868	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626868&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(NCCO)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-(2-hydroxyethylamino)-6-methoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1		34626869	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626869&database=RX&origin=ReaxysOutput&ln=	(318 of 1381)		2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			IFEWCMKHKYRCDF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.531	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626869	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626869&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1	2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1		34626869	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626869&database=RX&origin=ReaxysOutput&ln=	(318 of 1381)		2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			IFEWCMKHKYRCDF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.531	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626869	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626869&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1	2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1		34626869	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626869&database=RX&origin=ReaxysOutput&ln=	(318 of 1381)		2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			IFEWCMKHKYRCDF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		7	4.531	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626869	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626869&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=C2C=CC(=CN2N=C1)C1=CN(C)N=C1	2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626882	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626882&database=RX&origin=ReaxysOutput&ln=	(319 of 1381)		ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C25H24F3N5O5	C25H24F3N5O5	531.491			ZHCUIYGBBFHWPM-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	7	4.857	1	8	12	108.98	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626882	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626882&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626882	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626882&database=RX&origin=ReaxysOutput&ln=	(319 of 1381)		ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C25H24F3N5O5	C25H24F3N5O5	531.491			ZHCUIYGBBFHWPM-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	7	4.857	1	8	12	108.98	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626882	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626882&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626882	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626882&database=RX&origin=ReaxysOutput&ln=	(319 of 1381)		ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate	C25H24F3N5O5	C25H24F3N5O5	531.491			ZHCUIYGBBFHWPM-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	7	4.857	1	8	12	108.98	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626882	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626882&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)CN1C=C(C=N1)C1=CC2=NC=C(N2C=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	ethyl 2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetate					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(O)=O)N=C1		34626883	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626883&database=RX&origin=ReaxysOutput&ln=	(320 of 1381)		2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetic acid	C23H20F3N5O5	C23H20F3N5O5	503.438			SDGFNQWDQCNOMW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	7	4.113	2	8	10	119.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626883	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626883&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(O)=O)N=C1	2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetic acid					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(O)=O)N=C1		34626883	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626883&database=RX&origin=ReaxysOutput&ln=	(320 of 1381)		2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetic acid	C23H20F3N5O5	C23H20F3N5O5	503.438			SDGFNQWDQCNOMW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	7	4.113	2	8	10	119.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626883	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626883&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(CC(O)=O)N=C1	2-[4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]pyrazol-1-yl]acetic acid					EC50	nM	>	5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626884	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626884&database=RX&origin=ReaxysOutput&ln=	(321 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			MJVNIDIUWWKEFZ-UHFFFAOYSA-N				Identification(13); Spectra(3); Bioactivity(2)	4	7	4.731	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626884	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626884&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626884	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626884&database=RX&origin=ReaxysOutput&ln=	(321 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			MJVNIDIUWWKEFZ-UHFFFAOYSA-N				Identification(13); Spectra(3); Bioactivity(2)	4	7	4.731	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626884	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626884&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626884	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626884&database=RX&origin=ReaxysOutput&ln=	(321 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			MJVNIDIUWWKEFZ-UHFFFAOYSA-N				Identification(13); Spectra(3); Bioactivity(2)	4	7	4.731	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626884	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626884&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626884	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626884&database=RX&origin=ReaxysOutput&ln=	(321 of 1381)		2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			MJVNIDIUWWKEFZ-UHFFFAOYSA-N				Identification(13); Spectra(3); Bioactivity(2)	4	7	4.731	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626884	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626884&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2,6-dimethoxy-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=C2N=CC(=CN2N=C1)C1=CN(C)N=C1		34626885	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626885&database=RX&origin=ReaxysOutput&ln=	(322 of 1381)		2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H19F3N6O3	C21H19F3N6O3	460.415			QPMBZSCKZKTHLN-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	7	3.49	1	7	8	95.57	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626885	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626885&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=C2N=CC(=CN2N=C1)C1=CN(C)N=C1	2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=C2N=CC(=CN2N=C1)C1=CN(C)N=C1		34626885	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626885&database=RX&origin=ReaxysOutput&ln=	(322 of 1381)		2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C21H19F3N6O3	C21H19F3N6O3	460.415			QPMBZSCKZKTHLN-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	7	3.49	1	7	8	95.57	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626885	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626885&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=C2N=CC(=CN2N=C1)C1=CN(C)N=C1	2,6-dimethoxy-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CN=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626886	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626886&database=RX&origin=ReaxysOutput&ln=	(323 of 1381)		4-[6-(1-ethylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N6O3	C22H21F3N6O3	474.442			HISAZYJIGDQLNI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.179	1	7	9	96.09	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626886	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626886&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CN=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	4-[6-(1-ethylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCN1C=C(C=N1)C1=CN=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1		34626886	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626886&database=RX&origin=ReaxysOutput&ln=	(323 of 1381)		4-[6-(1-ethylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N6O3	C22H21F3N6O3	474.442			HISAZYJIGDQLNI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	7	4.179	1	7	9	96.09	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626886	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626886&database=RX&origin=ReaxysOutput&ln=	CCN1C=C(C=N1)C1=CN=C2N(C=NC2=C1)C1=CC(OC)=C(C(=O)NCC(F)(F)F)C(OC)=C1	4-[6-(1-ethylpyrazol-4-yl)imidazo[4,5-b]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NCC(F)(F)F)C(C)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626888	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626888&database=RX&origin=ReaxysOutput&ln=	(324 of 1381)		2-methoxy-6-methyl-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O2	C22H20F3N5O2	443.428			JEDPHTVCDXBJDD-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	5.253	1	6	7	73.45	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626888	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626888&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NCC(F)(F)F)C(C)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-methoxy-6-methyl-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NCC(F)(F)F)C(C)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626888	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626888&database=RX&origin=ReaxysOutput&ln=	(324 of 1381)		2-methoxy-6-methyl-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C22H20F3N5O2	C22H20F3N5O2	443.428			JEDPHTVCDXBJDD-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	7	5.253	1	6	7	73.45	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626888	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626888&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NCC(F)(F)F)C(C)=CC(=C1)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	2-methoxy-6-methyl-4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NO1		36081273	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081273&database=RX&origin=ReaxysOutput&ln=	(325 of 1381)		N-(3,5-dimethyl-1,2-isoxazolyl)-3-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H26N8O3S	C20H26N8O3S	458.544			LXRITECWUGVGTD-UHFFFAOYSA-N				Identification(14); Physical Data(2); Spectra(4); Bioactivity(4)	1	7	0.607	3	9	8	160.78	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081273	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081273&database=RX&origin=ReaxysOutput&ln=	CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NO1	N-(3,5-dimethyl-1,2-isoxazolyl)-3-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		800							6.1			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NO1		36081273	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081273&database=RX&origin=ReaxysOutput&ln=	(325 of 1381)		N-(3,5-dimethyl-1,2-isoxazolyl)-3-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H26N8O3S	C20H26N8O3S	458.544			LXRITECWUGVGTD-UHFFFAOYSA-N				Identification(14); Physical Data(2); Spectra(4); Bioactivity(4)	1	7	0.607	3	9	8	160.78	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081273	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081273&database=RX&origin=ReaxysOutput&ln=	CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NO1	N-(3,5-dimethyl-1,2-isoxazolyl)-3-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		800							6.1			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NO1		36081273	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081273&database=RX&origin=ReaxysOutput&ln=	(325 of 1381)		N-(3,5-dimethyl-1,2-isoxazolyl)-3-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H26N8O3S	C20H26N8O3S	458.544			LXRITECWUGVGTD-UHFFFAOYSA-N				Identification(14); Physical Data(2); Spectra(4); Bioactivity(4)	1	7	0.607	3	9	8	160.78	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									36081273	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081273&database=RX&origin=ReaxysOutput&ln=	CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C(C)=NO1						IC50	nM		800							6.1			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2Cl)=N1)N1CCN(CCO)CC1		39059470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059470&database=RX&origin=ReaxysOutput&ln=	(326 of 1381)		N-(2,4-dichlorothiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C19H21Cl2N7O2S2	C19H21Cl2N7O2S2	514.459			UXTSNWGOMSEBTG-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(3)		7	1.729	3	9	8	112.22	3	2	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		39059470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059470&database=RX&origin=ReaxysOutput&ln=	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2Cl)=N1)N1CCN(CCO)CC1						IC50	nM	<=	200							6.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2Cl)=N1)N1CCN(CCO)CC1		39059470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059470&database=RX&origin=ReaxysOutput&ln=	(326 of 1381)		N-(2,4-dichlorothiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C19H21Cl2N7O2S2	C19H21Cl2N7O2S2	514.459			UXTSNWGOMSEBTG-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(3)		7	1.729	3	9	8	112.22	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									39059470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059470&database=RX&origin=ReaxysOutput&ln=	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2Cl)=N1)N1CCN(CCO)CC1						IC50	nM	~	15 - 20							7.82			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2Cl)=N1)N1CCN(CCO)CC1		39059470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059470&database=RX&origin=ReaxysOutput&ln=	(326 of 1381)		N-(2,4-dichlorothiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C19H21Cl2N7O2S2	C19H21Cl2N7O2S2	514.459			UXTSNWGOMSEBTG-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(3)		7	1.729	3	9	8	112.22	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									39059470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059470&database=RX&origin=ReaxysOutput&ln=	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2Cl)=N1)N1CCN(CCO)CC1						IC50	nM	~	15 - 20							7.82			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC(=O)N1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1		39059471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059471&database=RX&origin=ReaxysOutput&ln=	(327 of 1381)		2-((6-(4-acetylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-chloro-4-methylthiophen-3-yl)thiazole-5-carboxamide	C20H22ClN7O2S2	C20H22ClN7O2S2	492.025			RIJYZTZQMRSSEU-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(3)		7	1.831	2	9	7	129.29	4	2	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		39059471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059471&database=RX&origin=ReaxysOutput&ln=	CC(=O)N1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1						IC50	nM	>=	200							6.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC(=O)N1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1		39059471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059471&database=RX&origin=ReaxysOutput&ln=	(327 of 1381)		2-((6-(4-acetylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-chloro-4-methylthiophen-3-yl)thiazole-5-carboxamide	C20H22ClN7O2S2	C20H22ClN7O2S2	492.025			RIJYZTZQMRSSEU-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(3)		7	1.831	2	9	7	129.29	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									39059471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059471&database=RX&origin=ReaxysOutput&ln=	CC(=O)N1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1						IC50	nM	~	150							6.82			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC(=O)N1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1		39059471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059471&database=RX&origin=ReaxysOutput&ln=	(327 of 1381)		2-((6-(4-acetylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-chloro-4-methylthiophen-3-yl)thiazole-5-carboxamide	C20H22ClN7O2S2	C20H22ClN7O2S2	492.025			RIJYZTZQMRSSEU-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(3)		7	1.831	2	9	7	129.29	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									39059471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059471&database=RX&origin=ReaxysOutput&ln=	CC(=O)N1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1						IC50	nM	~	150							6.82			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1		39059472	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059472&database=RX&origin=ReaxysOutput&ln=	(328 of 1381)		N-(2-chloro-4-methylthiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C19H22ClN7OS2	C19H22ClN7OS2	464.015			DFZKXFCZKLBBRG-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(3)		7	2.042	2	8	6	112.22	4	2	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		39059472	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059472&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1						IC50	nM	<=	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1		39059472	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059472&database=RX&origin=ReaxysOutput&ln=	(328 of 1381)		N-(2-chloro-4-methylthiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C19H22ClN7OS2	C19H22ClN7OS2	464.015			DFZKXFCZKLBBRG-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(3)		7	2.042	2	8	6	112.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									39059472	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059472&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1						IC50	nM	~	60							7.22			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1		39059472	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059472&database=RX&origin=ReaxysOutput&ln=	(328 of 1381)		N-(2-chloro-4-methylthiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C19H22ClN7OS2	C19H22ClN7OS2	464.015			DFZKXFCZKLBBRG-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(3)		7	2.042	2	8	6	112.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									39059472	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059472&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C)=NC(C)=N1						IC50	nM	~	60							7.22			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1		19438144	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D19438144&database=RX&origin=ReaxysOutput&ln=	(329 of 1381)	1025890-15-6	N-(2,6-dichlorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide; dasatinib; BMS-354825	C21H23Cl2N7O2S	C21H23Cl2N7O2S	508.431			AQYKQVZJARJBMR-UHFFFAOYSA-N				Identification(11); Spectra(2); Bioactivity(6)	1	6	2.387	3	9	8	134.75	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									19438144	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D19438144&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1	N-(2,6-dichlorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	<	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C=CC=C1		29671235	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29671235&database=RX&origin=ReaxysOutput&ln=	(330 of 1381)		N-(2-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; 2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(o-tolyl)thiazole-5-carboxamide	C22H27N7O2S	C22H27N7O2S	453.568			AMOFUFYOLNJZBB-UHFFFAOYSA-N				Identification(12); Physical Data(2); Spectra(6); Bioactivity(3)	4	6	1.369	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									29671235	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29671235&database=RX&origin=ReaxysOutput&ln=	CC1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C=CC=C1	2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(o-tolyl)thiazole-5-carboxamide					IC50	μM	<	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
[2H]C([2H])([2H])OC1=CC(=CC(OC([2H])([2H])[2H])=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1		34626584	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626584&database=RX&origin=ReaxysOutput&ln=	(331 of 1381)		4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2,6-bis(trideuteriomethoxy)-N-(2,2,2-trifluoroethyl)benzamide	C22H14(2)H6F3N5O3	C22H20F3N5O3	465.38			MJVNIDIUWWKEFZ-XERRXZQWSA-N				Identification(12); Spectra(2); Bioactivity(2)	5	6	4.731	1	6	8	82.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626584	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626584&database=RX&origin=ReaxysOutput&ln=	[2H]C([2H])([2H])OC1=CC(=CC(OC([2H])([2H])[2H])=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CN(C)N=C1	4-[7-(1-methylpyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]-2,6-bis(trideuteriomethoxy)-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCOCC1		34626633	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626633&database=RX&origin=ReaxysOutput&ln=	(332 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-(6-morpholino-3-pyridyl)benzimidazol-1-yl]benzamide	C27H29N5O4	C27H29N5O4	487.558			DJFLTXAFCABJMV-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.19	1	7	8	90.74	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626633	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626633&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCOCC1	N-ethyl-2,6-dimethoxy-4-[5-(6-morpholino-3-pyridyl)benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCOCC1		34626633	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626633&database=RX&origin=ReaxysOutput&ln=	(332 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-(6-morpholino-3-pyridyl)benzimidazol-1-yl]benzamide	C27H29N5O4	C27H29N5O4	487.558			DJFLTXAFCABJMV-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.19	1	7	8	90.74	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626633	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626633&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCOCC1	N-ethyl-2,6-dimethoxy-4-[5-(6-morpholino-3-pyridyl)benzimidazol-1-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1		34626635	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626635&database=RX&origin=ReaxysOutput&ln=	(333 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide	C27H32N6O4	C27H32N6O4	504.589			BHCBNUDVBZUZIK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	2.731	1	8	10	95.67	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626635	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626635&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1	N-ethyl-2,6-dimethoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1		34626635	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626635&database=RX&origin=ReaxysOutput&ln=	(333 of 1381)		N-ethyl-2,6-dimethoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide	C27H32N6O4	C27H32N6O4	504.589			BHCBNUDVBZUZIK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	2.731	1	8	10	95.67	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626635	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626635&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1	N-ethyl-2,6-dimethoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide					EC50	nM	>	1000 - 5000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCOCC1		34626660	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626660&database=RX&origin=ReaxysOutput&ln=	(334 of 1381)		2,6-dimethoxy-4-[5-(6-morpholino-3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C27H26F3N5O4	C27H26F3N5O4	541.53			DAOFUNPGKZGEGG-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	5.192	1	7	9	90.74	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626660	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626660&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCOCC1	2,6-dimethoxy-4-[5-(6-morpholino-3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCOCC1		34626660	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626660&database=RX&origin=ReaxysOutput&ln=	(334 of 1381)		2,6-dimethoxy-4-[5-(6-morpholino-3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C27H26F3N5O4	C27H26F3N5O4	541.53			DAOFUNPGKZGEGG-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	5.192	1	7	9	90.74	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626660	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626660&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CC=C(N=C1)N1CCOCC1	2,6-dimethoxy-4-[5-(6-morpholino-3-pyridyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1		34626670	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626670&database=RX&origin=ReaxysOutput&ln=	(335 of 1381)		2,6-dimethoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C27H29F3N6O4	C27H29F3N6O4	558.56			DYWQCTFVYQDDGV-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	3.733	1	8	11	95.67	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626670	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626670&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1	2,6-dimethoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1		34626670	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626670&database=RX&origin=ReaxysOutput&ln=	(335 of 1381)		2,6-dimethoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C27H29F3N6O4	C27H29F3N6O4	558.56			DYWQCTFVYQDDGV-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	3.733	1	8	11	95.67	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626670	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626670&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1	2,6-dimethoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1		34626677	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626677&database=RX&origin=ReaxysOutput&ln=	(336 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide	C28H30F2N6O4	C28H30F2N6O4	552.581			KQHNWVSHHHOQHN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	3.565	1	8	11	95.67	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626677	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626677&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1		34626677	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626677&database=RX&origin=ReaxysOutput&ln=	(336 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide	C28H30F2N6O4	C28H30F2N6O4	552.581			KQHNWVSHHHOQHN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	3.565	1	8	11	95.67	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626677	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626677&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1		34626677	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626677&database=RX&origin=ReaxysOutput&ln=	(336 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide	C28H30F2N6O4	C28H30F2N6O4	552.581			KQHNWVSHHHOQHN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	3.565	1	8	11	95.67	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626677	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626677&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1		34626678	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626678&database=RX&origin=ReaxysOutput&ln=	(337 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide	C27H30F2N6O4	C27H30F2N6O4	540.57			DMRSDXYRNDSJJK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	3.445	1	8	11	95.67	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				peripheral blood mononuclear cell		34626678	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626678&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1		34626678	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626678&database=RX&origin=ReaxysOutput&ln=	(337 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide	C27H30F2N6O4	C27H30F2N6O4	540.57			DMRSDXYRNDSJJK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	3.445	1	8	11	95.67	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626678	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626678&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1		34626678	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626678&database=RX&origin=ReaxysOutput&ln=	(337 of 1381)		2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide	C27H30F2N6O4	C27H30F2N6O4	540.57			DMRSDXYRNDSJJK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	3.445	1	8	11	95.67	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626678	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626678&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)N1C=NC2=CC(=CC=C12)C1=CN(CCN2CCOCC2)N=C1	2-(difluoromethoxy)-N-ethyl-6-methoxy-4-[5-[1-(2-morpholinoethyl)pyrazol-4-yl]benzimidazol-1-yl]benzamide					EC50	nM	>	100 - 1000			Lipopolysaccharide-induced tumor necrosis factor-alpha factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)N1CCOCC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1		34626793	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626793&database=RX&origin=ReaxysOutput&ln=	(338 of 1381)		[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-morpholinoazetidin-1-yl)methanone	C27H30N6O4	C27H30N6O4	502.573			SXAXIBXXYKQCIL-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	2.277	0	8	7	86.88	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626793	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626793&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(C1)N1CCOCC1)N1C=NC2=CC(=CC=C12)C1=CN(C)N=C1	[2,6-dimethoxy-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]phenyl]-(3-morpholinoazetidin-1-yl)methanone					IC50	nM	>	500							6.3			14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)N1CCOCC1		34626841	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626841&database=RX&origin=ReaxysOutput&ln=	(339 of 1381)		2,6-dimethoxy-4-[7-(6-morpholino-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C27H26F3N5O4	C27H26F3N5O4	541.53			AMYXEWONNXQYGA-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	5.643	1	7	9	90.22	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626841	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626841&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)N1CCOCC1	2,6-dimethoxy-4-[7-(6-morpholino-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										14205888; 34681992	AMARA peptide substrate	Other compound; Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)N1CCOCC1		34626841	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626841&database=RX&origin=ReaxysOutput&ln=	(339 of 1381)		2,6-dimethoxy-4-[7-(6-morpholino-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C27H26F3N5O4	C27H26F3N5O4	541.53			AMYXEWONNXQYGA-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	5.643	1	7	9	90.22	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	nonsteroid antiinflammatory agent	In Vitro (Efficacy)			human				CD14+ monocyte		34626841	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626841&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1=CC=C(N=C1)N1CCOCC1	2,6-dimethoxy-4-[7-(6-morpholino-3-pyridyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					EC50	nM		0.1 - 100			Lipopolysaccharide-induced tumor necrosis factor-alpha factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)N1CCOCC1		34626865	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626865&database=RX&origin=ReaxysOutput&ln=	(340 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-morpholinopyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C27H26F2N6O4	C27H26F2N6O4	536.538			KSMMXGISZXTZRZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.734	1	8	9	103.11	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626865	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626865&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1=CC=C(N=N1)N1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(6-morpholinopyridazin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(CC(F)F)C3CC3)C=CN12		35503054	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503054&database=RX&origin=ReaxysOutput&ln=	(341 of 1381)		N-cyclopropyl-4-[7-[2-[cyclopropyl(2,2-difluoroethyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C26H28F4N4O4	C26H28F4N4O4	536.526			BXJGUBKOHZGDTM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.35	1	5	14	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503054	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503054&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(CC(F)F)C3CC3)C=CN12	N-cyclopropyl-4-[7-[2-[cyclopropyl(2,2-difluoroethyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)CC(F)F)C=CN12		35503055	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503055&database=RX&origin=ReaxysOutput&ln=	(342 of 1381)		N-cyclopropyl-4-[7-[2-[2,2-difluoroethyl(methyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C24H26F4N4O4	C24H26F4N4O4	510.488			MFWGANVLDYCVBW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.807	1	5	13	77.33	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503055	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503055&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)CC(F)F)C=CN12	N-cyclopropyl-4-[7-[2-[2,2-difluoroethyl(methyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COCCN(CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1)CC(F)F		35503056	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503056&database=RX&origin=ReaxysOutput&ln=	(343 of 1381)		N-cyclopropyl-4-[7-[2-[2,2-difluoroethyl(2-methoxyethyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C26H30F4N4O5	C26H30F4N4O5	554.542			OHSSKNVNVFGOLO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.617	1	6	16	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503056	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503056&database=RX&origin=ReaxysOutput&ln=	COCCN(CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1)CC(F)F	N-cyclopropyl-4-[7-[2-[2,2-difluoroethyl(2-methoxyethyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=NC=CC=N3)C=CN12		35503057	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503057&database=RX&origin=ReaxysOutput&ln=	(344 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[methyl(pyrimidin-2-yl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H26F2N6O4	C26H26F2N6O4	524.527			OPXWZDZISHNSHD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.501	1	7	12	103.11	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503057	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503057&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=NC=CC=N3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[methyl(pyrimidin-2-yl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=CC=NC=N3)C=CN12		35503058	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503058&database=RX&origin=ReaxysOutput&ln=	(345 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[methyl(pyrimidin-4-yl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H26F2N6O4	C26H26F2N6O4	524.527			KPTXBSBGYWFMON-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.501	1	7	12	103.11	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503058	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503058&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=CC=NC=N3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[methyl(pyrimidin-4-yl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503060	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503060&database=RX&origin=ReaxysOutput&ln=	(346 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methyl-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			YWHIFOHPFTYREK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.02	1	6	10	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503060	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503060&database=RX&origin=ReaxysOutput&ln=	CC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methyl-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503061	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503061&database=RX&origin=ReaxysOutput&ln=	(347 of 1381)		6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydro-2H-isoquinolin-1-one	C22H23N3O5	C22H23N3O5	409.442			CLMIOXZDXAFIHE-QGZVFWFLSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	2.166	1	6	5	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503061	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503061&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydro-2H-isoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503061	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503061&database=RX&origin=ReaxysOutput&ln=	(347 of 1381)		6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydro-2H-isoquinolin-1-one	C22H23N3O5	C22H23N3O5	409.442			CLMIOXZDXAFIHE-QGZVFWFLSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	2.166	1	6	5	83.32	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503061	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503061&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydro-2H-isoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503061	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503061&database=RX&origin=ReaxysOutput&ln=	(347 of 1381)		6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydro-2H-isoquinolin-1-one	C22H23N3O5	C22H23N3O5	409.442			CLMIOXZDXAFIHE-QGZVFWFLSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	2.166	1	6	5	83.32	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503061	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503061&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydro-2H-isoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503062	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503062&database=RX&origin=ReaxysOutput&ln=	(348 of 1381)		2-(difluoromethoxy)-6-methyl-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H25F5N4O4	C24H25F5N4O4	528.479			NZEVLYIYULHQDB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.902	1	6	11	77.33	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503062	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503062&database=RX&origin=ReaxysOutput&ln=	CC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	2-(difluoromethoxy)-6-methyl-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
[H][C@]12CN(CCOC3=CC4=NC=C(N4C=C3)C3=CC4=C(C(=O)N(CC(F)(F)F)CC4)C(OC)=C3)[C@]([H])(CO1)C2		35503063	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503063&database=RX&origin=ReaxysOutput&ln=	(349 of 1381)		8-methoxy-6-[7-[2-[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H27F3N4O4	C26H27F3N4O4	516.52			JMJIAYQJKINDDN-ICSRJNTNSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	3.961	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503063	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503063&database=RX&origin=ReaxysOutput&ln=	[H][C@]12CN(CCOC3=CC4=NC=C(N4C=C3)C3=CC4=C(C(=O)N(CC(F)(F)F)CC4)C(OC)=C3)[C@]([H])(CO1)C2	8-methoxy-6-[7-[2-[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
[H][C@]12CN(CCOC3=CC4=NC=C(N4C=C3)C3=CC4=C(C(=O)N(CC(F)(F)F)CC4)C(OC)=C3)[C@]([H])(CO1)C2		35503063	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503063&database=RX&origin=ReaxysOutput&ln=	(349 of 1381)		8-methoxy-6-[7-[2-[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H27F3N4O4	C26H27F3N4O4	516.52			JMJIAYQJKINDDN-ICSRJNTNSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	3.961	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503063	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503063&database=RX&origin=ReaxysOutput&ln=	[H][C@]12CN(CCOC3=CC4=NC=C(N4C=C3)C3=CC4=C(C(=O)N(CC(F)(F)F)CC4)C(OC)=C3)[C@]([H])(CO1)C2	8-methoxy-6-[7-[2-[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3C4CCC3COC4)C=CN12		35503064	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503064&database=RX&origin=ReaxysOutput&ln=	(350 of 1381)		8-methoxy-6-[7-[2-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C27H29F3N4O4	C27H29F3N4O4	530.547			URNQVCLLEYVGDQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.319	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503064	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503064&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3C4CCC3COC4)C=CN12	8-methoxy-6-[7-[2-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CNC3)C=CN12		35503067	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503067&database=RX&origin=ReaxysOutput&ln=	(351 of 1381)		6-[7-[(3-fluoroazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H22F4N4O3	C23H22F4N4O3	478.446			RSDSJYUXBBCEGL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.164	1	5	7	68.1	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503067	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503067&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CNC3)C=CN12	6-[7-[(3-fluoroazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C)C3)C=CN12		35503068	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503068&database=RX&origin=ReaxysOutput&ln=	(352 of 1381)		6-[7-[(3-fluoro-1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H24F4N4O3	C24H24F4N4O3	492.473			ZJYGWAQREKOEDO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.403	0	5	7	59.31	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503068	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503068&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C)C3)C=CN12	6-[7-[(3-fluoro-1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C)C3)C=CN12		35503068	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503068&database=RX&origin=ReaxysOutput&ln=	(352 of 1381)		6-[7-[(3-fluoro-1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H24F4N4O3	C24H24F4N4O3	492.473			ZJYGWAQREKOEDO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.403	0	5	7	59.31	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503068	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503068&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C)C3)C=CN12	6-[7-[(3-fluoro-1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C)C3)C=CN12		35503068	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503068&database=RX&origin=ReaxysOutput&ln=	(352 of 1381)		6-[7-[(3-fluoro-1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H24F4N4O3	C24H24F4N4O3	492.473			ZJYGWAQREKOEDO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.403	0	5	7	59.31	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503068	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503068&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C)C3)C=CN12	6-[7-[(3-fluoro-1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CN=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503069	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503069&database=RX&origin=ReaxysOutput&ln=	(353 of 1381)		N-cyclopropyl-3-methoxy-5-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]pyridine-2-carboxamide	C23H27N5O4	C23H27N5O4	437.498			WWJJXHPSYKGLJY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	1.706	1	7	9	90.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503069	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503069&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CN=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	N-cyclopropyl-3-methoxy-5-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]pyridine-2-carboxamide					IC50	nM	>	100 - 500							7			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12		35503070	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503070&database=RX&origin=ReaxysOutput&ln=	(354 of 1381)		8-methoxy-6-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O4	C26H29F3N4O4	518.536			WCRQTYMOOPGQBG-QGZVFWFLSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.199	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503070	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503070&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12	8-methoxy-6-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12		35503070	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503070&database=RX&origin=ReaxysOutput&ln=	(354 of 1381)		8-methoxy-6-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O4	C26H29F3N4O4	518.536			WCRQTYMOOPGQBG-QGZVFWFLSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.199	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503070	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503070&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12	8-methoxy-6-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12		35503070	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503070&database=RX&origin=ReaxysOutput&ln=	(354 of 1381)		8-methoxy-6-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O4	C26H29F3N4O4	518.536			WCRQTYMOOPGQBG-QGZVFWFLSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.199	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503070	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503070&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12	8-methoxy-6-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CN=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503071	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503071&database=RX&origin=ReaxysOutput&ln=	(355 of 1381)		3-methoxy-5-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)pyridinc2-carboxamide	C22H24F3N5O4	C22H24F3N5O4	479.459			OASYTCDRFWTGNE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	2.588	1	7	10	90.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503071	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503071&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CN=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	3-methoxy-5-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)pyridinc2-carboxamide					IC50	nM	>	100 - 500							7			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CN=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCC3=CC=NN3C)C=CN12		35503072	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503072&database=RX&origin=ReaxysOutput&ln=	(356 of 1381)		3-methoxy-5-[7-[(2-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)pyridine-2-carboxamide	C21H19F3N6O3	C21H19F3N6O3	460.415			PBJZMXDRKIAQQL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.43	1	7	9	95.57	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503072	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503072&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CN=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCC3=CC=NN3C)C=CN12	3-methoxy-5-[7-[(2-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)pyridine-2-carboxamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CN=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503073	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503073&database=RX&origin=ReaxysOutput&ln=	(357 of 1381)		5-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-3-methoxy-N-(2,2,2-trifluoroethyl)pyridine-2-carboxamide	C21H21F3N4O5	C21H21F3N4O5	466.417			MZKWDEIMOQQZRL-OAHLLOKOSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	2.582	1	7	9	96.21	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503073	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503073&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CN=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	5-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-3-methoxy-N-(2,2,2-trifluoroethyl)pyridine-2-carboxamide					IC50	nM	>	100 - 500							7			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
FC(F)OC1=CC(=CN=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503074	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503074&database=RX&origin=ReaxysOutput&ln=	(358 of 1381)		N-cyclopropyl-3-(difluoromethoxy)-5-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]pyridine-2-carboxamide	C23H25F2N5O4	C23H25F2N5O4	473.479			ZMNVPNNTSQXNLO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	2.42	1	7	10	90.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503074	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503074&database=RX&origin=ReaxysOutput&ln=	FC(F)OC1=CC(=CN=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	N-cyclopropyl-3-(difluoromethoxy)-5-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]pyridine-2-carboxamide					IC50	nM	>	100 - 500							7			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3CC#N)C=CN12		35503075	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503075&database=RX&origin=ReaxysOutput&ln=	(359 of 1381)		4-[7-[[1-(cyanomethyl)-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C27H29F2N5O4	C27H29F2N5O4	525.555			GTMYMHDFGKBUIU-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.292	1	6	11	101.12	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503075	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503075&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3CC#N)C=CN12	4-[7-[[1-(cyanomethyl)-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(COC4)C3)C=CN12		35503077	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503077&database=RX&origin=ReaxysOutput&ln=	(360 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-6-azaspiro[3 .3]heptan-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			YDHAVRAWGGJQRN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.85	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503077	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503077&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(COC4)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-6-azaspiro[3 .3]heptan-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(COC4)C3)C=CN12		35503077	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503077&database=RX&origin=ReaxysOutput&ln=	(360 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-6-azaspiro[3 .3]heptan-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			YDHAVRAWGGJQRN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.85	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503077	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503077&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(COC4)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-6-azaspiro[3 .3]heptan-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(COC4)C3)C=CN12		35503077	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503077&database=RX&origin=ReaxysOutput&ln=	(360 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-6-azaspiro[3 .3]heptan-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			YDHAVRAWGGJQRN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.85	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503077	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503077&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(COC4)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-6-azaspiro[3 .3]heptan-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC3)C=CN12		35503078	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503078&database=RX&origin=ReaxysOutput&ln=	(361 of 1381)		4-[7-[3-(azetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			XENUUVJXRBCIHP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.404	1	5	12	77.33	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503078	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503078&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC3)C=CN12	4-[7-[3-(azetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC3)C=CN12		35503078	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503078&database=RX&origin=ReaxysOutput&ln=	(361 of 1381)		4-[7-[3-(azetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			XENUUVJXRBCIHP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.404	1	5	12	77.33	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503078	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503078&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC3)C=CN12	4-[7-[3-(azetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC3)C=CN12		35503078	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503078&database=RX&origin=ReaxysOutput&ln=	(361 of 1381)		4-[7-[3-(azetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			XENUUVJXRBCIHP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.404	1	5	12	77.33	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503078	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503078&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC3)C=CN12	4-[7-[3-(azetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(CC3)C(C)C)C=CN12		35503080	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503080&database=RX&origin=ReaxysOutput&ln=	(362 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(4-isopropylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H35F2N5O4	C28H35F2N5O4	543.614			WFBZZORKKTVORI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.424	1	6	12	80.57	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503080	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503080&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(CC3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(4-isopropylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(CC3)C(C)C)C=CN12		35503080	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503080&database=RX&origin=ReaxysOutput&ln=	(362 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(4-isopropylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H35F2N5O4	C28H35F2N5O4	543.614			WFBZZORKKTVORI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.424	1	6	12	80.57	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503080	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503080&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(CC3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(4-isopropylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(CC3)C(C)C)C=CN12		35503080	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503080&database=RX&origin=ReaxysOutput&ln=	(362 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(4-isopropylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H35F2N5O4	C28H35F2N5O4	543.614			WFBZZORKKTVORI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.424	1	6	12	80.57	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503080	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503080&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(CC3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(4-isopropylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(O)CC3)C=CN12		35503081	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503081&database=RX&origin=ReaxysOutput&ln=	(363 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(4-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			NDVDCBAPDQGBJM-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	4	6	4.09	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503081	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503081&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(4-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(O)CC3)C=CN12		35503081	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503081&database=RX&origin=ReaxysOutput&ln=	(363 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(4-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			NDVDCBAPDQGBJM-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	4	6	4.09	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503081	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503081&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(4-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCNCC3)C=CN12		35503082	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503082&database=RX&origin=ReaxysOutput&ln=	(364 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-piperazin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H31F2N5O4	C26H31F2N5O4	515.56			SZZVLSZFOYXESM-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	5	6	3.66	2	6	12	89.36	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503082	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503082&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCNCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-piperazin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCNCC3)C=CN12		35503082	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503082&database=RX&origin=ReaxysOutput&ln=	(364 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-piperazin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H31F2N5O4	C26H31F2N5O4	515.56			SZZVLSZFOYXESM-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	5	6	3.66	2	6	12	89.36	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503082	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503082&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCNCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-piperazin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCNCC3)C=CN12		35503082	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503082&database=RX&origin=ReaxysOutput&ln=	(364 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-piperazin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H31F2N5O4	C26H31F2N5O4	515.56			SZZVLSZFOYXESM-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	5	6	3.66	2	6	12	89.36	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503082	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503082&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCNCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-piperazin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN(C3)C(C)C)C=CN12		35503083	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503083&database=RX&origin=ReaxysOutput&ln=	(365 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropyl-3-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H34F2N4O4	C28H34F2N4O4	528.599			MKPGPLMDFSESTJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.519	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503083	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503083&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropyl-3-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN(C3)C(C)C)C=CN12		35503083	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503083&database=RX&origin=ReaxysOutput&ln=	(365 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropyl-3-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H34F2N4O4	C28H34F2N4O4	528.599			MKPGPLMDFSESTJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.519	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503083	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503083&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropyl-3-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCOCC33CCC3)C=CN12		35503084	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503084&database=RX&origin=ReaxysOutput&ln=	(366 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(8-oxa-5-azaspiro[3.5]nonan-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C29H34F2N4O5	C29H34F2N4O5	556.61			HDMUJIICBBITSZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.751	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503084	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503084&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCOCC33CCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(8-oxa-5-azaspiro[3.5]nonan-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCOCC33CCC3)C=CN12		35503084	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503084&database=RX&origin=ReaxysOutput&ln=	(366 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(8-oxa-5-azaspiro[3.5]nonan-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C29H34F2N4O5	C29H34F2N4O5	556.61			HDMUJIICBBITSZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.751	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503084	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503084&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCOCC33CCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(8-oxa-5-azaspiro[3.5]nonan-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3COCCN3C(C)C)C=CN12		35503085	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503085&database=RX&origin=ReaxysOutput&ln=	(367 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(4-isopropylmorpholin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			PIMKOSOVZQYDMW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.418	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503085	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503085&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3COCCN3C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(4-isopropylmorpholin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3COCCN3C(C)C)C=CN12		35503085	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503085&database=RX&origin=ReaxysOutput&ln=	(367 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(4-isopropylmorpholin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			PIMKOSOVZQYDMW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.418	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503085	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503085&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3COCCN3C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(4-isopropylmorpholin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4CC3CO4)C=CN12		35503086	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503086&database=RX&origin=ReaxysOutput&ln=	(368 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			HYCDKTQLJYKWSW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.078	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503086	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503086&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4CC3CO4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4CC3CO4)C=CN12		35503086	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503086&database=RX&origin=ReaxysOutput&ln=	(368 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			HYCDKTQLJYKWSW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.078	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503086	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503086&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4CC3CO4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-5-azabicyclo[2.2.1]heptan-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(COC4)C3)C=CN12		35503087	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503087&database=RX&origin=ReaxysOutput&ln=	(369 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-7-azaspiro[3.4]octan-7-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			KRDOENYVHMUFKO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.208	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503087	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503087&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(COC4)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-7-azaspiro[3.4]octan-7-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(COC4)C3)C=CN12		35503087	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503087&database=RX&origin=ReaxysOutput&ln=	(369 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-7-azaspiro[3.4]octan-7-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			KRDOENYVHMUFKO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.208	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503087	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503087&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(COC4)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-7-azaspiro[3.4]octan-7-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN3C3COC3)C=CN12		35503088	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503088&database=RX&origin=ReaxysOutput&ln=	(370 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[1-(oxetan-3-yl)pyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			CGHUIWHSSNYLPT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.078	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503088	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503088&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN3C3COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[1-(oxetan-3-yl)pyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3C(C)CCCC3C)C=CN12		35503089	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503089&database=RX&origin=ReaxysOutput&ln=	(371 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(2,6-dimethyl-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C29H36F2N4O4	C29H36F2N4O4	542.626			MVMWJVPKETWODR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	6.04	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503089	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503089&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3C(C)CCCC3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(2,6-dimethyl-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3C(C)CCCC3C)C=CN12		35503089	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503089&database=RX&origin=ReaxysOutput&ln=	(371 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(2,6-dimethyl-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C29H36F2N4O4	C29H36F2N4O4	542.626			MVMWJVPKETWODR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	6.04	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503089	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503089&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3C(C)CCCC3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(2,6-dimethyl-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4CCC(C3)O4)C=CN12		35503090	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503090&database=RX&origin=ReaxysOutput&ln=	(372 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			GXUCNLZQZOGVLI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.436	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503090	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503090&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4CCC(C3)O4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4CCC(C3)O4)C=CN12		35503090	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503090&database=RX&origin=ReaxysOutput&ln=	(372 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			GXUCNLZQZOGVLI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.436	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503090	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503090&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4CCC(C3)O4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3C4CCC3COC4)C=CN12		35503091	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503091&database=RX&origin=ReaxysOutput&ln=	(373 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			JMDCVFHBDVLGBQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.436	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503091	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503091&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3C4CCC3COC4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3C4CCC3COC4)C=CN12		35503091	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503091&database=RX&origin=ReaxysOutput&ln=	(373 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			JMDCVFHBDVLGBQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.436	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503091	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503091&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3C4CCC3COC4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(CCC4)C3)C=CN12		35503092	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503092&database=RX&origin=ReaxysOutput&ln=	(374 of 1381)		4-[7-[3-(2-azaspiro[3.3]heptan-2-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C28H32F2N4O4	C28H32F2N4O4	526.583			PJFWBNANGMVUBE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.325	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503092	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503092&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(CCC4)C3)C=CN12	4-[7-[3-(2-azaspiro[3.3]heptan-2-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(CCC4)C3)C=CN12		35503092	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503092&database=RX&origin=ReaxysOutput&ln=	(374 of 1381)		4-[7-[3-(2-azaspiro[3.3]heptan-2-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C28H32F2N4O4	C28H32F2N4O4	526.583			PJFWBNANGMVUBE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.325	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503092	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503092&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(CCC4)C3)C=CN12	4-[7-[3-(2-azaspiro[3.3]heptan-2-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3C(C)CCCC3C)C=CN12		35503093	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503093&database=RX&origin=ReaxysOutput&ln=	(375 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(2,6-dimethyl-1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H34F2N4O4	C28H34F2N4O4	528.599			GFAAETUSAQFDPI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.682	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503093	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503093&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3C(C)CCCC3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(2,6-dimethyl-1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN3C(C)C)C=CN12		35503095	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503095&database=RX&origin=ReaxysOutput&ln=	(376 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropylpyrrolidin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			FVINADFAJQHOHD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.324	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503095	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503095&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN3C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropylpyrrolidin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCOCC33COC3)C=CN12		35503096	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503096&database=RX&origin=ReaxysOutput&ln=	(377 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(2,8-dioxa-5-azaspiro[3.5]nonan-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H32F2N4O6	C28H32F2N4O6	558.582			GJKINVZRDXWKSQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.487	1	7	12	95.79	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503096	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503096&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCOCC33COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(2,8-dioxa-5-azaspiro[3.5]nonan-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(CC(O)C4)C3)C=CN12		35503097	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503097&database=RX&origin=ReaxysOutput&ln=	(378 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(6-hydroxy-2-azaspiro[3.3]heptan-2-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			PPWXUWXQPGLZAD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.084	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503097	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503097&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(CC(O)C4)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(6-hydroxy-2-azaspiro[3.3]heptan-2-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCN(CC3)C(C)C)C=CN12		35503098	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503098&database=RX&origin=ReaxysOutput&ln=	(379 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[2-(4-isopropylpiperazin-1-yl)ethoxy]ethoxy]imida zo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C30H39F2N5O5	C30H39F2N5O5	587.667			STEBBESVZXBXIV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.234	1	7	15	89.8	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503098	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503098&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCN(CC3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[2-(4-isopropylpiperazin-1-yl)ethoxy]ethoxy]imida zo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCN(CC3)C(C)C)C=CN12		35503098	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503098&database=RX&origin=ReaxysOutput&ln=	(379 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[2-(4-isopropylpiperazin-1-yl)ethoxy]ethoxy]imida zo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C30H39F2N5O5	C30H39F2N5O5	587.667			STEBBESVZXBXIV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.234	1	7	15	89.8	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503098	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503098&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCN(CC3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[2-(4-isopropylpiperazin-1-yl)ethoxy]ethoxy]imida zo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C3COC3)C=CN12		35503099	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503099&database=RX&origin=ReaxysOutput&ln=	(380 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[1-(oxetan-3-yl)pyrrolidin-2-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			NKRIMOLOEYILAP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.436	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503099	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503099&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C3COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[1-(oxetan-3-yl)pyrrolidin-2-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C3COC3)C=CN12		35503099	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503099&database=RX&origin=ReaxysOutput&ln=	(380 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[1-(oxetan-3-yl)pyrrolidin-2-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			NKRIMOLOEYILAP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.436	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503099	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503099&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C3COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[1-(oxetan-3-yl)pyrrolidin-2-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC33COC3)C=CN12		35503100	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503100&database=RX&origin=ReaxysOutput&ln=	(381 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(6-oxa-1-azaspiro[3.3]heptan-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			HOTSSXFQGQATTB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.035	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503100	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503100&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC33COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(6-oxa-1-azaspiro[3.3]heptan-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC33COC3)C=CN12		35503100	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503100&database=RX&origin=ReaxysOutput&ln=	(381 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(6-oxa-1-azaspiro[3.3]heptan-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			HOTSSXFQGQATTB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.035	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503100	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503100&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC33COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(6-oxa-1-azaspiro[3.3]heptan-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C(C)C)C=CN12		35503101	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503101&database=RX&origin=ReaxysOutput&ln=	(382 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(1-isopropylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H34F2N4O4	C28H34F2N4O4	528.599			UZGOWPNQMGUIHZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.682	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503101	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503101&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(1-isopropylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C(C)C)C=CN12		35503101	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503101&database=RX&origin=ReaxysOutput&ln=	(382 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(1-isopropylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H34F2N4O4	C28H34F2N4O4	528.599			UZGOWPNQMGUIHZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.682	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503101	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503101&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(1-isopropylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC33CCC3)C=CN12		35503102	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503102&database=RX&origin=ReaxysOutput&ln=	(383 of 1381)		4-[7-[3-(1-azaspiro[3.3]heptan-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C28H32F2N4O4	C28H32F2N4O4	526.583			XNODGWDMVFHARH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.299	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503102	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503102&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC33CCC3)C=CN12	4-[7-[3-(1-azaspiro[3.3]heptan-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC33CCC3)C=CN12		35503102	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503102&database=RX&origin=ReaxysOutput&ln=	(383 of 1381)		4-[7-[3-(1-azaspiro[3.3]heptan-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C28H32F2N4O4	C28H32F2N4O4	526.583			XNODGWDMVFHARH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.299	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503102	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503102&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC33CCC3)C=CN12	4-[7-[3-(1-azaspiro[3.3]heptan-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC4(COC4)C3)C=CN12		35503103	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503103&database=RX&origin=ReaxysOutput&ln=	(384 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-8-azaspiro[3 .5]nonan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C29H34F2N4O5	C29H34F2N4O5	556.61			NKPSGKYKMHZMRN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.566	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503103	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503103&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC4(COC4)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-8-azaspiro[3 .5]nonan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC4(COC4)C3)C=CN12		35503103	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503103&database=RX&origin=ReaxysOutput&ln=	(384 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-8-azaspiro[3 .5]nonan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C29H34F2N4O5	C29H34F2N4O5	556.61			NKPSGKYKMHZMRN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.566	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503103	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503103&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC4(COC4)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxa-8-azaspiro[3 .5]nonan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCCCC3)C=CN12		35503106	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503106&database=RX&origin=ReaxysOutput&ln=	(385 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(1-piperidyl)ethoxy]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H34F2N4O5	C28H34F2N4O5	544.599			GPZDIXXEILQGPI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.572	1	6	14	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503106	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503106&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(1-piperidyl)ethoxy]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCCCC3)C=CN12		35503106	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503106&database=RX&origin=ReaxysOutput&ln=	(385 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(1-piperidyl)ethoxy]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H34F2N4O5	C28H34F2N4O5	544.599			GPZDIXXEILQGPI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.572	1	6	14	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503106	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503106&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(1-piperidyl)ethoxy]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCCCC3)C=CN12		35503106	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503106&database=RX&origin=ReaxysOutput&ln=	(385 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(1-piperidyl)ethoxy]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H34F2N4O5	C28H34F2N4O5	544.599			GPZDIXXEILQGPI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.572	1	6	14	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503106	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503106&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(1-piperidyl)ethoxy]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCOCC3)C=CN12		35503107	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503107&database=RX&origin=ReaxysOutput&ln=	(386 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(2-morpholinoethoxy)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H32F2N4O6	C27H32F2N4O6	546.571			CIPPMRBWNRUXAZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.308	1	7	14	95.79	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503107	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503107&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(2-morpholinoethoxy)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCN(CC)CCOCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503108	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503108&database=RX&origin=ReaxysOutput&ln=	(387 of 1381)		N-cyclopropyl-4-[7-[2-[2-(diethylamino)ethoxy]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C27H34F2N4O5	C27H34F2N4O5	532.588			MZOPOUIGVQKSJG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.554	1	6	16	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503108	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503108&database=RX&origin=ReaxysOutput&ln=	CCN(CC)CCOCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-4-[7-[2-[2-(diethylamino)ethoxy]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(CCO)CC3)C=CN12		35503109	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503109&database=RX&origin=ReaxysOutput&ln=	(388 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[4-(2-hydroxyethyl)piperazin-1-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H33F2N5O5	C27H33F2N5O5	545.586			XMQLFCCQSDNOIR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	2.832	2	7	13	100.8	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503109	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503109&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(CCO)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[4-(2-hydroxyethyl)piperazin-1-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4=C(C3)N=CN4C)C=CN12		35503110	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503110&database=RX&origin=ReaxysOutput&ln=	(389 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-methyl-6,7-dihydro-4H-imidazo[4,5-c]pyridin-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C29H32F2N6O4	C29H32F2N6O4	566.608			HJXYTHDAPBSZRV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.447	1	7	12	95.15	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503110	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503110&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4=C(C3)N=CN4C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-methyl-6,7-dihydro-4H-imidazo[4,5-c]pyridin-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCN4C=CC=C4C3)C=CN12		35503111	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503111&database=RX&origin=ReaxysOutput&ln=	(390 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3,4-dihydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C29H31F2N5O4	C29H31F2N5O4	551.593			OCNXPJOWROJLNH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	6.031	1	6	12	82.26	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503111	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503111&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCN4C=CC=C4C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3,4-dihydro-1H-pyrrolo[1,2-a]pyrazin-2-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4=NC=CC=C4C3)C=CN12		35503112	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503112&database=RX&origin=ReaxysOutput&ln=	(391 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(7,8-dihydro-5H-1,6-naphthyridin-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C30H31F2N5O4	C30H31F2N5O4	563.604			ZBUBUJCDSIDMIZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.649	1	6	12	90.22	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503112	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503112&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4=NC=CC=C4C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(7,8-dihydro-5H-1,6-naphthyridin-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCN4C=CN=C4C3)C=CN12		35503113	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503113&database=RX&origin=ReaxysOutput&ln=	(392 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H30F2N6O4	C28H30F2N6O4	552.581			UODXVUPPWBCWOJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.174	1	7	12	95.15	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503113	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503113&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCN4C=CN=C4C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(6,8-dihydro-5H-imidazo[1,2-a]pyrazin-7-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCN4N=CN=C4C3)C=CN12		35503114	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503114&database=RX&origin=ReaxysOutput&ln=	(393 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H29F2N7O4	C27H29F2N7O4	553.569			NBTFNNDHDXWEGF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.824	1	8	12	108.04	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503114	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503114&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCN4N=CN=C4C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazin-7-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCN(C3)C(C)C)C=CN12		35503115	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503115&database=RX&origin=ReaxysOutput&ln=	(394 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-isopropylpyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			VGWIJCXZIXJXNU-KRWDZBQOSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.161	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503115	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503115&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-isopropylpyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCN(C3)C(C)C)C=CN12		35503115	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503115&database=RX&origin=ReaxysOutput&ln=	(394 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-isopropylpyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			VGWIJCXZIXJXNU-KRWDZBQOSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.161	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503115	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503115&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-isopropylpyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCN(C3)C3COC3)C=CN12		35503117	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503117&database=RX&origin=ReaxysOutput&ln=	(395 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3S)-1-(oxetan-3-yl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			DWZIAKOPHNZFIL-INIZCTEOSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.915	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503117	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503117&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCN(C3)C3COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3S)-1-(oxetan-3-yl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN(C3)C3COC3)C=CN12		35503118	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503118&database=RX&origin=ReaxysOutput&ln=	(396 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3S)-1-(oxetan-3-yl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			LZLRCYWUUXCBMD-KRWDZBQOSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.273	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503118	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503118&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN(C3)C3COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3S)-1-(oxetan-3-yl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(O)C3)C=CN12		35503119	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503119&database=RX&origin=ReaxysOutput&ln=	(397 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxypyrrolidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			GEJNUMBCFVNQKK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.732	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503119	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503119&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxypyrrolidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(O)C3)C=CN12		35503119	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503119&database=RX&origin=ReaxysOutput&ln=	(397 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxypyrrolidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			GEJNUMBCFVNQKK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.732	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503119	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503119&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxypyrrolidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4=C(C3)SC(C)=N4)C=CN12		35503120	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503120&database=RX&origin=ReaxysOutput&ln=	(398 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-methyl-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C29H31F2N5O4S	C29H31F2N5O4S	583.659			KBCHPXJMSJFFQJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.169	1	6	12	118.46	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503120	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503120&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4=C(C3)SC(C)=N4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-methyl-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CN(C)C(=O)O4)CC3)C=CN12		35503121	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503121&database=RX&origin=ReaxysOutput&ln=	(399 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(3-methyl-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C30H35F2N5O6	C30H35F2N5O6	599.635			MPYDHNOQRRTNFC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.396	1	8	12	106.87	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503121	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503121&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CN(C)C(=O)O4)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(3-methyl-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CN(C)C(=O)O4)CC3)C=CN12		35503121	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503121&database=RX&origin=ReaxysOutput&ln=	(399 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(3-methyl-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C30H35F2N5O6	C30H35F2N5O6	599.635			MPYDHNOQRRTNFC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.396	1	8	12	106.87	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503121	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503121&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CN(C)C(=O)O4)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(3-methyl-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CN(C)C(=O)O4)CC3)C=CN12		35503121	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503121&database=RX&origin=ReaxysOutput&ln=	(399 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(3-methyl-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C30H35F2N5O6	C30H35F2N5O6	599.635			MPYDHNOQRRTNFC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.396	1	8	12	106.87	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503121	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503121&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CN(C)C(=O)O4)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(3-methyl-2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(CC3)N(C)S(C)(=O)=O)C=CN12		35503122	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503122&database=RX&origin=ReaxysOutput&ln=	(400 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-[4-[methyl(methylsulfonyl)amino]-1-piperidyl]propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C29H37F2N5O6S	C29H37F2N5O6S	621.705			VNYNFURFYVDZJY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.246	1	8	14	123.09	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503122	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503122&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(CC3)N(C)S(C)(=O)=O)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-[4-[methyl(methylsulfonyl)amino]-1-piperidyl]propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC(O)C3)C=CN12		35503124	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503124&database=RX&origin=ReaxysOutput&ln=	(401 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			ORXQGPYGBZBTBH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.09	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503124	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503124&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC(O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC(O)C3)C=CN12		35503124	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503124&database=RX&origin=ReaxysOutput&ln=	(401 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			ORXQGPYGBZBTBH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.09	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503124	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503124&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC(O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC(O)C3)C=CN12		35503124	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503124&database=RX&origin=ReaxysOutput&ln=	(401 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			ORXQGPYGBZBTBH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.09	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503124	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503124&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC(O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN(C3)C(C)C)C=CN12		35503125	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503125&database=RX&origin=ReaxysOutput&ln=	(402 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-isopropyl-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H34F2N4O4	C28H34F2N4O4	528.599			MKPGPLMDFSESTJ-SFHVURJKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.519	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503125	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503125&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-isopropyl-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN(C3)C(C)C)C=CN12		35503125	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503125&database=RX&origin=ReaxysOutput&ln=	(402 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-isopropyl-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H34F2N4O4	C28H34F2N4O4	528.599			MKPGPLMDFSESTJ-SFHVURJKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.519	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503125	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503125&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-isopropyl-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCN(C3)C3COC3)C=CN12		35503127	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503127&database=RX&origin=ReaxysOutput&ln=	(403 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-1-(oxetan-3-yl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			DWZIAKOPHNZFIL-MRXNPFEDSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.915	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503127	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503127&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCN(C3)C3COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-1-(oxetan-3-yl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN(C3)C(C)C)C=CN12		35503129	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503129&database=RX&origin=ReaxysOutput&ln=	(404 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-isopropyl-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H34F2N4O4	C28H34F2N4O4	528.599			MKPGPLMDFSESTJ-GOSISDBHSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.519	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503129	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503129&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-isopropyl-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN(C3)C(C)C)C=CN12		35503129	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503129&database=RX&origin=ReaxysOutput&ln=	(404 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-isopropyl-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H34F2N4O4	C28H34F2N4O4	528.599			MKPGPLMDFSESTJ-GOSISDBHSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.519	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503129	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503129&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-isopropyl-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN(C3)C3COC3)C=CN12		35503130	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503130&database=RX&origin=ReaxysOutput&ln=	(405 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-1-(oxetan-3-yl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			LZLRCYWUUXCBMD-QGZVFWFLSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.273	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503130	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503130&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN(C3)C3COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-1-(oxetan-3-yl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(F)C(O)C3)C=CN12		35503131	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503131&database=RX&origin=ReaxysOutput&ln=	(406 of 1381)		N-cyclopropyl-4-[7-[3-(4,4-difluoro-3-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C27H30F4N4O5	C27H30F4N4O5	566.553			NYYIXNGFWSNFRX-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.613	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503131	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503131&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(F)C(O)C3)C=CN12	N-cyclopropyl-4-[7-[3-(4,4-difluoro-3-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(F)C(O)C3)C=CN12		35503131	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503131&database=RX&origin=ReaxysOutput&ln=	(406 of 1381)		N-cyclopropyl-4-[7-[3-(4,4-difluoro-3-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C27H30F4N4O5	C27H30F4N4O5	566.553			NYYIXNGFWSNFRX-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.613	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503131	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503131&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(F)C(O)C3)C=CN12	N-cyclopropyl-4-[7-[3-(4,4-difluoro-3-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)C(F)(F)C3)C=CN12		35503132	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503132&database=RX&origin=ReaxysOutput&ln=	(407 of 1381)		N-cyclopropyl-4-[7-[3-(3,3-difluoro-4-hydroxypyrrolidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C26H28F4N4O5	C26H28F4N4O5	552.526			KAXWICIFFSLORT-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.255	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503132	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503132&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)C(F)(F)C3)C=CN12	N-cyclopropyl-4-[7-[3-(3,3-difluoro-4-hydroxypyrrolidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)C(F)(F)C3)C=CN12		35503132	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503132&database=RX&origin=ReaxysOutput&ln=	(407 of 1381)		N-cyclopropyl-4-[7-[3-(3,3-difluoro-4-hydroxypyrrolidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C26H28F4N4O5	C26H28F4N4O5	552.526			KAXWICIFFSLORT-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.255	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503132	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503132&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)C(F)(F)C3)C=CN12	N-cyclopropyl-4-[7-[3-(3,3-difluoro-4-hydroxypyrrolidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC(C3)C#N)C=CN12		35503133	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503133&database=RX&origin=ReaxysOutput&ln=	(408 of 1381)		4-[7-[3-(3-cyano-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C28H31F2N5O4	C28H31F2N5O4	539.582			MTFIUQMGCTVZFD-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.283	1	6	12	101.12	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503133	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503133&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC(C3)C#N)C=CN12	4-[7-[3-(3-cyano-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(CC3)S(C)(=O)=O)C=CN12		35503134	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503134&database=RX&origin=ReaxysOutput&ln=	(409 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(4-methylsulfonyl-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H34F2N4O6S	C28H34F2N4O6S	592.664			TUICWZMXLKWCQP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.451	1	7	13	119.85	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503134	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503134&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(CC3)S(C)(=O)=O)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(4-methylsulfonyl-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)(C3)C(F)(F)F)C=CN12		35503135	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503135&database=RX&origin=ReaxysOutput&ln=	(410 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-[3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H27F5N4O5	C26H27F5N4O5	570.516			CENDIDUQNRJJMS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.793	2	6	13	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503135	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503135&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)(C3)C(F)(F)F)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-[3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)(C3)C(F)(F)F)C=CN12		35503135	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503135&database=RX&origin=ReaxysOutput&ln=	(410 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-[3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H27F5N4O5	C26H27F5N4O5	570.516			CENDIDUQNRJJMS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.793	2	6	13	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503135	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503135&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)(C3)C(F)(F)F)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-[3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCN(CCC#N)C3)C=CN12		35503136	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503136&database=RX&origin=ReaxysOutput&ln=	(411 of 1381)		4-[7-[[(3S)-1-(2-cyanoethyl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C27H29F2N5O4	C27H29F2N5O4	525.555			QMILYMWLMUNHCD-KRWDZBQOSA-N				Identification(13); Spectra(1); Bioactivity(2)	5	6	3.929	1	6	12	101.12	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503136	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503136&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCN(CCC#N)C3)C=CN12	4-[7-[[(3S)-1-(2-cyanoethyl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN(CCC#N)C3)C=CN12		35503138	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503138&database=RX&origin=ReaxysOutput&ln=	(412 of 1381)		4-[7-[[(3S)-1-(2-cyanoethyl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C28H31F2N5O4	C28H31F2N5O4	539.582			HAZYVFZFGVZNDJ-SFHVURJKSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.287	1	6	12	101.12	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503138	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503138&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN(CCC#N)C3)C=CN12	4-[7-[[(3S)-1-(2-cyanoethyl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3[C@@H](C)CCC[C@H]3C)C=CN12		35503139	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503139&database=RX&origin=ReaxysOutput&ln=	(413 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-[(2R,6S)-2,6-dimethyl-1-piperidyl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C29H36F2N4O4	C29H36F2N4O4	542.626			MVMWJVPKETWODR-KDURUIRLSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	6.04	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503139	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503139&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3[C@@H](C)CCC[C@H]3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-[(2R,6S)-2,6-dimethyl-1-piperidyl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C(F)(F)F)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503140	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503140&database=RX&origin=ReaxysOutput&ln=	(414 of 1381)		[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]phenyl][3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]methanone	C28H31F5N4O5	C28H31F5N4O5	598.57			MDVQVUBQFQXDLG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.256	1	6	12	88.77	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503140	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503140&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C(F)(F)F)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]phenyl][3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]methanone					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C(F)(F)F)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503140	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503140&database=RX&origin=ReaxysOutput&ln=	(414 of 1381)		[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]phenyl][3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]methanone	C28H31F5N4O5	C28H31F5N4O5	598.57			MDVQVUBQFQXDLG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.256	1	6	12	88.77	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503140	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503140&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C(F)(F)F)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]phenyl][3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]methanone					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(CC#N)C1)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503141	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503141&database=RX&origin=ReaxysOutput&ln=	(415 of 1381)		2-[1-[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzoyl]-3-hydroxyazetidin-3-yl]acetonitrile	C29H33F2N5O5	C29H33F2N5O5	569.608			OOXZQZZSDMRIJP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.482	1	7	12	112.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503141	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503141&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(CC#N)C1)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	2-[1-[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzoyl]-3-hydroxyazetidin-3-yl]acetonitrile					IC50	nM	>	100 - 500							7			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC#N)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503142	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503142&database=RX&origin=ReaxysOutput&ln=	(416 of 1381)		N-(cyanomethyl)-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H29F2N5O4	C26H29F2N5O4	513.544			WSSFOKWIUCLOLB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.07	1	6	12	101.12	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503142	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503142&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC#N)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	N-(cyanomethyl)-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC#N)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503142	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503142&database=RX&origin=ReaxysOutput&ln=	(416 of 1381)		N-(cyanomethyl)-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H29F2N5O4	C26H29F2N5O4	513.544			WSSFOKWIUCLOLB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.07	1	6	12	101.12	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503142	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503142&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC#N)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	N-(cyanomethyl)-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C(F)F)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503143	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503143&database=RX&origin=ReaxysOutput&ln=	(417 of 1381)		[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]phenyl]-[3-(difluoromethyl)-3-hydroxyazetidin-1-yl]methanone	C28H32F4N4O5	C28H32F4N4O5	580.579			HCEHCGFBDDPXKB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.74	1	6	12	88.77	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503143	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503143&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C(F)F)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]phenyl]-[3-(difluoromethyl)-3-hydroxyazetidin-1-yl]methanone					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C(F)F)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503143	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503143&database=RX&origin=ReaxysOutput&ln=	(417 of 1381)		[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]phenyl]-[3-(difluoromethyl)-3-hydroxyazetidin-1-yl]methanone	C28H32F4N4O5	C28H32F4N4O5	580.579			HCEHCGFBDDPXKB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	6	4.74	1	6	12	88.77	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503143	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503143&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C(F)F)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]phenyl]-[3-(difluoromethyl)-3-hydroxyazetidin-1-yl]methanone					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CO)CC3)C=CN12		35503145	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503145&database=RX&origin=ReaxysOutput&ln=	(418 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-[4-fluoro-4-(hydroxymethyl)-1-piperidyl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H33F3N4O5	C28H33F3N4O5	562.589			ANOCVOKRAKVINU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.527	2	6	13	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503145	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503145&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CO)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-[4-fluoro-4-(hydroxymethyl)-1-piperidyl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CO)CC3)C=CN12		35503145	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503145&database=RX&origin=ReaxysOutput&ln=	(418 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-[4-fluoro-4-(hydroxymethyl)-1-piperidyl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H33F3N4O5	C28H33F3N4O5	562.589			ANOCVOKRAKVINU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.527	2	6	13	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503145	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503145&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CO)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-[4-fluoro-4-(hydroxymethyl)-1-piperidyl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(C)(O)C3)C=CN12		35503146	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503146&database=RX&origin=ReaxysOutput&ln=	(419 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxy-3-methylazetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			TZFRYOSBUFUVLV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.791	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503146	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503146&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(C)(O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxy-3-methylazetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(C)(O)C3)C=CN12		35503146	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503146&database=RX&origin=ReaxysOutput&ln=	(419 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxy-3-methylazetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			TZFRYOSBUFUVLV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.791	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503146	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503146&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(C)(O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxy-3-methylazetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(F)(F)CN)C=CN12		35503148	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503148&database=RX&origin=ReaxysOutput&ln=	(420 of 1381)		4-[7-(3-amino-2,2-difluoropropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C22H22F4N4O4	C22H22F4N4O4	482.435			AGFQQSOWWIWJHL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	6	4.15	2	5	11	100.11	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503148	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503148&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(F)(F)CN)C=CN12	4-[7-(3-amino-2,2-difluoropropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC3=NC=CC=C3)C=CN12		35503149	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503149&database=RX&origin=ReaxysOutput&ln=	(421 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(2-pyridylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H25F2N5O4	C26H25F2N5O4	509.512			UIVFPFJTPCDXRH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.979	2	6	12	99.01	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503149	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503149&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC3=NC=CC=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(2-pyridylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC3=NC=CC=N3)C=CN12		35503150	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503150&database=RX&origin=ReaxysOutput&ln=	(422 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(pyrimidin-2-ylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H24F2N6O4	C25H24F2N6O4	510.5			SHIZPJRHWKHZRI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.938	2	7	12	111.9	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503150	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503150&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC3=NC=CC=N3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(pyrimidin-2-ylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC3=CC=NC=N3)C=CN12		35503151	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503151&database=RX&origin=ReaxysOutput&ln=	(423 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(pyrimidin-4-ylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H24F2N6O4	C25H24F2N6O4	510.5			JZRKNBIAFNPJLE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.938	2	7	12	111.9	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503151	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503151&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC3=CC=NC=N3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(pyrimidin-4-ylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CC(O)(C3)C(F)(F)F)C=CN12		35503153	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503153&database=RX&origin=ReaxysOutput&ln=	(424 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-[3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H27F5N4O6	C26H27F5N4O6	586.516			PGSYDTMNJZFQOQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.763	3	7	13	117.79	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503153	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503153&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CC(O)(C3)C(F)(F)F)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-[3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CC(O)(C3)C(F)(F)F)C=CN12		35503153	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503153&database=RX&origin=ReaxysOutput&ln=	(424 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-[3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H27F5N4O6	C26H27F5N4O6	586.516			PGSYDTMNJZFQOQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.763	3	7	13	117.79	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503153	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503153&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CC(O)(C3)C(F)(F)F)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-[3-hydroxy-3-(trifluoromethyl)azetidin-1-yl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CC[C@@H](O)C3)C=CN12		35503154	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503154&database=RX&origin=ReaxysOutput&ln=	(425 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-[(3R)-3-hydroxypyrrolidin-1-yl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6	C26H30F2N4O6	532.544			YABDUUQRUWKNDW-QNSVNVJESA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	2.702	3	7	12	117.79	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503154	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503154&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CC[C@@H](O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-[(3R)-3-hydroxypyrrolidin-1-yl]propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503155	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503155&database=RX&origin=ReaxysOutput&ln=	(426 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]piperidine-4-carboxylate	C30H36F2N4O6	C30H36F2N4O6	586.636			QMBALTYVIWTVRM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.916	1	7	15	103.63	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503155	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503155&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]piperidine-4-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503155	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503155&database=RX&origin=ReaxysOutput&ln=	(426 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]piperidine-4-carboxylate	C30H36F2N4O6	C30H36F2N4O6	586.636			QMBALTYVIWTVRM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.916	1	7	15	103.63	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503155	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503155&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]piperidine-4-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1)C1=CC=CC=C1		35503156	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503156&database=RX&origin=ReaxysOutput&ln=	(427 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-phenylpiperidine-4-carboxylate	C36H40F2N4O6	C36H40F2N4O6	662.734			DWFAVHKYPMDTDF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	6.823	1	7	16	103.63	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503156	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503156&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1)C1=CC=CC=C1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-phenylpiperidine-4-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1)C1=CC=CC=C1		35503156	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503156&database=RX&origin=ReaxysOutput&ln=	(427 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-phenylpiperidine-4-carboxylate	C36H40F2N4O6	C36H40F2N4O6	662.734			DWFAVHKYPMDTDF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	6.823	1	7	16	103.63	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503156	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503156&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1)C1=CC=CC=C1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-phenylpiperidine-4-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCC(O)CC3)C=CN12		35503157	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503157&database=RX&origin=ReaxysOutput&ln=	(428 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-(4-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O6	C27H32F2N4O6	546.571			LYEPAQXGPWBLKM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.06	3	7	12	117.79	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503157	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503157&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCC(O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-(4-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCC(O)CC3)C=CN12		35503157	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503157&database=RX&origin=ReaxysOutput&ln=	(428 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-(4-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O6	C27H32F2N4O6	546.571			LYEPAQXGPWBLKM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.06	3	7	12	117.79	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503157	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503157&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCC(O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-(4-hydroxy-1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(C)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503160	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503160&database=RX&origin=ReaxysOutput&ln=	(429 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-methylpiperidine-4-carboxylate	C31H38F2N4O6	C31H38F2N4O6	600.663			ATIJEQRQIWZLJK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.117	1	7	15	103.63	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503160	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503160&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(C)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-methylpiperidine-4-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(C)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503160	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503160&database=RX&origin=ReaxysOutput&ln=	(429 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-methylpiperidine-4-carboxylate	C31H38F2N4O6	C31H38F2N4O6	600.663			ATIJEQRQIWZLJK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.117	1	7	15	103.63	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503160	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503160&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(C)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-methylpiperidine-4-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(F)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503164	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503164&database=RX&origin=ReaxysOutput&ln=	(430 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-fluoropiperidine-4-carboxylate	C30H35F3N4O7	C30H35F3N4O7	620.626			KVVZSVOPGJQPAI-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.934	2	8	15	123.86	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503164	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503164&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(F)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-fluoropiperidine-4-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(F)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503164	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503164&database=RX&origin=ReaxysOutput&ln=	(430 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-fluoropiperidine-4-carboxylate	C30H35F3N4O7	C30H35F3N4O7	620.626			KVVZSVOPGJQPAI-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.934	2	8	15	123.86	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503164	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503164&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(F)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-fluoropiperidine-4-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(F)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503164	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503164&database=RX&origin=ReaxysOutput&ln=	(430 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-fluoropiperidine-4-carboxylate	C30H35F3N4O7	C30H35F3N4O7	620.626			KVVZSVOPGJQPAI-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.934	2	8	15	123.86	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503164	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503164&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(F)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-fluoropiperidine-4-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(C)CN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)C1		35503165	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503165&database=RX&origin=ReaxysOutput&ln=	(431 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-3-methylazetidine-3-carboxylate	C29H34F2N4O6	C29H34F2N4O6	572.609			JIGCHEYSWTWELD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.401	1	7	15	103.63	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503165	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503165&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(C)CN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)C1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-3-methylazetidine-3-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(C)CN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)C1		35503165	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503165&database=RX&origin=ReaxysOutput&ln=	(431 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-3-methylazetidine-3-carboxylate	C29H34F2N4O6	C29H34F2N4O6	572.609			JIGCHEYSWTWELD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.401	1	7	15	103.63	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503165	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503165&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(C)CN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)C1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-3-methylazetidine-3-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC(=O)[C@@H]1CN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CCO1		35503166	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503166&database=RX&origin=ReaxysOutput&ln=	(432 of 1381)		methyl (2S)-4-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]morpholine-2-carboxylate	C28H32F2N4O8	C28H32F2N4O8	590.581			LUIKDJQOZKUSHP-IMMUGOHXSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	2.632	2	9	14	133.09	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503166	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503166&database=RX&origin=ReaxysOutput&ln=	COC(=O)[C@@H]1CN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CCO1	methyl (2S)-4-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]morpholine-2-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC(=O)[C@@H]1CN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CCO1		35503166	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503166&database=RX&origin=ReaxysOutput&ln=	(432 of 1381)		methyl (2S)-4-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]morpholine-2-carboxylate	C28H32F2N4O8	C28H32F2N4O8	590.581			LUIKDJQOZKUSHP-IMMUGOHXSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	2.632	2	9	14	133.09	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503166	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503166&database=RX&origin=ReaxysOutput&ln=	COC(=O)[C@@H]1CN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CCO1	methyl (2S)-4-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]morpholine-2-carboxylate					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC(=O)[C@@H]1CN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CCO1		35503167	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503167&database=RX&origin=ReaxysOutput&ln=	(433 of 1381)		methyl (2S)-4-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]morpholine-2-carboxylate	C27H30F2N4O7	C27H30F2N4O7	560.555			NWSIEHCGRUMCCT-QFIPXVFZSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.304	1	8	13	112.86	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503167	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503167&database=RX&origin=ReaxysOutput&ln=	COC(=O)[C@@H]1CN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CCO1	methyl (2S)-4-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]morpholine-2-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(F)CCN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503168	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503168&database=RX&origin=ReaxysOutput&ln=	(434 of 1381)		ethyl 1-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]-4-fluoropiperidine-4-carboxylate	C29H33F3N4O6	C29H33F3N4O6	590.599			BERNGNXHMJNPFQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.606	1	7	14	103.63	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503168	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503168&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(F)CCN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]-4-fluoropiperidine-4-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(F)CCN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503168	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503168&database=RX&origin=ReaxysOutput&ln=	(434 of 1381)		ethyl 1-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]-4-fluoropiperidine-4-carboxylate	C29H33F3N4O6	C29H33F3N4O6	590.599			BERNGNXHMJNPFQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.606	1	7	14	103.63	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503168	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503168&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(F)CCN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]-4-fluoropiperidine-4-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(F)CCN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503168	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503168&database=RX&origin=ReaxysOutput&ln=	(434 of 1381)		ethyl 1-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]-4-fluoropiperidine-4-carboxylate	C29H33F3N4O6	C29H33F3N4O6	590.599			BERNGNXHMJNPFQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.606	1	7	14	103.63	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503168	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503168&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(F)CCN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]-4-fluoropiperidine-4-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(C3)C(=O)OC(C)(C)C)C=CN12		35503169	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503169&database=RX&origin=ReaxysOutput&ln=	(435 of 1381)		tert-butyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]azetidine-3-carboxylate	C30H36F2N4O6	C30H36F2N4O6	586.636			QFMRJYUYXGMCTE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.077	1	7	15	103.63	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503169	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503169&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(C3)C(=O)OC(C)(C)C)C=CN12	tert-butyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]azetidine-3-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1CCCN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)C1		35503171	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503171&database=RX&origin=ReaxysOutput&ln=	(436 of 1381)		ethyl 1-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]piperidine-3-carboxylate	C29H34F2N4O6	C29H34F2N4O6	572.609			AMSAQEHNWHKISV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.558	1	7	14	103.63	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503171	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503171&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1CCCN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)C1	ethyl 1-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]piperidine-3-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC(=O)C1CN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)C1		35503172	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503172&database=RX&origin=ReaxysOutput&ln=	(437 of 1381)		methyl 1-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]azetidine-3-carboxylate	C26H28F2N4O6	C26H28F2N4O6	530.528			LKLOOZWYMKKAMU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.419	1	7	13	103.63	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503172	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503172&database=RX&origin=ReaxysOutput&ln=	COC(=O)C1CN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)C1	methyl 1-[2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyethyl]azetidine-3-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1CCCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)C1		35503174	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503174&database=RX&origin=ReaxysOutput&ln=	(438 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]piperidine-3-carboxylate	C30H36F2N4O6	C30H36F2N4O6	586.636			QMXFQYSDWLWUFE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.916	1	7	15	103.63	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503174	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503174&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1CCCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)C1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]piperidine-3-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503196	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503196&database=RX&origin=ReaxysOutput&ln=	(439 of 1381)		6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H24F3N3O5	C24H24F3N3O5	491.467			YIBBAANYMONKKT-GOSISDBHSA-N				Identification(13); Spectra(2); Bioactivity(2)	8	6	3.733	0	6	7	74.53	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503196	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503196&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503196	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503196&database=RX&origin=ReaxysOutput&ln=	(439 of 1381)		6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H24F3N3O5	C24H24F3N3O5	491.467			YIBBAANYMONKKT-GOSISDBHSA-N				Identification(13); Spectra(2); Bioactivity(2)	8	6	3.733	0	6	7	74.53	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503196	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503196&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503196	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503196&database=RX&origin=ReaxysOutput&ln=	(439 of 1381)		6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H24F3N3O5	C24H24F3N3O5	491.467			YIBBAANYMONKKT-GOSISDBHSA-N				Identification(13); Spectra(2); Bioactivity(2)	8	6	3.733	0	6	7	74.53	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503196	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503196&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CC(C)OC(C)C3)C=CN12		35503199	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503199&database=RX&origin=ReaxysOutput&ln=	(440 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(2,6-dimethylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			OIORGHXZYNMEDG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	5	6	4.418	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503199	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503199&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CC(C)OC(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(2,6-dimethylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CC(F)(F)C3)C=CN12		35503200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503200&database=RX&origin=ReaxysOutput&ln=	(441 of 1381)		6-[7-[2-(3,3-difluoroazetidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H23F5N4O3	C24H23F5N4O3	510.464			PQCUDLCSCSXAGH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	10	6	4.81	0	5	8	59.31	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503200&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CC(F)(F)C3)C=CN12	6-[7-[2-(3,3-difluoroazetidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CC(F)(F)C3)C=CN12		35503200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503200&database=RX&origin=ReaxysOutput&ln=	(441 of 1381)		6-[7-[2-(3,3-difluoroazetidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H23F5N4O3	C24H23F5N4O3	510.464			PQCUDLCSCSXAGH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	10	6	4.81	0	5	8	59.31	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503200&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CC(F)(F)C3)C=CN12	6-[7-[2-(3,3-difluoroazetidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CC(F)(F)C3)C=CN12		35503200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503200&database=RX&origin=ReaxysOutput&ln=	(441 of 1381)		6-[7-[2-(3,3-difluoroazetidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H23F5N4O3	C24H23F5N4O3	510.464			PQCUDLCSCSXAGH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	10	6	4.81	0	5	8	59.31	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503200&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CC(F)(F)C3)C=CN12	6-[7-[2-(3,3-difluoroazetidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12		35503202	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503202&database=RX&origin=ReaxysOutput&ln=	(442 of 1381)		8-methoxy-6-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O4	C26H29F3N4O4	518.536			WCRQTYMOOPGQBG-KRWDZBQOSA-N				Identification(13); Spectra(1); Bioactivity(2)	10	6	4.199	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503202	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503202&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12	8-methoxy-6-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12		35503202	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503202&database=RX&origin=ReaxysOutput&ln=	(442 of 1381)		8-methoxy-6-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O4	C26H29F3N4O4	518.536			WCRQTYMOOPGQBG-KRWDZBQOSA-N				Identification(13); Spectra(1); Bioactivity(2)	10	6	4.199	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503202	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503202&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12	8-methoxy-6-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12		35503202	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503202&database=RX&origin=ReaxysOutput&ln=	(442 of 1381)		8-methoxy-6-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O4	C26H29F3N4O4	518.536			WCRQTYMOOPGQBG-KRWDZBQOSA-N				Identification(13); Spectra(1); Bioactivity(2)	10	6	4.199	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503202	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503202&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12	8-methoxy-6-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCNC3)C=CN12		35503205	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503205&database=RX&origin=ReaxysOutput&ln=	(443 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3S)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			HMPLKSVEOUQXEA-HNNXBMFYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.397	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503205	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503205&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCNC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3S)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCNC3)C=CN12		35503205	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503205&database=RX&origin=ReaxysOutput&ln=	(443 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3S)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			HMPLKSVEOUQXEA-HNNXBMFYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.397	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503205	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503205&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCNC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3S)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCO)C=CN12		35503206	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503206&database=RX&origin=ReaxysOutput&ln=	(444 of 1381)		6-[7-(2-hydroxyethoxy)imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C21H20F3N3O4	C21H20F3N3O4	435.403			HUYDNVDWVRRPEP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	9	6	3.577	1	5	7	76.3	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503206	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503206&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCO)C=CN12	6-[7-(2-hydroxyethoxy)imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCNC3)C=CN12		35503210	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503210&database=RX&origin=ReaxysOutput&ln=	(445 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			CYNTWQLEOYXPRP-CQSZACIVSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.039	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503210	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503210&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCNC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCNC3)C=CN12		35503210	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503210&database=RX&origin=ReaxysOutput&ln=	(445 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			CYNTWQLEOYXPRP-CQSZACIVSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.039	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503210	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503210&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCNC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCNC3)C=CN12		35503212	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503212&database=RX&origin=ReaxysOutput&ln=	(446 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			HMPLKSVEOUQXEA-OAHLLOKOSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.397	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503212	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503212&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCNC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCNC3)C=CN12		35503212	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503212&database=RX&origin=ReaxysOutput&ln=	(446 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			HMPLKSVEOUQXEA-OAHLLOKOSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.397	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503212	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503212&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCNC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3R)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(C)CN(C)C3)C=CN12		35503214	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503214&database=RX&origin=ReaxysOutput&ln=	(447 of 1381)		6-[7-[(1,3-dimethylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O3	C25H27F3N4O3	488.51			IBLOWDBNTAUTLH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.556	0	5	7	59.31	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503214	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503214&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(C)CN(C)C3)C=CN12	6-[7-[(1,3-dimethylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCN(CCO)C3)C=CN12		35503216	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503216&database=RX&origin=ReaxysOutput&ln=	(448 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-(2-hydroxyethyl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			PCDRORJABGMIMJ-INIZCTEOSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	3.569	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503216	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503216&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCN(CCO)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-(2-hydroxyethyl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C3)C(C)C)C=CN12		35503219	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503219&database=RX&origin=ReaxysOutput&ln=	(449 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropylpyrrolidin3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			VGWIJCXZIXJXNU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	5	6	5.161	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503219	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503219&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropylpyrrolidin3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C3)C(C)C)C=CN12		35503219	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503219&database=RX&origin=ReaxysOutput&ln=	(449 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropylpyrrolidin3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			VGWIJCXZIXJXNU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	5	6	5.161	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503219	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503219&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropylpyrrolidin3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC(=O)C(F)F)C=CN12		35503221	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503221&database=RX&origin=ReaxysOutput&ln=	(450 of 1381)		N-cyclopropyl-4-[7-[2-[(2,2-difluoroacetyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C23H22F4N4O5	C23H22F4N4O5	510.445			YINRAMQKQBOSSB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	3.922	2	6	13	103.19	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503221	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503221&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC(=O)C(F)F)C=CN12	N-cyclopropyl-4-[7-[2-[(2,2-difluoroacetyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC(=O)C(F)F)C=CN12		35503221	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503221&database=RX&origin=ReaxysOutput&ln=	(450 of 1381)		N-cyclopropyl-4-[7-[2-[(2,2-difluoroacetyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C23H22F4N4O5	C23H22F4N4O5	510.445			YINRAMQKQBOSSB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	3.922	2	6	13	103.19	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503221	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503221&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC(=O)C(F)F)C=CN12	N-cyclopropyl-4-[7-[2-[(2,2-difluoroacetyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(C)CNC3)C=CN12		35503225	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503225&database=RX&origin=ReaxysOutput&ln=	(451 of 1381)		8-methoxy-6-[7-[(3-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H25F3N4O3	C24H25F3N4O3	474.483			VKVKOSYKCTZZHA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.317	1	5	7	68.1	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503225	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503225&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(C)CNC3)C=CN12	8-methoxy-6-[7-[(3-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCNC3)C=CN12		35503229	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503229&database=RX&origin=ReaxysOutput&ln=	(452 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3S)-pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			CYNTWQLEOYXPRP-AWEZNQCLSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	6	4.039	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503229	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503229&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCNC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(3S)-pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2CCC#N		35503230	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503230&database=RX&origin=ReaxysOutput&ln=	(453 of 1381)		4-[7-[[(1S,5R)-8-(2-cyanoethyl)-8-azabicyclo[3.2.1]octan-3-yl]oxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C29H31F2N5O4	C29H31F2N5O4	551.593			FJCVDLFYLYMWIB-RLAPIPATSA-N				Identification(12); Spectra(1); Bioactivity(2)	5	6	4.672	1	6	11	101.12	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503230	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503230&database=RX&origin=ReaxysOutput&ln=	[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2CCC#N	4-[7-[[(1S,5R)-8-(2-cyanoethyl)-8-azabicyclo[3.2.1]octan-3-yl]oxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2CCC#N		35503230	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503230&database=RX&origin=ReaxysOutput&ln=	(453 of 1381)		4-[7-[[(1S,5R)-8-(2-cyanoethyl)-8-azabicyclo[3.2.1]octan-3-yl]oxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C29H31F2N5O4	C29H31F2N5O4	551.593			FJCVDLFYLYMWIB-RLAPIPATSA-N				Identification(12); Spectra(1); Bioactivity(2)	5	6	4.672	1	6	11	101.12	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503230	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503230&database=RX&origin=ReaxysOutput&ln=	[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2CCC#N	4-[7-[[(1S,5R)-8-(2-cyanoethyl)-8-azabicyclo[3.2.1]octan-3-yl]oxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OC3CCOCC3)C=CN12		35503231	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503231&database=RX&origin=ReaxysOutput&ln=	(454 of 1381)		2,6-dimethoxy-4-(7-tetrahydropyran-4-yloxyimidazo[1,2-a]pyridin-3-yl)-N-(2,2,2-trifluoroethyl)benzamide	C23H24F3N3O5	C23H24F3N3O5	479.456			ZRJZEPLRBYAXGS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	5	6	4.566	1	5	9	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503231	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503231&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OC3CCOCC3)C=CN12	2,6-dimethoxy-4-(7-tetrahydropyran-4-yloxyimidazo[1,2-a]pyridin-3-yl)-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OC3CCCN(C)C3)C=CN12		35503232	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503232&database=RX&origin=ReaxysOutput&ln=	(455 of 1381)		2,6-dimethoxy-4-[7-[(1-methyl-3-piperidyl)oxy]imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H27F3N4O4	C24H27F3N4O4	492.498			OZBCASFFHUJQOQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	5	6	4.609	1	5	9	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503232	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503232&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OC3CCCN(C)C3)C=CN12	2,6-dimethoxy-4-[7-[(1-methyl-3-piperidyl)oxy]imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503233	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503233&database=RX&origin=ReaxysOutput&ln=	(456 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H26F2N4O4	C23H26F2N4O4	460.481			FXZVEQJQOPFWJQ-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	6	3.898	1	5	11	77.33	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503233	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503233&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503233	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503233&database=RX&origin=ReaxysOutput&ln=	(456 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H26F2N4O4	C23H26F2N4O4	460.481			FXZVEQJQOPFWJQ-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	6	3.898	1	5	11	77.33	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503233	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503233&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503233	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503233&database=RX&origin=ReaxysOutput&ln=	(456 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H26F2N4O4	C23H26F2N4O4	460.481			FXZVEQJQOPFWJQ-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	6	3.898	1	5	11	77.33	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503233	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503233&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(F)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503234	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503234&database=RX&origin=ReaxysOutput&ln=	(457 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxylate	C30H35F3N4O6	C30H35F3N4O6	604.626			MRQZDSCRLGDCHH-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	6	4.964	1	7	15	103.63	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503234	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503234&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(F)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(F)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503234	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503234&database=RX&origin=ReaxysOutput&ln=	(457 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxylate	C30H35F3N4O6	C30H35F3N4O6	604.626			MRQZDSCRLGDCHH-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	6	4.964	1	7	15	103.63	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503234	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503234&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(F)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(F)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503234	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503234&database=RX&origin=ReaxysOutput&ln=	(457 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxylate	C30H35F3N4O6	C30H35F3N4O6	604.626			MRQZDSCRLGDCHH-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	6	6	4.964	1	7	15	103.63	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503234	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503234&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(F)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN(C)C)C=CN12		35503235	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503235&database=RX&origin=ReaxysOutput&ln=	(458 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(dimethylamino)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C24H28F2N4O4	C24H28F2N4O4	474.508			RGJXBOFCNJBLKT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.256	1	5	12	77.33	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503235	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503235&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(dimethylamino)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN(C)C)C=CN12		35503235	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503235&database=RX&origin=ReaxysOutput&ln=	(458 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(dimethylamino)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C24H28F2N4O4	C24H28F2N4O4	474.508			RGJXBOFCNJBLKT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.256	1	5	12	77.33	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503235	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503235&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(dimethylamino)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(C)C3)C=CN12		35503236	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503236&database=RX&origin=ReaxysOutput&ln=	(459 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			HKUHLDNCXYQELK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	3.92	1	5	10	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503236	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503236&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(C)C3)C=CN12		35503236	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503236&database=RX&origin=ReaxysOutput&ln=	(459 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			HKUHLDNCXYQELK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	3.92	1	5	10	77.33	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503236	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503236&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOCCOC1=C(C(=O)NC2CC2)C(OC)=CC(=C1)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503237	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503237&database=RX&origin=ReaxysOutput&ln=	(460 of 1381)		N-cyclopropyl-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2-ethoxyethoxy)-6-methoxybenzamide	C26H34N4O5	C26H34N4O5	482.58			QYLPJTVJMDYTJN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.417	1	6	14	86.56	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503237	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503237&database=RX&origin=ReaxysOutput&ln=	CCOCCOC1=C(C(=O)NC2CC2)C(OC)=CC(=C1)C1=CN=C2C=C(OCCN(C)C)C=CN12	N-cyclopropyl-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2-ethoxyethoxy)-6-methoxybenzamide					IC50	nM	>	100 - 500							7			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN(C)C=N3)C=CN12		35503239	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503239&database=RX&origin=ReaxysOutput&ln=	(461 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylimidazol-4-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H23F2N5O4	C24H23F2N5O4	483.475			UPWICXVISNHBFS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.323	1	6	10	91.91	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503239	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503239&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN(C)C=N3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylimidazol-4-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN3)C=CN12		35503240	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503240&database=RX&origin=ReaxysOutput&ln=	(462 of 1381)		4-[7-(azetidin-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C23H24F2N4O4	C23H24F2N4O4	458.465			HLQUXEXEIVDOLZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.844	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503240	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503240&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN3)C=CN12	4-[7-(azetidin-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3COCCN3)C=CN12		35503241	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503241&database=RX&origin=ReaxysOutput&ln=	(463 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(morpholin-3-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O5	C24H26F2N4O5	488.491			NUGFVTHSOGKAJU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.296	2	6	10	95.35	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503241	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503241&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3COCCN3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(morpholin-3-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCC3CCCN3C)C=CN12		35503242	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503242&database=RX&origin=ReaxysOutput&ln=	(464 of 1381)		8-methoxy-6-[7-[2-(1-methylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O3	C26H29F3N4O3	502.536			FEQNNHMMTARXJQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	6	5.04	0	5	8	59.31	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503242	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503242&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCC3CCCN3C)C=CN12	8-methoxy-6-[7-[2-(1-methylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCC3CCCN3C)C=CN12		35503242	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503242&database=RX&origin=ReaxysOutput&ln=	(464 of 1381)		8-methoxy-6-[7-[2-(1-methylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O3	C26H29F3N4O3	502.536			FEQNNHMMTARXJQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	8	6	5.04	0	5	8	59.31	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503242	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503242&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCC3CCCN3C)C=CN12	8-methoxy-6-[7-[2-(1-methylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3S(C)(=O)=O)C=CN12		35503243	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503243&database=RX&origin=ReaxysOutput&ln=	(465 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylsulfonyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O6S	C26H30F2N4O6S	564.61			OJBBFCACARYXIG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	4.393	1	7	11	119.85	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503243	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503243&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3S(C)(=O)=O)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylsulfonyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC(=O)N1CCCCC1COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503244	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503244&database=RX&origin=ReaxysOutput&ln=	(466 of 1381)		methyl 2-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]piperidine-1-carboxylate	C27H30F2N4O6	C27H30F2N4O6	544.555			MTGKPMBCGFMYKY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	4.759	1	7	12	103.63	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503244	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503244&database=RX&origin=ReaxysOutput&ln=	COC(=O)N1CCCCC1COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	methyl 2-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]piperidine-1-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CNC(=O)O4)CC3)C=CN12		35503245	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503245&database=RX&origin=ReaxysOutput&ln=	(467 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C29H33F2N5O6	C29H33F2N5O6	585.608			IOOVMRHGWXIOQQ-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	5	6	4.254	2	8	12	115.66	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503245	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503245&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CNC(=O)O4)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CNC(=O)O4)CC3)C=CN12		35503245	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503245&database=RX&origin=ReaxysOutput&ln=	(467 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C29H33F2N5O6	C29H33F2N5O6	585.608			IOOVMRHGWXIOQQ-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	5	6	4.254	2	8	12	115.66	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503245	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503245&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CNC(=O)O4)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CNC(=O)O4)CC3)C=CN12		35503245	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503245&database=RX&origin=ReaxysOutput&ln=	(467 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C29H33F2N5O6	C29H33F2N5O6	585.608			IOOVMRHGWXIOQQ-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	5	6	4.254	2	8	12	115.66	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503245	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503245&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4(CNC(=O)O4)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(2-oxo-1-oxa-3,8-diazaspiro[4.5]decan-8-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3C(C)=O)C=CN12		35503246	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503246&database=RX&origin=ReaxysOutput&ln=	(468 of 1381)		4-[7-[(1-acetyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			IMJRYNDXRBZQRF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	4.588	1	6	11	94.4	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503246	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503246&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3C(C)=O)C=CN12	4-[7-[(1-acetyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CNC(C)(C)COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503248	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503248&database=RX&origin=ReaxysOutput&ln=	(469 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-methyl-2-(methylamino)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H28F2N4O4	C24H28F2N4O4	474.508			RYVNBKJMHKBBCH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.536	2	5	11	86.12	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503248	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503248&database=RX&origin=ReaxysOutput&ln=	CNC(C)(C)COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-methyl-2-(methylamino)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN3)C=CN12		35503249	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503249&database=RX&origin=ReaxysOutput&ln=	(470 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(pyrrolidin-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			DTDLCVMXAJLFCV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.202	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503249	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503249&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(pyrrolidin-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=CC=C3)N=CN12		35503250	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503250&database=RX&origin=ReaxysOutput&ln=	(471 of 1381)		4-(7-benzyloxyimidazo[1,2-c]pyrimidin-3-yl)-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H22F2N4O4	C25H22F2N4O4	480.471			YWCOSCPOBICCMK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	5.442	1	5	10	86.98	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503250	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503250&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=CC=C3)N=CN12	4-(7-benzyloxyimidazo[1,2-c]pyrimidin-3-yl)-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CC[C@H](F)C3)C=CN12		35503251	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503251&database=RX&origin=ReaxysOutput&ln=	(472 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H27F3N4O4	C25H27F3N4O4	504.509			OPVNGFOZSXNBEO-INIZCTEOSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.548	1	5	11	77.33	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503251	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503251&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CC[C@H](F)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CC[C@H](F)C3)C=CN12		35503251	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503251&database=RX&origin=ReaxysOutput&ln=	(472 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H27F3N4O4	C25H27F3N4O4	504.509			OPVNGFOZSXNBEO-INIZCTEOSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.548	1	5	11	77.33	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503251	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503251&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CC[C@H](F)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[(3S)-3-fluoropyrrolidin-1-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503252	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503252&database=RX&origin=ReaxysOutput&ln=	(473 of 1381)		2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-(methylamino)-N-(2,2,2-trifluoroethyl)benzamide	C22H24F5N5O3	C22H24F5N5O3	501.456			WVUZDOSSPCCNPE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.94	2	6	12	80.13	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503252	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503252&database=RX&origin=ReaxysOutput&ln=	CNC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN(C)C)C=CN12	2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-(methylamino)-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503252	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503252&database=RX&origin=ReaxysOutput&ln=	(473 of 1381)		2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-(methylamino)-N-(2,2,2-trifluoroethyl)benzamide	C22H24F5N5O3	C22H24F5N5O3	501.456			WVUZDOSSPCCNPE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.94	2	6	12	80.13	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503252	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503252&database=RX&origin=ReaxysOutput&ln=	CNC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN(C)C)C=CN12	2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-(methylamino)-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCN1C=CN=C1COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503253	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503253&database=RX&origin=ReaxysOutput&ln=	(474 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-ethylimidazol-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H25F2N5O4	C25H25F2N5O4	497.501			CLLUTAWSIPFTJB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.432	1	6	11	91.91	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503253	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503253&database=RX&origin=ReaxysOutput&ln=	CCN1C=CN=C1COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-ethylimidazol-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCC(F)(F)CC3)C=CN12		35503254	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503254&database=RX&origin=ReaxysOutput&ln=	(475 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(4,4-difluoro-1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H28F4N4O4	C26H28F4N4O4	536.526			LUCLJYNEGIQYME-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	5.285	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503254	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503254&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCC(F)(F)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(4,4-difluoro-1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3CC(F)(F)F)C=CN12		35503255	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503255&database=RX&origin=ReaxysOutput&ln=	(476 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[1-(2,2,2-trifluoroethyl)-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H29F5N4O4	C27H29F5N4O4	568.544			AYVDTMSULYEBOG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	6.224	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503255	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503255&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3CC(F)(F)F)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[1-(2,2,2-trifluoroethyl)-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=NC=CC=C3)C=CN12		35503257	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503257&database=RX&origin=ReaxysOutput&ln=	(477 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[methyl(2-pyridyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H27F2N5O4	C27H27F2N5O4	523.539			KTRVBKPOZRJPRW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.542	1	6	12	90.22	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503257	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503257&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=NC=CC=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[methyl(2-pyridyl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=CC=CC=C3)C=CN12		35503258	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503258&database=RX&origin=ReaxysOutput&ln=	(478 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(N-methylanilino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H28F2N4O4	C28H28F2N4O4	522.552			YHBXOMYYJXTFDP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	6.066	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503258	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503258&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=CC=CC=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(N-methylanilino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CN(C3)C(=O)OC(C)(C)C)C=CN12		35503260	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503260&database=RX&origin=ReaxysOutput&ln=	(479 of 1381)		tert-butyl 3-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]-3-methylazetidine-1-carboxylate	C29H34F2N4O6	C29H34F2N4O6	572.609			QWCLZUWKMSCBGZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	5.575	1	7	13	103.63	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503260	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503260&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CN(C3)C(=O)OC(C)(C)C)C=CN12	tert-butyl 3-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]-3-methylazetidine-1-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CC(F)(F)CN3C)C=CN12		35503261	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503261&database=RX&origin=ReaxysOutput&ln=	(480 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(2S)-4,4-difluoro-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H26F4N4O4	C25H26F4N4O4	522.499			GXJQPUKAGXGZCL-INIZCTEOSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.964	1	5	10	77.33	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503261	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503261&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CC(F)(F)CN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(2S)-4,4-difluoro-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CC(F)(F)CN3C)C=CN12		35503261	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503261&database=RX&origin=ReaxysOutput&ln=	(480 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(2S)-4,4-difluoro-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H26F4N4O4	C25H26F4N4O4	522.499			GXJQPUKAGXGZCL-INIZCTEOSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	4.964	1	5	10	77.33	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503261	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503261&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CC(F)(F)CN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(2S)-4,4-difluoro-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503262	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503262&database=RX&origin=ReaxysOutput&ln=	(481 of 1381)		2-cyclopropyl-8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one	C26H30N4O4	C26H30N4O4	462.549			NCQKIKYQHVNIMN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	2.857	0	6	7	68.54	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503262	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503262&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	2-cyclopropyl-8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)(C)CO)C=CN12		35503263	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503263&database=RX&origin=ReaxysOutput&ln=	(482 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethylethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H25F2N3O5	C23H25F2N3O5	461.465			MZWJCLLKGHNDHP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.213	2	5	10	94.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503263	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503263&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)(C)CO)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethylethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)(C)CO)C=CN12		35503263	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503263&database=RX&origin=ReaxysOutput&ln=	(482 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethylethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H25F2N3O5	C23H25F2N3O5	461.465			MZWJCLLKGHNDHP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.213	2	5	10	94.32	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503263	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503263&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)(C)CO)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethylethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)(C)CO)C=CN12		35503263	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503263&database=RX&origin=ReaxysOutput&ln=	(482 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethylethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H25F2N3O5	C23H25F2N3O5	461.465			MZWJCLLKGHNDHP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.213	2	5	10	94.32	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503263	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503263&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)(C)CO)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethylethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503264	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503264&database=RX&origin=ReaxysOutput&ln=	(483 of 1381)		8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydro-2H-isoquinolin-1-one	C23H26N4O4	C23H26N4O4	422.484			OFHBJXDPOPJTQH-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	2.172	1	6	6	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503264	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503264&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydro-2H-isoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503264	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503264&database=RX&origin=ReaxysOutput&ln=	(483 of 1381)		8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydro-2H-isoquinolin-1-one	C23H26N4O4	C23H26N4O4	422.484			OFHBJXDPOPJTQH-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	2.172	1	6	6	77.33	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503264	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503264&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydro-2H-isoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)C=C2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503265	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503265&database=RX&origin=ReaxysOutput&ln=	(484 of 1381)		8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)isoquinolin-1-one	C25H25F3N4O4	C25H25F3N4O4	502.493			XFKNBZDCPMQLDT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	5	6	4.021	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503265	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503265&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)C=C2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)isoquinolin-1-one					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
FC(F)OC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503266&database=RX&origin=ReaxysOutput&ln=	(485 of 1381)		2-cyclopropyl-8-(difluoromethoxy)-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one	C26H28F2N4O4	C26H28F2N4O4	498.53			ORBHWAJYVHYZBT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	6	3.571	0	6	8	68.54	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503266&database=RX&origin=ReaxysOutput&ln=	FC(F)OC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	2-cyclopropyl-8-(difluoromethoxy)-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
FC(F)OC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503266&database=RX&origin=ReaxysOutput&ln=	(485 of 1381)		2-cyclopropyl-8-(difluoromethoxy)-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one	C26H28F2N4O4	C26H28F2N4O4	498.53			ORBHWAJYVHYZBT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	6	3.571	0	6	8	68.54	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503266&database=RX&origin=ReaxysOutput&ln=	FC(F)OC1=CC(=CC2=C1C(=O)N(CC2)C1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	2-cyclopropyl-8-(difluoromethoxy)-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)C3)C=CN12		35503267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503267&database=RX&origin=ReaxysOutput&ln=	(486 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxyazetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H28F2N4O5	C25H28F2N4O5	502.518			WERYRBQJOHRTHT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	5	6	3.374	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503267&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxyazetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)C3)C=CN12		35503267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503267&database=RX&origin=ReaxysOutput&ln=	(486 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxyazetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H28F2N4O5	C25H28F2N4O5	502.518			WERYRBQJOHRTHT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	5	6	3.374	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503267&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxyazetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)C3)C=CN12		35503267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503267&database=RX&origin=ReaxysOutput&ln=	(486 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxyazetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H28F2N4O5	C25H28F2N4O5	502.518			WERYRBQJOHRTHT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	5	6	3.374	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503267&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC(O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(3-hydroxyazetidin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
FC(F)CN1CCC2=C(C(OC(F)F)=CC(=C2)C2=CN=C3C=C(OCCN4CCOCC4)C=CN23)C1=O		35503268	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503268&database=RX&origin=ReaxysOutput&ln=	(487 of 1381)		2-(2,2-difluoroethyl)-8-(difluoromethoxy)-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one	C25H26F4N4O4	C25H26F4N4O4	522.499			JGAOWMRXAZGCBG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.937	0	6	9	68.54	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503268	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503268&database=RX&origin=ReaxysOutput&ln=	FC(F)CN1CCC2=C(C(OC(F)F)=CC(=C2)C2=CN=C3C=C(OCCN4CCOCC4)C=CN23)C1=O	2-(2,2-difluoroethyl)-8-(difluoromethoxy)-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3(CCCC3)C#N)C=CN12		35503269	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503269&database=RX&origin=ReaxysOutput&ln=	(488 of 1381)		4-[7-(1-cyanocyclopentoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H24F2N4O4	C25H24F2N4O4	482.487			AUUWMHVMAAJLMX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	5	6	4.55	1	5	9	97.88	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503269	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503269&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3(CCCC3)C#N)C=CN12	4-[7-(1-cyanocyclopentoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC)=C1)C(=O)N(CC(F)(F)F)CC2		35503270	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503270&database=RX&origin=ReaxysOutput&ln=	(489 of 1381)		8-methoxy-6-(7-methoxyimidazo[1,2-a]pyridin-3-yl)-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C20H18F3N3O3	C20H18F3N3O3	405.376			BGPJYVGKPPOWIQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		6	4.286	0	4	5	56.07	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503270	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503270&database=RX&origin=ReaxysOutput&ln=	COC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC)=C1)C(=O)N(CC(F)(F)F)CC2	8-methoxy-6-(7-methoxyimidazo[1,2-a]pyridin-3-yl)-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COCC(C)(C)OC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503271&database=RX&origin=ReaxysOutput&ln=	(490 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-methoxy-1,1-dimethylethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H27F2N3O5	C24H27F2N3O5	475.492			YBNSADDIWQORRC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	4.732	1	5	11	83.32	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503271&database=RX&origin=ReaxysOutput&ln=	COCC(C)(C)OC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-methoxy-1,1-dimethylethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)(C)C#N)C=CN12		35503272	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503272&database=RX&origin=ReaxysOutput&ln=	(491 of 1381)		4-[7-(1-cyano-1-methylethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C23H22F2N4O4	C23H22F2N4O4	456.449			OEBYSOOAMKHPTR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	4.174	1	5	9	97.88	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503272	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503272&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)(C)C#N)C=CN12	4-[7-(1-cyano-1-methylethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC)=C1)C(=O)N(CC(F)(F)F)CC2		35503273	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503273&database=RX&origin=ReaxysOutput&ln=	(492 of 1381)		6-(7-ethoxyimidazo[1,2-a]pyridin-3-yl)-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C21H20F3N3O3	C21H20F3N3O3	419.403			GYQAVQURNREMQM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)		6	4.709	0	4	6	56.07	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503273	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503273&database=RX&origin=ReaxysOutput&ln=	CCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC)=C1)C(=O)N(CC(F)(F)F)CC2	6-(7-ethoxyimidazo[1,2-a]pyridin-3-yl)-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
FC(F)(F)CN1CC2=CC(=CN=C2C1=O)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503274	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503274&database=RX&origin=ReaxysOutput&ln=	(493 of 1381)		3-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-6-(2,2,2-trifluoroethyl)-5H-pyrrolo[3,4-b]pyridin-7-one	C22H22F3N5O3	C22H22F3N5O3	461.444			TVEKZLDUYMLDBE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	2.503	0	7	7	72.2	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503274	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503274&database=RX&origin=ReaxysOutput&ln=	FC(F)(F)CN1CC2=CC(=CN=C2C1=O)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	3-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-6-(2,2,2-trifluoroethyl)-5H-pyrrolo[3,4-b]pyridin-7-one					IC50	nM	>	500							6.3			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503275	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503275&database=RX&origin=ReaxysOutput&ln=	(494 of 1381)		ethyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyacetate	C23H23F2N3O6	C23H23F2N3O6	475.449			IOWJSJHTGCAWFN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.171	1	6	12	100.39	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503275	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503275&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	ethyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyacetate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503275	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503275&database=RX&origin=ReaxysOutput&ln=	(494 of 1381)		ethyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyacetate	C23H23F2N3O6	C23H23F2N3O6	475.449			IOWJSJHTGCAWFN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.171	1	6	12	100.39	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503275	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503275&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	ethyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyacetate					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCN(CC3)C(C)C)C=CN12		35503276	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503276&database=RX&origin=ReaxysOutput&ln=	(495 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(4-isopropylpiperazin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C29H37F2N5O4	C29H37F2N5O4	557.641			ROVHMCCDHFNKOC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	4.782	1	6	13	80.57	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503276	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503276&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCN(CC3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(4-isopropylpiperazin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCN(CC3)C(C)C)C=CN12		35503276	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503276&database=RX&origin=ReaxysOutput&ln=	(495 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(4-isopropylpiperazin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C29H37F2N5O4	C29H37F2N5O4	557.641			ROVHMCCDHFNKOC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	4.782	1	6	13	80.57	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503276	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503276&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCN(CC3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(4-isopropylpiperazin-1-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCOC(C)=O)C=CN12		35503277	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503277&database=RX&origin=ReaxysOutput&ln=	(496 of 1381)		3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl acetate	C24H25F2N3O6	C24H25F2N3O6	489.476			RBNRFSUEAKDEFI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.434	1	6	13	100.39	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503277	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503277&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCOC(C)=O)C=CN12	3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl acetate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(C1)C#N)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503278	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503278&database=RX&origin=ReaxysOutput&ln=	(497 of 1381)		1-[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzoyl]azetidine-3-carbonitrile	C28H31F2N5O4	C28H31F2N5O4	539.582			HVFXYIKDBXDVPE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	6	4.03	0	6	11	92.33	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503278	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503278&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(C1)C#N)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	1-[2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzoyl]azetidine-3-carbonitrile					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C3)C3COC3)C=CN12		35503279	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503279&database=RX&origin=ReaxysOutput&ln=	(498 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[1-(oxetan-3-yl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			DWZIAKOPHNZFIL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	5	6	3.915	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503279	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503279&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C3)C3COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[1-(oxetan-3-yl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C3)C3COC3)C=CN12		35503279	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503279&database=RX&origin=ReaxysOutput&ln=	(498 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[1-(oxetan-3-yl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			DWZIAKOPHNZFIL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	5	6	3.915	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503279	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503279&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C3)C3COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[1-(oxetan-3-yl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CC#N)C3)C=CN12		35503280	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503280&database=RX&origin=ReaxysOutput&ln=	(499 of 1381)		4-[7-[[1-(cyanomethyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H25F2N5O4	C25H25F2N5O4	497.501			WOOLZWRJDWTTJB-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	6	3.413	1	6	11	101.12	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503280	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503280&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CC#N)C3)C=CN12	4-[7-[[1-(cyanomethyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CC#N)C3)C=CN12		35503280	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503280&database=RX&origin=ReaxysOutput&ln=	(499 of 1381)		4-[7-[[1-(cyanomethyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H25F2N5O4	C25H25F2N5O4	497.501			WOOLZWRJDWTTJB-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	6	3.413	1	6	11	101.12	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503280	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503280&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CC#N)C3)C=CN12	4-[7-[[1-(cyanomethyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CCC#N)C3)C=CN12		35503281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503281&database=RX&origin=ReaxysOutput&ln=	(500 of 1381)		4-[7-[[1-(2-cyanoethyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C26H27F2N5O4	C26H27F2N5O4	511.528			AGGLHJJGPZLXLO-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	6	3.571	1	6	12	101.12	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503281&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CCC#N)C3)C=CN12	4-[7-[[1-(2-cyanoethyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CCC#N)C3)C=CN12		35503281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503281&database=RX&origin=ReaxysOutput&ln=	(500 of 1381)		4-[7-[[1-(2-cyanoethyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C26H27F2N5O4	C26H27F2N5O4	511.528			AGGLHJJGPZLXLO-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	3	6	3.571	1	6	12	101.12	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503281&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CCC#N)C3)C=CN12	4-[7-[[1-(2-cyanoethyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCOS(C)(=O)=O)C=CN12		35503282	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503282&database=RX&origin=ReaxysOutput&ln=	(501 of 1381)		3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl methanesulfonate	C23H25F2N3O7S	C23H25F2N3O7S	525.53			SGSGZICFYXNSAQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	10	6	3.324	1	7	13	125.84	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503282	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503282&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCOS(C)(=O)=O)C=CN12	3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl methanesulfonate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CC(C)(C)O)C3)C=CN12		35503283	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503283&database=RX&origin=ReaxysOutput&ln=	(502 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			GWZXFAADUSSZKY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	5	6	4.088	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503283	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503283&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CC(C)(C)O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[1-(2-hydroxy-2-methylpropyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CCO)C3)C=CN12		35503284	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503284&database=RX&origin=ReaxysOutput&ln=	(503 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[1-(2-hydroxyethyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H28F2N4O5	C25H28F2N4O5	502.518			HHKPYYMUKLFRQK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	3.211	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503284	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503284&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(CCO)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[1-(2-hydroxyethyl)azetidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCN(CCO)C3)C=CN12		35503285	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503285&database=RX&origin=ReaxysOutput&ln=	(504 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-(2-hydroxyethyl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			PCDRORJABGMIMJ-MRXNPFEDSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	3.569	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503285	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503285&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCN(CCO)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-(2-hydroxyethyl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCN(CCO)C3)C=CN12		35503285	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503285&database=RX&origin=ReaxysOutput&ln=	(504 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-(2-hydroxyethyl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			PCDRORJABGMIMJ-MRXNPFEDSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	3.569	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503285	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503285&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCN(CCO)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-(2-hydroxyethyl)pyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CC3)C(N)=O)C=CN12		35503286	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503286&database=RX&origin=ReaxysOutput&ln=	(505 of 1381)		1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxamide	C28H32F3N5O5	C28H32F3N5O5	575.588			UHVKEWCODPREDH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	3.492	2	7	13	120.42	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503286	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503286&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CC3)C(N)=O)C=CN12	1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CC3)C(N)=O)C=CN12		35503286	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503286&database=RX&origin=ReaxysOutput&ln=	(505 of 1381)		1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxamide	C28H32F3N5O5	C28H32F3N5O5	575.588			UHVKEWCODPREDH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	3.492	2	7	13	120.42	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503286	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503286&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CC3)C(N)=O)C=CN12	1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCOCC3)C=CN12		35503287	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503287&database=RX&origin=ReaxysOutput&ln=	(506 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6	C26H30F2N4O6	532.544			TZHOUGOSZCJXIL-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	2	6	2.826	2	7	12	106.79	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503287	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503287&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCOCC3)C=CN12		35503287	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503287&database=RX&origin=ReaxysOutput&ln=	(506 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6	C26H30F2N4O6	532.544			TZHOUGOSZCJXIL-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	2	6	2.826	2	7	12	106.79	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503287	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503287&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCOCC3)C=CN12		35503287	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503287&database=RX&origin=ReaxysOutput&ln=	(506 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6	C26H30F2N4O6	532.544			TZHOUGOSZCJXIL-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	2	6	2.826	2	7	12	106.79	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503287	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503287&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CC3)C(O)=O)C=CN12		35503289	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503289&database=RX&origin=ReaxysOutput&ln=	(507 of 1381)		1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxylic acid	C28H31F3N4O6	C28H31F3N4O6	576.573			XSOCBUWUGVSEPN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.22	2	7	13	114.63	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503289	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503289&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CC3)C(O)=O)C=CN12	1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxylic acid					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CC3)C(O)=O)C=CN12		35503289	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503289&database=RX&origin=ReaxysOutput&ln=	(507 of 1381)		1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxylic acid	C28H31F3N4O6	C28H31F3N4O6	576.573			XSOCBUWUGVSEPN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	4.22	2	7	13	114.63	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503289	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503289&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC(F)(CC3)C(O)=O)C=CN12	1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-fluoropiperidine-4-carboxylic acid					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(O)CCN(C3)C(C)C)C=CN12		35503290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503290&database=RX&origin=ReaxysOutput&ln=	(508 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(3-hydroxy-1-isopropylpyrrolidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			FXOCJFMQJKATLL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	7	6	4.251	2	6	11	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503290&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(O)CCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(3-hydroxy-1-isopropylpyrrolidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)=O)C=CN12		35503291	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503291&database=RX&origin=ReaxysOutput&ln=	(509 of 1381)		2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyacetic acid	C21H19F2N3O6	C21H19F2N3O6	447.395			ZZRISNYHVCSEPB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	3.427	2	6	10	111.39	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503291	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503291&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)=O)C=CN12	2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxyacetic acid					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)CN1CCCCC1COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503294	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503294&database=RX&origin=ReaxysOutput&ln=	(510 of 1381)		ethyl 2-[2-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]-1-piperidyl]acetate	C29H34F2N4O6	C29H34F2N4O6	572.609			RHBXSLJBAAZBBP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	4.925	1	7	14	103.63	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503294	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503294&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)CN1CCCCC1COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	ethyl 2-[2-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]-1-piperidyl]acetate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCCCC3)C=CN12		35503296	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503296&database=RX&origin=ReaxysOutput&ln=	(511 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			ZHSJVAPNUWHIJR-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	4.09	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503296	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503296&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCCCC3)C=CN12		35503296	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503296&database=RX&origin=ReaxysOutput&ln=	(511 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			ZHSJVAPNUWHIJR-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	4.09	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503296	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503296&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCCCC3)C=CN12		35503296	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503296&database=RX&origin=ReaxysOutput&ln=	(511 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			ZHSJVAPNUWHIJR-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	4.09	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503296	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503296&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-hydroxy-3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN(CCO)C3)C=CN12		35503297	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503297&database=RX&origin=ReaxysOutput&ln=	(512 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-(2-hydroxyethyl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			CLBYFNQJTZTQON-KRWDZBQOSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	3.927	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503297	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503297&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN(CCO)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3S)-1-(2-hydroxyethyl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN(CCO)C3)C=CN12		35503298	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503298&database=RX&origin=ReaxysOutput&ln=	(513 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-(2-hydroxyethyl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			CLBYFNQJTZTQON-QGZVFWFLSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	3.927	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503298	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503298&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN(CCO)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-(2-hydroxyethyl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN(CCO)C3)C=CN12		35503298	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503298&database=RX&origin=ReaxysOutput&ln=	(513 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-(2-hydroxyethyl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			CLBYFNQJTZTQON-QGZVFWFLSA-N				Identification(13); Spectra(1); Bioactivity(2)	6	6	3.927	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503298	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503298&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN(CCO)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-(2-hydroxyethyl)-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCCN(C)C3)C=CN12		35503318	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503318&database=RX&origin=ReaxysOutput&ln=	(514 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-3-piperidyl)oxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			AVPDZQHDEWLONP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.441	1	5	9	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503318	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503318&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCCN(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-3-piperidyl)oxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)OC)C=CN12		35503319	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503319&database=RX&origin=ReaxysOutput&ln=	(515 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-methoxy-2-methylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H27F2N3O5	C24H27F2N3O5	475.492			NJNHBQBBDBFBSQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.732	1	5	11	83.32	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503319	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503319&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)OC)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-methoxy-2-methylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCN(C)CC3)C=CN12		35503320	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503320&database=RX&origin=ReaxysOutput&ln=	(516 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-4-piperidyl)oxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			XQPCXYHBJPDZEJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.441	1	5	9	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503320	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503320&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCN(C)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-4-piperidyl)oxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503321	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503321&database=RX&origin=ReaxysOutput&ln=	(517 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O5	C25H28F2N4O5	502.518			KNOCCCXGASNIAF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.498	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503321	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503321&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503321	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503321&database=RX&origin=ReaxysOutput&ln=	(517 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O5	C25H28F2N4O5	502.518			KNOCCCXGASNIAF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.498	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503321	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503321&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(C)CC3)C=CN12		35503322	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503322&database=RX&origin=ReaxysOutput&ln=	(518 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H31F2N5O4	C26H31F2N5O4	515.56			JNTGFXYRZMLGRU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.541	1	6	11	80.57	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503322	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503322&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(C)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(C)CC3)C=CN12		35503322	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503322&database=RX&origin=ReaxysOutput&ln=	(518 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H31F2N5O4	C26H31F2N5O4	515.56			JNTGFXYRZMLGRU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.541	1	6	11	80.57	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503322	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503322&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(C)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(C)CC3)C=CN12		35503322	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503322&database=RX&origin=ReaxysOutput&ln=	(518 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H31F2N5O4	C26H31F2N5O4	515.56			JNTGFXYRZMLGRU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.541	1	6	11	80.57	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503322	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503322&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCN(C)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCCC3)C=CN12		35503323	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503323&database=RX&origin=ReaxysOutput&ln=	(519 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			DAFGDMZQXDCPDT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	4.762	1	5	11	77.33	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503323	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503323&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCCC3)C=CN12		35503323	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503323&database=RX&origin=ReaxysOutput&ln=	(519 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			DAFGDMZQXDCPDT-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	4.762	1	5	11	77.33	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503323	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503323&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)N3CCOCC3)C=CN12		35503325	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503325&database=RX&origin=ReaxysOutput&ln=	(520 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-methyl-2-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			VDYAIJXLRUDJHD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.375	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503325	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503325&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)N3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-methyl-2-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)CN3CCOCC3)C=CN12		35503326	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503326&database=RX&origin=ReaxysOutput&ln=	(521 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methyl-2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			LAAFVHCZIIVZPE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.958	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503326	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503326&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)CN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methyl-2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCN(C)C3)C=CN12		35503327	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503327&database=RX&origin=ReaxysOutput&ln=	(522 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylpyrrolidin-3-yl)oxyimidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			RUWIJGVLDDEZJE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.083	1	5	9	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503327	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503327&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCN(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylpyrrolidin-3-yl)oxyimidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503328	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503328&database=RX&origin=ReaxysOutput&ln=	(523 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			JHRDFJQHLUMOSR-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	5.12	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503328	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503328&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503328	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503328&database=RX&origin=ReaxysOutput&ln=	(523 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			JHRDFJQHLUMOSR-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	5.12	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503328	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503328&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN=CN3C)C=CN12		35503330	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503330&database=RX&origin=ReaxysOutput&ln=	(524 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(3-methylimidazol-4-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H23F2N5O4	C24H23F2N5O4	483.475			AFPONXPVKNJEDV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.009	1	6	10	91.91	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503330	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503330&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN=CN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(3-methylimidazol-4-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCOCC3)C=CN12		35503332	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503332&database=RX&origin=ReaxysOutput&ln=	(525 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			YSHQJMRGCMXRGW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.856	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503332	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503332&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCOCC3)C=CN12		35503332	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503332&database=RX&origin=ReaxysOutput&ln=	(525 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			YSHQJMRGCMXRGW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.856	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503332	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503332&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3C)C=CN12		35503334	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503334&database=RX&origin=ReaxysOutput&ln=	(526 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			WYLJBNFKPGYZLE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.799	1	5	10	77.33	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503334	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503334&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3C)C=CN12		35503334	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503334&database=RX&origin=ReaxysOutput&ln=	(526 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			WYLJBNFKPGYZLE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.799	1	5	10	77.33	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503334	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503334&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCCN3C)C=CN12		35503336	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503336&database=RX&origin=ReaxysOutput&ln=	(527 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-methyl-2-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			TVXXRWGWKXIHCY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.157	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503336	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503336&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-methyl-2-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C)CC3)C=CN12		35503337	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503337&database=RX&origin=ReaxysOutput&ln=	(528 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-4-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			KIVIVZOVZSEPHR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.636	1	5	10	77.33	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503337	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503337&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-4-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC(C)=O)C=CN12		35503339	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503339&database=RX&origin=ReaxysOutput&ln=	(529 of 1381)		4-[7-(2-acetamidoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C23H24F2N4O5	C23H24F2N4O5	474.464			WALHPKSFZHDEIW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.545	2	6	12	103.19	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503339	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503339&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNC(C)=O)C=CN12	4-[7-(2-acetamidoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CN(C)C3)C=CN12		35503341	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503341&database=RX&origin=ReaxysOutput&ln=	(530 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylazetidin-3-yl)oxyimidazo[1,2-a]pyridin-3-yl]benzamide	C23H24F2N4O4	C23H24F2N4O4	458.465			ABVUQNQAFONJSF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.725	1	5	9	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503341	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503341&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CN(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylazetidin-3-yl)oxyimidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCO)C=CN12		35503342	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503342&database=RX&origin=ReaxysOutput&ln=	(531 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxyethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C21H21F2N3O5	C21H21F2N3O5	433.412			DYVLSTNRQWUPOU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	6	3.336	2	5	10	94.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503342	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503342&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCO)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxyethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC#N)C=CN12		35503343	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503343&database=RX&origin=ReaxysOutput&ln=	(532 of 1381)		4-[7-(2-cyanoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C22H20F2N4O4	C22H20F2N4O4	442.422			FNEMJMJCXVDMRN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.696	1	5	10	97.88	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503343	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503343&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC#N)C=CN12	4-[7-(2-cyanoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	500							6.3			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CO3)C=CN12		35503344	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503344&database=RX&origin=ReaxysOutput&ln=	(533 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxazol-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H20F2N4O5	C23H20F2N4O5	470.432			UFXWASCJLMEKDT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.595	1	5	10	100.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503344	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503344&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxazol-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN=CO3)C=CN12		35503345	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503345&database=RX&origin=ReaxysOutput&ln=	(534 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxazol-5-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H20F2N4O5	C23H20F2N4O5	470.432			KOQQOKSARVIZFS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.595	1	5	10	100.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503345	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503345&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN=CO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxazol-5-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN=CO3)C=CN12		35503345	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503345&database=RX&origin=ReaxysOutput&ln=	(534 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxazol-5-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H20F2N4O5	C23H20F2N4O5	470.432			KOQQOKSARVIZFS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.595	1	5	10	100.12	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503345	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503345&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN=CO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxazol-5-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)C#N)C=CN12		35503348	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503348&database=RX&origin=ReaxysOutput&ln=	(535 of 1381)		4-[7-(2-cyano-2-methylpropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H24F2N4O4	C24H24F2N4O4	470.476			JWAIKUOOOLXKGA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.19	1	5	10	97.88	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503348	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503348&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)C#N)C=CN12	4-[7-(2-cyano-2-methylpropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCO3)C=CN12		35503349	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503349&database=RX&origin=ReaxysOutput&ln=	(536 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxetan-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H23F2N3O5	C23H23F2N3O5	459.45			DOSPHBZPDCNHQC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.04	1	5	10	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503349	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503349&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxetan-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCO3)C=CN12		35503349	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503349&database=RX&origin=ReaxysOutput&ln=	(536 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxetan-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H23F2N3O5	C23H23F2N3O5	459.45			DOSPHBZPDCNHQC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.04	1	5	10	83.32	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503349	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503349&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxetan-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503357&database=RX&origin=ReaxysOutput&ln=	(537 of 1381)		6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H25F3N4O3	C23H25F3N4O3	462.472			RTSAQZCKRKDBEK-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	8	6	4.139	0	5	8	59.31	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503357&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12	6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503357&database=RX&origin=ReaxysOutput&ln=	(537 of 1381)		6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H25F3N4O3	C23H25F3N4O3	462.472			RTSAQZCKRKDBEK-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	8	6	4.139	0	5	8	59.31	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503357&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12	6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCC3)C=CN12		35503368	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503368&database=RX&origin=ReaxysOutput&ln=	(538 of 1381)		4-[7-(cyclobutylmethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H25F2N3O4	C24H25F2N3O4	457.477			NNMZSYFODCMCFT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	5.352	1	4	10	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503368	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503368&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCC3)C=CN12	4-[7-(cyclobutylmethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCF)C=CN12		35503374	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503374&database=RX&origin=ReaxysOutput&ln=	(539 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-fluoroethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C21H20F3N3O4	C21H20F3N3O4	435.403			PVLYSLXRIBOFQY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.673	1	4	10	74.09	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503374	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503374&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCF)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-fluoroethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCNCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503375	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503375&database=RX&origin=ReaxysOutput&ln=	(540 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(ethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H26F2N4O4	C23H26F2N4O4	460.481			VNEYMAYWSBYVNQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.082	2	5	12	86.12	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503375	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503375&database=RX&origin=ReaxysOutput&ln=	CCNCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(ethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCNCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503375	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503375&database=RX&origin=ReaxysOutput&ln=	(540 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(ethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H26F2N4O4	C23H26F2N4O4	460.481			VNEYMAYWSBYVNQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.082	2	5	12	86.12	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503375	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503375&database=RX&origin=ReaxysOutput&ln=	CCNCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(ethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COCCOCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503376&database=RX&origin=ReaxysOutput&ln=	(541 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(2-methoxyethoxy)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H27F2N3O6	C24H27F2N3O6	491.492			FJGQANILWBYZIP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.665	1	6	14	92.55	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503376&database=RX&origin=ReaxysOutput&ln=	COCCOCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(2-methoxyethoxy)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CN(C)C3)C=CN12		35503377	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503377&database=RX&origin=ReaxysOutput&ln=	(542 of 1381)		8-methoxy-6-[7-[(1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H25F3N4O3	C24H25F3N4O3	474.483			AEIHEYRJQFBMHY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.161	0	5	7	59.31	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503377	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503377&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CN(C)C3)C=CN12	8-methoxy-6-[7-[(1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CN(C)C3)C=CN12		35503377	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503377&database=RX&origin=ReaxysOutput&ln=	(542 of 1381)		8-methoxy-6-[7-[(1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H25F3N4O3	C24H25F3N4O3	474.483			AEIHEYRJQFBMHY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.161	0	5	7	59.31	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503377	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503377&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CN(C)C3)C=CN12	8-methoxy-6-[7-[(1-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCCCC3)C=CN12		35503378	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503378&database=RX&origin=ReaxysOutput&ln=	(543 of 1381)		8-methoxy-6-[7-[2-(1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O3	C26H29F3N4O3	502.536			QEUNQRAQSYEABI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.003	0	5	8	59.31	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503378	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503378&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCCCC3)C=CN12	8-methoxy-6-[7-[2-(1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCCCC3)C=CN12		35503378	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503378&database=RX&origin=ReaxysOutput&ln=	(543 of 1381)		8-methoxy-6-[7-[2-(1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O3	C26H29F3N4O3	502.536			QEUNQRAQSYEABI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.003	0	5	8	59.31	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503378	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503378&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCCCC3)C=CN12	8-methoxy-6-[7-[2-(1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CC3(F)F)C=CN12		35503380	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503380&database=RX&origin=ReaxysOutput&ln=	(544 of 1381)		N-cyclopropyl-4-[7-[(2,2-difluorocyclopropyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C23H21F4N3O4	C23H21F4N3O4	479.431			ANNCDFWSMRVFBZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.306	1	4	10	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503380	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503380&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CC3(F)F)C=CN12	N-cyclopropyl-4-[7-[(2,2-difluorocyclopropyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=CN=C3)C=CN12		35503381	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503381&database=RX&origin=ReaxysOutput&ln=	(545 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-pyridylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H22F2N4O4	C25H22F2N4O4	480.471			HHQAFPNBMZAUAU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.503	1	5	10	86.98	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503381	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503381&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=CN=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-pyridylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=NN3C)C=CN12		35503382	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503382&database=RX&origin=ReaxysOutput&ln=	(546 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H23F2N5O4	C24H23F2N5O4	483.475			FHFMGVTZCDVHQZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.34	1	6	10	91.91	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503382	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503382&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=NN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=NN3C)C=CN12		35503382	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503382&database=RX&origin=ReaxysOutput&ln=	(546 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H23F2N5O4	C24H23F2N5O4	483.475			FHFMGVTZCDVHQZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.34	1	6	10	91.91	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503382	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503382&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=NN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)C(F)(F)F)C=CN12		35503383	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503383&database=RX&origin=ReaxysOutput&ln=	(547 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2,2,2-trifluoro-1-methylethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20F5N3O4	C22H20F5N3O4	485.411			QCOIAHGDZKTSOT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.93	1	4	10	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503383	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503383&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)C(F)(F)F)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2,2,2-trifluoro-1-methylethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)C(F)(F)F)C=CN12		35503383	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503383&database=RX&origin=ReaxysOutput&ln=	(547 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2,2,2-trifluoro-1-methylethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20F5N3O4	C22H20F5N3O4	485.411			QCOIAHGDZKTSOT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.93	1	4	10	74.09	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503383	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503383&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC(C)C(F)(F)F)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2,2,2-trifluoro-1-methylethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CSC=N3)C=CN12		35503386	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503386&database=RX&origin=ReaxysOutput&ln=	(548 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(thiazol-4-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H20F2N4O4S	C23H20F2N4O4S	486.499			JHSGNPDLUNCTIN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.659	1	5	10	115.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503386	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503386&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CSC=N3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(thiazol-4-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CS3)C=CN12		35503387	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503387&database=RX&origin=ReaxysOutput&ln=	(549 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(thiazol-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H20F2N4O4S	C23H20F2N4O4S	486.499			BWXLYOKOWKUTHM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.96	1	5	10	115.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503387	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503387&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CS3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(thiazol-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCO3)C=CN12		35503388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503388&database=RX&origin=ReaxysOutput&ln=	(550 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydropyran-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H27F2N3O5	C25H27F2N3O5	487.503			XRJRKDTWNVEXCY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.756	1	5	10	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503388&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydropyran-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCO3)C=CN12		35503388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503388&database=RX&origin=ReaxysOutput&ln=	(550 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydropyran-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H27F2N3O5	C25H27F2N3O5	487.503			XRJRKDTWNVEXCY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.756	1	5	10	83.32	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503388&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydropyran-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCOCC3)C=CN12		35503389	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503389&database=RX&origin=ReaxysOutput&ln=	(551 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydropyran-4-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H27F2N3O5	C25H27F2N3O5	487.503			NZTAZIAAOQOYHU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.593	1	5	10	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503389	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503389&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydropyran-4-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503390&database=RX&origin=ReaxysOutput&ln=	(552 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C24H25F2N3O6	C24H25F2N3O6	489.476			LJIYORPJIDAHDJ-QGZVFWFLSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.492	1	6	10	92.55	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503390&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503390&database=RX&origin=ReaxysOutput&ln=	(552 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C24H25F2N3O6	C24H25F2N3O6	489.476			LJIYORPJIDAHDJ-QGZVFWFLSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.492	1	6	10	92.55	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503390&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503391	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503391&database=RX&origin=ReaxysOutput&ln=	(553 of 1381)		N-cyclopropyl-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-fluoro-6-methoxybenzamide	C22H25FN4O3	C22H25FN4O3	412.464			JTHHLLXOVWFOIO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	6	3.43	1	5	9	68.1	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503391	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503391&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12	N-cyclopropyl-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-fluoro-6-methoxybenzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CC(F)(F)C3)C=CN12		35503392	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503392&database=RX&origin=ReaxysOutput&ln=	(554 of 1381)		N-cyclopropyl-4-[7-[(3,3-difluorocyclobutyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C24H23F4N3O4	C24H23F4N3O4	493.458			FUVBXXHGTCTJAI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.664	1	4	10	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503392	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503392&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CC(F)(F)C3)C=CN12	N-cyclopropyl-4-[7-[(3,3-difluorocyclobutyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC2=C(C(OC)=CC(=C2)C2=CN=C3C=C(OCCN(C)C)C=CN23)C1=O		35503393	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503393&database=RX&origin=ReaxysOutput&ln=	(555 of 1381)		6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-ethyl-8-methoxy-3,4-dihydroisoquinolin-1-one	C23H28N4O3	C23H28N4O3	408.5			KNYXCKRALBXAHY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.137	0	5	7	59.31	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503393	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503393&database=RX&origin=ReaxysOutput&ln=	CCN1CCC2=C(C(OC)=CC(=C2)C2=CN=C3C=C(OCCN(C)C)C=CN23)C1=O	6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-ethyl-8-methoxy-3,4-dihydroisoquinolin-1-one					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503394	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503394&database=RX&origin=ReaxysOutput&ln=	(556 of 1381)		2-(2,2-difluoroethyl)-6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydroisoquinolin-1-one	C23H26F2N4O3	C23H26F2N4O3	444.481			BXMAOVXWLVZAFT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.623	0	5	8	59.31	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503394	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503394&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12	2-(2,2-difluoroethyl)-6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydroisoquinolin-1-one					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503394	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503394&database=RX&origin=ReaxysOutput&ln=	(556 of 1381)		2-(2,2-difluoroethyl)-6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydroisoquinolin-1-one	C23H26F2N4O3	C23H26F2N4O3	444.481			BXMAOVXWLVZAFT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.623	0	5	8	59.31	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503394	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503394&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12	2-(2,2-difluoroethyl)-6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCCN3CCOCC3)C=CN12		35503395	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503395&database=RX&origin=ReaxysOutput&ln=	(557 of 1381)		8-methoxy-6-[7-(3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O4	C26H29F3N4O4	518.536			IPEHUYMYFPDHGT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.097	0	6	9	68.54	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503395	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503395&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCCN3CCOCC3)C=CN12	8-methoxy-6-[7-(3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCCN3CCOCC3)C=CN12		35503395	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503395&database=RX&origin=ReaxysOutput&ln=	(557 of 1381)		8-methoxy-6-[7-(3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C26H29F3N4O4	C26H29F3N4O4	518.536			IPEHUYMYFPDHGT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.097	0	6	9	68.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503395	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503395&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCCN3CCOCC3)C=CN12	8-methoxy-6-[7-(3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCOC3)C=CN12		35503399	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503399&database=RX&origin=ReaxysOutput&ln=	(558 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydropyran-3-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H27F2N3O5	C25H27F2N3O5	487.503			VONUJRXELIUVTC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.593	1	5	10	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503399	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503399&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCOC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydropyran-3-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=COC=N3)C=CN12		35503400	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503400&database=RX&origin=ReaxysOutput&ln=	(559 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxazol-4-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H20F2N4O5	C23H20F2N4O5	470.432			QQKGGZMVCBSRTQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.909	1	5	10	100.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503400	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503400&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=COC=N3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxazol-4-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCC3)C=CN12		35503401	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503401&database=RX&origin=ReaxysOutput&ln=	(560 of 1381)		4-[7-(cyclopentylmethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H27F2N3O4	C25H27F2N3O4	471.504			YLYZCFKTDOHIHJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.921	1	4	10	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503401	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503401&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCC3)C=CN12	4-[7-(cyclopentylmethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCC(F)(F)C3)C=CN12		35503402	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503402&database=RX&origin=ReaxysOutput&ln=	(561 of 1381)		N-cyclopropyl-4-[7-(3,3-difluorocyclopentoxy)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C24H23F4N3O4	C24H23F4N3O4	493.458			ULBJICCKPJWLCT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.827	1	4	9	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503402	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503402&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCC(F)(F)C3)C=CN12	N-cyclopropyl-4-[7-(3,3-difluorocyclopentoxy)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN(C)C)C=CN12		35503405	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503405&database=RX&origin=ReaxysOutput&ln=	(562 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[2-(dimethylamino)ethoxy]ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H30F2N4O5	C25H30F2N4O5	504.534			PRYQHEPXTUZERK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.708	1	6	14	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503405	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503405&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCN(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-[2-(dimethylamino)ethoxy]ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)C)C=CN12		35503406	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503406&database=RX&origin=ReaxysOutput&ln=	(563 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2,2-dimethylpropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C24H27F2N3O4	C24H27F2N3O4	459.493			ANJDGAHLSILCRC-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.518	1	4	10	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503406	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503406&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2,2-dimethylpropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=CC=C3)C=CN12		35503408	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503408&database=RX&origin=ReaxysOutput&ln=	(564 of 1381)		4-(7-benzyloxyimidazo[1,2-a]pyridin-3-yl)-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C26H23F2N3O4	C26H23F2N3O4	479.483			GTCAHGMOLCLRIE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	9	6	5.755	1	4	10	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503408	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503408&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=CC=C3)C=CN12	4-(7-benzyloxyimidazo[1,2-a]pyridin-3-yl)-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCC3)C=CN12		35503409	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503409&database=RX&origin=ReaxysOutput&ln=	(565 of 1381)		4-[7-(cyclohexylmethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C26H29F2N3O4	C26H29F2N3O4	485.531			DSGGNBQDEBKZQU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	6.49	1	4	10	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503409	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503409&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCC3)C=CN12	4-[7-(cyclohexylmethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503410	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503410&database=RX&origin=ReaxysOutput&ln=	(566 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-methoxyethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H23F2N3O5	C22H23F2N3O5	447.439			WRUPGKPEERYHKK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.855	1	5	11	83.32	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503410	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503410&database=RX&origin=ReaxysOutput&ln=	COCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-methoxyethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503411	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503411&database=RX&origin=ReaxysOutput&ln=	(567 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-ethoxyethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H25F2N3O5	C23H25F2N3O5	461.465			MTKRGTAYKMXEPN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.278	1	5	12	83.32	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503411	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503411&database=RX&origin=ReaxysOutput&ln=	CCOCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-ethoxyethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCO)C=CN12		35503412	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503412&database=RX&origin=ReaxysOutput&ln=	(568 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(2-hydroxyethoxy)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H25F2N3O6	C23H25F2N3O6	477.465			UCMDCEXECFYYOQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.146	2	6	13	103.55	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503412	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503412&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCOCCO)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(2-hydroxyethoxy)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)CO)C=CN12		35503413	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503413&database=RX&origin=ReaxysOutput&ln=	(569 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(3-hydroxy-2,2-dimethylpropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C24H27F2N3O5	C24H27F2N3O5	475.492			FOKHUAZCASZNIO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.386	2	5	11	94.32	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503413	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503413&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)CO)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(3-hydroxy-2,2-dimethylpropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCC(F)(F)C3)C=CN12		35503414	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503414&database=RX&origin=ReaxysOutput&ln=	(570 of 1381)		N-cyclopropyl-4-[7-[(3,3-difluorocyclopentyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C25H25F4N3O4	C25H25F4N3O4	507.485			DAUOYDKZYMPIMP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	6.022	1	4	10	74.09	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503414	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503414&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCC(F)(F)C3)C=CN12	N-cyclopropyl-4-[7-[(3,3-difluorocyclopentyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CC(F)(F)C3)C=CN12		35503415	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503415&database=RX&origin=ReaxysOutput&ln=	(571 of 1381)		N-cyclopropyl-4-[7-[2-(3,3-difluorocyclobutyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C25H25F4N3O4	C25H25F4N3O4	507.485			GMZKAKXEDCOHFO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	6.022	1	4	11	74.09	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503415	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503415&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CC(F)(F)C3)C=CN12	N-cyclopropyl-4-[7-[2-(3,3-difluorocyclobutyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C(C)C)C(C)C)C=CN12		35503418	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503418&database=RX&origin=ReaxysOutput&ln=	(572 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(diisopropylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H34F2N4O4	C27H34F2N4O4	516.588			JWWMTBSWDIHWHY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.664	1	5	13	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503418	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503418&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C(C)C)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(diisopropylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C(C)C)C(C)C)C=CN12		35503418	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503418&database=RX&origin=ReaxysOutput&ln=	(572 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(diisopropylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H34F2N4O4	C27H34F2N4O4	516.588			JWWMTBSWDIHWHY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.664	1	5	13	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503418	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503418&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C(C)C)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(diisopropylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(C)CCO3)C=CN12		35503422	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503422&database=RX&origin=ReaxysOutput&ln=	(573 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(4-methylmorpholin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O5	C25H28F2N4O5	502.518			LIWANDDEVVJDOI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.535	1	6	10	86.56	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503422	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503422&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(C)CCO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(4-methylmorpholin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCN1CCCCC1COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503423	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503423&database=RX&origin=ReaxysOutput&ln=	(574 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-ethyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			JZHYQTJUZJBULM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.222	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503423	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503423&database=RX&origin=ReaxysOutput&ln=	CCN1CCCCC1COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-ethyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCN1CCCCC1COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503423	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503423&database=RX&origin=ReaxysOutput&ln=	(574 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-ethyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			JZHYQTJUZJBULM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.222	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503423	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503423&database=RX&origin=ReaxysOutput&ln=	CCN1CCCCC1COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-ethyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3=CC=NN3C)C=CN12		35503424	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503424&database=RX&origin=ReaxysOutput&ln=	(575 of 1381)		8-methoxy-6-[7-[(2-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H22F3N5O3	C24H22F3N5O3	485.466			FYUYIXJASJKTDQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.581	0	6	7	73.89	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503424	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503424&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3=CC=NN3C)C=CN12	8-methoxy-6-[7-[(2-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3=CC=NN3C)C=CN12		35503424	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503424&database=RX&origin=ReaxysOutput&ln=	(575 of 1381)		8-methoxy-6-[7-[(2-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H22F3N5O3	C24H22F3N5O3	485.466			FYUYIXJASJKTDQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.581	0	6	7	73.89	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503424	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503424&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3=CC=NN3C)C=CN12	8-methoxy-6-[7-[(2-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3=CN=CN3C)C=CN12		35503425	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503425&database=RX&origin=ReaxysOutput&ln=	(576 of 1381)		8-methoxy-6-[7-[(3-methylimidazol-4-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H22F3N5O3	C24H22F3N5O3	485.466			GHBDHVBBIVTZMU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.25	0	6	7	73.89	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503425	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503425&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3=CN=CN3C)C=CN12	8-methoxy-6-[7-[(3-methylimidazol-4-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN3C(=O)OC(C)(C)C)C=CN12		35503427	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503427&database=RX&origin=ReaxysOutput&ln=	(577 of 1381)		tert-butyl 2-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]azetidine1-carboxylate	C28H32F2N4O6	C28H32F2N4O6	558.582			LEVNMYMGRYFFIL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	6	5.343	1	7	13	103.63	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503427	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503427&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN3C(=O)OC(C)(C)C)C=CN12	tert-butyl 2-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]azetidine1-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)COC3)C=CN12		35503428	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503428&database=RX&origin=ReaxysOutput&ln=	(578 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(3-methyloxetan-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H25F2N3O5	C24H25F2N3O5	473.476			FCRBWOWMDKAZCA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.272	1	5	10	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503428	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503428&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(3-methyloxetan-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(F)F)C=CN12		35503432	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503432&database=RX&origin=ReaxysOutput&ln=	(579 of 1381)		N-cyclopropyl-4-[7-(2,2-difluoroethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C21H19F4N3O4	C21H19F4N3O4	453.393			LXDQJGGKCIVNKX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.954	1	4	10	74.09	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503432	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503432&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(F)F)C=CN12	N-cyclopropyl-4-[7-(2,2-difluoroethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(F)(F)F)C=CN12		35503434	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503434&database=RX&origin=ReaxysOutput&ln=	(580 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C21H18F5N3O4	C21H18F5N3O4	471.384			LAFCUXYLCZDOQH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.47	1	4	10	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503434	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503434&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(F)(F)F)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2,2,2-trifluoroethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCOC3)C=CN12		35503436	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503436&database=RX&origin=ReaxysOutput&ln=	(581 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydrofuran-3-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H25F2N3O5	C24H25F2N3O5	473.476			NUMNQLQTOLCUEQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.235	1	5	10	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503436	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503436&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCOC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydrofuran-3-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCO3)C=CN12		35503437	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503437&database=RX&origin=ReaxysOutput&ln=	(582 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydrofuran-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H25F2N3O5	C24H25F2N3O5	473.476			XJHBDVPPJFRAFK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.398	1	5	10	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503437	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503437&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(tetrahydrofuran-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CC=N3)C=CN12		35503439	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503439&database=RX&origin=ReaxysOutput&ln=	(583 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(pyrimidin-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H21F2N5O4	C24H21F2N5O4	481.459			QMNYBYYDBVJROY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.551	1	6	10	99.87	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503439	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503439&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CC=N3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(pyrimidin-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN=CS3)C=CN12		35503441	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503441&database=RX&origin=ReaxysOutput&ln=	(584 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(thiazol-5-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H20F2N4O4S	C23H20F2N4O4S	486.499			OFRSLOOAMXWTGQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.96	1	5	10	115.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503441	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503441&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN=CS3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(thiazol-5-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CC3)C=CN12		35503443	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503443&database=RX&origin=ReaxysOutput&ln=	(585 of 1381)		N-cyclopropyl-4-[7-(cyclopropylmethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C23H23F2N3O4	C23H23F2N3O4	443.45			YQYPZBSTSOTBDH-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.783	1	4	10	74.09	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503443	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503443&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CC3)C=CN12	N-cyclopropyl-4-[7-(cyclopropylmethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CC3)C=CN12		35503444	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503444&database=RX&origin=ReaxysOutput&ln=	(586 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylcyclopropyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H25F2N3O4	C24H25F2N3O4	457.477			CYTBGVGSMYBGDB-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.178	1	4	10	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503444	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503444&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylcyclopropyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3COCCO3)C=CN12		35503446	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503446&database=RX&origin=ReaxysOutput&ln=	(587 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1,4-dioxan-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C24H25F2N3O6	C24H25F2N3O6	489.476			LJIYORPJIDAHDJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.492	1	6	10	92.55	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503446	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503446&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3COCCO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1,4-dioxan-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=NC=C3)C=CN12		35503454	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503454&database=RX&origin=ReaxysOutput&ln=	(588 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(4-pyridylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H22F2N4O4	C25H22F2N4O4	480.471			BVRJCKZCVBHAEJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.503	1	5	10	86.98	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503454	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503454&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=NC=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(4-pyridylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)N)C=CN12		35503456	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503456&database=RX&origin=ReaxysOutput&ln=	(589 of 1381)		4-[7-(2-amino-2-methylpropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C23H26F2N4O4	C23H26F2N4O4	460.481			VZEMEHLAXUXHDO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.146	2	5	10	100.11	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503456	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503456&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)N)C=CN12	4-[7-(2-amino-2-methylpropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)N)C=CN12		35503456	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503456&database=RX&origin=ReaxysOutput&ln=	(589 of 1381)		4-[7-(2-amino-2-methylpropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C23H26F2N4O4	C23H26F2N4O4	460.481			VZEMEHLAXUXHDO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.146	2	5	10	100.11	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503456	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503456&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)N)C=CN12	4-[7-(2-amino-2-methylpropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CC=C3)C=CN12		35503457	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503457&database=RX&origin=ReaxysOutput&ln=	(590 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-pyridylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H22F2N4O4	C25H22F2N4O4	480.471			AXUFTGGSCIDXPZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.592	1	5	10	86.98	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503457	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503457&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CC=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-pyridylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)N(C)C)C=CN12		35503458	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503458&database=RX&origin=ReaxysOutput&ln=	(591 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)-2-methylpropoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H30F2N4O4	C25H30F2N4O4	488.534			IFFNSUPVEDBCSK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.775	1	5	11	77.33	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503458	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503458&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)(C)N(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)-2-methylpropoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCN(CC)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503459	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503459&database=RX&origin=ReaxysOutput&ln=	(592 of 1381)		N-cyclopropyl-4-[7-[2-(diethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C25H30F2N4O4	C25H30F2N4O4	488.534			AVKXDUSQKPWUMN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.744	1	5	13	77.33	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503459	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503459&database=RX&origin=ReaxysOutput&ln=	CCN(CC)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-4-[7-[2-(diethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCN(CC)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503459	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503459&database=RX&origin=ReaxysOutput&ln=	(592 of 1381)		N-cyclopropyl-4-[7-[2-(diethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C25H30F2N4O4	C25H30F2N4O4	488.534			AVKXDUSQKPWUMN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.744	1	5	13	77.33	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503459	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503459&database=RX&origin=ReaxysOutput&ln=	CCN(CC)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-4-[7-[2-(diethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CC(N)C3)C=CN12		35503460	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503460&database=RX&origin=ReaxysOutput&ln=	(593 of 1381)		4-[7-[(3-aminocyclobutyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			GSMMVBOYOXXTIW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.044	2	5	10	100.11	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503460	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503460&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CC(N)C3)C=CN12	4-[7-[(3-aminocyclobutyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CN3C)C=CN12		35503462	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503462&database=RX&origin=ReaxysOutput&ln=	(594 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylimidazol-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H23F2N5O4	C24H23F2N5O4	483.475			URCAGPMHGOMVJX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.009	1	6	10	91.91	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503462	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503462&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylimidazol-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CN3C)C=CN12		35503462	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503462&database=RX&origin=ReaxysOutput&ln=	(594 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylimidazol-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H23F2N5O4	C24H23F2N5O4	483.475			URCAGPMHGOMVJX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.009	1	6	10	91.91	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503462	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503462&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylimidazol-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCCN3C)C=CN12		35503464	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503464&database=RX&origin=ReaxysOutput&ln=	(595 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2R)-1-methyl-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			WYLJBNFKPGYZLE-GOSISDBHSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.799	1	5	10	77.33	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503464	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503464&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2R)-1-methyl-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCCN3C)C=CN12		35503464	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503464&database=RX&origin=ReaxysOutput&ln=	(595 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2R)-1-methyl-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			WYLJBNFKPGYZLE-GOSISDBHSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.799	1	5	10	77.33	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503464	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503464&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2R)-1-methyl-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCC3)C=CN12		35503466	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503466&database=RX&origin=ReaxysOutput&ln=	(596 of 1381)		4-[7-[2-(azetidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			PQYINNNQNGUCKE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.046	1	5	11	77.33	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503466	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503466&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCC3)C=CN12	4-[7-[2-(azetidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNCCO)C=CN12		35503468	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503468&database=RX&origin=ReaxysOutput&ln=	(597 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(2-hydroxyethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H26F2N4O5	C23H26F2N4O5	476.48			HFFFQXHUFVQVBL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	2.95	3	6	13	106.35	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503468	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503468&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCNCCO)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(2-hydroxyethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN)C=CN12		35503470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503470&database=RX&origin=ReaxysOutput&ln=	(598 of 1381)		4-[7-(3-aminopropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C22H24F2N4O4	C22H24F2N4O4	446.454			AWUTYEOQDXHRDA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.627	2	5	11	100.11	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503470&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN)C=CN12	4-[7-(3-aminopropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CNCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503473&database=RX&origin=ReaxysOutput&ln=	(599 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(methylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C22H24F2N4O4	C22H24F2N4O4	446.454			YXRBKKJHZFFYIG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	3.659	2	5	11	86.12	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503473&database=RX&origin=ReaxysOutput&ln=	CNCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(methylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CNCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503473&database=RX&origin=ReaxysOutput&ln=	(599 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(methylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C22H24F2N4O4	C22H24F2N4O4	446.454			YXRBKKJHZFFYIG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	3	6	3.659	2	5	11	86.12	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503473&database=RX&origin=ReaxysOutput&ln=	CNCCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(methylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN)C=CN12		35503475	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503475&database=RX&origin=ReaxysOutput&ln=	(600 of 1381)		4-[7-(2-aminoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C21H22F2N4O4	C21H22F2N4O4	432.427			CFTSVZPFFIQXBU-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	4	6	3.269	2	5	10	100.11	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503475	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503475&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN)C=CN12	4-[7-(2-aminoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN)C=CN12		35503475	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503475&database=RX&origin=ReaxysOutput&ln=	(600 of 1381)		4-[7-(2-aminoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C21H22F2N4O4	C21H22F2N4O4	432.427			CFTSVZPFFIQXBU-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	4	6	3.269	2	5	10	100.11	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503475	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503475&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN)C=CN12	4-[7-(2-aminoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3)C=CN12		35503476	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503476&database=RX&origin=ReaxysOutput&ln=	(601 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-piperidylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			DMDTZSMQGRQDBU-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	8	6	4.56	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503476	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503476&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-piperidylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3COCCO3)C=CN12		35503478	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503478&database=RX&origin=ReaxysOutput&ln=	(602 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(2S)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C24H25F2N3O6	C24H25F2N3O6	489.476			LJIYORPJIDAHDJ-KRWDZBQOSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.492	1	6	10	92.55	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503478	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503478&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3COCCO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(2S)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(N)C(C)C)C=CN12		35503480	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503480&database=RX&origin=ReaxysOutput&ln=	(603 of 1381)		4-[7-(2-amino-3-methylbutoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H28F2N4O4	C24H28F2N4O4	474.508			KLLGFIQRVBRHKW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.384	2	5	11	100.11	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503480	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503480&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(N)C(C)C)C=CN12	4-[7-(2-amino-3-methylbutoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CCO3)C=CN12		35503486	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503486&database=RX&origin=ReaxysOutput&ln=	(604 of 1381)		8-methoxy-6-[7-(oxetan-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H22F3N3O4	C23H22F3N3O4	461.441			QSNWIQSJOAYVFJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.281	0	5	7	65.3	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503486	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503486&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CCO3)C=CN12	8-methoxy-6-[7-(oxetan-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CCO3)C=CN12		35503486	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503486&database=RX&origin=ReaxysOutput&ln=	(604 of 1381)		8-methoxy-6-[7-(oxetan-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H22F3N3O4	C23H22F3N3O4	461.441			QSNWIQSJOAYVFJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.281	0	5	7	65.3	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503486	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503486&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CCO3)C=CN12	8-methoxy-6-[7-(oxetan-2-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3=CN=CO3)C=CN12		35503488	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503488&database=RX&origin=ReaxysOutput&ln=	(605 of 1381)		8-methoxy-6-[7-(oxazol-5-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H19F3N4O4	C23H19F3N4O4	472.423			HGHXEJRRNMWOHF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.836	0	5	7	82.1	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503488	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503488&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3=CN=CO3)C=CN12	8-methoxy-6-[7-(oxazol-5-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3=CN=CO3)C=CN12		35503488	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503488&database=RX&origin=ReaxysOutput&ln=	(605 of 1381)		8-methoxy-6-[7-(oxazol-5-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H19F3N4O4	C23H19F3N4O4	472.423			HGHXEJRRNMWOHF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.836	0	5	7	82.1	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503488	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503488&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3=CN=CO3)C=CN12	8-methoxy-6-[7-(oxazol-5-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CN(C)CCO3)C=CN12		35503490	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503490&database=RX&origin=ReaxysOutput&ln=	(606 of 1381)		8-methoxy-6-[7-[(4-methylmorpholin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O4	C25H27F3N4O4	504.509			AXTRCSQJFSRMDX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.776	0	6	7	68.54	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503490	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503490&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CN(C)CCO3)C=CN12	8-methoxy-6-[7-[(4-methylmorpholin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CN(C)CCO3)C=CN12		35503490	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503490&database=RX&origin=ReaxysOutput&ln=	(606 of 1381)		8-methoxy-6-[7-[(4-methylmorpholin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O4	C25H27F3N4O4	504.509			AXTRCSQJFSRMDX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.776	0	6	7	68.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503490	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503490&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3CN(C)CCO3)C=CN12	8-methoxy-6-[7-[(4-methylmorpholin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCN(CC)CCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC)=C1)C(=O)N(CC(F)(F)F)CC2		35503492	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503492&database=RX&origin=ReaxysOutput&ln=	(607 of 1381)		6-[7-[2-(diethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H29F3N4O3	C25H29F3N4O3	490.525			UMVZBVFGNCAMTN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.985	0	5	10	59.31	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503492	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503492&database=RX&origin=ReaxysOutput&ln=	CCN(CC)CCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC)=C1)C(=O)N(CC(F)(F)F)CC2	6-[7-[2-(diethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCN(CC)CCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC)=C1)C(=O)N(CC(F)(F)F)CC2		35503492	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503492&database=RX&origin=ReaxysOutput&ln=	(607 of 1381)		6-[7-[2-(diethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H29F3N4O3	C25H29F3N4O3	490.525			UMVZBVFGNCAMTN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.985	0	5	10	59.31	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503492	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503492&database=RX&origin=ReaxysOutput&ln=	CCN(CC)CCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC)=C1)C(=O)N(CC(F)(F)F)CC2	6-[7-[2-(diethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCC(N)COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503494	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503494&database=RX&origin=ReaxysOutput&ln=	(608 of 1381)		4-[7-(2-aminobutoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C23H26F2N4O4	C23H26F2N4O4	460.481			WJGNWJBAKNMMBL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.087	2	5	11	100.11	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503494	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503494&database=RX&origin=ReaxysOutput&ln=	CCC(N)COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	4-[7-(2-aminobutoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H](N)CC(C)C)C=CN12		35503495	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503495&database=RX&origin=ReaxysOutput&ln=	(609 of 1381)		4-[7-[(2S)-2-amino-4-methylpentoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H30F2N4O4	C25H30F2N4O4	488.534			SRFSXLPUFCFKQD-INIZCTEOSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.164	2	5	12	100.11	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503495	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503495&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H](N)CC(C)C)C=CN12	4-[7-[(2S)-2-amino-4-methylpentoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H](N)C3CCCCC3)C=CN12		35503497	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503497&database=RX&origin=ReaxysOutput&ln=	(610 of 1381)		4-[7-[(2S)-2-amino-2-cyclohexylethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			VAWYIKINKHXTBB-HXUWFJFHSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.751	2	5	11	100.11	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503497	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503497&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H](N)C3CCCCC3)C=CN12	4-[7-[(2S)-2-amino-2-cyclohexylethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(N)C3CCOC3)C=CN12		35503499	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503499&database=RX&origin=ReaxysOutput&ln=	(611 of 1381)		4-[7-(2-amino-2-tetrahydrofuran-3-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H28F2N4O5	C25H28F2N4O5	502.518			RIADXHLJUXSEKP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.496	2	6	11	109.34	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503499	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503499&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(N)C3CCOC3)C=CN12	4-[7-(2-amino-2-tetrahydrofuran-3-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(N)C3CCCO3)C=CN12		35503502	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503502&database=RX&origin=ReaxysOutput&ln=	(612 of 1381)		4-[7-(2-amino-2-tetrahydrofuran-2-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H28F2N4O5	C25H28F2N4O5	502.518			QVZHRLYHLMQWFX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.659	2	6	11	109.34	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503502	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503502&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(N)C3CCCO3)C=CN12	4-[7-(2-amino-2-tetrahydrofuran-2-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(N)C3CC3)C=CN12		35503504	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503504&database=RX&origin=ReaxysOutput&ln=	(613 of 1381)		4-[7-(2-amino-2-cyclopropylethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			DWFHAUMKOFCEBE-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.044	2	5	11	100.11	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503504	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503504&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(N)C3CC3)C=CN12	4-[7-(2-amino-2-cyclopropylethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)N)C=CN12		35503506	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503506&database=RX&origin=ReaxysOutput&ln=	(614 of 1381)		4-[7-(2-aminopropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C22H24F2N4O4	C22H24F2N4O4	446.454			ZQAMIATWRVMZBQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.729	2	5	10	100.11	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503506	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503506&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)N)C=CN12	4-[7-(2-aminopropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)N)C=CN12		35503506	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503506&database=RX&origin=ReaxysOutput&ln=	(614 of 1381)		4-[7-(2-aminopropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C22H24F2N4O4	C22H24F2N4O4	446.454			ZQAMIATWRVMZBQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.729	2	5	10	100.11	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503506	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503506&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)N)C=CN12	4-[7-(2-aminopropoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCCN3C)C=CN12		35503508	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503508&database=RX&origin=ReaxysOutput&ln=	(615 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2S)-1-methyl-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			WYLJBNFKPGYZLE-SFHVURJKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.799	1	5	10	77.33	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503508	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503508&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2S)-1-methyl-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCCN3C)C=CN12		35503508	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503508&database=RX&origin=ReaxysOutput&ln=	(615 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2S)-1-methyl-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			WYLJBNFKPGYZLE-SFHVURJKSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.799	1	5	10	77.33	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503508	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503508&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2S)-1-methyl-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503510	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503510&database=RX&origin=ReaxysOutput&ln=	(616 of 1381)		6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-ethoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H27F3N4O3	C24H27F3N4O3	476.499			BUNOXTAYQGZTBX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.562	0	5	9	59.31	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503510	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503510&database=RX&origin=ReaxysOutput&ln=	CCOC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12	6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-ethoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 500							7			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN(C3)C=O)C=CN12		35503512	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503512&database=RX&origin=ReaxysOutput&ln=	(617 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-formyl-3-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H28F2N4O5	C26H28F2N4O5	514.529			IILWQDRTGUQBSY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.189	1	6	11	94.4	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503512	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503512&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN(C3)C=O)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-formyl-3-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCNC3)C=CN12		35503514	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503514&database=RX&origin=ReaxysOutput&ln=	(618 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-piperidylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			HMPLKSVEOUQXEA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.397	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503514	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503514&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCNC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-piperidylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C)C3)C=CN12		35503516	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503516&database=RX&origin=ReaxysOutput&ln=	(619 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylpyrrolidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			SIYSLESMYWYOOU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.278	1	5	10	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503516	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503516&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCN(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylpyrrolidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3=NC=CC=C3)C=CN12		35503517	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503517&database=RX&origin=ReaxysOutput&ln=	(620 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-pyridyloxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H20F2N4O4	C24H20F2N4O4	466.444			OOCUWEMKBFTIBU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.087	1	5	9	86.98	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503517	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503517&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3=NC=CC=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-pyridyloxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(F)=C1		35503518	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503518&database=RX&origin=ReaxysOutput&ln=	(621 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-fluorobenzamide	C22H23F3N4O3	C22H23F3N4O3	448.445			CIWZPKZILZUHRR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.144	1	5	10	68.1	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503518	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503518&database=RX&origin=ReaxysOutput&ln=	CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(F)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-fluorobenzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503521	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503521&database=RX&origin=ReaxysOutput&ln=	(622 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-(methylamino)benzamide	C23H27F2N5O3	C23H27F2N5O3	459.496			QKXPPTRJPPSUEQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.058	2	6	11	80.13	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503521	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503521&database=RX&origin=ReaxysOutput&ln=	CNC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-(methylamino)benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503521	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503521&database=RX&origin=ReaxysOutput&ln=	(622 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-(methylamino)benzamide	C23H27F2N5O3	C23H27F2N5O3	459.496			QKXPPTRJPPSUEQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.058	2	6	11	80.13	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503521	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503521&database=RX&origin=ReaxysOutput&ln=	CNC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-(methylamino)benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3C(C)C)C=CN12		35503523	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503523&database=RX&origin=ReaxysOutput&ln=	(623 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C28H34F2N4O4	C28H34F2N4O4	528.599			WISCNBXMZXPGTQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.682	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503523	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503523&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3CC(F)F)C=CN12		35503525	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503525&database=RX&origin=ReaxysOutput&ln=	(624 of 1381)		N-cyclopropyl-4-[7-[[1-(2,2-difluoroethyl)-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C27H30F4N4O4	C27H30F4N4O4	550.553			RBZOJIWTEORNAP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.708	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503525	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503525&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCCN3CC(F)F)C=CN12	N-cyclopropyl-4-[7-[[1-(2,2-difluoroethyl)-2-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCC3)C=CN12		35503527	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503527&database=RX&origin=ReaxysOutput&ln=	(625 of 1381)		4-[7-(cyclobutoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C23H23F2N3O4	C23H23F2N3O4	443.45			HCCYGNPUUJPYIL-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.946	1	4	9	74.09	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503527	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503527&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCC3)C=CN12	4-[7-(cyclobutoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3COC3)C=CN12		35503529	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503529&database=RX&origin=ReaxysOutput&ln=	(626 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxetan-3-yloxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H21F2N3O5	C22H21F2N3O5	445.423			FYWPXWDOGCTCCU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.682	1	5	9	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503529	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503529&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3COC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxetan-3-yloxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NCC(F)(F)F)C(F)=C1		35503530	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503530&database=RX&origin=ReaxysOutput&ln=	(627 of 1381)		2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-fluoro-N-(2,2,2-trifluoroethyl)benzamide	C21H20F6N4O3	C21H20F6N4O3	490.405			NAWSAQFOLVNLPI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	6	5.026	1	5	11	68.1	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503530	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503530&database=RX&origin=ReaxysOutput&ln=	CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NCC(F)(F)F)C(F)=C1	2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-fluoro-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC(F)F)=C1		35503531	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503531&database=RX&origin=ReaxysOutput&ln=	(628 of 1381)		N-cyclopropyl-2,6-bis(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C23H24F4N4O4	C23H24F4N4O4	496.462			JTAGLJQPKGVETR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.612	1	5	12	77.33	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503531	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503531&database=RX&origin=ReaxysOutput&ln=	CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC(F)F)=C1	N-cyclopropyl-2,6-bis(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC(F)F)=C1		35503531	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503531&database=RX&origin=ReaxysOutput&ln=	(628 of 1381)		N-cyclopropyl-2,6-bis(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C23H24F4N4O4	C23H24F4N4O4	496.462			JTAGLJQPKGVETR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.612	1	5	12	77.33	4	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503531	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503531&database=RX&origin=ReaxysOutput&ln=	CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC(F)F)=C1	N-cyclopropyl-2,6-bis(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3=CC=CC=C3)C=CN12		35503533	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503533&database=RX&origin=ReaxysOutput&ln=	(629 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-phenoxyimidazo[1,2-a]pyridin-3-yl)benzamide	C25H21F2N3O4	C25H21F2N3O4	465.456			LGHJGVKANDBMIP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.611	1	4	9	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503533	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503533&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3=CC=CC=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-phenoxyimidazo[1,2-a]pyridin-3-yl)benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COCC1CN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CCO1		35503535	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503535&database=RX&origin=ReaxysOutput&ln=	(630 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(methoxymethyl)morpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H32F2N4O6	C27H32F2N4O6	546.571			LYBIVSRLXJMSBV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	3.345	1	7	13	95.79	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503535	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503535&database=RX&origin=ReaxysOutput&ln=	COCC1CN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CCO1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(methoxymethyl)morpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COCC1CN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CCO1		35503535	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503535&database=RX&origin=ReaxysOutput&ln=	(630 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(methoxymethyl)morpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H32F2N4O6	C27H32F2N4O6	546.571			LYBIVSRLXJMSBV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	3.345	1	7	13	95.79	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503535	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503535&database=RX&origin=ReaxysOutput&ln=	COCC1CN(CCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CCO1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(methoxymethyl)morpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CNC1CC(C1)OC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503537	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503537&database=RX&origin=ReaxysOutput&ln=	(631 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(methylamino)cyclobutoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			BOYNYCSRWMUEEM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.239	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503537	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503537&database=RX&origin=ReaxysOutput&ln=	CNC1CC(C1)OC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[3-(methylamino)cyclobutoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CC4(COC4)C3)C=CN12		35503541	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503541&database=RX&origin=ReaxysOutput&ln=	(632 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-oxaspiro[3.3]heptan-6-yloxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H25F2N3O5	C25H25F2N3O5	485.487			ODFWQKZDNJTDOW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.392	1	5	9	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503541	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503541&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CC4(COC4)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-oxaspiro[3.3]heptan-6-yloxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCOC3)C=CN12		35503543	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503543&database=RX&origin=ReaxysOutput&ln=	(633 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-tetrahydrofuran-3-yloxyimidazo[1,2-a]pyridin-3-yl)benzamide	C23H23F2N3O5	C23H23F2N3O5	459.45			UYPNQALWVXBDLK-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.04	1	5	9	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503543	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503543&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCOC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-tetrahydrofuran-3-yloxyimidazo[1,2-a]pyridin-3-yl)benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CC(C3)C#N)C=CN12		35503545	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503545&database=RX&origin=ReaxysOutput&ln=	(634 of 1381)		4-[7-(3-cyanocyclobutoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H22F2N4O4	C24H22F2N4O4	468.46			HVLOZSMWAORQSM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.109	1	5	9	97.88	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503545	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503545&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CC(C3)C#N)C=CN12	4-[7-(3-cyanocyclobutoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503547	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503547&database=RX&origin=ReaxysOutput&ln=	(635 of 1381)		2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H23F5N4O4	C22H23F5N4O4	502.441			LCVJIYLNHXSLKS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.78	1	5	12	77.33	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503547	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503547&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN(C)C)C=CN12	2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503547	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503547&database=RX&origin=ReaxysOutput&ln=	(635 of 1381)		2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H23F5N4O4	C22H23F5N4O4	502.441			LCVJIYLNHXSLKS-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.78	1	5	12	77.33	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503547	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503547&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN(C)C)C=CN12	2-(difluoromethoxy)-4-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503549	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503549&database=RX&origin=ReaxysOutput&ln=	(636 of 1381)		6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-(methylamino)-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H26F3N5O2	C23H26F3N5O2	461.487			KDPLLSYINYDRJA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.87	1	6	8	62.11	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503549	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503549&database=RX&origin=ReaxysOutput&ln=	CNC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12	6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-(methylamino)-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503549	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503549&database=RX&origin=ReaxysOutput&ln=	(636 of 1381)		6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-(methylamino)-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C23H26F3N5O2	C23H26F3N5O2	461.487			KDPLLSYINYDRJA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.87	1	6	8	62.11	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503549	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503549&database=RX&origin=ReaxysOutput&ln=	CNC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12	6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-(methylamino)-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	5000			Tumor necrosis factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(N)CCCCC3)C=CN12		35503553	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503553&database=RX&origin=ReaxysOutput&ln=	(637 of 1381)		4-[7-[(1-aminocyclohexyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			WFYQYCYIQLTSSM-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.091	2	5	10	100.11	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503553	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503553&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(N)CCCCC3)C=CN12	4-[7-[(1-aminocyclohexyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(N)COC3)C=CN12		35503555	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503555&database=RX&origin=ReaxysOutput&ln=	(638 of 1381)		4-[7-[(3-aminooxetan-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C23H24F2N4O5	C23H24F2N4O5	474.464			BRPCQDXFHLMCQF-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	2.9	2	6	10	109.34	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503555	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503555&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(N)COC3)C=CN12	4-[7-[(3-aminooxetan-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(N)CC3)C=CN12		35503557	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503557&database=RX&origin=ReaxysOutput&ln=	(639 of 1381)		4-[7-[(1-aminocyclopropyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C23H24F2N4O4	C23H24F2N4O4	458.465			KCGLYKHZNANLSP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.806	2	5	10	100.11	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503557	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503557&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(N)CC3)C=CN12	4-[7-[(1-aminocyclopropyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CCCCN3)C=CN12		35503558	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503558&database=RX&origin=ReaxysOutput&ln=	(640 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			FHYRGRCSNLQNBW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.977	2	5	10	86.12	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503558	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503558&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CCCCN3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CCCCN3)C=CN12		35503558	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503558&database=RX&origin=ReaxysOutput&ln=	(640 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			FHYRGRCSNLQNBW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.977	2	5	10	86.12	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503558	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503558&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CCCCN3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methyl-2-piperidyl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(N)CCC3)C=CN12		35503562	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503562&database=RX&origin=ReaxysOutput&ln=	(641 of 1381)		4-[7-[(1-aminocyclobutyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			IEZZRXLRJVVPMO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.164	2	5	10	100.11	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503562	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503562&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(N)CCC3)C=CN12	4-[7-[(1-aminocyclobutyl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CN3C(C)C)C=CN12		35503564	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503564&database=RX&origin=ReaxysOutput&ln=	(642 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropylimidazol-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H27F2N5O4	C26H27F2N5O4	511.528			VDKVGJLNASRIRZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.892	1	6	11	91.91	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503564	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503564&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC=CN3C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1-isopropylimidazol-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(N)CCOC3)C=CN12		35503566	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503566&database=RX&origin=ReaxysOutput&ln=	(643 of 1381)		4-[7-[(3-aminotetrahydrofuran-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H26F2N4O5	C24H26F2N4O5	488.491			OXVXVWFXDQRHQN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.258	2	6	10	109.34	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503566	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503566&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(N)CCOC3)C=CN12	4-[7-[(3-aminotetrahydrofuran-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3C#N)C=CN12		35503567	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503567&database=RX&origin=ReaxysOutput&ln=	(644 of 1381)		4-[7-[2-(3-cyanomorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C26H27F2N5O5	C26H27F2N5O5	527.528			QLLFSZOXFXVHRN-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.094	1	7	11	110.35	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503567	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503567&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3C#N)C=CN12	4-[7-[2-(3-cyanomorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC(C3)C(F)(F)F)C=CN12		35503569	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503569&database=RX&origin=ReaxysOutput&ln=	(645 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(trifluoromethyl)morpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H27F5N4O5	C26H27F5N4O5	570.516			IESJFJPQCZVODG-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	4.96	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503569	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503569&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC(C3)C(F)(F)F)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[2-(trifluoromethyl)morpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CNCCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(=O)N(CC(F)(F)F)CC2)C(OC)=C1		35503573	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503573&database=RX&origin=ReaxysOutput&ln=	(646 of 1381)		8-methoxy-6-[7-[2-(methylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C22H23F3N4O3	C22H23F3N4O3	448.445			QDXMPDJLUMBSTP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.9	1	5	8	68.1	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503573	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503573&database=RX&origin=ReaxysOutput&ln=	CNCCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(=O)N(CC(F)(F)F)CC2)C(OC)=C1	8-methoxy-6-[7-[2-(methylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CC(F)(F)C3)C=CN12		35503575	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503575&database=RX&origin=ReaxysOutput&ln=	(647 of 1381)		N-cyclopropyl-4-[7-[2-(3,3-difluoroazetidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C24H24F4N4O4	C24H24F4N4O4	508.473			URUIISMABUTFGX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.569	1	5	11	77.33	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503575	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503575&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CC(F)(F)C3)C=CN12	N-cyclopropyl-4-[7-[2-(3,3-difluoroazetidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3CN(C)CCO3)C=CN12		35503577	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503577&database=RX&origin=ReaxysOutput&ln=	(648 of 1381)		8-methoxy-6-[7-[[(2R)-4-methylmorpholin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O4	C25H27F3N4O4	504.509			AXTRCSQJFSRMDX-LJQANCHMSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.776	0	6	7	68.54	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503577	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503577&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3CN(C)CCO3)C=CN12	8-methoxy-6-[7-[[(2R)-4-methylmorpholin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3CN(C)CCO3)C=CN12		35503577	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503577&database=RX&origin=ReaxysOutput&ln=	(648 of 1381)		8-methoxy-6-[7-[[(2R)-4-methylmorpholin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O4	C25H27F3N4O4	504.509			AXTRCSQJFSRMDX-LJQANCHMSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.776	0	6	7	68.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503577	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503577&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3CN(C)CCO3)C=CN12	8-methoxy-6-[7-[[(2R)-4-methylmorpholin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@@H]3CN(C)CCO3)C=CN12		35503579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503579&database=RX&origin=ReaxysOutput&ln=	(649 of 1381)		8-methoxy-6-[7-[[(2S)-4-methylmorpholin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O4	C25H27F3N4O4	504.509			AXTRCSQJFSRMDX-IBGZPJMESA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.776	0	6	7	68.54	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503579&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@@H]3CN(C)CCO3)C=CN12	8-methoxy-6-[7-[[(2S)-4-methylmorpholin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@@H]3CN(C)CCO3)C=CN12		35503579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503579&database=RX&origin=ReaxysOutput&ln=	(649 of 1381)		8-methoxy-6-[7-[[(2S)-4-methylmorpholin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O4	C25H27F3N4O4	504.509			AXTRCSQJFSRMDX-IBGZPJMESA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.776	0	6	7	68.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503579	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503579&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@@H]3CN(C)CCO3)C=CN12	8-methoxy-6-[7-[[(2S)-4-methylmorpholin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3(C)C)C=CN12		35503583	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503583&database=RX&origin=ReaxysOutput&ln=	(650 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(3,3-dimethylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			ZTENAZNNTGHRGI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.375	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503583	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503583&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(3,3-dimethylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3C4CCC3COC4)C=CN12		35503585	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503585&database=RX&origin=ReaxysOutput&ln=	(651 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			WPVJOJYABCNJNR-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	4.078	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503585	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503585&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3C4CCC3COC4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3C4CCC3COC4)C=CN12		35503585	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503585&database=RX&origin=ReaxysOutput&ln=	(651 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			WPVJOJYABCNJNR-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	4.078	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503585	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503585&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3C4CCC3COC4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3C4CCC3COC4)C=CN12		35503585	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503585&database=RX&origin=ReaxysOutput&ln=	(651 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			WPVJOJYABCNJNR-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	4.078	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503585	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503585&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3C4CCC3COC4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC(C)(C)C3)C=CN12		35503586	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503586&database=RX&origin=ReaxysOutput&ln=	(652 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(2,2-dimethylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O5	C27H32F2N4O5	530.572			FJXOKWWJFAGTAV-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.375	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503586	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503586&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC(C)(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(2,2-dimethylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CC4CCC(C3)O4)C=CN12		35503587	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503587&database=RX&origin=ReaxysOutput&ln=	(653 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O5	C27H30F2N4O5	528.556			ZCRHAOYORQRLQP-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.078	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503587	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503587&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CC4CCC(C3)O4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC(C3)C3CC3)C=CN12		35503589	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503589&database=RX&origin=ReaxysOutput&ln=	(654 of 1381)		N-cyclopropyl-4-[7-[2-(2-cyclopropylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C28H32F2N4O5	C28H32F2N4O5	542.583			LWITUPZBGVCPSQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.273	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503589	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503589&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC(C3)C3CC3)C=CN12	N-cyclopropyl-4-[7-[2-(2-cyclopropylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC(C)=NN3C)C=CN12		35503591	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503591&database=RX&origin=ReaxysOutput&ln=	(655 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(2,5-dimethylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H25F2N5O4	C25H25F2N5O4	497.501			YFOUTWZJVPXDON-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.521	1	6	10	91.91	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503591	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503591&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC(C)=NN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(2,5-dimethylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN(C)N=C3)C=CN12		35503593	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503593&database=RX&origin=ReaxysOutput&ln=	(656 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylpyrazol-4-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H23F2N5O4	C24H23F2N5O4	483.475			BBGNCXZTNFMYIW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.285	1	6	10	91.91	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503593	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503593&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CN(C)N=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylpyrazol-4-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NN(C)C=C3)C=CN12		35503595	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503595&database=RX&origin=ReaxysOutput&ln=	(657 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H23F2N5O4	C24H23F2N5O4	483.475			XAMCMDPSRMHXNT-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.285	1	6	10	91.91	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503595	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503595&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NN(C)C=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylpyrazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3COCCN3C)C=CN12		35503597	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503597&database=RX&origin=ReaxysOutput&ln=	(658 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(4-methylmorpholin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O5	C25H28F2N4O5	502.518			QLTUSVNZNIDNLA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.535	1	6	10	86.56	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503597	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503597&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3COCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(4-methylmorpholin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)N(C)C)C=CN12		35503598	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503598&database=RX&origin=ReaxysOutput&ln=	(659 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C24H28F2N4O4	C24H28F2N4O4	474.508			RCUJANWBEPKQLZ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.358	1	5	11	77.33	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503598	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503598&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(C)N(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCC(COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1)N(C)C		35503599	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503599&database=RX&origin=ReaxysOutput&ln=	(660 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)butoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H30F2N4O4	C25H30F2N4O4	488.534			ARKVSJMCCKLFGA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.716	1	5	12	77.33	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503599	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503599&database=RX&origin=ReaxysOutput&ln=	CCC(COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1)N(C)C	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)butoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3=CN(C)N=C3)C=CN12		35503601	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503601&database=RX&origin=ReaxysOutput&ln=	(661 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-methylpyrazol-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H25F2N5O4	C25H25F2N5O4	497.501			AWTADBPRXWWFNJ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.443	1	6	11	91.91	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503601	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503601&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3=CN(C)N=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-methylpyrazol-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NN=C(O3)C3CC3)C=CN12		35503603	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503603&database=RX&origin=ReaxysOutput&ln=	(662 of 1381)		N-cyclopropyl-4-[7-[(5-cyclopropyl-1,3,4-oxadiazol-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C25H23F2N5O5	C25H23F2N5O5	511.485			XNAJPRLDQVOHPY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.124	1	6	11	113.01	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503603	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503603&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NN=C(O3)C3CC3)C=CN12	N-cyclopropyl-4-[7-[(5-cyclopropyl-1,3,4-oxadiazol-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
[H][C@]12CN(CCOC3=CC4=NC=C(N4C=C3)C3=CC(OC(F)F)=C(C(=O)NC4CC4)C(OC)=C3)[C@]([H])(CO1)C2		35503605	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503605&database=RX&origin=ReaxysOutput&ln=	(663 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H28F2N4O5	C26H28F2N4O5	514.529			ZEAULWBRMKZQLJ-HKUYNNGSSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.72	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503605	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503605&database=RX&origin=ReaxysOutput&ln=	[H][C@]12CN(CCOC3=CC4=NC=C(N4C=C3)C3=CC(OC(F)F)=C(C(=O)NC4CC4)C(OC)=C3)[C@]([H])(CO1)C2	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
[H][C@]12CN(CCOC3=CC4=NC=C(N4C=C3)C3=CC(OC(F)F)=C(C(=O)NC4CC4)C(OC)=C3)[C@]([H])(CO1)C2		35503605	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503605&database=RX&origin=ReaxysOutput&ln=	(663 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H28F2N4O5	C26H28F2N4O5	514.529			ZEAULWBRMKZQLJ-HKUYNNGSSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.72	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503605	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503605&database=RX&origin=ReaxysOutput&ln=	[H][C@]12CN(CCOC3=CC4=NC=C(N4C=C3)C3=CC(OC(F)F)=C(C(=O)NC4CC4)C(OC)=C3)[C@]([H])(CO1)C2	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(F)CNC3)C=CN12		35503622	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503622&database=RX&origin=ReaxysOutput&ln=	(664 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(3-fluoroazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H23F3N4O4	C23H23F3N4O4	476.455			WWCQCGYAYUCSRW-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	4	6	3.923	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503622	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503622&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(F)CNC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(3-fluoroazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CNC3)C=CN12		35503624	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503624&database=RX&origin=ReaxysOutput&ln=	(665 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(3-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			KCPVULDKDGYKCO-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	2	6	4.076	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503624	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503624&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CNC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(3-methylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)NC=C2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503626	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503626&database=RX&origin=ReaxysOutput&ln=	(666 of 1381)		8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-2H-isoquinolin-1-one	C23H24N4O4	C23H24N4O4	420.468			HFCJMZZTVPRCAR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	2.454	1	6	6	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503626	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503626&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)NC=C2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-2H-isoquinolin-1-one					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCC(F)(F)C3)C=CN12		35503628	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503628&database=RX&origin=ReaxysOutput&ln=	(667 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(3,3-difluoro-1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H28F4N4O4	C26H28F4N4O4	536.526			NIDRIZZTYHDSNQ-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.285	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503628	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503628&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCC(F)(F)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(3,3-difluoro-1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCC(F)C3)C=CN12		35503632	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503632&database=RX&origin=ReaxysOutput&ln=	(668 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(3-fluoro-1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H29F3N4O4	C26H29F3N4O4	518.536			AFSIGNPEALAMCX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.906	1	5	11	77.33	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503632	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503632&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCC(F)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(3-fluoro-1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC(C3)C#N)C=CN12		35503634	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503634&database=RX&origin=ReaxysOutput&ln=	(669 of 1381)		4-[7-[2-(2-cyanomorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C26H27F2N5O5	C26H27F2N5O5	527.528			SJQXJLCOCNKOEY-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.094	1	7	11	110.35	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503634	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503634&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC(C3)C#N)C=CN12	4-[7-[2-(2-cyanomorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC(C)C3)C=CN12		35503636	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503636&database=RX&origin=ReaxysOutput&ln=	(670 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(2-methylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			OCZKZJOLCXXNTD-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.958	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503636	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503636&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(2-methylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)CC#N)C=CN12		35503638	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503638&database=RX&origin=ReaxysOutput&ln=	(671 of 1381)		4-[7-[2-[cyanomethyl(methyl)a mino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C24H25F2N5O4	C24H25F2N5O4	485.49			LKRHNZUEOHZEON-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.391	1	6	12	101.12	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503638	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503638&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)CC#N)C=CN12	4-[7-[2-[cyanomethyl(methyl)a mino]ethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCC(C3)C#N)C=CN12		35503639	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503639&database=RX&origin=ReaxysOutput&ln=	(672 of 1381)		4-[7-[2-(3-cyano-1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C27H29F2N5O4	C27H29F2N5O4	525.555			GYMPRZNIMGOMDU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.925	1	6	11	101.12	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503639	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503639&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCC(C3)C#N)C=CN12	4-[7-[2-(3-cyano-1-piperidyl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503641	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503641&database=RX&origin=ReaxysOutput&ln=	(673 of 1381)		2-(2,2-difluoroethyl)-8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one	C25H28F2N4O4	C25H28F2N4O4	486.519			ULHJTVBMPBQESZ-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.223	0	6	8	68.54	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503641	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503641&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	2-(2,2-difluoroethyl)-8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503641	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503641&database=RX&origin=ReaxysOutput&ln=	(673 of 1381)		2-(2,2-difluoroethyl)-8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one	C25H28F2N4O4	C25H28F2N4O4	486.519			ULHJTVBMPBQESZ-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.223	0	6	8	68.54	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503641	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503641&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	2-(2,2-difluoroethyl)-8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503641	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503641&database=RX&origin=ReaxysOutput&ln=	(673 of 1381)		2-(2,2-difluoroethyl)-8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one	C25H28F2N4O4	C25H28F2N4O4	486.519			ULHJTVBMPBQESZ-UHFFFAOYSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.223	0	6	8	68.54	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503641	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503641&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	2-(2,2-difluoroethyl)-8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503643	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503643&database=RX&origin=ReaxysOutput&ln=	(674 of 1381)		2-(2,2-difluoroethyl)-6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydroisoquinolin-1-one	C24H25F2N3O5	C24H25F2N3O5	473.476			WSHSWCFHCDYFIE-GOSISDBHSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.217	0	6	7	74.53	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503643	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503643&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	2-(2,2-difluoroethyl)-6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503643	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503643&database=RX&origin=ReaxysOutput&ln=	(674 of 1381)		2-(2,2-difluoroethyl)-6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydroisoquinolin-1-one	C24H25F2N3O5	C24H25F2N3O5	473.476			WSHSWCFHCDYFIE-GOSISDBHSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.217	0	6	7	74.53	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503643	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503643&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	2-(2,2-difluoroethyl)-6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydroisoquinolin-1-one					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12		35503643	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503643&database=RX&origin=ReaxysOutput&ln=	(674 of 1381)		2-(2,2-difluoroethyl)-6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydroisoquinolin-1-one	C24H25F2N3O5	C24H25F2N3O5	473.476			WSHSWCFHCDYFIE-GOSISDBHSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.217	0	6	7	74.53	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503643	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503643&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)F)CC2)C1=CN=C2C=C(OC[C@H]3COCCO3)C=CN12	2-(2,2-difluoroethyl)-6-[7-[[(2R)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CN(C)C3)C=CN12		35503645	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503645&database=RX&origin=ReaxysOutput&ln=	(675 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1,3-dimethylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			VRFZOPHYGQCHLX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.315	1	5	10	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503645	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503645&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CN(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1,3-dimethylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CN(C)C3)C=CN12		35503645	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503645&database=RX&origin=ReaxysOutput&ln=	(675 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1,3-dimethylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			VRFZOPHYGQCHLX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.315	1	5	10	77.33	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503645	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503645&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CN(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1,3-dimethylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CN(C)C3)C=CN12		35503645	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503645&database=RX&origin=ReaxysOutput&ln=	(675 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1,3-dimethylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			VRFZOPHYGQCHLX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.315	1	5	10	77.33	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503645	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503645&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CN(C)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[(1,3-dimethylazetidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C(=O)NC2CC2)C(C)=CC(=C1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503647	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503647&database=RX&origin=ReaxysOutput&ln=	(676 of 1381)		N-cyclopropyl-2-methoxy-6-methyl-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H30N4O4	C25H30N4O4	450.538			YAXZVWFPSSSFIU-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.306	1	6	9	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503647	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503647&database=RX&origin=ReaxysOutput&ln=	COC1=C(C(=O)NC2CC2)C(C)=CC(=C1)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	N-cyclopropyl-2-methoxy-6-methyl-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=CC=NC=C3)C=CN12		35503649	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503649&database=RX&origin=ReaxysOutput&ln=	(677 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[methyl(4-pyridyl)amino]ethoxy]i midazo[1,2-a]pyridin-3-yl]benzamide	C27H27F2N5O4	C27H27F2N5O4	523.539			FQWCKYKZIHJVPR-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.814	1	6	12	90.22	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503649	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503649&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=CC=NC=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[methyl(4-pyridyl)amino]ethoxy]i midazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@@H]3COCCO3)C=CN12		35503650	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503650&database=RX&origin=ReaxysOutput&ln=	(678 of 1381)		6-[7-[[(2S)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H24F3N3O5	C24H24F3N3O5	491.467			YIBBAANYMONKKT-SFHVURJKSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.733	0	6	7	74.53	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503650	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503650&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@@H]3COCCO3)C=CN12	6-[7-[[(2S)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@@H]3COCCO3)C=CN12		35503650	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503650&database=RX&origin=ReaxysOutput&ln=	(678 of 1381)		6-[7-[[(2S)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H24F3N3O5	C24H24F3N3O5	491.467			YIBBAANYMONKKT-SFHVURJKSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.733	0	6	7	74.53	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503650	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503650&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@@H]3COCCO3)C=CN12	6-[7-[[(2S)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@@H]3COCCO3)C=CN12		35503650	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503650&database=RX&origin=ReaxysOutput&ln=	(678 of 1381)		6-[7-[[(2S)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H24F3N3O5	C24H24F3N3O5	491.467			YIBBAANYMONKKT-SFHVURJKSA-N				Identification(13); Spectra(2); Bioactivity(2)	1	6	3.733	0	6	7	74.53	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503650	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503650&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@@H]3COCCO3)C=CN12	6-[7-[[(2S)-1,4-dioxan-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NN=CN3C)C=CN12		35503653	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503653&database=RX&origin=ReaxysOutput&ln=	(679 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(4-methyl-1,2,4-triazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C23H22F2N6O4	C23H22F2N6O4	484.462			IKUFJTXFZWVGSX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.096	1	7	10	104.8	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503653	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503653&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NN=CN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(4-methyl-1,2,4-triazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NN=CN3C)C=CN12		35503653	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503653&database=RX&origin=ReaxysOutput&ln=	(679 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(4-methyl-1,2,4-triazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C23H22F2N6O4	C23H22F2N6O4	484.462			IKUFJTXFZWVGSX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.096	1	7	10	104.8	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503653	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503653&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NN=CN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(4-methyl-1,2,4-triazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	5000			Tumor necrosis factor				5.3			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NN=CN3C)C=CN12		35503653	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503653&database=RX&origin=ReaxysOutput&ln=	(679 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(4-methyl-1,2,4-triazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C23H22F2N6O4	C23H22F2N6O4	484.462			IKUFJTXFZWVGSX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	5.096	1	7	10	104.8	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503653	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503653&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NN=CN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(4-methyl-1,2,4-triazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC(C)=NO3)C=CN12		35503657	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503657&database=RX&origin=ReaxysOutput&ln=	(680 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C23H21F2N5O5	C23H21F2N5O5	485.447			LQAXAOLRCMZNAA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.18	1	5	10	113.01	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503657	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503657&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NC(C)=NO3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(3-methyl-1,2,4-oxadiazol-5-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503659	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503659&database=RX&origin=ReaxysOutput&ln=	(681 of 1381)		2-(difluoromethoxy)-6-methoxy-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H25F5N4O5	C24H25F5N4O5	544.478			VVZPKEQSSBGSAA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.38	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503659	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503659&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	2-(difluoromethoxy)-6-methoxy-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503659	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503659&database=RX&origin=ReaxysOutput&ln=	(681 of 1381)		2-(difluoromethoxy)-6-methoxy-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H25F5N4O5	C24H25F5N4O5	544.478			VVZPKEQSSBGSAA-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.38	1	6	12	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503659	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503659&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	2-(difluoromethoxy)-6-methoxy-4-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NOC(C)=N3)C=CN12		35503661	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503661&database=RX&origin=ReaxysOutput&ln=	(682 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C23H21F2N5O5	C23H21F2N5O5	485.447			WCPOITYDCIUHHI-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	4.18	1	5	10	113.01	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503661	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503661&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=NOC(C)=N3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3C)C=CN12		35503663	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503663&database=RX&origin=ReaxysOutput&ln=	(683 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(3-methylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			SXSMHRFWIOFPIX-UHFFFAOYSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.958	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503663	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503663&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOCC3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(3-methylmorpholin-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12		35503664	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503664&database=RX&origin=ReaxysOutput&ln=	(684 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			SXSMHRFWIOFPIX-INIZCTEOSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.958	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503664	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503664&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12		35503664	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503664&database=RX&origin=ReaxysOutput&ln=	(684 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			SXSMHRFWIOFPIX-INIZCTEOSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.958	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503664	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503664&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12		35503664	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503664&database=RX&origin=ReaxysOutput&ln=	(684 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			SXSMHRFWIOFPIX-INIZCTEOSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.958	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503664	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503664&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@@H]3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3S)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12		35503666	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503666&database=RX&origin=ReaxysOutput&ln=	(685 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			SXSMHRFWIOFPIX-MRXNPFEDSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.958	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503666	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503666&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12		35503666	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503666&database=RX&origin=ReaxysOutput&ln=	(685 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			SXSMHRFWIOFPIX-MRXNPFEDSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.958	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503666	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503666&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12		35503666	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503666&database=RX&origin=ReaxysOutput&ln=	(685 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			SXSMHRFWIOFPIX-MRXNPFEDSA-N				Identification(13); Spectra(1); Bioactivity(2)	1	6	3.958	1	6	11	86.56	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503666	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503666&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCOC[C@H]3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[(3R)-3-methylmorpholin-4-yl]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CN=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081266&database=RX&origin=ReaxysOutput&ln=	(686 of 1381)		N((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(3-methylpyridin-2-yl)thiazole-5-carboxamide; 2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(3-methylpyridin-2-yl)-1,3-thiazole-5-carboxamide	C21H26N8O2S	C21H26N8O2S	454.556			HYMHVNNHIASECU-UHFFFAOYSA-N				Identification(11); Physical Data(2); Spectra(4); Bioactivity(4)	1	6	0.845	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081266&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CN=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1	N((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(3-methylpyridin-2-yl)thiazole-5-carboxamide					IC50	nM		1100							5.96			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CN=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081266&database=RX&origin=ReaxysOutput&ln=	(686 of 1381)		N((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(3-methylpyridin-2-yl)thiazole-5-carboxamide; 2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(3-methylpyridin-2-yl)-1,3-thiazole-5-carboxamide	C21H26N8O2S	C21H26N8O2S	454.556			HYMHVNNHIASECU-UHFFFAOYSA-N				Identification(11); Physical Data(2); Spectra(4); Bioactivity(4)	1	6	0.845	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081266&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CN=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1	2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(3-methylpyridin-2-yl)-1,3-thiazole-5-carboxamide					IC50	nM		1100							5.96			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CN=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		36081266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081266&database=RX&origin=ReaxysOutput&ln=	(686 of 1381)		N((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(3-methylpyridin-2-yl)thiazole-5-carboxamide; 2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(3-methylpyridin-2-yl)-1,3-thiazole-5-carboxamide	C21H26N8O2S	C21H26N8O2S	454.556			HYMHVNNHIASECU-UHFFFAOYSA-N				Identification(11); Physical Data(2); Spectra(4); Bioactivity(4)	1	6	0.845	3	10	8	147.64	4	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									36081266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081266&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CN=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1						IC50	nM		1100							5.96			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2CN3CCC2CC3)=N1)N1CCN(CCO)CC1		38898233	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898233&database=RX&origin=ReaxysOutput&ln=	(687 of 1381)		2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(quinuclidine-3-yl)thiazole-5-carboxamide	C22H32N8O2S	C22H32N8O2S	472.614			MPIBCTUFGUTVSG-UHFFFAOYSA-N				Identification(11); Bioactivity(2)		6	-0.005	3	10	8	83.98	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38898233	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898233&database=RX&origin=ReaxysOutput&ln=	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2CN3CCC2CC3)=N1)N1CCN(CCO)CC1						IC50	nM		8850							5.05			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(NC=C2C2=CN=C(O2)C2=CC=C(Br)N2)=CC(Br)=C1		23173001	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D23173001&database=RX&origin=ReaxysOutput&ln=	(688 of 1381)		breitfussin B	C16H11Br2N3O2	C16H11Br2N3O2	437.09			KKRMILJOOIDRQT-UHFFFAOYSA-N				Identification(6); Physical Data(3); Spectra(16); Bioactivity(2)	42	5	4.16	2	3	3	66.84	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									23173001	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D23173001&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(NC=C2C2=CN=C(O2)C2=CC=C(Br)N2)=CC(Br)=C1	breitfussin B					IC50	μM	>	50							1			73010	ATP	Other compound	Article; Hansen, Kine Ø.; Andersen, Jeanette H.; Bayer, Annette; Pandey, Sunil K.; Lorentzen, Marianne; Jørgensen, Kåre B.; Sydnes, Magne O.; Guttormsen, Yngve; Baumann, Matthias; Koch, Uwe; Klebl, Bert; Eickhoff, Jan; Haug, Bengt Erik; Isaksson, Johan; Hansen, Espen H.; Journal of Medicinal Chemistry; vol. 62; 22; (2019); p. 10167 - 10181;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78442548&database=RX&origin=ReaxysOutput&ln=	
CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C(=O)NC2=C(C)C=CC=C2C)C2=CC=C(OC)C=C2OC)C=C1		29296637	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29296637&database=RX&origin=ReaxysOutput&ln=	(689 of 1381)		1-(2,4-dimethoxyphenyl)-3-(2,6-dimethylphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)urea; HG-10-11-01	C33H39N7O3	C33H39N7O3	581.718			SFGRWGIXZWOTPI-UHFFFAOYSA-N				Identification(11); Physical Data(2); Spectra(2); Bioactivity(2)	3	5	5.242	2	8	11	95.09	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29296637	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29296637&database=RX&origin=ReaxysOutput&ln=	CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N(C(=O)NC2=C(C)C=CC=C2C)C2=CC=C(OC)C=C2OC)C=C1	1-(2,4-dimethoxyphenyl)-3-(2,6-dimethylphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)urea					IC50	nM		17.4							7.76						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=CN=NC=C3)C=CN12		35503059	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503059&database=RX&origin=ReaxysOutput&ln=	(690 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[methyl(pyridazin-4-yl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H26F2N6O4	C26H26F2N6O4	524.527			CYCRGJUPTQDBGN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.984	1	7	12	103.11	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503059	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503059&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN(C)C3=CN=NC=C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-[methyl(pyridazin-4-yl)amino]ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C3)C(=O)OC(C)(C)C)C=CN12		35503065	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503065&database=RX&origin=ReaxysOutput&ln=	(691 of 1381)		tert-butyl 3-fluoro-3-[[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]azetidine-1-carboxylate	C28H30F4N4O5	C28H30F4N4O5	578.564			ZONYDCMXMZXJHT-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.663	0	7	10	85.61	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503065	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503065&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C3)C(=O)OC(C)(C)C)C=CN12	tert-butyl 3-fluoro-3-[[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]azetidine-1-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C3)C(=O)OC(C)(C)C)C=CN12		35503065	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503065&database=RX&origin=ReaxysOutput&ln=	(691 of 1381)		tert-butyl 3-fluoro-3-[[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]azetidine-1-carboxylate	C28H30F4N4O5	C28H30F4N4O5	578.564			ZONYDCMXMZXJHT-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.663	0	7	10	85.61	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503065	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503065&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C3)C(=O)OC(C)(C)C)C=CN12	tert-butyl 3-fluoro-3-[[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]azetidine-1-carboxylate					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C3)C(=O)OC(C)(C)C)C=CN12		35503065	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503065&database=RX&origin=ReaxysOutput&ln=	(691 of 1381)		tert-butyl 3-fluoro-3-[[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]azetidine-1-carboxylate	C28H30F4N4O5	C28H30F4N4O5	578.564			ZONYDCMXMZXJHT-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.663	0	7	10	85.61	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503065	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503065&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(F)CN(C3)C(=O)OC(C)(C)C)C=CN12	tert-butyl 3-fluoro-3-[[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]azetidine-1-carboxylate					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(C)CN(C3)C(=O)OC(C)(C)C)C=CN12		35503066	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503066&database=RX&origin=ReaxysOutput&ln=	(692 of 1381)		tert-butyl 3-[[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]-3-methyl-azetidine-1-carboxylate	C29H33F3N4O5	C29H33F3N4O5	574.6			QHZJZKXHVWIDHG-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	3	5	5.816	0	7	10	85.61	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503066	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503066&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCC3(C)CN(C3)C(=O)OC(C)(C)C)C=CN12	tert-butyl 3-[[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]-3-methyl-azetidine-1-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2CC(=O)OCC		35503076	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503076&database=RX&origin=ReaxysOutput&ln=	(693 of 1381)		ethyl 2-[(1R,5S)-3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-8-azabicyclo[3.2.1]octan-8-yl]acetate	C30H34F2N4O6	C30H34F2N4O6	584.62			QOGRNUCLRACYSI-RLAPIPATSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.147	1	7	13	103.63	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503076	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503076&database=RX&origin=ReaxysOutput&ln=	[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2CC(=O)OCC	ethyl 2-[(1R,5S)-3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-8-azabicyclo[3.2.1]octan-8-yl]acetate					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2CC(=O)OCC		35503076	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503076&database=RX&origin=ReaxysOutput&ln=	(693 of 1381)		ethyl 2-[(1R,5S)-3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-8-azabicyclo[3.2.1]octan-8-yl]acetate	C30H34F2N4O6	C30H34F2N4O6	584.62			QOGRNUCLRACYSI-RLAPIPATSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.147	1	7	13	103.63	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503076	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503076&database=RX&origin=ReaxysOutput&ln=	[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2CC(=O)OCC	ethyl 2-[(1R,5S)-3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-8-azabicyclo[3.2.1]octan-8-yl]acetate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC3)C=CN12		35503079	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503079&database=RX&origin=ReaxysOutput&ln=	(694 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-pyrrolidin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			FWYCNMPMDKPSID-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.762	1	5	12	77.33	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503079	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503079&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-pyrrolidin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC3)C=CN12		35503079	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503079&database=RX&origin=ReaxysOutput&ln=	(694 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-pyrrolidin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			FWYCNMPMDKPSID-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.762	1	5	12	77.33	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503079	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503079&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-pyrrolidin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC3)C=CN12		35503079	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503079&database=RX&origin=ReaxysOutput&ln=	(694 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-pyrrolidin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			FWYCNMPMDKPSID-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.762	1	5	12	77.33	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503079	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503079&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-pyrrolidin-1-ylpropoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4=NC=NC=C4C3)C=CN12		35503104	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503104&database=RX&origin=ReaxysOutput&ln=	(695 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C29H30F2N6O4	C29H30F2N6O4	564.592			JUXDKZDSCXJTDB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.608	1	7	12	103.11	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503104	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503104&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCC4=NC=NC=C4C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCN(C3)C(C)C)C=CN12		35503128	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503128&database=RX&origin=ReaxysOutput&ln=	(696 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-isopropylpyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			VGWIJCXZIXJXNU-QGZVFWFLSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.161	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503128	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503128&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-isopropylpyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCN(C3)C(C)C)C=CN12		35503128	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503128&database=RX&origin=ReaxysOutput&ln=	(696 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-isopropylpyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			VGWIJCXZIXJXNU-QGZVFWFLSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.161	1	5	11	77.33	2	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503128	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503128&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCN(C3)C(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R)-1-isopropylpyrrolidin-3-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCS(=O)(=O)CC3)C=CN12		35503152	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503152&database=RX&origin=ReaxysOutput&ln=	(697 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1,4-thiazinan-4-yl)-2-hydroxypropoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O7S	C26H30F2N4O7S	580.61			POBBXWWDDOIDGL-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	2.766	2	8	12	140.08	3	0	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503152	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503152&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCS(=O)(=O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1,4-thiazinan-4-yl)-2-hydroxypropoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCS(=O)(=O)CC3)C=CN12		35503152	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503152&database=RX&origin=ReaxysOutput&ln=	(697 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1,4-thiazinan-4-yl)-2-hydroxypropoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O7S	C26H30F2N4O7S	580.61			POBBXWWDDOIDGL-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	2.766	2	8	12	140.08	3	0	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503152	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503152&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CCS(=O)(=O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1,4-thiazinan-4-yl)-2-hydroxypropoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(O)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503161	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503161&database=RX&origin=ReaxysOutput&ln=	(698 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-hydroxypiperidine-4-carboxylate	C30H36F2N4O7	C30H36F2N4O7	602.635			BWDBOSSQBNNYNE-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	5	3.969	2	8	15	123.86	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503161	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503161&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(O)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-hydroxypiperidine-4-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(O)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503161	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503161&database=RX&origin=ReaxysOutput&ln=	(698 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-hydroxypiperidine-4-carboxylate	C30H36F2N4O7	C30H36F2N4O7	602.635			BWDBOSSQBNNYNE-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	5	3.969	2	8	15	123.86	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503161	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503161&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(O)CCN(CCCOC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxypropyl]-4-hydroxypiperidine-4-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CC(C3)C(=O)OC(C)(C)C)C=CN12		35503173	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503173&database=RX&origin=ReaxysOutput&ln=	(699 of 1381)		tert-butyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]azetidine-3-carboxylate	C30H36F2N4O7	C30H36F2N4O7	602.635			YPNMZVJVLHZODP-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	5	4.047	2	8	15	123.86	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503173	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503173&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CC(C3)C(=O)OC(C)(C)C)C=CN12	tert-butyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]azetidine-3-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CC(C3)C(=O)OC(C)(C)C)C=CN12		35503173	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503173&database=RX&origin=ReaxysOutput&ln=	(699 of 1381)		tert-butyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]azetidine-3-carboxylate	C30H36F2N4O7	C30H36F2N4O7	602.635			YPNMZVJVLHZODP-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	5	4.047	2	8	15	123.86	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503173	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503173&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(O)CN3CC(C3)C(=O)OC(C)(C)C)C=CN12	tert-butyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]azetidine-3-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCS(=O)(=O)CC3)C=CN12		35503256	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503256&database=RX&origin=ReaxysOutput&ln=	(700 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1,4-thiazinan-4-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6S	C26H30F2N4O6S	564.61			MSGXEICVDKNUEX-UHFFFAOYSA-N				Identification(12); Spectra(2); Bioactivity(2)	5	5	3.796	1	7	12	119.85	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503256	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503256&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCS(=O)(=O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1,4-thiazinan-4-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCS(=O)(=O)CC3)C=CN12		35503256	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503256&database=RX&origin=ReaxysOutput&ln=	(700 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1,4-thiazinan-4-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6S	C26H30F2N4O6S	564.61			MSGXEICVDKNUEX-UHFFFAOYSA-N				Identification(12); Spectra(2); Bioactivity(2)	5	5	3.796	1	7	12	119.85	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503256	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503256&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCS(=O)(=O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1,4-thiazinan-4-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCS(=O)(=O)CC3)C=CN12		35503256	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503256&database=RX&origin=ReaxysOutput&ln=	(700 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1,4-thiazinan-4-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6S	C26H30F2N4O6S	564.61			MSGXEICVDKNUEX-UHFFFAOYSA-N				Identification(12); Spectra(2); Bioactivity(2)	5	5	3.796	1	7	12	119.85	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503256	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503256&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCS(=O)(=O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1,4-thiazinan-4-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(F)CN(C3)C(=O)OC(C)(C)C)C=CN12		35503259	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503259&database=RX&origin=ReaxysOutput&ln=	(701 of 1381)		tert-butyl 3-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]-3-fluoroazetidine-1-carboxylate	C28H31F3N4O6	C28H31F3N4O6	576.573			VKCDEVPPOLKJLE-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	4	5	5.422	1	7	13	103.63	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503259	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503259&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(F)CN(C3)C(=O)OC(C)(C)C)C=CN12	tert-butyl 3-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]-3-fluoroazetidine-1-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC(=O)NCC(F)(F)COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		35503288	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503288&database=RX&origin=ReaxysOutput&ln=	(702 of 1381)		methyl N-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2,2-difluoropropyl]carbamate	C24H24F4N4O6	C24H24F4N4O6	540.471			ATDFLKHDWHLFNU-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.597	2	7	14	112.42	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503288	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503288&database=RX&origin=ReaxysOutput&ln=	COC(=O)NCC(F)(F)COC1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	methyl N-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2,2-difluoropropyl]carbamate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCOCC3)C=CN12		35503317	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503317&database=RX&origin=ReaxysOutput&ln=	(703 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-tetrahydropyran-4-yloxyimidazo[1,2-a]pyridin-3-yl)benzamide	C24H25F2N3O5	C24H25F2N3O5	473.476			NWWUVFSBMLKSGP-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.398	1	5	9	83.32	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503317	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503317&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-tetrahydropyran-4-yloxyimidazo[1,2-a]pyridin-3-yl)benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C)C=CN12		35503329	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503329&database=RX&origin=ReaxysOutput&ln=	(704 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-methylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			BKGITEOISLJRGU-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.799	1	5	11	77.33	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503329	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503329&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-methylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C)C=CN12		35503329	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503329&database=RX&origin=ReaxysOutput&ln=	(704 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-methylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			BKGITEOISLJRGU-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.799	1	5	11	77.33	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503329	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503329&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(1-methylpyrrolidin-2-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCC3)C=CN12		35503331	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503331&database=RX&origin=ReaxysOutput&ln=	(705 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-pyrrolidin-1-ylethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			IHWCIAWAWVGSHN-UHFFFAOYSA-N				Identification(12); Spectra(2); Bioactivity(2)	1	5	4.404	1	5	11	77.33	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503331	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503331&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-pyrrolidin-1-ylethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(C)C(=O)C3)C=CN12		35503338	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503338&database=RX&origin=ReaxysOutput&ln=	(706 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-5-oxopyrrolidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H26F2N4O5	C25H26F2N4O5	500.502			MVEXSBXSXIRZSD-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.539	1	6	10	94.4	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503338	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503338&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(C)C(=O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methyl-5-oxopyrrolidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN3C)C=CN12		35503340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503340&database=RX&origin=ReaxysOutput&ln=	(707 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylpyrrolidin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			QIYIPWPKRPBNQZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.441	1	5	10	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503340&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(1-methylpyrrolidin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC(=O)C1(COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503397	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503397&database=RX&origin=ReaxysOutput&ln=	(708 of 1381)		methyl 1-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]cyclopropanecarboxylate	C25H25F2N3O6	C25H25F2N3O6	501.487			VHZHTEWHTAZHCS-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.06	1	6	12	100.39	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503397	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503397&database=RX&origin=ReaxysOutput&ln=	COC(=O)C1(COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	methyl 1-[[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxymethyl]cyclopropanecarboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CC4CCC3C4)C=CN12		35503398	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503398&database=RX&origin=ReaxysOutput&ln=	(709 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-norbornan-2-yloxyimidazo[1,2-a]pyridin-3-yl)benzamide	C26H27F2N3O4	C26H27F2N3O4	483.515			DSUOTXXKEPOOIZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.769	1	4	9	74.09	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503398	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503398&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CC4CCC3C4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-norbornan-2-yloxyimidazo[1,2-a]pyridin-3-yl)benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CC4CCC3C4)C=CN12		35503398	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503398&database=RX&origin=ReaxysOutput&ln=	(709 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-norbornan-2-yloxyimidazo[1,2-a]pyridin-3-yl)benzamide	C26H27F2N3O4	C26H27F2N3O4	483.515			DSUOTXXKEPOOIZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.769	1	4	9	74.09	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503398	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503398&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CC4CCC3C4)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-norbornan-2-yloxyimidazo[1,2-a]pyridin-3-yl)benzamide					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCC3=O)C=CN12		35503403	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503403&database=RX&origin=ReaxysOutput&ln=	(710 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(2-oxopyrrolidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H26F2N4O5	C25H26F2N4O5	500.502			HEHAZXYLCXKFBK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.665	1	6	11	94.4	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503403	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503403&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCCC3=O)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[2-(2-oxopyrrolidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCOCC3)C=CN12		35503404	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503404&database=RX&origin=ReaxysOutput&ln=	(711 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-tetrahydropyran-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H29F2N3O5	C26H29F2N3O5	501.53			FPNPNYBQZUNHGQ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.951	1	5	11	83.32	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503404	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503404&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCC3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-tetrahydropyran-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC#N)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503407	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503407&database=RX&origin=ReaxysOutput&ln=	(712 of 1381)		2-[6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-1-oxo-3,4-dihydroisoquinolin-2-yl]acetonitrile	C23H25N5O3	C23H25N5O3	419.483			MQWNLTPHIKUNBL-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	2.207	0	6	7	83.1	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503407	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503407&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC#N)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12	2-[6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-1-oxo-3,4-dihydroisoquinolin-2-yl]acetonitrile					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC#N)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12		35503407	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503407&database=RX&origin=ReaxysOutput&ln=	(712 of 1381)		2-[6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-1-oxo-3,4-dihydroisoquinolin-2-yl]acetonitrile	C23H25N5O3	C23H25N5O3	419.483			MQWNLTPHIKUNBL-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	2.207	0	6	7	83.1	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503407	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503407&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC#N)CC2)C1=CN=C2C=C(OCCN(C)C)C=CN12	2-[6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-1-oxo-3,4-dihydroisoquinolin-2-yl]acetonitrile					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCC(F)(F)CC3)C=CN12		35503416	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503416&database=RX&origin=ReaxysOutput&ln=	(713 of 1381)		N-cyclopropyl-4-[7-(4,4-difluorocyclohexoxy)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C25H25F4N3O4	C25H25F4N3O4	507.485			QHPZZXTVOUGPPN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	6.185	1	4	9	74.09	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503416	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503416&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC3CCC(F)(F)CC3)C=CN12	N-cyclopropyl-4-[7-(4,4-difluorocyclohexoxy)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN3C)C=CN12		35503419	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503419&database=RX&origin=ReaxysOutput&ln=	(714 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			QIYIPWPKRPBNQZ-KRWDZBQOSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.441	1	5	10	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503419	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503419&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN3C)C=CN12		35503419	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503419&database=RX&origin=ReaxysOutput&ln=	(714 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			QIYIPWPKRPBNQZ-KRWDZBQOSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.441	1	5	10	77.33	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503419	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503419&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN3CC(F)F)C=CN12		35503420	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503420&database=RX&origin=ReaxysOutput&ln=	(715 of 1381)		N-cyclopropyl-4-[7-[[(2R)-1-(2,2-difluoroethyl)pyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide	C26H28F4N4O4	C26H28F4N4O4	536.526			HYGNTLWVQUOSDX-QGZVFWFLSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.35	1	5	12	77.33	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503420	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503420&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN3CC(F)F)C=CN12	N-cyclopropyl-4-[7-[[(2R)-1-(2,2-difluoroethyl)pyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN3C)C=CN12		35503421	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503421&database=RX&origin=ReaxysOutput&ln=	(716 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			QIYIPWPKRPBNQZ-QGZVFWFLSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.441	1	5	10	77.33	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503421	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503421&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN3C)C=CN12		35503421	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503421&database=RX&origin=ReaxysOutput&ln=	(716 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			QIYIPWPKRPBNQZ-QGZVFWFLSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.441	1	5	10	77.33	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503421	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503421&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H]3CCCN3C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCC(=O)N3)C=CN12		35503448	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503448&database=RX&origin=ReaxysOutput&ln=	(717 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(5-oxopyrrolidin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H24F2N4O5	C24H24F2N4O5	486.475			QYQFKQBOFTYXIA-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.56	2	6	10	103.19	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503448	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503448&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CCC(=O)N3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(5-oxopyrrolidin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(=O)N(C)C)C=CN12		35503451	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503451&database=RX&origin=ReaxysOutput&ln=	(718 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)-2-oxoethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C23H24F2N4O5	C23H24F2N4O5	474.464			FHKNFHZXYGTRFF-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.359	1	6	11	94.4	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503451	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503451&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(=O)N(C)C)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(dimethylamino)-2-oxoethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CNC(=O)C3)C=CN12		35503452	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503452&database=RX&origin=ReaxysOutput&ln=	(719 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(5-oxopyrrolidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H24F2N4O5	C24H24F2N4O5	486.475			DHDTVOAWXABADH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.397	2	6	10	103.19	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503452	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503452&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CNC(=O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(5-oxopyrrolidin-3-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(CN)CCC3)C=CN12		35503471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503471&database=RX&origin=ReaxysOutput&ln=	(720 of 1381)		4-[7-[[1-(aminomethyl)cyclobutyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			NBKNXVOXZJFQPD-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.548	2	5	11	100.11	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503471&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(CN)CCC3)C=CN12	4-[7-[[1-(aminomethyl)cyclobutyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCCC3)C=CN12		35503482	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503482&database=RX&origin=ReaxysOutput&ln=	(721 of 1381)		8-methoxy-6-[7-(2-pyrrolidin-1-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O3	C25H27F3N4O3	488.51			ZGJJYZOMISMEDP-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.645	0	5	8	59.31	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503482	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503482&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCCC3)C=CN12	8-methoxy-6-[7-(2-pyrrolidin-1-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCCC3)C=CN12		35503482	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503482&database=RX&origin=ReaxysOutput&ln=	(721 of 1381)		8-methoxy-6-[7-(2-pyrrolidin-1-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O3	C25H27F3N4O3	488.51			ZGJJYZOMISMEDP-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.645	0	5	8	59.31	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503482	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503482&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCCC3)C=CN12	8-methoxy-6-[7-(2-pyrrolidin-1-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3CCCN3C)C=CN12		35503484	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503484&database=RX&origin=ReaxysOutput&ln=	(722 of 1381)		8-methoxy-6-[7-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O3	C25H27F3N4O3	488.51			OIYNNVVWRJIEQH-GOSISDBHSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.682	0	5	7	59.31	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503484	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503484&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3CCCN3C)C=CN12	8-methoxy-6-[7-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3CCCN3C)C=CN12		35503484	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503484&database=RX&origin=ReaxysOutput&ln=	(722 of 1381)		8-methoxy-6-[7-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O3	C25H27F3N4O3	488.51			OIYNNVVWRJIEQH-GOSISDBHSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.682	0	5	7	59.31	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503484	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503484&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OC[C@H]3CCCN3C)C=CN12	8-methoxy-6-[7-[[(2R)-1-methylpyrrolidin-2-yl]methoxy]imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(N)C3CCOCC3)C=CN12		35503500	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503500&database=RX&origin=ReaxysOutput&ln=	(723 of 1381)		4-[7-(2-amino-2-tetrahydropyran-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			BMZLFNMUFBLTMW-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.854	2	6	11	109.34	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503500	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503500&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC(N)C3CCOCC3)C=CN12	4-[7-(2-amino-2-tetrahydropyran-4-ylethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CCCN3)C=CN12		35503551	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503551&database=RX&origin=ReaxysOutput&ln=	(724 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methylpyrrolidin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			RLDZSTROUNUSMN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.619	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503551	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503551&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CCCN3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methylpyrrolidin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CCCN3)C=CN12		35503551	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503551&database=RX&origin=ReaxysOutput&ln=	(724 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methylpyrrolidin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			RLDZSTROUNUSMN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.619	2	5	10	86.12	4	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503551	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503551&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3(C)CCCN3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(2-methylpyrrolidin-2-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCC(F)(F)C3)C=CN12		35503571	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503571&database=RX&origin=ReaxysOutput&ln=	(725 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(3,3-difluoropyrrolidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H26F4N4O4	C25H26F4N4O4	522.499			GSYXRLCECBVROH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.927	1	5	11	77.33	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503571	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503571&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCC(F)(F)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(3,3-difluoropyrrolidin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=CN=N3)C=CN12		35503652	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503652&database=RX&origin=ReaxysOutput&ln=	(726 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(pyridazin-3-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H21F2N5O4	C24H21F2N5O4	481.459			FGZMFSWYTVKCFM-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.762	1	6	10	99.87	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503652	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503652&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3=CC=CN=N3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(pyridazin-3-ylmethoxy)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(C)C(=O)O3)C=CN12		35503655	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503655&database=RX&origin=ReaxysOutput&ln=	(727 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(3-methyl-2-oxooxazolidin-5-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C24H24F2N4O6	C24H24F2N4O6	502.475			RQUQDOAQBSRLHN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.685	1	7	10	103.63	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503655	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503655&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCC3CN(C)C(=O)O3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[(3-methyl-2-oxooxazolidin-5-yl)methoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C(O)C(C)C		37157846	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157846&database=RX&origin=ReaxysOutput&ln=	(728 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1,3-trimethyl-butyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C26H31F2N3O4	C26H31F2N3O4	487.547			RZBNLNAEOGWZBR-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.086	2	5	10	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157846	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157846&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C(O)C(C)C	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1,3-trimethyl-butyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCCN(C)C1		37157850	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157850&database=RX&origin=ReaxysOutput&ln=	(729 of 1381)		2,6-dimethoxy-4-[5-(1-methyl-3-piperidyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H27F3N4O3	C24H27F3N4O3	476.499			QSTGYYYMBVMQEQ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.132	1	5	8	29.96	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157850	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157850&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCCN(C)C1	2,6-dimethoxy-4-[5-(1-methyl-3-piperidyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCCNC1		37157852	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157852&database=RX&origin=ReaxysOutput&ln=	(730 of 1381)		2,6-dimethoxy-4-[5-(3-piperidyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H25F3N4O3	C23H25F3N4O3	462.472			QEVOQJYYZWISLH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.893	2	5	8	29.96	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157852	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157852&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCCNC1	2,6-dimethoxy-4-[5-(3-piperidyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCCN(CC#N)C1		37157853	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157853&database=RX&origin=ReaxysOutput&ln=	(731 of 1381)		4-[5-[1-(cyanomethyl)-3-piperidyl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C25H26F3N5O3	C25H26F3N5O3	501.508			BENBJZWNHIPPRD-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.625	1	6	9	53.75	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157853	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157853&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCCN(CC#N)C1	4-[5-[1-(cyanomethyl)-3-piperidyl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C(C)(C)C#N		37157854	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157854&database=RX&origin=ReaxysOutput&ln=	(732 of 1381)		4-[5-(1-cyano-1-methyl-ethyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N4O3	C22H21F3N4O3	446.429			JIHDSHQLNNSTIC-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.309	1	5	8	53.75	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157854	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157854&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C(C)(C)C#N	4-[5-(1-cyano-1-methyl-ethyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C(C)(C)C#N		37157854	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157854&database=RX&origin=ReaxysOutput&ln=	(732 of 1381)		4-[5-(1-cyano-1-methyl-ethyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N4O3	C22H21F3N4O3	446.429			JIHDSHQLNNSTIC-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.309	1	5	8	53.75	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157854	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157854&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C(C)(C)C#N	4-[5-(1-cyano-1-methyl-ethyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C(C)(C)C#N		37157855	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157855&database=RX&origin=ReaxysOutput&ln=	(733 of 1381)		4-[5-(1-cyano-1-methyl-ethyl)benzimidazol-1-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide	C23H24N4O3	C23H24N4O3	404.469			LOJHSRHDFPRPTH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.427	1	5	7	53.75	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157855	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157855&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C(C)(C)C#N	4-[5-(1-cyano-1-methyl-ethyl)benzimidazol-1-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C(C)(C)C#N		37157855	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157855&database=RX&origin=ReaxysOutput&ln=	(733 of 1381)		4-[5-(1-cyano-1-methyl-ethyl)benzimidazol-1-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide	C23H24N4O3	C23H24N4O3	404.469			LOJHSRHDFPRPTH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.427	1	5	7	53.75	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157855	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157855&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C(C)(C)C#N	4-[5-(1-cyano-1-methyl-ethyl)benzimidazol-1-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1(CCC1)C#N		37157856	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157856&database=RX&origin=ReaxysOutput&ln=	(734 of 1381)		4-[5-(1-cyanocyclobutyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H21F3N4O3	C23H21F3N4O3	458.44			MUXZOOJQGYWUAK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.538	1	5	8	53.75	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157856	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157856&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1(CCC1)C#N	4-[5-(1-cyanocyclobutyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1(CCC1)C#N		37157857	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157857&database=RX&origin=ReaxysOutput&ln=	(735 of 1381)		4-[5-(1-cyanocyclobutyl)benzimidazol-1-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide	C24H24N4O3	C24H24N4O3	416.48			AVFFJFDVLWEKAO-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.656	1	5	7	53.75	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157857	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157857&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C1(CCC1)C#N	4-[5-(1-cyanocyclobutyl)benzimidazol-1-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C(C)C#N		37157858	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157858&database=RX&origin=ReaxysOutput&ln=	(736 of 1381)		4-[5-(1-cyanoethyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C21H19F3N4O3	C21H19F3N4O3	432.402			QSJFTUCFUORAST-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.599	1	5	8	53.75	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157858	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157858&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C(C)C#N	4-[5-(1-cyanoethyl)benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157860	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157860&database=RX&origin=ReaxysOutput&ln=	(737 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N4O3	C22H21F3N4O3	446.429			ZJZRDBGLQKBOJT-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.76	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157860	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157860&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157860	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157860&database=RX&origin=ReaxysOutput&ln=	(737 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C22H21F3N4O3	C22H21F3N4O3	446.429			ZJZRDBGLQKBOJT-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.76	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157860	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157860&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157861	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157861&database=RX&origin=ReaxysOutput&ln=	(738 of 1381)		2-[3-[4-(3,3-difluoroazetidine-1-carbonyl)-3,5-dimethoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C23H22F2N4O3	C23H22F2N4O3	440.449			IFRYFRUSKJTTCX-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.148	0	5	6	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157861	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157861&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[4-(3,3-difluoroazetidine-1-carbonyl)-3,5-dimethoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157861	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157861&database=RX&origin=ReaxysOutput&ln=	(738 of 1381)		2-[3-[4-(3,3-difluoroazetidine-1-carbonyl)-3,5-dimethoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C23H22F2N4O3	C23H22F2N4O3	440.449			IFRYFRUSKJTTCX-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.148	0	5	6	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157861	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157861&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[4-(3,3-difluoroazetidine-1-carbonyl)-3,5-dimethoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157862	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157862&database=RX&origin=ReaxysOutput&ln=	(739 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H22F2N4O3	C23H22F2N4O3	440.449			LYBBGGAESSOSLO-UHFFFAOYSA-N				Identification(12); Spectra(2); Bioactivity(2)	5	5	4.592	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157862	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157862&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157862	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157862&database=RX&origin=ReaxysOutput&ln=	(739 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H22F2N4O3	C23H22F2N4O3	440.449			LYBBGGAESSOSLO-UHFFFAOYSA-N				Identification(12); Spectra(2); Bioactivity(2)	5	5	4.592	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157862	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157862&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)C#N		37157869	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157869&database=RX&origin=ReaxysOutput&ln=	(740 of 1381)		4-[7-(1-cyanoethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C22H20F2N4O3	C22H20F2N4O3	426.423			AFDPCEKGFYDEEQ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.882	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157869	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157869&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)C#N	4-[7-(1-cyanoethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)C#N		37157869	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157869&database=RX&origin=ReaxysOutput&ln=	(740 of 1381)		4-[7-(1-cyanoethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C22H20F2N4O3	C22H20F2N4O3	426.423			AFDPCEKGFYDEEQ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.882	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157869	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157869&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)C#N	4-[7-(1-cyanoethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCC(C)(C#N)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37157870	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157870&database=RX&origin=ReaxysOutput&ln=	(741 of 1381)		4-[7-(1-cyano-1-methyl-propyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C24H24F2N4O3	C24H24F2N4O3	454.476			WKJBAEGZCCXMSZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.161	1	5	9	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157870	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157870&database=RX&origin=ReaxysOutput&ln=	CCC(C)(C#N)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	4-[7-(1-cyano-1-methyl-propyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCC(C)(C#N)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37157870	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157870&database=RX&origin=ReaxysOutput&ln=	(741 of 1381)		4-[7-(1-cyano-1-methyl-propyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C24H24F2N4O3	C24H24F2N4O3	454.476			WKJBAEGZCCXMSZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.161	1	5	9	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157870	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157870&database=RX&origin=ReaxysOutput&ln=	CCC(C)(C#N)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	4-[7-(1-cyano-1-methyl-propyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157871	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157871&database=RX&origin=ReaxysOutput&ln=	(742 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide	C23H24N4O3	C23H24N4O3	404.469			OULAPWWIUGRGDY-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.878	1	5	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157871	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157871&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157871	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157871&database=RX&origin=ReaxysOutput&ln=	(742 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide	C23H24N4O3	C23H24N4O3	404.469			OULAPWWIUGRGDY-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.878	1	5	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157871	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157871&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157873	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157873&database=RX&origin=ReaxysOutput&ln=	(743 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-ethyl-2,6-dimethoxy-benzamide	C22H24N4O3	C22H24N4O3	392.458			BHULEFSTXAGVRF-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.758	1	5	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157873	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157873&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-ethyl-2,6-dimethoxy-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157873	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157873&database=RX&origin=ReaxysOutput&ln=	(743 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-ethyl-2,6-dimethoxy-benzamide	C22H24N4O3	C22H24N4O3	392.458			BHULEFSTXAGVRF-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.758	1	5	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157873	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157873&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-ethyl-2,6-dimethoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC#N)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157875	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157875&database=RX&origin=ReaxysOutput&ln=	(744 of 1381)		N-(cyanomethyl)-4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-benzamide	C22H21N5O3	C22H21N5O3	403.44			LUXWGEKHALHKPZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	2.828	1	6	7	81.95	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157875	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157875&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC#N)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	N-(cyanomethyl)-4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC#N)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157875	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157875&database=RX&origin=ReaxysOutput&ln=	(744 of 1381)		N-(cyanomethyl)-4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-benzamide	C22H21N5O3	C22H21N5O3	403.44			LUXWGEKHALHKPZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	2.828	1	6	7	81.95	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157875	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157875&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC#N)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	N-(cyanomethyl)-4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C#N		37157876	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157876&database=RX&origin=ReaxysOutput&ln=	(745 of 1381)		4-[7-(1-cyanocyclopropyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H20F2N4O3	C23H20F2N4O3	438.434			JBBHBEKYSTTWPB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.252	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157876	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157876&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C#N	4-[7-(1-cyanocyclopropyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C#N		37157876	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157876&database=RX&origin=ReaxysOutput&ln=	(745 of 1381)		4-[7-(1-cyanocyclopropyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H20F2N4O3	C23H20F2N4O3	438.434			JBBHBEKYSTTWPB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.252	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157876	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157876&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C#N	4-[7-(1-cyanocyclopropyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CCC1)C#N		37157877	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157877&database=RX&origin=ReaxysOutput&ln=	(746 of 1381)		4-[7-(1-cyanocyclobutyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C24H22F2N4O3	C24H22F2N4O3	452.46			VAHKFTGMVAZOKX-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.821	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157877	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157877&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CCC1)C#N	4-[7-(1-cyanocyclobutyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CCC1)C#N		37157877	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157877&database=RX&origin=ReaxysOutput&ln=	(746 of 1381)		4-[7-(1-cyanocyclobutyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C24H22F2N4O3	C24H22F2N4O3	452.46			VAHKFTGMVAZOKX-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.821	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157877	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157877&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CCC1)C#N	4-[7-(1-cyanocyclobutyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)O		37157878	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157878&database=RX&origin=ReaxysOutput&ln=	(747 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C22H23F2N3O4	C22H23F2N3O4	431.439			QZZQINWVVYBKGM-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.955	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157878	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157878&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)O	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(CC=C)(CC=C)C#N		37157879	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157879&database=RX&origin=ReaxysOutput&ln=	(748 of 1381)		4-[7-(1-allyl-1-cyano-but-3-enyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C27H26F2N4O3	C27H26F2N4O3	492.525			KXMWYHSYNHZFNK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	6.136	1	5	12	58.16	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157879	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157879&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(CC=C)(CC=C)C#N	4-[7-(1-allyl-1-cyano-but-3-enyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157882	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157882&database=RX&origin=ReaxysOutput&ln=	(749 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(cyclopropylmethyl)-2-(difluoromethoxy)-6-methoxy-benzamide	C24H24F2N4O3	C24H24F2N4O3	454.476			POMCNVIVOVNEPC-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.787	1	5	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157882	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157882&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(cyclopropylmethyl)-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCN(C)C(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157883	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157883&database=RX&origin=ReaxysOutput&ln=	(750 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-ethyl-6-methoxy-N-methyl-benzamide	C23H24F2N4O3	C23H24F2N4O3	442.465			RFEUSELXVKQPGR-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(1)		5	4.614	0	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157883	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157883&database=RX&origin=ReaxysOutput&ln=	CCN(C)C(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-ethyl-6-methoxy-N-methyl-benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCC(O)CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157884	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157884&database=RX&origin=ReaxysOutput&ln=	(751 of 1381)		2-[3-[3-(difluoromethoxy)-4-(4-hydroxypiperidine-1-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C25H26F2N4O4	C25H26F2N4O4	484.503			YWBSXMXYEZFJMG-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.025	1	6	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157884	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157884&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCC(O)CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-4-(4-hydroxypiperidine-1-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1COC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157886	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157886&database=RX&origin=ReaxysOutput&ln=	(752 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-(oxetan-3-yl)benzamide	C23H22F2N4O4	C23H22F2N4O4	456.449			ZLBXOLFPUOBCGH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.686	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157886	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157886&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1COC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-(oxetan-3-yl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCCCO)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157887	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157887&database=RX&origin=ReaxysOutput&ln=	(753 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(3-hydroxypropyl)-6-methoxy-benzamide	C23H24F2N4O4	C23H24F2N4O4	458.465			XTVJCNIKTGRQPP-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.698	2	6	10	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157887	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157887&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCCCO)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(3-hydroxypropyl)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COCCCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157888	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157888&database=RX&origin=ReaxysOutput&ln=	(754 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-(3-methoxypropyl)benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			PBQPHGNRMRMOFB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.217	1	6	11	58.16	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157888	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157888&database=RX&origin=ReaxysOutput&ln=	COCCCNC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-(3-methoxypropyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1CCN(CC1)C(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157889	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157889&database=RX&origin=ReaxysOutput&ln=	(755 of 1381)		2-[3-[3-(difluoromethoxy)-5-methoxy-4-(4-methoxypiperidine-1-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C26H28F2N4O4	C26H28F2N4O4	498.53			LMFCUIOLAJKSBO-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.544	0	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157889	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157889&database=RX&origin=ReaxysOutput&ln=	COC1CCN(CC1)C(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-5-methoxy-4-(4-methoxypiperidine-1-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCOCC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157891	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157891&database=RX&origin=ReaxysOutput&ln=	(756 of 1381)		2-[3-[3-(difluoromethoxy)-5-methoxy-4-(morpholine-4-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C24H24F2N4O4	C24H24F2N4O4	470.476			SXJDCOYKGALXEH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.791	0	6	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157891	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157891&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCOCC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-5-methoxy-4-(morpholine-4-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCN(C)CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157892	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157892&database=RX&origin=ReaxysOutput&ln=	(757 of 1381)		2-[3-[3-(difluoromethoxy)-5-methoxy-4-(4-methylpiperazine-1-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C25H27F2N5O3	C25H27F2N5O3	483.518			IZWXWMGRQHMVDV-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.834	0	6	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157892	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157892&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCN(C)CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-5-methoxy-4-(4-methylpiperazine-1-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157893	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157893&database=RX&origin=ReaxysOutput&ln=	(758 of 1381)		2-[3-[3-(difluoromethoxy)-4-(3-hydroxyazetidine-1-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C23H22F2N4O4	C23H22F2N4O4	456.449			UINTYDLNWXWSGY-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.309	1	6	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157893	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157893&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-4-(3-hydroxyazetidine-1-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC2(COC2)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157894	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157894&database=RX&origin=ReaxysOutput&ln=	(759 of 1381)		2-[3-[3-(difluoromethoxy)-5-methoxy-4-(2-oxa-6-azaspiro[3.3]heptane-6-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C25H24F2N4O4	C25H24F2N4O4	482.487			UXYKYZONHQHBTB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.785	0	6	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157894	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157894&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC2(COC2)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-5-methoxy-4-(2-oxa-6-azaspiro[3.3]heptane-6-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC1=NN(C)C=C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157895	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157895&database=RX&origin=ReaxysOutput&ln=	(760 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-[(1-methylpyrazol-3-yl)methyl]benzamide	C25H24F2N6O3	C25H24F2N6O3	494.501			HQPWSTBZZBBMNZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.289	1	7	9	71.05	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157895	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157895&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC1=NN(C)C=C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-[(1-methylpyrazol-3-yl)methyl]benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CCCC1)C#N		37157896	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157896&database=RX&origin=ReaxysOutput&ln=	(761 of 1381)		4-[7-(1-cyanocyclopentyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C25H24F2N4O3	C25H24F2N4O3	466.487			DIMNPUHIWRMIJB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.39	1	5	8	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157896	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157896&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CCCC1)C#N	4-[7-(1-cyanocyclopentyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)O		37157897	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157897&database=RX&origin=ReaxysOutput&ln=	(762 of 1381)		4-[7-(1-hydroxyethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C20H20F3N3O4	C20H20F3N3O4	423.392			ZJGPQCUZXOAFMA-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	4.013	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157897	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157897&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)O	4-[7-(1-hydroxyethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)N		37157898	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157898&database=RX&origin=ReaxysOutput&ln=	(763 of 1381)		4-[7-(1-amino-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C21H23F3N4O3	C21H23F3N4O3	436.434			NGLWXSPCWUYYRG-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.056	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157898	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157898&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)N	4-[7-(1-amino-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C(C)O		37157903	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157903&database=RX&origin=ReaxysOutput&ln=	(764 of 1381)		4-[7-(2-hydroxy-1,1-dimethyl-propyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H26F3N3O4	C23H26F3N3O4	465.472			CLQGYGFGOJGTMA-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.599	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157903	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157903&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C(C)O	4-[7-(2-hydroxy-1,1-dimethyl-propyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCNC1		37157905	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157905&database=RX&origin=ReaxysOutput&ln=	(765 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-piperidyl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O3	C24H26F2N4O3	456.492			UAYHSVNMYDDEQJ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.176	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157905	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157905&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCNC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-piperidyl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN(C)C1		37157906	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157906&database=RX&origin=ReaxysOutput&ln=	(766 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methyl-3-piperidyl)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O3	C25H28F2N4O3	470.519			LILDQASPAHKBHX-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.415	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157906	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157906&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN(C)C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methyl-3-piperidyl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCN(C)CC1		37157907	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157907&database=RX&origin=ReaxysOutput&ln=	(767 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methyl-4-piperidyl)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O3	C25H28F2N4O3	470.519			YAWBPAFUZUQTKQ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.415	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157907	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157907&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCN(C)CC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methyl-4-piperidyl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157908	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157908&database=RX&origin=ReaxysOutput&ln=	(768 of 1381)		2-[3-[4-(3,3-difluoroazetidine-1-carbonyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C23H20F4N4O3	C23H20F4N4O3	476.43			HSBSPESFLSKPLE-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.862	0	5	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157908	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157908&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[4-(3,3-difluoroazetidine-1-carbonyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157909	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157909&database=RX&origin=ReaxysOutput&ln=	(769 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2-difluoroethyl)-2-(difluoromethoxy)-6-methoxy-benzamide	C22H20F4N4O3	C22H20F4N4O3	464.419			WBKPUPCOUZQBEQ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.958	1	5	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157909	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157909&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2-difluoroethyl)-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC(C)C(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157910	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157910&database=RX&origin=ReaxysOutput&ln=	(770 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(2,2-difluoro-1-methyl-ethyl)-6-methoxy-benzamide	C23H22F4N4O3	C23H22F4N4O3	478.446			UDKKDKCKETUJTG-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.418	1	5	9	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157910	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157910&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC(C)C(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(2,2-difluoro-1-methyl-ethyl)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(C)C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157911	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157911&database=RX&origin=ReaxysOutput&ln=	(771 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-isobutyl-6-methoxy-benzamide	C24H26F2N4O3	C24H26F2N4O3	456.492			DXTAJGZVYRAUSF-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.127	1	5	9	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157911	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157911&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(C)C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-isobutyl-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157913	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157913&database=RX&origin=ReaxysOutput&ln=	(772 of 1381)		2-[3-[4-(3-cyclopropyl-3-hydroxy-azetidine-1-carbonyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C26H26F2N4O4	C26H26F2N4O4	496.514			HFSXHJKMAZEOAC-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.041	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157913	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157913&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[4-(3-cyclopropyl-3-hydroxy-azetidine-1-carbonyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157914	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157914&database=RX&origin=ReaxysOutput&ln=	(773 of 1381)		2-[3-[3-(difluoromethoxy)-4-[3-hydroxy-3-(trifluoromethyl)azetidine-1-carbonyl]-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C24H21F5N4O4	C24H21F5N4O4	524.447			ZBXDBQWKNFKSNZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.728	1	6	8	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157914	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157914&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-4-[3-hydroxy-3-(trifluoromethyl)azetidine-1-carbonyl]-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(C1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157915	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157915&database=RX&origin=ReaxysOutput&ln=	(774 of 1381)		2-[3-[3-(difluoromethoxy)-5-methoxy-4-[3-(trifluoromethyl)azetidine-1-carbonyl]phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C24H21F5N4O3	C24H21F5N4O3	508.448			GFJINFZHZKSDPJ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.638	0	5	8	58.16	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157915	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157915&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(C1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-5-methoxy-4-[3-(trifluoromethyl)azetidine-1-carbonyl]phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(C1)C#N)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157916	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157916&database=RX&origin=ReaxysOutput&ln=	(775 of 1381)		1-[4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzoyl]azetidine-3-carbonitrile	C24H21F2N5O3	C24H21F2N5O3	465.459			TYRHLIVNYAXIBA-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.502	0	6	7	81.95	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157916	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157916&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(C1)C#N)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	1-[4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzoyl]azetidine-3-carbonitrile					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC(C)C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157917	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157917&database=RX&origin=ReaxysOutput&ln=	(776 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-isopropyl-6-methoxy-benzamide	C23H24F2N4O3	C23H24F2N4O3	442.465			RYPYZZCYUMPOJK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.932	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157917	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157917&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC(C)C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-isopropyl-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157918	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157918&database=RX&origin=ReaxysOutput&ln=	(777 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C23H21F3N4O3	C23H21F3N4O3	458.44			DGCZTIYMVWMEQK-LSDHHAIUSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.736	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157918	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157918&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1(CC1)C(C)C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157919	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157919&database=RX&origin=ReaxysOutput&ln=	(778 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(1-isopropylcyclopropyl)-6-methoxy-benzamide	C26H28F2N4O3	C26H28F2N4O3	482.53			YWYFYPAASDMRKC-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.664	1	5	9	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157919	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157919&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1(CC1)C(C)C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(1-isopropylcyclopropyl)-6-methoxy-benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COCC1(CC1)NC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157920	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157920&database=RX&origin=ReaxysOutput&ln=	(779 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-[1-(methoxymethyl)cyclopropyl]benzamide	C25H26F2N4O4	C25H26F2N4O4	484.503			BRCNFXOTPADITJ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.396	1	6	10	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157920	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157920&database=RX&origin=ReaxysOutput&ln=	COCC1(CC1)NC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-[1-(methoxymethyl)cyclopropyl]benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N(C)CC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157921	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157921&database=RX&origin=ReaxysOutput&ln=	(780 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(cyclopropylmethyl)-2-(difluoromethoxy)-6-methoxy-N-methyl-benzamide	C25H26F2N4O3	C25H26F2N4O3	468.503			KUNYHLAPIOEVCV-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.929	0	5	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157921	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157921&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N(C)CC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(cyclopropylmethyl)-2-(difluoromethoxy)-6-methoxy-N-methyl-benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCC1(CC1)NC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157922	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157922&database=RX&origin=ReaxysOutput&ln=	(781 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(1-ethylcyclopropyl)-6-methoxy-benzamide	C25H26F2N4O3	C25H26F2N4O3	468.503			MPRSCMOHTOFMIG-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.367	1	5	9	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157922	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157922&database=RX&origin=ReaxysOutput&ln=	CCC1(CC1)NC(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(1-ethylcyclopropyl)-6-methoxy-benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N(C)C1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157923	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157923&database=RX&origin=ReaxysOutput&ln=	(782 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-N-methyl-benzamide	C24H24F2N4O3	C24H24F2N4O3	454.476			SATNLDOFJJSEHZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.734	0	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157923	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157923&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N(C)C1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-N-methyl-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC1CCOC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157924	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157924&database=RX&origin=ReaxysOutput&ln=	(783 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-(tetrahydrofuran-3-ylmethyl)benzamide	C25H26F2N4O4	C25H26F2N4O4	484.503			JXMDVZVCUBHCOF-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.239	1	6	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157924	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157924&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC1CCOC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-(tetrahydrofuran-3-ylmethyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CCOC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157925	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157925&database=RX&origin=ReaxysOutput&ln=	(784 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-tetrahydrofuran-3-yl-benzamide	C24H24F2N4O4	C24H24F2N4O4	470.476			BFAGOUVCEGISMZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.044	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157925	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157925&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CCOC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-tetrahydrofuran-3-yl-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC(CO)C1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157926	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157926&database=RX&origin=ReaxysOutput&ln=	(785 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(1-cyclopropyl-2-hydroxy-ethyl)-2-(difluoromethoxy)-6-methoxy-benzamide	C25H26F2N4O4	C25H26F2N4O4	484.503			AJNOOVRBOXSSCQ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.115	2	6	10	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157926	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157926&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC(CO)C1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(1-cyclopropyl-2-hydroxy-ethyl)-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157927	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157927&database=RX&origin=ReaxysOutput&ln=	(786 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(3,3-difluorocyclobutyl)-2-(difluoromethoxy)-6-methoxy-benzamide	C24H22F4N4O3	C24H22F4N4O3	490.457			ZRCKZWXSCBIAFQ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.473	1	5	8	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157927	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157927&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC(F)(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(3,3-difluorocyclobutyl)-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C#C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157928	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157928&database=RX&origin=ReaxysOutput&ln=	(787 of 1381)		2-[3-[3-(difluoromethoxy)-4-(3-ethynyl-3-hydroxy-azetidine-1-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C25H22F2N4O4	C25H22F2N4O4	480.471			WKOBRZPXNOMUMI-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.33	1	6	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157928	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157928&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(O)(C1)C#C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-4-(3-ethynyl-3-hydroxy-azetidine-1-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC1CCC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157929	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157929&database=RX&origin=ReaxysOutput&ln=	(788 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(cyclobutylmethyl)-2-(difluoromethoxy)-6-methoxy-benzamide	C25H26F2N4O3	C25H26F2N4O3	468.503			SWCSLKPLWWDJSO-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.356	1	5	9	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157929	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157929&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC1CCC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(cyclobutylmethyl)-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@H]1CCCC[C@@H]1N)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157930	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157930&database=RX&origin=ReaxysOutput&ln=	(789 of 1381)		N-[(1S,2S)-2-aminocyclohexyl]-4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide	C26H29F2N5O3	C26H29F2N5O3	497.545			JJPVFRDNDQHQIN-ROUUACIJSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.569	2	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157930	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157930&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@H]1CCCC[C@@H]1N)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	N-[(1S,2S)-2-aminocyclohexyl]-4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157933	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157933&database=RX&origin=ReaxysOutput&ln=	(790 of 1381)		2-[3-[3-(difluoromethoxy)-4-(3-fluoroazetidine-1-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C23H21F3N4O3	C23H21F3N4O3	458.44			VXZJCSXNWZDMQP-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.483	0	5	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157933	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157933&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-4-(3-fluoroazetidine-1-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(CO)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157934	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157934&database=RX&origin=ReaxysOutput&ln=	(791 of 1381)		2-[3-[3-(difluoromethoxy)-4-[3-(hydroxymethyl)azetidine-1-carbonyl]-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C24H24F2N4O4	C24H24F2N4O4	470.476			JFDXYOWCNYHJOG-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.504	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157934	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157934&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(CO)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-4-[3-(hydroxymethyl)azetidine-1-carbonyl]-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1CN(C1)C(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157935	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157935&database=RX&origin=ReaxysOutput&ln=	(792 of 1381)		2-[3-[3-(difluoromethoxy)-5-methoxy-4-(3-methoxyazetidine-1-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C24H24F2N4O4	C24H24F2N4O4	470.476			IWLVCBNSJNDICQ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.828	0	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157935	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157935&database=RX&origin=ReaxysOutput&ln=	COC1CN(C1)C(=O)C1=C(OC(F)F)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-5-methoxy-4-(3-methoxyazetidine-1-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC2(CN(C)C2)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157936	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157936&database=RX&origin=ReaxysOutput&ln=	(793 of 1381)		2-[3-[3-(difluoromethoxy)-5-methoxy-4-(6-methyl-2,6-diazaspiro[3.3]heptane-2-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C26H27F2N5O3	C26H27F2N5O3	495.529			HEKNFEVLZKNFDJ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.828	0	6	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157936	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157936&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC2(CN(C)C2)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-5-methoxy-4-(6-methyl-2,6-diazaspiro[3.3]heptane-2-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC(C1CC1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157937	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157937&database=RX&origin=ReaxysOutput&ln=	(794 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(1-cyclopropyl-2,2,2-trifluoro-ethyl)-2-(difluoromethoxy)-6-methoxy-benzamide	C25H23F5N4O3	C25H23F5N4O3	522.475			UKOQFCMOHOGOAT-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	6.249	1	5	10	58.16	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157937	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157937&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC(C1CC1)C(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(1-cyclopropyl-2,2,2-trifluoro-ethyl)-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC(C)C1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157938	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157938&database=RX&origin=ReaxysOutput&ln=	(795 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(1-cyclopropylethyl)-2-(difluoromethoxy)-6-methoxy-benzamide	C25H26F2N4O3	C25H26F2N4O3	468.503			GCCJUELCNNZVGH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.247	1	5	9	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157938	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157938&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC(C)C1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-(1-cyclopropylethyl)-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC1COC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157939	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157939&database=RX&origin=ReaxysOutput&ln=	(796 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-(oxetan-3-ylmethyl)benzamide	C24H24F2N4O4	C24H24F2N4O4	470.476			OUIARPACHQXBSM-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.881	1	6	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157939	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157939&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC1COC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-(oxetan-3-ylmethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(N)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157940	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157940&database=RX&origin=ReaxysOutput&ln=	(797 of 1381)		2-[3-[4-(3-aminoazetidine-1-carbonyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C23H23F2N5O3	C23H23F2N5O3	455.464			DJODDKNJCSKGIL-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.242	1	6	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157940	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157940&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(N)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[4-(3-aminoazetidine-1-carbonyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCC1C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157941	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157941&database=RX&origin=ReaxysOutput&ln=	(798 of 1381)		2-[3-[3-(difluoromethoxy)-5-methoxy-4-(2-methylazetidine-1-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C24H24F2N4O3	C24H24F2N4O3	454.476			QJDGZFGVAJVZFR-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.799	0	5	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157941	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157941&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCC1C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-5-methoxy-4-(2-methylazetidine-1-carbonyl)phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCC1CO)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157942	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157942&database=RX&origin=ReaxysOutput&ln=	(799 of 1381)		2-[3-[3-(difluoromethoxy)-4-[2-(hydroxymethyl)azetidine-1-carbonyl]-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C24H24F2N4O4	C24H24F2N4O4	470.476			FKXXYBNFJFPIQN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.667	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157942	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157942&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCC1CO)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-4-[2-(hydroxymethyl)azetidine-1-carbonyl]-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CNC1)C#N		37157946	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157946&database=RX&origin=ReaxysOutput&ln=	(800 of 1381)		4-[7-(3-cyanoazetidin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H21F2N5O3	C23H21F2N5O3	453.448			MNBUNTXHRGFODV-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.15	2	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157946	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157946&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CNC1)C#N	4-[7-(3-cyanoazetidin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(COC1)C#N		37157952	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157952&database=RX&origin=ReaxysOutput&ln=	(801 of 1381)		4-[7-(3-cyanooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H20F2N4O4	C23H20F2N4O4	454.433			REQCZNJXTSUQQB-UHFFFAOYSA-N				Identification(12); Spectra(2); Bioactivity(2)	1	5	3.346	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157952	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157952&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(COC1)C#N	4-[7-(3-cyanooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(N=CN12)C(C)(C)OC		37157953	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157953&database=RX&origin=ReaxysOutput&ln=	(802 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methoxy-1-methyl-ethyl)imidazo[1,2-c]pyrimidin-3-yl]benzamide	C22H24F2N4O4	C22H24F2N4O4	446.454			KSINRGQEMFTRBA-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.522	1	6	9	47.26	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157953	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157953&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(N=CN12)C(C)(C)OC	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methoxy-1-methyl-ethyl)imidazo[1,2-c]pyrimidin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(N=CN12)C(C)(C)O		37157954	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157954&database=RX&origin=ReaxysOutput&ln=	(803 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-ethyl)imidazo[1,2-c]pyrimidin-3-yl]-6-methoxy-benzamide	C21H22F2N4O4	C21H22F2N4O4	432.427			ZWCCUDVTGDLHGA-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.003	2	6	8	47.26	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157954	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157954&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(N=CN12)C(C)(C)O	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-ethyl)imidazo[1,2-c]pyrimidin-3-yl]-6-methoxy-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)OC		37157955	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157955&database=RX&origin=ReaxysOutput&ln=	(804 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methoxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H25F2N3O4	C23H25F2N3O4	445.466			XHTOXKFZRRCCRH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.474	1	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157955	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157955&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)OC	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methoxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CN(C)C1)C#N		37157956	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157956&database=RX&origin=ReaxysOutput&ln=	(805 of 1381)		4-[7-(3-cyano-1-methyl-azetidin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C24H23F2N5O3	C24H23F2N5O3	467.475			YQXNONFHISVBMW-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.389	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157956	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157956&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CN(C)C1)C#N	4-[7-(3-cyano-1-methyl-azetidin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CN(C1)C(C)=O)C#N		37157957	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157957&database=RX&origin=ReaxysOutput&ln=	(806 of 1381)		4-[7-(1-acetyl-3-cyano-azetidin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C25H23F2N5O4	C25H23F2N5O4	495.486			OSTYTHMVXJNPQO-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.178	1	7	9	75.23	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157957	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157957&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CN(C1)C(C)=O)C#N	4-[7-(1-acetyl-3-cyano-azetidin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CCOC1)C#N		37157958	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157958&database=RX&origin=ReaxysOutput&ln=	(807 of 1381)		4-[7-(3-cyanotetrahydrofuran-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C24H22F2N4O4	C24H22F2N4O4	468.46			RUTUGFVFAJLJIM-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.704	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157958	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157958&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CCOC1)C#N	4-[7-(3-cyanotetrahydrofuran-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCC(O)(CC)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37157959	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157959&database=RX&origin=ReaxysOutput&ln=	(808 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-ethyl-1-hydroxy-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C24H27F2N3O4	C24H27F2N3O4	459.493			ZSMMIUQIAPYZNH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.671	2	5	10	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157959	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157959&database=RX&origin=ReaxysOutput&ln=	CCC(O)(CC)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-ethyl-1-hydroxy-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CN=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1(COC1)C#N		37157960	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157960&database=RX&origin=ReaxysOutput&ln=	(809 of 1381)		5-[7-(3-cyanooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-3-methoxy-N-(2,2,2-trifluoroethyl)pyridine-2-carboxamide	C20H16F3N5O3	C20H16F3N5O3	431.374			HHYXSMUCMWTJHZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	2.436	1	7	7	71.05	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157960	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157960&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CN=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1(COC1)C#N	5-[7-(3-cyanooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-3-methoxy-N-(2,2,2-trifluoroethyl)pyridine-2-carboxamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCC(CC)(OC)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37157961	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157961&database=RX&origin=ReaxysOutput&ln=	(810 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-ethyl-1-methoxy-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C25H29F2N3O4	C25H29F2N3O4	473.52			CVACDVRCIQTMGB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.19	1	5	11	34.37	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157961	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157961&database=RX&origin=ReaxysOutput&ln=	CCC(CC)(OC)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-ethyl-1-methoxy-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CN=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157963	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157963&database=RX&origin=ReaxysOutput&ln=	(811 of 1381)		5-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-3-methoxy-N-(2,2,2-trifluoroethyl)pyridine-2-carboxamide	C20H18F3N5O2	C20H18F3N5O2	417.39			IFROWGIYGVOQAN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.682	1	6	7	71.05	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157963	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157963&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CN=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	5-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-3-methoxy-N-(2,2,2-trifluoroethyl)pyridine-2-carboxamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCOC(C)(C)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37157964	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157964&database=RX&origin=ReaxysOutput&ln=	(812 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-ethoxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C24H27F2N3O4	C24H27F2N3O4	459.493			POIUOPDTBDEODS-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.897	1	5	10	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157964	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157964&database=RX&origin=ReaxysOutput&ln=	CCOC(C)(C)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-ethoxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C(F)(F)F		37157965	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157965&database=RX&origin=ReaxysOutput&ln=	(813 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2,2,2-trifluoro-1-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20F5N3O4	C22H20F5N3O4	485.411			ILDYUIRAHFMGLZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.957	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157965	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157965&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C(F)(F)F	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2,2,2-trifluoro-1-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C1(COC1)C#N		37157966	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157966&database=RX&origin=ReaxysOutput&ln=	(814 of 1381)		4-[7-(3-cyanooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C23H19F3N4O4	C23H19F3N4O4	472.423			KBFGNQNUSOSLQP-LSDHHAIUSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.49	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157966	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157966&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C1(COC1)C#N	4-[7-(3-cyanooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)F		37157967	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157967&database=RX&origin=ReaxysOutput&ln=	(815 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-fluoro-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C22H22F3N3O3	C22H22F3N3O3	433.43			HVJXWCWRPUJEAQ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.95	1	4	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157967	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157967&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)F	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-fluoro-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C(C)C		37157969	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157969&database=RX&origin=ReaxysOutput&ln=	(816 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1,2-dimethyl-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C24H27F2N3O4	C24H27F2N3O4	459.493			WTHWYVHDCDELLK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.61	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157969	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157969&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C(C)C	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1,2-dimethyl-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCC(C)(O)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37157970	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157970&database=RX&origin=ReaxysOutput&ln=	(817 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C23H25F2N3O4	C23H25F2N3O4	445.466			FJWMUNSALNIGQY-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	4.313	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157970	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157970&database=RX&origin=ReaxysOutput&ln=	CCC(C)(O)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C1CC1		37157971	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157971&database=RX&origin=ReaxysOutput&ln=	(818 of 1381)		N-cyclopropyl-4-[7-(1-cyclopropyl-1-hydroxy-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide	C24H25F2N3O4	C24H25F2N3O4	457.477			XBHHWRGXJCZDSW-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	4.27	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157971	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157971&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C1CC1	N-cyclopropyl-4-[7-(1-cyclopropyl-1-hydroxy-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C(=O)N1CC(O)C1		37157976	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157976&database=RX&origin=ReaxysOutput&ln=	(819 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-(3-hydroxyazetidine-1-carbonyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C26H26F2N4O5	C26H26F2N4O5	512.513			MYVNPAHFANOGPK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.191	2	7	10	51.44	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157976	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157976&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C(=O)N1CC(O)C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-(3-hydroxyazetidine-1-carbonyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CCCCC1		37157977	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157977&database=RX&origin=ReaxysOutput&ln=	(820 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(1-piperidyl)ethyl]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O3	C26H30F2N4O3	484.546			CZEJGKCQBUJOSN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	3	5	5.271	1	5	9	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157977	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157977&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CCCCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(1-piperidyl)ethyl]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCN(CC)C(C)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37157979	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157979&database=RX&origin=ReaxysOutput&ln=	(821 of 1381)		N-cyclopropyl-4-[7-[1-(diethylamino)ethyl]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide	C25H30F2N4O3	C25H30F2N4O3	472.535			DGPCYDINZVZWDX-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.253	1	5	11	34.37	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157979	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157979&database=RX&origin=ReaxysOutput&ln=	CCN(CC)C(C)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-4-[7-[1-(diethylamino)ethyl]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)NC(C)C		37157980	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157980&database=RX&origin=ReaxysOutput&ln=	(822 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-(isopropylamino)ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C24H28F2N4O3	C24H28F2N4O3	458.508			FVYVKSSHSQBYOB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.051	2	5	10	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157980	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157980&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)NC(C)C	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-(isopropylamino)ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)CO		37157981	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157981&database=RX&origin=ReaxysOutput&ln=	(823 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C23H25F2N3O4	C23H25F2N3O4	445.466			KOVHKQMVKAWESA-UHFFFAOYSA-N				Identification(12); Spectra(2); Bioactivity(2)	2	5	3.971	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157981	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157981&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)CO	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CNC(C)C)CC1		37157982	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157982&database=RX&origin=ReaxysOutput&ln=	(824 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-[(isopropylamino)methyl]cyclopropyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C26H30F2N4O3	C26H30F2N4O3	484.546			KVFGAMDUUXHCJL-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.837	2	5	11	34.37	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157982	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157982&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CNC(C)C)CC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-[(isopropylamino)methyl]cyclopropyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CC2(COC2)C1		37157983	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157983&database=RX&origin=ReaxysOutput&ln=	(825 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(2-oxa-6-azaspiro[3.3]heptan-6-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H28F2N4O4	C26H28F2N4O4	498.53			NWZQCIMLCWTWCZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.001	1	6	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157983	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157983&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CC2(COC2)C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(2-oxa-6-azaspiro[3.3]heptan-6-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N(C)CCO		37157984	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157984&database=RX&origin=ReaxysOutput&ln=	(826 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-[2-hydroxyethyl(methyl)amino]ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C24H28F2N4O4	C24H28F2N4O4	474.508			YXSDRCIVELYZPM-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.698	2	6	11	34.37	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157984	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157984&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N(C)CCO	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-[2-hydroxyethyl(methyl)amino]ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CC(O)C1		37157985	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157985&database=RX&origin=ReaxysOutput&ln=	(827 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-(3-hydroxyazetidin-1-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			PULDTZCVVDUSCB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.525	2	6	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157985	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157985&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CC(O)C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-(3-hydroxyazetidin-1-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CC(F)(F)C1		37157986	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157986&database=RX&origin=ReaxysOutput&ln=	(828 of 1381)		N-cyclopropyl-4-[7-[1-(3,3-difluoroazetidin-1-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide	C24H24F4N4O3	C24H24F4N4O3	492.473			WVZVRELIPSYGTO-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.078	1	5	9	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157986	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157986&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CC(F)(F)C1	N-cyclopropyl-4-[7-[1-(3,3-difluoroazetidin-1-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CCO[C@H](CO)C1		37157987	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157987&database=RX&origin=ReaxysOutput&ln=	(829 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-[(2S)-2-(hydroxymethyl)morpholin-4-yl]ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			SDOBMQBXOBORRO-FUBQLUNQSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.335	2	7	10	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157987	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157987&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CCO[C@H](CO)C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-[(2S)-2-(hydroxymethyl)morpholin-4-yl]ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3CCC3)C(F)=CN12		37157992	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157992&database=RX&origin=ReaxysOutput&ln=	(830 of 1381)		4-(7-cyclobutyl-6-fluoro-imidazo[1,2-a]pyridin-3-yl)-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H22F3N3O3	C23H22F3N3O3	445.441			SSFWQUSJLNFIBB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.714	1	4	8	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157992	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157992&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3CCC3)C(F)=CN12	4-(7-cyclobutyl-6-fluoro-imidazo[1,2-a]pyridin-3-yl)-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C(C)O		37157994	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157994&database=RX&origin=ReaxysOutput&ln=	(831 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethyl-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C24H27F2N3O4	C24H27F2N3O4	459.493			WUFGOTTXSWBIFA-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.431	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157994	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157994&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C(C)O	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethyl-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(O)CCC1		37157995	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157995&database=RX&origin=ReaxysOutput&ln=	(832 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxycyclobutyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C23H23F2N3O4	C23H23F2N3O4	443.45			VDRPKBWPRUJZOS-UHFFFAOYSA-N				Identification(12); Spectra(2); Bioactivity(2)	1	5	3.973	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157995	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157995&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(O)CCC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxycyclobutyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1COC1		37157996	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157996&database=RX&origin=ReaxysOutput&ln=	(833 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H21F2N3O4	C22H21F2N3O4	429.423			MZHDEVQOFYXHGJ-UHFFFAOYSA-N				Identification(12); Spectra(2); Bioactivity(2)	1	5	3.656	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157996	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157996&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1COC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(oxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(O)CC#N		37157997	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157997&database=RX&origin=ReaxysOutput&ln=	(834 of 1381)		4-[7-(2-cyano-1-hydroxy-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C22H20F2N4O4	C22H20F2N4O4	442.422			XMAJKBPFQFMXJZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.073	2	6	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157997	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157997&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(O)CC#N	4-[7-(2-cyano-1-hydroxy-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(CO)C#N		37157998	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157998&database=RX&origin=ReaxysOutput&ln=	(835 of 1381)		4-[7-(1-cyano-2-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H22F2N4O4	C23H22F2N4O4	456.449			QVZXIYIDWMNPEK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	3.46	2	6	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157998	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157998&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(CO)C#N	4-[7-(1-cyano-2-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(O)COC1		37157999	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157999&database=RX&origin=ReaxysOutput&ln=	(836 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(3-hydroxyoxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C22H21F2N3O5	C22H21F2N3O5	445.423			YDCKRNANILHTJC-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	3	5	2.709	2	6	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157999	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157999&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(O)COC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(3-hydroxyoxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CC#N		37158001	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158001&database=RX&origin=ReaxysOutput&ln=	(837 of 1381)		4-[7-(2-cyano-1-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H22F2N4O4	C23H22F2N4O4	456.449			KYNOZHUGIXKPHE-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.183	2	6	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158001	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158001&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CC#N	4-[7-(2-cyano-1-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1C=CN=C1		37158003	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158003&database=RX&origin=ReaxysOutput&ln=	(838 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-2-imidazol-1-yl-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C25H25F2N5O4	C25H25F2N5O4	497.501			PZSWDDQKEUAWBV-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.588	2	7	10	47.26	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158003	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158003&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1C=CN=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-2-imidazol-1-yl-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COCC(C)(O)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158004	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158004&database=RX&origin=ReaxysOutput&ln=	(839 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-2-methoxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C23H25F2N3O5	C23H25F2N3O5	461.465			BQLZWIVJKHEXBX-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.342	2	6	10	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158004	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158004&database=RX&origin=ReaxysOutput&ln=	COCC(C)(O)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-2-methoxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1CCCCC1		37158007	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158007&database=RX&origin=ReaxysOutput&ln=	(840 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-hydroxy-1-methyl-2-(1-piperidyl)ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			USGDXWKDCXEXSF-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.249	2	6	10	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158007	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158007&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1CCCCC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-hydroxy-1-methyl-2-(1-piperidyl)ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1COCCN1		37158009	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158009&database=RX&origin=ReaxysOutput&ln=	(841 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-morpholin-3-ylimidazo[1,2-a]pyridin-3-yl)benzamide	C23H24F2N4O4	C23H24F2N4O4	458.465			XLJMPXOVFDYWNM-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.345	2	6	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158009	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158009&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1COCCN1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-morpholin-3-ylimidazo[1,2-a]pyridin-3-yl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1CC(F)(F)C1		37158011	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158011&database=RX&origin=ReaxysOutput&ln=	(842 of 1381)		N-cyclopropyl-4-[7-[2-(3,3-difluoroazetidin-1-yl)-1-hydroxy-1-methyl-ethyl]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide	C25H26F4N4O4	C25H26F4N4O4	522.499			VLSLRCZVSPUUEB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.056	2	6	10	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158011	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158011&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1CC(F)(F)C1	N-cyclopropyl-4-[7-[2-(3,3-difluoroazetidin-1-yl)-1-hydroxy-1-methyl-ethyl]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1COCCN1C		37158012	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158012&database=RX&origin=ReaxysOutput&ln=	(843 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(4-methylmorpholin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O4	C24H26F2N4O4	472.492			FJUKKWFVJAHUPR-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.584	1	6	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158012	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158012&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1COCCN1C	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(4-methylmorpholin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1C=NC=N1		37158013	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158013&database=RX&origin=ReaxysOutput&ln=	(844 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-hydroxy-1-methyl-2-(1,2,4-triazol-1-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C24H24F2N6O4	C24H24F2N6O4	498.489			AZXUNJQVADHPFS-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.062	2	8	10	60.15	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158013	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158013&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1C=NC=N1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-hydroxy-1-methyl-2-(1,2,4-triazol-1-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COCC(C)(C#N)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158014	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158014&database=RX&origin=ReaxysOutput&ln=	(845 of 1381)		4-[7-(1-cyano-2-methoxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C24H24F2N4O4	C24H24F2N4O4	470.476			OJQUVCIQOHHQIL-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.979	1	6	10	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158014	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158014&database=RX&origin=ReaxysOutput&ln=	COCC(C)(C#N)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	4-[7-(1-cyano-2-methoxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(O)C1CCC1		37158016	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158016&database=RX&origin=ReaxysOutput&ln=	(846 of 1381)		4-[7-[cyclobutyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C24H25F2N3O4	C24H25F2N3O4	457.477			VQHMMPYFYBLETF-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.729	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158016	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158016&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(O)C1CCC1	4-[7-[cyclobutyl(hydroxy)methyl]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CN2C(C=C1C(C)(C)C#N)=NC=C2C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158017	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158017&database=RX&origin=ReaxysOutput&ln=	(847 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)-6-methoxy-imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C24H24F2N4O4	C24H24F2N4O4	470.476			NFHLMUGZHHWBJE-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.507	1	5	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158017	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158017&database=RX&origin=ReaxysOutput&ln=	COC1=CN2C(C=C1C(C)(C)C#N)=NC=C2C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	4-[7-(1-cyano-1-methyl-ethyl)-6-methoxy-imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCN1		37158018	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158018&database=RX&origin=ReaxysOutput&ln=	(848 of 1381)		4-[7-(azetidin-2-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C22H22F2N4O3	C22H22F2N4O3	428.438			VNXZTAGNFGFDRO-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	3.893	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158018	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158018&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCN1	4-[7-(azetidin-2-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C1(O)CCC1		37158019	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158019&database=RX&origin=ReaxysOutput&ln=	(849 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[7-(1-hydroxycyclobutyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C23H22F3N3O4	C23H22F3N3O4	461.441			UVIYOVVHSWWGHC-LSDHHAIUSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.117	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158019	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158019&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C1(O)CCC1	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[7-(1-hydroxycyclobutyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C1COC1		37158020	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158020&database=RX&origin=ReaxysOutput&ln=	(850 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[7-(oxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C22H20F3N3O4	C22H20F3N3O4	447.414			NRMZKADXAGYPEY-LSDHHAIUSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.8	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158020	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158020&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C1COC1	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[7-(oxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(F)COC1		37158021	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158021&database=RX&origin=ReaxysOutput&ln=	(851 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(3-fluorooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C22H20F3N3O4	C22H20F3N3O4	447.414			CKNXVOVLXOKURV-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.704	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158021	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158021&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(F)COC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(3-fluorooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N		37158022	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158022&database=RX&origin=ReaxysOutput&ln=	(852 of 1381)		4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H22F2N4O3	C23H22F2N4O3	440.449			WIKQHCNIPKUWDQ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.392	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158022	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158022&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N	4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN(C)CCO		37158023	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158023&database=RX&origin=ReaxysOutput&ln=	(853 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-hydroxy-2-[2-hydroxyethyl(methyl)amino]-1-methyl-ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C25H30F2N4O5	C25H30F2N4O5	504.534			OSAQXLBVEGQBPS-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	2.676	3	7	12	34.37	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158023	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158023&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN(C)CCO	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-hydroxy-2-[2-hydroxyethyl(methyl)amino]-1-methyl-ethyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(C)CN(C)CCO1		37158024	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158024&database=RX&origin=ReaxysOutput&ln=	(854 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2,4-dimethylmorpholin-2-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			VNSNRPUFRDSKSH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.694	1	6	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158024	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158024&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(C)CN(C)CCO1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2,4-dimethylmorpholin-2-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C(C)(C)O		37158025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158025&database=RX&origin=ReaxysOutput&ln=	(855 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[7-(1-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C22H22F3N3O4	C22H22F3N3O4	449.43			XTADKOKDFHAKKB-UONOGXRCSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.099	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158025	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158025&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C(C)(C)O	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[7-(1-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(COC1)OC		37158026	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158026&database=RX&origin=ReaxysOutput&ln=	(856 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-methoxyoxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H23F2N3O5	C23H23F2N3O5	459.45			LQUBSTJSEXVXBE-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.228	1	6	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158026	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158026&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(COC1)OC	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-methoxyoxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1(C)CN(C)CCO1		37158027	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158027&database=RX&origin=ReaxysOutput&ln=	(857 of 1381)		2-(difluoromethoxy)-4-[7-(2,4-dimethylmorpholin-2-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H25F5N4O4	C24H25F5N4O4	528.479			OVPBIQWWOSQMQD-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.576	1	6	9	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158027	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158027&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1(C)CN(C)CCO1	2-(difluoromethoxy)-4-[7-(2,4-dimethylmorpholin-2-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CN2C(C=C1C1COC1)=NC=C2C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158028	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158028&database=RX&origin=ReaxysOutput&ln=	(858 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[6-methoxy-7-(oxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H23F2N3O5	C23H23F2N3O5	459.45			RQBUZXRMTILDNL-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.571	1	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158028	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158028&database=RX&origin=ReaxysOutput&ln=	COC1=CN2C(C=C1C1COC1)=NC=C2C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[6-methoxy-7-(oxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C1COC1		37158029	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158029&database=RX&origin=ReaxysOutput&ln=	(859 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[6-(oxetan-3-yl)pyrazolo[1,5-a]pyridin-3-yl]benzamide	C22H21F2N3O4	C22H21F2N3O4	429.423			WKQUXXAYPYSHGM-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.456	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158029	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158029&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C1COC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[6-(oxetan-3-yl)pyrazolo[1,5-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1COC1		37158030	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158030&database=RX&origin=ReaxysOutput&ln=	(860 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[6-(oxetan-3-yl)pyrazolo[1,5-a]pyridin-3-yl]benzamide	C22H20F3N3O4	C22H20F3N3O4	447.414			ZLPJWZSFQXHGSW-JKSUJKDBSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.6	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158030	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158030&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1COC1	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[6-(oxetan-3-yl)pyrazolo[1,5-a]pyridin-3-yl]benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(C)COCCO1		37158031	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158031&database=RX&origin=ReaxysOutput&ln=	(861 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-methyl-1,4-dioxan-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H25F2N3O5	C24H25F2N3O5	473.476			PAAWDWCIPMEVTK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.651	1	6	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158031	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158031&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(C)COCCO1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(2-methyl-1,4-dioxan-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C(OCCO)=CN12)C(C)(C)C#N		37158032	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158032&database=RX&origin=ReaxysOutput&ln=	(862 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)-6-(2-hydroxyethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C25H26F2N4O5	C25H26F2N4O5	500.502			TZDCPSWQBVNQOV-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.798	2	6	11	58.16	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158032	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158032&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C(OCCO)=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)-6-(2-hydroxyethoxy)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C1(O)COC1		37158034	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158034&database=RX&origin=ReaxysOutput&ln=	(863 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[7-(3-hydroxyoxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C22H20F3N3O5	C22H20F3N3O5	463.413			SMDPXDCAFKEMQX-UONOGXRCSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	2.853	2	6	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158034	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158034&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C1(O)COC1	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[7-(3-hydroxyoxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)O		37158037	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158037&database=RX&origin=ReaxysOutput&ln=	(864 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[6-(1-hydroxy-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide	C22H22F3N3O4	C22H22F3N3O4	449.43			OLFCGMGJABXZJP-LSDHHAIUSA-N				Identification(12); Spectra(2); Bioactivity(2)		5	3.899	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158037	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158037&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)O	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[6-(1-hydroxy-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2N=CC(=CN2N=C1)C(C)(C)C#N		37158040	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158040&database=RX&origin=ReaxysOutput&ln=	(865 of 1381)		4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyrimidin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			AFNYNWQEQQHDHH-LSDHHAIUSA-N				Identification(12); Spectra(2); Bioactivity(2)		5	3.495	1	6	8	71.05	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158040	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158040&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2N=CC(=CN2N=C1)C(C)(C)C#N	4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyrimidin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C1COCCO1		37158041	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158041&database=RX&origin=ReaxysOutput&ln=	(866 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[6-(1,4-dioxan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide	C23H23F2N3O5	C23H23F2N3O5	459.45			RLOVAFPVMFRAHH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.341	1	6	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158041	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158041&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C1COCCO1	N-cyclopropyl-2-(difluoromethoxy)-4-[6-(1,4-dioxan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)CO		37158042	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158042&database=RX&origin=ReaxysOutput&ln=	(867 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[6-(2-hydroxy-1,1-dimethyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide	C23H25F2N3O4	C23H25F2N3O4	445.466			WTBPGYVUBFQPRY-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.771	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158042	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158042&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)CO	N-cyclopropyl-2-(difluoromethoxy)-4-[6-(2-hydroxy-1,1-dimethyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COCC(C)(C)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158045	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158045&database=RX&origin=ReaxysOutput&ln=	(868 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[6-(2-methoxy-1,1-dimethyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]benzamide	C24H27F2N3O4	C24H27F2N3O4	459.493			MIJPBUQCNFQCMV-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.29	1	5	10	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158045	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158045&database=RX&origin=ReaxysOutput&ln=	COCC(C)(C)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[6-(2-methoxy-1,1-dimethyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)OCCO		37158046	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158046&database=RX&origin=ReaxysOutput&ln=	(869 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[6-[1-(2-hydroxyethoxy)-1-methyl-ethyl]pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide	C24H27F2N3O5	C24H27F2N3O5	475.492			IXNDATPCCWTEQI-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.565	2	6	11	34.37	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158046	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158046&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)OCCO	N-cyclopropyl-2-(difluoromethoxy)-4-[6-[1-(2-hydroxyethoxy)-1-methyl-ethyl]pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1COCCO1		37158047	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158047&database=RX&origin=ReaxysOutput&ln=	(870 of 1381)		2-(difluoromethoxy)-4-[6-(1,4-dioxan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C23H22F3N3O5	C23H22F3N3O5	477.44			IBWQLTIXRNKBIY-QRFGBVCESA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.485	1	6	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158047	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158047&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1COCCO1	2-(difluoromethoxy)-4-[6-(1,4-dioxan-2-yl)pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)CO		37158049	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158049&database=RX&origin=ReaxysOutput&ln=	(871 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[6-(2-hydroxy-1,1-dimethyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide	C23H24F3N3O4	C23H24F3N3O4	463.456			XTANCFUZUVABDO-JKSUJKDBSA-N				Identification(12); Spectra(1); Bioactivity(2)	3	5	3.915	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158049	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158049&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)CO	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[6-(2-hydroxy-1,1-dimethyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N		37158050	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158050&database=RX&origin=ReaxysOutput&ln=	(872 of 1381)		4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-2,6-dimethoxy-benzamide	C23H23FN4O3	C23H23FN4O3	422.459			OAJIOGLJTFTDQK-DLBZAZTESA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.822	1	5	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158050	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158050&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N						IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)S(C)(=O)=O		37158051	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158051&database=RX&origin=ReaxysOutput&ln=	(873 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[6-(1-methyl-1-methylsulfonyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]benzamide	C23H24F3N3O5S	C23H24F3N3O5S	511.522			ORMVMDNPJNYMAC-JKSUJKDBSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.081	1	6	9	68.51	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158051	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158051&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)S(C)(=O)=O	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[6-(1-methyl-1-methylsulfonyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C1=NOC(C)=N1		37158052	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158052&database=RX&origin=ReaxysOutput&ln=	(874 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[6-[1-methyl-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide	C25H25F2N5O4	C25H25F2N5O4	497.501			VBXIYIXXJVFSPD-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.034	1	5	9	73.29	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158052	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158052&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C1=NOC(C)=N1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[6-[1-methyl-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C1=NC(C)=NO1		37158053	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158053&database=RX&origin=ReaxysOutput&ln=	(875 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[6-[1-methyl-1-(3-methyl-1,2,4-oxadiazol-5-yl)ethyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide	C25H25F2N5O4	C25H25F2N5O4	497.501			LQEZKRIMGFZTIE-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	5.034	1	5	9	73.29	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158053	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158053&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C1=NC(C)=NO1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[6-[1-methyl-1-(3-methyl-1,2,4-oxadiazol-5-yl)ethyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCC1)C#N		37158056	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158056&database=RX&origin=ReaxysOutput&ln=	(876 of 1381)		4-[6-(1-cyanocyclobutyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C24H21F3N4O3	C24H21F3N4O3	470.451			QUAWDZRKCUGHLP-DLBZAZTESA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.765	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158056	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158056&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCC1)C#N	4-[6-(1-cyanocyclobutyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N		37158058	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158058&database=RX&origin=ReaxysOutput&ln=	(877 of 1381)		4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-fluoro-6-methoxy-benzamide	C22H21FN4O2	C22H21FN4O2	392.433			CHPWVSBWISFXFB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	4	5	3.924	1	5	6	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158058	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158058&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N	4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-fluoro-6-methoxy-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)N		37158062	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158062&database=RX&origin=ReaxysOutput&ln=	(878 of 1381)		4-[6-(1-amino-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C22H23F3N4O3	C22H23F3N4O3	448.445			PFPLYFHUGDKJLH-LSDHHAIUSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.832	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158062	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158062&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)N	4-[6-(1-amino-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(N)CCC1		37158063	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158063&database=RX&origin=ReaxysOutput&ln=	(879 of 1381)		4-[6-(1-aminocyclobutyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C23H23F3N4O3	C23H23F3N4O3	460.456			GBUUQVYFYZQGFY-JKSUJKDBSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.85	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158063	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158063&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(N)CCC1	4-[6-(1-aminocyclobutyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)COCC1COC1		37158064	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158064&database=RX&origin=ReaxysOutput&ln=	(880 of 1381)		2-(difluoromethoxy)-4-[6-[1,1-dimethyl-2-(oxetan-3-ylmethoxy)ethyl]pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C27H30F3N3O5	C27H30F3N3O5	533.548			SCIVIDMKOXTPPR-VQTJNVASSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.266	1	6	12	34.37	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158064	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158064&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)COCC1COC1	2-(difluoromethoxy)-4-[6-[1,1-dimethyl-2-(oxetan-3-ylmethoxy)ethyl]pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)COC1COC1		37158066	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158066&database=RX&origin=ReaxysOutput&ln=	(881 of 1381)		2-(difluoromethoxy)-4-[6-[1,1-dimethyl-2-(oxetan-3-yloxy)ethyl]pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C26H28F3N3O5	C26H28F3N3O5	519.521			UQVANQLCCOMAFN-RBUKOAKNSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.071	1	6	11	34.37	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158066	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158066&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)COC1COC1	2-(difluoromethoxy)-4-[6-[1,1-dimethyl-2-(oxetan-3-yloxy)ethyl]pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(O)CCC1		37158067	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158067&database=RX&origin=ReaxysOutput&ln=	(882 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[6-(1-hydroxycyclobutyl)pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide	C23H22F3N3O4	C23H22F3N3O4	461.441			UYSFYQFCDZAEOR-JKSUJKDBSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.917	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158067	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158067&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(O)CCC1	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[6-(1-hydroxycyclobutyl)pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCC1)NCC#N		37158069	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158069&database=RX&origin=ReaxysOutput&ln=	(883 of 1381)		4-[6-[1-(cyanomethylamino)cyclobutyl]pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C25H24F3N5O3	C25H24F3N5O3	499.492			ZTOGEUKXIGWYSN-ZWKOTPCHSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.733	2	6	10	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158069	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158069&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCC1)NCC#N	4-[6-[1-(cyanomethylamino)cyclobutyl]pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCC1)NCC(F)F		37158070	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158070&database=RX&origin=ReaxysOutput&ln=	(884 of 1381)		4-[6-[1-(2,2-difluoroethylamino)cyclobutyl]pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C25H25F5N4O3	C25H25F5N4O3	524.491			KVCIZLRNPSNURH-DLBZAZTESA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.149	2	5	11	34.37	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158070	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158070&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCC1)NCC(F)F	4-[6-[1-(2,2-difluoroethylamino)cyclobutyl]pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCC1)C(=O)N1CCOCC1		37158073	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158073&database=RX&origin=ReaxysOutput&ln=	(885 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[6-[1-(morpholine-4-carbonyl)cyclobutyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide	C28H29F3N4O5	C28H29F3N4O5	558.557			DMBXYEDSHZGUSP-VQTJNVASSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.186	1	7	10	51.44	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158073	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158073&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCC1)C(=O)N1CCOCC1	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[6-[1-(morpholine-4-carbonyl)cyclobutyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCC1		37158224	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158224&database=RX&origin=ReaxysOutput&ln=	(886 of 1381)		4-(7-cyclobutylimidazo[1,2-a]pyridin-3-yl)-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H23F2N3O3	C23H23F2N3O3	427.451			VWWKYIJYZQTPTK-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	5.764	1	4	8	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158224	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158224&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCC1	4-(7-cyclobutylimidazo[1,2-a]pyridin-3-yl)-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CC1)C#N		37158252	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158252&database=RX&origin=ReaxysOutput&ln=	(887 of 1381)		4-[6-(1-cyanocyclopropyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C23H19F3N4O3	C23H19F3N4O3	456.424			RKZJTHQQNVXOLD-JKSUJKDBSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	4.196	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158252	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158252&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CC1)C#N	4-[6-(1-cyanocyclopropyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C(=O)N1CCOCC1		37158253	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158253&database=RX&origin=ReaxysOutput&ln=	(888 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(morpholine-4-carbonyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H28F2N4O5	C27H28F2N4O5	526.54			UENOWCKBBRUMKM-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.673	1	7	10	51.44	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158253	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158253&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C(=O)N1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(morpholine-4-carbonyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(O)CCOC1		37158256	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158256&database=RX&origin=ReaxysOutput&ln=	(889 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(3-hydroxytetrahydrofuran-3-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C23H23F2N3O5	C23H23F2N3O5	459.45			NRIUIPSHRZBJEB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	3.067	2	6	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158256	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158256&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(O)CCOC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(3-hydroxytetrahydrofuran-3-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C(C)(C)C#N		37158260	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158260&database=RX&origin=ReaxysOutput&ln=	(890 of 1381)		4-[5-(1-cyano-1-methyl-ethyl)benzimidazol-1-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H22F2N4O3	C23H22F2N4O3	440.449			RTZCQVKOCKASOL-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	11	5	4.141	1	5	8	53.75	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158260	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158260&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)N1C=NC2=CC(=CC=C12)C(C)(C)C#N	4-[5-(1-cyano-1-methyl-ethyl)benzimidazol-1-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCN(CC#N)CC1		37158262	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158262&database=RX&origin=ReaxysOutput&ln=	(891 of 1381)		4-[5-[1-(cyanomethyl)-4-piperidyl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C25H26F3N5O3	C25H26F3N5O3	501.508			FPKBGMKHDIUHAU-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	3.625	1	6	9	53.75	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158262	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158262&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCN(CC#N)CC1	4-[5-[1-(cyanomethyl)-4-piperidyl]benzimidazol-1-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3CN(C3)C(C)=O)C(F)=CN12		37158263	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158263&database=RX&origin=ReaxysOutput&ln=	(892 of 1381)		4-[7-(1-acetylazetidin-3-yl)-6-fluoro-imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C24H23F3N4O4	C24H23F3N4O4	488.466			JNPQVBNNAVZZEB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.649	1	6	9	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158263	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158263&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3CN(C3)C(C)=O)C(F)=CN12	4-[7-(1-acetylazetidin-3-yl)-6-fluoro-imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CN(C)C1		37158265	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158265&database=RX&origin=ReaxysOutput&ln=	(893 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylazetidin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H24F2N4O3	C23H24F2N4O3	442.465			CZNZOZMQBWXANZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	3.699	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158265	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158265&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CN(C)C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylazetidin-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCN1C		37158266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158266&database=RX&origin=ReaxysOutput&ln=	(894 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylazetidin-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C23H24F2N4O3	C23H24F2N4O3	442.465			USPHVZKWEQPFKM-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.132	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158266	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158266&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCN1C	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylazetidin-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCN(C)CC1		37158269	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158269&database=RX&origin=ReaxysOutput&ln=	(895 of 1381)		2,6-dimethoxy-4-[5-(1-methyl-4-piperidyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H27F3N4O3	C24H27F3N4O3	476.499			XFPGCAQQTOGPQZ-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.132	1	5	8	29.96	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158269	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158269&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCN(C)CC1	2,6-dimethoxy-4-[5-(1-methyl-4-piperidyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCNCC1		37158270	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158270&database=RX&origin=ReaxysOutput&ln=	(896 of 1381)		2,6-dimethoxy-4-[5-(4-piperidyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H25F3N4O3	C23H25F3N4O3	462.472			CTKNNVFJLLBXPF-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	3.893	2	5	8	29.96	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158270	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158270&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCNCC1	2,6-dimethoxy-4-[5-(4-piperidyl)benzimidazol-1-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCNCC1		37158271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158271&database=RX&origin=ReaxysOutput&ln=	(897 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(4-piperidyl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O3	C24H26F2N4O3	456.492			KXTYILBXJHIWBF-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	4.176	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158271	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158271&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCNCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(4-piperidyl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)O		37158272	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158272&database=RX&origin=ReaxysOutput&ln=	(898 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxyethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C21H21F2N3O4	C21H21F2N3O4	417.412			GHGQJIIJHMPDTO-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	3	5	3.845	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158272	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158272&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)O	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxyethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)O		37158275	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158275&database=RX&origin=ReaxysOutput&ln=	(899 of 1381)		4-[7-(1-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C21H22F3N3O4	C21H22F3N3O4	437.419			PXXOEHSOXDODPB-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	4.123	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158275	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158275&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)O	4-[7-(1-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@H]1C[C@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N		37158277	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158277&database=RX&origin=ReaxysOutput&ln=	(900 of 1381)		4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1S,2R)-2-fluorocyclopropyl]-6-methoxy-benzamide	C23H21F3N4O3	C23H21F3N4O3	458.44			BDTLFPRHEXLZDV-CVEARBPZSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.536	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158277	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158277&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@H]1C[C@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N	4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1S,2R)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1C=CC=N1		37158280	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158280&database=RX&origin=ReaxysOutput&ln=	(901 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-2-pyrazol-1-yl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C25H25F2N5O4	C25H25F2N5O4	497.501			RATRYNKDTPVEQU-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.919	2	7	10	47.26	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158280	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158280&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1C=CC=N1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-2-pyrazol-1-yl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C1(F)COC1		37158283	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158283&database=RX&origin=ReaxysOutput&ln=	(902 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[7-(3-fluorooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C22H19F4N3O4	C22H19F4N3O4	465.404			LBGLIZJDIQTSRE-UONOGXRCSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.848	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158283	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158283&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=CN12)C1(F)COC1	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[7-(3-fluorooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)N		37158285	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158285&database=RX&origin=ReaxysOutput&ln=	(903 of 1381)		4-[7-(1-amino-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C22H24F2N4O3	C22H24F2N4O3	430.454			FOVLZGYQKCDGPD-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	3.888	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158285	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158285&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)N	4-[7-(1-amino-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C1=NOC(C)=N1		37158339	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158339&database=RX&origin=ReaxysOutput&ln=	(904 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-methyl-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H25F2N5O4	C25H25F2N5O4	497.501			BQKUNHVAWOYHLH-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	5.234	1	5	9	73.29	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158339	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158339&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C1=NOC(C)=N1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-methyl-1-(5-methyl-1,2,4-oxadiazol-3-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CN(C1)C(C)=O		37158340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158340&database=RX&origin=ReaxysOutput&ln=	(905 of 1381)		4-[7-(1-acetylazetidin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C24H24F2N4O4	C24H24F2N4O4	470.476			HRPCITFILOWKNU-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	3.488	1	6	9	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158340&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CN(C1)C(C)=O	4-[7-(1-acetylazetidin-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)CN		37158341	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158341&database=RX&origin=ReaxysOutput&ln=	(906 of 1381)		4-[7-(2-amino-1,1-dimethyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H26F2N4O3	C23H26F2N4O3	444.481			AKZMBEGIQGRRIN-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.904	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158341	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158341&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)CN	4-[7-(2-amino-1,1-dimethyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CO)CC1		37158342	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158342&database=RX&origin=ReaxysOutput&ln=	(907 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-(hydroxymethyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C23H23F2N3O4	C23H23F2N3O4	443.45			OAESQAGKFZXAJA-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	3	5	3.631	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158342	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158342&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CO)CC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-(hydroxymethyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCC(O)C(C)(C)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158348	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158348&database=RX&origin=ReaxysOutput&ln=	(908 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethyl-butyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C25H29F2N3O4	C25H29F2N3O4	473.52			GSIKUCUJIDDCHE-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.789	2	5	10	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158348	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158348&database=RX&origin=ReaxysOutput&ln=	CCC(O)C(C)(C)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-1,1-dimethyl-butyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(Cl)COC1		37158349	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158349&database=RX&origin=ReaxysOutput&ln=	(909 of 1381)		4-[7-(3-chlorooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C22H20ClF2N3O4	C22H20ClF2N3O4	463.868			CRNRWBMGPPIREA-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	3.841	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158349	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158349&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(Cl)COC1	4-[7-(3-chlorooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N		37158350	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158350&database=RX&origin=ReaxysOutput&ln=	(910 of 1381)		4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C23H21F3N4O3	C23H21F3N4O3	458.44			BDTLFPRHEXLZDV-JKSUJKDBSA-N				Identification(12); Spectra(2); Bioactivity(2)	8	5	4.536	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158350	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158350&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N	4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C1CCO1		37158352	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158352&database=RX&origin=ReaxysOutput&ln=	(911 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-methyl-1-(oxetan-2-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]benzamide	C25H27F2N3O4	C25H27F2N3O4	471.504			UFFBLCOPKCNQLT-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)		5	4.675	1	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158352	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158352&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C1CCO1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-methyl-1-(oxetan-2-yl)ethyl]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N		37158355	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158355&database=RX&origin=ReaxysOutput&ln=	(912 of 1381)		4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide	C23H24N4O3	C23H24N4O3	404.469			STAIHLQNIPEMES-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.678	1	5	7	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158355	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158355&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N	4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COCCOC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N		37158356	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158356&database=RX&origin=ReaxysOutput&ln=	(913 of 1381)		4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-methoxy-6-(2-methoxyethoxy)benzamide	C25H28N4O4	C25H28N4O4	448.522			PMLLJAXYAWMPJR-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.488	1	6	10	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158356	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158356&database=RX&origin=ReaxysOutput&ln=	COCCOC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N	4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-methoxy-6-(2-methoxyethoxy)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OCCO)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N		37158357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158357&database=RX&origin=ReaxysOutput&ln=	(914 of 1381)		4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-(2-hydroxyethoxy)-6-methoxy-benzamide	C24H26N4O4	C24H26N4O4	434.495			UMBKYCZMRNNSRF-UHFFFAOYSA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	2.969	2	6	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158357&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OCCO)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N	4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-(2-hydroxyethoxy)-6-methoxy-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)NCCO		37158359	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158359&database=RX&origin=ReaxysOutput&ln=	(915 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[6-[1-(2-hydroxyethylamino)-1-methyl-ethyl]pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide	C24H27F3N4O4	C24H27F3N4O4	492.498			WXYRQTKULLSTJX-DLBZAZTESA-N				Identification(12); Spectra(1); Bioactivity(2)	1	5	3.513	3	6	11	34.37	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158359	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158359&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)NCCO	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[6-[1-(2-hydroxyethylamino)-1-methyl-ethyl]pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCN(CC)CC(C)(C)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1		37158362	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158362&database=RX&origin=ReaxysOutput&ln=	(916 of 1381)		4-[6-[2-(diethylamino)-1,1-dimethyl-ethyl]pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C27H33F3N4O3	C27H33F3N4O3	518.579			CFUZZEVAAAADNV-VQTJNVASSA-N				Identification(12); Spectra(1); Bioactivity(2)	2	5	5.323	1	5	12	34.37	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158362	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158362&database=RX&origin=ReaxysOutput&ln=	CCN(CC)CC(C)(C)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1	4-[6-[2-(diethylamino)-1,1-dimethyl-ethyl]pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CC1=C(NC(=O)C2=CN=C(NC3=NC(C)=NC(=C3)N3CCN(CCO)CC3)S2)C(Cl)=CS1		39059469	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059469&database=RX&origin=ReaxysOutput&ln=	(917 of 1381)			C20H24ClN7O2S2	C20H24ClN7O2S2	494.041			PKJTVQJCYWTEFT-UHFFFAOYSA-N				Identification(11); Spectra(2); Bioactivity(3)		5	1.333	3	9	8	112.22	4	2	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		39059469	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059469&database=RX&origin=ReaxysOutput&ln=	CC1=C(NC(=O)C2=CN=C(NC3=NC(C)=NC(=C3)N3CCN(CCO)CC3)S2)C(Cl)=CS1						IC50	nM	<=	200							6.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=C(NC(=O)C2=CN=C(NC3=NC(C)=NC(=C3)N3CCN(CCO)CC3)S2)C(Cl)=CS1		39059469	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059469&database=RX&origin=ReaxysOutput&ln=	(917 of 1381)			C20H24ClN7O2S2	C20H24ClN7O2S2	494.041			PKJTVQJCYWTEFT-UHFFFAOYSA-N				Identification(11); Spectra(2); Bioactivity(3)		5	1.333	3	9	8	112.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									39059469	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059469&database=RX&origin=ReaxysOutput&ln=	CC1=C(NC(=O)C2=CN=C(NC3=NC(C)=NC(=C3)N3CCN(CCO)CC3)S2)C(Cl)=CS1						IC50	nM	~	40 - 45							7.4			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=C(NC(=O)C2=CN=C(NC3=NC(C)=NC(=C3)N3CCN(CCO)CC3)S2)C(Cl)=CS1		39059469	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059469&database=RX&origin=ReaxysOutput&ln=	(917 of 1381)			C20H24ClN7O2S2	C20H24ClN7O2S2	494.041			PKJTVQJCYWTEFT-UHFFFAOYSA-N				Identification(11); Spectra(2); Bioactivity(3)		5	1.333	3	9	8	112.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									39059469	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059469&database=RX&origin=ReaxysOutput&ln=	CC1=C(NC(=O)C2=CN=C(NC3=NC(C)=NC(=C3)N3CCN(CCO)CC3)S2)C(Cl)=CS1						IC50	nM	~	40 - 45							7.4			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC(=C)CCOP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N		10505216	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D10505216&database=RX&origin=ReaxysOutput&ln=	(918 of 1381)		ApppI; isopentenyl adenosine-triphosphate	C15H24N5O13P3	C15H24N5O13P3	575.303	heterocyclic		VQJRBOQULSKKGC-SDBHATRESA-N				Identification(8); Spectra(2); Bioactivity(5)	2	4	-3.968	6	18	12	297.56	1	0	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									10505216	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D10505216&database=RX&origin=ReaxysOutput&ln=	CC(=C)CCOP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N						IC50	μM	>	10							1						Article; Malwal, Satish R.; O'Dowd, Bing; Feng, Xinxin; Turhanen, Petri; Shin, Christopher; Yao, Jiaqi; Kim, Boo Kyung; Baig, Noman; Zhou, Tianhui; Bansal, Sandhya; Khade, Rahul L.; Zhang, Yong; Oldfield, Eric; Journal of the American Chemical Society; vol. 140; 24; (2018); p. 7568 - 7578;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D73905000&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(NC=C2C2=C(I)N=C(O2)C2=CC=CN2)=CC(Br)=C1		23173000	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D23173000&database=RX&origin=ReaxysOutput&ln=	(919 of 1381)	1416313-95-5	breitfussin A	C16H11BrIN3O2	C16H11BrIN3O2	484.091			QFXGRFBNODUHIK-UHFFFAOYSA-N				Identification(6); Physical Data(2); Spectra(14); Bioactivity(2)	17	4	4.744	2	3	3	66.84	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									23173000	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D23173000&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(NC=C2C2=C(I)N=C(O2)C2=CC=CN2)=CC(Br)=C1	breitfussin A					IC50	μM	>	50							1			73010	ATP	Other compound	Article; Hansen, Kine Ø.; Andersen, Jeanette H.; Bayer, Annette; Pandey, Sunil K.; Lorentzen, Marianne; Jørgensen, Kåre B.; Sydnes, Magne O.; Guttormsen, Yngve; Baumann, Matthias; Koch, Uwe; Klebl, Bert; Eickhoff, Jan; Haug, Bengt Erik; Isaksson, Johan; Hansen, Espen H.; Journal of Medicinal Chemistry; vol. 62; 22; (2019); p. 10167 - 10181;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78442548&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2F)=CC(=N1)N1CCN(CCO)CC1		24511959	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D24511959&database=RX&origin=ReaxysOutput&ln=	(920 of 1381)		N-(2-chloro-6-fluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H23ClFN7O2S	C21H23ClFN7O2S	491.977			FSCJURGWSGGSMO-UHFFFAOYSA-N				Identification(9); Spectra(2); Bioactivity(2)	1	4	1.926	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									24511959	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D24511959&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2F)=CC(=N1)N1CCN(CCO)CC1	N-(2-chloro-6-fluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	<	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(C)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1		24511960	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D24511960&database=RX&origin=ReaxysOutput&ln=	(921 of 1381)		N-(2,6-dimethylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C23H29N7O2S	C23H29N7O2S	467.595			ZJNRVTXELRYZHD-UHFFFAOYSA-N				Identification(9); Spectra(2); Bioactivity(2)	1	4	1.595	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									24511960	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D24511960&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(C)=C1NC(=O)C1=CN=C(NC2=CC(=NC(C)=N2)N2CCN(CCO)CC2)S1	N-(2,6-dimethylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	<	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC=C2C=C(C(=O)N(C[C@H]3OC[C@H](N)CO3)C2=N1)C1=C(Cl)C=C(C=C1)C1=NC(C)=CC=C1		27946858	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27946858&database=RX&origin=ReaxysOutput&ln=	(922 of 1381)		8-[(5-amino-1,3-dioxan-2-yl)methyl]-6-[2-chloro-4-(6-methyl-2-pyridyl)phenyl]-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one	C25H25ClN6O3	C25H25ClN6O3	492.965			ZBCMHWUFWQFPLV-VVOJOOEHSA-N				Identification(9); Spectra(4); Bioactivity(4)		4	2.611	2	9	5	115.49	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		27946858	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27946858&database=RX&origin=ReaxysOutput&ln=	CNC1=NC=C2C=C(C(=O)N(C[C@H]3OC[C@H](N)CO3)C2=N1)C1=C(Cl)C=C(C=C1)C1=NC(C)=CC=C1						IC50	nM		24							7.62						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2)=CC(=N1)N1CCN(CCO)CC1		29228337	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29228337&database=RX&origin=ReaxysOutput&ln=	(923 of 1381)		dasatinib; N-(2-chlorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H24ClN7O2S	C21H24ClN7O2S	473.986			OIJRUNSYNMNOEK-UHFFFAOYSA-N				Identification(9); Spectra(2); Bioactivity(3)	1	4	1.765	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									29228337	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29228337&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2)=CC(=N1)N1CCN(CCO)CC1	N-(2-chlorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	>	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=CC=C2)=CC(=N1)N1CCN(CCO)CC1		29671233	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29671233&database=RX&origin=ReaxysOutput&ln=	(924 of 1381)		N-phenyl-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide; ((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-phenylthiazole-5-carboxamide	C21H25N7O2S	C21H25N7O2S	439.541			JVHHEWOMBLCEMP-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(6); Bioactivity(3)	4	4	1.143	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									29671233	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29671233&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=CC=C2)=CC(=N1)N1CCN(CCO)CC1	((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-phenylthiazole-5-carboxamide					IC50	μM	>	1							6						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC(C)S(=O)(=O)C1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C=CC=C1		33633214	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633214&database=RX&origin=ReaxysOutput&ln=	(925 of 1381)		2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-(propane-2-sulfonyl)phenyl)thiazole-5-carboxamide	C24H31N7O4S2	C24H31N7O4S2	545.687			DGPCQIFMRPFLJM-UHFFFAOYSA-N				Identification(10); Spectra(2); Bioactivity(2)	1	4	2.177	3	11	10	177.27	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633214	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633214&database=RX&origin=ReaxysOutput&ln=	CC(C)S(=O)(=O)C1=C(NC(=O)C2=CN=C(NC3=CC(=NC(C)=N3)N3CCN(CCO)CC3)S2)C=CC=C1	2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-(propane-2-sulfonyl)phenyl)thiazole-5-carboxamide					IC50	μM	>	1							6						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCS(=N)(=O)CC3)C=CN12		35503123	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503123&database=RX&origin=ReaxysOutput&ln=	(926 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1-imino-1-oxo-1,4-thiazinan-4-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H31F2N5O5S	C26H31F2N5O5S	563.625			RBIHBKVXJGBBAY-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.363	2	7	12	126.63	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503123	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503123&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCS(=N)(=O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1-imino-1-oxo-1,4-thiazinan-4-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCS(=N)(=O)CC3)C=CN12		35503123	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503123&database=RX&origin=ReaxysOutput&ln=	(926 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1-imino-1-oxo-1,4-thiazinan-4-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H31F2N5O5S	C26H31F2N5O5S	563.625			RBIHBKVXJGBBAY-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.363	2	7	12	126.63	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503123	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503123&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CCS(=N)(=O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1-imino-1-oxo-1,4-thiazinan-4-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(CCS4(=O)=O)C3)C=CN12		35503126	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503126&database=RX&origin=ReaxysOutput&ln=	(927 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1λ6-thia-6-azaspiro[3.3]heptan-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C27H30F2N4O6S	C27H30F2N4O6S	576.621			JWRZBEROBPFSBG-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	3.79	1	7	12	119.85	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503126	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503126&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCCN3CC4(CCS4(=O)=O)C3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[3-(1,1-dioxo-1λ6-thia-6-azaspiro[3.3]heptan-6-yl)propoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(C)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503162	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503162&database=RX&origin=ReaxysOutput&ln=	(928 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-methylpiperidine-4-carboxylate	C31H38F2N4O7	C31H38F2N4O7	616.662			XWZZFSARDAAPQB-UHFFFAOYSA-N				Identification(10); Spectra(1); Bioactivity(2)	1	4	4.087	2	8	15	123.86	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503162	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503162&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(C)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-methylpiperidine-4-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(C)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503162	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503162&database=RX&origin=ReaxysOutput&ln=	(928 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-methylpiperidine-4-carboxylate	C31H38F2N4O7	C31H38F2N4O7	616.662			XWZZFSARDAAPQB-UHFFFAOYSA-N				Identification(10); Spectra(1); Bioactivity(2)	1	4	4.087	2	8	15	123.86	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503162	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503162&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(C)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-methylpiperidine-4-carboxylate					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(O)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503163	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503163&database=RX&origin=ReaxysOutput&ln=	(929 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-hydroxypiperidine-4-carboxylate	C30H36F2N4O8	C30H36F2N4O8	618.635			JTHPTVUYUYWDFV-UHFFFAOYSA-N				Identification(10); Spectra(1); Bioactivity(2)	1	4	2.939	3	9	15	144.09	3	0	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503163	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503163&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(O)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-hydroxypiperidine-4-carboxylate					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
CCOC(=O)C1(O)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1		35503163	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503163&database=RX&origin=ReaxysOutput&ln=	(929 of 1381)		ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-hydroxypiperidine-4-carboxylate	C30H36F2N4O8	C30H36F2N4O8	618.635			JTHPTVUYUYWDFV-UHFFFAOYSA-N				Identification(10); Spectra(1); Bioactivity(2)	1	4	2.939	3	9	15	144.09	3	0	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503163	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503163&database=RX&origin=ReaxysOutput&ln=	CCOC(=O)C1(O)CCN(CC(O)COC2=CC3=NC=C(N3C=C2)C2=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C2)CC1	ethyl 1-[3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxyphenyl]imidazo[1,2-a]pyridin-7-yl]oxy-2-hydroxypropyl]-4-hydroxypiperidine-4-carboxylate					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCS(=O)(=O)CC3)C=CN12		35503333	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503333&database=RX&origin=ReaxysOutput&ln=	(930 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H28F2N4O6S	C25H28F2N4O6S	550.583			SZZKBDGYKNJMME-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	3.438	1	7	11	119.85	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503333	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503333&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OCCN3CCS(=O)(=O)CC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCS(=O)(=O)CC3)C=CN12		35503379	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503379&database=RX&origin=ReaxysOutput&ln=	(931 of 1381)		6-[7-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O5S	C25H27F3N4O5S	552.574			NUSMUFVTLVIQJU-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	3.679	0	7	8	101.83	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503379	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503379&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCS(=O)(=O)CC3)C=CN12	6-[7-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCS(=O)(=O)CC3)C=CN12		35503379	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503379&database=RX&origin=ReaxysOutput&ln=	(931 of 1381)		6-[7-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O5S	C25H27F3N4O5S	552.574			NUSMUFVTLVIQJU-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	3.679	0	7	8	101.83	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503379	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503379&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCS(=O)(=O)CC3)C=CN12	6-[7-[2-(1,1-dioxo-1,4-thiazinan-4-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl]-8-methoxy-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCOCC1		37157849	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157849&database=RX&origin=ReaxysOutput&ln=	(932 of 1381)		2,6-dimethoxy-4-(5-tetrahydropyran-4-ylbenzimidazol-1-yl)-N-(2,2,2-trifluoroethyl)benzamide	C23H24F3N3O4	C23H24F3N3O4	463.456			PWXUNLJWCCFIRX-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.089	1	5	8	29.96	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157849	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157849&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCOCC1	2,6-dimethoxy-4-(5-tetrahydropyran-4-ylbenzimidazol-1-yl)-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCN(CC1)C(=O)OC(C)(C)C		37157859	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157859&database=RX&origin=ReaxysOutput&ln=	(933 of 1381)		tert-butyl 4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]piperidine-1-carboxylate	C28H33F3N4O5	C28H33F3N4O5	562.589			FSKZZUKZZWXVMF-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	5.843	1	7	11	51.44	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157859	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157859&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCN(CC1)C(=O)OC(C)(C)C	tert-butyl 4-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]piperidine-1-carboxylate					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157863	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157863&database=RX&origin=ReaxysOutput&ln=	(934 of 1381)		2-[3-(8-methoxy-1-oxo-3,4-dihydro-2H-isoquinolin-6-yl)imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C21H20N4O2	C21H20N4O2	360.415			RJNXZZNLUKQWLN-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	3.266	1	5	3	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157863	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157863&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-(8-methoxy-1-oxo-3,4-dihydro-2H-isoquinolin-6-yl)imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157863	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157863&database=RX&origin=ReaxysOutput&ln=	(934 of 1381)		2-[3-(8-methoxy-1-oxo-3,4-dihydro-2H-isoquinolin-6-yl)imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C21H20N4O2	C21H20N4O2	360.415			RJNXZZNLUKQWLN-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	3.266	1	5	3	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157863	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157863&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)NCC2)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-(8-methoxy-1-oxo-3,4-dihydro-2H-isoquinolin-6-yl)imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCCN(C1)C(=O)OC(C)(C)C		37157864	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157864&database=RX&origin=ReaxysOutput&ln=	(935 of 1381)		tert-butyl 3-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]piperidine-1-carboxylate	C28H33F3N4O5	C28H33F3N4O5	562.589			JQJDTWFEXNTEDR-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	5.843	1	7	11	51.44	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157864	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157864&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCCN(C1)C(=O)OC(C)(C)C	tert-butyl 3-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]piperidine-1-carboxylate					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCN(C)CC1		37157865	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157865&database=RX&origin=ReaxysOutput&ln=	(936 of 1381)		2,6-dimethoxy-4-[7-(1-methyl-4-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H27F3N4O3	C24H27F3N4O3	476.499			CAPRGWDESUWDNE-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	4.583	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157865	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157865&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCN(C)CC1	2,6-dimethoxy-4-[7-(1-methyl-4-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCN(C)CC1		37157865	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157865&database=RX&origin=ReaxysOutput&ln=	(936 of 1381)		2,6-dimethoxy-4-[7-(1-methyl-4-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H27F3N4O3	C24H27F3N4O3	476.499			CAPRGWDESUWDNE-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	4.583	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157865	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157865&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCN(C)CC1	2,6-dimethoxy-4-[7-(1-methyl-4-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCCNC1		37157867	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157867&database=RX&origin=ReaxysOutput&ln=	(937 of 1381)		2,6-dimethoxy-4-[7-(3-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H25F3N4O3	C23H25F3N4O3	462.472			UHERBRHOHQDFKX-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.344	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157867	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157867&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCCNC1	2,6-dimethoxy-4-[7-(3-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCCNC1		37157867	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157867&database=RX&origin=ReaxysOutput&ln=	(937 of 1381)		2,6-dimethoxy-4-[7-(3-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C23H25F3N4O3	C23H25F3N4O3	462.472			UHERBRHOHQDFKX-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.344	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157867	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157867&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCCNC1	2,6-dimethoxy-4-[7-(3-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCCN(C)C1		37157868	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157868&database=RX&origin=ReaxysOutput&ln=	(938 of 1381)		2,6-dimethoxy-4-[7-(1-methyl-3-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H27F3N4O3	C24H27F3N4O3	476.499			RTLGYFFGSDBWOA-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.583	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157868	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157868&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCCN(C)C1	2,6-dimethoxy-4-[7-(1-methyl-3-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCCN(C)C1		37157868	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157868&database=RX&origin=ReaxysOutput&ln=	(938 of 1381)		2,6-dimethoxy-4-[7-(1-methyl-3-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide	C24H27F3N4O3	C24H27F3N4O3	476.499			RTLGYFFGSDBWOA-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.583	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157868	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157868&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCCN(C)C1	2,6-dimethoxy-4-[7-(1-methyl-3-piperidyl)imidazo[1,2-a]pyridin-3-yl]-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C(N)=O		37157872	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157872&database=RX&origin=ReaxysOutput&ln=	(939 of 1381)		4-[7-(2-amino-1,1-dimethyl-2-oxo-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide	C23H26N4O4	C23H26N4O4	422.484			NFMVVOAYCTWAEP-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.039	2	6	8	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157872	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157872&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C(N)=O	4-[7-(2-amino-1,1-dimethyl-2-oxo-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2,6-dimethoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C1=C(OC)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C(N)=O		37157874	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157874&database=RX&origin=ReaxysOutput&ln=	(940 of 1381)		4-[7-(2-amino-1,1-dimethyl-2-oxo-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-ethyl-2,6-dimethoxy-benzamide	C22H26N4O4	C22H26N4O4	410.473			SFTAAGQWHWTYEA-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	2.919	2	6	8	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157874	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157874&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C1=C(OC)C=C(C=C1OC)C1=CN=C2C=C(C=CN12)C(C)(C)C(N)=O	4-[7-(2-amino-1,1-dimethyl-2-oxo-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-ethyl-2,6-dimethoxy-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCOCC1		37157880	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157880&database=RX&origin=ReaxysOutput&ln=	(941 of 1381)		2,6-dimethoxy-4-(7-tetrahydropyran-4-ylimidazo[1,2-a]pyridin-3-yl)-N-(2,2,2-trifluoroethyl)benzamide	C23H24F3N3O4	C23H24F3N3O4	463.456			ZXIHKCQSZLDKHE-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	4.54	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157880	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157880&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CCOCC1	2,6-dimethoxy-4-(7-tetrahydropyran-4-ylimidazo[1,2-a]pyridin-3-yl)-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NCCN1CCOCC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157885	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157885&database=RX&origin=ReaxysOutput&ln=	(942 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-(2-morpholinoethyl)benzamide	C26H29F2N5O4	C26H29F2N5O4	513.544			UDRCBLPTVGDLJH-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.502	1	7	10	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157885	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157885&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NCCN1CCOCC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-N-(2-morpholinoethyl)benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCC(F)(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157890	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157890&database=RX&origin=ReaxysOutput&ln=	(943 of 1381)		2-[3-[3-(difluoromethoxy)-4-(3,3-difluoropyrrolidine-1-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C24H22F4N4O3	C24H22F4N4O3	490.457			POAIDZWGPQNJKI-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	5.22	0	5	7	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157890	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157890&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCC(F)(F)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-4-(3,3-difluoropyrrolidine-1-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C(C)=O		37157899	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157899&database=RX&origin=ReaxysOutput&ln=	(944 of 1381)		4-[7-(1,1-dimethyl-2-oxo-propyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C23H24F3N3O4	C23H24F3N3O4	463.456			MCGZSHKAXMHHFH-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.914	1	5	9	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157899	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157899&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C(C)(C)C(C)=O	4-[7-(1,1-dimethyl-2-oxo-propyl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CN(C1)C(=O)OC(C)(C)C		37157900	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157900&database=RX&origin=ReaxysOutput&ln=	(945 of 1381)		tert-butyl 3-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]azetidine-1-carboxylate	C26H29F3N4O5	C26H29F3N4O5	534.535			DLLDMNATQJTSRM-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	5.127	1	7	11	51.44	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157900	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157900&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1CN(C1)C(=O)OC(C)(C)C	tert-butyl 3-[3-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]imidazo[1,2-a]pyridin-7-yl]azetidine-1-carboxylate					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CN(C1)C(=O)OC(C)(C)C		37157901	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157901&database=RX&origin=ReaxysOutput&ln=	(946 of 1381)		tert-butyl 3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]azetidine-1-carboxylate	C27H30F2N4O5	C27H30F2N4O5	528.556			NQSQECJNTCGGFR-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.959	1	7	11	51.44	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157901	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157901&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CN(C1)C(=O)OC(C)(C)C	tert-butyl 3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]azetidine-1-carboxylate					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCN(CC1)C(=O)OC(C)(C)C		37157902	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157902&database=RX&origin=ReaxysOutput&ln=	(947 of 1381)		tert-butyl 4-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]piperidine-1-carboxylate	C29H34F2N4O5	C29H34F2N4O5	556.61			MCHZUVVBWWTGEW-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	5.675	1	7	11	51.44	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157902	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157902&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCN(CC1)C(=O)OC(C)(C)C	tert-butyl 4-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]piperidine-1-carboxylate					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN(C1)C(=O)OC(C)(C)C		37157904	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157904&database=RX&origin=ReaxysOutput&ln=	(948 of 1381)		tert-butyl 3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]piperidine-1-carboxylate	C29H34F2N4O5	C29H34F2N4O5	556.61			KEIKVGHNMAXEER-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	5.675	1	7	11	51.44	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157904	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157904&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN(C1)C(=O)OC(C)(C)C	tert-butyl 3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]piperidine-1-carboxylate					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CS(=O)(=O)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157912	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157912&database=RX&origin=ReaxysOutput&ln=	(949 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(1,1-dioxothietan-3-yl)-6-methoxy-benzamide	C23H22F2N4O5S	C23H22F2N4O5S	504.514			RXVJDEZJLLKYMT-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.626	1	7	8	92.3	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157912	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157912&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CS(=O)(=O)C1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(1,1-dioxothietan-3-yl)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(C1)NC(=O)OC(C)(C)C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157931	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157931&database=RX&origin=ReaxysOutput&ln=	(950 of 1381)		tert-butyl N-[1-[4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzoyl]azetidin-3-yl]carbamate	C28H31F2N5O5	C28H31F2N5O5	555.581			QEIIWWXMJYFLCU-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	4.989	1	8	11	75.23	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157931	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157931&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CC(C1)NC(=O)OC(C)(C)C)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	tert-butyl N-[1-[4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzoyl]azetidin-3-yl]carbamate					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2N=CC(=CN2N=C1)C1CCOCC1		37157932	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157932&database=RX&origin=ReaxysOutput&ln=	(951 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(6-tetrahydropyran-4-ylpyrazolo[1,5-a]pyrimidin-3-yl)benzamide	C23H24F2N4O4	C23H24F2N4O4	458.465			BFYIXROXBWOYMI-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	3.131	1	6	8	47.26	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157932	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157932&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2N=CC(=CN2N=C1)C1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(6-tetrahydropyran-4-ylpyrazolo[1,5-a]pyrimidin-3-yl)benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1(CCOCC1)C#N		37157943	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157943&database=RX&origin=ReaxysOutput&ln=	(952 of 1381)		4-[7-(4-cyanotetrahydropyran-4-yl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide	C24H23F3N4O4	C24H23F3N4O4	488.466			FVQYUGLUKJNVSL-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.23	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157943	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157943&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)C1=CN=C2C=C(C=CN12)C1(CCOCC1)C#N	4-[7-(4-cyanotetrahydropyran-4-yl)imidazo[1,2-a]pyridin-3-yl]-2,6-dimethoxy-N-(2,2,2-trifluoroethyl)benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCOCC1		37157944	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157944&database=RX&origin=ReaxysOutput&ln=	(953 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-tetrahydropyran-4-ylimidazo[1,2-a]pyridin-3-yl)benzamide	C24H25F2N3O4	C24H25F2N3O4	457.477			XBEQYLZSEZVXQR-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.372	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157944	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157944&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-tetrahydropyran-4-ylimidazo[1,2-a]pyridin-3-yl)benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(N=CN12)C1CCOCC1		37157945	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157945&database=RX&origin=ReaxysOutput&ln=	(954 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-tetrahydropyran-4-ylimidazo[1,2-c]pyrimidin-3-yl)benzamide	C23H24F2N4O4	C23H24F2N4O4	458.465			RYKUSLKXZFKZHH-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.42	1	6	8	47.26	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157945	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157945&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(N=CN12)C1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-tetrahydropyran-4-ylimidazo[1,2-c]pyrimidin-3-yl)benzamide					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)NC2)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157947	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157947&database=RX&origin=ReaxysOutput&ln=	(955 of 1381)		2-[3-(7-methoxy-1-oxo-isoindolin-5-yl)imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C20H18N4O2	C20H18N4O2	346.389			ZRYQWJHDCNPAPD-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.108	1	5	3	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157947	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157947&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)NC2)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-(7-methoxy-1-oxo-isoindolin-5-yl)imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C1CCOCC1		37157948	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157948&database=RX&origin=ReaxysOutput&ln=	(956 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(6-tetrahydropyran-4-ylpyrazolo[1,5-a]pyridin-3-yl)benzamide	C24H25F2N3O4	C24H25F2N3O4	457.477			WAWSNDVNQQLARC-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	4.172	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157948	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157948&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(6-tetrahydropyran-4-ylpyrazolo[1,5-a]pyridin-3-yl)benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC(=O)C1(CC1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37157949	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157949&database=RX&origin=ReaxysOutput&ln=	(957 of 1381)		methyl 1-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]cyclopropanecarboxylate	C24H23F2N3O5	C24H23F2N3O5	471.461			XSAZIZSXEYBMDP-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.462	1	6	10	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157949	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157949&database=RX&origin=ReaxysOutput&ln=	COC(=O)C1(CC1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	methyl 1-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]cyclopropanecarboxylate					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C(O)=O		37157950	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157950&database=RX&origin=ReaxysOutput&ln=	(958 of 1381)		1-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]cyclopropanecarboxylic acid	C23H21F2N3O5	C23H21F2N3O5	457.434			HJZVBDWTZIDKSK-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	4	4	4.141	2	6	9	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157950	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157950&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C(O)=O	1-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]cyclopropanecarboxylic acid					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CCOCC1)C#N		37157951	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157951&database=RX&origin=ReaxysOutput&ln=	(959 of 1381)		4-[7-(4-cyanotetrahydropyran-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C25H24F2N4O4	C25H24F2N4O4	482.487			MRPWVKMJVMPHIQ-UHFFFAOYSA-N				Identification(11); Spectra(2); Bioactivity(2)		4	4.062	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157951	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157951&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CCOCC1)C#N	4-[7-(4-cyanotetrahydropyran-4-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C1CCOCC1		37157968	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157968&database=RX&origin=ReaxysOutput&ln=	(960 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-tetrahydropyran-4-yl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C26H29F2N3O5	C26H29F2N3O5	501.53			FXQAZUZNHIGXGM-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.08	2	6	9	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157968	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157968&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-tetrahydropyran-4-yl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CCOCC1		37157972	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157972&database=RX&origin=ReaxysOutput&ln=	(961 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-morpholinoethyl)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			WTJQHNRSVRBIAG-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.007	1	6	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157972	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157972&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-morpholinoethyl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COCCNC(=O)C1(CC1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37157974	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157974&database=RX&origin=ReaxysOutput&ln=	(962 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(2-methoxyethylcarbamoyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H28F2N4O5	C26H28F2N4O5	514.529			FVSPLWBMSWOCDJ-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.741	2	7	13	51.44	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157974	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157974&database=RX&origin=ReaxysOutput&ln=	COCCNC(=O)C1(CC1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(2-methoxyethylcarbamoyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCN(CC)C(=O)C1(CC1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37157975	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157975&database=RX&origin=ReaxysOutput&ln=	(963 of 1381)		N-cyclopropyl-4-[7-[1-(diethylcarbamoyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide	C27H30F2N4O4	C27H30F2N4O4	512.556			YLKMRPKCVSPASD-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	4.919	1	6	12	51.44	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157975	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157975&database=RX&origin=ReaxysOutput&ln=	CCN(CC)C(=O)C1(CC1)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-4-[7-[1-(diethylcarbamoyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C(=O)NCCO		37157978	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157978&database=RX&origin=ReaxysOutput&ln=	(964 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-(2-hydroxyethylcarbamoyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C25H26F2N4O5	C25H26F2N4O5	500.502			QLMWUWULSILRMI-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.222	3	7	12	51.44	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157978	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157978&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CC1)C(=O)NCCO	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[1-(2-hydroxyethylcarbamoyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3CN(C3)C(=O)OC(C)(C)C)C(F)=CN12		37157988	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157988&database=RX&origin=ReaxysOutput&ln=	(965 of 1381)		tert-butyl 3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]-6-fluoro-imidazo[1,2-a]pyridin-7-yl]azetidine-1-carboxylate	C27H29F3N4O5	C27H29F3N4O5	546.546			BPSGIBUNZQZBNB-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	5.12	1	7	11	51.44	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157988	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157988&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3CN(C3)C(=O)OC(C)(C)C)C(F)=CN12	tert-butyl 3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]-6-fluoro-imidazo[1,2-a]pyridin-7-yl]azetidine-1-carboxylate					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)CN1CCOCC1		37157989	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157989&database=RX&origin=ReaxysOutput&ln=	(966 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1,1-dimethyl-2-morpholino-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C27H32F2N4O4	C27H32F2N4O4	514.572			AJBBYSQYAJTEMS-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.133	1	6	10	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157989	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157989&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)CN1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1,1-dimethyl-2-morpholino-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3CCOCC3)C(F)=CN12		37157990	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157990&database=RX&origin=ReaxysOutput&ln=	(967 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-(6-fluoro-7-tetrahydropyran-4-yl-imidazo[1,2-a]pyridin-3-yl)-6-methoxy-benzamide	C24H24F3N3O4	C24H24F3N3O4	475.467			MADJUNQIGGKTSC-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.533	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157990	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157990&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3CCOCC3)C(F)=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-(6-fluoro-7-tetrahydropyran-4-yl-imidazo[1,2-a]pyridin-3-yl)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CN2C(C=C1C1CCOCC1)=NC=C2C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37157991	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157991&database=RX&origin=ReaxysOutput&ln=	(968 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(6-methoxy-7-tetrahydropyran-4-yl-imidazo[1,2-a]pyridin-3-yl)benzamide	C25H27F2N3O5	C25H27F2N3O5	487.503			AOILMGRVYNWFLK-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.287	1	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157991	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157991&database=RX&origin=ReaxysOutput&ln=	COC1=CN2C(C=C1C1CCOCC1)=NC=C2C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(6-methoxy-7-tetrahydropyran-4-yl-imidazo[1,2-a]pyridin-3-yl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN1C		37157993	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157993&database=RX&origin=ReaxysOutput&ln=	(969 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylpyrrolidin-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C24H26F2N4O3	C24H26F2N4O3	456.492			BYZQKWBODWVRLF-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	4.49	1	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157993	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157993&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN1C	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methylpyrrolidin-2-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1CCOCC1		37158000	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158000&database=RX&origin=ReaxysOutput&ln=	(970 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-2-morpholino-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C26H30F2N4O5	C26H30F2N4O5	516.545			WOIPWERPDGBWSP-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	2.985	2	7	10	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158000	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158000&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)CN1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-2-morpholino-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3CCOCC3)C(OCCO)=CN12		37158005	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158005&database=RX&origin=ReaxysOutput&ln=	(971 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[6-(2-hydroxyethoxy)-7-tetrahydropyran-4-yl-imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C26H29F2N3O6	C26H29F2N3O6	517.53			ZLWDUAGHKNJOHK-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.578	2	6	11	34.37	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158005	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158005&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C3CCOCC3)C(OCCO)=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[6-(2-hydroxyethoxy)-7-tetrahydropyran-4-yl-imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC(=O)C(C)(C#N)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158006	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158006&database=RX&origin=ReaxysOutput&ln=	(972 of 1381)		methyl 2-cyano-2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]propanoate	C24H22F2N4O5	C24H22F2N4O5	484.459			JKVKRTLRORZVDN-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.038	1	7	10	75.23	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158006	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158006&database=RX&origin=ReaxysOutput&ln=	COC(=O)C(C)(C#N)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	methyl 2-cyano-2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]propanoate					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1COCCN1C(=O)OC(C)(C)C		37158008	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158008&database=RX&origin=ReaxysOutput&ln=	(973 of 1381)		tert-butyl 3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]morpholine-4-carboxylate	C28H32F2N4O6	C28H32F2N4O6	558.582			SKQGZSSETDURLF-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	4.844	1	8	11	51.44	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158008	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158008&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1COCCN1C(=O)OC(C)(C)C	tert-butyl 3-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]morpholine-4-carboxylate					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN1		37158010	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158010&database=RX&origin=ReaxysOutput&ln=	(974 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-pyrrolidin-2-ylimidazo[1,2-a]pyridin-3-yl)benzamide	C23H24F2N4O3	C23H24F2N4O3	442.465			WVLLUJFBYLTZNX-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	3	4	4.251	2	5	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158010	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158010&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-(7-pyrrolidin-2-ylimidazo[1,2-a]pyridin-3-yl)benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COCCN1CCCC1C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158015	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158015&database=RX&origin=ReaxysOutput&ln=	(975 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(2-methoxyethyl)pyrrolidin-2-yl]imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			KNZLELAYQVOUSX-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	4.3	1	6	11	34.37	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158015	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158015&database=RX&origin=ReaxysOutput&ln=	COCCN1CCCC1C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(2-methoxyethyl)pyrrolidin-2-yl]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)N1CCOCC1		37158036	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158036&database=RX&origin=ReaxysOutput&ln=	(976 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methyl-1-morpholino-ethyl)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H30F2N4O4	C26H30F2N4O4	500.545			MHYYZFCWAHWJLJ-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	4.117	1	6	9	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158036	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158036&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)N1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-methyl-1-morpholino-ethyl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=NN12)C(C)(C)C#N		37158038	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158038&database=RX&origin=ReaxysOutput&ln=	(977 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-b]pyridazin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C22H20F3N5O3	C22H20F3N5O3	459.428			PUPYPWDUYBJKDX-UONOGXRCSA-N				Identification(11); Spectra(2); Bioactivity(2)		4	3.906	1	6	8	71.05	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158038	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158038&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=CN=C2C=C(C=NN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-b]pyridazin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C1(CCOCC1)C#N		37158043	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158043&database=RX&origin=ReaxysOutput&ln=	(978 of 1381)		4-[6-(4-cyanotetrahydropyran-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C25H24F2N4O4	C25H24F2N4O4	482.487			VCAAYDRFUXXWSZ-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.862	1	6	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158043	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158043&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C1(CCOCC1)C#N	4-[6-(4-cyanotetrahydropyran-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)C(C)(C)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158054	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158054&database=RX&origin=ReaxysOutput&ln=	(979 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[6-[2-(ethylamino)-1,1-dimethyl-2-oxo-ethyl]pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide	C25H28F2N4O4	C25H28F2N4O4	486.519			IDHUURZMUOJQCX-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	4.494	2	6	11	51.44	4	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158054	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158054&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)C(C)(C)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[6-[2-(ethylamino)-1,1-dimethyl-2-oxo-ethyl]pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)COCC(=O)N(C)C		37158057	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158057&database=RX&origin=ReaxysOutput&ln=	(980 of 1381)		2-(difluoromethoxy)-4-[6-[2-[2-(dimethylamino)-2-oxo-ethoxy]-1,1-dimethyl-ethyl]pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C27H31F3N4O5	C27H31F3N4O5	548.562			PYBPXHMLYSKLRD-RBUKOAKNSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.748	1	7	13	51.44	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158057	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158057&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)COCC(=O)N(C)C	2-(difluoromethoxy)-4-[6-[2-[2-(dimethylamino)-2-oxo-ethoxy]-1,1-dimethyl-ethyl]pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CNC(=O)COCC(C)(C)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1		37158059	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158059&database=RX&origin=ReaxysOutput&ln=	(981 of 1381)		2-(difluoromethoxy)-4-[6-[1,1-dimethyl-2-[2-(methylamino)-2-oxo-ethoxy]ethyl]pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C26H29F3N4O5	C26H29F3N4O5	534.535			XQSYOCQUHBVTFB-ZWKOTPCHSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.606	2	7	13	51.44	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158059	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158059&database=RX&origin=ReaxysOutput&ln=	CNC(=O)COCC(C)(C)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1	2-(difluoromethoxy)-4-[6-[1,1-dimethyl-2-[2-(methylamino)-2-oxo-ethoxy]ethyl]pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCC1)C(N)=O		37158060	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158060&database=RX&origin=ReaxysOutput&ln=	(982 of 1381)		4-[6-(1-carbamoylcyclobutyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C24H23F3N4O4	C24H23F3N4O4	488.466			RYBNIGGIIJCEJW-JKSUJKDBSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.926	2	6	9	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158060	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158060&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCC1)C(N)=O	4-[6-(1-carbamoylcyclobutyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)OCCN1CCOCC1		37158061	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158061&database=RX&origin=ReaxysOutput&ln=	(983 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[6-[1-methyl-1-(2-morpholinoethoxy)ethyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide	C28H33F3N4O5	C28H33F3N4O5	562.589			HCVCPZSYYVLOKM-LEWJYISDSA-N				Identification(11); Spectra(1); Bioactivity(2)		4	3.871	1	7	12	34.37	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158061	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158061&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)OCCN1CCOCC1	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[6-[1-methyl-1-(2-morpholinoethoxy)ethyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCCCOC(=O)NC(C)(C)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1		37158065	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158065&database=RX&origin=ReaxysOutput&ln=	(984 of 1381)		butyl N-[1-[3-[3-(difluoromethoxy)-4-[[(1R,2S)-2-fluorocyclopropyl]carbamoyl]-5-methoxy-phenyl]pyrazolo[1,5-a]pyridin-6-yl]-1-methyl-ethyl]carbamate	C27H31F3N4O5	C27H31F3N4O5	548.562			HLQUROURUQYRHL-RBUKOAKNSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	5.629	2	7	14	51.44	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158065	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158065&database=RX&origin=ReaxysOutput&ln=	CCCCOC(=O)NC(C)(C)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1	butyl N-[1-[3-[3-(difluoromethoxy)-4-[[(1R,2S)-2-fluorocyclopropyl]carbamoyl]-5-methoxy-phenyl]pyrazolo[1,5-a]pyridin-6-yl]-1-methyl-ethyl]carbamate					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)CN1CCOCC1		37158068	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158068&database=RX&origin=ReaxysOutput&ln=	(985 of 1381)		2-(difluoromethoxy)-4-[6-(1,1-dimethyl-2-morpholino-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C27H31F3N4O4	C27H31F3N4O4	532.563			XLISVSWXAHHLIA-VQTJNVASSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.077	1	6	10	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158068	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158068&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)CN1CCOCC1	2-(difluoromethoxy)-4-[6-(1,1-dimethyl-2-morpholino-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC(=O)NC1(CCC1)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1		37158071	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158071&database=RX&origin=ReaxysOutput&ln=	(986 of 1381)		methyl N-[1-[3-[3-(difluoromethoxy)-4-[[(1R,2S)-2-fluorocyclopropyl]carbamoyl]-5-methoxy-phenyl]pyrazolo[1,5-a]pyridin-6-yl]cyclobutyl]carbamate	C25H25F3N4O5	C25H25F3N4O5	518.493			VYQZALGGSBSDMK-DLBZAZTESA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.297	2	7	11	51.44	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158071	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158071&database=RX&origin=ReaxysOutput&ln=	COC(=O)NC1(CCC1)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1	methyl N-[1-[3-[3-(difluoromethoxy)-4-[[(1R,2S)-2-fluorocyclopropyl]carbamoyl]-5-methoxy-phenyl]pyrazolo[1,5-a]pyridin-6-yl]cyclobutyl]carbamate					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CNC(=O)C1(CCC1)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1		37158072	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158072&database=RX&origin=ReaxysOutput&ln=	(987 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[6-[1-(methylcarbamoyl)cyclobutyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide	C25H25F3N4O4	C25H25F3N4O4	502.493			KEQFLAFUPBJREA-DLBZAZTESA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.444	2	6	10	51.44	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158072	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158072&database=RX&origin=ReaxysOutput&ln=	CNC(=O)C1(CCC1)C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1	2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-4-[6-[1-(methylcarbamoyl)cyclobutyl]pyrazolo[1,5-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(O)CCOCC1		37158220	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158220&database=RX&origin=ReaxysOutput&ln=	(988 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(4-hydroxytetrahydropyran-4-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C24H25F2N3O5	C24H25F2N3O5	473.476			LYXOFVJFYWXBCJ-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	3.425	2	6	8	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158220	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158220&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(O)CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(4-hydroxytetrahydropyran-4-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCOCC1)C#N		37158254	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158254&database=RX&origin=ReaxysOutput&ln=	(989 of 1381)		4-[6-(4-cyanotetrahydropyran-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C25H23F3N4O4	C25H23F3N4O4	500.477			GNNRKWCDWNDJLM-ZWKOTPCHSA-N				Identification(11); Spectra(1); Bioactivity(2)	2	4	4.006	1	6	8	58.16	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158254	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158254&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C1(CCOCC1)C#N	4-[6-(4-cyanotetrahydropyran-4-yl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN1C(C)=O		37158264	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158264&database=RX&origin=ReaxysOutput&ln=	(990 of 1381)		4-[7-(1-acetylpyrrolidin-2-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C25H26F2N4O4	C25H26F2N4O4	484.503			HKNPMFJXBQTBEM-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	4.279	1	6	9	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158264	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158264&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN1C(C)=O	4-[7-(1-acetylpyrrolidin-2-yl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CCCC1		37158267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158267&database=RX&origin=ReaxysOutput&ln=	(991 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-pyrrolidin-1-ylethyl)imidazo[1,2-a]pyridin-3-yl]benzamide	C25H28F2N4O3	C25H28F2N4O3	470.519			RBXARRKXFFFFSS-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	4	4	4.913	1	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158267	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158267&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)N1CCCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(1-pyrrolidin-1-ylethyl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)CN1CCCC1		37158268	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158268&database=RX&origin=ReaxysOutput&ln=	(992 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1,1-dimethyl-2-pyrrolidin-1-yl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C27H32F2N4O3	C27H32F2N4O3	498.573			OOKXVVQVEXTELY-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	2	4	5.039	1	5	10	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158268	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158268&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(C)CN1CCCC1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1,1-dimethyl-2-pyrrolidin-1-yl-ethyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC(=O)C(F)(F)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158343	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158343&database=RX&origin=ReaxysOutput&ln=	(993 of 1381)		methyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2,2-difluoro-acetate	C22H19F4N3O5	C22H19F4N3O5	481.404			SNSKQERKFSFCAP-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	6	4	4.633	1	6	10	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158343	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158343&database=RX&origin=ReaxysOutput&ln=	COC(=O)C(F)(F)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	methyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2,2-difluoro-acetate					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(F)(F)C(O)=O		37158344	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158344&database=RX&origin=ReaxysOutput&ln=	(994 of 1381)		2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2,2-difluoro-acetic acid	C21H17F4N3O5	C21H17F4N3O5	467.377			BVZURURIAZKCQR-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	5	4	4.312	2	6	9	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158344	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158344&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(F)(F)C(O)=O	2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2,2-difluoro-acetic acid					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CN2CCOCC2)CC1		37158346	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158346&database=RX&origin=ReaxysOutput&ln=	(995 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(morpholinomethyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]benzamide	C27H30F2N4O4	C27H30F2N4O4	512.556			FXSLQMQPJBSLPL-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	3	4	3.793	1	6	10	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158346	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158346&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(CN2CCOCC2)CC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-[1-(morpholinomethyl)cyclopropyl]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN1C(C)C		37158347	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158347&database=RX&origin=ReaxysOutput&ln=	(996 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-isopropylpyrrolidin-2-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C26H30F2N4O3	C26H30F2N4O3	484.546			SFHOCERSZREOIM-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	1	4	5.373	1	5	9	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158347	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158347&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN1C(C)C	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-isopropylpyrrolidin-2-yl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(COC1)N1CCOCC1		37158351	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158351&database=RX&origin=ReaxysOutput&ln=	(997 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-morpholinooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide	C26H28F2N4O5	C26H28F2N4O5	514.529			MLJXTYBMHDFZBF-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	2	4	2.871	1	7	9	34.37	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158351	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158351&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1(COC1)N1CCOCC1	N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-4-[7-(3-morpholinooxetan-3-yl)imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C(N)=O		37158354	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158354&database=RX&origin=ReaxysOutput&ln=	(998 of 1381)		4-[6-(2-amino-1,1-dimethyl-2-oxo-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H24F2N4O4	C23H24F2N4O4	458.465			JCAVNXVZSSLQAP-UHFFFAOYSA-N				Identification(11); Spectra(1); Bioactivity(2)	7	4	3.553	2	6	9	51.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158354	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158354&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=C2C=CC(=CN2N=C1)C(C)(C)C(N)=O	4-[6-(2-amino-1,1-dimethyl-2-oxo-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CN1C(=O)C(=CC2=CN=C(NC3=CC4=C(NC=C4)C=C3)N=C12)S(=O)(=O)C1=CC=C(F)C=C1F		23293999	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D23293999&database=RX&origin=ReaxysOutput&ln=	(999 of 1381)	1312471-39-8	2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one	C22H15F2N5O3S	C22H15F2N5O3S	467.456			ZEHBZHZMQSHZFI-UHFFFAOYSA-N				Identification(10); Spectra(1); Bioactivity(95)	1	3	3.164	2	8	4	116.43	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	inhibitory activity	In Vitro (Efficacy)		Inhibitory concentration of compound against human SIK FAMILY KINASE 3 was determined							23293999	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D23293999&database=RX&origin=ReaxysOutput&ln=	CN1C(=O)C(=CC2=CN=C(NC3=CC4=C(NC=C4)C=C3)N=C12)S(=O)(=O)C1=CC=C(F)C=C1F						IC50	µM	>	10							1						Article; Reddy, M.V. Ramana; Akula, Balireddy; Jatiani, Shashidhar; Vasquez-Del Carpio, Rodrigo; Billa, Vinay K.; Mallireddigari, Muralidhar R.; Cosenza, Stephen C.; Venkata Subbaiah; Bharathi, E. Vijaya; Pallela, Venkat R.; Ramkumar, Poornima; Jain, Rinku; Aggarwal, Aneel K.; Reddy, E. Premkumar; Bioorganic and Medicinal Chemistry; vol. 24; 4; (2016); p. 521 - 544;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68148964&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(CC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1		26277728	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D26277728&database=RX&origin=ReaxysOutput&ln=	(1000 of 1381)			C23H27ClN6O2S	C23H27ClN6O2S	487.025			JXEIFWYMJZWNJC-UHFFFAOYSA-N				Identification(7); Bioactivity(1)		3	1.528	2	8	8	122.72	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS1 in VAIKIIDKTQLDEENLKK) in HL-60 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				HL-60 cell line		26277728	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D26277728&database=RX&origin=ReaxysOutput&ln=	CC1=NC(CC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1						IC50	µM	=	0.29							6.54				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(CC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1		26277728	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D26277728&database=RX&origin=ReaxysOutput&ln=	(1000 of 1381)			C23H27ClN6O2S	C23H27ClN6O2S	487.025			JXEIFWYMJZWNJC-UHFFFAOYSA-N				Identification(7); Bioactivity(1)		3	1.528	2	8	8	122.72	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human				In Vitro (Efficacy)		Inhibitory concentration of the compound against recombinant Human QSK (at LYS2 in DLKAENLLLDANLNIK) in PC-3 cell line in presence of ADP upon pre-incubation for 15 minutes was determined	human				PC-3		26277728	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D26277728&database=RX&origin=ReaxysOutput&ln=	CC1=NC(CC2=NC=C(S2)C(=O)NC2=C(C)C=CC=C2Cl)=CC(=N1)N1CCN(CCO)CC1						IC50	µM	=	0.48							6.32				ADP	Other compound	Article; Patricelli, Matthew P.; Nomanbhoy, Tyzoon K.; Wu, Jiangyue; Brown, Heidi; Zhou, David; Zhang, Jianming; Jagannathan, Subadhra; Aban, Arwin; Okerberg, Eric; Herring, Chris; Nordin, Brian; Weissig, Helge; Yang, Qingkai; Lee, Jiing-Dwan; Gray, Nathanael S.; Kozarich, John W.; Chemistry and Biology; vol. 18; 6; (2011); p. 699 - 710;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20070575&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1)C1=NNC2=NC=CC(C3=CSC=C3)=C12		27004200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004200&database=RX&origin=ReaxysOutput&ln=	(1001 of 1381)	1613708-90-9	3-(2-methoxyphenyl)-4-(thiophen-3-yl)-1H-pyrazolo[3,4-b]pyridine; 3-(2-methoxyphenyl)-4-(3-thienyl)-1H-pyrazolo[3,4-b]pyridine	C17H13N3OS	C17H13N3OS	307.376			RJJCZDUHXYAVNB-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(3)	4	3	4.692	1	3	3	79.04	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004200	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004200&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1)C1=NNC2=NC=CC(C3=CSC=C3)=C12	24; ; Example 1-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC=C2C=C(C(=O)N(C[C@H]3OC[C@H](N)CO3)C2=N1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1C		27946859	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27946859&database=RX&origin=ReaxysOutput&ln=	(1002 of 1381)		8-[(5-amino-1,3-dioxan-2-yl)methyl]-6-[2-chloro-4-(3-methyl-2-pyridyl)phenyl]-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one; 8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-methylpyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one	C25H25ClN6O3	C25H25ClN6O3	492.965			JRCJXODVUXPOGA-CYWCHRQTSA-N				Identification(8); Physical Data(2); Spectra(6); Bioactivity(3)	5	3	2.522	2	9	5	115.49	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		27946859	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27946859&database=RX&origin=ReaxysOutput&ln=	CNC1=NC=C2C=C(C(=O)N(C[C@H]3OC[C@H](N)CO3)C2=N1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1C	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-methylpyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		14							7.85						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
C[C@H](N1N=NC2=C1C1=CC(=CC=C1N=C2)C1=CC=C2OC=NC2=C1)C1=CC=C(F)C=C1		31585038	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D31585038&database=RX&origin=ReaxysOutput&ln=	(1003 of 1381)		(S)-(-)-5-(1-(1-(4-fluorophenyl)ethyl)-1H-[1,2,3]-triazolo-[4,5-c]quinolin-8-yl)benzo[d]oxazole	C24H16FN5O	C24H16FN5O	409.422			BHKVSOQUPYXVRZ-AWEZNQCLSA-N				Identification(9); Physical Data(3); Spectra(7); Bioactivity(3)	9	3	4.629	0	5	3	69.63	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Transfected	Inhibitor		In Vitro (Efficacy)									31585038	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D31585038&database=RX&origin=ReaxysOutput&ln=	C[C@H](N1N=NC2=C1C1=CC(=CC=C1N=C2)C1=CC=C2OC=NC2=C1)C1=CC=C(F)C=C1	(S)-(-)-5-(1-(1-(4-fluorophenyl)ethyl)-1H-[1,2,3]-triazolo-[4,5-c]quinolin-8-yl)benzo[d]oxazole					IC50	nM	>	10000							1			11333840	ATP	Substrate	Article; Sun, Qi-Zheng; Lin, Gui-Feng; Li, Lin-Li; Jin, Xi-Ting; Huang, Lu-Yi; Zhang, Guo; Yang, Wei; Chen, Kai; Xiang, Rong; Chen, Chong; Wei, Yu-Quan; Lu, Guang-Wen; Yang, Sheng-Yong; Journal of Medicinal Chemistry; vol. 60; 14; (2017); p. 6337 - 6352;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D71733105&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CC=C2Br)=CC(=N1)N1CCN(CCO)CC1		33633199	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633199&database=RX&origin=ReaxysOutput&ln=	(1004 of 1381)		N-(2,6-dibromophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H23Br2N7O2S	C21H23Br2N7O2S	597.333			PTJUOBYPYVPNAI-UHFFFAOYSA-N				Identification(9); Spectra(2); Bioactivity(2)	1	3	2.739	3	9	8	134.75	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633199	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633199&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CC=C2Br)=CC(=N1)N1CCN(CCO)CC1	N-(2,6-dibromophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	>	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC(=O)N1CCN(CC1)C1=NC(C)=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=C1		33633204	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633204&database=RX&origin=ReaxysOutput&ln=	(1005 of 1381)		2-((6-(4-acetylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide	C22H24ClN7O2S	C22H24ClN7O2S	485.997			YQYFBBSNEIONRO-UHFFFAOYSA-N				Identification(9); Spectra(1); Bioactivity(2)	1	3	2.489	2	9	7	131.59	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633204	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633204&database=RX&origin=ReaxysOutput&ln=	CC(=O)N1CCN(CC1)C1=NC(C)=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CC=C2C)=C1	2-((6-(4-acetylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide					IC50	μM	<	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(F)C=CC=C2F)=CC(=N1)N1CCN(CCO)CC1		33633210	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633210&database=RX&origin=ReaxysOutput&ln=	(1006 of 1381)		N-(2,6-difluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H23F2N7O2S	C21H23F2N7O2S	475.522			CSSMZGSBKMELBS-UHFFFAOYSA-N				Identification(9); Spectra(2); Bioactivity(2)	1	3	1.465	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633210	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633210&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(F)C=CC=C2F)=CC(=N1)N1CCN(CCO)CC1	N-(2,6-difluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	<	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CC=C2F)=CC(=N1)N1CCN(CCO)CC1		33633211	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633211&database=RX&origin=ReaxysOutput&ln=	(1007 of 1381)		N-(2-bromo-6-fluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H23BrFN7O2S	C21H23BrFN7O2S	536.428			HHZBHNFTWDJVJS-UHFFFAOYSA-N				Identification(9); Spectra(2); Bioactivity(2)	1	3	2.102	3	9	8	134.75	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633211	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633211&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Br)C=CC=C2F)=CC(=N1)N1CCN(CCO)CC1	N-(2-bromo-6-fluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	<	0.1							7						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC(=CC=C2)C#C)=CC(=N1)N1CCN(CCO)CC1		33633212	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633212&database=RX&origin=ReaxysOutput&ln=	(1008 of 1381)		N-(3-ethynylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C23H25N7O2S	C23H25N7O2S	463.563			HNGLVQAJTPNUJI-UHFFFAOYSA-N				Identification(9); Spectra(2); Bioactivity(2)	1	3	1.641	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633212	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633212&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC(=CC=C2)C#C)=CC(=N1)N1CCN(CCO)CC1	N-(3-ethynylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	>	1							6						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=C(F)C=C2)=CC(=N1)N1CCN(CCO)CC1		33633213	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633213&database=RX&origin=ReaxysOutput&ln=	(1009 of 1381)		N-(4-fluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H24FN7O2S	C21H24FN7O2S	457.532			YXOKEVVRNXCIBF-UHFFFAOYSA-N				Identification(9); Spectra(2); Bioactivity(2)	1	3	1.304	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633213	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633213&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=C(F)C=C2)=CC(=N1)N1CCN(CCO)CC1	N-(4-fluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	>	1							6						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=C(Br)C=C2F)=CC(=N1)N1CCN(CCO)CC1		33633215	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633215&database=RX&origin=ReaxysOutput&ln=	(1010 of 1381)		N-(4-bromo-6-fluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H23BrFN7O2S	C21H23BrFN7O2S	536.428			ULINCGUQYAIKGK-UHFFFAOYSA-N				Identification(9); Spectra(2); Bioactivity(2)	1	3	2.102	3	9	8	134.75	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633215	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633215&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC=C(Br)C=C2F)=CC(=N1)N1CCN(CCO)CC1	N-(4-bromo-6-fluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	>	0.5							6.3						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=NC(C)=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=C1		36081274	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081274&database=RX&origin=ReaxysOutput&ln=	(1011 of 1381)		N-(4-chloro-2-methylpyridin-3-yl)-2-((2-methyl)-(6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H23ClN8OS	C20H23ClN8OS	458.975			INSVCYRFDCTMIA-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(4); Bioactivity(4)	1	3	1.537	2	9	6	127.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081274	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081274&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=NC(C)=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=C1	N-(4-chloro-2-methylpyridin-3-yl)-2-((2-methyl)-6-((4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		8850							5.05			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=NC(C)=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=C1		36081274	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081274&database=RX&origin=ReaxysOutput&ln=	(1011 of 1381)		N-(4-chloro-2-methylpyridin-3-yl)-2-((2-methyl)-(6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H23ClN8OS	C20H23ClN8OS	458.975			INSVCYRFDCTMIA-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(4); Bioactivity(4)	1	3	1.537	2	9	6	127.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081274	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081274&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=NC(C)=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=C1	N-(4-chloro-2-methylpyridin-3-yl)-2-((2-methyl)-(6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		493							6.31			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=NC(C)=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=C1		36081274	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081274&database=RX&origin=ReaxysOutput&ln=	(1011 of 1381)		N-(4-chloro-2-methylpyridin-3-yl)-2-((2-methyl)-(6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H23ClN8OS	C20H23ClN8OS	458.975			INSVCYRFDCTMIA-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(4); Bioactivity(4)	1	3	1.537	2	9	6	127.41	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									36081274	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081274&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=NC(C)=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=C1						IC50	nM		493							6.31			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)N[C@H]2CN3CCC2CC3)=CC(=N1)N1CCN(CCO)CC1		36081276	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081276&database=RX&origin=ReaxysOutput&ln=	(1012 of 1381)		(R)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(quinuclidine-3-yl)thiazole-5-carboxamide	C22H32N8O2S	C22H32N8O2S	472.614			MPIBCTUFGUTVSG-KRWDZBQOSA-N				Identification(11); Physical Data(2); Spectra(4); Bioactivity(3)	1	3	-0.005	3	10	8	137.99	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081276	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081276&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)N[C@H]2CN3CCC2CC3)=CC(=N1)N1CCN(CCO)CC1	(R)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(quinuclidine-3-yl)thiazole-5-carboxamide					IC50	nM		1510							5.82			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)N[C@H]2CN3CCC2CC3)=CC(=N1)N1CCN(CCO)CC1		36081276	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081276&database=RX&origin=ReaxysOutput&ln=	(1012 of 1381)		(R)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(quinuclidine-3-yl)thiazole-5-carboxamide	C22H32N8O2S	C22H32N8O2S	472.614			MPIBCTUFGUTVSG-KRWDZBQOSA-N				Identification(11); Physical Data(2); Spectra(4); Bioactivity(3)	1	3	-0.005	3	10	8	137.99	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									36081276	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081276&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)N[C@H]2CN3CCC2CC3)=CC(=N1)N1CCN(CCO)CC1	(R)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-N-(quinuclidine-3-yl)thiazole-5-carboxamide					IC50	nM		8850							5.05			73010; 14205888; 37051685	ATP; γ33P-ATP; RBER-CHKtide	Other compound; Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(OC(C)(C)CO)=CN2N=C1		37037379	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037379&database=RX&origin=ReaxysOutput&ln=	(1013 of 1381)		2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-4-[6-(2-hydroxy-1,1-dimethyl-ethoxy)pyrazolo[1,5-a]pyridin-3-yl]-6-methoxy-benzamide	C23H24F3N3O5	C23H24F3N3O5	479.456			YKEJTMGCKFMGKB-JKSUJKDBSA-N				Identification(10); Spectra(2); Bioactivity(2)	9	3	4.157	2	5	10	34.37	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									37037379	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037379&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(OC(C)(C)CO)=CN2N=C1						IC50	nM		0.01 - 10										73010	ATP	Other compound	Patent; GALAPAGOS; WO2020/239660; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807679&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(=O)N(CC(F)(F)F)CCC2=CC(=C1)C1=C2C=CC(OCCN3CCOCC3)=CN2N=C1		37037385	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037385&database=RX&origin=ReaxysOutput&ln=	(1014 of 1381)		8-methoxy-6-[6-(2-(N-morpholinyl)ethoxy)pyrazolo[1,5-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one; 8-methoxy-6-[6-(2-morpholinoethoxy)pyrazolo[1,5-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C25H27F3N4O4	C25H27F3N4O4	504.509			OYZURSFQUYCTIJ-UHFFFAOYSA-N				Identification(10); Spectra(2); Bioactivity(2)	7	3	3.539	0	6	8	34.37	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									37037385	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037385&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(=O)N(CC(F)(F)F)CCC2=CC(=C1)C1=C2C=CC(OCCN3CCOCC3)=CN2N=C1						IC50	nM		0.01 - 10										73010	ATP	Other compound	Patent; GALAPAGOS; WO2020/239660; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807679&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(OC(C)(C)CN3CCOCC3)=CN2N=C1		37037387	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037387&database=RX&origin=ReaxysOutput&ln=	(1015 of 1381)		2-(difluoromethoxy)-4-[6-(1,1-dimethyl-2-(N-morpholinyl)-ethoxy)pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide; 2-(difluoromethoxy)-4-[6-(1,1-dimethyl-2-morpholino-ethoxy)pyrazolo[1,5-a]pyridin-3-yl]-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C27H31F3N4O5	C27H31F3N4O5	548.562			ULHKXQAOOHVMDP-VQTJNVASSA-N				Identification(10); Spectra(2); Bioactivity(2)	10	3	4.319	1	6	11	34.37	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									37037387	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037387&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(OC(C)(C)CN3CCOCC3)=CN2N=C1						IC50	nM	>	10 - 100							8			73010	ATP	Other compound	Patent; GALAPAGOS; WO2020/239660; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807679&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=C2N=CC(OCCN3CCOCC3)=CN2N=C1		37037388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037388&database=RX&origin=ReaxysOutput&ln=	(1016 of 1381)		8-methoxy-6-[6-(2-(N-morpholinyl)ethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one; 8-methoxy-6-[6-(2-morpholinoethoxy)pyrazolo[1,5-a]pyrimidin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H26F3N5O4	C24H26F3N5O4	505.497			YAUOGWZWDYXEJH-UHFFFAOYSA-N				Identification(10); Spectra(2); Bioactivity(2)	7	3	2.498	0	7	8	47.26	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									37037388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037388&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=C2N=CC(OCCN3CCOCC3)=CN2N=C1						IC50	nM	>	10 - 100							8			73010	ATP	Other compound	Patent; GALAPAGOS; WO2020/239660; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807679&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCN(CC1)C(=O)OC(C)(C)C		37157848	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157848&database=RX&origin=ReaxysOutput&ln=	(1017 of 1381)		tert-butyl 4-[1-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]benzimidazol-5-yl]piperidine-1-carboxylate	C28H33F3N4O5	C28H33F3N4O5	562.589			HIKPURGLBMMHQD-UHFFFAOYSA-N				Identification(10); Spectra(1); Bioactivity(2)	3	3	5.392	1	7	11	47.03	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157848	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157848&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCN(CC1)C(=O)OC(C)(C)C	tert-butyl 4-[1-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]benzimidazol-5-yl]piperidine-1-carboxylate					IC50	nM	>	100 - 500							7			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCCN(C1)C(=O)OC(C)(C)C		37157851	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157851&database=RX&origin=ReaxysOutput&ln=	(1018 of 1381)		tert-butyl 3-[1-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]benzimidazol-5-yl]piperidine-1-carboxylate	C28H33F3N4O5	C28H33F3N4O5	562.589			ULUMAUWKOUVGBS-UHFFFAOYSA-N				Identification(10); Spectra(1); Bioactivity(2)	1	3	5.392	1	7	11	47.03	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157851	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157851&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC)=C1C(=O)NCC(F)(F)F)N1C=NC2=CC(=CC=C12)C1CCCN(C1)C(=O)OC(C)(C)C	tert-butyl 3-[1-[3,5-dimethoxy-4-(2,2,2-trifluoroethylcarbamoyl)phenyl]benzimidazol-5-yl]piperidine-1-carboxylate					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCS(=O)(=O)CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37157881	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157881&database=RX&origin=ReaxysOutput&ln=	(1019 of 1381)		2-[3-[3-(difluoromethoxy)-4-(1,1-dioxo-1,4-thiazinane-4-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C24H24F2N4O5S	C24H24F2N4O5S	518.541			WBNLZQWALHVDCV-UHFFFAOYSA-N				Identification(10); Spectra(1); Bioactivity(2)		3	3.731	0	7	7	92.3	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37157881	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37157881&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N1CCS(=O)(=O)CC1)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[3-(difluoromethoxy)-4-(1,1-dioxo-1,4-thiazinane-4-carbonyl)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	500							6.3			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN1C(=O)OC(C)(C)C		37158002	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158002&database=RX&origin=ReaxysOutput&ln=	(1020 of 1381)		tert-butyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]pyrrolidine-1-carboxylate	C28H32F2N4O5	C28H32F2N4O5	542.583			JXJXSQISPHFBJT-UHFFFAOYSA-N				Identification(10); Spectra(1); Bioactivity(2)	1	3	5.75	1	7	11	51.44	2	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158002	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158002&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C1CCCN1C(=O)OC(C)(C)C	tert-butyl 2-[3-[4-(cyclopropylcarbamoyl)-3-(difluoromethoxy)-5-methoxy-phenyl]imidazo[1,2-a]pyridin-7-yl]pyrrolidine-1-carboxylate					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
[2H]C([2H])([2H])C(C#N)(C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1)C([2H])([2H])[2H]		37158039	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158039&database=RX&origin=ReaxysOutput&ln=	(1021 of 1381)		4-[7-[1-cyano-2,2,2-trideuterio-1-(trideuteriomethyl)ethyl]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H16(2)H6F2N4O3	C23H22F2N4O3	446.402			LYBBGGAESSOSLO-WFGJKAKNSA-N				Identification(10); Spectra(1); Bioactivity(2)		3	4.592	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158039	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158039&database=RX&origin=ReaxysOutput&ln=	[2H]C([2H])([2H])C(C#N)(C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1)C([2H])([2H])[2H]	4-[7-[1-cyano-2,2,2-trideuterio-1-(trideuteriomethyl)ethyl]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37158338	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158338&database=RX&origin=ReaxysOutput&ln=	(1022 of 1381)		2-[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C23H21F3N4O2	C23H21F3N4O2	442.441			COTYIRLXRYLFIX-UHFFFAOYSA-N				Identification(10); Spectra(1); Bioactivity(2)	1	3	4.833	0	5	5	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158338	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158338&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37158338	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158338&database=RX&origin=ReaxysOutput&ln=	(1022 of 1381)		2-[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile	C23H21F3N4O2	C23H21F3N4O2	442.441			COTYIRLXRYLFIX-UHFFFAOYSA-N				Identification(10); Spectra(1); Bioactivity(2)	1	3	4.833	0	5	5	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158338	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158338&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	2-[3-[8-methoxy-1-oxo-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-6-yl]imidazo[1,2-a]pyridin-7-yl]-2-methyl-propanenitrile					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)COS(C)(=O)=O		37158358	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158358&database=RX&origin=ReaxysOutput&ln=	(1023 of 1381)		[2-[3-[3-(difluoromethoxy)-4-[[(1R,2S)-2-fluorocyclopropyl]carbamoyl]-5-methoxy-phenyl]pyrazolo[1,5-a]pyridin-6-yl]-2-methyl-propyl] methanesulfonate	C24H26F3N3O6S	C24H26F3N3O6S	541.548			FUKQNCYIDLRRNI-DLBZAZTESA-N				Identification(10); Spectra(1); Bioactivity(2)	1	3	3.545	1	7	11	68.51	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158358	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158358&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)COS(C)(=O)=O	[2-[3-[3-(difluoromethoxy)-4-[[(1R,2S)-2-fluorocyclopropyl]carbamoyl]-5-methoxy-phenyl]pyrazolo[1,5-a]pyridin-6-yl]-2-methyl-propyl] methanesulfonate					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
[2H]C([2H])([2H])C(C#N)(C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1)C([2H])([2H])[2H]		37158361	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158361&database=RX&origin=ReaxysOutput&ln=	(1024 of 1381)		4-[6-[1-cyano-2,2,2-trideuterio-1-(trideuteriomethyl)ethyl]pyrazolo[1.5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide	C23H15(2)H6F3N4O3	C23H21F3N4O3	464.392			BDTLFPRHEXLZDV-LVDQYXKPSA-N				Identification(10); Spectra(1); Bioactivity(2)	7	3	4.536	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158361	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158361&database=RX&origin=ReaxysOutput&ln=	[2H]C([2H])([2H])C(C#N)(C1=CN2N=CC(=C2C=C1)C1=CC(OC(F)F)=C(C(=O)N[C@@H]2C[C@@H]2F)C(OC)=C1)C([2H])([2H])[2H]	4-[6-[1-cyano-2,2,2-trideuterio-1-(trideuteriomethyl)ethyl]pyrazolo[1.5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-[(1R,2S)-2-fluorocyclopropyl]-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(F)SC=C2Cl)=N1)N1CCN(CCO)CC1		38898220	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898220&database=RX&origin=ReaxysOutput&ln=	(1025 of 1381)		N-(4-chloro-2-fluorothiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C19H21ClFN7O2S2	C19H21ClFN7O2S2	498.005			LNPBPOLMSAORLA-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	4	3	1.268	3	9	8	112.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38898220	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898220&database=RX&origin=ReaxysOutput&ln=	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(F)SC=C2Cl)=N1)N1CCN(CCO)CC1	N-(4-chloro-2-fluorothiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		50 - 100							7.3						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=NC(C)=N1		38898228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898228&database=RX&origin=ReaxysOutput&ln=	(1026 of 1381)		N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H22ClF2N7OS2	C20H22ClF2N7OS2	514.023			ODYLETLDBBYSCS-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	12	3	2.879	2	8	7	112.22	3	2	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38898228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898228&database=RX&origin=ReaxysOutput&ln=	CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=NC(C)=N1	N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=NC(C)=N1		38898228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898228&database=RX&origin=ReaxysOutput&ln=	(1026 of 1381)		N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H22ClF2N7OS2	C20H22ClF2N7OS2	514.023			ODYLETLDBBYSCS-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	12	3	2.879	2	8	7	112.22	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		38898228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898228&database=RX&origin=ReaxysOutput&ln=	CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=NC(C)=N1	N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=NC(C)=N1		38898228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898228&database=RX&origin=ReaxysOutput&ln=	(1026 of 1381)		N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H22ClF2N7OS2	C20H22ClF2N7OS2	514.023			ODYLETLDBBYSCS-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	12	3	2.879	2	8	7	112.22	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		38898228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898228&database=RX&origin=ReaxysOutput&ln=	CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=NC(C)=N1	N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=NC(C)=N1		38898228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898228&database=RX&origin=ReaxysOutput&ln=	(1026 of 1381)		N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H22ClF2N7OS2	C20H22ClF2N7OS2	514.023			ODYLETLDBBYSCS-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	12	3	2.879	2	8	7	112.22	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38898228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898228&database=RX&origin=ReaxysOutput&ln=	CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=NC(C)=N1	N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		20 - 50							7.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CN1CCCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		38898232	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898232&database=RX&origin=ReaxysOutput&ln=	(1027 of 1381)		N-(1-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methyl-1,4-diazepan-1-yl)pyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide	C20H23ClFN7OS2	C20H23ClFN7OS2	496.032			BOIJMCSADFTSLH-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	12	3	2.5	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38898232	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898232&database=RX&origin=ReaxysOutput&ln=	CN1CCCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1	N-(1-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methyl-1,4-diazepan-1-yl)pyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide					IC50	nM		20 - 50							7.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(F)SC=C2Cl)=NC(C)=N1		38898240	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898240&database=RX&origin=ReaxysOutput&ln=	(1028 of 1381)		N-(4-chloro-2-fluorothiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C18H19ClFN7OS2	C18H19ClFN7OS2	467.979			DRCVYXQIMOQLCU-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	4	3	1.977	2	8	6	112.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38898240	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898240&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(F)SC=C2Cl)=NC(C)=N1	N-(4-chloro-2-fluorothiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		20 - 50							7.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		38898241	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898241&database=RX&origin=ReaxysOutput&ln=	(1029 of 1381)		N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C19H21ClFN7OS2	C19H21ClFN7OS2	482.005			VRZBRJOVEGGUSI-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	12	3	2.142	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38898241	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898241&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1	N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		38898241	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898241&database=RX&origin=ReaxysOutput&ln=	(1029 of 1381)		N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C19H21ClFN7OS2	C19H21ClFN7OS2	482.005			VRZBRJOVEGGUSI-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	12	3	2.142	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		38898241	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898241&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1	N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		38898241	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898241&database=RX&origin=ReaxysOutput&ln=	(1029 of 1381)		N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C19H21ClFN7OS2	C19H21ClFN7OS2	482.005			VRZBRJOVEGGUSI-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	12	3	2.142	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		38898241	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898241&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1	N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		38898241	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898241&database=RX&origin=ReaxysOutput&ln=	(1029 of 1381)		N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide	C19H21ClFN7OS2	C19H21ClFN7OS2	482.005			VRZBRJOVEGGUSI-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	12	3	2.142	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38898241	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898241&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1	N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	20							7.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=N1)N1CCNC(=O)C1		38898242	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898242&database=RX&origin=ReaxysOutput&ln=	(1030 of 1381)		N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(3-oxopiperazin-1-yl)pyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide	C18H17ClFN7O2S2	C18H17ClFN7O2S2	481.962			JDUUJTHFJORBON-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	12	3	1.461	3	9	7	129.29	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38898242	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898242&database=RX&origin=ReaxysOutput&ln=	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=N1)N1CCNC(=O)C1	N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(3-oxopiperazin-1-yl)pyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide					IC50	nM		50 - 100							7.3						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)(F)F)=N1)N1CCN(CCO)CC1		38898243	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898243&database=RX&origin=ReaxysOutput&ln=	(1031 of 1381)		N-(2-chloro-4-(trifluoromethyl)thiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H21ClF3N7O2S2	C20H21ClF3N7O2S2	548.013			WXBMZGPQDSOPBO-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	9	3	2.032	3	9	9	112.22	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38898243	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898243&database=RX&origin=ReaxysOutput&ln=	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)(F)F)=N1)N1CCN(CCO)CC1	N-(2-chloro-4-(trifluoromethyl)thiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		50 - 100							7.3						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=N1)N1CCN(CCO)CC1		38898247	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898247&database=RX&origin=ReaxysOutput&ln=	(1032 of 1381)		N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H23ClFN7O2S2	C20H23ClFN7O2S2	512.032			WNRXJPMQODYBIL-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	12	3	1.433	3	9	9	112.22	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38898247	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898247&database=RX&origin=ReaxysOutput&ln=	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=N1)N1CCN(CCO)CC1	N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		20 - 50							7.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		38898249	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898249&database=RX&origin=ReaxysOutput&ln=	(1033 of 1381)		N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H23ClFN7OS2	C20H23ClFN7OS2	496.032			IDZKTMGGJKOKPE-UHFFFAOYSA-N				Identification(10); Physical Data(3); Spectra(3); Bioactivity(2)	13	3	2.602	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38898249	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898249&database=RX&origin=ReaxysOutput&ln=	CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1	N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		38898249	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898249&database=RX&origin=ReaxysOutput&ln=	(1033 of 1381)		N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H23ClFN7OS2	C20H23ClFN7OS2	496.032			IDZKTMGGJKOKPE-UHFFFAOYSA-N				Identification(10); Physical Data(3); Spectra(3); Bioactivity(2)	13	3	2.602	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		38898249	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898249&database=RX&origin=ReaxysOutput&ln=	CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1	N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		38898249	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898249&database=RX&origin=ReaxysOutput&ln=	(1033 of 1381)		N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H23ClFN7OS2	C20H23ClFN7OS2	496.032			IDZKTMGGJKOKPE-UHFFFAOYSA-N				Identification(10); Physical Data(3); Spectra(3); Bioactivity(2)	13	3	2.602	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38898249	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898249&database=RX&origin=ReaxysOutput&ln=	CC1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1	N-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-2-((6-(3,4-dimethylpiperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		20 - 50							7.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=NC(C)=N1		38898251	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898251&database=RX&origin=ReaxysOutput&ln=	(1034 of 1381)		N-(1-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide	C19H20ClF2N7OS2	C19H20ClF2N7OS2	499.996			ZATJAIQPRBTMDO-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(2)	13	3	2.419	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38898251	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38898251&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=NC(C)=N1	N-(1-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((2-methyl-6-(4-methylpiperazin-1-yl)pyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide					IC50	nM	<	20							7.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
FC1=CC=CC(C2=CNC3=NC=C(C=C23)C2=CSC=C2)=C1Cl		27004110	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004110&database=RX&origin=ReaxysOutput&ln=	(1035 of 1381)	1613710-28-3	3-(2-chloro-3-fluorophenyl)-5-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridine	C17H10ClFN2S	C17H10ClFN2S	328.797			PLVCQVRLAFJNOX-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	4	2	5.587	1	2	2	56.92	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004110	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004110&database=RX&origin=ReaxysOutput&ln=	FC1=CC=CC(C2=CNC3=NC=C(C=C23)C2=CSC=C2)=C1Cl	229; Example 114-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1=CC=CC(C2=CNC3=NC=C(C=C23)C2=CC=C(CN3CCOCC3)S2)=C1Cl		27004126	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004126&database=RX&origin=ReaxysOutput&ln=	(1036 of 1381)	1613710-47-6	4-((5-(3-(2-chloro-3-fluorophenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)thiophen-2-yl)methyl)morpholine	C22H19ClFN3OS	C22H19ClFN3OS	427.93			LNLFVRCGHIRAGC-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	4	2	4.27	1	4	4	69.39	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004126	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004126&database=RX&origin=ReaxysOutput&ln=	FC1=CC=CC(C2=CNC3=NC=C(C=C23)C2=CC=C(CN3CCOCC3)S2)=C1Cl	263; Example 133-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CC1=C(Cl)SC(NC2=CN=C3NC=C(C3=C2)C2=C(Cl)C(F)=CC=C2)=N1		27004127	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004127&database=RX&origin=ReaxysOutput&ln=	(1037 of 1381)	1613710-48-7	5-chloro-N-(3-(2-chloro-3-fluorophenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-4-methylthiazol-2-amine	C17H11Cl2FN4S	C17H11Cl2FN4S	393.272			BUJCTKGGICLMKS-UHFFFAOYSA-N				Identification(8); Bioactivity(2)		2	4.873	2	4	3	81.84	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004127	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004127&database=RX&origin=ReaxysOutput&ln=	CC1=C(Cl)SC(NC2=CN=C3NC=C(C3=C2)C2=C(Cl)C(F)=CC=C2)=N1	Example 134-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CN(C)S(=O)(=O)C1=CC(=CC=C1)C1=CN=C2NC=C(C2=C1)C1=C(Cl)C(F)=CC=C1		27004128	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004128&database=RX&origin=ReaxysOutput&ln=	(1038 of 1381)	1613710-49-8	3-(3-(2-chloro-3-fluorophenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-N,N-dimethylbenzenesulfonamide	C21H17ClFN3O2S	C21H17ClFN3O2S	429.902			HFUSRFLKRRKCEM-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	4	2	5.32	1	5	4	74.44	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004128	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004128&database=RX&origin=ReaxysOutput&ln=	CN(C)S(=O)(=O)C1=CC(=CC=C1)C1=CN=C2NC=C(C2=C1)C1=C(Cl)C(F)=CC=C1	232; Example 135-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1=C(C=CC=C1Cl)C1=CNC2=NC=C(C=C12)C1=CSC=C1		27004131	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004131&database=RX&origin=ReaxysOutput&ln=	(1039 of 1381)	1613710-52-3	3-(3-chloro-2-fluorophenyl)-5-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridine	C17H10ClFN2S	C17H10ClFN2S	328.797			LRPAITRRRQEJHS-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)		2	5.587	1	2	2	56.92	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004131	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004131&database=RX&origin=ReaxysOutput&ln=	FC1=C(C=CC=C1Cl)C1=CNC2=NC=C(C=C12)C1=CSC=C1	165; Example 138-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCOCC2)S1		27004135	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004135&database=RX&origin=ReaxysOutput&ln=	(1040 of 1381)	1613710-56-7	4-((5-(3-(3-fluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)thiophen-2-yl)methyl)morpholine	C23H22FN3O2S	C23H22FN3O2S	423.511			DFFCYPKUEFNFBA-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	4	2	3.563	1	4	5	78.62	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004135	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004135&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCOCC2)S1	235; Example 142-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCC2)S1		27004141	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004141&database=RX&origin=ReaxysOutput&ln=	(1041 of 1381)	1613710-88-5	3-(3-fluoro-2-methoxyphenyl)-5-(5-(pyrrolidin-1-ylmethyl)thiophen-2-yl)-1H-pyrrolo[2,3-b]pyridine	C23H22FN3OS	C23H22FN3OS	407.512			QUQHOJCZKDWJBM-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	4	2	4.469	1	3	5	69.39	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004141	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004141&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCC2)S1	266; Example 174-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCCC2)S1		27004142	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004142&database=RX&origin=ReaxysOutput&ln=	(1042 of 1381)	1613710-89-6	3-(3-fluoro-2-methoxyphenyl)-5-(5-(piperidin-1-ylmethyl)thiophen-2-yl)-1H-pyrrolo[2,3-b]pyridine	C24H24FN3OS	C24H24FN3OS	421.538			ZFPIVEXNIZPFRC-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	4	2	4.827	1	3	5	69.39	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004142	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004142&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCCC2)S1	268; Example 175-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCC2)S1		27004144	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004144&database=RX&origin=ReaxysOutput&ln=	(1043 of 1381)	1613710-91-0	3-(3,5-difluoro-2-methoxyphenyl)-5-(5-(pyrrolidin-1-ylmethyl)thiophen-2-yl)-1H-pyrrolo[2,3-b]pyridine	C23H21F2N3OS	C23H21F2N3OS	425.502			QQEJRDVANDBDRM-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	4	2	4.63	1	3	5	69.39	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004144	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004144&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCC2)S1	273; Example 177-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCCC2)S1		27004145	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004145&database=RX&origin=ReaxysOutput&ln=	(1044 of 1381)	1613710-92-1	3-(3,5-difluoro-2-methoxyphenyl)-5-(5-(piperidin-1-ylmethyl)thiophen-2-yl)-1H-pyrrolo[2,3-b]pyridine	C24H23F2N3OS	C24H23F2N3OS	439.529			IAELVBXPXZTLQP-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	4	2	4.988	1	3	5	69.39	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004145	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004145&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCCC2)S1	275; Example 178-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=CC(=C1)S(=O)(=O)N(C)C(C)(C)C		27004147	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004147&database=RX&origin=ReaxysOutput&ln=	(1045 of 1381)	1613710-94-3	N-(tert-butyl)-3-(3-(3-fluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-N-methylbenzenesulfonamide	C25H26FN3O3S	C25H26FN3O3S	467.564			VTPIFSOGLMCTJF-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	4	2	5.913	1	5	6	83.67	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004147	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004147&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=CC(=C1)S(=O)(=O)N(C)C(C)(C)C	240; Example 180-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CC=CC(=C1)S(=O)(=O)N(C)C(C)(C)C		27004148	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004148&database=RX&origin=ReaxysOutput&ln=	(1046 of 1381)	1613710-95-4	N-(tert-butyl)-3-(3-(3,5-difluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-N-methylbenzenesulfonamide	C25H25F2N3O3S	C25H25F2N3O3S	485.555			AAIHIPJANRQPLT-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	4	2	6.074	1	5	6	83.67	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004148	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004148&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CC=CC(=C1)S(=O)(=O)N(C)C(C)(C)C	242; Example 181-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=CC(=C1)S(=O)(=O)N(C)C		27004151	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004151&database=RX&origin=ReaxysOutput&ln=	(1047 of 1381)	1613710-98-7	3-(3-(3-fluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-N,N-dimethylbenzenesulfonamide	C22H20FN3O3S	C22H20FN3O3S	425.484			IPVKZXDJBVJRCT-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	4	2	4.613	1	5	5	83.67	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004151	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004151&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=CC(=C1)S(=O)(=O)N(C)C	249; Example 184-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CC=CC(=C1)S(=O)(=O)N(C)C		27004152	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004152&database=RX&origin=ReaxysOutput&ln=	(1048 of 1381)	1613710-99-8	3-(3-(3,5-difluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-N,N-dimethylbenzenesulfonamide	C22H19F2N3O3S	C22H19F2N3O3S	443.474			FJNBWMCCZNKJCS-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	4	2	4.774	1	5	5	83.67	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004152	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004152&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CC=CC(=C1)S(=O)(=O)N(C)C	251; Example 185-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCNCC1		27004154	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004154&database=RX&origin=ReaxysOutput&ln=	(1049 of 1381)	1613711-05-9	3-(3,5-difluoro-2-methoxyphenyl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C22H21F2N5O	C22H21F2N5O	409.438			LZCGMQZFMKDCSR-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	7	2	4.336	2	5	4	67.76	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004154	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004154&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCNCC1	282; Example 191-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CN(C(C)(C)C)S(=O)(=O)C1=CC(=CC=C1)C1=CN=C2NC=C(C2=C1)C1=CC=CC2=C1OC(F)(F)O2		27004160	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004160&database=RX&origin=ReaxysOutput&ln=	(1050 of 1381)	1613711-10-6	N-(tert-butyl)-3-(3-(2,2-difluorobenzo[d][1,3]dioxol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-N-methylbenzenesulfonamide	C25H23F2N3O4S	C25H23F2N3O4S	499.538			MUNQNSONLNYBRJ-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	4	2	6.034	1	5	5	92.9	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004160	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004160&database=RX&origin=ReaxysOutput&ln=	CN(C(C)(C)C)S(=O)(=O)C1=CC(=CC=C1)C1=CN=C2NC=C(C2=C1)C1=CC=CC2=C1OC(F)(F)O2	298; Example 196-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1(F)OC2=C(O1)C(=CC=C2)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCC2)S1		27004161	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004161&database=RX&origin=ReaxysOutput&ln=	(1051 of 1381)	1613711-11-7	3-(2,2-difluorobenzo[d][1,3]dioxol-4-yl)-5-(5-(pyrrolidin-1-ylmethyl)thiophen-2-yl)-1H-pyrrolo[2,3-b]pyridine	C23H19F2N3O2S	C23H19F2N3O2S	439.486			KMOVIHDDHRLMGY-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	4	2	4.59	1	3	4	78.62	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004161	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004161&database=RX&origin=ReaxysOutput&ln=	FC1(F)OC2=C(O1)C(=CC=C2)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCC2)S1	300; Example 197-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1(F)OC2=C(O1)C(=CC=C2)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCCC2)S1		27004162	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004162&database=RX&origin=ReaxysOutput&ln=	(1052 of 1381)	1613711-12-8	3-(2,2-difluorobenzo[d][1,3]dioxol-4-yl)-5-(5-(piperidin-1-ylmethyl)thiophen-2-yl)-1H-pyrrolo[2,3-b]pyridine	C24H21F2N3O2S	C24H21F2N3O2S	453.512			RDSOUGNBPMROFC-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	4	2	4.948	1	3	4	78.62	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004162	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004162&database=RX&origin=ReaxysOutput&ln=	FC1(F)OC2=C(O1)C(=CC=C2)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCCC2)S1	302; Example 198-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCOCC2)S1		27004164	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004164&database=RX&origin=ReaxysOutput&ln=	(1053 of 1381)	1613711-14-0	4-((5-(3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl)thiophen-2-yl)methyl)morpholine	C23H19F2N3O3S	C23H19F2N3O3S	455.485			DISPZDZAOGUSGB-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	2	2	3.684	1	4	4	87.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004164	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004164&database=RX&origin=ReaxysOutput&ln=	FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCOCC2)S1	309; Example 200-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CN=C(S1)N1CCOCC1		27004165	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004165&database=RX&origin=ReaxysOutput&ln=	(1054 of 1381)	1613711-15-1	4-(5-(3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl)thiazol-2-yl)morpholine	C21H16F2N4O3S	C21H16F2N4O3S	442.446			AYBBSAFJYYSJPA-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	2	2	3.772	1	5	3	100.74	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004165	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004165&database=RX&origin=ReaxysOutput&ln=	FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CN=C(S1)N1CCOCC1	311; Example 201-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CN(C(C)(C)C)S(=O)(=O)C1=CC(=CC=C1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1		27004166	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004166&database=RX&origin=ReaxysOutput&ln=	(1055 of 1381)	1613711-16-2	N-(tert-butyl)-3-(3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-N-methylbenzenesulfonamide	C25H23F2N3O4S	C25H23F2N3O4S	499.538			DPQQVPTYQAXBSK-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	2	2	6.034	1	5	5	92.9	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004166	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004166&database=RX&origin=ReaxysOutput&ln=	CN(C(C)(C)C)S(=O)(=O)C1=CC(=CC=C1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1	313; Example 202-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCC2)S1		27004167	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004167&database=RX&origin=ReaxysOutput&ln=	(1056 of 1381)	1613711-17-3	3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-5-(5-(pyrrolidin-1-ylmethyl)thiophen-2-yl)-1H-pyrrolo[2,3-b]pyridine	C23H19F2N3O2S	C23H19F2N3O2S	439.486			SAHWPLOVDGCPGC-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	2	2	4.59	1	3	4	78.62	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004167	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004167&database=RX&origin=ReaxysOutput&ln=	FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCC2)S1	315; Example 203-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCCC2)S1		27004168	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004168&database=RX&origin=ReaxysOutput&ln=	(1057 of 1381)	1613711-18-4	3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-5-(5-(piperidin-1-ylmethyl)thiophen-2-yl)-1H-pyrrolo[2,3-b]pyridine	C24H21F2N3O2S	C24H21F2N3O2S	453.512			IRCNLNQMWACDQL-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	2	2	4.948	1	3	4	78.62	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004168	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004168&database=RX&origin=ReaxysOutput&ln=	FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCCCC2)S1	318; Example 204-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCNCC1		27004171	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004171&database=RX&origin=ReaxysOutput&ln=	(1058 of 1381)	1613711-20-8	3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C22H19F2N5O2	C22H19F2N5O2	423.422			DEKKSSSRNUVOAX-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	9	2	4.296	2	5	3	76.99	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004171	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004171&database=RX&origin=ReaxysOutput&ln=	FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCNCC1	324; Example 206-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CSC(=N1)N1CCOCC1		27004172	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004172&database=RX&origin=ReaxysOutput&ln=	(1059 of 1381)	1613711-21-9	4-(4-(3-(3-fluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)thiazol-2-yl)morpholine	C21H19FN4O2S	C21H19FN4O2S	410.472			KNBAZUJMKRSTES-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	5	2	4.35	1	5	4	91.51	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004172	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004172&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CSC(=N1)N1CCOCC1	327; Example 207-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1(F)OC2=C(O1)C(=CC=C2)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCNCC1		27004174	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004174&database=RX&origin=ReaxysOutput&ln=	(1060 of 1381)	1613711-23-1	3-(2,2-difluorobenzo[d][1,3]dioxol-4-yl)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C22H19F2N5O2	C22H19F2N5O2	423.422			AZBMKQMOQKIXHJ-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	5	2	4.296	2	5	3	76.99	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004174	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004174&database=RX&origin=ReaxysOutput&ln=	FC1(F)OC2=C(O1)C(=CC=C2)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCNCC1	332; Example 209-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1=CC=CC(F)=C1C(=O)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCNCC1		27004175	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004175&database=RX&origin=ReaxysOutput&ln=	(1061 of 1381)	1613711-24-2	(2,6-difluorophenyl)(5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methanone	C22H19F2N5O	C22H19F2N5O	407.423			FFFLSHBXLBHCCF-UHFFFAOYSA-N				Identification(8); Bioactivity(2)		2	4.464	2	6	4	75.6	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004175	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004175&database=RX&origin=ReaxysOutput&ln=	FC1=CC=CC(F)=C1C(=O)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCNCC1	Example 210-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)S(=O)(=O)N1CCN(C)CC1		27004176	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004176&database=RX&origin=ReaxysOutput&ln=	(1062 of 1381)	1613711-25-3	3-(3,5-difluoro-2-methoxyphenyl)-5-(1-((4-methylpiperazin-1-yl)sulfonyl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C22H22F2N6O3S	C22H22F2N6O3S	488.518			WYKRTBLAZZIYBY-UHFFFAOYSA-N				Identification(8); Bioactivity(2)		2	2.983	1	8	5	104.73	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004176	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004176&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)S(=O)(=O)N1CCN(C)CC1	Example 211-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCN(C)CC1		27004177	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004177&database=RX&origin=ReaxysOutput&ln=	(1063 of 1381)	1613711-26-4	3-(3,5-difluoro-2-methoxyphenyl)-5-(1-(1-methylpiperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C23H23F2N5O	C23H23F2N5O	423.465			KXBXVYGKUHXCMP-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	2	2	4.575	1	5	4	58.97	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004177	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004177&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCN(C)CC1	334; Example 212-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1=CC=CC(F)=C1C(=O)C1=CNC2=NC=C(C=C12)C1=CN=C(S1)N1CCOCC1		27004178	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004178&database=RX&origin=ReaxysOutput&ln=	(1064 of 1381)	1613711-27-5	(2,6-difluorophenyl)(5-(2-morpholinothiazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)methanone	C21H16F2N4O2S	C21H16F2N4O2S	426.446			UFIBKRHLZWQCAZ-UHFFFAOYSA-N				Identification(8); Bioactivity(2)		2	3.94	1	6	4	99.35	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004178	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004178&database=RX&origin=ReaxysOutput&ln=	FC1=CC=CC(F)=C1C(=O)C1=CNC2=NC=C(C=C12)C1=CN=C(S1)N1CCOCC1	Example 213-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCN(CC1)S(C)(=O)=O		27004179	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004179&database=RX&origin=ReaxysOutput&ln=	(1065 of 1381)	1613711-28-6	3-(3,5-difluoro-2-methoxyphenyl)-5-(1-(1-(methylsulfonyl)piperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C23H23F2N5O3S	C23H23F2N5O3S	487.53			NIFLRVAYOHHDFN-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	5	2	4.169	1	7	5	101.49	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004179	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004179&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCN(CC1)S(C)(=O)=O	336; Example 214-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CCS(=O)(=O)N1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=C(OC)C(F)=CC(F)=C1		27004180	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004180&database=RX&origin=ReaxysOutput&ln=	(1066 of 1381)	1613711-29-7	3-(3,5-difluoro-2-methoxyphenyl)-5-(1-(1-(ethylsulfonyl)piperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C24H25F2N5O3S	C24H25F2N5O3S	501.557			ONYGVAKIIZGNFO-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	5	2	4.527	1	7	6	101.49	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004180	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004180&database=RX&origin=ReaxysOutput&ln=	CCS(=O)(=O)N1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=C(OC)C(F)=CC(F)=C1	338; Example 215-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CCCS(=O)(=O)N1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=C(OC)C(F)=CC(F)=C1		27004182	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004182&database=RX&origin=ReaxysOutput&ln=	(1067 of 1381)	1613711-30-0	3-(3,5-difluoro-2-methoxyphenyl)-5-(1-(1-(propylsulfonyl)piperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C25H27F2N5O3S	C25H27F2N5O3S	515.584			RKBOHDUJLWJHMJ-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	5	2	4.885	1	7	7	101.49	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004182	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004182&database=RX&origin=ReaxysOutput&ln=	CCCS(=O)(=O)N1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=C(OC)C(F)=CC(F)=C1	340; Example 216-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)N1C=C(C=N1)N1CCN(CCO)CC1		27004184	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004184&database=RX&origin=ReaxysOutput&ln=	(1068 of 1381)	1613711-32-2	2-(4-(1-(3-(3,5-difluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazol-4-yl)piperazin-1-yl)ethanol	C23H24F2N6O2	C23H24F2N6O2	454.479			CWXXUOQVEMDQSH-UHFFFAOYSA-N				Identification(8); Bioactivity(2)		2	3.475	2	7	6	82.44	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004184	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004184&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)N1C=C(C=N1)N1CCN(CCO)CC1	Example 218-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)S(=O)(=O)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1		27004185	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004185&database=RX&origin=ReaxysOutput&ln=	(1069 of 1381)	1613711-33-3	3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-5-(1-((4-methylpiperazin-1-yl)sulfonyl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C22H20F2N6O4S	C22H20F2N6O4S	502.501			WYFURHGOMHVKEL-UHFFFAOYSA-N				Identification(8); Bioactivity(2)		2	2.943	1	8	4	113.96	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004185	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004185&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)S(=O)(=O)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1	Example 219-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1		27004186	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004186&database=RX&origin=ReaxysOutput&ln=	(1070 of 1381)	1613711-34-4	3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-5-(1-(1-methylpiperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C23H21F2N5O2	C23H21F2N5O2	437.449			PTLGEZNGAGGZGJ-UHFFFAOYSA-N				Identification(8); Physical Data(1); Bioactivity(2)	5	2	4.535	1	5	3	68.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004186	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004186&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1	341; Example 220-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CS(=O)(=O)N1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1		27004187	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004187&database=RX&origin=ReaxysOutput&ln=	(1071 of 1381)	1613711-35-5	3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-5-(1-(1-(methylsulfonyl)piperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C23H21F2N5O4S	C23H21F2N5O4S	501.514			MRUYTOJULSLDDU-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	5	2	4.129	1	7	4	110.72	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004187	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004187&database=RX&origin=ReaxysOutput&ln=	CS(=O)(=O)N1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1	343; Example 221-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CCS(=O)(=O)N1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1		27004188	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004188&database=RX&origin=ReaxysOutput&ln=	(1072 of 1381)	1613711-36-6	3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-5-(1-(1-(ethylsulfonyl)piperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C24H23F2N5O4S	C24H23F2N5O4S	515.541			QQMWQCCBQQFLNP-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	5	2	4.487	1	7	5	110.72	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004188	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004188&database=RX&origin=ReaxysOutput&ln=	CCS(=O)(=O)N1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1	344; Example 222-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CCCS(=O)(=O)N1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1		27004189	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004189&database=RX&origin=ReaxysOutput&ln=	(1073 of 1381)	1613711-37-7	3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-5-(1-(1-(propylsulfonyl)piperidin-4-yl)-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine	C25H25F2N5O4S	C25H25F2N5O4S	529.567			FGLIWEYWTVXWIS-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	5	2	4.845	1	7	6	110.72	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004189	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004189&database=RX&origin=ReaxysOutput&ln=	CCCS(=O)(=O)N1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1	345; Example 223-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
OCCN1CCN(CC1)C1=CN(N=C1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1		27004191	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004191&database=RX&origin=ReaxysOutput&ln=	(1074 of 1381)	1613711-39-9	2-(4-(1-(3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazol-4-yl)piperazin-1-yl)ethanol	C23H22F2N6O3	C23H22F2N6O3	468.463			VBZFERFTPMRATL-UHFFFAOYSA-N				Identification(8); Bioactivity(2)		2	3.435	2	7	5	91.67	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004191	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004191&database=RX&origin=ReaxysOutput&ln=	OCCN1CCN(CC1)C1=CN(N=C1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1	Example 225-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCN(CCO)CC1		27004192	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004192&database=RX&origin=ReaxysOutput&ln=	(1075 of 1381)	1613711-40-2	2-(4-(4-(3-(3,5-difluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazol-1-yl)piperidin-1-yl)ethanol	C24H25F2N5O2	C24H25F2N5O2	453.492			CLWCWTCVUWUDIN-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	1	2	3.866	2	6	6	79.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004192	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004192&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN(N=C1)C1CCN(CCO)CC1	347; Example 226-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
OCCN1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1		27004193	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004193&database=RX&origin=ReaxysOutput&ln=	(1076 of 1381)	1613711-41-3	2-(4-(4-(3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazol-1-yl)piperidin-1-yl)ethanol	C24H23F2N5O3	C24H23F2N5O3	467.475			FVZDPCBYHDMAOS-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	5	2	3.826	2	6	5	88.43	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004193	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004193&database=RX&origin=ReaxysOutput&ln=	OCCN1CCC(CC1)N1C=C(C=N1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1	348; Example 227-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(NC=C2C2=CN=C(O2)C2=CC=CN2)=CC(Br)=C1		28546687	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D28546687&database=RX&origin=ReaxysOutput&ln=	(1077 of 1381)		5-(6-bromo-4-methoxy-1H-indol-3-yl)-2-(1H-pyrrol-2-yl)oxazole; breitfussin D	C16H12BrN3O2	C16H12BrN3O2	358.194			HCBIATVCCJRSKR-UHFFFAOYSA-N				Identification(7); Physical Data(4); Spectra(15); Bioactivity(2)	15	2	3.352	2	3	3	66.84	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									28546687	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D28546687&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(NC=C2C2=CN=C(O2)C2=CC=CN2)=CC(Br)=C1	5-(6-bromo-4-methoxy-1H-indol-3-yl)-2-(1H-pyrrol-2-yl)oxazole					IC50	μM	>	50							1			73010	ATP	Other compound	Article; Hansen, Kine Ø.; Andersen, Jeanette H.; Bayer, Annette; Pandey, Sunil K.; Lorentzen, Marianne; Jørgensen, Kåre B.; Sydnes, Magne O.; Guttormsen, Yngve; Baumann, Matthias; Koch, Uwe; Klebl, Bert; Eickhoff, Jan; Haug, Bengt Erik; Isaksson, Johan; Hansen, Espen H.; Journal of Medicinal Chemistry; vol. 62; 22; (2019); p. 10167 - 10181;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78442548&database=RX&origin=ReaxysOutput&ln=	
OC(=O)C(F)(F)F.CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N2C=CN=C2NC2=C(C)C=CC=C2C)C=C1		29253380	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29253380&database=RX&origin=ReaxysOutput&ln=	(1078 of 1381)		6-(2-((2,6-dimethylphenyl)amino)-1H-imidazol-1-yl)-N-(4-(4-ethylpiperazin-1-yl)phenyl)pyrimidin-4-amine trifluoroacetic acid; HG-10-7-01	C27H32N8*xC2HF3O2	(x)C2HF3O2*C27H32N8				UFSFVSMZBZWBMX-UHFFFAOYSA-N				Identification(8); Physical Data(4); Spectra(4); Bioactivity(3)	3	2		3	10	8	111.44	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29253380	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29253380&database=RX&origin=ReaxysOutput&ln=	OC(=O)C(F)(F)F.CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N2C=CN=C2NC2=C(C)C=CC=C2C)C=C1						IC50	μM		0.12							6.92						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
OC(=O)C(F)(F)F.CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N2C=CN=C2NC2=C(C)C=CC=C2C)C=C1		29253380	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29253380&database=RX&origin=ReaxysOutput&ln=	(1078 of 1381)		6-(2-((2,6-dimethylphenyl)amino)-1H-imidazol-1-yl)-N-(4-(4-ethylpiperazin-1-yl)phenyl)pyrimidin-4-amine trifluoroacetic acid; HG-10-7-01	C27H32N8*xC2HF3O2	(x)C2HF3O2*C27H32N8				UFSFVSMZBZWBMX-UHFFFAOYSA-N				Identification(8); Physical Data(4); Spectra(4); Bioactivity(3)	3	2		3	10	8	111.44	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29253380	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29253380&database=RX&origin=ReaxysOutput&ln=	OC(=O)C(F)(F)F.CCN1CCN(CC1)C1=CC=C(NC2=CC(=NC=N2)N2C=CN=C2NC2=C(C)C=CC=C2C)C=C1						IC50	nM		120							6.92						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC(Cl)=C(F)C=C2)=CC(=N1)N1CCN(CCO)CC1		33633206	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633206&database=RX&origin=ReaxysOutput&ln=	(1079 of 1381)		N-(3-chloro-4-fluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H23ClFN7O2S	C21H23ClFN7O2S	491.977			HKQFQJJKXCZLON-UHFFFAOYSA-N				Identification(8); Spectra(2); Bioactivity(2)	1	2	1.926	3	9	8	134.75	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									33633206	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33633206&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=CC(Cl)=C(F)C=C2)=CC(=N1)N1CCN(CCO)CC1	N-(3-chloro-4-fluorophenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	μM	>	5							5.3						Patent; IOMX THERAPEUTICS AG; WO2018/193084; (2018); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75343594&database=RX&origin=ReaxysOutput&ln=	
[2H]C([2H])([2H])OC1=C(C(=O)NC2([2H])C([2H])([2H])C2([2H])[2H])C(OC(F)F)=CC(=C1)N1C=NC2=C1C=CC(=C2)C1=CN(C)N=C1		34626585	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626585&database=RX&origin=ReaxysOutput&ln=	(1080 of 1381)		2-(difluoromethoxy)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(1,2,2,3,3-pentadeuteriocyclopropyl)-6-(trideuteriomethoxy)benzamide	C23H13(2)H8F2N5O3	C23H21F2N5O3	461.385			PFTXFNSHFZLJNT-NPHRVKHMSA-N				Identification(8); Spectra(2); Bioactivity(2)	10	2	4.112	1	6	8	83.2	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									34626585	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D34626585&database=RX&origin=ReaxysOutput&ln=	[2H]C([2H])([2H])OC1=C(C(=O)NC2([2H])C([2H])([2H])C2([2H])[2H])C(OC(F)F)=CC(=C1)N1C=NC2=C1C=CC(=C2)C1=CN(C)N=C1	2-(difluoromethoxy)-4-[5-(1-methylpyrazol-4-yl)benzimidazol-1-yl]-N-(1,2,2,3,3-pentadeuteriocyclopropyl)-6-(trideuteriomethoxy)benzamide					IC50	nM		0.01 - 10										34681992	AMARA peptide substrate	Substrate	Patent; GALAPAGOS; (340 pag.)WO2019/105886; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D76998533&database=RX&origin=ReaxysOutput&ln=	
COC1=CC2=C(NC=C2C2=CN=C(O2)C2=CC=CN2)C=C1Br		35270396	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35270396&database=RX&origin=ReaxysOutput&ln=	(1081 of 1381)		breitfussin C	C16H12BrN3O2	C16H12BrN3O2	358.194			XCOSAQGGGZDYJN-UHFFFAOYSA-N				Identification(7); Physical Data(4); Spectra(14); Bioactivity(2)	13	2	3.352	2	3	3	66.84	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									35270396	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35270396&database=RX&origin=ReaxysOutput&ln=	COC1=CC2=C(NC=C2C2=CN=C(O2)C2=CC=CN2)C=C1Br	5-(6-bromo-5-methoxy-1H-indol-3-yl)-2-(1H-pyrrol-2-yl)oxazole					IC50	μM		1.2							5.92			73010	ATP	Other compound	Article; Hansen, Kine Ø.; Andersen, Jeanette H.; Bayer, Annette; Pandey, Sunil K.; Lorentzen, Marianne; Jørgensen, Kåre B.; Sydnes, Magne O.; Guttormsen, Yngve; Baumann, Matthias; Koch, Uwe; Klebl, Bert; Eickhoff, Jan; Haug, Bengt Erik; Isaksson, Johan; Hansen, Espen H.; Journal of Medicinal Chemistry; vol. 62; 22; (2019); p. 10167 - 10181;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78442548&database=RX&origin=ReaxysOutput&ln=	
Cl.[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2		35503228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503228&database=RX&origin=ReaxysOutput&ln=	(1082 of 1381)		4-[7-[[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]oxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide hydrochloride salt	C26H28F2N4O4*ClH	C26H28F2N4O4*ClH	534.99			RSQJBMBDYBWWDB-SLNDRTLMSA-N				Identification(8); Spectra(1); Bioactivity(2)	5	2	5.294	2	5	9	86.12	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503228&database=RX&origin=ReaxysOutput&ln=	Cl.[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2	4-[7-[[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]oxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide hydrochloride salt					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
Cl.[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2		35503228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503228&database=RX&origin=ReaxysOutput&ln=	(1082 of 1381)		4-[7-[[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]oxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide hydrochloride salt	C26H28F2N4O4*ClH	C26H28F2N4O4*ClH	534.99			RSQJBMBDYBWWDB-SLNDRTLMSA-N				Identification(8); Spectra(1); Bioactivity(2)	5	2	5.294	2	5	9	86.12	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503228	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503228&database=RX&origin=ReaxysOutput&ln=	Cl.[H][C@]12CC[C@]([H])(CC(C1)OC1=CC3=NC=C(N3C=C1)C1=CC(OC(F)F)=C(C(=O)NC3CC3)C(OC)=C1)N2	4-[7-[[(1R,5S)-8-azabicyclo[3.2.1]octan-3-yl]oxy]imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxybenzamide hydrochloride salt					IC50	nM	>	1000 - 5000			Tumor necrosis factor				6			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H](O)CN3CCOCC3)C=CN12		35503292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503292&database=RX&origin=ReaxysOutput&ln=	(1083 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6	C26H30F2N4O6	532.544			TZHOUGOSZCJXIL-GOSISDBHSA-N				Identification(7); Spectra(1); Bioactivity(1)	2	2	2.826	2	7	12	106.79	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503292&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H](O)CN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H](O)CN3CCOCC3)C=CN12		35503292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503292&database=RX&origin=ReaxysOutput&ln=	(1083 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6	C26H30F2N4O6	532.544			TZHOUGOSZCJXIL-GOSISDBHSA-N				Identification(7); Spectra(1); Bioactivity(1)	2	2	2.826	2	7	12	106.79	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503292&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H](O)CN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H](O)CN3CCOCC3)C=CN12		35503292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503292&database=RX&origin=ReaxysOutput&ln=	(1083 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6	C26H30F2N4O6	532.544			TZHOUGOSZCJXIL-GOSISDBHSA-N				Identification(7); Spectra(1); Bioactivity(1)	2	2	2.826	2	7	12	106.79	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503292&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@H](O)CN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H](O)CN3CCOCC3)C=CN12		35503293	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503293&database=RX&origin=ReaxysOutput&ln=	(1084 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6	C26H30F2N4O6	532.544			TZHOUGOSZCJXIL-SFHVURJKSA-N				Identification(7); Spectra(1); Bioactivity(1)	2	2	2.826	2	7	12	106.79	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503293	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503293&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H](O)CN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H](O)CN3CCOCC3)C=CN12		35503293	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503293&database=RX&origin=ReaxysOutput&ln=	(1084 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6	C26H30F2N4O6	532.544			TZHOUGOSZCJXIL-SFHVURJKSA-N				Identification(7); Spectra(1); Bioactivity(1)	2	2	2.826	2	7	12	106.79	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503293	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503293&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H](O)CN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H](O)CN3CCOCC3)C=CN12		35503293	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503293&database=RX&origin=ReaxysOutput&ln=	(1084 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C26H30F2N4O6	C26H30F2N4O6	532.544			TZHOUGOSZCJXIL-SFHVURJKSA-N				Identification(7); Spectra(1); Bioactivity(1)	2	2	2.826	2	7	12	106.79	3	1	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503293	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503293&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H](O)CN3CCOCC3)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(2-hydroxy-3-morpholinopropoxy)imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.1 - 100			Tumor necrosis factor							8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(OCCN3CCOCC3)C=NN12		37037389	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037389&database=RX&origin=ReaxysOutput&ln=	(1085 of 1381)		8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-b]pyridazin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one	C24H26F3N5O4	C24H26F3N5O4	505.497			FAZLMQYMNSONHW-UHFFFAOYSA-N				Identification(9); Spectra(2); Bioactivity(2)	7	2	2.909	0	7	8	47.26	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									37037389	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037389&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(CCN(CC(F)(F)F)C2=O)=CC(=C1)C1=CN=C2C=C(OCCN3CCOCC3)C=NN12						IC50	nM	>	10 - 100							8			73010	ATP	Other compound	Patent; GALAPAGOS; WO2020/239660; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807679&database=RX&origin=ReaxysOutput&ln=	
CC1=C(CN2CCN(CC2)C(=O)C2=CC3=C(O2)C(=CC=C3)C(N)=O)SC2=C1N=C(N=C2N1CCOCC1)C1=CN=C(N)N=C1		37415638	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37415638&database=RX&origin=ReaxysOutput&ln=	(1086 of 1381)		2-(4-((2-(2-aminopyrimidin-5-yl )-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazine-1-carbonyl)benzofuran-7-carboxamide; 2-(4-{[2-(2-aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}piperazine-1-carbonyl)-1-benzofuran-7-carboxamide	C30H31N9O4S	C30H31N9O4S	613.7			QGOJFKKLWHNNFG-UHFFFAOYSA-N				Identification(8); Physical Data(3); Spectra(4); Bioactivity(3)	7	2	0.546	2	12	7	127.08	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									37415638	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37415638&database=RX&origin=ReaxysOutput&ln=	CC1=C(CN2CCN(CC2)C(=O)C2=CC3=C(O2)C(=CC=C3)C(N)=O)SC2=C1N=C(N=C2N1CCOCC1)C1=CN=C(N)N=C1	2-(4-((2-(2-aminopyrimidin-5-yl )-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazine-1-carbonyl)benzofuran-7-carboxamide					IC50	M		2.02E-09							8.69						Article; Wu, Zhengyang; Bai, Ying; Jin, Jiaming; Jiang, Teng; Shen, Hui; Ju, Qiurong; Zhu, Qihua; Xu, Yungen; European Journal of Medicinal Chemistry; vol. 217; (2021);	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D83319831&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CNC2)=C2C=C(N)N=CC2=C1		37673287	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673287&database=RX&origin=ReaxysOutput&ln=	(1087 of 1381)		N5-(azetidin-3-yl)-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	C19H19FN4	C19H19FN4	322.385			ZANZTKVFQUABRY-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	2	2	3.572	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673287	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673287&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CNC2)=C2C=C(N)N=CC2=C1	N5-(azetidin-3-yl)-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.6426							9.19						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CNC2)=C2C=C(N)N=CC2=C1		37673287	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673287&database=RX&origin=ReaxysOutput&ln=	(1087 of 1381)		N5-(azetidin-3-yl)-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	C19H19FN4	C19H19FN4	322.385			ZANZTKVFQUABRY-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	2	2	3.572	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673287	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673287&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CNC2)=C2C=C(N)N=CC2=C1	N5-(azetidin-3-yl)-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.6426							9.19			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1		37673288	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673288&database=RX&origin=ReaxysOutput&ln=	(1088 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3R)-pyrrolidin-3-yl]isoquinoline-3,5-diamine	C20H21FN4	C20H21FN4	336.412			LLGZGYWIEGIHBZ-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.93	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673288	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673288&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[(3R)-pyrrolidin-3-yl]isoquinoline3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.2309							9.64						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1		37673288	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673288&database=RX&origin=ReaxysOutput&ln=	(1088 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3R)-pyrrolidin-3-yl]isoquinoline-3,5-diamine	C20H21FN4	C20H21FN4	336.412			LLGZGYWIEGIHBZ-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.93	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673288	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673288&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[(3R)-pyrrolidin-3-yl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.2309							9.64			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCCN2)=C2C=C(N)N=CC2=C1		37673289	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673289&database=RX&origin=ReaxysOutput&ln=	(1089 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-2-piperidyl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			OVFRJFBBKNDTEN-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.646	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673289	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673289&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCCN2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-2-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		8.931							8.05						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCCN2)=C2C=C(N)N=CC2=C1		37673289	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673289&database=RX&origin=ReaxysOutput&ln=	(1089 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-2-piperidyl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			OVFRJFBBKNDTEN-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.646	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673289	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673289&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCCN2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-2-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		8.931							8.05			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1		37673290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673290&database=RX&origin=ReaxysOutput&ln=	(1090 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-pyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			CUBGLPCITODQQU-CQSZACIVSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.125	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673290&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-pyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.5699							9.24						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1		37673290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673290&database=RX&origin=ReaxysOutput&ln=	(1090 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-pyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			CUBGLPCITODQQU-CQSZACIVSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.125	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673290&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-pyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.5699							9.24			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCNC2)=C2C=C(N)N=CC2=C1		37673291	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673291&database=RX&origin=ReaxysOutput&ln=	(1091 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3S)-pyrrolidin-3-yl]isoquinoline-3,5-diamine	C20H21FN4	C20H21FN4	336.412			LLGZGYWIEGIHBZ-HNNXBMFYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.93	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673291	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673291&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[(3S)-pyrrolidin-3-yl]isoquinoline3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3246							9.49						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCNC2)=C2C=C(N)N=CC2=C1		37673291	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673291&database=RX&origin=ReaxysOutput&ln=	(1091 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3S)-pyrrolidin-3-yl]isoquinoline-3,5-diamine	C20H21FN4	C20H21FN4	336.412			LLGZGYWIEGIHBZ-HNNXBMFYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.93	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673291	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673291&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[(3S)-pyrrolidin-3-yl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3246							9.49			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NCC2CCNCC2)=C2C=C(N)N=CC2=C1		37673292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673292&database=RX&origin=ReaxysOutput&ln=	(1092 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-(4-piperidylmethyl)isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			QFUBQMUTDSGSIU-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.483	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673292&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NCC2CCNCC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-(4-piperidylmethyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.02							8.99						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NCC2CCNCC2)=C2C=C(N)N=CC2=C1		37673292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673292&database=RX&origin=ReaxysOutput&ln=	(1092 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-(4-piperidylmethyl)isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			QFUBQMUTDSGSIU-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.483	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673292&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NCC2CCNCC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-(4-piperidylmethyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.02							8.99			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCNC2)=C2C=C(N)N=CC2=C1		37673293	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673293&database=RX&origin=ReaxysOutput&ln=	(1093 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-pyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			CUBGLPCITODQQU-AWEZNQCLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.125	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673293	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673293&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-pyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.269							9.57						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCNC2)=C2C=C(N)N=CC2=C1		37673293	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673293&database=RX&origin=ReaxysOutput&ln=	(1093 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-pyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			CUBGLPCITODQQU-AWEZNQCLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.125	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673293	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673293&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-pyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.269							9.57			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCNC2)=C2C=C(N)N=CC2=C1		37673294	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673294&database=RX&origin=ReaxysOutput&ln=	(1094 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-3-piperidyl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			SAROZLPNNCCTPO-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.483	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673294	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673294&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-3-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.9655							9.02						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCNC2)=C2C=C(N)N=CC2=C1		37673294	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673294&database=RX&origin=ReaxysOutput&ln=	(1094 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-3-piperidyl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			SAROZLPNNCCTPO-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.483	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673294	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673294&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-3-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.9655							9.02			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NCC2CNC2)=C2C=C(N)N=CC2=C1		37673295	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673295&database=RX&origin=ReaxysOutput&ln=	(1095 of 1381)		N5-(azetidin-3-ylmethyl)-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	C20H21FN4	C20H21FN4	336.412			BOMHVYFLJZCKIM-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.767	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673295	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673295&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NCC2CNC2)=C2C=C(N)N=CC2=C1	N5-(azetidin-3-ylmethyl)-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.1947							9.71						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NCC2CNC2)=C2C=C(N)N=CC2=C1		37673295	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673295&database=RX&origin=ReaxysOutput&ln=	(1095 of 1381)		N5-(azetidin-3-ylmethyl)-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	C20H21FN4	C20H21FN4	336.412			BOMHVYFLJZCKIM-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.767	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673295	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673295&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NCC2CNC2)=C2C=C(N)N=CC2=C1	N5-(azetidin-3-ylmethyl)-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.1947							9.71			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCN2)=C2C=C(N)N=CC2=C1		37673296	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673296&database=RX&origin=ReaxysOutput&ln=	(1096 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-pyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			DYFSJLNZWKTCBW-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.288	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673296	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673296&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCN2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-pyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		3.103							8.51						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCN2)=C2C=C(N)N=CC2=C1		37673296	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673296&database=RX&origin=ReaxysOutput&ln=	(1096 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-pyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			DYFSJLNZWKTCBW-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.288	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673296	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673296&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCN2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-pyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		3.103							8.51			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCN2)=C2C=C(N)N=CC2=C1		37673297	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673297&database=RX&origin=ReaxysOutput&ln=	(1097 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-pyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			DYFSJLNZWKTCBW-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.288	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673297	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673297&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCN2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-pyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.012							9						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCN2)=C2C=C(N)N=CC2=C1		37673297	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673297&database=RX&origin=ReaxysOutput&ln=	(1097 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-pyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			DYFSJLNZWKTCBW-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.288	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673297	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673297&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCN2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-pyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.012							9			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCCN2)=C2C=C(N)N=CC2=C1		37673298	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673298&database=RX&origin=ReaxysOutput&ln=	(1098 of 1381)		7-(2-fluoro-6-methyl-phenyl)-N5-[[(2S)-2-piperidyl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			OVFRJFBBKNDTEN-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.646	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673298	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673298&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCCN2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methyl-phenyl)-N5-[[(2S)-2-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.431							8.61						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCCN2)=C2C=C(N)N=CC2=C1		37673298	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673298&database=RX&origin=ReaxysOutput&ln=	(1098 of 1381)		7-(2-fluoro-6-methyl-phenyl)-N5-[[(2S)-2-piperidyl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			OVFRJFBBKNDTEN-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.646	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673298	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673298&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@@H]2CCCCN2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-2-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.431							8.61			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CNC1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673299	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673299&database=RX&origin=ReaxysOutput&ln=	(1099 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[4-(methylamino)1-piperidyl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[4-(methylamino)-1-piperidyl]isoquinoline-3-amine	C22H25FN4	C22H25FN4	364.466			XDFNSVGBMRBFCX-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.971	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673299	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673299&database=RX&origin=ReaxysOutput&ln=	CNC1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[4-(methylamino)1-piperidyl]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.944							8.71						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CNC1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673299	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673299&database=RX&origin=ReaxysOutput&ln=	(1099 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[4-(methylamino)1-piperidyl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[4-(methylamino)-1-piperidyl]isoquinoline-3-amine	C22H25FN4	C22H25FN4	364.466			XDFNSVGBMRBFCX-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.971	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673299	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673299&database=RX&origin=ReaxysOutput&ln=	CNC1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[4-(methylamino)-1-piperidyl]isoquinoline-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.944							8.71			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673300	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673300&database=RX&origin=ReaxysOutput&ln=	(1100 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)pyrrolidin-1-yl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)pyrrolidin-1-yl]isoquinoline-3-amine	C21H23FN4	C21H23FN4	350.439			YAZJQYBERCMZSB-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.613	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673300	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673300&database=RX&origin=ReaxysOutput&ln=	CN[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)pyrrolidin-1-yl]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		4.695							8.33						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673300	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673300&database=RX&origin=ReaxysOutput&ln=	(1100 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)pyrrolidin-1-yl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)pyrrolidin-1-yl]isoquinoline-3-amine	C21H23FN4	C21H23FN4	350.439			YAZJQYBERCMZSB-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.613	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673300	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673300&database=RX&origin=ReaxysOutput&ln=	CN[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)pyrrolidin-1-yl]isoquinoline-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		4.695							8.33			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCCCNC2)=C2C=C(N)N=CC2=C1		37673301	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673301&database=RX&origin=ReaxysOutput&ln=	(1101 of 1381)		N5-[(3R)-azepan-3-yl]-7-(2-fluoro-6-methylphenyl)-isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			QMHKWCHNTZQYLJ-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.646	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673301	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673301&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCCCNC2)=C2C=C(N)N=CC2=C1	N5-[(3R)-azepan-3-yl]-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.647							8.78						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCCCNC2)=C2C=C(N)N=CC2=C1		37673301	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673301&database=RX&origin=ReaxysOutput&ln=	(1101 of 1381)		N5-[(3R)-azepan-3-yl]-7-(2-fluoro-6-methylphenyl)-isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			QMHKWCHNTZQYLJ-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.646	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673301	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673301&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCCCNC2)=C2C=C(N)N=CC2=C1	N5-[(3R)-azepan-3-yl]-7-(2-fluoro-6-methylphenyl)-isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.647							8.78			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673302&database=RX&origin=ReaxysOutput&ln=	(1102 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)-1-piperidyl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)-1-piperidyl]isoquinoline-3-amine	C22H25FN4	C22H25FN4	364.466			WPSQPXOTPCDCFY-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.971	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673302&database=RX&origin=ReaxysOutput&ln=	CN[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)-1-piperidyl]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		7.09							8.15						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673302&database=RX&origin=ReaxysOutput&ln=	(1102 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)-1-piperidyl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)-1-piperidyl]isoquinoline-3-amine	C22H25FN4	C22H25FN4	364.466			WPSQPXOTPCDCFY-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.971	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673302&database=RX&origin=ReaxysOutput&ln=	CN[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylamino)-1-piperidyl]isoquinoline-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		7.09							8.15			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673303	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673303&database=RX&origin=ReaxysOutput&ln=	(1103 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylamino)-1-piperidyl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylamino)-1-piperidyl]isoquinoline-3-amine	C22H25FN4	C22H25FN4	364.466			WPSQPXOTPCDCFY-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.971	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673303	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673303&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylamino)-1-piperidyl]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		4.449							8.35						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673303	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673303&database=RX&origin=ReaxysOutput&ln=	(1103 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylamino)-1-piperidyl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylamino)-1-piperidyl]isoquinoline-3-amine	C22H25FN4	C22H25FN4	364.466			WPSQPXOTPCDCFY-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.971	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673303	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673303&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylamino)-1-piperidyl]isoquinoline-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		4.449							8.35			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CNC[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673305	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673305&database=RX&origin=ReaxysOutput&ln=	(1104 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylaminomethyl)-1-piperidyl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylaminomethyl)-1-piperidyl]isoquinoline-3-amine	C23H27FN4	C23H27FN4	378.493			NHNAJIPYGAVKQJ-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.166	2	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673305	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673305&database=RX&origin=ReaxysOutput&ln=	CNC[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylaminomethyl)-1-piperidyl]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		9.362							8.03						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CNC[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673305	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673305&database=RX&origin=ReaxysOutput&ln=	(1104 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylaminomethyl)-1-piperidyl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylaminomethyl)-1-piperidyl]isoquinoline-3-amine	C23H27FN4	C23H27FN4	378.493			NHNAJIPYGAVKQJ-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.166	2	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673305	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673305&database=RX&origin=ReaxysOutput&ln=	CNC[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylaminomethyl)-1-piperidyl]isoquinoline-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		9.362							8.03			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CNC[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673306	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673306&database=RX&origin=ReaxysOutput&ln=	(1105 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylaminomethyl)-1-piperidyl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylaminomethyl)-1-piperidyl]isoquinoline-3-amine	C23H27FN4	C23H27FN4	378.493			NHNAJIPYGAVKQJ-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.166	2	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673306	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673306&database=RX&origin=ReaxysOutput&ln=	CNC[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylaminomethyl)-1-piperidyl]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		13.64							7.87						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CNC[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673306	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673306&database=RX&origin=ReaxysOutput&ln=	(1105 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylaminomethyl)-1-piperidyl]isoquinolin-3-amine; 7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylaminomethyl)-1-piperidyl]isoquinoline-3-amine	C23H27FN4	C23H27FN4	378.493			NHNAJIPYGAVKQJ-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.166	2	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673306	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673306&database=RX&origin=ReaxysOutput&ln=	CNC[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(3S)-3-(methylaminomethyl)-1-piperidyl]isoquinoline-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		13.64							7.87			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCCCNC2)=C2C=C(N)N=CC2=C1		37673307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673307&database=RX&origin=ReaxysOutput&ln=	(1106 of 1381)		N5-[(3S)-azepan-3-yl]-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			QMHKWCHNTZQYLJ-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.646	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673307&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCCCNC2)=C2C=C(N)N=CC2=C1	N5-[(3S)-azepan-3-yl]-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.1712							9.77						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCCCNC2)=C2C=C(N)N=CC2=C1		37673307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673307&database=RX&origin=ReaxysOutput&ln=	(1106 of 1381)		N5-[(3S)-azepan-3-yl]-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			QMHKWCHNTZQYLJ-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.646	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673307&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCCCNC2)=C2C=C(N)N=CC2=C1	N5-[(3S)-azepan-3-yl]-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.1712							9.77			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673308	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673308&database=RX&origin=ReaxysOutput&ln=	(1107 of 1381)		7-(2-fluoro-6-methyl-phenyl)-5-[(3R)-3-(methylamino)pyrrolidin-1-yl]isoquinolin-3-amine	C21H23FN4	C21H23FN4	350.439			YAZJQYBERCMZSB-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.613	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673308	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673308&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methyl-phenyl)-5-[(3R)-3-(methylamino)pyrrolidin-1-yl]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		7.501							8.12						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673308	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673308&database=RX&origin=ReaxysOutput&ln=	(1107 of 1381)		7-(2-fluoro-6-methyl-phenyl)-5-[(3R)-3-(methylamino)pyrrolidin-1-yl]isoquinolin-3-amine	C21H23FN4	C21H23FN4	350.439			YAZJQYBERCMZSB-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.613	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673308	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673308&database=RX&origin=ReaxysOutput&ln=	CN[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(3R)-3-(methylamino)pyrrolidin-1-yl]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		7.501							8.12			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCCNC2)=C2C=C(N)N=CC2=C1		37673309	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673309&database=RX&origin=ReaxysOutput&ln=	(1108 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3R)-3-piperidyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			MBWUDZLBKIOCLW-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.288	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673309	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673309&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[(3R)-3-piperidyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.281							8.89						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCCNC2)=C2C=C(N)N=CC2=C1		37673309	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673309&database=RX&origin=ReaxysOutput&ln=	(1108 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3R)-3-piperidyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			MBWUDZLBKIOCLW-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.288	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673309	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673309&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@@H]2CCCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[(3R)-3-piperidyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.281							8.89			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCCNC2)=C2C=C(N)N=CC2=C1		37673310	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673310&database=RX&origin=ReaxysOutput&ln=	(1109 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3S)-3-piperidyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			MBWUDZLBKIOCLW-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.288	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673310	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673310&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[(3S)-3-piperidyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.0838							10.1						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCCNC2)=C2C=C(N)N=CC2=C1		37673310	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673310&database=RX&origin=ReaxysOutput&ln=	(1109 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3S)-3-piperidyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			MBWUDZLBKIOCLW-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.288	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673310	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673310&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N[C@H]2CCCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[(3S)-3-piperidyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.0838							10.1			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC2=C(NC3CCNCC3)C=C(C=C2C=N1)C1=C(F)C=CC=C1C		37673311	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673311&database=RX&origin=ReaxysOutput&ln=	(1110 of 1381)		7-(2-fluoro-6-methylphenyl)-N3-methyl-N5-(4-piperidyl)isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			SOXWYZCECQBPLQ-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	3	2	4.751	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673311	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673311&database=RX&origin=ReaxysOutput&ln=	CNC1=CC2=C(NC3CCNCC3)C=C(C=C2C=N1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N3-methyl-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3494							9.46						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC2=C(NC3CCNCC3)C=C(C=C2C=N1)C1=C(F)C=CC=C1C		37673311	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673311&database=RX&origin=ReaxysOutput&ln=	(1110 of 1381)		7-(2-fluoro-6-methylphenyl)-N3-methyl-N5-(4-piperidyl)isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			SOXWYZCECQBPLQ-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	3	2	4.751	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673311	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673311&database=RX&origin=ReaxysOutput&ln=	CNC1=CC2=C(NC3CCNCC3)C=C(C=C2C=N1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N3-methyl-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3494							9.46			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC(C)NC1=CC2=C(NC3CCNCC3)C=C(C=C2C=N1)C1=C(F)C=CC=C1C		37673312	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673312&database=RX&origin=ReaxysOutput&ln=	(1111 of 1381)		7-(2-fluoro-6-methylphenyl)-N3-isopropyl-N5-(4-piperidyl)isoquinoline-3,5-diamine	C24H29FN4	C24H29FN4	392.519			XZQSUGKSSAEMBR-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.634	3	4	5	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673312	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673312&database=RX&origin=ReaxysOutput&ln=	CC(C)NC1=CC2=C(NC3CCNCC3)C=C(C=C2C=N1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N3-isopropyl-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.5039							9.3						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC(C)NC1=CC2=C(NC3CCNCC3)C=C(C=C2C=N1)C1=C(F)C=CC=C1C		37673312	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673312&database=RX&origin=ReaxysOutput&ln=	(1111 of 1381)		7-(2-fluoro-6-methylphenyl)-N3-isopropyl-N5-(4-piperidyl)isoquinoline-3,5-diamine	C24H29FN4	C24H29FN4	392.519			XZQSUGKSSAEMBR-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.634	3	4	5	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673312	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673312&database=RX&origin=ReaxysOutput&ln=	CC(C)NC1=CC2=C(NC3CCNCC3)C=C(C=C2C=N1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N3-isopropyl-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.5039							9.3			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CNC1CN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673313	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673313&database=RX&origin=ReaxysOutput&ln=	(1112 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[3-(methylamino)azetidin-1-yl]isoquinolin-3-amine	C20H21FN4	C20H21FN4	336.412			CNKDYRDKQIOBGI-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.255	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673313	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673313&database=RX&origin=ReaxysOutput&ln=	CNC1CN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[3-(methylamino)azetidin-1-yl]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.4474							9.35						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CNC1CN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673313	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673313&database=RX&origin=ReaxysOutput&ln=	(1112 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[3-(methylamino)azetidin-1-yl]isoquinolin-3-amine	C20H21FN4	C20H21FN4	336.412			CNKDYRDKQIOBGI-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.255	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673313	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673313&database=RX&origin=ReaxysOutput&ln=	CNC1CN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[3-(methylamino)azetidin-1-yl]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.4474							9.35			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1		37673314	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673314&database=RX&origin=ReaxysOutput&ln=	(1113 of 1381)		7-(2-chloro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	C21H23ClN4	C21H23ClN4	366.893			MCRKHERRGUNWDQ-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(3)	2	2	4.749	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673314	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673314&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1	7-(2-chloro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.916							8.53						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1		37673314	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673314&database=RX&origin=ReaxysOutput&ln=	(1113 of 1381)		7-(2-chloro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	C21H23ClN4	C21H23ClN4	366.893			MCRKHERRGUNWDQ-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(3)	2	2	4.749	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673314	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673314&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1	7-(2-chloro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.916							8.53			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC(NC2CNC2)=C2C=C(N)N=CC2=C1		37673315	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673315&database=RX&origin=ReaxysOutput&ln=	(1114 of 1381)		N5-(azetidin-3-yl)-7-(2-chloro-6-methylphenyl)isoquinoline-3,5-diamine	C19H19ClN4	C19H19ClN4	338.84			UZLWVSLJUQPRQB-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.033	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673315	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673315&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC(NC2CNC2)=C2C=C(N)N=CC2=C1	N5-(azetidin-3-yl)-7-(2-chloro-6-methylphenyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		9.521							8.02						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC(NC2CNC2)=C2C=C(N)N=CC2=C1		37673315	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673315&database=RX&origin=ReaxysOutput&ln=	(1114 of 1381)		N5-(azetidin-3-yl)-7-(2-chloro-6-methylphenyl)isoquinoline-3,5-diamine	C19H19ClN4	C19H19ClN4	338.84			UZLWVSLJUQPRQB-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.033	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673315	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673315&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC(NC2CNC2)=C2C=C(N)N=CC2=C1	N5-(azetidin-3-yl)-7-(2-chloro-6-methylphenyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		9.521							8.02			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC=C2C(C=NC(N)=C2C(=O)NC2CCNCC2)=C1		37673325	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673325&database=RX&origin=ReaxysOutput&ln=	(1115 of 1381)		3-amino-7-(2-chloro-6-methylphenyl)-N-(4-piperidyl)isoquinoline-4-carboxamide	C22H23ClN4O	C22H23ClN4O	394.904			IQKJKPMPHVURRS-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.937	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673325	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673325&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC=C2C(C=NC(N)=C2C(=O)NC2CCNCC2)=C1	3-amino-7-(2-chloro-6-methylphenyl)-N-(4-piperidyl)isoquinoline-4-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		61.69							7.21						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC=C2C(C=NC(N)=C2C(=O)NC2CCNCC2)=C1		37673325	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673325&database=RX&origin=ReaxysOutput&ln=	(1115 of 1381)		3-amino-7-(2-chloro-6-methylphenyl)-N-(4-piperidyl)isoquinoline-4-carboxamide	C22H23ClN4O	C22H23ClN4O	394.904			IQKJKPMPHVURRS-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.937	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673325	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673325&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC=C2C(C=NC(N)=C2C(=O)NC2CCNCC2)=C1	3-amino-7-(2-chloro-6-methylphenyl)-N-(4-piperidyl)isoquinoline-4-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		61.69							7.21			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC=C2C(C=NC(N)=C2C(=O)N[C@@H]2CCNC2)=C1		37673326	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673326&database=RX&origin=ReaxysOutput&ln=	(1116 of 1381)		3-amino-7-(2-chloro-6-methylphenyl)-N-[(3R)-pyrrolidin-3-yl]isoquinoline-4-carboxamide	C21H21ClN4O	C21H21ClN4O	380.877			PMGXNYHZNVIVSS-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.579	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673326	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673326&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC=C2C(C=NC(N)=C2C(=O)N[C@@H]2CCNC2)=C1	3-amino-7-(2-chloro-6-methylphenyl)-N-[(3R)pyrrolidin-3-yl]isoquinoline-4-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		100.4							7						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC=C2C(C=NC(N)=C2C(=O)N[C@@H]2CCNC2)=C1		37673326	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673326&database=RX&origin=ReaxysOutput&ln=	(1116 of 1381)		3-amino-7-(2-chloro-6-methylphenyl)-N-[(3R)-pyrrolidin-3-yl]isoquinoline-4-carboxamide	C21H21ClN4O	C21H21ClN4O	380.877			PMGXNYHZNVIVSS-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.579	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673326	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673326&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC=C2C(C=NC(N)=C2C(=O)N[C@@H]2CCNC2)=C1	3-amino-7-(2-chloro-6-methylphenyl)-N-[(3R)-pyrrolidin-3-yl]isoquinoline-4-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		100.4							7			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CCNCC2)=C2C=C(N)N=CC2=C1		37673328	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673328&database=RX&origin=ReaxysOutput&ln=	(1117 of 1381)		N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidine-4-carboxamide	C22H23FN4O	C22H23FN4O	378.449			STSNFPOAHWOXSU-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	4	2	3.559	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673328	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673328&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CCNCC2)=C2C=C(N)N=CC2=C1	N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidine-4-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		36.85							7.43						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CCNCC2)=C2C=C(N)N=CC2=C1		37673328	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673328&database=RX&origin=ReaxysOutput&ln=	(1117 of 1381)		N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidine-4-carboxamide	C22H23FN4O	C22H23FN4O	378.449			STSNFPOAHWOXSU-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	4	2	3.559	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673328	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673328&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CCNCC2)=C2C=C(N)N=CC2=C1	N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidine-4-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		36.85							7.43			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CNC2)=C2C=C(N)N=CC2=C1		37673329	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673329&database=RX&origin=ReaxysOutput&ln=	(1118 of 1381)		N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]azetidine-3-carboxamide	C20H19FN4O	C20H19FN4O	350.395			JUUQLQXCEQXTFY-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.272	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673329	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673329&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CNC2)=C2C=C(N)N=CC2=C1	N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]azetidine-3-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		35.4							7.45						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CNC2)=C2C=C(N)N=CC2=C1		37673329	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673329&database=RX&origin=ReaxysOutput&ln=	(1118 of 1381)		N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]azetidine-3-carboxamide	C20H19FN4O	C20H19FN4O	350.395			JUUQLQXCEQXTFY-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.272	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673329	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673329&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CNC2)=C2C=C(N)N=CC2=C1	N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]azetidine-3-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		35.4							7.45			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CCNC2)=C2C=C(N)N=CC2=C1		37673330	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673330&database=RX&origin=ReaxysOutput&ln=	(1119 of 1381)		N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidine-3-carboxamide	C21H21FN4O	C21H21FN4O	364.422			JJIGRICUTCPGJV-UHFFFAOYSA-N				Identification(9); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.63	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673330	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673330&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CCNC2)=C2C=C(N)N=CC2=C1	N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidine-3-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		8.893							8.05						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CCNC2)=C2C=C(N)N=CC2=C1		37673330	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673330&database=RX&origin=ReaxysOutput&ln=	(1119 of 1381)		N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidine-3-carboxamide	C21H21FN4O	C21H21FN4O	364.422			JJIGRICUTCPGJV-UHFFFAOYSA-N				Identification(9); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.63	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673330	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673330&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC(=O)C2CCNC2)=C2C=C(N)N=CC2=C1	N-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidine-3-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		8.893							8.05			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(OC2CCNCC2)=C2C=C(N)N=CC2=C1		37673331	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673331&database=RX&origin=ReaxysOutput&ln=	(1120 of 1381)		7-(2-fluoro-6-methylphenyl)-5-(4-piperidyloxy)isoquinolin-3-amine	C21H22FN3O	C21H22FN3O	351.424			ACYDKCYOHXJTJE-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.557	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673331	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673331&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(OC2CCNCC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-5-(4-piperidyloxy)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.1254							9.9						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(OC2CCNCC2)=C2C=C(N)N=CC2=C1		37673331	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673331&database=RX&origin=ReaxysOutput&ln=	(1120 of 1381)		7-(2-fluoro-6-methylphenyl)-5-(4-piperidyloxy)isoquinolin-3-amine	C21H22FN3O	C21H22FN3O	351.424			ACYDKCYOHXJTJE-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.557	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673331	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673331&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(OC2CCNCC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-5-(4-piperidyloxy)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.1254							9.9			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(O[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1		37673333	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673333&database=RX&origin=ReaxysOutput&ln=	(1121 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3R)-pyrrolidin-3-yl]oxyisoquinolin-3-amine	C20H20FN3O	C20H20FN3O	337.397			ZAYGXZGNZBNYII-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.199	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673333	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673333&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(O[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-5-[(3R)-pyrrolidin-3-yl]oxyisoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.2978							9.53						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(O[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1		37673333	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673333&database=RX&origin=ReaxysOutput&ln=	(1121 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(3R)-pyrrolidin-3-yl]oxyisoquinolin-3-amine	C20H20FN3O	C20H20FN3O	337.397			ZAYGXZGNZBNYII-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.199	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673333	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673333&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(O[C@@H]2CCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-5-[(3R)-pyrrolidin-3-yl]oxyisoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.2978							9.53			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=CN=CC2=C1		37673334	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673334&database=RX&origin=ReaxysOutput&ln=	(1122 of 1381)		7-(2-fluoro-6-methylphenyl)-N-(4-piperidyl)isoquinolin-5-amine	C21H22FN3	C21H22FN3	335.424			MTCVNDABCIFAQW-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.377	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673334	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673334&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=CN=CC2=C1	7-(2-fluoro-6-methylphenyl)-N-(4-piperidyl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.7781							9.11						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=CN=CC2=C1		37673334	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673334&database=RX&origin=ReaxysOutput&ln=	(1122 of 1381)		7-(2-fluoro-6-methylphenyl)-N-(4-piperidyl)isoquinolin-5-amine	C21H22FN3	C21H22FN3	335.424			MTCVNDABCIFAQW-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.377	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673334	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673334&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=CN=CC2=C1	7-(2-fluoro-6-methylphenyl)-N-(4-piperidyl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.7781							9.11			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2C=CN=CC2=C1		37673335	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673335&database=RX&origin=ReaxysOutput&ln=	(1123 of 1381)		7-(2-chloro-6-methylphenyl)-N-(4-piperidyl)isoquinolin-5-amine	C21H22ClN3	C21H22ClN3	351.879			MSKVPWMLVBFRIG-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.838	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673335	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673335&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2C=CN=CC2=C1	7-(2-chloro-6-methylphenyl)-N-(4-piperidyl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		3.232							8.49						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2C=CN=CC2=C1		37673335	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673335&database=RX&origin=ReaxysOutput&ln=	(1123 of 1381)		7-(2-chloro-6-methylphenyl)-N-(4-piperidyl)isoquinolin-5-amine	C21H22ClN3	C21H22ClN3	351.879			MSKVPWMLVBFRIG-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.838	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673335	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673335&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2C=CN=CC2=C1	7-(2-chloro-6-methylphenyl)-N-(4-piperidyl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		3.232							8.49			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(C(=O)NC2CCNCC2)=C2C=C(N)N=CC2=C1		37673337	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673337&database=RX&origin=ReaxysOutput&ln=	(1124 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-N-(4-piperidyl)isoquinoline-5-carboxamide	C22H23FN4O	C22H23FN4O	378.449			DEILQYULMKEKSN-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	6	2	4.047	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673337	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673337&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(C(=O)NC2CCNCC2)=C2C=C(N)N=CC2=C1	3-amino-7-(2-fluoro-6-methyl-phenyl)-N-(4-piperidyl)isoquinoline-5-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		11.54							7.94						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(C(=O)NC2CCNCC2)=C2C=C(N)N=CC2=C1		37673337	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673337&database=RX&origin=ReaxysOutput&ln=	(1124 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-N-(4-piperidyl)isoquinoline-5-carboxamide	C22H23FN4O	C22H23FN4O	378.449			DEILQYULMKEKSN-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	6	2	4.047	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673337	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673337&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(C(=O)NC2CCNCC2)=C2C=C(N)N=CC2=C1	3-amino-7-(2-fluoro-6-methylphenyl)-N-(4-piperidyl)isoquinoline-5-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		11.54							7.94			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(C(=O)NC2CCNC2)=C2C=C(N)N=CC2=C1		37673338	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673338&database=RX&origin=ReaxysOutput&ln=	(1125 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-N-(pyrrolidin-3-yl)isoquinoline-5-carboxamide	C21H21FN4O	C21H21FN4O	364.422			XNLRDAZUEHPOKP-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.689	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673338	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673338&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(C(=O)NC2CCNC2)=C2C=C(N)N=CC2=C1	3-amino-7-(2-fluoro-6-methylphenyl)-N-pyrrolidin-3-ylisoquinoline-5-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM	>	100000							1						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(C(=O)NC2CCNC2)=C2C=C(N)N=CC2=C1		37673338	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673338&database=RX&origin=ReaxysOutput&ln=	(1125 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-N-(pyrrolidin-3-yl)isoquinoline-5-carboxamide	C21H21FN4O	C21H21FN4O	364.422			XNLRDAZUEHPOKP-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.689	3	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673338	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673338&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(C(=O)NC2CCNC2)=C2C=C(N)N=CC2=C1	3-amino-7-(2-fluoro-6-methylphenyl)-N-(pyrrolidin-3-yl)isoquinoline-5-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM	>	100000							1			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673339	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673339&database=RX&origin=ReaxysOutput&ln=	(1126 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			YKVFUZZUJAYAJW-UHFFFAOYSA-N				Identification(10); Physical Data(3); Spectra(2); Bioactivity(3)	5	2	4.527	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673339	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673339&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.8827							9.05						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673339	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673339&database=RX&origin=ReaxysOutput&ln=	(1126 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			YKVFUZZUJAYAJW-UHFFFAOYSA-N				Identification(10); Physical Data(3); Spectra(2); Bioactivity(3)	5	2	4.527	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673339	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673339&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.8827							9.05			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673340&database=RX&origin=ReaxysOutput&ln=	(1127 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-1-methylpyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			JWHMSZWHZLBGPO-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.527	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673340&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-1-methylpyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		3.846							8.41						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673340&database=RX&origin=ReaxysOutput&ln=	(1127 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-1-methylpyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			JWHMSZWHZLBGPO-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.527	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673340&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-1-methylpyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		3.846							8.41			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCCC[C@@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673341	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673341&database=RX&origin=ReaxysOutput&ln=	(1128 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-1-methyl-2-piperidyl]methyl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			DERUAGOSRBUOMY-GOSISDBHSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.885	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673341	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673341&database=RX&origin=ReaxysOutput&ln=	CN1CCCC[C@@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-1-methyl-2-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		6.299							8.2						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCCC[C@@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673341	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673341&database=RX&origin=ReaxysOutput&ln=	(1128 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-1-methyl-2-piperidyl]methyl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			DERUAGOSRBUOMY-GOSISDBHSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.885	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673341	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673341&database=RX&origin=ReaxysOutput&ln=	CN1CCCC[C@@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-1-methyl-2-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		6.299							8.2			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN(C)C1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673342	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673342&database=RX&origin=ReaxysOutput&ln=	(1129 of 1381)		5-[4-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C23H27FN4	C23H27FN4	378.493			WDSZGWPERYHZLP-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.21	1	4	3	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673342	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673342&database=RX&origin=ReaxysOutput&ln=	CN(C)C1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[4-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.449							8.61						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN(C)C1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673342	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673342&database=RX&origin=ReaxysOutput&ln=	(1129 of 1381)		5-[4-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C23H27FN4	C23H27FN4	378.493			WDSZGWPERYHZLP-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.21	1	4	3	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673342	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673342&database=RX&origin=ReaxysOutput&ln=	CN(C)C1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[4-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.449							8.61			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673343	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673343&database=RX&origin=ReaxysOutput&ln=	(1130 of 1381)		5-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C22H25FN4	C22H25FN4	364.466			ZVKGIXUFMCIVFU-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.852	1	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673343	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673343&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		8.64							8.06						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673343	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673343&database=RX&origin=ReaxysOutput&ln=	(1130 of 1381)		5-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C22H25FN4	C22H25FN4	364.466			ZVKGIXUFMCIVFU-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.852	1	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673343	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673343&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		8.64							8.06			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673344	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673344&database=RX&origin=ReaxysOutput&ln=	(1131 of 1381)		5-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C22H25FN4	C22H25FN4	364.466			ZVKGIXUFMCIVFU-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.852	1	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673344	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673344&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		27.42							7.56						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673344	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673344&database=RX&origin=ReaxysOutput&ln=	(1131 of 1381)		5-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C22H25FN4	C22H25FN4	364.466			ZVKGIXUFMCIVFU-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.852	1	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673344	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673344&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3S)-3-(dimethylamino)pyrrolidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		27.42							7.56			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN(C)C[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673345	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673345&database=RX&origin=ReaxysOutput&ln=	(1132 of 1381)		5-[(3R)-3-[(dimethylamino)methyl]-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C24H29FN4	C24H29FN4	392.519			FDEMIFPSYBZWRQ-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.405	1	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673345	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673345&database=RX&origin=ReaxysOutput&ln=	CN(C)C[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3R)-3-[(dimethylamino)methyl]-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		42.36							7.37						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN(C)C[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673345	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673345&database=RX&origin=ReaxysOutput&ln=	(1132 of 1381)		5-[(3R)-3-[(dimethylamino)methyl]-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C24H29FN4	C24H29FN4	392.519			FDEMIFPSYBZWRQ-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.405	1	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673345	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673345&database=RX&origin=ReaxysOutput&ln=	CN(C)C[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3R)-3-[(dimethylamino)methyl]-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		42.36							7.37			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN(C)C[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673346	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673346&database=RX&origin=ReaxysOutput&ln=	(1133 of 1381)		5-[(3S)-3-[(dimethylamino)methyl]-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C24H29FN4	C24H29FN4	392.519			FDEMIFPSYBZWRQ-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.405	1	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673346	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673346&database=RX&origin=ReaxysOutput&ln=	CN(C)C[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3S)-3-[(dimethylamino)methyl]-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		39.54							7.4						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN(C)C[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673346	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673346&database=RX&origin=ReaxysOutput&ln=	(1133 of 1381)		5-[(3S)-3-[(dimethylamino)methyl]-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C24H29FN4	C24H29FN4	392.519			FDEMIFPSYBZWRQ-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.405	1	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673346	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673346&database=RX&origin=ReaxysOutput&ln=	CN(C)C[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3S)-3-[(dimethylamino)methyl]-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		39.54							7.4			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37673347	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673347&database=RX&origin=ReaxysOutput&ln=	(1134 of 1381)		7-(2-chloro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	C22H25ClN4	C22H25ClN4	380.92			USAYHTMERQFXFW-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	2	2	4.988	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673347	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673347&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	7-(2-chloro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.937							8.53						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37673347	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673347&database=RX&origin=ReaxysOutput&ln=	(1134 of 1381)		7-(2-chloro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	C22H25ClN4	C22H25ClN4	380.92			USAYHTMERQFXFW-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	2	2	4.988	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673347	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673347&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	7-(2-chloro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.937							8.53			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37673348	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673348&database=RX&origin=ReaxysOutput&ln=	(1135 of 1381)		7-(2-chloro-6-methylphenyl)-N5-(1-methylazetidin-3-yl)isoquinoline-3,5-diamine	C20H21ClN4	C20H21ClN4	352.867			MWNIOZDGXQIOER-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.272	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673348	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673348&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	7-(2-chloro-6-methylphenyl)-N5-(1-methylazetidin-3-yl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		10.09							8						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37673348	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673348&database=RX&origin=ReaxysOutput&ln=	(1135 of 1381)		7-(2-chloro-6-methylphenyl)-N5-(1-methylazetidin-3-yl)isoquinoline-3,5-diamine	C20H21ClN4	C20H21ClN4	352.867			MWNIOZDGXQIOER-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.272	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673348	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673348&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	7-(2-chloro-6-methylphenyl)-N5-(1-methylazetidin-3-yl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		10.09							8			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC1=C2C=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673350	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673350&database=RX&origin=ReaxysOutput&ln=	(1136 of 1381)		7-(2-fluoro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinolin-5-amine	C20H20FN3	C20H20FN3	321.397			OMMJSHIZQJRXNK-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	6	2	3.9	1	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673350	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673350&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC1=C2C=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		4.572							8.34						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC1=C2C=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673350	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673350&database=RX&origin=ReaxysOutput&ln=	(1136 of 1381)		7-(2-fluoro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinolin-5-amine	C20H20FN3	C20H20FN3	321.397			OMMJSHIZQJRXNK-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	6	2	3.9	1	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673350	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673350&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC1=C2C=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		4.572							8.34			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37673351	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673351&database=RX&origin=ReaxysOutput&ln=	(1137 of 1381)		7-(2-chloro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinolin-5-amine	C22H24ClN3	C22H24ClN3	365.906			QQGVUVBJUIKPSD-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.077	1	3	3	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673351	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673351&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	7-(2-chloro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.145							8.94						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37673351	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673351&database=RX&origin=ReaxysOutput&ln=	(1137 of 1381)		7-(2-chloro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinolin-5-amine	C22H24ClN3	C22H24ClN3	365.906			QQGVUVBJUIKPSD-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.077	1	3	3	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673351	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673351&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	7-(2-chloro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.145							8.94			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC1=C2C=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37673352	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673352&database=RX&origin=ReaxysOutput&ln=	(1138 of 1381)		7-(2-chloro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinolin-5-amine	C20H20ClN3	C20H20ClN3	337.852			GBPCHQGQRXKPSV-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.361	1	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673352	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673352&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC1=C2C=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	7-(2-chloro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		27.18							7.57						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC1=C2C=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37673352	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673352&database=RX&origin=ReaxysOutput&ln=	(1138 of 1381)		7-(2-chloro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinolin-5-amine	C20H20ClN3	C20H20ClN3	337.852			GBPCHQGQRXKPSV-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.361	1	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673352	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673352&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC1=C2C=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	7-(2-chloro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		27.18							7.57			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673353	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673353&database=RX&origin=ReaxysOutput&ln=	(1139 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-(1-methylazetidin-3-yl)isoquinoline-3,5-diamine	C20H21FN4	C20H21FN4	336.412			HWAZNLNRABAIOU-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.811	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673353	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673353&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methyl-phenyl)-N5-(1-methylazetidin-3-yl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.9926							9						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673353	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673353&database=RX&origin=ReaxysOutput&ln=	(1139 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-(1-methylazetidin-3-yl)isoquinoline-3,5-diamine	C20H21FN4	C20H21FN4	336.412			HWAZNLNRABAIOU-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	3.811	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673353	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673353&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-(1-methylazetidin-3-yl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.9926							9			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673354	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673354&database=RX&origin=ReaxysOutput&ln=	(1140 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3R)-1-methylpyrrolidin-3-yl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			CAVLZGMKOHSXFO-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.169	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673354	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673354&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[(3R)-1-methylpyrrolidin-3-yl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.9862							9.01						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673354	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673354&database=RX&origin=ReaxysOutput&ln=	(1140 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3R)-1-methylpyrrolidin-3-yl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			CAVLZGMKOHSXFO-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.169	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673354	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673354&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[(3R)-1-methylpyrrolidin-3-yl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.9862							9.01			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673355	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673355&database=RX&origin=ReaxysOutput&ln=	(1141 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3S)-1-methylpyrrolidin-3-yl]isoquinoline-3,5-diamine; 7-(2-fluoro-6-methylphenyl)-N5-[(3)-1-methylpyrrolidin-3-yl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			CAVLZGMKOHSXFO-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.169	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673355	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673355&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[(3S)-1-methylpyrrolidin-3-yl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		4.145							8.38						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673355	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673355&database=RX&origin=ReaxysOutput&ln=	(1141 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3S)-1-methylpyrrolidin-3-yl]isoquinoline-3,5-diamine; 7-(2-fluoro-6-methylphenyl)-N5-[(3)-1-methylpyrrolidin-3-yl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			CAVLZGMKOHSXFO-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.169	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673355	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673355&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[(3)-1-methylpyrrolidin-3-yl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		4.145							8.38			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)CC1		37673356	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673356&database=RX&origin=ReaxysOutput&ln=	(1142 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(1-methyl-4-piperidyl)methyl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			PPOCONXOJARVDX-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.722	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673356	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673356&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)CC1	7-(2-fluoro-6-methylphenyl)-N5-[(1-methyl-4-piperidyl)methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		5.668							8.25						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)CC1		37673356	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673356&database=RX&origin=ReaxysOutput&ln=	(1142 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(1-methyl-4-piperidyl)methyl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			PPOCONXOJARVDX-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.722	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673356	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673356&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)CC1	7-(2-fluoro-6-methylphenyl)-N5-[(1-methyl-4-piperidyl)methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		5.668							8.25			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC(CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1		37673357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673357&database=RX&origin=ReaxysOutput&ln=	(1143 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(1-methylazetidin-3-yl)methyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			BAQLCVUGDWKZKV-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.006	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673357&database=RX&origin=ReaxysOutput&ln=	CN1CC(CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1	7-(2-fluoro-6-methylphenyl)-N5-[(1-methylazetidin-3-yl)methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.289							8.89						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC(CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1		37673357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673357&database=RX&origin=ReaxysOutput&ln=	(1143 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(1-methylazetidin-3-yl)methyl]isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			BAQLCVUGDWKZKV-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.006	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673357&database=RX&origin=ReaxysOutput&ln=	CN1CC(CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1	7-(2-fluoro-6-methylphenyl)-N5-[(1-methylazetidin-3-yl)methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.289							8.89			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1		37673358	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673358&database=RX&origin=ReaxysOutput&ln=	(1144 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-1-methylpyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			CPJZSORKELHGPD-HNNXBMFYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.364	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673358	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673358&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-1-methylpyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.7647							9.12						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1		37673358	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673358&database=RX&origin=ReaxysOutput&ln=	(1144 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-1-methylpyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			CPJZSORKELHGPD-HNNXBMFYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.364	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673358	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673358&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-1-methylpyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.7647							9.12			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1		37673359	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673359&database=RX&origin=ReaxysOutput&ln=	(1145 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-1-methylpyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			CPJZSORKELHGPD-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.364	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673359	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673359&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-1-methylpyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.995							8.7						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1		37673359	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673359&database=RX&origin=ReaxysOutput&ln=	(1145 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-1-methylpyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			CPJZSORKELHGPD-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.364	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673359	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673359&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-1-methylpyrrolidin-3-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.995							8.7			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1		37673360	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673360&database=RX&origin=ReaxysOutput&ln=	(1146 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-1-methyl-3-piperidyl]methyl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			HSJJXDVSFPTZHU-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.722	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673360	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673360&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-1-methyl-3-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.638							8.79						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1		37673360	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673360&database=RX&origin=ReaxysOutput&ln=	(1146 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-1-methyl-3-piperidyl]methyl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			HSJJXDVSFPTZHU-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.722	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673360	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673360&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-1-methyl-3-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.638							8.79			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1		37673361	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673361&database=RX&origin=ReaxysOutput&ln=	(1147 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-1-methyl-3-piperidyl]methyl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			HSJJXDVSFPTZHU-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.722	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673361	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673361&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-1-methyl-3-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		3.744							8.43						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1		37673361	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673361&database=RX&origin=ReaxysOutput&ln=	(1147 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-1-methyl-3-piperidyl]methyl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			HSJJXDVSFPTZHU-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.722	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673361	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673361&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@H](CNC2=C3C=C(N)N=CC3=CC(=C2)C2=C(F)C=CC=C2C)C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3R)-1-methyl-3-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		3.744							8.43			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCCC[C@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673362	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673362&database=RX&origin=ReaxysOutput&ln=	(1148 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-1-methyl-2-piperidyl]methyl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			DERUAGOSRBUOMY-SFHVURJKSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.885	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673362	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673362&database=RX&origin=ReaxysOutput&ln=	CN1CCCC[C@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-1-methyl-2-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.597							8.8						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCCC[C@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673362	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673362&database=RX&origin=ReaxysOutput&ln=	(1148 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-1-methyl-2-piperidyl]methyl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			DERUAGOSRBUOMY-SFHVURJKSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.885	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673362	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673362&database=RX&origin=ReaxysOutput&ln=	CN1CCCC[C@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[[(2S)-1-methyl-2-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.597							8.8			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN(C)C1CN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673363	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673363&database=RX&origin=ReaxysOutput&ln=	(1149 of 1381)		5-[3-(dimethylamino)azetidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C21H23FN4	C21H23FN4	350.439			VNPVCWZOIHFXFM-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.494	1	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673363	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673363&database=RX&origin=ReaxysOutput&ln=	CN(C)C1CN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[3-(dimethylamino)azetidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.239							8.65						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN(C)C1CN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673363	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673363&database=RX&origin=ReaxysOutput&ln=	(1149 of 1381)		5-[3-(dimethylamino)azetidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C21H23FN4	C21H23FN4	350.439			VNPVCWZOIHFXFM-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.494	1	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673363	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673363&database=RX&origin=ReaxysOutput&ln=	CN(C)C1CN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[3-(dimethylamino)azetidin-1-yl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.239							8.65			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673366	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673366&database=RX&origin=ReaxysOutput&ln=	(1150 of 1381)		5-[(3S)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C23H27FN4	C23H27FN4	378.493			PRRXAXHGLAOUQJ-SFHVURJKSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.21	1	4	3	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673366	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673366&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3S)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		10.28							7.99						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673366	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673366&database=RX&origin=ReaxysOutput&ln=	(1150 of 1381)		5-[(3S)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C23H27FN4	C23H27FN4	378.493			PRRXAXHGLAOUQJ-SFHVURJKSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.21	1	4	3	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673366	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673366&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3S)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		10.28							7.99			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC2=C(C=C(C=C2C=N1)C1=C(F)C=CC=C1C)N1CCC[C@@H](C1)N(C)C		37673367	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673367&database=RX&origin=ReaxysOutput&ln=	(1151 of 1381)		5-[(3S)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)-N-methylisoquinolin-3-amine	C24H29FN4	C24H29FN4	392.519			UIODUYUNVYWQKB-IBGZPJMESA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.673	1	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673367	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673367&database=RX&origin=ReaxysOutput&ln=	CNC1=CC2=C(C=C(C=C2C=N1)C1=C(F)C=CC=C1C)N1CCC[C@@H](C1)N(C)C	5-[(3S)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)-N-methylisoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		7.347							8.13						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC2=C(C=C(C=C2C=N1)C1=C(F)C=CC=C1C)N1CCC[C@@H](C1)N(C)C		37673367	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673367&database=RX&origin=ReaxysOutput&ln=	(1151 of 1381)		5-[(3S)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)-N-methylisoquinolin-3-amine	C24H29FN4	C24H29FN4	392.519			UIODUYUNVYWQKB-IBGZPJMESA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.673	1	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673367	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673367&database=RX&origin=ReaxysOutput&ln=	CNC1=CC2=C(C=C(C=C2C=N1)C1=C(F)C=CC=C1C)N1CCC[C@@H](C1)N(C)C	5-[(3S)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)-N-methylisoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		7.347							8.13			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673368	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673368&database=RX&origin=ReaxysOutput&ln=	(1152 of 1381)		5-[(3R)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C23H27FN4	C23H27FN4	378.493			PRRXAXHGLAOUQJ-GOSISDBHSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.21	1	4	3	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673368	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673368&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3R)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.226							8.65						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673368	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673368&database=RX&origin=ReaxysOutput&ln=	(1152 of 1381)		5-[(3R)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C23H27FN4	C23H27FN4	378.493			PRRXAXHGLAOUQJ-GOSISDBHSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.21	1	4	3	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673368	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673368&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@@H]1CCCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	5-[(3R)-3-(dimethylamino)-1-piperidyl]-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.226							8.65			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673370	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673370&database=RX&origin=ReaxysOutput&ln=	(1153 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3R)-1-methyl-3-piperidyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			QDNZFMMQPSUVJT-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.527	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673370	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673370&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[(3R)-1-methyl-3-piperidyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.623							8.79						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673370	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673370&database=RX&origin=ReaxysOutput&ln=	(1153 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3R)-1-methyl-3-piperidyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			QDNZFMMQPSUVJT-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.527	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673370	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673370&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[(3R)-1-methyl-3-piperidyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.623							8.79			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673371	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673371&database=RX&origin=ReaxysOutput&ln=	(1154 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3S)-1-methyl-3-piperidyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			QDNZFMMQPSUVJT-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.527	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673371	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673371&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[(3S)-1-methyl-3-piperidyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.979							8.7						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673371	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673371&database=RX&origin=ReaxysOutput&ln=	(1154 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3S)-1-methyl-3-piperidyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			QDNZFMMQPSUVJT-KRWDZBQOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.527	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673371	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673371&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[(3S)-1-methyl-3-piperidyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.979							8.7			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673372	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673372&database=RX&origin=ReaxysOutput&ln=	(1155 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-1-methylpyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			JWHMSZWHZLBGPO-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.527	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673372	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673372&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-1-methylpyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.528							9.28						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673372	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673372&database=RX&origin=ReaxysOutput&ln=	(1155 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-1-methylpyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			JWHMSZWHZLBGPO-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.527	2	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673372	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673372&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@@H]1CNC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[[(2R)-1-methylpyrrolidin-2-yl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.528							9.28			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC(=O)C1=C(N)N=CC2=CC(=CC=C12)C1=C(Cl)C=CC=C1C		37673375	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673375&database=RX&origin=ReaxysOutput&ln=	(1156 of 1381)		3-amino-7-(2-chloro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinoline-4-carboxamide	C23H25ClN4O	C23H25ClN4O	408.931			KWAXMLHFDHSZQV-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.176	2	5	4	29.96	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673375	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673375&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC(=O)C1=C(N)N=CC2=CC(=CC=C12)C1=C(Cl)C=CC=C1C	3-amino-7-(2-chloro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinoline-4-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		72.52							7.14						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC(=O)C1=C(N)N=CC2=CC(=CC=C12)C1=C(Cl)C=CC=C1C		37673375	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673375&database=RX&origin=ReaxysOutput&ln=	(1156 of 1381)		3-amino-7-(2-chloro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinoline-4-carboxamide	C23H25ClN4O	C23H25ClN4O	408.931			KWAXMLHFDHSZQV-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	5.176	2	5	4	29.96	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673375	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673375&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC(=O)C1=C(N)N=CC2=CC(=CC=C12)C1=C(Cl)C=CC=C1C	3-amino-7-(2-chloro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinoline-4-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		72.52							7.14			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC(=O)C1=C(N)N=CC2=CC(=CC=C12)C1=C(F)C=CC=C1C		37673376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673376&database=RX&origin=ReaxysOutput&ln=	(1157 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinoline-4-carboxamide	C21H21FN4O	C21H21FN4O	364.422			QKCJEZCGUNUNRU-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	8	2	3.999	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673376&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC(=O)C1=C(N)N=CC2=CC(=CC=C12)C1=C(F)C=CC=C1C	3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinoline-4-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		129.8							6.89						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC(=O)C1=C(N)N=CC2=CC(=CC=C12)C1=C(F)C=CC=C1C		37673376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673376&database=RX&origin=ReaxysOutput&ln=	(1157 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinoline-4-carboxamide	C21H21FN4O	C21H21FN4O	364.422			QKCJEZCGUNUNRU-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	8	2	3.999	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673376&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC(=O)C1=C(N)N=CC2=CC(=CC=C12)C1=C(F)C=CC=C1C	3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinoline-4-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		129.8							6.89			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(C1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673386	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673386&database=RX&origin=ReaxysOutput&ln=	(1158 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methylpyrrolidin-3-yl)isoquinoline-5-carboxamide	C22H23FN4O	C22H23FN4O	378.449			TVTOLGYEOSPQAQ-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	3	2	3.928	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673386	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673386&database=RX&origin=ReaxysOutput&ln=	CN1CCC(C1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methylpyrrolidin-3-yl)isoquinoline-5-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		38.83							7.41						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(C1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673386	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673386&database=RX&origin=ReaxysOutput&ln=	(1158 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methylpyrrolidin-3-yl)isoquinoline-5-carboxamide	C22H23FN4O	C22H23FN4O	378.449			TVTOLGYEOSPQAQ-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	3	2	3.928	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673386	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673386&database=RX&origin=ReaxysOutput&ln=	CN1CCC(C1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methylpyrrolidin-3-yl)isoquinoline-5-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		38.83							7.41			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673387	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673387&database=RX&origin=ReaxysOutput&ln=	(1159 of 1381)		3-amino-7-(2-fluoro-6-methyl-phenyl)-N-(1- methylazetidin-3- yl)isoquinoline-5-carboxamide	C21H21FN4O	C21H21FN4O	364.422			YTGUPESDZYCVGL-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)		2	3.57	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673387	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673387&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	3-amino-7-(2-fluoro-6-methyl-phenyl)-N-(1- methylazetidin-3- yl)isoquinoline-5-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		61.39							7.21						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673387	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673387&database=RX&origin=ReaxysOutput&ln=	(1159 of 1381)		3-amino-7-(2-fluoro-6-methyl-phenyl)-N-(1- methylazetidin-3- yl)isoquinoline-5-carboxamide	C21H21FN4O	C21H21FN4O	364.422			YTGUPESDZYCVGL-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)		2	3.57	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673387	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673387&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methylazetidin-3-yl)isoquinoline-5-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		61.39							7.21			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)OC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673388&database=RX&origin=ReaxysOutput&ln=	(1160 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(1-methyl-4-piperidyl)oxy]isoquinolin-3-amine	C22H24FN3O	C22H24FN3O	365.45			YDNMLIVFKQGVCI-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.796	1	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673388&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)OC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methyl-phenyl)-5-[(1-methyl-4-piperidyl)oxy]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.9155							9.04						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)OC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673388&database=RX&origin=ReaxysOutput&ln=	(1160 of 1381)		7-(2-fluoro-6-methylphenyl)-5-[(1-methyl-4-piperidyl)oxy]isoquinolin-3-amine	C22H24FN3O	C22H24FN3O	365.45			YDNMLIVFKQGVCI-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.796	1	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673388&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)OC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-[(1-methyl-4-piperidyl)oxy]isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.9155							9.04			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)OC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673389	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673389&database=RX&origin=ReaxysOutput&ln=	(1161 of 1381)		7-(2-fluoro-6-methylphenyl)-5-(1-methylazetidin-3-yl)oxyisoquinolin-3-amine	C20H20FN3O	C20H20FN3O	337.397			JZTXKWHNVKFRBS-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.08	1	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673389	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673389&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)OC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-(1-methylazetidin-3-yl)oxyisoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		5.273							8.28						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)OC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673389	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673389&database=RX&origin=ReaxysOutput&ln=	(1161 of 1381)		7-(2-fluoro-6-methylphenyl)-5-(1-methylazetidin-3-yl)oxyisoquinolin-3-amine	C20H20FN3O	C20H20FN3O	337.397			JZTXKWHNVKFRBS-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.08	1	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673389	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673389&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)OC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-(1-methylazetidin-3-yl)oxyisoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		5.273							8.28			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673390&database=RX&origin=ReaxysOutput&ln=	(1162 of 1381)		7-(2-fluoro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinolin-5-amine	C22H24FN3	C22H24FN3	349.451			KRNWRITVLVOYMZ-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	12	2	4.616	1	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673390&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		5.013							8.3						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673390&database=RX&origin=ReaxysOutput&ln=	(1162 of 1381)		7-(2-fluoro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinolin-5-amine	C22H24FN3	C22H24FN3	349.451			KRNWRITVLVOYMZ-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	12	2	4.616	1	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673390&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		5.013							8.3			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N2CCC(O)CC2)=C2C=C(N)N=CC2=C1		37673391	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673391&database=RX&origin=ReaxysOutput&ln=	(1163 of 1381)		1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-4-ol	C21H22FN3O	C21H22FN3O	351.424			IBKBXUYADDJVRR-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	4	2	4.648	2	4	2	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673391	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673391&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N2CCC(O)CC2)=C2C=C(N)N=CC2=C1	1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-4-ol	5E-05 - 1 μM				Ki (inhibition constant)	nM		176.1							6.75						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N2CCC(O)CC2)=C2C=C(N)N=CC2=C1		37673391	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673391&database=RX&origin=ReaxysOutput&ln=	(1163 of 1381)		1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-4-ol	C21H22FN3O	C21H22FN3O	351.424			IBKBXUYADDJVRR-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	4	2	4.648	2	4	2	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673391	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673391&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N2CCC(O)CC2)=C2C=C(N)N=CC2=C1	1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-4-ol	5E-05 - 1 μM				Ki (inhibition constant)	nM		176.1							6.75			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N2CC[C@@H](O)C2)=C2C=C(N)N=CC2=C1		37673394	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673394&database=RX&origin=ReaxysOutput&ln=	(1164 of 1381)		(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-ol	C20H20FN3O	C20H20FN3O	337.397			XAONSTMPIVDBMV-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.29	2	4	2	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673394	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673394&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N2CC[C@@H](O)C2)=C2C=C(N)N=CC2=C1	(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-ol	5E-05 - 1 μM				Ki (inhibition constant)	nM		552.6							6.26						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N2CC[C@@H](O)C2)=C2C=C(N)N=CC2=C1		37673394	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673394&database=RX&origin=ReaxysOutput&ln=	(1164 of 1381)		(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-ol	C20H20FN3O	C20H20FN3O	337.397			XAONSTMPIVDBMV-OAHLLOKOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.29	2	4	2	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673394	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673394&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N2CC[C@@H](O)C2)=C2C=C(N)N=CC2=C1	(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-ol	5E-05 - 1 μM				Ki (inhibition constant)	nM		552.6							6.26			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N2CCC[C@H](O)C2)=C2C=C(N)N=CC2=C1		37673395	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673395&database=RX&origin=ReaxysOutput&ln=	(1165 of 1381)		(3S)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-3-ol	C21H22FN3O	C21H22FN3O	351.424			LGUVQELOAYBYFA-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.648	2	4	2	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673395	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673395&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N2CCC[C@H](O)C2)=C2C=C(N)N=CC2=C1	(3S)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-3-ol	5E-05 - 1 μM				Ki (inhibition constant)	nM		201.3							6.7						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N2CCC[C@H](O)C2)=C2C=C(N)N=CC2=C1		37673395	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673395&database=RX&origin=ReaxysOutput&ln=	(1165 of 1381)		(3S)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-3-ol	C21H22FN3O	C21H22FN3O	351.424			LGUVQELOAYBYFA-INIZCTEOSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.648	2	4	2	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673395	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673395&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N2CCC[C@H](O)C2)=C2C=C(N)N=CC2=C1	(3S)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-3-ol	5E-05 - 1 μM				Ki (inhibition constant)	nM		201							6.7			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N2CCC[C@@H](O)C2)=C2C=C(N)N=CC2=C1		37673396	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673396&database=RX&origin=ReaxysOutput&ln=	(1166 of 1381)		(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-3-ol	C21H22FN3O	C21H22FN3O	351.424			LGUVQELOAYBYFA-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.648	2	4	2	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673396	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673396&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N2CCC[C@@H](O)C2)=C2C=C(N)N=CC2=C1	(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-3-ol	5E-05 - 1 μM				Ki (inhibition constant)	nM		130.3							6.89						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(N2CCC[C@@H](O)C2)=C2C=C(N)N=CC2=C1		37673396	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673396&database=RX&origin=ReaxysOutput&ln=	(1166 of 1381)		(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-3-ol	C21H22FN3O	C21H22FN3O	351.424			LGUVQELOAYBYFA-MRXNPFEDSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.648	2	4	2	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673396	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673396&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(N2CCC[C@@H](O)C2)=C2C=C(N)N=CC2=C1	(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]piperidin-3-ol	5E-05 - 1 μM				Ki (inhibition constant)	nM		130.3							6.89			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCC(O)CC2)=C2C=C(N)N=CC2=C1		37673397	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673397&database=RX&origin=ReaxysOutput&ln=	(1167 of 1381)		4-[[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]amino]cyclohexanol	C22H24FN3O	C22H24FN3O	365.45			WTXYLVCAJVKSBN-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.718	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673397	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673397&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCC(O)CC2)=C2C=C(N)N=CC2=C1	4-[[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]amino]cyclohexanol	5E-05 - 1 μM				Ki (inhibition constant)	nM		14.94							7.83						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCC(O)CC2)=C2C=C(N)N=CC2=C1		37673397	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673397&database=RX&origin=ReaxysOutput&ln=	(1167 of 1381)		4-[[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]amino]cyclohexanol	C22H24FN3O	C22H24FN3O	365.45			WTXYLVCAJVKSBN-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.718	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673397	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673397&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCC(O)CC2)=C2C=C(N)N=CC2=C1	4-[[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]amino]cyclohexanol	5E-05 - 1 μM				Ki (inhibition constant)	nM		14.94							7.83			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCOCC2)=C2C=C(N)N=CC2=C1		37673398	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673398&database=RX&origin=ReaxysOutput&ln=	(1168 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-tetrahydropyran-4-ylisoquinoline-3,5-diamine	C21H22FN3O	C21H22FN3O	351.424			DFBHZGRTXJQTQQ-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	4	2	4.484	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673398	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673398&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCOCC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-tetrahydropyran-4-ylisoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		78.06							7.11						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCOCC2)=C2C=C(N)N=CC2=C1		37673398	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673398&database=RX&origin=ReaxysOutput&ln=	(1168 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-tetrahydropyran-4-ylisoquinoline-3,5-diamine	C21H22FN3O	C21H22FN3O	351.424			DFBHZGRTXJQTQQ-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	4	2	4.484	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673398	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673398&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCOCC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-tetrahydropyran-4-ylisoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		78.06							7.11			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC(=O)N[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673400	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673400&database=RX&origin=ReaxysOutput&ln=	(1169 of 1381)		N-[(3S)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-yl]acetamide	C22H23FN4O	C22H23FN4O	378.449			IHLWFJGUQUTUPC-KRWDZBQOSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	4	2	4.499	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673400	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673400&database=RX&origin=ReaxysOutput&ln=	CC(=O)N[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	N-[(3S)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-yl]acetamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		430.7							6.37						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC(=O)N[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673400	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673400&database=RX&origin=ReaxysOutput&ln=	(1169 of 1381)		N-[(3S)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-yl]acetamide	C22H23FN4O	C22H23FN4O	378.449			IHLWFJGUQUTUPC-KRWDZBQOSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	4	2	4.499	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673400	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673400&database=RX&origin=ReaxysOutput&ln=	CC(=O)N[C@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	N-[(3S)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-yl]acetamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		430.7							6.37			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC(=O)N[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673401	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673401&database=RX&origin=ReaxysOutput&ln=	(1170 of 1381)		N-[(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-yl]acetamide	C22H23FN4O	C22H23FN4O	378.449			IHLWFJGUQUTUPC-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.499	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673401	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673401&database=RX&origin=ReaxysOutput&ln=	CC(=O)N[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	N-[(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-yl]acetamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		234.4							6.63						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC(=O)N[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673401	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673401&database=RX&origin=ReaxysOutput&ln=	(1170 of 1381)		N-[(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-yl]acetamide	C22H23FN4O	C22H23FN4O	378.449			IHLWFJGUQUTUPC-QGZVFWFLSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.499	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673401	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673401&database=RX&origin=ReaxysOutput&ln=	CC(=O)N[C@@H]1CCN(C1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	N-[(3R)-1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]pyrrolidin-3-yl]acetamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		234.4							6.63			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC(=O)NC1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673402	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673402&database=RX&origin=ReaxysOutput&ln=	(1171 of 1381)		N-[1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]-4-piperidyl]acetamide	C23H25FN4O	C23H25FN4O	392.476			KHYHLNHJOTYUKI-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.857	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673402	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673402&database=RX&origin=ReaxysOutput&ln=	CC(=O)NC1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	N-[1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]-4-piperidyl]acetamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		20.27							7.69						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC(=O)NC1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673402	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673402&database=RX&origin=ReaxysOutput&ln=	(1171 of 1381)		N-[1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]-4-piperidyl]acetamide	C23H25FN4O	C23H25FN4O	392.476			KHYHLNHJOTYUKI-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.857	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673402	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673402&database=RX&origin=ReaxysOutput&ln=	CC(=O)NC1CCN(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	N-[1-[3-amino-7-(2-fluoro-6-methylphenyl)-5-isoquinolyl]-4-piperidyl]acetamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		20.27							7.69			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=C(NC(C)=O)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673403	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673403&database=RX&origin=ReaxysOutput&ln=	(1172 of 1381)		N-[7-(2-fluoro-6-methylphenyl)-5-[(1-methyl-4-piperidyl)amino]-3-isoquinolyl]acetamide	C24H27FN4O	C24H27FN4O	406.503			SPQILPLPYXKURR-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.598	2	5	5	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673403	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673403&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=C(NC(C)=O)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	N-[7-(2-fluoro-6-methyl-phenyl)-5-[(1-methyl-4-piperidyl)amino]-3-isoquinolyl]acetamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3008							9.52						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=C(NC(C)=O)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673403	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673403&database=RX&origin=ReaxysOutput&ln=	(1172 of 1381)		N-[7-(2-fluoro-6-methylphenyl)-5-[(1-methyl-4-piperidyl)amino]-3-isoquinolyl]acetamide	C24H27FN4O	C24H27FN4O	406.503			SPQILPLPYXKURR-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.598	2	5	5	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673403	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673403&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=C(NC(C)=O)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	N-[7-(2-fluoro-6-methylphenyl)-5-[(1-methyl-4-piperidyl)amino]-3-isoquinolyl]acetamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3008							9.52			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673404	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673404&database=RX&origin=ReaxysOutput&ln=	(1173 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinoline-5-carboxamide	C23H25FN4O	C23H25FN4O	392.476			NTNIWOOBIUXLFX-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.286	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673404	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673404&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	3-amino-7-(2-fluoro-6-methyl-phenyl)-N-(1-methyl-4-piperidyl)isoquinoline-5-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		13.78							7.86						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673404	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673404&database=RX&origin=ReaxysOutput&ln=	(1173 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinoline-5-carboxamide	C23H25FN4O	C23H25FN4O	392.476			NTNIWOOBIUXLFX-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	5	2	4.286	2	5	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673404	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673404&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC(=O)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	3-amino-7-(2-fluoro-6-methylphenyl)-N-(1-methyl-4-piperidyl)isoquinoline-5-carboxamide	5E-05 - 1 μM				Ki (inhibition constant)	nM		13.78							7.86			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673405	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673405&database=RX&origin=ReaxysOutput&ln=	(1174 of 1381)		7-(2-fluoro-6-methylphenyl)-5-(1-methyl-4-piperidyl)isoquinolin-3-amine	C22H24FN3	C22H24FN3	349.451			BHYRAFLGZFJBQG-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	3	2	4.77	1	3	2	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673405	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673405&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methyl-phenyl)-5-(1-methyl-4-piperidyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.4733							9.33						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673405	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673405&database=RX&origin=ReaxysOutput&ln=	(1174 of 1381)		7-(2-fluoro-6-methylphenyl)-5-(1-methyl-4-piperidyl)isoquinolin-3-amine	C22H24FN3	C22H24FN3	349.451			BHYRAFLGZFJBQG-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	3	2	4.77	1	3	2	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673405	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673405&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)C1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-5-(1-methyl-4-piperidyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.4733							9.33			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC(CC1)NC1=C2C=C(N)N=CC2=C(F)C(=C1)C1=C(F)C=CC=C1C		37673406	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673406&database=RX&origin=ReaxysOutput&ln=	(1175 of 1381)		N5-(1-ethyl-4-piperidyl)-8-fluoro-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	C23H26F2N4	C23H26F2N4	396.483			OKSWUNBXHJMGHG-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	8	2	5.111	2	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673406	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673406&database=RX&origin=ReaxysOutput&ln=	CCN1CCC(CC1)NC1=C2C=C(N)N=CC2=C(F)C(=C1)C1=C(F)C=CC=C1C	N5-(1-ethyl-4-piperidyl)-8-fluoro-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		77							7.11						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC(CC1)NC1=C2C=C(N)N=CC2=C(F)C(=C1)C1=C(F)C=CC=C1C		37673406	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673406&database=RX&origin=ReaxysOutput&ln=	(1175 of 1381)		N5-(1-ethyl-4-piperidyl)-8-fluoro-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	C23H26F2N4	C23H26F2N4	396.483			OKSWUNBXHJMGHG-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	8	2	5.111	2	4	4	12.89	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673406	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673406&database=RX&origin=ReaxysOutput&ln=	CCN1CCC(CC1)NC1=C2C=C(N)N=CC2=C(F)C(=C1)C1=C(F)C=CC=C1C	N5-(1-ethyl-4-piperidyl)-8-fluoro-7-(2-fluoro-6-methylphenyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		77							7.11			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=C(N)N=CC2=C(F)C(=C1)C1=C(F)C=CC=C1C		37673407	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673407&database=RX&origin=ReaxysOutput&ln=	(1176 of 1381)		8-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	C22H24F2N4	C22H24F2N4	382.456			FASUOHOQZFMFCY-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.688	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673407	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673407&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=C(N)N=CC2=C(F)C(=C1)C1=C(F)C=CC=C1C	8-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		24.96							7.6						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=C(N)N=CC2=C(F)C(=C1)C1=C(F)C=CC=C1C		37673407	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673407&database=RX&origin=ReaxysOutput&ln=	(1176 of 1381)		8-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	C22H24F2N4	C22H24F2N4	382.456			FASUOHOQZFMFCY-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.688	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673407	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673407&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=C(N)N=CC2=C(F)C(=C1)C1=C(F)C=CC=C1C	8-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		24.96							7.6			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1F		37673409	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673409&database=RX&origin=ReaxysOutput&ln=	(1177 of 1381)		8-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	C21H22F2N4	C21H22F2N4	368.429			AEVPINUNXONSFM-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	9	2	4.449	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673409	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673409&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1F	8-fluoro-7-(2-fluoro-6-methyl-phenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		22.08							7.66						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1F		37673409	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673409&database=RX&origin=ReaxysOutput&ln=	(1177 of 1381)		8-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	C21H22F2N4	C21H22F2N4	368.429			AEVPINUNXONSFM-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(1); Bioactivity(3)	9	2	4.449	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673409	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673409&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1F	8-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		22.08							7.66			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=C(F)C(NC2CCNCC2)=C2C=C(N)N=CC2=C1		37673410	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673410&database=RX&origin=ReaxysOutput&ln=	(1178 of 1381)		6-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	C21H22F2N4	C21H22F2N4	368.429			JYWVZOQKKXZZII-UHFFFAOYSA-N				Identification(11); Physical Data(2); Spectra(1); Bioactivity(3)	2	2	4.449	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673410	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673410&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=C(F)C(NC2CCNCC2)=C2C=C(N)N=CC2=C1	6-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.4516							9.34						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=C(F)C(NC2CCNCC2)=C2C=C(N)N=CC2=C1		37673410	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673410&database=RX&origin=ReaxysOutput&ln=	(1178 of 1381)		6-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	C21H22F2N4	C21H22F2N4	368.429			JYWVZOQKKXZZII-UHFFFAOYSA-N				Identification(11); Physical Data(2); Spectra(1); Bioactivity(3)	2	2	4.449	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673410	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673410&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=C(F)C(NC2CCNCC2)=C2C=C(N)N=CC2=C1	6-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.4516							9.34			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1F)C1=C(F)C=CC=C1C		37673411	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673411&database=RX&origin=ReaxysOutput&ln=	(1179 of 1381)		6-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	C22H24F2N4	C22H24F2N4	382.456			ZPSXNFOAGKVLDF-UHFFFAOYSA-N				Identification(11); Physical Data(2); Spectra(1); Bioactivity(3)	2	2	4.688	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673411	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673411&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1F)C1=C(F)C=CC=C1C	6-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3125							9.5						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1F)C1=C(F)C=CC=C1C		37673411	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673411&database=RX&origin=ReaxysOutput&ln=	(1179 of 1381)		6-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	C22H24F2N4	C22H24F2N4	382.456			ZPSXNFOAGKVLDF-UHFFFAOYSA-N				Identification(11); Physical Data(2); Spectra(1); Bioactivity(3)	2	2	4.688	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673411	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673411&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=C(N)N=CC2=CC(=C1F)C1=C(F)C=CC=C1C	6-fluoro-7-(2-fluoro-6-methylphenyl)-N5-(1-methyl-4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3125							9.5			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C(C=NC(N)=C2C#N)=C1		37673412	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673412&database=RX&origin=ReaxysOutput&ln=	(1180 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-5-(4-piperidylamino)isoquinoline-4-carbonitrile	C22H22FN5	C22H22FN5	375.449			LCNATEVGTZUSMK-UHFFFAOYSA-N				Identification(11); Physical Data(2); Spectra(1); Bioactivity(3)	7	2	4.011	3	5	3	36.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673412	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673412&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C(C=NC(N)=C2C#N)=C1	3-amino-7-(2-fluoro-6-methylphenyl)-5-(4-piperidylamino)isoquinoline-4-carbonitrile	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.2712							9.57						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C(C=NC(N)=C2C#N)=C1		37673412	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673412&database=RX&origin=ReaxysOutput&ln=	(1180 of 1381)		3-amino-7-(2-fluoro-6-methylphenyl)-5-(4-piperidylamino)isoquinoline-4-carbonitrile	C22H22FN5	C22H22FN5	375.449			LCNATEVGTZUSMK-UHFFFAOYSA-N				Identification(11); Physical Data(2); Spectra(1); Bioactivity(3)	7	2	4.011	3	5	3	36.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673412	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673412&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C(C=NC(N)=C2C#N)=C1	3-amino-7-(2-fluoro-6-methylphenyl)-5-(4-piperidylamino)isoquinoline-4-carbonitrile	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.2712							9.57			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1		37673576	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673576&database=RX&origin=ReaxysOutput&ln=	(1181 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			XZPQYYUYFLAJJX-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(3)	4	2	4.288	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673576	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673576&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3523							9.45						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1		37673576	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673576&database=RX&origin=ReaxysOutput&ln=	(1181 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	C21H23FN4	C21H23FN4	350.439			XZPQYYUYFLAJJX-UHFFFAOYSA-N				Identification(10); Physical Data(2); Spectra(2); Bioactivity(3)	4	2	4.288	3	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673576	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673576&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-(4-piperidyl)isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3523							9.45			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCNC2)=C2C=C(N)N=CC2=C1		37673577	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673577&database=RX&origin=ReaxysOutput&ln=	(1182 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-3-piperidyl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			SAROZLPNNCCTPO-HNNXBMFYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.483	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673577	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673577&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-3-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.37							8.86						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCNC2)=C2C=C(N)N=CC2=C1		37673577	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673577&database=RX&origin=ReaxysOutput&ln=	(1182 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-3-piperidyl]methyl]isoquinoline-3,5-diamine	C22H25FN4	C22H25FN4	364.466			SAROZLPNNCCTPO-HNNXBMFYSA-N				Identification(8); Physical Data(2); Spectra(1); Bioactivity(3)	1	2	4.483	3	4	4	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37673577	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673577&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC[C@H]2CCCNC2)=C2C=C(N)N=CC2=C1	7-(2-fluoro-6-methylphenyl)-N5-[[(3S)-3-piperidyl]methyl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.37							8.86			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=N1)N1CCN(CCO)CC1		38933772	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38933772&database=RX&origin=ReaxysOutput&ln=	(1183 of 1381)		N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H22ClF2N7O2S2	C20H22ClF2N7O2S2	530.022			BPNJZPLOQCLHCW-UHFFFAOYSA-N				Identification(9); Physical Data(2); Spectra(2); Bioactivity(2)	13	2	1.71	3	9	9	112.22	3	2	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38933772	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38933772&database=RX&origin=ReaxysOutput&ln=	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=N1)N1CCN(CCO)CC1	N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=N1)N1CCN(CCO)CC1		38933772	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38933772&database=RX&origin=ReaxysOutput&ln=	(1183 of 1381)		N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H22ClF2N7O2S2	C20H22ClF2N7O2S2	530.022			BPNJZPLOQCLHCW-UHFFFAOYSA-N				Identification(9); Physical Data(2); Spectra(2); Bioactivity(2)	13	2	1.71	3	9	9	112.22	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		38933772	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38933772&database=RX&origin=ReaxysOutput&ln=	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=N1)N1CCN(CCO)CC1	N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=N1)N1CCN(CCO)CC1		38933772	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38933772&database=RX&origin=ReaxysOutput&ln=	(1183 of 1381)		N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C20H22ClF2N7O2S2	C20H22ClF2N7O2S2	530.022			BPNJZPLOQCLHCW-UHFFFAOYSA-N				Identification(9); Physical Data(2); Spectra(2); Bioactivity(2)	13	2	1.71	3	9	9	112.22	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	antineoplastic agent	In Vitro (Efficacy)									38933772	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38933772&database=RX&origin=ReaxysOutput&ln=	CC1=NC(=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2C(F)F)=N1)N1CCN(CCO)CC1	N-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM	<	20							7.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
FC1=CC=C(CN2CCOC3=CC(=CC=C3C2=O)C2=CN=C3NC=CC3=C2)C=C1		39347247	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39347247&database=RX&origin=ReaxysOutput&ln=	(1184 of 1381)		4-(4-fluorobenzyl)-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one	C23H18FN3O2	C23H18FN3O2	387.413			UVLOISNMRLZTPF-UHFFFAOYSA-N				Identification(10); Physical Data(1); Spectra(5); Bioactivity(3)	4	2	4.714	1	4	3	29.96	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Transfected	Inhibitor		In Vitro (Efficacy)									39347247	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39347247&database=RX&origin=ReaxysOutput&ln=	FC1=CC=C(CN2CCOC3=CC(=CC=C3C2=O)C2=CN=C3NC=CC3=C2)C=C1	4-(4-fluorobenzyl)-8-(1H-pyrrolo[2,3-b]pyridin-5-yl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one					IC50	μM	>	10							1			73010	ATP	Other compound	Article; Li, Yueshan;Zhang, Liting;Yang, Ruicheng;Qiao, Zeen;Wu, Ming;Huang, Chong;Tian, Chenyu;Luo, Xinling;Yang, Wei;Zhang, Yun;Li, Linli;Yang, Shengyong; Journal of Medicinal Chemistry; vol. 65; 3; (2022); p. 1786 - 1807;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D112720671&database=RX&origin=ReaxysOutput&ln=	
C[C@H]1COCCN1C1=NC(=NC(=C1)C1=NC=CC=C1)C1=CC=C(NC(=O)NCCO)C=C1		21806438	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806438&database=RX&origin=ReaxysOutput&ln=	(1185 of 1381)	1333108-54-5	(S)-1-(2-hydroxyethyl)-3-(4-(4-(3-methylmorpholino)-6-(pyridin-2-yl)pyrimidin-2-yl)phenyl)urea	C23H26N6O3	C23H26N6O3	434.498			GGBHVXUYZDMBGY-INIZCTEOSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(8)	1	1	1.926	3	9	8	112.5	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected			In Vitro (Efficacy)	Binding							Lysate	21806438	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806438&database=RX&origin=ReaxysOutput&ln=	C[C@H]1COCCN1C1=NC(=NC(=C1)C1=NC=CC=C1)C1=CC=C(NC(=O)NCCO)C=C1	43					IC50	µM	>	10							1						Patent; GLAXOSMITHKLINE PLC; WO2011/107585; (2011); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20004727&database=RX&origin=ReaxysOutput&ln=	
CCNC(=O)NC1=CC=C(C=C1)C1=NC(=NC(=C1)C1=CC=CC=C1C#N)N1CCOC[C@@H]1C		21806445	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806445&database=RX&origin=ReaxysOutput&ln=	(1186 of 1381)	1333108-23-8	(S)-1-(4-(6-(2-cyanophenyl)-2-(3-methylmorpholino)pyrimidin-4-yl)phenyl)-3-ethylurea	C25H26N6O2	C25H26N6O2	442.52			HMPBCWNVAMNFQM-KRWDZBQOSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(3)	3	1	3.944	2	8	7	103.17	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected			In Vitro (Efficacy)	Binding							Lysate	21806445	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806445&database=RX&origin=ReaxysOutput&ln=	CCNC(=O)NC1=CC=C(C=C1)C1=NC(=NC(=C1)C1=CC=CC=C1C#N)N1CCOC[C@@H]1C	8					IC50	µM	>	10							1						Patent; GLAXOSMITHKLINE PLC; WO2011/107585; (2011); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20004727&database=RX&origin=ReaxysOutput&ln=	
C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)NC2CC2)C=C1)C1=CC=CN=C1S(C)(=O)=O		21806464	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806464&database=RX&origin=ReaxysOutput&ln=	(1187 of 1381)	1333108-57-8	(S)-1-cyclopropyl-3-(4-(2-(3-methylmorpholino)-6-(2-(methylsulfonyl)pyridin-3-yl)pyrimidin-4-yl)phenyl)urea	C25H28N6O4S	C25H28N6O4S	508.601			AYFMGFVQGPQWMU-INIZCTEOSA-N				Identification(7); Spectra(2); Bioactivity(8)	1	1	2.699	2	10	8	134.79	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected			In Vitro (Efficacy)	Binding							Lysate	21806464	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806464&database=RX&origin=ReaxysOutput&ln=	C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)NC2CC2)C=C1)C1=CC=CN=C1S(C)(=O)=O	46					IC50	µM	>	10							1						Patent; GLAXOSMITHKLINE PLC; WO2011/107585; (2011); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20004727&database=RX&origin=ReaxysOutput&ln=	
C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)NC2CC2)C=C1)C1=CC=CC=C1S(C)(=O)=O		21806465	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806465&database=RX&origin=ReaxysOutput&ln=	(1188 of 1381)	1333108-19-2	(S)-1-cyclopropyl-3-(4-(2-(3-methylmorpholino)-6-(2-(methylsulfonyl)phenyl)pyrimidin-4-yl)phenyl)urea	C26H29N5O4S	C26H29N5O4S	507.613			YMYFYJFNZDCJOC-KRWDZBQOSA-N				Identification(7); Spectra(2); Bioactivity(7)	1	1	3.862	2	9	8	121.9	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected			In Vitro (Efficacy)	Binding							Lysate	21806465	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806465&database=RX&origin=ReaxysOutput&ln=	C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)NC2CC2)C=C1)C1=CC=CC=C1S(C)(=O)=O	4					IC50	µM	>	10							1						Patent; GLAXOSMITHKLINE PLC; WO2011/107585; (2011); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20004727&database=RX&origin=ReaxysOutput&ln=	
C[C@H]1COCCN1C1=NC(=NC(=C1)C1=CC=CC=C1S(C)(=O)=O)C1=CC=C(NC(=O)NC2CC2)C=C1		21806466	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806466&database=RX&origin=ReaxysOutput&ln=	(1189 of 1381)	1333108-21-6	(S)-1-cyclopropyl-3-(4-(4-(3-methylmorpholino)-6-(2-(methylsulfonyl)phenyl)pyrimidin-2-yl)phenyl)urea	C26H29N5O4S	C26H29N5O4S	507.613			IDENRNUGQYRFOJ-KRWDZBQOSA-N				Identification(7); Spectra(2); Bioactivity(8)	1	1	3.862	2	9	8	121.9	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected			In Vitro (Efficacy)	Binding							Lysate	21806466	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806466&database=RX&origin=ReaxysOutput&ln=	C[C@H]1COCCN1C1=NC(=NC(=C1)C1=CC=CC=C1S(C)(=O)=O)C1=CC=C(NC(=O)NC2CC2)C=C1	6					IC50	µM	>	10							1						Patent; GLAXOSMITHKLINE PLC; WO2011/107585; (2011); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20004727&database=RX&origin=ReaxysOutput&ln=	
C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)NC2CC2)C=C1)C1=CC(F)=CC=C1S(C)(=O)=O		21806476	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806476&database=RX&origin=ReaxysOutput&ln=	(1190 of 1381)	1333108-51-2	(S)-1-cyclopropyl-3-(4-(6-(5-fluoro-2-(methylsulfonyl)phenyl)-2-(3-methylmorpholino)pyrimidin-4-yl)phenyl)urea	C26H28FN5O4S	C26H28FN5O4S	525.604			ZIJIQRPMBGAFSQ-INIZCTEOSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(8)	1	1	4.023	2	9	8	121.9	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected			In Vitro (Efficacy)	Binding							Lysate	21806476	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806476&database=RX&origin=ReaxysOutput&ln=	C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)NC2CC2)C=C1)C1=CC(F)=CC=C1S(C)(=O)=O	40					IC50	µM	>	10							1						Patent; GLAXOSMITHKLINE PLC; WO2011/107585; (2011); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20004727&database=RX&origin=ReaxysOutput&ln=	
C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)N[C@H]2CCC[C@@H]2O)C=C1)C1=CC(F)=CC=C1S(C)(=O)=O		21806499	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806499&database=RX&origin=ReaxysOutput&ln=	(1191 of 1381)	1333108-86-3	1-(4-(6-(5-fluoro-2-(methylsulfonyl)phenyl)-2-((S)-3-methylmorpholino)pyrimidin-4-yl)phenyl)-3-((1S,2S)-2-hydroxycyclopentyl)urea	C28H32FN5O5S	C28H32FN5O5S	569.657			PUJGVJMIZWEUSM-WVBBGBOVSA-N				Identification(7); Spectra(2); Bioactivity(8)	1	1	4.138	3	10	8	142.13	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected			In Vitro (Efficacy)	Binding							Lysate	21806499	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D21806499&database=RX&origin=ReaxysOutput&ln=	C[C@H]1COCCN1C1=NC(=CC(=N1)C1=CC=C(NC(=O)N[C@H]2CCC[C@@H]2O)C=C1)C1=CC(F)=CC=C1S(C)(=O)=O	76					IC50	µM	>	10							1						Patent; GLAXOSMITHKLINE PLC; WO2011/107585; (2011); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D20004727&database=RX&origin=ReaxysOutput&ln=	
O=S(=O)(N1CCCC1)C1=CC=CC(=C1)C1=CNC2=NC=CC(C3=CSC=C3)=C12		27004104	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004104&database=RX&origin=ReaxysOutput&ln=	(1192 of 1381)	1613710-12-5	3-(3-(pyrrolidin-1-ylsulfonyl)phenyl)-4-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridine	C21H19N3O2S2	C21H19N3O2S2	409.533			DQRJOWCWBWAKEL-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	5	1	4.398	1	5	4	102.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004104	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004104&database=RX&origin=ReaxysOutput&ln=	O=S(=O)(N1CCCC1)C1=CC=CC(=C1)C1=CNC2=NC=CC(C3=CSC=C3)=C12	205; Example 97-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
O=S(=O)(N1CCCC1)C1=CC=C(C=C1)C1=CNC2=NC=CC(C3=CSC=C3)=C12		27004105	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004105&database=RX&origin=ReaxysOutput&ln=	(1193 of 1381)	1613710-13-6	3-(4-(pyrrolidin-1-ylsulfonyl)phenyl)-4-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridine	C21H19N3O2S2	C21H19N3O2S2	409.533			MYUIWBZRBCBQSL-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	5	1	4.398	1	5	4	102.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004105	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004105&database=RX&origin=ReaxysOutput&ln=	O=S(=O)(N1CCCC1)C1=CC=C(C=C1)C1=CNC2=NC=CC(C3=CSC=C3)=C12	209; Example 98-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1)C1=CNC2=NC=C(C=C12)C1=CC=C(C)O1		27004111	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004111&database=RX&origin=ReaxysOutput&ln=	(1194 of 1381)	1613710-29-4	3-(2-methoxyphenyl)-5-(5-methylfuran-2-yl)-1H-pyrrolo[2,3-b]pyridine	C19H16N2O2	C19H16N2O2	304.348			YWRMYAKTHPDKIP-UHFFFAOYSA-N				Identification(7); Spectra(2); Bioactivity(2)	4	1	4.3	1	2	3	51.05	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004111	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004111&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1)C1=CNC2=NC=C(C=C12)C1=CC=C(C)O1	120; Example 115-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=C(O1)C1=C2C(NC=C2C2=C(Cl)C(F)=CC=C2)=NC=C1		27004112	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004112&database=RX&origin=ReaxysOutput&ln=	(1195 of 1381)	1613710-30-7	3-(2-chloro-3-fluorophenyl)-4-(5-methylfuran-2-yl)-1H-pyrrolo[2,3-b]pyridine	C18H12ClFN2O	C18H12ClFN2O	326.757			QXVAQNYEVVMKKJ-UHFFFAOYSA-N				Identification(7); Bioactivity(2)		1	5.168	1	2	2	41.82	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004112	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004112&database=RX&origin=ReaxysOutput&ln=	CC1=CC=C(O1)C1=C2C(NC=C2C2=C(Cl)C(F)=CC=C2)=NC=C1	Example 116-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1F)C1=CNC2=NC=CC(C3=CSC=C3)=C12		27004115	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004115&database=RX&origin=ReaxysOutput&ln=	(1196 of 1381)	1613710-34-1	3-(3-fluoro-2-methoxyphenyl)-4-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridine	C18H13FN2OS	C18H13FN2OS	324.378			RKQVQJOMRJAFFC-UHFFFAOYSA-N				Identification(7); Spectra(2); Bioactivity(2)	5	1	4.88	1	2	3	66.15	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004115	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004115&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1F)C1=CNC2=NC=CC(C3=CSC=C3)=C12	145; Example 120-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
OC1=C(C=CC=C1)C1=CNC2=NC=C(C=C12)C1=CSC=C1		27004118	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004118&database=RX&origin=ReaxysOutput&ln=	(1197 of 1381)	1613710-37-4	2-(5-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)phenol	C17H12N2OS	C17H12N2OS	292.361			CWWHZPPMUADZQC-UHFFFAOYSA-N				Identification(7); Spectra(2); Bioactivity(2)	4	1	4.398	2	2	2	77.15	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004118	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004118&database=RX&origin=ReaxysOutput&ln=	OC1=C(C=CC=C1)C1=CNC2=NC=C(C=C12)C1=CSC=C1	132; Example 123-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
OC1=C(F)C=C(F)C=C1C1=CNC2=NC=C(C=C12)C1=CSC=C1		27004119	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004119&database=RX&origin=ReaxysOutput&ln=	(1198 of 1381)	1613710-38-5	2,4-difluoro-6-(5-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)phenol	C17H10F2N2OS	C17H10F2N2OS	328.342			VIWVBXCHUKSGML-UHFFFAOYSA-N				Identification(7); Spectra(2); Bioactivity(2)	4	1	4.72	2	2	2	77.15	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004119	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004119&database=RX&origin=ReaxysOutput&ln=	OC1=C(F)C=C(F)C=C1C1=CNC2=NC=C(C=C12)C1=CSC=C1	153; Example 124-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1(F)CN(C1)C1=CNC2=NC=C(C=C12)C1=CSC=C1		27004129	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004129&database=RX&origin=ReaxysOutput&ln=	(1199 of 1381)	1613710-50-1	3-(3,3-difluoroazetidin-1-yl)-5-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridine	C14H11F2N3S	C14H11F2N3S	291.324			FZRYJGFKMPBVGP-UHFFFAOYSA-N				Identification(7); Bioactivity(2)		1	4.271	1	3	2	60.16	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004129	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004129&database=RX&origin=ReaxysOutput&ln=	FC1(F)CN(C1)C1=CNC2=NC=C(C=C12)C1=CSC=C1	Example 136-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1=C(C=CN=C1Cl)C1=CNC2=NC=C(C=C12)C1=CSC=C1		27004134	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004134&database=RX&origin=ReaxysOutput&ln=	(1200 of 1381)	1613710-55-6	3-(2-chloro-3-fluoropyridin-4-yl)-5-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridine	C16H9ClFN3S	C16H9ClFN3S	329.785			XKQDXRYJVGSWIP-UHFFFAOYSA-N				Identification(7); Bioactivity(2)		1	4.424	1	3	2	69.81	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004134	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004134&database=RX&origin=ReaxysOutput&ln=	FC1=C(C=CN=C1Cl)C1=CNC2=NC=C(C=C12)C1=CSC=C1	Example 141-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(C)O1		27004139	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004139&database=RX&origin=ReaxysOutput&ln=	(1201 of 1381)	1613710-82-9	3-(3-fluoro-2-methoxyphenyl)-5-(5-methylfuran-2-yl)-1H-pyrrolo[2,3-b]pyridine	C19H15FN2O2	C19H15FN2O2	322.339			GAKUBYZPVHZPTP-UHFFFAOYSA-N				Identification(7); Spectra(2); Bioactivity(2)	4	1	4.461	1	2	3	51.05	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004139	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004139&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC=C(C)O1	259; Example 168-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CN=C(S1)N1CCOCC1		27004143	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004143&database=RX&origin=ReaxysOutput&ln=	(1202 of 1381)	1613710-90-9	4-(5-(3-(3-fluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)thiazol-2-yl)morpholine	C21H19FN4O2S	C21H19FN4O2S	410.472			UJKXZNGZMIYMNY-UHFFFAOYSA-N				Identification(7); Spectra(2); Bioactivity(2)	4	1	3.651	1	5	4	91.51	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004143	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004143&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CN=C(S1)N1CCOCC1	271; Example 176-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN=C(S1)N1CCOCC1		27004146	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004146&database=RX&origin=ReaxysOutput&ln=	(1203 of 1381)	1613710-93-2	4-(5-(3-(3,5-difluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)thiazol-2-yl)morpholine	C21H18F2N4O2S	C21H18F2N4O2S	428.462			AJADPGWZMBLTKF-UHFFFAOYSA-N				Identification(7); Spectra(2); Bioactivity(2)	4	1	3.812	1	5	4	91.51	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004146	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004146&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CN=C(S1)N1CCOCC1	277; Example 179-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC(=CC=C1)S(=O)(=O)N1CCCC1		27004149	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004149&database=RX&origin=ReaxysOutput&ln=	(1204 of 1381)	1613710-96-5	3-(3-fluoro-2-methoxyphenyl)-5-(3-(pyrrolidin-1-ylsulfonyl)phenyl)-1H-pyrrolo[2,3-b]pyridine	C24H22FN3O3S	C24H22FN3O3S	451.521			KLLQUXJHEIZXFD-UHFFFAOYSA-N				Identification(7); Spectra(2); Bioactivity(2)	4	1	5.119	1	5	5	83.67	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004149	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004149&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1F)C1=CNC2=NC=C(C=C12)C1=CC(=CC=C1)S(=O)(=O)N1CCCC1	245; Example 182-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CC(=CC=C1)S(=O)(=O)N1CCCC1		27004150	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004150&database=RX&origin=ReaxysOutput&ln=	(1205 of 1381)	1613710-97-6	3-(3,5-difluoro-2-methoxyphenyl)-5-(3-(pyrrolidin-1-ylsulfonyl)phenyl)-1H-pyrrolo[2,3-b]pyridine	C24H21F2N3O3S	C24H21F2N3O3S	469.512			HEIPVBANFJPFNH-UHFFFAOYSA-N				Identification(7); Spectra(2); Bioactivity(2)	4	1	5.28	1	5	5	83.67	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004150	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004150&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CC(=CC=C1)S(=O)(=O)N1CCCC1	247; Example 183-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
OC1=C(C=CC=C1)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCOCC2)S1		27004155	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004155&database=RX&origin=ReaxysOutput&ln=	(1206 of 1381)	1613711-06-0	2-(5-(5-(morpholinomethyl)thiophen-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)phenol	C22H21N3O2S	C22H21N3O2S	391.494			ASSYQUGLNHNRKC-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	4	1	3.081	2	4	4	89.62	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004155	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004155&database=RX&origin=ReaxysOutput&ln=	OC1=C(C=CC=C1)C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCOCC2)S1	286; Example 192-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
OC1=C(F)C=CC=C1C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCOCC2)S1		27004156	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004156&database=RX&origin=ReaxysOutput&ln=	(1207 of 1381)	1613711-07-1	2-fluoro-6-(5-(5-(morpholinomethyl)thiophen-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)phenol	C22H20FN3O2S	C22H20FN3O2S	409.484			CXQGBXHQJAJXBB-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	4	1	3.242	2	4	4	89.62	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004156	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004156&database=RX&origin=ReaxysOutput&ln=	OC1=C(F)C=CC=C1C1=CNC2=NC=C(C=C12)C1=CC=C(CN2CCOCC2)S1	290; Example 193-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC=C1)C1=CNC2=NC=CC(C3=CSC=C3)=C12		27004159	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004159&database=RX&origin=ReaxysOutput&ln=	(1208 of 1381)	1613709-06-0	3-(2-methoxyphenyl)-4-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridine	C18H14N2OS	C18H14N2OS	306.388			DWCWDHQQOAZMPN-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	5	1	4.719	1	2	3	66.15	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004159	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004159&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC=C1)C1=CNC2=NC=CC(C3=CSC=C3)=C12	52; Example 17-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1(F)OC2=C(O1)C(=CC=C2)C1=CNC2=NC=C(C=C12)C1=CSC(=N1)N1CCOCC1		27004163	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004163&database=RX&origin=ReaxysOutput&ln=	(1209 of 1381)	1613711-13-9	4-(4-(3-(2,2-difluorobenzo[d][1,3]dioxol-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl)thiazol-2-yl)morpholine	C21H16F2N4O3S	C21H16F2N4O3S	442.446			HGZLVOFRJLUIDB-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	5	1	4.471	1	5	3	100.74	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004163	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004163&database=RX&origin=ReaxysOutput&ln=	FC1(F)OC2=C(O1)C(=CC=C2)C1=CNC2=NC=C(C=C12)C1=CSC(=N1)N1CCOCC1	306; Example 199-table 4					IC50	µM	>	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CSC(=N1)N1CCOCC1		27004169	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004169&database=RX&origin=ReaxysOutput&ln=	(1210 of 1381)	1613711-19-5	4-(4-(3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl)thiazol-2-yl)morpholine	C21H16F2N4O3S	C21H16F2N4O3S	442.446			NNDLRAPDLWWQNC-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	3	1	4.471	1	5	3	100.74	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004169	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004169&database=RX&origin=ReaxysOutput&ln=	FC1(F)OC2=C(O1)C=C(C=C2)C1=CNC2=NC=C(C=C12)C1=CSC(=N1)N1CCOCC1	321; Example 205-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CSC(=N1)N1CCOCC1		27004173	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004173&database=RX&origin=ReaxysOutput&ln=	(1211 of 1381)	1613711-22-0	4-(4-(3-(3,5-difluoro-2-methoxyphenyl)-1H-pyrrolo[2,3-b]pyridin-5-yl)thiazol-2-yl)morpholine	C21H18F2N4O2S	C21H18F2N4O2S	428.462			ILVPQWQQNQEAMT-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	4	1	4.511	1	5	4	91.51	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004173	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004173&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)C1=CSC(=N1)N1CCOCC1	329; Example 208-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)N1C=C(C=N1)N1CCN(CC1)S(C)(=O)=O		27004183	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004183&database=RX&origin=ReaxysOutput&ln=	(1212 of 1381)	1613711-31-1	3-(3,5-difluoro-2-methoxyphenyl)-5-(4-(4-(methylsulfonyl)piperazin-1-yl)-1H-pyrazol-1-yl)-1H-pyrrolo[2,3-b]pyridine	C22H22F2N6O3S	C22H22F2N6O3S	488.518			JEOWODWFWQRMNO-UHFFFAOYSA-N				Identification(7); Bioactivity(2)		1	3.778	1	8	5	104.73	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004183	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004183&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=C(F)C=C1F)C1=CNC2=NC=C(C=C12)N1C=C(C=N1)N1CCN(CC1)S(C)(=O)=O	Example 217-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CS(=O)(=O)N1CCN(CC1)C1=CN(N=C1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1		27004190	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004190&database=RX&origin=ReaxysOutput&ln=	(1213 of 1381)	1613711-38-8	3-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-5-(4-(4-(methylsulfonyl)piperazin-1-yl)-1H-pyrazol-1-yl)-1H-pyrrolo[2,3-b]pyridine	C22H20F2N6O4S	C22H20F2N6O4S	502.501			WTOKRZPAMZJTNL-UHFFFAOYSA-N				Identification(7); Bioactivity(2)		1	3.738	1	8	4	113.96	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004190	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004190&database=RX&origin=ReaxysOutput&ln=	CS(=O)(=O)N1CCN(CC1)C1=CN(N=C1)C1=CN=C2NC=C(C2=C1)C1=CC2=C(OC(F)(F)O2)C=C1	Example 224-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CCOC1=CC=CC=C1C1=NNC2=NC=CC(C3=CSC=C3)=C12		27004208	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004208&database=RX&origin=ReaxysOutput&ln=	(1214 of 1381)	1613708-94-3	3-(2-ethoxyphenyl)-4-(thiophen-3-yl)-1H-pyrazolo[3,4-b]pyridine	C18H15N3OS	C18H15N3OS	321.403			DPPRGHMNIUXNJY-UHFFFAOYSA-N				Identification(6); Physical Data(1); Spectra(2); Bioactivity(2)	4	1	5.115	1	3	4	79.04	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004208	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004208&database=RX&origin=ReaxysOutput&ln=	CCOC1=CC=CC=C1C1=NNC2=NC=CC(C3=CSC=C3)=C12	32; Example 5-table 4					IC50	µM	<	0.1							7						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
FC1=CC(F)=C(C=C1)C1=NNC2=NC=CC(C3=CSC=C3)=C12		27004334	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004334&database=RX&origin=ReaxysOutput&ln=	(1215 of 1381)	1613708-91-0	3-(2,4-difluorophenyl)-4-(thiophen-3-yl)-1H-pyrazolo[3,4-b]pyridine	C16H9F2N3S	C16H9F2N3S	313.33			ZSSCZNJNYHXRDL-UHFFFAOYSA-N				Identification(7); Bioactivity(2)		1	5.099	1	3	2	69.81	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004334	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004334&database=RX&origin=ReaxysOutput&ln=	FC1=CC(F)=C(C=C1)C1=NNC2=NC=CC(C3=CSC=C3)=C12	Example 2-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
COC1=C(C=CC(Cl)=C1)C1=NNC2=NC=CC(C3=CSC=C3)=C12		27004466	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004466&database=RX&origin=ReaxysOutput&ln=	(1216 of 1381)	1613708-95-4	3-(4-chloro-2-methoxyphenyl)-4-(thiophen-3-yl)-1H-pyrazolo[3,4-b]pyridine	C17H12ClN3OS	C17H12ClN3OS	341.821			SHTSYAONSNRGSH-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	4	1	5.314	1	3	3	79.04	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004466	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004466&database=RX&origin=ReaxysOutput&ln=	COC1=C(C=CC(Cl)=C1)C1=NNC2=NC=CC(C3=CSC=C3)=C12	36; Example 6-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
CCN(CC)S(=O)(=O)C1=C(C=CC=C1)C1=CNC2=NC=CC(C3=CSC=C3)=C12		27004473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004473&database=RX&origin=ReaxysOutput&ln=	(1217 of 1381)	1613710-10-3	N,N-diethyl-2-(4-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl)benzenesulfonamide	C21H21N3O2S2	C21H21N3O2S2	411.549			RTHLRNKEOUHIDI-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	5	1	4.738	1	5	6	102.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004473&database=RX&origin=ReaxysOutput&ln=	CCN(CC)S(=O)(=O)C1=C(C=CC=C1)C1=CNC2=NC=CC(C3=CSC=C3)=C12	197; Example 95-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
O=S(=O)(N1CCC1)C1=CC=C(C=C1)C1=CNC2=NC=CC(C3=CSC=C3)=C12		27004474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004474&database=RX&origin=ReaxysOutput&ln=	(1218 of 1381)	1613710-11-4	3-(4-(azetidin-1-ylsulfonyl)phenyl)-4-(thiophen-3-yl)-1H-pyrrolo[2,3-b]pyridine	C20H17N3O2S2	C20H17N3O2S2	395.506			BEELWHZJTNMRQE-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	5	1	4.04	1	5	4	102.68	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild					In Vitro (Efficacy)	Enzymology inhibition								27004474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D27004474&database=RX&origin=ReaxysOutput&ln=	O=S(=O)(N1CCC1)C1=CC=C(C=C1)C1=CNC2=NC=CC(C3=CSC=C3)=C12	201; Example 96-table 4					IC50	µM	>	1							6						Patent; ARRIEN PHARMACEUTICALS LLC; WO2014/93383; (2014); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D63764272&database=RX&origin=ReaxysOutput&ln=	
OC(=O)C(F)(F)F.COC1=CC=C(N(C(=O)NC2=C(C)C=CC=C2C)C2=CC(NC3=CC=C(C=C3)N3CCN(C)CC3)=NC=N2)C(OC)=C1		29296635	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29296635&database=RX&origin=ReaxysOutput&ln=	(1219 of 1381)		1-(2,4-dimethoxyphenyl)-3-(2,6-dimethylphenyl)-1-(6-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)urea trifluoroacetate; HG-9-91-01	C32H37N7O3*xC2HF3O2	(x)C2HF3O2*C32H37N7O3				QBUCDXTWVOGSMQ-UHFFFAOYSA-N				Identification(5); Physical Data(2); Spectra(3); Bioactivity(2)	7	1		3	10	11	132.39	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29296635	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29296635&database=RX&origin=ReaxysOutput&ln=	OC(=O)C(F)(F)F.COC1=CC=C(N(C(=O)NC2=C(C)C=CC=C2C)C2=CC(NC3=CC=C(C=C3)N3CCN(C)CC3)=NC=N2)C(OC)=C1	1-(2,4-dimethoxyphenyl)-3-(2,6-dimethylphenyl)-1-(6-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)urea trifluoroacetate					IC50	μM		19.4							4.71						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
OC(=O)C(F)(F)F.CN(C(=O)NC1=C(C)C=CC=C1C)C1=CC(NC2=CC=C(C=C2)N2CCN(C)CC2)=NC=N1		29296639	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29296639&database=RX&origin=ReaxysOutput&ln=	(1220 of 1381)		3-(2,6-dimethylphenyl)-1-methyl-1-(6-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)urea trifluoroacetate; HG-9-148-01	C25H31N7O*xC2HF3O2	(x)C2HF3O2*C25H31N7O				JNKNJGWJZSVTJD-UHFFFAOYSA-N				Identification(5); Physical Data(2); Spectra(2); Bioactivity(2)		1		3	10	8	113.93	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29296639	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29296639&database=RX&origin=ReaxysOutput&ln=	OC(=O)C(F)(F)F.CN(C(=O)NC1=C(C)C=CC=C1C)C1=CC(NC2=CC=C(C=C2)N2CCN(C)CC2)=NC=N1	3-(2,6-dimethylphenyl)-1-methyl-1-(6-((4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)urea trifluoroacetate					IC50	nM		49.3							7.31						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
OC(=O)C(F)(F)F.COC1=CC=C(N(C(=O)OC2=C(C)C=CC=C2C)C2=CC=NC(NC3=CC(OC)=C(OC)C(OC)=C3)=N2)C(OC)=C1		29296640	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29296640&database=RX&origin=ReaxysOutput&ln=	(1221 of 1381)		2,6-dimethylphenyl (2,4-dimethoxyphenyl)(2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)carbamate trifluoroacetate; HG-9-88-01	C30H32N4O7*C2HF3O2	C2HF3O2*C30H32N4O7	674.631			DYSPHEGGEAXOBJ-UHFFFAOYSA-N				Identification(5); Physical Data(2); Spectra(2); Bioactivity(2)		1		2	7	13	150.8	2	0	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29296640	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29296640&database=RX&origin=ReaxysOutput&ln=	OC(=O)C(F)(F)F.COC1=CC=C(N(C(=O)OC2=C(C)C=CC=C2C)C2=CC=NC(NC3=CC(OC)=C(OC)C(OC)=C3)=N2)C(OC)=C1	2,6-dimethylphenyl (2,4-dimethoxyphenyl)(2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)carbamate trifluoroacetate					IC50	nM		64.1							7.19						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
OC(=O)C(F)(F)F.CN(C(=O)OC1=C(C)C=CC=C1C)C1=NC(NC2=CC=C(C=C2)N2CCN(C)CC2)=NC=C1		29296642	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29296642&database=RX&origin=ReaxysOutput&ln=	(1222 of 1381)		2,6-dimethylphenyl (2-chloropyrimidin-4-yl)(methyl)carbamate; HG-9-150-01	C25H30N6O2*C2HF3O2	C2HF3O2*C25H30N6O2	560.576			NZECHJFUIXQUAU-UHFFFAOYSA-N				Identification(5); Physical Data(2); Spectra(2); Bioactivity(2)	3	1		2	9	8	111.13	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild		Transfected	Inhibitor		In Vitro (Efficacy)									29296642	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D29296642&database=RX&origin=ReaxysOutput&ln=	OC(=O)C(F)(F)F.CN(C(=O)OC1=C(C)C=CC=C1C)C1=NC(NC2=CC=C(C=C2)N2CCN(C)CC2)=NC=C1	2,6-dimethylphenyl (2-chloropyrimidin-4-yl)(methyl)carbamate					IC50	nM		85.8							7.07						Patent; HARVARD UNIVERSITY; DANA-FARBER CANCER INSTITUTE; BROAD INSTITUTE; MASS GENERAL BRIGHAM INC; WO2016/23014; (2016); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D68668991&database=RX&origin=ReaxysOutput&ln=	
N.NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1		32973360	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D32973360&database=RX&origin=ReaxysOutput&ln=	(1223 of 1381)		adenosine 5'-β,γ-dichloromethylenetriphosphate, tetra-ammonium salt	C11H16Cl2N5O12P3*4H3N	C11H16Cl2N5O12P3*4H3N	642.224			YLHCLSZFOKLUAF-MCDZGGTQSA-N				Identification(6); Physical Data(1); Spectra(3); Bioactivity(2)	1	1	-4.462	8	18	8	299.33	1	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									32973360	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D32973360&database=RX&origin=ReaxysOutput&ln=	N.NC1=C2N=CN([C@@H]3O[C@H](COP(O)(=O)OP(O)(=O)C(Cl)(Cl)P(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1	adenosine 5'-β,γ-dichloromethylenetriphosphate, tetra-ammonium salt					IC50	μM	>	10							1						Article; Malwal, Satish R.; O'Dowd, Bing; Feng, Xinxin; Turhanen, Petri; Shin, Christopher; Yao, Jiaqi; Kim, Boo Kyung; Baig, Noman; Zhou, Tianhui; Bansal, Sandhya; Khade, Rahul L.; Zhang, Yong; Oldfield, Eric; Journal of the American Chemical Society; vol. 140; 24; (2018); p. 7568 - 7578;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D73905000&database=RX&origin=ReaxysOutput&ln=	
C[C@@H](COC(F)F)NC1=NC=C2C(=N1)N(C=C2C1=CC=C(CN2CCN(C)CC2)C=C1)[C@H]1CC[C@H](O)CC1		33998285	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33998285&database=RX&origin=ReaxysOutput&ln=	(1224 of 1381)		4-[2-[[(1S)-2-(difluoromethoxy)-1-methylethyl]amino]-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanol	C28H38F2N6O2	C28H38F2N6O2	528.646			YVWQQVWNJQNNLQ-VJBMBRPKSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)		1	4.111	2	8	9	78.68	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									33998285	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33998285&database=RX&origin=ReaxysOutput&ln=	C[C@@H](COC(F)F)NC1=NC=C2C(=N1)N(C=C2C1=CC=C(CN2CCN(C)CC2)C=C1)[C@H]1CC[C@H](O)CC1	4-[2-[[(1S)-2-(difluoromethoxy)-1-methylethyl]amino]-5-[4-[(4-methylpiperazin-1-yl)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanol					IC50	nM		2340							5.63			73010	ATP	Substrate	Patent; PFIZER INC; WO2019/6548; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75800680&database=RX&origin=ReaxysOutput&ln=	
C[C@@H](COC(F)F)NC1=NC=C2C(=CN([C@H]3CC[C@H](O)CC3)C2=N1)C1=CC=C(CN(C)C)C=C1		33998286	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33998286&database=RX&origin=ReaxysOutput&ln=	(1225 of 1381)		4-[2-[[(1S)-2-(difluoromethoxy)-1-methylethyl]amino]-5-[4-[(dimethylamino)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanol	C25H33F2N5O2	C25H33F2N5O2	473.566			ZBEJKMZLBKBAPC-VDGAXYAQSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	4	1	4.468	2	7	9	75.44	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									33998286	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33998286&database=RX&origin=ReaxysOutput&ln=	C[C@@H](COC(F)F)NC1=NC=C2C(=CN([C@H]3CC[C@H](O)CC3)C2=N1)C1=CC=C(CN(C)C)C=C1	4-[2-[[(1S)-2-(difluoromethoxy)-1-methylethyl]amino]-5-[4-[(dimethylamino)methyl]phenyl]pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanol					IC50	nM		1633							5.79			73010	ATP	Substrate	Patent; PFIZER INC; WO2019/6548; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75800680&database=RX&origin=ReaxysOutput&ln=	
C[C@@H](COC(F)F)NC1=NC=C2C(=CN([C@H]3CC[C@H](O)CC3)C2=N1)C1=CN(C)N=C1		33998289	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33998289&database=RX&origin=ReaxysOutput&ln=	(1226 of 1381)		4-[2-[[(1S)-2-(difluoromethoxy)-1-methylethyl]amino]-5-(1-methylpyrazol-4-yl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanol	C20H26F2N6O2	C20H26F2N6O2	420.462			GCMZXCLPFRUPOI-QEJZJMRPSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)		1	3.21	2	8	7	90.02	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									33998289	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D33998289&database=RX&origin=ReaxysOutput&ln=	C[C@@H](COC(F)F)NC1=NC=C2C(=CN([C@H]3CC[C@H](O)CC3)C2=N1)C1=CN(C)N=C1	4-[2-[[(1S)-2-(difluoromethoxy)-1-methylethyl]amino]-5-(1-methylpyrazol-4-yl)pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanol					IC50	nM		2096							5.68			73010	ATP	Substrate	Patent; PFIZER INC; WO2019/6548; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D75800680&database=RX&origin=ReaxysOutput&ln=	
CCOC1=CC(=NC=C1Cl)N1CC(C1)N1C(=O)NC2=C1C=CC=C2		35210506	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35210506&database=RX&origin=ReaxysOutput&ln=	(1227 of 1381)		1-{1-[5-chloro-4-(ethoxy)pyrid-2-yl]azetidin-3-yl}-1,3-dihydro-2H-benzimidazol-2-one	C17H17ClN4O2	C17H17ClN4O2	344.801			CFMZCFRRDZDHFC-UHFFFAOYSA-N				Identification(6); Physical Data(1); Spectra(2); Bioactivity(2)	1	1	3.006	1	5	4	57.7	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									35210506	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35210506&database=RX&origin=ReaxysOutput&ln=	CCOC1=CC(=NC=C1Cl)N1CC(C1)N1C(=O)NC2=C1C=CC=C2	1-{1-[5-chloro-4-(ethoxy)pyrid-2-yl]azetidin-3-yl}-1,3-dihydro-2H-benzimidazol-2-one					IC50	μM	>	1							6						Article; De Lucas, Ana Isabel; Vega, Juan Antonio; Matesanz, Encarnación; Linares, María Lourdes; García Molina, Aránzazu; Tresadern, Gary; Lavreysen, Hilde; Trabanco, Andrés A.; Cid, José María; ACS Medicinal Chemistry Letters; vol. 11; 3; (2020); p. 303 - 308;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78128245&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1CC[C@H]1O)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503144	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503144&database=RX&origin=ReaxysOutput&ln=	(1228 of 1381)		2-(difluoromethoxy)-N-[(1R,2R)-2-hydroxycyclobutyl]-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide	C28H34F2N4O5	C28H34F2N4O5	544.599		racemate	XZYGECNKBLOXNX-IFMALSPDSA-N				Identification(6); Bioactivity(2)	1	1	4.877	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503144	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503144&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1CC[C@H]1O)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	2-(difluoromethoxy)-N-[(1R,2R)-2-hydroxycyclobutyl]-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1CC[C@@H]1O)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12		35503175	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503175&database=RX&origin=ReaxysOutput&ln=	(1229 of 1381)		2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-[(1R,2S)-2-hydroxycyclobutyl]benzamide	C28H34F2N4O5	C28H34F2N4O5	544.599		racemate	XZYGECNKBLOXNX-IRLDBZIGSA-N				Identification(6); Bioactivity(2)	7	1	4.877	2	6	12	97.56	3	1	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503175	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503175&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1CC[C@@H]1O)C1=CN=C2C=C(OCCCN3CCCCC3)C=CN12	2-(difluoromethoxy)-6-methoxy-4-[7-[3-(1-piperidyl)propoxy]imidazo[1,2-a]pyridin-3-yl]-N-[(1R,2S)-2-hydroxycyclobutyl]benzamide					IC50	nM	>	10 - 100							8			73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CNCC[C@H]3O)C=CN12		35503226	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503226&database=RX&origin=ReaxysOutput&ln=	(1230 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R,4S)-4-hydroxy-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide	C25H28F2N4O5	C25H28F2N4O5	502.518		racemate	PNEQHPQDMMKXJI-HNAYVOBHSA-N				Identification(7); Bioactivity(2)	1	1	3.367	3	6	10	106.35	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503226	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503226&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(OC[C@@H]3CNCC[C@H]3O)C=CN12	N-cyclopropyl-2-(difluoromethoxy)-4-[7-[[(3R,4S)-4-hydroxy-3-piperidyl]methoxy]imidazo[1,2-a]pyridin-3-yl]-6-methoxybenzamide					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
Cl.COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503238	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503238&database=RX&origin=ReaxysOutput&ln=	(1231 of 1381)		8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one dihydrochloride salt	C25H27F3N4O4*2ClH	C25H27F3N4O4*2ClH	577.431			CSHMFXHGSKSBJM-UHFFFAOYSA-N				Identification(6); Spectra(4); Bioactivity(2)	8	1	4.251	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503238	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503238&database=RX&origin=ReaxysOutput&ln=	Cl.COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one dihydrochloride salt					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
Cl.COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503238	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503238&database=RX&origin=ReaxysOutput&ln=	(1231 of 1381)		8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one dihydrochloride salt	C25H27F3N4O4*2ClH	C25H27F3N4O4*2ClH	577.431			CSHMFXHGSKSBJM-UHFFFAOYSA-N				Identification(6); Spectra(4); Bioactivity(2)	8	1	4.251	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503238	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503238&database=RX&origin=ReaxysOutput&ln=	Cl.COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one dihydrochloride salt					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
Cl.COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12		35503238	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503238&database=RX&origin=ReaxysOutput&ln=	(1231 of 1381)		8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one dihydrochloride salt	C25H27F3N4O4*2ClH	C25H27F3N4O4*2ClH	577.431			CSHMFXHGSKSBJM-UHFFFAOYSA-N				Identification(6); Spectra(4); Bioactivity(2)	8	1	4.251	0	6	8	68.54	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				Monocyte-derived dendritic cell		35503238	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503238&database=RX&origin=ReaxysOutput&ln=	Cl.COC1=CC(=CC2=C1C(=O)N(CC(F)(F)F)CC2)C1=CN=C2C=C(OCCN3CCOCC3)C=CN12	8-methoxy-6-[7-(2-morpholinoethoxy)imidazo[1,2-a]pyridin-3-yl]-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one dihydrochloride salt					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
OC=O.CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC(F)F)=C1)C(=O)N(CC(F)F)CC2		35503247	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503247&database=RX&origin=ReaxysOutput&ln=	(1232 of 1381)		2-(2,2-difluoroethyl)-8-(difluoromethoxy)-6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-3,4dihydroisoquinolin-1-one formic acid	C23H24F4N4O3*xCH2O2	(x)CH2O2*C23H24F4N4O3				PCEWTGJKGRZWGJ-UHFFFAOYSA-N				Identification(6); Spectra(1); Bioactivity(2)		1		1	7	9	96.61	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									35503247	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503247&database=RX&origin=ReaxysOutput&ln=	OC=O.CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC(F)F)=C1)C(=O)N(CC(F)F)CC2	2-(2,2-difluoroethyl)-8-(difluoromethoxy)-6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-3,4dihydroisoquinolin-1-one formic acid					IC50	nM		0.01 - 10										73010; 1719757; 34681992	ATP; AMARA peptide substrate	Other compound; Other compound; Substrate	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
OC=O.CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC(F)F)=C1)C(=O)N(CC(F)F)CC2		35503247	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503247&database=RX&origin=ReaxysOutput&ln=	(1232 of 1381)		2-(2,2-difluoroethyl)-8-(difluoromethoxy)-6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-3,4dihydroisoquinolin-1-one formic acid	C23H24F4N4O3*xCH2O2	(x)CH2O2*C23H24F4N4O3				PCEWTGJKGRZWGJ-UHFFFAOYSA-N				Identification(6); Spectra(1); Bioactivity(2)		1		1	7	9	96.61	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818178624 + 818251685 + 818361277	q9h0k1 + p57059 + q9y2k2				Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	immunomodulating agent	In Vitro (Efficacy)			human				monocyte-derived macrophage		35503247	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35503247&database=RX&origin=ReaxysOutput&ln=	OC=O.CN(C)CCOC1=CC2=NC=C(N2C=C1)C1=CC2=C(C(OC(F)F)=C1)C(=O)N(CC(F)F)CC2	2-(2,2-difluoroethyl)-8-(difluoromethoxy)-6-[7-[2-(dimethylamino)ethoxy]imidazo[1,2-a]pyridin-3-yl]-3,4dihydroisoquinolin-1-one formic acid					IC50	nM	>	100 - 1000			Tumor necrosis factor				7			8187061	lipopolysaccharide	Inductive agent	Patent; GALAPAGOS NV; GALAPAGOS; WO2019/238424; (2019); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78741076&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(NC=C2C2=CN=C(O2)C2=CC(Br)=CN2)=CC(Br)=C1		35541030	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35541030&database=RX&origin=ReaxysOutput&ln=	(1233 of 1381)		2-(4-bromo-1H-pyrrol-2-yl)-5-(6-bromo-4-methoxyl-1H-indol-3-yl)oxazole; breitfussin E	C16H11Br2N3O2	C16H11Br2N3O2	437.09			DIUDONROVOIHIO-UHFFFAOYSA-N				Identification(6); Physical Data(1); Spectra(6); Bioactivity(2)		1	4.105	2	3	3	66.84	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									35541030	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35541030&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(NC=C2C2=CN=C(O2)C2=CC(Br)=CN2)=CC(Br)=C1	2-(4-bromo-1H-pyrrol-2-yl)-5-(6-bromo-4-methoxyl-1H-indol-3-yl)oxazole					IC50	μM	>	50							1			73010	ATP	Other compound	Article; Hansen, Kine Ø.; Andersen, Jeanette H.; Bayer, Annette; Pandey, Sunil K.; Lorentzen, Marianne; Jørgensen, Kåre B.; Sydnes, Magne O.; Guttormsen, Yngve; Baumann, Matthias; Koch, Uwe; Klebl, Bert; Eickhoff, Jan; Haug, Bengt Erik; Isaksson, Johan; Hansen, Espen H.; Journal of Medicinal Chemistry; vol. 62; 22; (2019); p. 10167 - 10181;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78442548&database=RX&origin=ReaxysOutput&ln=	
COC1=C2C(NC(I)=C2C2=CN=C(O2)C2=CC=CN2)=CC(Br)=C1		35541031	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35541031&database=RX&origin=ReaxysOutput&ln=	(1234 of 1381)		5-(6-bromo-2-iodo-4-methoxy-1H-indol-3-yl)-2-(1H-pyrrol-2-yl)oxazole; breitfussin F	C16H11BrIN3O2	C16H11BrIN3O2	484.091			NDWPRZFOCQREKV-UHFFFAOYSA-N				Identification(6); Physical Data(1); Spectra(6); Bioactivity(2)		1	4.43	2	3	3	66.84	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									35541031	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D35541031&database=RX&origin=ReaxysOutput&ln=	COC1=C2C(NC(I)=C2C2=CN=C(O2)C2=CC=CN2)=CC(Br)=C1	5-(6-bromo-2-iodo-4-methoxy-1H-indol-3-yl)-2-(1H-pyrrol-2-yl)oxazole					IC50	μM	>	50							1			73010	ATP	Other compound	Article; Hansen, Kine Ø.; Andersen, Jeanette H.; Bayer, Annette; Pandey, Sunil K.; Lorentzen, Marianne; Jørgensen, Kåre B.; Sydnes, Magne O.; Guttormsen, Yngve; Baumann, Matthias; Koch, Uwe; Klebl, Bert; Eickhoff, Jan; Haug, Bengt Erik; Isaksson, Johan; Hansen, Espen H.; Journal of Medicinal Chemistry; vol. 62; 22; (2019); p. 10167 - 10181;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D78442548&database=RX&origin=ReaxysOutput&ln=	
CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CC1)NCCO		36081275	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081275&database=RX&origin=ReaxysOutput&ln=	(1235 of 1381)		N(4-chloro-2-methylpyridin-3-yl)-2-((6-((2-hydroxyethyl)amino)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide	C21H26ClN9O2S	C21H26ClN9O2S	504.016			WCASUTYOLBKUOJ-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(2); Bioactivity(2)	1	1	0.754	4	11	9	159.67	2	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									36081275	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D36081275&database=RX&origin=ReaxysOutput&ln=	CC1=NC(NC2=NC=C(S2)C(=O)NC2=C(Cl)C=CN=C2C)=CC(=N1)N1CCN(CC1)NCCO	N(4-chloro-2-methylpyridin-3-yl)-2-((6-((2-hydroxyethyl)amino)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide					IC50	nM		493							6.31			73010; 37051685	ATP; RBER-CHKtide	Other compound; Substrate	Patent; IOMX THERAPEUTICS AG; EP3643713; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D79879478&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(OC(C)(C)CN3CC4(COC4)C3)=CN2N=C1		37037390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037390&database=RX&origin=ReaxysOutput&ln=	(1236 of 1381)			C28H31F3N4O5	C28H31F3N4O5	560.573			UITAJQPCJAVJHZ-VQTJNVASSA-N				Identification(7); Spectra(2); Bioactivity(2)	10	1	4.313	1	6	11	34.37	3	1	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									37037390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37037390&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(OC(C)(C)CN3CC4(COC4)C3)=CN2N=C1						IC50	nM	>	10 - 100							8			73010	ATP	Other compound	Patent; GALAPAGOS; WO2020/239660; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807679&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@H]1F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N		37158035	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158035&database=RX&origin=ReaxysOutput&ln=	(1237 of 1381)		4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(2-fluorocyclopropyl)-6-methoxy-benzamide	C23H21F3N4O3	C23H21F3N4O3	458.44		racemate	DGCZTIYMVWMEQK-HUUCEWRRSA-N				Identification(7); Bioactivity(2)		1	4.736	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158035	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158035&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@H]1F)C1=CN=C2C=C(C=CN12)C(C)(C)C#N	4-[7-(1-cyano-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(2-fluorocyclopropyl)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N		37158048	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158048&database=RX&origin=ReaxysOutput&ln=	(1238 of 1381)		4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-[2-fluorocyclopropyl]-2,6-dimethoxy-benzamide	C23H21F3N4O3	C23H21F3N4O3	458.44		racemate	BDTLFPRHEXLZDV-HZPDHXFCSA-N				Identification(7); Bioactivity(2)		1	4.536	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158048	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158048&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N	4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-N-[2-fluorocyclopropyl]-2,6-dimethoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C1CC1		37158210	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158210&database=RX&origin=ReaxysOutput&ln=	(1239 of 1381)		N-cyclopropyl-4-[7-(1-cyclopropyl-1-hydroxy-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide	C24H25F2N3O4	C24H25F2N3O4	457.477			XBHHWRGXJCZDSW-XMMPIXPASA-N				Identification(6); Bioactivity(1)	1	1	4.27	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158210	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158210&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C1CC1	N-cyclopropyl-4-[7-(1-cyclopropyl-1-hydroxy-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCC(C)(O)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158211	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158211&database=RX&origin=ReaxysOutput&ln=	(1240 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C23H25F2N3O4	C23H25F2N3O4	445.466			FJWMUNSALNIGQY-HSZRJFAPSA-N				Identification(6); Bioactivity(1)	1	1	4.313	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158211	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158211&database=RX&origin=ReaxysOutput&ln=	CCC(C)(O)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(CO)C#N		37158212	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158212&database=RX&origin=ReaxysOutput&ln=	(1241 of 1381)		4-[7-(1-cyano-2-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H22F2N4O4	C23H22F2N4O4	456.449			QVZXIYIDWMNPEK-HSZRJFAPSA-N				Identification(6); Bioactivity(1)	1	1	3.46	2	6	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158212	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158212&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(CO)C#N	4-[7-(1-cyano-2-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C1CC1		37158215	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158215&database=RX&origin=ReaxysOutput&ln=	(1242 of 1381)		N-cyclopropyl-4-[7-(1-cyclopropyl-1-hydroxy-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide	C24H25F2N3O4	C24H25F2N3O4	457.477			XBHHWRGXJCZDSW-DEOSSOPVSA-N				Identification(6); Bioactivity(1)	1	1	4.27	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158215	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158215&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(O)C1CC1	N-cyclopropyl-4-[7-(1-cyclopropyl-1-hydroxy-ethyl)imidazo[1,2-a]pyridin-3-yl]-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CCC(C)(O)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1		37158216	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158216&database=RX&origin=ReaxysOutput&ln=	(1243 of 1381)		N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide	C23H25F2N3O4	C23H25F2N3O4	445.466			FJWMUNSALNIGQY-QHCPKHFHSA-N				Identification(6); Bioactivity(1)	1	1	4.313	2	5	9	34.37	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158216	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158216&database=RX&origin=ReaxysOutput&ln=	CCC(C)(O)C1=CC2=NC=C(N2C=C1)C1=CC(OC(F)F)=C(C(=O)NC2CC2)C(OC)=C1	N-cyclopropyl-2-(difluoromethoxy)-4-[7-(1-hydroxy-1-methyl-propyl)imidazo[1,2-a]pyridin-3-yl]-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(CO)C#N		37158217	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158217&database=RX&origin=ReaxysOutput&ln=	(1244 of 1381)		4-[7-(1-cyano-2-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide	C23H22F2N4O4	C23H22F2N4O4	456.449			QVZXIYIDWMNPEK-QHCPKHFHSA-N				Identification(6); Bioactivity(1)	1	1	3.46	2	6	9	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158217	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158217&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)NC1CC1)C1=CN=C2C=C(C=CN12)C(C)(CO)C#N	4-[7-(1-cyano-2-hydroxy-1-methyl-ethyl)imidazo[1,2-a]pyridin-3-yl]-N-cyclopropyl-2-(difluoromethoxy)-6-methoxy-benzamide					IC50	nM	>	10 - 100							8			73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N		37158276	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158276&database=RX&origin=ReaxysOutput&ln=	(1245 of 1381)		4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(2-fluorocyclopropyl)-6-methoxy-benzamide	C23H21F3N4O3	C23H21F3N4O3	458.44		racemate	BDTLFPRHEXLZDV-JKSUJKDBSA-N				Identification(7); Bioactivity(2)		1	4.536	1	5	8	58.16	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									37158276	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37158276&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC(OC(F)F)=C1C(=O)N[C@@H]1C[C@@H]1F)C1=C2C=CC(=CN2N=C1)C(C)(C)C#N	4-[6-(1-cyano-1-methyl-ethyl)pyrazolo[1,5-a]pyridin-3-yl]-2-(difluoromethoxy)-N-(2-fluorocyclopropyl)-6-methoxy-benzamide					IC50	nM		0.01 - 10										73010	ATP	Substrate	Patent; GALAPAGOS; WO2020/239658; (2020); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D81807639&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N(CC2CCNCC2)C1=O		37612355	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612355&database=RX&origin=ReaxysOutput&ln=	(1246 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-(4-piperidylmethyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442			IJKZUJRGXHLXAI-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.852	2	6	3	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612355	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612355&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N(CC2CCNCC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-(4-piperidylmethyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.5497							9.26						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N(C2CNC2)C1=O		37612357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612357&database=RX&origin=ReaxysOutput&ln=	(1247 of 1381)		7-amino-1-(azetidin-3-yl)-3-(2-fluoro-6-methyl-phenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C17H18FN5O	C17H18FN5O	327.361			GEBLDDVFXMZYQE-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	0.941	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612357	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612357&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N(C2CNC2)C1=O	7-amino-1-(azetidin-3-yl)-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		35.3							7.45						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612358	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612358&database=RX&origin=ReaxysOutput&ln=	(1248 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-(1-methylazetidin-3-yl)-4H-pyrido[4,3-d]pyrimidin-2-one	C18H20FN5O	C18H20FN5O	341.388			YLQRZAIQTFDVBM-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.18	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612358	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612358&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-(1-methylazetidin-3-yl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		124.5							6.9						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1N1CC2=C(C=C(N)N=C2)N(C2CCNCC2)C1=O		37612359	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612359&database=RX&origin=ReaxysOutput&ln=	(1249 of 1381)		7-amino-3-(2-chloro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C19H22ClN5O	C19H22ClN5O	371.87			WYWPCSHGVBBSLH-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.118	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612359	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612359&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1N1CC2=C(C=C(N)N=C2)N(C2CCNCC2)C1=O	7-amino-3-(2-chloro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		10.76							7.97						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(Cl)C=CC=C1C		37612360	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612360&database=RX&origin=ReaxysOutput&ln=	(1250 of 1381)		7-amino-3-(2-chloro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24ClN5O	C20H24ClN5O	385.896			PFRJFLNMTJIKIJ-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.357	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612360	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612360&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(Cl)C=CC=C1C	7-amino-3-(2-chloro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		9.457							8.02						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1N1CC2=C(C=C(N)N=C2)N(C2CNC2)C1=O		37612361	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612361&database=RX&origin=ReaxysOutput&ln=	(1251 of 1381)		7-amino-1-(azetidin-3-yl)-3-(2-chloro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C17H18ClN5O	C17H18ClN5O	343.816			DTEGLCVAVAPZBI-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.402	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612361	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612361&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1N1CC2=C(C=C(N)N=C2)N(C2CNC2)C1=O	7-amino-1-(azetidin-3-yl)-3-(2-chloro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		45.63							7.34						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(Cl)C=CC=C1C		37612362	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612362&database=RX&origin=ReaxysOutput&ln=	(1252 of 1381)		7-amino-3-(2-chloro-6-methylphenyl)-1-(1-methylazetidin-3-yl)-4H-pyrido[4,3-d]pyrimidin-2-one	C18H20ClN5O	C18H20ClN5O	357.843			KPSRSNFUZIMHRS-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.641	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612362	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612362&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(Cl)C=CC=C1C	7-amino-3-(2-chloro-6-methylphenyl)-1-(1-methylazetidin-3-yl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		144.7							6.84						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@H]2CCNC2)C1=O		37612363	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612363&database=RX&origin=ReaxysOutput&ln=	(1253 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-pyrrolidin-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one	C18H20FN5O	C18H20FN5O	341.388			MGGONBWPUDRPKM-ZDUSSCGKSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	1.299	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612363	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612363&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@H]2CCNC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-pyrrolidin-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		15.4							7.81						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612364	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612364&database=RX&origin=ReaxysOutput&ln=	(1254 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methylpyrrolidin-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one	C19H22FN5O	C19H22FN5O	355.415			DNGGPKCQLMCKTF-AWEZNQCLSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	1.538	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612364	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612364&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methylpyrrolidin-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		85.43							7.07						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612365	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612365&database=RX&origin=ReaxysOutput&ln=	(1255 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-1-methylpyrrolidin-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one	C19H22FN5O	C19H22FN5O	355.415			DNGGPKCQLMCKTF-CQSZACIVSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	1.538	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612365	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612365&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-1-methylpyrrolidin-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		37.88							7.42						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612366	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612366&database=RX&origin=ReaxysOutput&ln=	(1256 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-1-methyl-3-piperidyl]-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442			SLXGJNVPZREYMR-OAHLLOKOSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.896	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612366	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612366&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-1-methyl-3-piperidyl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		5.04							8.3						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612368	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612368&database=RX&origin=ReaxysOutput&ln=	(1257 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methyl-3-piperidyl]-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442			SLXGJNVPZREYMR-HNNXBMFYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.896	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612368	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612368&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methyl-3-piperidyl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		5.886							8.23						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCCC[C@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612369	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612369&database=RX&origin=ReaxysOutput&ln=	(1258 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-1-methylazepan-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one	C21H26FN5O	C21H26FN5O	383.469			DYTHMYGKKBFHKG-MRXNPFEDSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.254	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612369	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612369&database=RX&origin=ReaxysOutput&ln=	CN1CCCC[C@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-1-methylazepan-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		14.51							7.84						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612370	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612370&database=RX&origin=ReaxysOutput&ln=	(1259 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(4R)-1-methylazepan-4-yl]-4H-pyrido[4,3-d]pyrimidin-2-one	C21H26FN5O	C21H26FN5O	383.469			SEQPWSSTPDZMRI-MRXNPFEDSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.254	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612370	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612370&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(4R)-1-methylazepan-4-yl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.3025							9.52						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCCC[C@@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612371	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612371&database=RX&origin=ReaxysOutput&ln=	(1260 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methylazepan-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one	C21H26FN5O	C21H26FN5O	383.469			DYTHMYGKKBFHKG-INIZCTEOSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.254	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612371	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612371&database=RX&origin=ReaxysOutput&ln=	CN1CCCC[C@@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methylazepan-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		48.82							7.31						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612372	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612372&database=RX&origin=ReaxysOutput&ln=	(1261 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(4S)-1-methylazepan-4-yl]-4H-pyrido[4,3-d]pyrimidin-2-one	C21H26FN5O	C21H26FN5O	383.469			SEQPWSSTPDZMRI-INIZCTEOSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.254	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612372	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612372&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(4S)-1-methylazepan-4-yl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		6.153							8.21						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N(CC2CCNCC2)C1=O		37612373	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612373&database=RX&origin=ReaxysOutput&ln=	(1262 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-(4-piperidylmethyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23FN6O	C19H23FN6O	370.43			YBNHLEFUWAICOM-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.539	2	7	3	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612373	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612373&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N(CC2CCNCC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-(4-piperidylmethyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.7211							9.14						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1N1CC2=CN=C(N)N=C2N(C2CNC2)C1=O		37612374	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612374&database=RX&origin=ReaxysOutput&ln=	(1263 of 1381)		7-amino-1-(azetidin-3-yl)-3-(2-chloro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C16H17ClN6O	C16H17ClN6O	344.804			YZLAWCCKPJNBSI-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.089	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612374	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612374&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1N1CC2=CN=C(N)N=C2N(C2CNC2)C1=O	7-amino-1-(azetidin-3-yl)-3-(2-chloro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		9.467							8.02						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=CN=C2N(C2CCNCC2)C1=O		37612375	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612375&database=RX&origin=ReaxysOutput&ln=	(1264 of 1381)		3-(2-fluoro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C18H20FN5O	C18H20FN5O	341.388			DEZKUSBAQSRCOL-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.433	1	6	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612375	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612375&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=CN=C2N(C2CCNCC2)C1=O	3-(2-fluoro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		489							6.31						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1N1CC2=CN=CN=C2N(C2CCNCC2)C1=O		37612376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612376&database=RX&origin=ReaxysOutput&ln=	(1265 of 1381)		3-(2-chloro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C18H20ClN5O	C18H20ClN5O	357.843			XQWUHPKWSFACQJ-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.894	1	6	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612376	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612376&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1N1CC2=CN=CN=C2N(C2CCNCC2)C1=O	3-(2-chloro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		1405							5.85						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC(CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612377	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612377&database=RX&origin=ReaxysOutput&ln=	(1266 of 1381)		7-amino-1-(1-ethyl-4-piperidyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C20H25FN6O	C20H25FN6O	384.457			KALZJDNNAGXQKZ-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.006	1	7	3	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612377	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612377&database=RX&origin=ReaxysOutput&ln=	CCN1CCC(CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	7-amino-1-(1-ethyl-4-piperidyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		7.184							8.14						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612379	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612379&database=RX&origin=ReaxysOutput&ln=	(1267 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-(1-methylazetidin-3-yl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C17H19FN6O	C17H19FN6O	342.376			NWAYKDDPKGDIKY-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	0.867	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612379	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612379&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-(1-methylazetidin-3-yl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		47.95							7.32						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(Cl)C=CC=C1C		37612380	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612380&database=RX&origin=ReaxysOutput&ln=	(1268 of 1381)		7-amino-3-(2-chloro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23ClN6O	C19H23ClN6O	386.884			OYIIOLJYSFEIHI-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.044	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612380	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612380&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(Cl)C=CC=C1C	7-amino-3-(2-chloro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		27.82							7.56						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CC(C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(Cl)C=CC=C1C		37612381	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612381&database=RX&origin=ReaxysOutput&ln=	(1269 of 1381)		7-amino-3-(2-chloro-6-methylphenyl)-1-(1-methylazetidin-3-yl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C17H19ClN6O	C17H19ClN6O	358.83			VQBWBXXYUYFCMS-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.328	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612381	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612381&database=RX&origin=ReaxysOutput&ln=	CN1CC(C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(Cl)C=CC=C1C	7-amino-3-(2-chloro-6-methylphenyl)-1-(1-methylazetidin-3-yl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		54.66							7.26						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)N1C(=O)N(CC2=C1C=CN=C2)C1=C(F)C=CC=C1C		37612382	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612382&database=RX&origin=ReaxysOutput&ln=	(1270 of 1381)		3-(2-fluoro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C20H23FN4O	C20H23FN4O	354.427			ZIZOFKHVFMWITI-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.985	0	5	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612382	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612382&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)N1C(=O)N(CC2=C1C=CN=C2)C1=C(F)C=CC=C1C	3-(2-fluoro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		24.04							7.62						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC(CC1)N1C(=O)N(CC2=C1C=CN=C2)C1=C(F)C=CC=C1C		37612383	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612383&database=RX&origin=ReaxysOutput&ln=	(1271 of 1381)		1-(1-ethyl-4-piperidyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C21H25FN4O	C21H25FN4O	368.454			ZBLGLTGKIDMUTJ-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.408	0	5	3	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612383	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612383&database=RX&origin=ReaxysOutput&ln=	CCN1CCC(CC1)N1C(=O)N(CC2=C1C=CN=C2)C1=C(F)C=CC=C1C	1-(1-ethyl-4-piperidyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		36.33							7.44						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)N1C(=O)N(CC2=CN=CN=C12)C1=C(F)C=CC=C1C		37612384	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612384&database=RX&origin=ReaxysOutput&ln=	(1272 of 1381)		3-(2-fluoro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H22FN5O	C19H22FN5O	355.415			LCNHWDLTUHVWTD-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.672	0	6	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612384	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612384&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)N1C(=O)N(CC2=CN=CN=C12)C1=C(F)C=CC=C1C	3-(2-fluoro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		895.1							6.05						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC(CC1)N1C(=O)N(CC2=CN=CN=C12)C1=C(F)C=CC=C1C		37612385	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612385&database=RX&origin=ReaxysOutput&ln=	(1273 of 1381)		1-(1-ethyl-4-piperidyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442			NWWXTKOZMCFRER-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.095	0	6	3	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612385	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612385&database=RX&origin=ReaxysOutput&ln=	CCN1CCC(CC1)N1C(=O)N(CC2=CN=CN=C12)C1=C(F)C=CC=C1C	1-(1-ethyl-4-piperidyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		956							6.02						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)N1C(=O)N(CC2=CN=CN=C12)C1=C(Cl)C=CC=C1C		37612386	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612386&database=RX&origin=ReaxysOutput&ln=	(1274 of 1381)		3-(2-chloro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H22ClN5O	C19H22ClN5O	371.87			PCAXOIGNTGLMNF-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.133	0	6	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612386	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612386&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)N1C(=O)N(CC2=CN=CN=C12)C1=C(Cl)C=CC=C1C	3-(2-chloro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		2224							5.65						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC(CC1)N1C(=O)N(CC2=CN=CN=C12)C1=C(Cl)C=CC=C1C		37612387	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612387&database=RX&origin=ReaxysOutput&ln=	(1275 of 1381)		3-(2-chloro-6-methylphenyl)-1-(1-ethyl-4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C20H24ClN5O	C20H24ClN5O	385.896			WHKYFGHGXGGLIF-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.556	0	6	3	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612387	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612387&database=RX&origin=ReaxysOutput&ln=	CCN1CCC(CC1)N1C(=O)N(CC2=CN=CN=C12)C1=C(Cl)C=CC=C1C	3-(2-chloro-6-methylphenyl)-1-(1-ethyl-4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		1696							5.77						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612388&database=RX&origin=ReaxysOutput&ln=	(1276 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methylpyrrolidin-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C18H21FN6O	C18H21FN6O	356.403			RGLHFGAPNAGSBE-ZDUSSCGKSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.225	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612388	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612388&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methylpyrrolidin-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		64.53							7.19						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CC[C@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612390&database=RX&origin=ReaxysOutput&ln=	(1277 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-1-methylpyrrolidin-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C18H21FN6O	C18H21FN6O	356.403			RGLHFGAPNAGSBE-CYBMUJFWSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.225	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612390	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612390&database=RX&origin=ReaxysOutput&ln=	CN1CC[C@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-1-methylpyrrolidin-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		62.65							7.2						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)N1C(=O)N(CC2=C1C=CN=C2)C1=C(Cl)C=CC=C1C		37612391	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612391&database=RX&origin=ReaxysOutput&ln=	(1278 of 1381)		3-(2-chloro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C20H23ClN4O	C20H23ClN4O	370.882			GSUQUNIFRMIUHK-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.446	0	5	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612391	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612391&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)N1C(=O)N(CC2=C1C=CN=C2)C1=C(Cl)C=CC=C1C	3-(2-chloro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		144.1							6.84						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC(CC1)N1C(=O)N(CC2=C1C=CN=C2)C1=C(Cl)C=CC=C1C		37612392	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612392&database=RX&origin=ReaxysOutput&ln=	(1279 of 1381)		3-(2-chloro-6-methylphenyl)-1-(1-ethyl-4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C21H25ClN4O	C21H25ClN4O	384.909			AGFYILPFSQKDDQ-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.869	0	5	3	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612392	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612392&database=RX&origin=ReaxysOutput&ln=	CCN1CCC(CC1)N1C(=O)N(CC2=C1C=CN=C2)C1=C(Cl)C=CC=C1C	3-(2-chloro-6-methylphenyl)-1-(1-ethyl-4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		212.8							6.67						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612393	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612393&database=RX&origin=ReaxysOutput&ln=	(1280 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(4R)-1-methylazepan-4-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C20H25FN6O	C20H25FN6O	384.457			UMUBBVBEQHFGAX-OAHLLOKOSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.941	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612393	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612393&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(4R)-1-methylazepan-4-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		1.483							8.83						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612394	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612394&database=RX&origin=ReaxysOutput&ln=	(1281 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(4S)-1-methylazepan-4-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C20H25FN6O	C20H25FN6O	384.457			UMUBBVBEQHFGAX-HNNXBMFYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.941	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612394	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612394&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(4S)-1-methylazepan-4-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		2.124							8.67						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCCC[C@@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612395	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612395&database=RX&origin=ReaxysOutput&ln=	(1282 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methylazepan-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C20H25FN6O	C20H25FN6O	384.457			SUOGJHVUNLVXRN-HNNXBMFYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.941	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612395	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612395&database=RX&origin=ReaxysOutput&ln=	CN1CCCC[C@@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methylazepan-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		8.611							8.06						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612396	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612396&database=RX&origin=ReaxysOutput&ln=	(1283 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methyl-3-piperidyl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23FN6O	C19H23FN6O	370.43			MKEMHDUCUJDPOK-AWEZNQCLSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.583	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612396	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612396&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-1-methyl-3-piperidyl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		6.649							8.18						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCCC[C@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612397	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612397&database=RX&origin=ReaxysOutput&ln=	(1284 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-1-methylazepan-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C20H25FN6O	C20H25FN6O	384.457			SUOGJHVUNLVXRN-OAHLLOKOSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.941	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612397	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612397&database=RX&origin=ReaxysOutput&ln=	CN1CCCC[C@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-1-methylazepan-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		46.73							7.33						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@H]1CC[C@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612398	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612398&database=RX&origin=ReaxysOutput&ln=	(1285 of 1381)		cis-7-amino-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C21H27FN6O	C21H27FN6O	398.483			UOWAHZCOONGHPW-IYBDPMFKSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.336	1	7	3	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612398	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612398&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@H]1CC[C@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	cis-7-amino-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		3.87							8.41						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC2=C(CN(C(=O)N2[C@@H]2CC[C@@H](CC2)N(C)C)C2=C(F)C=CC=C2C)C=N1		37612399	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612399&database=RX&origin=ReaxysOutput&ln=	(1286 of 1381)		cis-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-7-(methylamino)-4H-pyrido[4,3-d]pyrimidin-2-one	C23H30FN5O	C23H30FN5O	411.523			HDLZZALFLUYQJI-HDICACEKSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	3.112	1	6	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612399	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612399&database=RX&origin=ReaxysOutput&ln=	CNC1=CC2=C(CN(C(=O)N2[C@@H]2CC[C@@H](CC2)N(C)C)C2=C(F)C=CC=C2C)C=N1	cis-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-7-(methylamino)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		18.42							7.74						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@H]1CC[C@H](CC1)N1C(=O)N(CC2=C1C=C(N=C2)N(C)C)C1=C(F)C=CC=C1C		37612401	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612401&database=RX&origin=ReaxysOutput&ln=	(1287 of 1381)		cis-7-(dimethylamino)-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C24H32FN5O	C24H32FN5O	425.549			QOSHTOXPOMRKQT-KDURUIRLSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	3.675	0	6	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612401	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612401&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@H]1CC[C@H](CC1)N1C(=O)N(CC2=C1C=C(N=C2)N(C)C)C1=C(F)C=CC=C1C	cis-7-(dimethylamino)-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		565.5							6.25						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@H]1CCC[C@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612402	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612402&database=RX&origin=ReaxysOutput&ln=	(1288 of 1381)		7-amino-1-[cis-3-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C22H28FN5O	C22H28FN5O	397.496		racemate	JRQWVCDNVPCNES-DLBZAZTESA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.649	1	6	3	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612402	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612402&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@H]1CCC[C@H](C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-1-[cis-3-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		13.38							7.87						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@H]1CCC[C@H](C1)N1C(=O)N(CC2=C1C=C(N=C2)N(C)C)C1=C(F)C=CC=C1C		37612403	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612403&database=RX&origin=ReaxysOutput&ln=	(1289 of 1381)		7-(dimethylamino)-1-[cis-3-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C24H32FN5O	C24H32FN5O	425.549		racemate	YQRDFTRBHGJVID-RBUKOAKNSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	3.675	0	6	4	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612403	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612403&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@H]1CCC[C@H](C1)N1C(=O)N(CC2=C1C=C(N=C2)N(C)C)C1=C(F)C=CC=C1C	7-(dimethylamino)-1-[cis-3-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		1368							5.86						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCCNC2)C1=O		37612404	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612404&database=RX&origin=ReaxysOutput&ln=	(1290 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-3-piperidyl]-4H-pyrido[4,3-d]pyrimidin-2-one	C19H22FN5O	C19H22FN5O	355.415			QUNLNVSKJAJDAK-CQSZACIVSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	1.657	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612404	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612404&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCCNC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-3-piperidyl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		3.999							8.4						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@H]2CCCNC2)C1=O		37612405	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612405&database=RX&origin=ReaxysOutput&ln=	(1291 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-3-piperidyl]-4H-pyrido[4,3-d]pyrimidin-2-one	C19H22FN5O	C19H22FN5O	355.415			QUNLNVSKJAJDAK-AWEZNQCLSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	1.657	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612405	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612405&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@H]2CCCNC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-3-piperidyl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		3.209							8.49						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCCCNC2)C1=O		37612406	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612406&database=RX&origin=ReaxysOutput&ln=	(1292 of 1381)		7-amino-3-(2-fluoro-6-methyl-phenyl)-1-[(3R)-azepan-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442			SRZLYGRGYTWZCN-OAHLLOKOSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	2.015	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612406	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612406&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCCCNC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-azepan-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		1.365							8.86						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCCNCC2)C1=O		37612407	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612407&database=RX&origin=ReaxysOutput&ln=	(1293 of 1381)		7-amino-3-(2-fluoro-6-methyl-phenyl)-1-[(4R)-azepan-4-yl]-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442			ZFXDCBJYTJQSNY-OAHLLOKOSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	2.015	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612407	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612407&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCCNCC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(4R)-azepan-4-yl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.8203							9.09						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=CN=C2)N([C@H]2CCCCNC2)C1=O		37612408	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612408&database=RX&origin=ReaxysOutput&ln=	(1294 of 1381)		3-(2-fluoro-6-methylphenyl)-1-[(3S)-azepan-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one	C20H23FN4O	C20H23FN4O	354.427			DTJJKFNGWJZRCE-INIZCTEOSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	2.104	1	5	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612408	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612408&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=CN=C2)N([C@H]2CCCCNC2)C1=O	3-(2-fluoro-6-methylphenyl)-1-[(3S)-azepan-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		287.5							6.54						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@H]2CCCCNC2)C1=O		37612409	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612409&database=RX&origin=ReaxysOutput&ln=	(1295 of 1381)		7-amino-1-[(3S)-azepan-3-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442			SRZLYGRGYTWZCN-HNNXBMFYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	2.015	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612409	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612409&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@H]2CCCCNC2)C1=O	7-amino-1-[(3S)-azepan-3-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		68.01							7.17						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@H]2CCCNCC2)C1=O		37612410	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612410&database=RX&origin=ReaxysOutput&ln=	(1296 of 1381)		7-amino-1-[(4S)-azepan-4-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442			ZFXDCBJYTJQSNY-HNNXBMFYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	2.015	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612410	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612410&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@H]2CCCNCC2)C1=O	7-amino-1-[(4S)-azepan-4-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		4.14							8.38						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCC[C@@H](N)C2)C1=O		37612412	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612412&database=RX&origin=ReaxysOutput&ln=	(1297 of 1381)		7-amino-1-[(trans)-3-aminocyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442		racemate	ZORIXQCPZAIWCZ-HUUCEWRRSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.02	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612412	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612412&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCC[C@@H](N)C2)C1=O	7-amino-1-[(trans)-3-aminocyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		4.71							8.33						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCC[C@H](N)C2)C1=O		37612413	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612413&database=RX&origin=ReaxysOutput&ln=	(1298 of 1381)		7-amino-1-[(cis)-3-aminocyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442		racemate	ZORIXQCPZAIWCZ-LSDHHAIUSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	3	1	2.02	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612413	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612413&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCC[C@H](N)C2)C1=O	7-amino-1-[(cis)-3-aminocyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		1.455							8.84						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CNC1CCCC(C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612414	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612414&database=RX&origin=ReaxysOutput&ln=	(1299 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[3-(methylamino)cyclohexyl]-4H-pyrido[4,3-d]pyrimidin-2-one	C21H26FN5O	C21H26FN5O	383.469			ONRGYAGVKSJOOV-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.41	2	6	3	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612414	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612414&database=RX&origin=ReaxysOutput&ln=	CNC1CCCC(C1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[3-(methylamino)cyclohexyl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		3.047							8.52						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN[C@H]1CC[C@@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612415	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612415&database=RX&origin=ReaxysOutput&ln=	(1300 of 1381)		trans-7-amino-3-(2-fluoro-6-methylphenyl)-1-[4-(methylamino)cyclohexyl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C20H25FN6O	C20H25FN6O	384.457			UPZJERRHLPEVLC-SHTZXODSSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.097	2	7	3	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612415	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612415&database=RX&origin=ReaxysOutput&ln=	CN[C@H]1CC[C@@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	trans-7-amino-3-(2-fluoro-6-methylphenyl)-1-[4-(methylamino)cyclohexyl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.2802							9.55						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN[C@H]1CC[C@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612416	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612416&database=RX&origin=ReaxysOutput&ln=	(1301 of 1381)		cis-7-amino-3-(2-fluoro-6-methylphenyl)-1-[4-(methylamino)cyclohexyl]-4H-pyrido[4,3-d]pyrimidin-2-one	C21H26FN5O	C21H26FN5O	383.469			UKBYYQNFAMCOBW-IYBDPMFKSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.41	2	6	3	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612416	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612416&database=RX&origin=ReaxysOutput&ln=	CN[C@H]1CC[C@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	cis-7-amino-3-(2-fluoro-6-methylphenyl)-1-[4-(methylamino)cyclohexyl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		4.714							8.33						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN[C@H]1CC[C@@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612417	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612417&database=RX&origin=ReaxysOutput&ln=	(1302 of 1381)		trans-7-amino-3-(2-fluoro-6-methylphenyl)-1-[4-(methylamino)cyclohexyl]-4H-pyrido[4,3-d]pyrimidin-2-one	C21H26FN5O	C21H26FN5O	383.469			UKBYYQNFAMCOBW-WKILWMFISA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.41	2	6	3	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612417	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612417&database=RX&origin=ReaxysOutput&ln=	CN[C@H]1CC[C@@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	trans-7-amino-3-(2-fluoro-6-methylphenyl)-1-[4-(methylamino)cyclohexyl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		1.348							8.87						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1N1CC2=C(C=CN=C2)N(C2CCNCC2)C1=O		37612418	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612418&database=RX&origin=ReaxysOutput&ln=	(1303 of 1381)		3-(2-chloro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C19H21ClN4O	C19H21ClN4O	356.855			UEFQOZYGUPODPB-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.207	1	5	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612418	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612418&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1N1CC2=C(C=CN=C2)N(C2CCNCC2)C1=O	3-(2-chloro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		98.82							7.01						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@@H]2CCNC2)C1=O		37612419	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612419&database=RX&origin=ReaxysOutput&ln=	(1304 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-pyrrolidin-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C17H19FN6O	C17H19FN6O	342.376			ULVGVDJAISBKOT-GFCCVEGCSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	0.986	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612419	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612419&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@@H]2CCNC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-pyrrolidin-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		41.26							7.38						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@@H]2CCCNCC2)C1=O		37612420	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612420&database=RX&origin=ReaxysOutput&ln=	(1305 of 1381)		7-amino-1-[(4R)-azepan-4-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23FN6O	C19H23FN6O	370.43			WUCZDTOBJMYFPJ-CQSZACIVSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.702	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612420	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612420&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@@H]2CCCNCC2)C1=O	7-amino-1-[(4R)-azepan-4-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.8449							9.07						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@H]2CCCNCC2)C1=O		37612421	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612421&database=RX&origin=ReaxysOutput&ln=	(1306 of 1381)		7-amino-1-[(4S)-azepan-4-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23FN6O	C19H23FN6O	370.43			WUCZDTOBJMYFPJ-AWEZNQCLSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.702	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612421	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612421&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@H]2CCCNCC2)C1=O	7-amino-1-[(4S)-azepan-4-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.9265							9.03						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@H]2CCCCNC2)C1=O		37612423	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612423&database=RX&origin=ReaxysOutput&ln=	(1307 of 1381)		7-amino-1-[(3S)-azepan-3-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23FN6O	C19H23FN6O	370.43			PKHTWCADCNAGFW-AWEZNQCLSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.702	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612423	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612423&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@H]2CCCCNC2)C1=O	7-amino-1-[(3S)-azepan-3-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		5.924							8.23						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@H]2CCCNC2)C1=O		37612424	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612424&database=RX&origin=ReaxysOutput&ln=	(1308 of 1381)		7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-3-piperidyl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C18H21FN6O	C18H21FN6O	356.403			YQOUKIMJPVCBCH-ZDUSSCGKSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.344	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612424	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612424&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@H]2CCCNC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-3-piperidyl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		6.28							8.2						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@@H]2CCCCNC2)C1=O		37612425	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612425&database=RX&origin=ReaxysOutput&ln=	(1309 of 1381)		7-amino-1-[(3R)-azepan-3-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23FN6O	C19H23FN6O	370.43			PKHTWCADCNAGFW-CQSZACIVSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.702	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612425	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612425&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@@H]2CCCCNC2)C1=O	7-amino-1-[(3R)-azepan-3-yl]-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		21.06							7.68						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@@H]2CCCNC2)C1=O		37612426	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612426&database=RX&origin=ReaxysOutput&ln=	(1310 of 1381)		7-amino-3-(2-fluoro-6-methyl-phenyl)-1-[(3R)-3-piperidyl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C18H21FN6O	C18H21FN6O	356.403			YQOUKIMJPVCBCH-CYBMUJFWSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	1.344	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612426	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612426&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@@H]2CCCNC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-3-piperidyl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		9.919							8						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@@H]2CC[C@H](N)CC2)C1=O		37612427	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612427&database=RX&origin=ReaxysOutput&ln=	(1311 of 1381)		7-amino-1-(4-aminocyclohexyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23FN6O	C19H23FN6O	370.43			SDOURAAORTWGRK-OKILXGFUSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	1.707	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612427	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612427&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@@H]2CC[C@H](N)CC2)C1=O	7-amino-1-(4-aminocyclohexyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		1.98							8.7						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N(C2CCCC(N)C2)C1=O		37612428	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612428&database=RX&origin=ReaxysOutput&ln=	(1312 of 1381)		7-amino-1-(3-aminocyclohexyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23FN6O	C19H23FN6O	370.43			VTQAJEXWJREIGF-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.707	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612428	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612428&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N(C2CCCC(N)C2)C1=O	7-amino-1-(3-aminocyclohexyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		3.038							8.52						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N(C2CCC(N)C2)C1=O		37612429	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612429&database=RX&origin=ReaxysOutput&ln=	(1313 of 1381)		7-amino-1-(3-aminocyclopentyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C18H21FN6O	C18H21FN6O	356.403			LCNYLYWBEUFKKN-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.349	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612429	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612429&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N(C2CCC(N)C2)C1=O	7-amino-1-(3-aminocyclopentyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		1.176							8.93						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@H]2CC[C@H](N)CC2)C1=O		37612430	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612430&database=RX&origin=ReaxysOutput&ln=	(1314 of 1381)		trans-7-amino-1-(4-aminocyclohexyl)-3-(2-fluoro-6-methyl-phenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23FN6O	C19H23FN6O	370.43			SDOURAAORTWGRK-HDJSIYSDSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	1.707	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612430	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612430&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@H]2CC[C@H](N)CC2)C1=O	7-amino-1-(4-aminocyclohexyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.7393							9.13						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N(C2CCNCC2)C1=O		37612453	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612453&database=RX&origin=ReaxysOutput&ln=	(1315 of 1381)		7-Amino-3-(2-fluoro-6-methyl-phenyl)-1-(4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C19H22FN5O	C19H22FN5O	355.415			QJMHMFOWIAIZHL-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	3	1	1.657	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612453	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612453&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N(C2CCNCC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		1.786							8.75						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612454	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612454&database=RX&origin=ReaxysOutput&ln=	(1316 of 1381)		7-Amino-3-(2-fluoro-6-methyl-phenyl)-1-(1-methyl-4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442			CZJIOESWRNZRKD-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	4	1	1.896	1	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612454	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612454&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.9745							9.01						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CNC1=CC2=C(CN(C(=O)N2C2CN(C)C2)C2=C(F)C=CC=C2C)C=N1		37612456	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612456&database=RX&origin=ReaxysOutput&ln=	(1317 of 1381)		3-(2-Fluoro-6-methyl-phenyl)-7-(methylamino)-1-(1-methylazetidin-3-yl)-4H-pyrido[4,3-d]pyrimidin-2-one	C19H22FN5O	C19H22FN5O	355.415			TYFZBGOCFQVZFB-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.643	1	6	3	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612456	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612456&database=RX&origin=ReaxysOutput&ln=	CNC1=CC2=C(CN(C(=O)N2C2CN(C)C2)C2=C(F)C=CC=C2C)C=N1	3-(2-fluoro-6-methylphenyl)-7-(methylamino)-1-(1-methylazetidin-3-yl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		177.3							6.75						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N(C2CCNCC2)C1=O		37612457	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612457&database=RX&origin=ReaxysOutput&ln=	(1318 of 1381)		7-Amino-3-(2-fluoro-6-methyl-phenyl)-1-(4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C18H21FN6O	C18H21FN6O	356.403			NKHJIOVPFZCWFJ-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(2); Bioactivity(2)	8	1	1.344	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612457	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612457&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N(C2CCNCC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		4.438							8.35						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N(C2CNC2)C1=O		37612458	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612458&database=RX&origin=ReaxysOutput&ln=	(1319 of 1381)		7-Amino-1-(azetidin-3-yl)-3-(2-fluoro-6-methyl-phenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C16H17FN6O	C16H17FN6O	328.349			SEOSHQHCTRARGR-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	0.628	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612458	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612458&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N(C2CNC2)C1=O	7-amino-1-(azetidin-3-yl)-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		10.897							7.96						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1N1CC2=CN=C(N)N=C2N(C2CCNCC2)C1=O		37612459	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612459&database=RX&origin=ReaxysOutput&ln=	(1320 of 1381)		7-Amino-3-(2-chloro-6-methyl-phenyl)-1-(4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C18H21ClN6O	C18H21ClN6O	372.857			PSSHSFWWMAJKIP-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.805	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612459	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612459&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1N1CC2=CN=C(N)N=C2N(C2CCNCC2)C1=O	7-amino-3-(2-chloro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		18.74							7.73						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=CN=C2)N(C2CCNCC2)C1=O		37612460	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612460&database=RX&origin=ReaxysOutput&ln=	(1321 of 1381)		3-(2-Fluoro-6-methyl-phenyl)-1-(4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C19H21FN4O	C19H21FN4O	340.4			XDSXPVJGRFHQBD-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	5	1	1.746	1	5	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612460	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612460&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=CN=C2)N(C2CCNCC2)C1=O	3-(2-fluoro-6-methylphenyl)-1-(4-piperidyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		21.17							7.67						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612461	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612461&database=RX&origin=ReaxysOutput&ln=	(1322 of 1381)		7-Amino-3-(2-fluoro-6-methyl-phenyl)-1-(1-methyl-4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23FN6O	C19H23FN6O	370.43			JTUOFEXSLAQOST-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	8	1	1.583	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612461	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612461&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-(1-methyl-4-piperidyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		4.116							8.39						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN1CCC[C@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612462	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612462&database=RX&origin=ReaxysOutput&ln=	(1323 of 1381)		7-Amino-3-(2-fluoro-6-methyl-phenyl)-1-[(3R)-1-methyl-3-piperidyl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C19H23FN6O	C19H23FN6O	370.43			MKEMHDUCUJDPOK-CQSZACIVSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	1.583	1	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612462	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612462&database=RX&origin=ReaxysOutput&ln=	CN1CCC[C@H](C1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-1-methyl-3-piperidyl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		14							7.85						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@H]1CC[C@@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612463	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612463&database=RX&origin=ReaxysOutput&ln=	(1324 of 1381)		trans-7-Amino-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methyl-phenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one	C21H27FN6O	C21H27FN6O	398.483			UOWAHZCOONGHPW-WKILWMFISA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.336	1	7	3	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612463	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612463&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@H]1CC[C@@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	trans-7-amino-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.9918							9						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@H]1CC[C@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612464	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612464&database=RX&origin=ReaxysOutput&ln=	(1325 of 1381)		cis-7-Amino-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methyl-phenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C22H28FN5O	C22H28FN5O	397.496			IOLILZIYGFNNMG-CALCHBBNSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.649	1	6	3	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612464	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612464&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@H]1CC[C@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	cis-7-amino-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		1.185							8.92						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCNC2)C1=O		37612465	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612465&database=RX&origin=ReaxysOutput&ln=	(1326 of 1381)		7-Amino-3-(2-fluoro-6-methyl-phenyl)-1-[(3R)-pyrrolidin-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one	C18H20FN5O	C18H20FN5O	341.388			MGGONBWPUDRPKM-CYBMUJFWSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	1.299	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612465	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612465&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CCNC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3R)-pyrrolidin-3-yl]-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		16.61							7.78						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@H]2CC[C@H](N)CC2)C1=O		37612467	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612467&database=RX&origin=ReaxysOutput&ln=	(1327 of 1381)		Trans-7-amino-1-(4-aminocyclohexyl)-3-(2-fluoro-6-methyl-phenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442			HTFBRURDOKLHNK-SHTZXODSSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	2.02	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612467	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612467&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@H]2CC[C@H](N)CC2)C1=O	trans-7-amino-1-(4-aminocyclohexyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.2788							9.55						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN(C)[C@H]1CC[C@@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C		37612468	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612468&database=RX&origin=ReaxysOutput&ln=	(1328 of 1381)		Trans-7-amino-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methyl-phenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C22H28FN5O	C22H28FN5O	397.496			IOLILZIYGFNNMG-QAQDUYKDSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	2.649	1	6	3	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612468	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612468&database=RX&origin=ReaxysOutput&ln=	CN(C)[C@H]1CC[C@@H](CC1)N1C(=O)N(CC2=C1C=C(N)N=C2)C1=C(F)C=CC=C1C	trans-7-amino-1-[4-(dimethylamino)cyclohexyl]-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.1435							9.84						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CN[C@H]1CC[C@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C		37612469	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612469&database=RX&origin=ReaxysOutput&ln=	(1329 of 1381)		cis-7-Amino-3-(2-fluoro-6-methyl-phenyl)-1-[4-(methylamino)cyclohexyl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C20H25FN6O	C20H25FN6O	384.457			UPZJERRHLPEVLC-GASCZTMLSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	2	1	2.097	2	7	3	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612469	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612469&database=RX&origin=ReaxysOutput&ln=	CN[C@H]1CC[C@H](CC1)N1C(=O)N(CC2=CN=C(N)N=C12)C1=C(F)C=CC=C1C	cis-7-amino-3-(2-fluoro-6-methylphenyl)-1-[4-(methylamino)cyclohexyl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		2.596							8.59						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CC[C@H](N)CC2)C1=O		37612470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612470&database=RX&origin=ReaxysOutput&ln=	(1330 of 1381)		cis-7-Amino-1-(4-aminocyclohexyl)-3-(2-fluoro-6-methyl-phenyl)-4H-pyrido[4,3-d]pyrimidin-2-one	C20H24FN5O	C20H24FN5O	369.442			HTFBRURDOKLHNK-GASCZTMLSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	5	1	2.02	2	6	2	29.96	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612470	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612470&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=C(C=C(N)N=C2)N([C@@H]2CC[C@H](N)CC2)C1=O	cis-7-amino-1-(4-aminocyclohexyl)-3-(2-fluoro-6-methylphenyl)-4H-pyrido[4,3-d]pyrimidin-2-one					Ki (inhibition constant)	nM		0.944							9.03						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@H]2CCNC2)C1=O		37612471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612471&database=RX&origin=ReaxysOutput&ln=	(1331 of 1381)		7-Amino-3-(2-fluoro-6-methyl-phenyl)-1-[(3S)-pyrrolidin-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one	C17H19FN6O	C17H19FN6O	342.376			ULVGVDJAISBKOT-LBPRGKRZSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	0.986	2	7	2	42.85	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild				antiproliferative agent	In Vitro (Efficacy)									37612471	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37612471&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1N1CC2=CN=C(N)N=C2N([C@H]2CCNC2)C1=O	7-amino-3-(2-fluoro-6-methylphenyl)-1-[(3S)-pyrrolidin-3-yl]-4H-pyrimido[4,5-d]pyrimidin-2-one					Ki (inhibition constant)	nM		20.76							7.68						Patent; CANCER RESEARCH UK; WO2021/84266; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114844&database=RX&origin=ReaxysOutput&ln=	
CC1=C(OC2CNC2)C=CC(F)=C1C1=CC=C2C=C(N)N=CC2=C1		37673332	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673332&database=RX&origin=ReaxysOutput&ln=	(1332 of 1381)		(2-fluoro-6-methyl-5-(azetidin-3-yloxy)-7-phenyl)isoquinolin-3-amine	C19H18FN3O	C19H18FN3O	323.37			DBBGFSPNHZTKFJ-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	3.63	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673332	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673332&database=RX&origin=ReaxysOutput&ln=	CC1=C(OC2CNC2)C=CC(F)=C1C1=CC=C2C=C(N)N=CC2=C1	(2-fluoro-6-methyl-5-(azetidin-3-yloxy)-7-phenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.066							8.68						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CNC2)=C2C=CN=CC2=C1		37673336	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673336&database=RX&origin=ReaxysOutput&ln=	(1333 of 1381)		N-(azetidin-3-yl)-7-(2-fluoro-6-methylphenyl)isoquinolin5-amine	C19H18FN3	C19H18FN3	307.37			DCTRJEHZUKJRCO-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	3.661	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673336	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673336&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CNC2)=C2C=CN=CC2=C1	N-(azetidin-3-yl)-7-(2-fluoro-6-methylphenyl)isoquinolin5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		3.164							8.5						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CN1CCCC[C@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37673364	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673364&database=RX&origin=ReaxysOutput&ln=	(1334 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3R)-1-methylazepan-3-yl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			UYQBMGNKLUTOKN-GOSISDBHSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	4.885	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	enzyme inhibitor	In Vitro (Efficacy)									37673364	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37673364&database=RX&origin=ReaxysOutput&ln=	CN1CCCC[C@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[(3R)-1-methylazepan-3-yl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		4.898							8.31						Patent; CANCER RESEARCH UK; WO2021/84265; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114843&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(OC2CNC2)=C2C=C(N)N=CC2=C1		37964532	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964532&database=RX&origin=ReaxysOutput&ln=	(1335 of 1381)		5-(azetidin-3-yloxy)-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	C19H18FN3O	C19H18FN3O	323.37			RQTJAYFTIVUCCC-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	3.841	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964532	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964532&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(OC2CNC2)=C2C=C(N)N=CC2=C1	5-(azetidin-3-yloxy)-7-(2-fluoro-6-methylphenyl)isoquinolin-3-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		2.066							8.68			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC(NC2CNC2)=C2C=CN=CC2=C1		37964533	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964533&database=RX&origin=ReaxysOutput&ln=	(1336 of 1381)		N-(azetidin-3-yl)-7-(2-chloro-6-methylphenyl)isoquinolin-5-amine	C19H18ClN3	C19H18ClN3	323.825			SRYMKHDBEOIRBR-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	4.122	2	3	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964533	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964533&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC(NC2CNC2)=C2C=CN=CC2=C1	N-(azetidin-3-yl)-7-(2-chloro-6-methylphenyl)isoquinolin-5-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		3.164							8.5			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCCC[C@@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37964534	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964534&database=RX&origin=ReaxysOutput&ln=	(1337 of 1381)		7-(2-fluoro-6-methylphenyl)-N5-[(3S)-1-methylazepan-3-yl]isoquinoline-3,5-diamine	C23H27FN4	C23H27FN4	378.493			UYQBMGNKLUTOKN-SFHVURJKSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	4.885	2	4	3	12.89	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964534	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964534&database=RX&origin=ReaxysOutput&ln=	CN1CCCC[C@@H](C1)NC1=C2C=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	7-(2-fluoro-6-methylphenyl)-N5-[(3S)-1-methylazepan-3-yl]isoquinoline-3,5-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		4.898							8.31			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=C(N)N=CC2=NC(=C1)C1=C(F)C=CC=C1C		37964536	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964536&database=RX&origin=ReaxysOutput&ln=	(1338 of 1381)		2-(2-fluoro-6-methylphenyl)-N4-(1-methyl-4-piperidyl)-1,7-naphthyridine-4,6-diamine	C21H24FN5	C21H24FN5	365.453			FWQRLEHPXAUARD-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	11	1	3.453	2	5	3	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964536	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964536&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=C(N)N=CC2=NC(=C1)C1=C(F)C=CC=C1C	2-(2-fluoro-6-methylphenyl)-N4-(1-methyl-4-piperidyl)-1,7-naphthyridine-4,6-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		488.2							6.31			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2C=CN=CC2=NC(=C1)C1=C(F)C=CC=C1C		37964537	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964537&database=RX&origin=ReaxysOutput&ln=	(1339 of 1381)		2-(2-fluoro-6-methylphenyl)-N-(1-methyl-4-piperidyl)-1,7-naphthyridin-4-amine	C21H23FN4	C21H23FN4	350.439			VCMVZJCTYWYLHD-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	5	1	3.542	1	4	3	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964537	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964537&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2C=CN=CC2=NC(=C1)C1=C(F)C=CC=C1C	2-(2-fluoro-6-methylphenyl)-N-(1-methyl-4-piperidyl)-1,7-naphthyridin-4-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		531.3							6.27			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2N=CN=CC2=C1		37964538	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964538&database=RX&origin=ReaxysOutput&ln=	(1340 of 1381)		6-(2-fluoro-6-methylphenyl)-N-(4-piperidyl)quinazolin-8-amine	C20H21FN4	C20H21FN4	336.412			AWYYXQMIRJUTKP-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	9	1	3.425	2	4	3	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964538	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964538&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2N=CN=CC2=C1	6-(2-fluoro-6-methylphenyl)-N-(4-piperidyl)quinazolin-8-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		6.919							8.16			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2N=C(N)N=CC2=C1		37964539	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964539&database=RX&origin=ReaxysOutput&ln=	(1341 of 1381)		6-(2-fluoro-6-methylphenyl)-N8-(4-piperidyl)quinazolin-2,8-diamine	C20H22FN5	C20H22FN5	351.427			LCYAZGUILTZDMD-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	3.336	3	5	3	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964539	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964539&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(F)=C1C1=CC(NC2CCNCC2)=C2N=C(N)N=CC2=C1	6-(2-fluoro-6-methylphenyl)-N8-(4-piperidyl)quinazolin-2,8-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3545							9.45			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2N=C(N)N=CC2=C1		37964540	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964540&database=RX&origin=ReaxysOutput&ln=	(1342 of 1381)		6-(2-chloro-6-methylphenyl)-N8-(4-piperidyl)quinazolin-2,8-diamine	C20H22ClN5	C20H22ClN5	367.881			JXFUJGXUKLQREL-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	3.797	3	5	3	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964540	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964540&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2N=C(N)N=CC2=C1	6-(2-chloro-6-methylphenyl)-N8-(4-piperidyl)quinazolin-2,8-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.5099							9.29			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2N=CN=CC2=C1		37964541	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964541&database=RX&origin=ReaxysOutput&ln=	(1343 of 1381)		6-(2-chloro-6-methylphenyl)-N-(4-piperidyl)quinazolin-8-amine	C20H21ClN4	C20H21ClN4	352.867			AKMUHVFOJHIFDY-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	3.886	2	4	3	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964541	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964541&database=RX&origin=ReaxysOutput&ln=	CC1=CC=CC(Cl)=C1C1=CC(NC2CCNCC2)=C2N=CN=CC2=C1	6-(2-chloro-6-methylphenyl)-N-(4-piperidyl)quinazolin-8-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		15.65							7.8			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2N=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C		37964542	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964542&database=RX&origin=ReaxysOutput&ln=	(1344 of 1381)		6-(2-fluoro-6-methylphenyl)-N-(1-methyl-4-piperidyl)quinazolin-8-amine	C21H23FN4	C21H23FN4	350.439			BSHTVTYFABGUNU-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	8	1	3.664	1	4	3	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964542	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964542&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2N=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C	6-(2-fluoro-6-methylphenyl)-N-(1-methyl-4-piperidyl)quinazolin-8-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		4.995							8.3			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC(CC1)NC1=C2N=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C		37964543	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964543&database=RX&origin=ReaxysOutput&ln=	(1345 of 1381)		N-(1-ethyl-4-piperidyl)-6-(2-fluoro-6-methylphenyl)quinazolin-8-amine	C22H25FN4	C22H25FN4	364.466			PCGAYTLOWNYISH-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	4.087	1	4	4	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964543	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964543&database=RX&origin=ReaxysOutput&ln=	CCN1CCC(CC1)NC1=C2N=CN=CC2=CC(=C1)C1=C(F)C=CC=C1C	N-(1-ethyl-4-piperidyl)-6-(2-fluoro-6-methylphenyl)quinazolin-8-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		6.35							8.2			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC(CC1)NC1=C2N=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37964544	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964544&database=RX&origin=ReaxysOutput&ln=	(1346 of 1381)		N8-(1-ethyl-4-piperidyl)-6-(2-fluoro-6-methylphenyl)quinazoline-2,8-diamine	C22H26FN5	C22H26FN5	379.48			SJIASFKBWNOTAV-UHFFFAOYSA-N				Identification(8); Physical Data(1); Spectra(1); Bioactivity(2)	8	1	3.998	2	5	4	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964544	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964544&database=RX&origin=ReaxysOutput&ln=	CCN1CCC(CC1)NC1=C2N=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	N8-(1-ethyl-4-piperidyl)-6-(2-fluoro-6-methylphenyl)quinazoline-2,8-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.215							8.91			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC(CC1)NC1=C2N=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37964545	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964545&database=RX&origin=ReaxysOutput&ln=	(1347 of 1381)		6-(2-chloro-6-methylphenyl)-N8-(1-ethyl-4-piperidyl)quinazoline-2,8-diamine	C22H26ClN5	C22H26ClN5	395.935			SDTFXPPOQAHDER-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	4.459	2	5	4	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964545	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964545&database=RX&origin=ReaxysOutput&ln=	CCN1CCC(CC1)NC1=C2N=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	6-(2-chloro-6-methylphenyl)-N8-(1-ethyl-4-piperidyl)quinazoline-2,8-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		1.458							8.84			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2N=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37964546	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964546&database=RX&origin=ReaxysOutput&ln=	(1348 of 1381)		6-(2-chloro-6-methylphenyl)-N8-(1-methyl-4-piperidyl)quinazoline-2,8-diamine	C21H24ClN5	C21H24ClN5	381.908			HYDISRVOVVCXKK-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	4.036	2	5	3	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964546	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964546&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2N=C(N)N=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	6-(2-chloro-6-methylphenyl)-N8-(1-methyl-4-piperidyl)quinazoline-2,8-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.3393							9.47			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2N=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37964547	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964547&database=RX&origin=ReaxysOutput&ln=	(1349 of 1381)		6-(2-chloro-6-methylphenyl)-N8-(1-methyl-4-piperidyl)quinazolin-8-amine	C21H23ClN4	C21H23ClN4	366.893			SXACKSBQYQWKGS-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	4.125	1	4	3	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964547	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964547&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2N=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	6-(2-chloro-6-methylphenyl)-N8-(1-methyl-4-piperidyl)quinazolin-8-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		17.25							7.76			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CCN1CCC(CC1)NC1=C2N=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C		37964548	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964548&database=RX&origin=ReaxysOutput&ln=	(1350 of 1381)		6-(2-chloro-6-methylphenyl)-N-(1-ethyl-4-piperidyl)quinazolin-8-amine	C22H25ClN4	C22H25ClN4	380.92			SKQKAXOONRWUTB-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	4.548	1	4	4	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964548	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964548&database=RX&origin=ReaxysOutput&ln=	CCN1CCC(CC1)NC1=C2N=CN=CC2=CC(=C1)C1=C(Cl)C=CC=C1C	6-(2-chloro-6-methylphenyl)-N-(1-ethyl-4-piperidyl)quinazolin-8-amine	5E-05 - 1 μM				Ki (inhibition constant)	nM		20.91							7.68			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
CN1CCC(CC1)NC1=C2N=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C		37964549	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964549&database=RX&origin=ReaxysOutput&ln=	(1351 of 1381)		6-(2-fluoro-6-methylphenyl)-N8-(1-methyl-4-piperidyl)quinazoline-2,8-diamine	C21H24FN5	C21H24FN5	365.453			BKBDVPNRVPRLAQ-UHFFFAOYSA-N				Identification(7); Physical Data(1); Spectra(1); Bioactivity(2)	1	1	3.575	2	5	3	25.78	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									37964549	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D37964549&database=RX&origin=ReaxysOutput&ln=	CN1CCC(CC1)NC1=C2N=C(N)N=CC2=CC(=C1)C1=C(F)C=CC=C1C	6-(2-fluoro-6-methylphenyl)-N8-(1-methyl-4-piperidyl)quinazoline-2,8-diamine	5E-05 - 1 μM				Ki (inhibition constant)	nM		0.4497							9.35			73010	ATP	Other compound	Patent; CANCER RESEARCH UK; WO2021/84264; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D84114842&database=RX&origin=ReaxysOutput&ln=	
C[C@@H]1CCCN1C1=C(C#N)C2=C(N)N=C(NC3=C(C)N(N=C3)[C@@H]3CCOC3)N=C2N1C		38143687	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38143687&database=RX&origin=ReaxysOutput&ln=	(1352 of 1381)		4-amino-7-methyl-2-((5-methyl-1-((R)-tetrahydrofuran-3-yl)-1H-pyrazol-4-yl)amino)-6-((R)-2-methylpyrrolidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile	C21H27N9O	C21H27N9O	421.505			QSDVZPULRUJSBC-TZMCWYRMSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	15	1	3.324	2	10	4	62.46	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor		In Vitro (Efficacy)							peripheral blood mononuclear cell		38143687	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38143687&database=RX&origin=ReaxysOutput&ln=	C[C@@H]1CCCN1C1=C(C#N)C2=C(N)N=C(NC3=C(C)N(N=C3)[C@@H]3CCOC3)N=C2N1C	4-amino-7-methyl-2-((5-methyl-1-((R)-tetrahydrofuran-3-yl)-1H-pyrazol-4-yl)amino)-6-((R)-2-methylpyrrolidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile	0.001 - 10 μM				IC50	μM	>	10							1						Article; Williamson, Douglas S.; Smith, Garrick P.; Mikkelsen, Gitte K.; Jensen, Thomas; Acheson-Dossang, Pamela; Badolo, Lassina; Bedford, Simon T.; Chell, Victoria; Chen, I-Jen; Dokurno, Pawel; Hentzer, Morten; Newland, Samantha; Ray, Stuart C.; Shaw, Terry; Surgenor, Allan E.; Terry, Lindsey; Wang, Yikang; Christensen, Kenneth V.; Journal of Medicinal Chemistry; vol. 64; 14; (2021); p. 10312 - 10332;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D95349286&database=RX&origin=ReaxysOutput&ln=	
COC1=C(NC2=NC3=C(C=N2)C=C(C(=O)N3C[C@H]2OC[C@H](N)CO2)C2=C(Cl)C=C(C=C2)C2=NC(C)=CC=C2)C=CC=C1		38450100	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450100&database=RX&origin=ReaxysOutput&ln=	(1353 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(6-methylpyridin-2-yl)phenyl)-2-((2-methoxyphenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one	C31H29ClN6O4	C31H29ClN6O4	585.062			OPWAUHSYJGDGRB-BFZJZIARSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	1	1	4.092	2	9	7	55.74	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		38450100	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450100&database=RX&origin=ReaxysOutput&ln=	COC1=C(NC2=NC3=C(C=N2)C=C(C(=O)N3C[C@H]2OC[C@H](N)CO2)C2=C(Cl)C=C(C=C2)C2=NC(C)=CC=C2)C=CC=C1	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(6-methylpyridin-2-yl)phenyl)-2-((2-methoxyphenyl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		83							7.08						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1		38450103	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450103&database=RX&origin=ReaxysOutput&ln=	(1354 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(pyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one	C24H23ClN6O3	C24H23ClN6O3	478.938			HPANRCQNPHMMEF-OQIWPSSASA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	5	1	2.296	2	9	5	55.74	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		38450103	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450103&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(pyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		117							6.93						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(C)=CC=C1F		38450105	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450105&database=RX&origin=ReaxysOutput&ln=	(1355 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-fluoro-6-methylpyridin-2-yl)-phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one	C25H24ClFN6O3	C25H24ClFN6O3	510.955			PTVQIBSBMWRMNS-OQIWPSSASA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	5	1	2.772	2	9	5	55.74	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		38450105	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450105&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(C)=CC=C1F	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-fluoro-6-methylpyridin-2-yl)-phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		7							8.15						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1F		38450107	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450107&database=RX&origin=ReaxysOutput&ln=	(1356 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-fluoropyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one; MRIA9	C24H22ClFN6O3	C24H22ClFN6O3	496.928			QKNBRNSGPNCARD-SGNKCFNYSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	4	1	2.457	2	9	5	55.74	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									38450107	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450107&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1F	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-fluoropyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		127							6.9						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1F		38450107	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450107&database=RX&origin=ReaxysOutput&ln=	(1356 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-fluoropyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one; MRIA9	C24H22ClFN6O3	C24H22ClFN6O3	496.928			QKNBRNSGPNCARD-SGNKCFNYSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	4	1	2.457	2	9	5	55.74	4	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor		In Vitro (Efficacy)									38450107	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450107&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1F	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-fluoropyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		22							7.66						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1F		38450107	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450107&database=RX&origin=ReaxysOutput&ln=	(1356 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-fluoropyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one; MRIA9	C24H22ClFN6O3	C24H22ClFN6O3	496.928			QKNBRNSGPNCARD-SGNKCFNYSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	4	1	2.457	2	9	5	55.74	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		38450107	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450107&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1F	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-fluoropyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		127							6.9						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1Cl		38450109	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450109&database=RX&origin=ReaxysOutput&ln=	(1357 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-chloropyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one	C24H22Cl2N6O3	C24H22Cl2N6O3	513.383			VQTNVISLBLAEJQ-SGNKCFNYSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	5	1	2.918	2	9	5	55.74	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		38450109	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450109&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1Cl	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-chloropyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		9							8.05						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1OC		38450112	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450112&database=RX&origin=ReaxysOutput&ln=	(1358 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-methoxypyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one	C25H25ClN6O4	C25H25ClN6O4	508.964			XFDLZPVEEQEQIU-OQIWPSSASA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	5	1	2.211	2	9	6	55.74	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		38450112	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450112&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC=CC=C1OC	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-methoxypyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		153							6.82						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(C)=CC=C1OC		38450114	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450114&database=RX&origin=ReaxysOutput&ln=	(1359 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-methoxy-6-methylpyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one	C26H27ClN6O4	C26H27ClN6O4	522.991			SPYPSRDGJWPJCB-VVOJOOEHSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	5	1	2.526	2	9	6	55.74	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		38450114	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450114&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(C)=CC=C1OC	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(3-methoxy-6-methylpyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		84							7.08						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(=CC=C1)C(F)(F)F		38450116	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450116&database=RX&origin=ReaxysOutput&ln=	(1360 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(6-(trifluoromethyl)pyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one	C25H22ClF3N6O3	C25H22ClF3N6O3	546.936			HWJXHFSDLKCNIG-WEHONNDLSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	5	1	3.31	2	9	6	55.74	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		38450116	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450116&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(=CC=C1)C(F)(F)F	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(6-(trifluoromethyl)pyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		508							6.29						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(=CC=C1)C(F)F		38450118	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450118&database=RX&origin=ReaxysOutput&ln=	(1361 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(6-(difluoromethyl)pyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one	C25H23ClF2N6O3	C25H23ClF2N6O3	528.946			SPTBMDXMZIQSLW-WEHONNDLSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	5	1	2.988	2	9	6	55.74	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		38450118	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450118&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(=CC=C1)C(F)F	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(6-(difluoromethyl)pyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		50							7.3						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(OC)=CC=C1		38450119	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450119&database=RX&origin=ReaxysOutput&ln=	(1362 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(6-methoxypyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one	C25H25ClN6O4	C25H25ClN6O4	508.964			RVDALFWFYZMJSN-CIEDQVTBSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	5	1	2.939	2	9	6	55.74	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		38450119	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450119&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(OC)=CC=C1	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(6-methoxypyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		80							7.1						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(C)=CC(C)=C1		38450120	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450120&database=RX&origin=ReaxysOutput&ln=	(1363 of 1381)		8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(4,6-dimethylpyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one	C26H27ClN6O3	C26H27ClN6O3	506.992			XDMARPCWPSMUIF-RXAXNXDRSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	5	1	3.048	2	9	5	55.74	3	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)							HEK293T cell line		38450120	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38450120&database=RX&origin=ReaxysOutput&ln=	CNC1=NC2=C(C=N1)C=C(C(=O)N2C[C@H]1OC[C@H](N)CO1)C1=C(Cl)C=C(C=C1)C1=NC(C)=CC(C)=C1	8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(4,6-dimethylpyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one					IC50	nM		120							6.92						Article; Tesch, Roberta; Rak, Marcel; Raab, Monika; Berger, Lena M.; Kronenberger, Thales; Joerger, Andreas C.; Berger, Benedict-Tilman; Abdi, Ismahan; Hanke, Thomas; Poso, Antti; Strebhardt, Klaus; Sanhaji, Mourad; Knapp, Stefan; Journal of Medicinal Chemistry; vol. 64; 12; (2021); p. 8142 - 8160;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D92557457&database=RX&origin=ReaxysOutput&ln=	
C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C		38578167	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38578167&database=RX&origin=ReaxysOutput&ln=	(1364 of 1381)		4-amino-7-methyl-2-((5-methyl-1-((S)-tetrahydrofuran-3-yl)-1H-pyrazol-4-yl)amino)-6-((R)-2-methylpyrrolidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile	C21H27N9O	C21H27N9O	421.505			QSDVZPULRUJSBC-OCCSQVGLSA-N				Identification(6); Physical Data(2); Spectra(4); Bioactivity(2)	15	1	3.324	2	10	4	62.46	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor		In Vitro (Efficacy)							peripheral blood mononuclear cell		38578167	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38578167&database=RX&origin=ReaxysOutput&ln=	C[C@@H]1CCCN1C1=C(C#N)C2=C(N=C(NC3=C(C)N(N=C3)[C@H]3CCOC3)N=C2N)N1C	4-amino-7-methyl-2-((5-methyl-1-((S)-tetrahydrofuran-3-yl)-1H-pyrazol-4-yl)amino)-6-((R)-2-methylpyrrolidin-1-yl)-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile	0.001 - 10 μM				IC50	μM	>	10							1						Article; Williamson, Douglas S.; Smith, Garrick P.; Mikkelsen, Gitte K.; Jensen, Thomas; Acheson-Dossang, Pamela; Badolo, Lassina; Bedford, Simon T.; Chell, Victoria; Chen, I-Jen; Dokurno, Pawel; Hentzer, Morten; Newland, Samantha; Ray, Stuart C.; Shaw, Terry; Surgenor, Allan E.; Terry, Lindsey; Wang, Yikang; Christensen, Kenneth V.; Journal of Medicinal Chemistry; vol. 64; 14; (2021); p. 10312 - 10332;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D95349286&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(C)ON=C1C		38958275	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958275&database=RX&origin=ReaxysOutput&ln=	(1365 of 1381)		3-(3,5-dimethylisoxazol-4-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H34N8O4	C30H34N8O4	570.651			PJXWXGQONXRERJ-UHFFFAOYSA-N				Identification(7); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	3.45	1	8	7	81.77	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958275	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958275&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(C)ON=C1C	3-(3,5-dimethylisoxazol-4-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM		800 - 1000							6.1			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F		38958280	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958280&database=RX&origin=ReaxysOutput&ln=	(1366 of 1381)		3-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1-methylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C29H28ClF2N7O2S	C29H28ClF2N7O2S	612.103			LLVIYRMKRROCGO-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	14	1	4.638	1	8	7	83.98	3	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38958280	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958280&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F	3-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1-methylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	500 - 1000							6.3						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F		38958280	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958280&database=RX&origin=ReaxysOutput&ln=	(1366 of 1381)		3-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1-methylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C29H28ClF2N7O2S	C29H28ClF2N7O2S	612.103			LLVIYRMKRROCGO-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	14	1	4.638	1	8	7	83.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958280	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958280&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F	3-(2-chloro-4-(difluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1-methylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	<	50							7.3			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958281&database=RX&origin=ReaxysOutput&ln=	(1367 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H31ClFN7O3S	C30H31ClFN7O3S	624.139			XSJDARRTQANRJX-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.276	1	8	8	83.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		38958281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958281&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958281&database=RX&origin=ReaxysOutput&ln=	(1367 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H31ClFN7O3S	C30H31ClFN7O3S	624.139			XSJDARRTQANRJX-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.276	1	8	8	83.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		38958281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958281&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	100 - 500							7						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958281&database=RX&origin=ReaxysOutput&ln=	(1367 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H31ClFN7O3S	C30H31ClFN7O3S	624.139			XSJDARRTQANRJX-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.276	1	8	8	83.98	3	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38958281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958281&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	100 - 500							7						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958281&database=RX&origin=ReaxysOutput&ln=	(1367 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H31ClFN7O3S	C30H31ClFN7O3S	624.139			XSJDARRTQANRJX-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.276	1	8	8	83.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958281	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958281&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM		100 - 200							7			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958290&database=RX&origin=ReaxysOutput&ln=	(1368 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(4-methoxyphenyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C31H32ClFN6O3S	C31H32ClFN6O3S	623.151			JSWLDSQSPFLWAF-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	6	1	4.8	1	7	8	71.09	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		38958290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958290&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(4-methoxyphenyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	1000 - 1500							6						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958290&database=RX&origin=ReaxysOutput&ln=	(1368 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(4-methoxyphenyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C31H32ClFN6O3S	C31H32ClFN6O3S	623.151			JSWLDSQSPFLWAF-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	6	1	4.8	1	7	8	71.09	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		38958290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958290&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(4-methoxyphenyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	1000 - 1500							6						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958290&database=RX&origin=ReaxysOutput&ln=	(1368 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(4-methoxyphenyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C31H32ClFN6O3S	C31H32ClFN6O3S	623.151			JSWLDSQSPFLWAF-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	6	1	4.8	1	7	8	71.09	3	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38958290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958290&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(4-methoxyphenyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	1000 - 1500							6						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CC=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958290&database=RX&origin=ReaxysOutput&ln=	(1368 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(4-methoxyphenyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C31H32ClFN6O3S	C31H32ClFN6O3S	623.151			JSWLDSQSPFLWAF-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	6	1	4.8	1	7	8	71.09	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958290	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958290&database=RX&origin=ReaxysOutput&ln=	COC1=CC=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(4-methoxyphenyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM		100 - 200							7			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958292&database=RX&origin=ReaxysOutput&ln=	(1369 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-((4-(4-methylpiperazin-1-yl)phenyl)amino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C28H28ClFN8O2S	C28H28ClFN8O2S	595.1			URIAJDGWFTZRCF-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.048	1	9	7	83.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		38958292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958292&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-((4-(4-methylpiperazin-1-yl)phenyl)amino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958292&database=RX&origin=ReaxysOutput&ln=	(1369 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-((4-(4-methylpiperazin-1-yl)phenyl)amino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C28H28ClFN8O2S	C28H28ClFN8O2S	595.1			URIAJDGWFTZRCF-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.048	1	9	7	83.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		38958292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958292&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-((4-(4-methylpiperazin-1-yl)phenyl)amino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	100 - 500							7						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958292&database=RX&origin=ReaxysOutput&ln=	(1369 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-((4-(4-methylpiperazin-1-yl)phenyl)amino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C28H28ClFN8O2S	C28H28ClFN8O2S	595.1			URIAJDGWFTZRCF-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.048	1	9	7	83.98	3	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38958292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958292&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-((4-(4-methylpiperazin-1-yl)phenyl)amino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	500 - 1000							6.3						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958292&database=RX&origin=ReaxysOutput&ln=	(1369 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-((4-(4-methylpiperazin-1-yl)phenyl)amino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C28H28ClFN8O2S	C28H28ClFN8O2S	595.1			URIAJDGWFTZRCF-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.048	1	9	7	83.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958292	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958292&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)N3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-((4-(4-methylpiperazin-1-yl)phenyl)amino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	<	50							7.3			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF		38958302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958302&database=RX&origin=ReaxysOutput&ln=	(1370 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(4-(1,2-dimethylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H31ClFN7O2S	C30H31ClFN7O2S	608.139			DCGNBVBWBPJVJS-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	14	1	4.821	1	8	7	83.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		38958302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958302&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(4-(1,2-dimethylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF		38958302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958302&database=RX&origin=ReaxysOutput&ln=	(1370 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(4-(1,2-dimethylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H31ClFN7O2S	C30H31ClFN7O2S	608.139			DCGNBVBWBPJVJS-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	14	1	4.821	1	8	7	83.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		38958302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958302&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(4-(1,2-dimethylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	500 - 1000							6.3						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF		38958302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958302&database=RX&origin=ReaxysOutput&ln=	(1370 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(4-(1,2-dimethylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H31ClFN7O2S	C30H31ClFN7O2S	608.139			DCGNBVBWBPJVJS-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	14	1	4.821	1	8	7	83.98	3	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38958302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958302&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(4-(1,2-dimethylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	500 - 1000							6.3						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF		38958302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958302&database=RX&origin=ReaxysOutput&ln=	(1370 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(4-(1,2-dimethylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H31ClFN7O2S	C30H31ClFN7O2S	608.139			DCGNBVBWBPJVJS-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	14	1	4.821	1	8	7	83.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958302	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958302&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(4-(1,2-dimethylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	<	50							7.3			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC=C1NC1=NC=C2CN(C3=C(Cl)SC=C3CF)C(=O)N(C)C2=N1)C1CCN(C)CC1		38958307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958307&database=RX&origin=ReaxysOutput&ln=	(1371 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-methyl3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C25H28ClFN6O2S	C25H28ClFN6O2S	531.054			GUOVUXMOWZVWDR-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	6	1	3.319	1	7	6	71.09	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		38958307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958307&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC=C1NC1=NC=C2CN(C3=C(Cl)SC=C3CF)C(=O)N(C)C2=N1)C1CCN(C)CC1	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-methyl3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>	1500							5.82						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC=C1NC1=NC=C2CN(C3=C(Cl)SC=C3CF)C(=O)N(C)C2=N1)C1CCN(C)CC1		38958307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958307&database=RX&origin=ReaxysOutput&ln=	(1371 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-methyl3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C25H28ClFN6O2S	C25H28ClFN6O2S	531.054			GUOVUXMOWZVWDR-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	6	1	3.319	1	7	6	71.09	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		38958307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958307&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC=C1NC1=NC=C2CN(C3=C(Cl)SC=C3CF)C(=O)N(C)C2=N1)C1CCN(C)CC1	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-methyl3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>	1500							5.82						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC=C1NC1=NC=C2CN(C3=C(Cl)SC=C3CF)C(=O)N(C)C2=N1)C1CCN(C)CC1		38958307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958307&database=RX&origin=ReaxysOutput&ln=	(1371 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-methyl3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C25H28ClFN6O2S	C25H28ClFN6O2S	531.054			GUOVUXMOWZVWDR-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	6	1	3.319	1	7	6	71.09	3	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38958307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958307&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC=C1NC1=NC=C2CN(C3=C(Cl)SC=C3CF)C(=O)N(C)C2=N1)C1CCN(C)CC1	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-methyl3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	1000 - 1500							6						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CC(=CC=C1NC1=NC=C2CN(C3=C(Cl)SC=C3CF)C(=O)N(C)C2=N1)C1CCN(C)CC1		38958307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958307&database=RX&origin=ReaxysOutput&ln=	(1371 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-methyl3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C25H28ClFN6O2S	C25H28ClFN6O2S	531.054			GUOVUXMOWZVWDR-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	6	1	3.319	1	7	6	71.09	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958307	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958307&database=RX&origin=ReaxysOutput&ln=	COC1=CC(=CC=C1NC1=NC=C2CN(C3=C(Cl)SC=C3CF)C(=O)N(C)C2=N1)C1CCN(C)CC1	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-methyl3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	<	50							7.3			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(C)N(C)N=C1C		38958313	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958313&database=RX&origin=ReaxysOutput&ln=	(1372 of 1381)		7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C31H37N9O3	C31H37N9O3	583.693			ZYZJPWNAMMJHEF-UHFFFAOYSA-N				Identification(7); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	3.303	1	10	7	68.63	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958313	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958313&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(C)N(C)N=C1C	7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3-(1,3,5-trimethyl-1H-pyrazol-4-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>	10000							1			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CC(C)N(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF		38958317	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958317&database=RX&origin=ReaxysOutput&ln=	(1373 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1,2,6-trimethylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C31H33ClFN7O2S	C31H33ClFN7O2S	622.166			QPWUFCARHIDPHM-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	15	1	5.281	1	8	7	83.98	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		38958317	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958317&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CC(C)N(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1,2,6-trimethylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CC(C)N(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF		38958317	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958317&database=RX&origin=ReaxysOutput&ln=	(1373 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1,2,6-trimethylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C31H33ClFN7O2S	C31H33ClFN7O2S	622.166			QPWUFCARHIDPHM-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	15	1	5.281	1	8	7	83.98	2	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		38958317	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958317&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CC(C)N(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1,2,6-trimethylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	100 - 500							7						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CC(C)N(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF		38958317	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958317&database=RX&origin=ReaxysOutput&ln=	(1373 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1,2,6-trimethylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C31H33ClFN7O2S	C31H33ClFN7O2S	622.166			QPWUFCARHIDPHM-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	15	1	5.281	1	8	7	83.98	2	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38958317	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958317&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CC(C)N(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1,2,6-trimethylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	500 - 1000							6.3						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CC(C)N(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF		38958317	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958317&database=RX&origin=ReaxysOutput&ln=	(1373 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1,2,6-trimethylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C31H33ClFN7O2S	C31H33ClFN7O2S	622.166			QPWUFCARHIDPHM-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	15	1	5.281	1	8	7	83.98	2	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958317	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958317&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CC(C)N(C)C(C)C3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1,2,6-trimethylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	<	50							7.3			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C		38958320	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958320&database=RX&origin=ReaxysOutput&ln=	(1374 of 1381)		3-(2-chloro-4-methylthiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H32ClN7O3S	C30H32ClN7O3S	606.148			YVFIXEJMDQMBKH-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.176	1	8	7	83.98	3	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38958320	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958320&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C	3-(2-chloro-4-methylthiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	1000 - 1500							6						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C		38958320	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958320&database=RX&origin=ReaxysOutput&ln=	(1374 of 1381)		3-(2-chloro-4-methylthiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C30H32ClN7O3S	C30H32ClN7O3S	606.148			YVFIXEJMDQMBKH-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.176	1	8	7	83.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958320	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958320&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C	3-(2-chloro-4-methylthiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(5-methoxypyridin-2-yl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM		200 - 400							6.7			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958326	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958326&database=RX&origin=ReaxysOutput&ln=	(1375 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1-methylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C29H29ClFN7O2S	C29H29ClFN7O2S	594.112			FQUACTAYPNDNQQ-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	14	1	4.361	1	8	7	83.98	3	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38958326	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958326&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1-methylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	500 - 1000							6.3						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958326	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958326&database=RX&origin=ReaxysOutput&ln=	(1375 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1-methylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C29H29ClFN7O2S	C29H29ClFN7O2S	594.112			FQUACTAYPNDNQQ-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)	14	1	4.361	1	8	7	83.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958326	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958326&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-1-(5-methoxypyridin-2-yl)-7-(4-(1-methylpiperidin-4-yl)phenylamino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	<	50							7.3			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COCCN1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958340&database=RX&origin=ReaxysOutput&ln=	(1376 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(2-methoxyethyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C27H32ClFN6O3S	C27H32ClFN6O3S	575.107			FTUSLGYPSJSAPZ-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)		1	3.129	1	8	9	71.09	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		38958340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958340&database=RX&origin=ReaxysOutput&ln=	COCCN1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(2-methoxyethyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>	1500							5.82						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COCCN1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958340&database=RX&origin=ReaxysOutput&ln=	(1376 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(2-methoxyethyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C27H32ClFN6O3S	C27H32ClFN6O3S	575.107			FTUSLGYPSJSAPZ-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)		1	3.129	1	8	9	71.09	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		38958340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958340&database=RX&origin=ReaxysOutput&ln=	COCCN1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(2-methoxyethyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50		Not determined/not detected														Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COCCN1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958340&database=RX&origin=ReaxysOutput&ln=	(1376 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(2-methoxyethyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C27H32ClFN6O3S	C27H32ClFN6O3S	575.107			FTUSLGYPSJSAPZ-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)		1	3.129	1	8	9	71.09	3	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		38958340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958340&database=RX&origin=ReaxysOutput&ln=	COCCN1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(2-methoxyethyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>=	1000 - 1500							6						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COCCN1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF		38958340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958340&database=RX&origin=ReaxysOutput&ln=	(1376 of 1381)		3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(2-methoxyethyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C27H32ClFN6O3S	C27H32ClFN6O3S	575.107			FTUSLGYPSJSAPZ-UHFFFAOYSA-N				Identification(8); Physical Data(2); Spectra(2); Bioactivity(2)		1	3.129	1	8	9	71.09	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									38958340	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D38958340&database=RX&origin=ReaxysOutput&ln=	COCCN1C(=O)N(CC2=CN=C(NC3=CC=C(C=C3OC)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1CF	3-(2-chloro-4-(fluoromethyl)thiophen-3-yl)-7-(2-methoxy-4-(1-methylpiperidin-4-yl)phenylamino)-1-(2-methoxyethyl)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	<	50							7.3			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CC[C@H](NC1=C2N=C(O)NC2=NC=N1)C1=C(C(=O)C2=C(O1)C=CC=C2)C1=CC=CC(F)=C1		39038140	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39038140&database=RX&origin=ReaxysOutput&ln=	(1377 of 1381)		(S)-3-(3-fluorophenyl)-2-(1-((8-hydroxy-9H-purin-6-yl)amino)propyl)-4H-chromen-4-one	C23H18FN5O3	C23H18FN5O3	431.426			UTVRREZCXZYGOL-HNNXBMFYSA-N				Identification(7); Physical Data(2); Spectra(2); Bioactivity(2)	2	1	4.492	3	6	5	55.74	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									39038140	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39038140&database=RX&origin=ReaxysOutput&ln=	CC[C@H](NC1=C2N=C(O)NC2=NC=N1)C1=C(C(=O)C2=C(O1)C=CC=C2)C1=CC=CC(F)=C1	(S)-3-(3-fluorophenyl)-2-(1-((8-hydroxy-9H-purin-6-yl)amino)propyl)-4H-chromen-4-one					IC50	nM		237							6.63						Patent; ALEMBIC PHARMACEUTICALS LIMITED; WO2021/229452; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D106122066&database=RX&origin=ReaxysOutput&ln=	
C[C@@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		39059473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059473&database=RX&origin=ReaxysOutput&ln=	(1378 of 1381)			C20H23ClFN7OS2	C20H23ClFN7OS2	496.032			IDZKTMGGJKOKPE-LLVKDONJSA-N				Identification(6); Physical Data(2); Spectra(2); Bioactivity(1)	13	1	2.602	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		39059473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059473&database=RX&origin=ReaxysOutput&ln=	C[C@@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1						IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
C[C@@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		39059473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059473&database=RX&origin=ReaxysOutput&ln=	(1378 of 1381)			C20H23ClFN7OS2	C20H23ClFN7OS2	496.032			IDZKTMGGJKOKPE-LLVKDONJSA-N				Identification(6); Physical Data(2); Spectra(2); Bioactivity(1)	13	1	2.602	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		39059473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059473&database=RX&origin=ReaxysOutput&ln=	C[C@@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1						IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
C[C@@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		39059473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059473&database=RX&origin=ReaxysOutput&ln=	(1378 of 1381)			C20H23ClFN7OS2	C20H23ClFN7OS2	496.032			IDZKTMGGJKOKPE-LLVKDONJSA-N				Identification(6); Physical Data(2); Spectra(2); Bioactivity(1)	13	1	2.602	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		39059473	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059473&database=RX&origin=ReaxysOutput&ln=	C[C@@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1						IC50	nM	<	200							6.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
C[C@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		39059474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059474&database=RX&origin=ReaxysOutput&ln=	(1379 of 1381)			C20H23ClFN7OS2	C20H23ClFN7OS2	496.032			IDZKTMGGJKOKPE-NSHDSACASA-N				Identification(6); Physical Data(2); Spectra(2); Bioactivity(1)	13	1	2.602	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3 [mouse]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	821129755	q6p4s6				Serine/threonine-protein kinase SIK3 [mouse]	Serine/threonine-protein kinase SIK3 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		39059474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059474&database=RX&origin=ReaxysOutput&ln=	C[C@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1						IC50	nM	<	200							6.7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
C[C@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		39059474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059474&database=RX&origin=ReaxysOutput&ln=	(1379 of 1381)			C20H23ClFN7OS2	C20H23ClFN7OS2	496.032			IDZKTMGGJKOKPE-NSHDSACASA-N				Identification(6); Physical Data(2); Spectra(2); Bioactivity(1)	13	1	2.602	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		39059474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059474&database=RX&origin=ReaxysOutput&ln=	C[C@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1						IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
C[C@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1		39059474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059474&database=RX&origin=ReaxysOutput&ln=	(1379 of 1381)			C20H23ClFN7OS2	C20H23ClFN7OS2	496.032			IDZKTMGGJKOKPE-NSHDSACASA-N				Identification(6); Physical Data(2); Spectra(2); Bioactivity(1)	13	1	2.602	2	8	7	112.22	4	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		39059474	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39059474&database=RX&origin=ReaxysOutput&ln=	C[C@H]1CN(CCN1C)C1=CC(NC2=NC=C(S2)C(=O)NC2=C(Cl)SC=C2CF)=NC(C)=N1						IC50	nM	<	100							7						Patent; IOMX THERAPEUTICS AG; EP3901151; (2021); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104926516&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=C(OC)C=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F		39163710	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39163710&database=RX&origin=ReaxysOutput&ln=	(1380 of 1381)			C30H30ClF2N7O3S	C30H30ClF2N7O3S	642.129			BVARUJOWWRVZJT-UHFFFAOYSA-N				Identification(7); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.553	1	8	8	83.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							HCT 116 cell line		39163710	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39163710&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=C(OC)C=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F						IC50	nM	>	1500							5.82						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=C(OC)C=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F		39163710	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39163710&database=RX&origin=ReaxysOutput&ln=	(1380 of 1381)			C30H30ClF2N7O3S	C30H30ClF2N7O3S	642.129			BVARUJOWWRVZJT-UHFFFAOYSA-N				Identification(7); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.553	1	8	8	83.98	3	2	Serine/threonine-protein kinase SIK2 [human];+Serine/threonine-protein kinase SIK1 [human];+Serine/threonine-protein kinase SIK3 [human];+Proto-oncogene tyrosine-protein kinase Src [human];+Tyrosine-protein kinase ABL1 [human]	kiaa0781; qik; qin-induced kinase; salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + p60-src; pp60c-src; proto-oncogene c-src; proto-oncogene tyrosine-protein kinase src; src; src1 + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; jtk7; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	818178624 + 818251685 + 818361277 + 818398053 + 818328922	q9h0k1 + p57059 + q9y2k2 + p12931 + p00519	1a07; 1a08; 1a09; 1a1a; 1a1b; 1a1c; 1a1e; 1fmk; 1hcs; 1hct; 1ksw; 1o41; 1o42; 1o43; 1o44; 1o45; 1o46; 1o47; 1o48; 1o49; 1o4a; 1o4b; 1o4c; 1o4d; 1o4e; 1o4f; 1o4g; 1o4h; 1o4i; 1o4j; 1o4k; 1o4l; 1o4m; 1o4n; 1o4o; 1o4p; 1o4q; 1o4r; 1shd; 1y57; 1yi6; 1yoj; 1yol; 1yom; 2bdf; 2bdj; 2h8h; 2src; 3vro; 3zmp; 3zmq; 4f59; 4f5a; 4f5b; 4hxj; 4k11; 4mxo; 4mxx; 4mxy; 4mxz; 6ate; 6c4s; 6e6e; 6ehj + 1ab2; 1abl; 1awo; 1bbz; 1ju5; 1opl; 1zzp; 2abl; 2e2b; 2f4j; 2fo0; 2g1t; 2g2f; 2g2h; 2g2i; 2gqg; 2hiw; 2hyy; 2hz0; 2hz4; 2hzi; 2o88; 2v7a; 3cs9; 3eg0; 3eg1; 3eg2; 3eg3; 3egu; 3k2m; 3pyy; 3qri; 3qrj; 3qrk; 3t04; 3ue4; 3uyo; 4j9b; 4j9c; 4j9d; 4j9e; 4j9f; 4j9g; 4j9h; 4j9i; 4jjb; 4jjc; 4jjd; 4twp; 4wa9; 4xey; 4yc8; 4zog; 5dc0; 5dc4; 5dc9; 5hu9; 5mo4; 5np2; 5oaz; 6amv; 6amw; 6bl8; 6npe; 6npu; 6npv			Proto-oncogene tyrosine-protein kinase Src [human]; Serine/threonine-protein kinase SIK1 [human]; Serine/threonine-protein kinase SIK2 [human]; Serine/threonine-protein kinase SIK3 [human]; Tyrosine-protein kinase ABL1 [human]	Serine/threonine-protein kinase SIK2 [human]:Wild + Serine/threonine-protein kinase SIK1 [human]:Wild + Serine/threonine-protein kinase SIK3 [human]:Wild + Proto-oncogene tyrosine-protein kinase Src [human]:Wild + Tyrosine-protein kinase ABL1 [human]:Wild	human	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							PANC-1 cell line		39163710	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39163710&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=C(OC)C=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F						IC50	nM	>	1500							5.82						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=C(OC)C=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F		39163710	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39163710&database=RX&origin=ReaxysOutput&ln=	(1380 of 1381)			C30H30ClF2N7O3S	C30H30ClF2N7O3S	642.129			BVARUJOWWRVZJT-UHFFFAOYSA-N				Identification(7); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.553	1	8	8	83.98	3	2	Serine/threonine-protein kinase SIK2 [mouse];+Serine/threonine-protein kinase SIK1 [mouse];+Serine/threonine-protein kinase SIK3 [mouse];+Proto-oncogene tyrosine-protein kinase Src [mouse];+Tyrosine-protein kinase ABL1 [mouse]	salt-inducible kinase 2; serine/threonine-protein kinase sik2; serine/threonine-protein kinase snf1-like kinase 2; sik-2; sik2; snf1lk2 + hrt-20; msk; myocardial snf1-like kinase; salt-inducible kinase 1; serine/threonine-protein kinase sik1; serine/threonine-protein kinase snf1-like kinase 1; serine/threonine-protein kinase snf1lk; sik; sik-1; sik1; snf1lk + kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3 + proto-oncogene tyrosine-protein kinase src + abelson murine leukemia viral oncogene homolog 1; abelson tyrosine-protein kinase 1; abl; abl1; p150; proto-oncogene c-abl; tyrosine-protein kinase abl1	821133720 + 821127009 + 821129755 + 824655532 + 821107256	q8cfh6 + q60670 + q6p4s6 + p00520	1abo; 1abq; 1fpu; 1iep; 1m52; 1opj; 1opk; 2hzn; 2qoh; 2z60; 3dk3; 3dk6; 3dk7; 3ik3; 3k5v; 3kf4; 3kfa; 3ms9; 3mss; 3oxz; 3oy3; 5ih2; 6hd4; 6hd6			Proto-oncogene tyrosine-protein kinase Src [mouse]; Serine/threonine-protein kinase SIK1 [mouse]; Serine/threonine-protein kinase SIK2 [mouse]; Serine/threonine-protein kinase SIK3 [mouse]; Tyrosine-protein kinase ABL1 [mouse]	Serine/threonine-protein kinase SIK2 [mouse]:Wild + Serine/threonine-protein kinase SIK1 [mouse]:Wild + Serine/threonine-protein kinase SIK3 [mouse]:Wild + Proto-oncogene tyrosine-protein kinase Src [mouse]:Wild + Tyrosine-protein kinase ABL1 [mouse]:Wild	mouse	Non Transfected	Inhibitor	antineoplastic agent	Toxicity/Safety Pharmacology							MC-38 cell line		39163710	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39163710&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=C(OC)C=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F						IC50	nM	>=	1000 - 1500							6						Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=C(OC)C=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F		39163710	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39163710&database=RX&origin=ReaxysOutput&ln=	(1380 of 1381)			C30H30ClF2N7O3S	C30H30ClF2N7O3S	642.129			BVARUJOWWRVZJT-UHFFFAOYSA-N				Identification(7); Physical Data(2); Spectra(2); Bioactivity(2)	9	1	4.553	1	8	8	83.98	3	2	Serine/threonine-protein kinase SIK3	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	820102200					Serine/threonine-protein kinase SIK3	Serine/threonine-protein kinase SIK3:Wild			Inhibitor	protein serine threonine kinase inhibitor	In Vitro (Efficacy)									39163710	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D39163710&database=RX&origin=ReaxysOutput&ln=	COC1=CN=C(C=C1)N1C(=O)N(CC2=CN=C(NC3=C(OC)C=C(C=C3)C3CCN(C)CC3)N=C12)C1=C(Cl)SC=C1C(F)F						IC50	nM		100 - 200							7			14205888; 37051685	γ33P-ATP; RBER-CHKtide	Substrate; Substrate	Patent; IOMX THERAPEUTICS AG; WO2021/219731; (2021); A2;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D104953434&database=RX&origin=ReaxysOutput&ln=	
CN1CCN(CC1)C1=CC=C(NC2=NC=C3CN(C(=O)N(C3=N2)C23CC4CC(CC(C4)C2)C3)C2=C(C)C=CC=C2C)C=C1		40120938	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D40120938&database=RX&origin=ReaxysOutput&ln=	(1381 of 1381)		1-(adamantan-1-yl)-3-(2,6-dimethylphenyl)-7-((4-(4-methylpiperazin-1-yl)phenyl)amino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one	C35H43N7O	C35H43N7O	577.773			RMZNAIQSDYKGDA-UHFFFAOYSA-N				Identification(7); Physical Data(3); Spectra(2); Bioactivity(2)	5	1	6.131	1	8	5	42.85	2	2	Serine/threonine-protein kinase SIK3 [human]	kiaa0999; qsk; salt-inducible kinase 3; serine/threonine-protein kinase qsk; serine/threonine-protein kinase sik3; sik-3; sik3	818361277	q9y2k2				Serine/threonine-protein kinase SIK3 [human]	Serine/threonine-protein kinase SIK3 [human]:Wild	human		Inhibitor		In Vitro (Efficacy)									40120938	https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN%3D40120938&database=RX&origin=ReaxysOutput&ln=	CN1CCN(CC1)C1=CC=C(NC2=NC=C3CN(C(=O)N(C3=N2)C23CC4CC(CC(C4)C2)C3)C2=C(C)C=CC=C2C)C=C1	1-(adamantan-1-yl)-3-(2,6-dimethylphenyl)-7-((4-(4-methylpiperazin-1-yl)phenyl)amino)-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one					IC50	nM	>	20							7.7			3692530; 73010	Magnesium acetate; ATP	Substrate; Substrate	Patent; SOLTEGO; WO2022/61312; (2022); A1;	https://www.reaxys.com/reaxys/secured/hopinto.do?context=C&query=CNR.CNR%3D116211702&database=RX&origin=ReaxysOutput&ln=	
